Clustering O 0 1.3013986972509883e-06
of O 0 5.651353873759035e-08
missense O 0 4.624045232048957e-06
mutations O 0 1.1782206854604738e-07
in O 0 8.136172291450805e-10
the O 0 2.6473626846268417e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 3.893716893799137e-06
in O 0 3.998949793526663e-08
a O 0 4.2099390640260026e-08
sporadic B-Disease 0 2.317576036148239e-05
T I-Disease 1 0.7931061387062073
- I-Disease 0 0.0008670699899084866
cell I-Disease 0 0.0003741283726412803
leukaemia I-Disease 1 0.9999384880065918
. O 0 1.3497682402885403e-06

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.8590589165687561
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.0828414553909482e-10
is O 0 5.4627266252160744e-12
a O 0 1.5022349683646574e-11
recessive B-Disease 0 1.6490203336161358e-07
multi I-Disease 1 0.8789554834365845
- I-Disease 1 0.9973226189613342
system I-Disease 0 0.23098595440387726
disorder I-Disease 1 1.0
caused O 0 3.293237114121439e-06
by O 0 4.202642123196654e-10
mutations O 0 6.2982881132711555e-09
in O 0 2.2254939557875275e-10
the O 0 5.30652077834759e-10
ATM O 0 2.319999623523472e-07
gene O 0 1.995624998585299e-09
at O 0 1.0993536747605503e-08
11q22 O 0 1.4283690461525111e-06
- O 0 3.0058805577937164e-07
q23 O 0 3.360855998835177e-06
( O 0 1.2491946366210982e-09
ref O 0 3.111535988864489e-07
. O 0 5.796333413243815e-10
3 O 0 1.155863404989077e-08
) O 0 3.3613284378120056e-10
. O 0 6.9893304477375295e-09

The O 0 9.546072732291577e-08
risk O 0 7.29099565432989e-06
of O 0 1.0642189636200783e-06
cancer B-Disease 1 0.9999997615814209
, O 0 1.9301831244433743e-09
especially O 0 2.739202420443121e-09
lymphoid B-Disease 0 0.0008298555621877313
neoplasias I-Disease 1 0.9999973773956299
, O 0 2.477750782325927e-10
is O 0 7.044889845098101e-12
substantially O 0 7.490247866392963e-10
elevated O 0 3.8999715457066486e-08
in O 0 4.840887246615466e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.712458015390439e-07
and O 0 1.1732310435663695e-11
has O 0 5.495279578604517e-12
long O 0 6.633378742126883e-12
been O 0 5.894877468104465e-12
associated O 0 4.878012577202995e-11
with O 0 1.5155894594887087e-10
chromosomal O 1 1.0
instability O 1 1.0
. O 0 1.3695793313672766e-05

By O 0 3.854607300013413e-09
analysing O 0 1.0943477946057101e-07
tumour B-Disease 1 1.0
DNA O 0 1.23572235111169e-07
from O 0 1.0934017025121534e-09
patients O 0 2.231904244753835e-10
with O 0 6.730568793272829e-12
sporadic B-Disease 0 1.4396403003047453e-07
T I-Disease 0 4.176964921498438e-06
- I-Disease 0 6.064544209039013e-07
cell I-Disease 0 9.11462393560214e-07
prolymphocytic I-Disease 0 8.332209290529136e-06
leukaemia I-Disease 1 0.5524791479110718
( O 0 1.3370600182582848e-09
T B-Disease 0 2.74128467481205e-07
- I-Disease 0 1.4365818401529395e-07
PLL I-Disease 0 6.561238592439622e-07
) O 0 8.68870322912052e-11
, O 0 1.6423657572817163e-11
a O 0 7.250301053973729e-11
rare O 0 4.3371900515509765e-10
clonal B-Disease 0 3.996815394202713e-07
malignancy I-Disease 0 1.049967158905929e-05
with O 0 1.8535128293306613e-11
similarities O 0 2.842608648467859e-10
to O 0 1.0220668755778206e-09
a O 0 4.041766921147882e-09
mature B-Disease 0 1.937718963063162e-07
T I-Disease 0 5.967459628664074e-07
- I-Disease 0 2.007562613925984e-07
cell I-Disease 0 2.2561624746231246e-07
leukaemia I-Disease 0 0.06422320753335953
seen O 0 5.757299081921019e-09
in O 0 1.3389690467491278e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 1.6244968703560403e-09
we O 0 1.451557901654965e-10
demonstrate O 0 2.288796062399623e-11
a O 0 1.1618072823238457e-11
high O 0 4.792905655692792e-11
frequency O 0 4.1447609233635774e-10
of O 0 3.008618909561278e-10
ATM O 0 1.3465115671351668e-06
mutations O 0 6.009286153130233e-07
in O 0 5.83942849630148e-08
T B-Disease 0 0.00011834681208711118
- I-Disease 0 1.7210093574249186e-05
PLL I-Disease 0 4.555928899208084e-05
. O 0 2.277024009345041e-07

In O 0 3.7814242404010656e-08
marked O 0 1.0476229661549041e-08
contrast O 0 1.3737683213221885e-09
to O 0 9.601869299658006e-10
the O 0 1.8632471954216356e-10
ATM O 0 1.3278622645884752e-07
mutation O 0 4.061488034778904e-09
pattern O 0 2.110600938465268e-08
in O 0 3.0841238451984054e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 3.5189231528676146e-09
the O 0 1.4631380829133178e-10
most O 0 1.8218200385777816e-12
frequent O 0 3.375330180285796e-12
nucleotide O 0 9.389102689771889e-11
changes O 0 1.0779118049530911e-11
in O 0 1.3766547797555706e-11
this O 0 1.281366818206564e-10
leukaemia B-Disease 0 4.372021976450924e-06
were O 0 8.889517566501581e-09
missense O 0 3.0078845156822354e-06
mutations O 0 1.3893218238081317e-06
. O 0 8.589225330979389e-08

These O 0 6.0328724238445375e-09
clustered O 0 1.9525119299146354e-08
in O 0 1.206972022327335e-10
the O 0 1.951132450050963e-10
region O 0 2.916455299484255e-09
corresponding O 0 2.8641837790388536e-09
to O 0 3.478676235957323e-09
the O 0 6.765958904253466e-10
kinase O 0 8.437019261009482e-08
domain O 0 5.085057637188584e-07
, O 0 5.853816043011051e-11
which O 0 1.059343932019452e-11
is O 0 1.1684118950139322e-11
highly O 0 2.4791628819298417e-11
conserved O 0 1.0189209198596672e-10
in O 0 1.9797039008118134e-11
ATM O 0 3.530347498781339e-07
- O 0 2.472673266140646e-08
related O 0 5.647385670215499e-09
proteins O 0 7.094110021643729e-11
in O 0 4.9437474947122695e-11
mouse O 0 5.180837425733387e-10
, O 0 6.473654251548666e-11
yeast O 0 1.6106511679936375e-08
and O 0 4.0890668628890126e-09
Drosophila O 0 1.2807478810827888e-07
. O 0 8.618547653327369e-09

The O 0 1.9803835016318772e-07
resulting O 0 1.9753096580643614e-07
amino O 0 2.858245977677143e-07
- O 0 1.4955245930536876e-08
acid O 0 1.64402944591302e-08
substitutions O 0 8.842417908994094e-10
are O 0 3.613282589798317e-11
predicted O 0 3.7450618606271746e-08
to O 0 3.820024740974759e-09
interfere O 0 1.477971434127312e-08
with O 0 6.237597938163475e-11
ATP O 0 1.6433542668892187e-06
binding O 0 6.538900976238438e-08
or O 0 2.5905373401968745e-09
substrate O 0 1.1355513152011554e-07
recognition O 0 6.3293099650252316e-09
. O 0 8.982354415820737e-09

Two O 0 7.814674063411076e-08
of O 0 1.7090074777570408e-07
seventeen O 0 7.951038583087211e-07
mutated O 0 2.0320466376233526e-07
T B-Disease 0 7.085681090757134e-07
- I-Disease 0 9.584312010701979e-08
PLL I-Disease 0 3.2872205224521167e-07
samples O 0 2.075179889038381e-10
had O 0 1.0438441777615992e-10
a O 0 2.404743938699827e-11
previously O 0 3.129471126683825e-10
reported O 0 7.303605720210271e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999942779541016
T I-Disease 1 1.0
allele O 0 1.2620406778296456e-05
. O 0 1.5944426934311196e-07

In O 0 3.5835213907375874e-08
contrast O 0 9.9530534924952e-09
, O 0 1.6231868071869826e-09
no O 0 3.3956630840492608e-09
mutations O 0 8.400885320725138e-09
were O 0 1.586841213985224e-09
detected O 0 5.603971953149767e-09
in O 0 1.4397893988160604e-10
the O 0 9.110446841376074e-10
p53 O 0 1.4847327811651212e-08
gene O 0 3.232361933669381e-09
, O 0 1.5269164405085078e-11
suggesting O 0 7.303779803180532e-11
that O 0 8.766337482313258e-12
this O 0 4.552172527816367e-10
tumour B-Disease 1 1.0
suppressor O 0 0.004660547710955143
is O 0 2.6963631327703297e-10
not O 0 2.8685219130575312e-11
frequently O 0 7.111419959848764e-12
altered O 0 7.325949569203516e-11
in O 0 2.7287649570495454e-11
this O 0 6.224669668597471e-10
leukaemia B-Disease 0 0.00031021572067402303
. O 0 8.397540085525179e-08

Occasional O 0 2.252238118671812e-06
missense O 0 9.017373486130964e-06
mutations O 0 1.1064559402029772e-07
in O 0 5.791150892164865e-10
ATM O 0 7.726575859123841e-06
were O 0 9.871548911632999e-09
also O 0 2.5044711096655625e-11
found O 0 1.247022277106602e-11
in O 0 1.3996334473354022e-11
tumour B-Disease 1 1.0
DNA O 0 6.811127661876526e-08
from O 0 9.836172987220948e-10
patients O 0 2.5503724132569516e-11
with O 0 7.714100083537623e-13
B B-Disease 0 1.8303015281162516e-07
- I-Disease 0 3.734733056148798e-08
cell I-Disease 0 1.8393637901681359e-06
non I-Disease 0 0.00040813744999468327
- I-Disease 0 0.0001395942672388628
Hodgkins I-Disease 1 0.9998995065689087
lymphomas I-Disease 0 1.8605237528390717e-06
( O 0 3.101635615010423e-11
B B-Disease 0 6.490849102647189e-08
- I-Disease 0 3.868948272867101e-09
NHL I-Disease 0 8.890653546700378e-09
) O 0 5.235278356663375e-12
and O 0 8.173103686892613e-12
a O 0 7.083594266710236e-10
B B-Disease 0 5.409211212281662e-07
- I-Disease 0 4.1609947487586396e-08
NHL I-Disease 0 5.200301984586986e-07
cell O 0 3.320030259601481e-07
line O 0 2.780796819479292e-07
. O 0 5.9586223954966044e-08

The O 0 2.497356765829295e-09
evidence O 0 1.044009989570327e-09
of O 0 1.4189498187544558e-10
a O 0 1.6908937791604295e-11
significant O 0 9.162844788468405e-11
proportion O 0 5.71715730313116e-10
of O 0 3.826666206130369e-10
loss O 0 7.241597876905814e-10
- O 0 3.758957589639067e-09
of O 0 1.884701994470106e-08
- O 0 3.76620601372224e-09
function O 0 4.377698203938962e-10
mutations O 0 1.0407746886542668e-10
and O 0 1.3858406609779106e-12
a O 0 1.994728514309596e-11
complete O 0 2.621078909470498e-09
absence O 0 2.4550271149337277e-08
of O 0 3.3934746124231197e-09
the O 0 2.202681370633286e-10
normal O 0 1.16519002779647e-10
copy O 0 7.318379929843744e-11
of O 0 4.5182638186425095e-10
ATM O 0 6.362149065353151e-07
in O 0 2.6336607894528186e-10
the O 0 5.202037134388604e-10
majority O 0 7.692319003993475e-11
of O 0 1.939039151466204e-09
mutated O 0 1.1851694381448397e-07
tumours B-Disease 1 0.9999957084655762
establishes O 0 1.8801456391770444e-08
somatic O 0 5.501814115405068e-08
inactivation O 0 2.7795081791737175e-07
of O 0 1.055275311578896e-09
this O 0 3.15489891156151e-11
gene O 0 2.3671547361159284e-11
in O 0 6.014067282372748e-12
the O 0 6.082897380244034e-11
pathogenesis O 0 8.247944549566455e-08
of O 0 3.023775008159646e-08
sporadic B-Disease 0 0.00033943928428925574
T I-Disease 1 0.9997242093086243
- I-Disease 0 0.32834184169769287
PLL I-Disease 0 8.262076153187081e-05
and O 0 3.705551976374011e-10
suggests O 0 1.241971803178643e-10
that O 0 4.954071874951893e-12
ATM O 0 6.604329882975435e-08
acts O 0 4.93432228410029e-09
as O 0 6.847607481041962e-10
a O 0 3.1191174088007756e-08
tumour B-Disease 1 1.0
suppressor O 0 0.0003753756172955036
. O 0 3.524037026636506e-07

As O 0 8.973331411255003e-09
constitutional O 0 8.778334148473732e-08
DNA O 0 1.0970161667955836e-08
was O 0 6.997009638354257e-10
not O 0 8.982649693511924e-12
available O 0 1.2454772456427232e-11
, O 0 1.3641633829497568e-11
a O 0 1.5575327694250518e-09
putative O 0 1.3567976566264406e-05
hereditary O 1 0.9999998807907104
predisposition O 1 1.0
to O 1 0.8306444883346558
T B-Disease 1 0.8280491232872009
- I-Disease 0 4.825136329600355e-06
PLL I-Disease 0 1.2302668892516522e-06
will O 0 4.4873629811981175e-10
require O 0 1.1929718324310556e-10
further O 0 1.0184570964355544e-09
investigation O 0 3.4894616085523467e-09
. O 0 4.926618557554718e-10
. O 0 2.8797297879634698e-09

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 1.2721487109956797e-05
kinase O 0 7.664663144169026e-07
is O 0 6.382814415895055e-11
involved O 0 1.700931062664779e-11
in O 0 1.4544276156699953e-12
the O 0 7.355404479936212e-12
modulation O 0 3.207389631665336e-10
of O 0 5.610193420935161e-10
the O 0 2.9958205360891554e-10
Ca2 O 0 6.5205902899379e-09
+ O 0 8.730212641694379e-08
homeostasis O 0 7.594348971906584e-08
in O 0 3.6811376169509913e-09
skeletal O 0 1.6076976407930488e-06
muscle O 0 7.081465582814417e-07
cells O 0 9.325823953076906e-07
. O 0 1.3466896575664578e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.77744925369916e-06
DM B-Disease 1 1.0
) O 0 2.2934654175799096e-09
, O 0 2.1516385895203882e-11
the O 0 1.4416325772037553e-11
most O 0 1.2381393653393413e-11
prevalent O 0 3.2994128673635714e-07
muscular B-Disease 1 0.999549925327301
disorder I-Disease 1 0.9999908208847046
in O 0 8.40854763595189e-09
adults O 0 4.8635921956474704e-08
, O 0 4.262183314618362e-11
is O 0 7.214655262099967e-11
caused O 0 1.343871858239254e-08
by O 0 9.345442197883358e-10
( O 0 5.284000348382278e-09
CTG O 0 1.161027967100381e-06
) O 0 1.2723315456764084e-10
n O 0 3.0849534038424054e-09
- O 0 2.452751113324325e-09
repeat O 0 1.6208849817900273e-09
expansion O 0 6.800879304158514e-10
in O 0 2.32828738927493e-11
a O 0 4.408783407794381e-11
gene O 0 1.2238244272155807e-11
encoding O 0 5.5282712435600345e-11
a O 0 4.2600886707155894e-10
protein O 0 4.650590135213406e-09
kinase O 0 1.7015931064179313e-07
( O 0 3.688587657535436e-09
DM B-Disease 1 0.9999998807907104
protein O 0 8.214237823267467e-08
kinase O 0 3.077772703363735e-08
; O 0 8.462471001724481e-11
DMPK O 0 2.4316479994013207e-06
) O 0 9.707374661049872e-12
and O 0 2.2497761032608254e-12
involves O 0 1.177111012828913e-11
changes O 0 4.5886610483547585e-11
in O 0 9.842247850055941e-11
cytoarchitecture O 0 1.2594520626407757e-07
and O 0 2.2371433594514656e-09
ion O 0 4.402674221637426e-06
homeostasis O 0 3.386698381291353e-06
. O 0 2.233452818245496e-07

To O 0 6.608979674638249e-08
obtain O 0 5.897183541492268e-08
clues O 0 3.588740327131745e-08
to O 0 4.971948963650163e-10
the O 0 2.926310860296155e-10
normal O 0 3.474651233403847e-09
biological O 0 8.218386859937254e-09
role O 0 6.949792408228461e-10
of O 0 2.6526381091684925e-09
DMPK O 0 0.0013980123912915587
in O 0 1.761614143447332e-08
cellular O 0 3.63748995368951e-08
ion O 0 1.607797821634449e-05
homeostasis O 0 5.915646397625096e-06
, O 0 2.1446020515014652e-09
we O 0 5.516508916336704e-10
have O 0 7.615744840316907e-12
compared O 0 9.415573182236514e-11
the O 0 1.0711612846714402e-10
resting O 0 5.072352537993652e-10
[ O 0 6.627513815526953e-11
Ca2 O 0 1.8835284720797318e-10
+ O 0 2.6839679367895997e-09
] O 0 5.039721084898474e-09
i O 0 1.1106562336493653e-09
, O 0 6.279757529953356e-12
the O 0 3.86031831500766e-12
amplitude O 0 6.617131148578537e-11
and O 0 2.0353469343953323e-12
shape O 0 5.18966924989428e-10
of O 0 5.947375369963481e-10
depolarization O 0 6.323409351693954e-09
- O 0 1.6282822201674207e-08
induced O 0 1.9713424137535185e-07
Ca2 O 0 4.698665900804144e-09
+ O 0 6.63077059925854e-09
transients O 0 2.956728017977639e-08
, O 0 7.579544630820223e-12
and O 0 1.6304419836812856e-12
the O 0 1.783771221008923e-11
content O 0 1.220223921905017e-10
of O 0 3.1100369501935177e-10
ATP O 0 1.0328343336141188e-07
- O 0 1.034825469758971e-08
driven O 0 4.220493732276509e-09
ion O 0 4.44464873794459e-08
pumps O 0 1.4745635823487646e-09
in O 0 6.934375990086394e-11
cultured O 0 4.259058883349098e-09
skeletal O 0 2.277568356134907e-08
muscle O 0 3.7944416497737166e-09
cells O 0 5.763187704843631e-09
of O 0 1.6181759265876394e-09
wild O 0 2.520209041456667e-10
- O 0 7.076136898653829e-11
type O 0 4.3821510309349776e-10
and O 0 1.1112998715701039e-10
DMPK O 0 2.3169308406068012e-05
[ O 0 3.937493033845385e-07
- O 0 1.0476995157659985e-05
/ O 0 0.00024420206318609416
- O 0 0.00015075401461217552
] O 0 6.609624961129157e-06
knockout O 0 0.0006049817311577499
mice O 0 4.570708824758185e-07
. O 0 2.693806067100013e-08

In O 0 2.247495274332323e-07
vitro O 0 6.71555881126551e-07
- O 0 1.186024221055959e-07
differentiated O 0 8.300196441268781e-08
DMPK O 0 8.043371781241149e-05
[ O 0 4.6622449190181214e-07
- O 0 6.338696493912721e-06
/ O 0 6.282146932790056e-05
- O 0 1.0533480235608295e-05
] O 0 3.012073079844413e-07
myotubes O 0 9.743395139594213e-07
exhibit O 0 4.734485581359138e-10
a O 0 3.1159508306899397e-10
higher O 0 7.069924201630329e-09
resting O 0 5.456060492292636e-09
[ O 0 5.421265103500161e-10
Ca2 O 0 2.173995428123021e-09
+ O 0 2.766549123123241e-08
] O 0 4.835620970311538e-08
i O 0 1.291011653137275e-08
than O 0 1.5398861075155423e-09
do O 0 1.020084239300445e-09
wild O 0 2.767485685062354e-10
- O 0 1.5905009254080227e-10
type O 0 3.4236797841202815e-09
myotubes O 0 2.786299319268437e-06
because O 0 1.0696673546917168e-09
of O 0 1.9791160377202743e-10
an O 0 6.561526495751924e-12
altered O 0 2.4619459249031195e-10
open O 0 1.9456261046713053e-09
probability O 0 6.0164402349016655e-09
of O 0 1.0552612117464832e-09
voltage O 0 1.7885113265947439e-06
- O 0 9.048596183447444e-08
dependent O 0 1.2439882013381975e-08
l O 0 1.1822258449978307e-10
- O 0 1.1511934461250206e-10
type O 0 1.8736105722449992e-10
Ca2 O 0 2.576630020456605e-10
+ O 0 4.2876738270969383e-10
and O 0 8.749703739319159e-11
Na O 0 2.9047524385816814e-09
+ O 0 6.813707376096545e-10
channels O 0 7.724760386906837e-09
. O 0 4.5458583564084165e-09

The O 0 1.2099902733098133e-06
mutant O 0 1.8551338598626899e-06
myotubes O 0 1.286746464757016e-05
exhibit O 0 7.158026171794063e-09
smaller O 0 1.6280081727160223e-09
and O 0 2.824622202801663e-10
slower O 0 2.234372509235527e-08
Ca2 O 0 7.197481721732402e-09
+ O 0 2.2709996105874097e-09
responses O 0 6.391683710083029e-11
upon O 0 1.0093422625478965e-10
triggering O 0 2.7722193984835997e-10
by O 0 9.490030289383e-12
acetylcholine O 0 1.0420807328159754e-08
or O 0 2.288348843748622e-09
high O 0 1.1019358758801445e-08
external O 0 7.68897123748502e-08
K O 0 4.252356688994041e-07
+ O 0 3.353301636366268e-08
. O 0 6.341091207673344e-09

In O 0 4.4506208496386535e-08
addition O 0 2.1372434932942497e-09
, O 0 8.706274590153384e-10
we O 0 1.2989668229934637e-09
observed O 0 3.428971551144855e-10
that O 0 1.5450295123148328e-12
these O 0 3.548222046040328e-12
Ca2 O 0 2.4820610011744293e-09
+ O 0 2.415145239353933e-08
transients O 0 9.630250730197076e-08
partially O 0 2.90915491696353e-09
result O 0 1.5260495644930927e-10
from O 0 3.413302626653625e-11
an O 0 5.506233056312704e-12
influx O 0 1.4533247001680127e-11
of O 0 5.766876559620826e-11
extracellular O 0 5.354243715061102e-10
Ca2 O 0 6.054691192858286e-10
+ O 0 2.880722882458997e-10
through O 0 1.7459832191146774e-11
the O 0 4.611033430079736e-11
l O 0 7.428397480468973e-11
- O 0 1.2090527190533606e-10
type O 0 4.4307205127047666e-10
Ca2 O 0 2.33447061681602e-09
+ O 0 3.9041894162039625e-09
channel O 0 2.7787017131686298e-08
. O 0 2.743657301351732e-09

Neither O 0 1.8832866999218822e-07
the O 0 9.98594429368893e-10
content O 0 6.048319622919962e-10
nor O 0 3.456512853716731e-09
the O 0 1.2060814846837076e-10
activity O 0 8.524976280455121e-10
of O 0 1.389338866175649e-09
Na O 0 1.2679527650050204e-08
+ O 0 1.3088483186152189e-08
/ O 0 1.1681400025054245e-07
K O 0 1.5023653077150811e-07
+ O 0 3.4026002015963286e-09
ATPase O 0 4.2014418610847315e-09
and O 0 9.581484217147107e-11
sarcoplasmic O 0 9.87957271547657e-09
reticulum O 0 4.6334842629391915e-09
Ca2 O 0 1.0560082808197535e-09
+ O 0 1.366790014500907e-09
- O 0 3.341996401839964e-10
ATPase O 0 6.985035327922162e-10
are O 0 2.134486381047407e-12
affected O 0 2.796727779919017e-11
by O 0 4.4274153787604575e-11
DMPK O 0 0.0007460485212504864
absence O 0 2.929734364442993e-06
. O 0 1.456727289905757e-07

In O 0 8.750451030437034e-08
conclusion O 0 1.2413308922987198e-06
, O 0 2.276125510292104e-09
our O 0 2.3712001806508454e-10
data O 0 3.205100768122193e-11
suggest O 0 1.1298923602298672e-10
that O 0 1.5829100183384348e-11
DMPK O 0 0.0015631834976375103
is O 0 2.4916743668335073e-10
involved O 0 1.2529259574289853e-10
in O 0 7.824263806299747e-12
modulating O 0 3.542626469954513e-10
the O 0 8.145111668467209e-11
initial O 0 1.3018532085684598e-10
events O 0 5.557681051482355e-12
of O 0 3.752127428202634e-11
excitation O 0 1.0414135687142334e-07
- O 0 3.223197211355e-07
contraction O 0 3.371142298647101e-08
coupling O 0 1.7181096545471064e-09
in O 0 5.266008185067506e-10
skeletal O 0 4.512325801897532e-08
muscle O 0 1.4657455693622978e-08
. O 0 6.610830105557852e-09
. O 0 2.5301140738065442e-08

Constitutional O 0 6.354442302836105e-05
RB1 O 0 0.0004314070974942297
- O 0 4.404752871778328e-06
gene O 0 3.598073616828401e-09
mutations O 0 1.1296005020255961e-08
in O 0 1.064939872397197e-10
patients O 0 2.1452471743454993e-10
with O 0 2.1071104930325824e-11
isolated O 0 1.6627161585347494e-06
unilateral B-Disease 1 0.9998100399971008
retinoblastoma I-Disease 1 1.0
. O 0 3.349026883370243e-05

In O 0 1.3774230467333837e-07
most O 0 1.1693495061138037e-09
patients O 0 3.2739888577992815e-10
with O 0 4.07237308111541e-12
isolated O 0 5.2787751059213406e-08
unilateral B-Disease 1 0.9690002202987671
retinoblastoma I-Disease 1 1.0
, O 0 1.650478793635557e-07
tumor B-Disease 1 0.9999105930328369
development O 0 1.6679095438121294e-07
is O 0 1.251760362031007e-10
initiated O 0 1.567788787681934e-09
by O 0 4.48233047900537e-11
somatic O 0 1.993643650166632e-08
inactivation O 0 2.2491119011647243e-07
of O 0 9.413206880637404e-10
both O 0 3.799840650464681e-11
alleles O 0 4.051675384086906e-10
of O 0 9.806293554959211e-10
the O 0 1.821992889894375e-09
RB1 O 0 3.3643095775914844e-06
gene O 0 3.9888945480015536e-08
. O 0 1.951216255235977e-08

However O 0 1.3594203096545243e-07
, O 0 7.039013816267925e-10
some O 0 3.462104561369195e-11
of O 0 3.5023955957669273e-10
these O 0 1.960767832820398e-11
patients O 0 1.313796710311621e-10
can O 0 1.406248867352744e-10
transmit O 0 4.913597706490691e-08
retinoblastoma B-Disease 0 0.000215205320273526
predisposition O 0 0.11242645233869553
to O 0 6.328195354399213e-07
their O 0 1.5027186606175746e-08
offspring O 0 9.33116481860452e-08
. O 0 1.8616896468870436e-08

To O 0 6.616330594511055e-09
determine O 0 2.5480653143006293e-09
the O 0 4.217029156428076e-11
frequency O 0 1.4242759194260657e-09
and O 0 6.954983464146913e-12
nature O 0 4.731468342122902e-11
of O 0 1.5715093115709067e-10
constitutional O 0 6.797046836481968e-08
RB1 O 0 8.933449180403841e-07
- O 0 1.266318960801982e-08
gene O 0 1.7747990577188233e-10
mutations O 0 4.963156552406645e-10
in O 0 7.700433173052357e-12
patients O 0 1.894444497108072e-11
with O 0 2.850076077920427e-12
isolated O 0 2.032058290524219e-07
unilateral B-Disease 1 0.9999803304672241
retinoblastoma I-Disease 1 1.0
, O 0 1.4921281987767543e-08
we O 0 8.76984096453981e-10
analyzed O 0 8.749336671831642e-11
DNA O 0 2.5486812660346914e-10
from O 0 8.71352556081062e-12
peripheral O 0 1.949252315114336e-08
blood O 0 8.043104848809435e-09
and O 0 2.365287410377448e-10
from O 0 3.3520211051296656e-09
tumor B-Disease 0 9.060233423952013e-06
tissue O 0 1.280537048842234e-06
. O 0 1.0747175593905922e-07

The O 0 2.602365078985258e-08
analysis O 0 9.547270529708385e-09
of O 0 2.3783465508131485e-07
tumors B-Disease 1 1.0
from O 0 1.6138807268362143e-07
54 O 0 7.962469084077384e-08
( O 0 8.232890758019806e-11
71 O 0 4.654053142871817e-08
% O 0 2.2774890862109487e-09
) O 0 9.122052939403158e-12
of O 0 5.344224507375372e-10
76 O 0 3.7781223483079884e-08
informative O 0 2.256225428709513e-09
patients O 0 6.257679929788651e-10
showed O 0 1.253903786357924e-10
loss O 0 1.5935442965187008e-09
of O 0 6.745898950555329e-09
constitutional O 0 6.550149919348769e-06
heterozygosity O 0 0.0010232174536213279
( O 0 1.7736410029556282e-07
LOH O 1 0.9999231100082397
) O 0 4.896546501598209e-10
at O 0 9.678326584605657e-09
intragenic O 0 5.599545715995191e-07
loci O 0 5.983529831610213e-07
. O 0 3.6589355545402213e-08

Three O 0 4.0770835596504185e-08
of O 0 4.454170721146511e-08
13 O 0 2.0883531703930203e-07
uninformative O 0 0.0004686192551162094
patients O 0 4.5108201618404564e-08
had O 0 2.6017396237421053e-08
constitutional O 0 3.046170832021744e-06
deletions O 0 5.894253263249993e-06
. O 0 4.2746705730678514e-07

For O 0 8.108526117212023e-08
39 O 0 2.3837780815938459e-07
randomly O 0 1.1995396675956727e-08
selected O 0 4.255577579215242e-08
tumors B-Disease 1 1.0
, O 0 7.758652742495542e-08
SSCP O 1 0.9999878406524658
, O 0 2.5313406126770133e-07
hetero O 0 1.8312092606720398e-06
- O 0 2.2569881963363514e-08
duplex O 0 2.775904839324994e-08
analysis O 0 1.719076658801555e-09
, O 0 7.69303787340192e-11
sequencing O 0 1.7289578657653237e-09
, O 0 6.376851824363428e-11
and O 0 7.383098299396096e-11
Southern O 0 4.508882156528671e-09
blot O 0 1.2080838018846407e-07
analysis O 0 6.089319048996344e-10
were O 0 3.145507465607267e-11
used O 0 1.3841400248182367e-11
to O 0 3.1271082945316664e-10
identify O 0 1.492491796817319e-09
mutations O 0 4.8430695898105114e-08
. O 0 2.5296893468862436e-08

Mutations O 0 2.784312528092414e-06
were O 0 1.8782495558866685e-08
detected O 0 1.5505619899158773e-08
in O 0 1.9994758626573628e-10
21 O 0 2.9264741741030775e-09
( O 0 3.168340242942769e-11
91 O 0 5.799876134915394e-09
% O 0 8.490574909814086e-10
) O 0 2.309252095100689e-11
of O 0 3.127951231363113e-09
23 O 0 1.9175327906850725e-05
tumors B-Disease 1 1.0
with O 0 6.727783556925715e-07
LOH O 1 1.0
. O 0 6.676097655144986e-06

In O 0 5.429549077007323e-08
6 O 0 2.26369280653671e-07
( O 0 3.61153412731241e-10
38 O 0 3.670258763577294e-08
% O 0 1.0674783279540634e-09
) O 0 1.7978575225785498e-11
of O 0 2.853431269045359e-09
16 O 0 9.26865959627321e-06
tumors B-Disease 1 1.0
without O 0 0.0008869754383340478
LOH O 1 1.0
, O 0 7.570796767275567e-10
one O 0 4.2418839274471765e-11
mutation O 0 8.103458876140834e-11
was O 0 2.8982982680503255e-10
detected O 0 5.508739020498865e-10
, O 0 3.0982278374780403e-12
and O 0 3.774240035087084e-12
in O 0 4.515143120498166e-11
9 O 0 1.9108211901652794e-08
( O 0 1.518280362544644e-10
56 O 0 1.6779136302602637e-08
% O 0 6.520511908192361e-10
) O 0 1.100946851045892e-11
of O 0 1.2876418820084723e-09
the O 0 1.0815467277325297e-07
tumors B-Disease 1 1.0
without O 0 0.0002713762514758855
LOH O 1 0.9999995231628418
, O 0 2.2268538124592396e-09
both O 0 2.5007301784896185e-10
mutations O 0 3.576697826801478e-09
were O 0 6.439778155176157e-10
found O 0 5.051845053394288e-10
. O 0 3.006578097597412e-09

Thus O 0 2.50109110311314e-07
, O 0 3.53197998625987e-10
a O 0 2.045978664266812e-10
total O 0 2.8399912976873054e-10
of O 0 7.431742721220047e-11
45 O 0 1.7912736849368116e-09
mutations O 0 9.444031112693096e-10
were O 0 1.943914890167875e-10
identified O 0 1.7792775031111319e-09
in O 0 2.139694865732622e-09
tumors B-Disease 1 1.0
of O 0 3.552019188646227e-05
36 O 0 4.707406333182007e-05
patients O 0 7.971449633714656e-08
. O 0 1.8998649409240898e-07

Thirty O 0 2.599850404294557e-06
- O 0 5.585769713434274e-08
nine O 0 2.5291331251509064e-09
of O 0 5.331274866016145e-10
the O 0 3.6869188257959706e-10
mutations O 0 4.799991959458794e-09
- O 0 8.184831479240984e-09
including O 0 1.8426360437473477e-10
34 O 0 4.0166618475723226e-08
small O 0 1.1200912419795372e-09
mutations O 0 2.1792571658352244e-07
, O 0 9.29038235231161e-10
2 O 0 2.0940649392287014e-07
large O 0 7.10534342474034e-09
structural O 0 9.516004502074793e-05
alterations O 0 0.0001500660291640088
, O 0 1.3231582052242175e-08
and O 0 4.176163415081646e-09
hypermethylation O 0 0.1632840484380722
in O 0 5.75920694245724e-07
3 O 0 0.010325278155505657
tumors O 1 1.0
- O 0 2.543017956213589e-07
were O 0 1.8022745518209149e-09
not O 0 4.2735329164322877e-10
detected O 0 1.0255819526960863e-09
in O 0 8.872953587146792e-12
the O 0 2.2254418793887787e-11
corresponding O 0 1.1668719324120502e-09
peripheral O 0 1.9180920673989021e-07
blood O 0 8.648422067381034e-08
DNA O 0 7.003824862295005e-07
. O 0 3.5674201370738956e-08

In O 0 5.129467695041967e-08
6 O 0 1.337706549975337e-07
( O 0 1.674931859874107e-10
17 O 0 1.0467920752432747e-08
% O 0 5.062329999638848e-10
) O 0 4.0130316604491956e-12
of O 0 2.473708737849023e-10
the O 0 9.263858569141803e-10
36 O 0 3.977028129042992e-08
patients O 0 8.014280905577209e-10
, O 0 1.7420580603055846e-11
a O 0 1.9503026971179338e-10
mutation O 0 1.7056466239395718e-09
was O 0 2.700858203752432e-09
detected O 0 6.47120024233061e-10
in O 0 1.7451842054816424e-11
constitutional O 0 8.434617448926929e-09
DNA O 0 3.840958484602197e-08
, O 0 2.447631333724054e-11
and O 0 7.414677379025125e-12
1 O 0 1.1508476838173465e-08
of O 0 3.120929348288115e-10
these O 0 7.88030751763813e-12
mutations O 0 1.400906168846916e-09
is O 0 7.570674122325816e-12
known O 0 4.162526660161925e-12
to O 0 2.1528823862526636e-11
be O 0 3.83715975660337e-11
associated O 0 4.686095261829948e-11
with O 0 3.95909780653847e-12
reduced O 0 1.709924291048992e-08
expressivity O 0 5.340864390745992e-06
. O 0 1.2663097948006907e-07

The O 0 8.20856449479379e-09
presence O 0 1.238100039158141e-10
of O 0 2.4414126276184334e-10
a O 0 5.995322294172212e-11
constitutional O 0 4.55816984157309e-09
mutation O 0 1.119978110253328e-09
was O 0 1.5358873894921743e-10
not O 0 2.1797884677821067e-12
associated O 0 2.543055609843803e-12
with O 0 2.950212705968118e-14
an O 0 6.067375334789515e-13
early O 0 1.0159252328278967e-09
age O 0 9.98993066048115e-09
at O 0 6.427436805012121e-09
treatment O 0 2.4882290006189578e-08
. O 0 3.9279438368566844e-08

In O 0 7.504397814273034e-08
1 O 0 1.3417043192021083e-05
patient O 0 1.6673845948389499e-06
, O 0 4.513967866159874e-09
somatic O 0 2.0792605937458575e-05
mosaicism O 0 0.03143244981765747
was O 0 8.801738715646934e-08
demonstrated O 0 3.6229180766511604e-10
by O 0 2.370878146584765e-11
molecular O 0 3.6437214356865866e-10
analysis O 0 1.3352645378272854e-11
of O 0 4.2838628477870344e-11
DNA O 0 4.171488154902647e-10
and O 0 1.1075179835728921e-11
RNA O 0 4.042013834748559e-09
from O 0 5.486225918005516e-10
peripheral O 0 4.197615339762706e-07
blood O 0 1.5090971317022195e-07
. O 0 4.025827138320892e-08

In O 0 1.0960460627984503e-07
2 O 0 2.283844878547825e-06
patients O 0 2.657585929100037e-09
without O 0 1.1638912056355366e-09
a O 0 1.20533927283617e-09
detectable O 0 6.601621862500906e-07
mutation O 0 6.1325766687048144e-09
in O 0 4.5249540225889007e-11
peripheral O 0 6.8737584513201e-08
blood O 0 5.2052982368877565e-08
, O 0 1.872317439977067e-10
mosaicism O 0 1.165926846624643e-06
was O 0 2.516694186383006e-09
suggested O 0 2.2320874315528982e-10
because O 0 2.938345400327336e-11
1 O 0 4.104522943748634e-09
of O 0 9.800660977221654e-11
the O 0 5.971811933846993e-11
patients O 0 2.5211501289423843e-11
showed O 0 1.7267622054450982e-10
multifocal O 1 0.9999966621398926
tumors B-Disease 1 1.0
and O 0 1.3300354595457975e-08
the O 0 2.4236346263251107e-09
other O 0 5.962396375236434e-12
later O 0 6.178986211580195e-10
developed O 0 2.382730679428846e-09
bilateral B-Disease 0 4.701475700130686e-05
retinoblastoma I-Disease 0 0.40786096453666687
. O 0 1.860372890405415e-06

In O 0 2.6779966688650347e-08
conclusion O 0 9.727428817996042e-08
, O 0 8.95634733044659e-10
our O 0 1.800335991397617e-10
results O 0 5.905548272622241e-11
emphasize O 0 1.4549839111310803e-10
that O 0 2.645055615507763e-12
the O 0 2.437702990853996e-11
manifestation O 0 2.735203175063816e-09
and O 0 5.41433876899422e-11
transmissibility O 0 1.0593236510203496e-07
of O 0 5.095275312783087e-10
retinoblastoma B-Disease 0 2.346175875800327e-08
depend O 0 6.917708628151331e-10
on O 0 1.0604993549989672e-09
the O 0 5.500514974055015e-11
nature O 0 7.420028480531471e-11
of O 0 6.304868432893684e-11
the O 0 2.1519916057477495e-11
first O 0 4.353797530831649e-11
mutation O 0 8.133343998295572e-11
, O 0 1.7352654686428326e-12
its O 0 1.9515400580261133e-12
time O 0 7.120734557553021e-11
in O 0 4.2594365534665e-11
development O 0 3.40467281034762e-08
, O 0 2.990898917420992e-10
and O 0 6.481833125793202e-11
the O 0 9.94000992626809e-11
number O 0 9.064902474487102e-12
and O 0 2.634361478959235e-12
types O 0 4.4833567414137576e-11
of O 0 2.405768084745574e-10
cells O 0 2.608738502996033e-10
that O 0 4.493182301917864e-12
are O 0 2.166272586659468e-12
affected O 0 2.564930490223105e-10
. O 0 3.485495503330327e-10
. O 0 1.053007814277862e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.8547724485397339
the I-Disease 0 2.3771385713189375e-06
fifth I-Disease 0 9.516349308569261e-08
component I-Disease 0 1.0405215356001918e-08
of I-Disease 0 2.504397134117653e-09
complement I-Disease 0 9.724322458382062e-10
in O 0 1.3841527923830199e-08
man O 0 1.2185781770313042e-06
. O 0 1.337608352969255e-07

I O 1 0.9849804639816284
. O 0 1.1762253961933311e-05

Clinical O 0 0.00010417715384392068
, O 0 1.108986680264934e-08
immunochemical O 0 0.06753192096948624
, O 0 2.036282964468228e-08
and O 0 4.0405492285344735e-09
family O 0 7.3613097839597685e-09
studies O 0 1.1748227279895218e-08
. O 0 1.9160511399718416e-08

The O 0 6.409233144211157e-09
first O 0 1.725952158970756e-10
recognized O 0 7.276040187020882e-11
human O 0 5.159980220881266e-10
kindred O 0 1.704515639744386e-08
with O 0 1.255433118574345e-10
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 0 0.0021602569613605738
fifth I-Disease 0 8.297773206322745e-07
component I-Disease 0 2.581620783814742e-08
of I-Disease 0 3.5890206362410026e-08
complement I-Disease 0 8.581377386462918e-09
( O 0 2.2580075587086412e-09
C5 O 1 0.9982323050498962
) O 0 5.723769236354315e-10
is O 0 5.737739172673173e-10
described O 0 2.7382791145669216e-08
. O 0 6.809685970665669e-08

The O 0 2.2189693993368564e-07
proband O 0 6.761932309018448e-05
, O 0 7.872443252843198e-10
a O 0 4.077763682275304e-10
20 O 0 2.24520113611959e-09
- O 0 4.890134963630999e-10
year O 0 1.1515761677571845e-09
- O 0 2.2764567120248103e-08
old O 0 4.846738121955241e-08
black O 0 2.2352826534177694e-10
female O 0 7.022914368104427e-12
with O 0 6.084762034508362e-12
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9968241453170776
age O 0 0.0007038282346911728
11 O 0 2.113376496026831e-08
, O 0 1.3133851645141803e-11
lacked O 0 1.7255581408193166e-09
serum O 0 5.073709452574349e-09
hemolytic O 0 7.211135653051315e-07
complement O 0 1.1230797403172232e-09
activity O 0 2.675872678992164e-08
, O 0 3.167234530199181e-11
even O 0 3.1614721951456204e-10
during O 0 1.3011124622153147e-08
remission O 0 2.9529672929129447e-07
. O 0 6.94131729872538e-09

C5 O 0 0.0018266801489517093
was O 0 7.180232842074474e-06
undetectable O 0 1.0923849913524464e-06
in O 0 6.572430377715932e-10
her O 0 1.9817817525913384e-11
serum O 0 6.949218978036242e-11
by O 0 1.6077880346521134e-11
both O 0 3.3101751895081577e-10
immunodiffusion O 0 4.953357802151004e-06
and O 0 1.7331586832369794e-08
hemolytic O 0 0.20171315968036652
assays O 0 4.664582957047969e-05
. O 0 2.258949052702519e-06

Other O 0 5.738264308163821e-10
complement O 0 9.72702543511339e-11
components O 0 6.74570288516918e-10
were O 0 1.2515646852229168e-10
normal O 0 1.0673562034213546e-09
during O 0 5.891174215122419e-10
remission O 0 5.224465127184885e-08
of O 0 2.7212987419034107e-09
lupus O 0 5.028872692491859e-06
, O 0 1.5009131715260082e-09
but O 0 4.319862689783349e-09
C1 O 0 7.713773811701685e-06
, O 0 1.7039338828794826e-08
C4 O 0 4.6212586312321946e-05
, O 0 7.624708864284457e-09
C2 O 0 9.590810350346146e-07
, O 0 2.1485488943540076e-09
and O 0 4.183003277091757e-09
C3 O 0 0.0005022074328735471
levels O 0 2.565207751104026e-06
fell O 0 0.00014429645671043545
during O 0 2.738833586590772e-07
exacerbations O 0 6.084587948862463e-05
. O 0 7.211349384306232e-08

A O 0 4.402674221637426e-06
younger O 0 4.58043096784877e-08
half O 0 1.642857050399016e-08
- O 0 7.332111096047811e-08
sister O 0 8.256397165951057e-08
, O 0 6.15426321015633e-10
who O 0 7.939001123169476e-10
had O 0 9.29084809087044e-09
no O 0 2.5295060268604175e-08
underlying O 1 0.9977726340293884
disease O 1 0.9999995231628418
, O 0 3.87350179709145e-10
was O 0 3.851390317777259e-08
also O 0 8.082912811291365e-11
found O 0 1.0352469576035972e-10
to O 0 4.885336135629359e-09
lack O 0 3.2181910114559287e-07
immunochemically O 0 0.0003206912078894675
detectable O 1 0.8799231052398682
C5 O 1 0.7351558208465576
. O 0 1.402826114826894e-06

By O 0 1.282155750459424e-07
hemolytic O 1 0.9966446161270142
assay O 0 0.00010670314077287912
, O 0 1.718543174433762e-08
she O 0 1.1452365444863943e-10
exhibited O 0 3.6898789579353775e-11
1 O 0 4.9557993264670586e-09
- O 0 1.606437871615185e-09
2 O 0 1.5246488516140744e-08
% O 0 9.244953691478486e-10
of O 0 1.4592640984467664e-10
the O 0 1.469996763203696e-10
normal O 0 2.3363770917939064e-09
serum O 0 3.693177763608446e-09
C5 O 0 2.949502402316284e-07
level O 0 1.635534729871324e-08
and O 0 5.800002492173384e-11
normal O 0 2.3313468933139347e-09
concentrations O 0 1.1852339110163257e-09
of O 0 5.316750512074364e-11
other O 0 3.702870475519315e-12
complement O 0 6.563207616272493e-11
components O 0 9.407647105774686e-09
. O 0 1.4706545314879804e-08

C5 O 0 0.00011842559615615755
levels O 0 2.332347293076964e-07
of O 0 5.292776439347335e-09
other O 0 1.5502875025386054e-11
family O 0 2.8102081425784853e-11
members O 0 9.263967631206738e-13
were O 0 2.0827525468170016e-11
either O 0 5.73373459822335e-10
normal O 0 8.521680250339614e-09
or O 0 2.2430599044831467e-10
approximately O 0 6.462702040188617e-10
half O 0 9.326672767429045e-10
- O 0 2.5585651375337193e-09
normal O 0 3.830114447822552e-09
, O 0 1.1191270132826503e-11
consistent O 0 7.2100603265568e-11
with O 0 1.6397418362359972e-12
autosomal O 0 6.012461994941987e-08
codominant O 0 6.916150709912472e-07
inheritance O 0 6.646334327342629e-08
of O 0 1.6260220947472703e-09
the O 0 2.3328936005206913e-10
gene O 0 9.081508323127707e-10
determining O 0 9.002646379485668e-07
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 8.798666385700926e-06

Normal O 0 0.0001557021023472771
hemolytic O 0 0.245661661028862
titers O 0 3.7474208511412144e-05
were O 0 9.967966896340386e-09
restored O 0 6.912739269893109e-09
to O 0 1.6431945804029624e-09
both O 0 4.397791852905897e-10
homozygous O 0 1.1188495108171992e-07
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 7.382573130598757e-07
C5D B-Disease 1 1.0
) O 0 6.889349535299516e-09
sera O 0 2.6094728156067504e-08
by O 0 3.686598769314653e-12
addition O 0 1.0122142707347237e-11
of O 0 9.65505342342965e-10
highly O 0 2.0389441246493334e-09
purified O 0 4.471902315117404e-08
human O 0 1.078551434829933e-07
C5 O 0 0.00020097427477594465
. O 0 2.5505033818262746e-07

In O 0 3.147048488472137e-08
specific O 0 7.386996259128864e-08
C5 O 0 0.00012561677431222051
titrations O 0 1.3015937838645186e-05
, O 0 1.7384947925691563e-09
however O 0 8.64777083275925e-10
, O 0 2.957986980356431e-11
it O 0 3.1867345567926364e-11
was O 0 1.8718970817843683e-09
noted O 0 2.5575427192725542e-11
that O 0 1.098789679035428e-12
when O 0 3.935390208154033e-12
limited O 0 3.825385321010177e-12
amounts O 0 3.581283325448936e-10
of O 0 1.3333570914042525e-09
C5 O 0 1.0790014357553446e-06
were O 0 1.7142732788855142e-09
assayed O 0 9.865168237865873e-09
in O 0 5.749169803420662e-12
the O 0 3.0883162780576123e-12
presence O 0 1.349870085501359e-12
of O 0 1.8124802006469487e-11
low O 0 1.039065389285554e-09
dilutions O 0 2.692378231472503e-08
of O 0 9.8058827724401e-10
either O 0 2.6959751764366047e-08
C5D B-Disease 1 1.0
serum O 0 3.25015662383521e-07
, O 0 3.4802472015371677e-10
curving O 0 1.62897197952816e-08
rather O 0 2.137560406456629e-10
than O 0 4.709732950858303e-11
linear O 0 9.844116632962141e-09
dose O 0 4.857631097365811e-08
- O 0 3.2548302941748375e-10
response O 0 4.286543689446809e-11
plots O 0 1.3750265370759962e-09
were O 0 7.504372817601634e-11
consistently O 0 8.072789658974955e-11
obtained O 0 8.75945496692232e-11
, O 0 2.29603246137966e-11
suggesting O 0 1.0954176454802678e-10
some O 0 1.89321995580638e-11
inhibitory O 0 1.0728389732150845e-08
effect O 0 3.107665804691351e-07
. O 0 3.55481368785604e-08

Further O 0 1.464661778527443e-07
studies O 0 2.1714468001476916e-09
suggested O 0 5.588108309417805e-10
that O 0 1.0865152527683719e-11
low O 0 8.319450017779673e-09
dilutions O 0 2.1531286620302126e-07
of O 0 2.9353865116377165e-08
C5D B-Disease 1 1.0
serum O 0 1.333795296432072e-08
contain O 0 5.606746317221578e-11
a O 0 2.0742133705065058e-11
factor O 0 3.196419517959015e-11
( O 0 1.0380378197630269e-12
or O 0 3.0626090552487995e-10
factors O 0 2.3542479077320877e-09
) O 0 1.1137756515677832e-11
interfering O 0 2.9125917233585596e-09
at O 0 3.43668626889837e-09
some O 0 1.9830369984985552e-11
step O 0 6.332328883473792e-09
in O 0 4.023410771214486e-11
the O 0 1.3438831991674505e-10
hemolytic O 0 4.837355049858161e-07
assay O 0 6.741283442579515e-08
of O 0 3.917484434623475e-07
C5 O 0 0.0032221535220742226
, O 0 1.0079091727899225e-10
rather O 0 3.551907379328867e-11
than O 0 1.857313781938874e-11
a O 0 1.2613518562964998e-10
true O 0 7.753437891722115e-10
C5 O 0 5.895799404243007e-07
inhibitor O 0 6.232730243027618e-08
or O 0 4.726421920508983e-09
inactivator O 0 2.2059768980398076e-06
. O 0 2.58915573425611e-08

Of O 0 4.6203024339774856e-07
clinical O 0 2.5392425868631108e-06
interest O 0 6.612421543650271e-08
are O 0 2.0760192176449976e-10
( O 0 1.207755007115452e-10
a O 0 3.449753538387057e-10
) O 0 2.7302890850955386e-12
the O 0 2.642977850464412e-12
documentation O 0 1.2213648148406975e-10
of O 0 1.3465183135163983e-10
membranous O 0 1.7931972251972184e-05
glomerulonephritis B-Disease 1 1.0
, O 0 5.134126723760346e-08
vasculitis B-Disease 1 1.0
, O 0 4.0263113731953126e-08
and O 0 2.798456364416779e-07
arthritis B-Disease 1 1.0
in O 0 1.5374399708889541e-06
an O 0 4.2866949989672776e-09
individual O 0 9.489243835147931e-10
lacking O 0 2.1068295609438792e-05
C5 O 1 0.9996445178985596
( O 0 1.1723420012543784e-09
and O 0 2.1453003262728032e-10
its O 0 6.718900436020192e-11
biologic O 0 1.991014109137268e-08
functions O 0 1.9504245440948864e-11
) O 0 9.671295882196507e-13
, O 0 1.0418898816616506e-12
and O 0 2.9620336131769287e-12
( O 0 1.4832246542084704e-11
b O 0 3.447900631670109e-09
) O 0 3.332877376860388e-12
a O 0 6.102862659673747e-11
remarkable O 0 4.6529013281171316e-11
propensity O 0 1.2416792927183451e-08
to O 0 6.941740959831577e-09
bacterial B-Disease 1 1.0
infections I-Disease 1 0.9999997615814209
in O 0 1.1939370325730891e-10
the O 0 9.657093180681642e-11
proband O 0 4.9149569747442e-08
, O 0 1.6262748092632506e-11
even O 0 2.361653060611868e-11
during O 0 1.0744843903509604e-10
periods O 0 6.242766303898861e-10
of O 0 1.1162219759608405e-10
low O 0 6.827679532861453e-10
- O 0 7.111966571216044e-11
dose O 0 8.915357341265917e-10
or O 0 6.22196044686163e-11
alternate O 0 6.736817770303105e-10
- O 0 2.8826754316924053e-09
day O 0 2.034562074371138e-09
corticosteroid O 0 1.0062927913168096e-06
therapy O 0 1.0284466611665266e-07
. O 0 1.1423535895005443e-08

Other O 0 8.131459949822784e-09
observations O 0 9.255685107234513e-09
indicate O 0 1.5180986467910884e-09
that O 0 1.593615690798078e-11
the O 0 8.970674203467865e-10
C5D B-Disease 1 1.0
state O 0 4.560100297368308e-09
is O 0 4.108153053850039e-11
compatible O 0 4.0037770321355026e-10
with O 0 6.075947904526924e-12
normal O 0 2.1294837004859346e-09
coagulation O 0 5.805576019923819e-09
function O 0 1.456022968859827e-09
and O 0 6.1741735855880275e-12
the O 0 1.351488712608706e-11
capacity O 0 1.0591705984497324e-10
to O 0 1.9119494876207455e-10
mount O 0 3.036223716890163e-08
a O 0 1.37998243943116e-08
neutrophilic O 0 9.503489854978397e-05
leukocytosis O 0 2.3267384676728398e-06
during O 0 6.66039454699785e-08
pyogenic B-Disease 0 4.092985363968182e-06
infection I-Disease 0 1.5866883984472224e-07
. O 0 8.941599682898982e-10
. O 0 6.8778738260277805e-09

Susceptibility O 0 0.000316343066515401
to O 0 1.7459482478443533e-05
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.00014318147441372275
twins O 0 1.7698307885893882e-07
: O 0 4.843835835904864e-12
the O 0 1.5314022619450363e-11
role O 0 2.115413920422693e-11
of O 0 8.128257095174618e-11
genes O 0 1.0844329600967484e-10
, O 0 5.745927691980235e-11
HLA O 0 5.466298716783058e-06
, O 0 2.4044011226465045e-10
and O 0 2.7849544892433187e-10
the O 0 1.205130661929843e-08
environment O 0 4.271463751592819e-07
. O 0 1.9789504790423962e-07

OBJECTIVE O 0 2.943007530120667e-05
To O 0 6.145656428202528e-09
determine O 0 2.3852180230932163e-09
the O 0 3.7959579923807496e-11
relative O 0 3.3725167103426656e-09
effects O 0 3.3426502454858564e-08
of O 0 2.2550035172486105e-09
genetic O 0 1.3744031690521297e-08
and O 0 1.5507133771519577e-11
environmental O 0 2.061774750927725e-09
factors O 0 2.472010651732859e-10
in O 0 2.985783278605658e-12
susceptibility O 0 3.1930301958027485e-08
to O 0 5.135997298566508e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 3.3151086427096743e-06
AS B-Disease 1 1.0
) O 0 4.255843233380574e-09
. O 0 2.0813578416323253e-08

METHODS O 0 4.271124635124579e-05
Twins O 0 1.4707056550378184e-07
with O 0 1.642829448866845e-11
AS B-Disease 1 0.9999922513961792
were O 0 2.5422325702906257e-11
identified O 0 6.426715930263338e-12
from O 0 1.9896131183555488e-12
the O 0 3.2885992106573836e-12
Royal O 0 3.85918824674647e-10
National O 0 8.8660652153294e-09
Hospital O 0 3.2539885523874545e-06
for O 0 5.122796853385125e-09
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 2.0060174392710906e-06
. O 0 2.957860090191389e-07

Clinical O 0 8.812791747914162e-06
and O 0 1.5152088472802916e-09
radiographic O 0 6.688988918313044e-08
examinations O 0 4.960918431606842e-07
were O 0 9.450481508466169e-10
performed O 0 2.4237433240981154e-11
to O 0 2.181598825201636e-11
establish O 0 8.150461416889243e-10
diagnoses O 0 8.86497764440719e-06
, O 0 1.4849330653987636e-09
and O 0 3.2959008855470984e-09
disease O 0 0.2839350998401642
severity O 1 0.9639955163002014
was O 0 3.169650852896666e-08
assessed O 0 7.660641898610265e-09
using O 0 5.067785427415039e-11
a O 0 3.8998169277215666e-11
combination O 0 1.6579494721558063e-10
of O 0 5.854455253917479e-10
validated O 0 7.435932758426134e-09
scoring O 0 3.2426683560515812e-09
systems O 0 1.1207313121985862e-07
. O 0 6.067343605309361e-08

HLA O 0 5.455981590785086e-05
typing O 0 3.200853626594835e-08
for O 0 4.70738514835034e-09
HLA O 0 1.2324111366979196e-06
- O 0 5.1812481416391165e-08
B27 O 0 7.9516229334331e-07
, O 0 3.5016878285887287e-10
HLA O 0 1.2505449831223814e-07
- O 0 1.1965918922385299e-08
B60 O 0 5.189477292333322e-07
, O 0 1.2303807972458003e-10
and O 0 4.0643691190389575e-10
HLA O 0 3.1794650112715317e-06
- O 0 4.7097944388951873e-07
DR1 O 0 0.0002482698764652014
was O 0 2.037017132749952e-08
performed O 0 1.2458667777992538e-11
by O 0 1.6937753283263746e-12
polymerase O 0 1.0634099156803245e-09
chain O 0 3.893412259259321e-10
reaction O 0 1.9726328209790367e-11
with O 0 1.0399262831070621e-12
sequence O 0 1.1710586667046385e-10
- O 0 6.41381253663198e-11
specific O 0 4.997722027888507e-11
primers O 0 4.773132555868642e-09
, O 0 5.1811215040498126e-11
and O 0 7.7086656502523e-11
zygosity O 0 5.541078849091718e-07
was O 0 3.773405055085277e-08
assessed O 0 6.56554490774397e-08
using O 0 3.331942055595505e-09
microsatellite O 0 2.009624950005673e-06
markers O 0 7.0108757199705e-07
. O 0 1.1802843147279418e-07

Genetic O 0 8.63628156366758e-06
and O 0 2.498671713979661e-09
environmental O 0 9.502252318327464e-09
variance O 0 3.949781834933219e-09
components O 0 5.944257308598822e-10
were O 0 4.2165947816696914e-11
assessed O 0 2.3090782619306083e-09
with O 0 1.1769106739514812e-12
the O 0 5.700212177273123e-11
program O 0 2.9063237927395846e-11
Mx O 0 6.447376854623599e-09
, O 0 2.5347215645843413e-12
using O 0 1.3925389704197433e-12
data O 0 5.9634081527037974e-12
from O 0 5.174038281152704e-12
this O 0 5.453346975381468e-12
and O 0 2.153550992048392e-12
previous O 0 4.589448959757547e-11
studies O 0 3.7055924301254706e-11
of O 0 8.313969651618791e-11
twins O 0 6.071853020372942e-10
with O 0 2.8423360887153137e-11
AS B-Disease 1 1.0
. O 0 1.558681361757408e-07

RESULTS O 0 8.490937375427166e-07
Six O 0 1.9940697981724043e-08
of O 0 9.130753042541073e-09
8 O 0 1.4045716056898527e-07
monozygotic O 0 4.725090434476442e-07
( O 0 7.68864527600499e-09
MZ O 0 1.0244796612823848e-05
) O 0 1.1820545930962822e-10
twin O 0 4.059335534378761e-09
pairs O 0 6.022071036282384e-11
were O 0 4.157944544225245e-10
disease O 0 1.059372181089202e-07
concordant O 0 2.1281018689478515e-06
, O 0 1.5519451002088402e-10
compared O 0 3.152199612443951e-10
with O 0 2.6139108239009445e-12
4 O 0 8.597777600982681e-09
of O 0 1.9196937373067158e-09
15 O 0 1.1922359988147946e-08
B27 O 0 6.406711463569081e-07
- O 0 2.286613565161133e-08
positive O 0 1.0592479116056097e-09
dizygotic O 0 1.2616688138678e-07
( O 0 8.286933361745241e-10
DZ O 0 5.910008553655643e-07
) O 0 2.604466468880684e-11
twin O 0 5.615652942658755e-10
pairs O 0 1.8284690168207662e-12
( O 0 3.7208816756895136e-12
27 O 0 5.50109735542037e-09
% O 0 6.17394413371386e-10
) O 0 5.999860330785367e-12
and O 0 2.8857864015074952e-11
4 O 0 1.6280585768413403e-08
of O 0 3.6980343232073665e-09
32 O 0 2.5893829302958693e-08
DZ O 0 1.057370127455215e-06
twin O 0 2.9438627091593617e-09
pairs O 0 1.2568100206389321e-11
overall O 0 1.9512738647087247e-10
( O 0 1.520267592369784e-11
12 O 0 2.2029427171332827e-09
. O 0 1.0007771694686696e-10
5 O 0 9.675908962947233e-09
% O 0 1.7876216062973072e-09
) O 0 3.2313371423065007e-10
. O 0 1.6747449649301416e-08

Nonsignificant O 0 0.00031966069946065545
increases O 0 1.4878686727115564e-07
in O 0 3.208668331033948e-10
similarity O 0 1.450555925375241e-10
with O 0 7.392813032754131e-13
regard O 0 4.727817026761727e-10
to O 0 2.368908402772263e-10
age O 0 4.000054065755876e-09
at O 0 8.327146194808677e-10
disease O 0 1.1247718312290544e-08
onset O 0 5.38789936399553e-06
and O 0 5.593362578659722e-11
all O 0 2.4932656633724903e-11
of O 0 2.636304508030207e-10
the O 0 1.9393708861059622e-10
disease O 0 9.841206960459203e-09
severity O 0 4.2699522140310364e-08
scores O 0 1.482786948781012e-10
assessed O 0 5.126315372194767e-09
were O 0 1.065742494255062e-10
noted O 0 1.4107245926986423e-10
in O 0 2.6799767960383747e-10
disease O 0 9.025601599432775e-08
- O 0 4.3737966137769035e-08
concordant O 0 2.3715347197139636e-05
MZ O 0 0.00011568037734832615
twins O 0 1.3595728987070288e-08
compared O 0 1.0670875294493953e-09
with O 0 1.2428674756037594e-10
concordant O 0 8.050716132856905e-05
DZ O 1 0.9810205698013306
twins O 0 6.280707111727679e-06
. O 0 2.6144999765165267e-07

HLA O 0 9.432112710783258e-05
- O 0 6.442585345212137e-07
B27 O 0 2.322373575225356e-06
and O 0 2.066167098524474e-10
B60 O 0 1.274256788974526e-07
were O 0 5.3152700990599655e-11
associated O 0 2.603741180995378e-11
with O 0 5.214248087123674e-13
the O 0 5.900755439824934e-10
disease O 0 4.2156202084697725e-08
in O 0 1.882742017844663e-10
probands O 0 1.1782417459471617e-05
, O 0 1.6217376053173638e-10
and O 0 1.5327874386406037e-11
the O 0 2.295744566671587e-10
rate O 0 2.9329131123745356e-08
of O 0 4.78107775592207e-09
disease O 0 1.2667712212532933e-07
concordance O 0 2.1116026704959268e-09
was O 0 6.384425210725908e-10
significantly O 0 2.0947853174302367e-10
increased O 0 2.2252860665261665e-10
among O 0 1.566008954456688e-11
DZ O 0 7.375598443104536e-07
twin O 0 9.545304102687169e-09
pairs O 0 6.7982008911116054e-12
in O 0 2.0033980984573985e-12
which O 0 1.5593792533283302e-12
the O 0 4.3628749918367404e-11
co O 0 1.3749471006185843e-10
- O 0 5.002349645621962e-10
twin O 0 9.092080976991213e-10
was O 0 8.478275859147288e-10
positive O 0 1.180830433433755e-11
for O 0 1.1002205223265005e-11
both O 0 1.253939729828346e-10
B27 O 0 4.251271548127988e-06
and O 0 1.815101846602829e-08
DR1 O 1 0.9868893623352051
. O 0 1.2332765209066565e-06

Additive O 0 3.896123871527379e-06
genetic O 0 3.057840842757287e-07
effects O 0 7.185455075386926e-08
were O 0 1.2317896702640496e-10
estimated O 0 5.869221775256506e-11
to O 0 1.254254859694992e-11
contribute O 0 5.620086687696535e-11
97 O 0 3.6595340091594153e-09
% O 0 6.162567123269014e-10
of O 0 6.258428497663004e-11
the O 0 6.633685267765088e-11
population O 0 2.8107871932747663e-11
variance O 0 4.1986723431364226e-08
. O 0 3.5789241792372195e-08

CONCLUSION O 0 2.7639556719805114e-05
Susceptibility O 0 0.0006415267125703394
to O 0 2.0542044865123898e-07
AS B-Disease 1 1.0
is O 0 2.982496749570629e-10
largely O 0 1.8643350752078902e-10
genetically O 0 1.2398888860065682e-10
determined O 0 2.9233724330168798e-09
, O 0 1.3777343849108448e-11
and O 0 9.89079564778228e-12
the O 0 2.2143495370663402e-10
environmental O 0 9.244623733195567e-09
trigger O 0 1.66622520225701e-08
for O 0 1.0595949812008953e-10
the O 0 4.190925384506272e-09
disease O 0 1.4607905541197397e-05
is O 0 2.788414776855319e-10
probably O 0 1.6230234933800602e-08
ubiquitous O 0 5.372150724269886e-08
. O 0 4.6574633927320974e-08

HLA O 0 0.0001540528319310397
- O 0 4.871209853263281e-07
B27 O 0 6.016047109369538e-07
accounts O 0 2.3135373825033945e-11
for O 0 4.223861278102037e-12
a O 0 1.8259189299429934e-11
minority O 0 1.9939449397154974e-11
of O 0 3.1896350144444696e-11
the O 0 8.084685698683813e-11
overall O 0 2.0272292733380937e-09
genetic O 0 6.118162332313659e-08
susceptibility O 0 1.2166460692242254e-05
to O 0 3.0028543278604047e-06
AS B-Disease 1 1.0
. O 0 3.8253056118264794e-06

Cell O 0 6.934200882824371e-06
cycle O 0 1.8497739802114666e-06
- O 0 1.7799944629359743e-08
dependent O 0 1.9129362982539533e-08
colocalization O 0 9.277336516788637e-07
of O 0 3.831709349810808e-08
BARD1 O 0 0.0010940550127997994
and O 0 8.435566911657588e-09
BRCA1 O 0 1.4261523517689056e-08
proteins O 0 1.0490235763382927e-10
in O 0 4.884194437781986e-11
discrete O 0 1.508795755000847e-08
nuclear O 0 2.5287640710303094e-06
domains O 0 1.5619937130395556e-06
. O 0 7.351042796699403e-08

Germ O 0 4.300834552850574e-05
- O 0 6.423591685233987e-07
line O 0 8.363031156477518e-08
mutations O 0 7.774707100338674e-09
of O 0 1.2141674332610819e-09
the O 0 3.2379943171179093e-10
BRCA1 O 0 5.007602776885278e-09
gene O 0 5.844102424212849e-10
predispose O 0 1.206728512670452e-07
women O 0 1.030858384765132e-11
to O 0 4.797076277873735e-11
early O 0 1.7227677062692237e-07
- O 0 3.7535044157266384e-06
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 2.276803989786913e-08
compromising O 0 7.460099737954806e-08
the O 0 1.7558502429793066e-09
genes O 0 1.1401718458259325e-09
presumptive O 0 2.0928704103084783e-08
function O 0 3.1481742213124164e-10
as O 0 9.082901965273837e-12
a O 0 1.9255599892353814e-10
tumor B-Disease 0 3.014625065134169e-07
suppressor O 0 6.268966444622492e-06
. O 0 1.0845192122133085e-07

Although O 0 1.6183255979740352e-07
the O 0 1.8018903702454736e-08
biochemical O 0 7.56520321942844e-08
properties O 0 1.257987634062374e-07
of O 0 2.7619147857649295e-08
BRCA1 O 0 3.942813364687936e-08
polypeptides O 0 2.5637383327392627e-09
are O 0 2.231868119137448e-12
not O 0 7.946341501474663e-12
understood O 0 2.325905024136432e-10
, O 0 1.4644068293059864e-12
their O 0 1.9922247445486319e-13
expression O 0 7.00351842491953e-12
pattern O 0 2.1858817533804142e-10
and O 0 5.728853589431759e-12
subcellular O 0 4.256835950400273e-08
localization O 0 2.118328268352343e-08
suggest O 0 7.944908619883506e-10
a O 0 1.1610857414412479e-10
role O 0 4.1211964396659084e-11
in O 0 4.819067367378693e-11
cell O 0 9.84965708994423e-09
- O 0 1.8915443433797918e-08
cycle O 0 2.102525513691944e-07
regulation O 0 1.9956949870447716e-07
. O 0 3.012365468180178e-08

When O 0 1.0148353339900495e-06
resting O 0 2.6625725695339497e-06
cells O 0 1.043841191261663e-08
are O 0 1.4865532416141747e-10
induced O 0 6.738622460034094e-08
to O 0 1.2085874523393159e-09
proliferate O 0 8.374344773187659e-09
, O 0 3.504024154166174e-11
the O 0 1.1003616073868017e-10
steady O 0 1.1891672091479677e-09
- O 0 1.0287826840427172e-10
state O 0 1.0704014757889624e-10
levels O 0 1.1778555908392718e-09
of O 0 3.297282447078942e-10
BRCA1 O 0 1.872479060693877e-09
increase O 0 9.30971744139697e-10
in O 0 1.1152791884461166e-10
late O 0 1.670392890673611e-07
G1 O 0 2.1372079217485407e-08
and O 0 6.8488283620771195e-12
reach O 0 1.6218273946044803e-10
a O 0 1.6164222738090928e-11
maximum O 0 2.321761893853136e-09
during O 0 2.1526096460888766e-09
S O 0 5.460502734422334e-07
phase O 0 8.562029734093812e-07
. O 0 5.93376192625783e-08

Moreover O 0 1.4559467444996699e-06
, O 0 3.7714964484791835e-09
in O 0 2.059876269555616e-09
S O 0 2.3696215976087842e-06
phase O 0 4.205956884106854e-06
cells O 0 1.2606941268700211e-08
, O 0 2.0028730063348377e-10
BRCA1 O 0 5.8628839560981305e-09
polypeptides O 0 2.117087172237575e-09
are O 0 6.12540435040998e-11
hyperphosphorylated O 0 6.375073269282439e-08
and O 0 6.213590753034737e-10
accumulate O 0 2.7938782398706508e-09
into O 0 4.549725041158581e-10
discrete O 0 1.5012261656011106e-08
subnuclear O 0 1.0339563232264481e-06
foci O 0 3.981783720519161e-07
termed O 0 2.2356371687237697e-07
" O 0 4.6204430503848926e-08
BRCA1 O 0 1.9828628694540384e-07
nuclear O 0 9.409583981323522e-06
dots O 0 1.1016563803423196e-06
. O 0 1.950522943161559e-07

" O 0 1.9215911379433237e-05
BRCA1 O 0 2.9790155167574994e-05
associates O 0 1.0772248515422689e-06
in O 0 8.004157336927165e-09
vivo O 0 5.588326956740275e-08
with O 0 5.145330776029633e-12
a O 0 3.920614055630267e-09
structurally O 0 1.6893883980628743e-07
related O 0 1.0896947344463115e-07
protein O 0 2.132168674506829e-06
termed O 0 8.061228072619997e-06
BARD1 O 1 0.9983782768249512
. O 0 7.775494736961264e-07

Here O 0 3.5772049500337744e-07
we O 0 2.7189122064896765e-09
show O 0 3.729509409633458e-11
that O 0 1.7320513513024993e-12
the O 0 1.926679649155716e-11
steady O 0 6.854154466218176e-10
- O 0 1.895558709996692e-10
state O 0 1.4480847077003034e-10
levels O 0 5.603586927804827e-09
of O 0 5.058094831866811e-09
BARD1 O 0 0.04078647121787071
, O 0 1.4258136338263228e-10
unlike O 0 4.604512257588844e-11
those O 0 3.100547249501595e-11
of O 0 4.680755782970891e-10
BRCA1 O 0 5.866821695121871e-09
, O 0 3.288368882747861e-11
remain O 0 1.1354229362270374e-10
relatively O 0 1.5142770717901932e-11
constant O 0 1.6336373920289304e-10
during O 0 2.1900591062884445e-10
cell O 0 1.4711820206514403e-08
cycle O 0 4.235131711993745e-08
progression O 0 6.595769264094997e-08
. O 0 5.86777293420937e-09

However O 0 1.5972963751664793e-07
, O 0 3.4046712116264644e-09
immunostaining O 0 1.754883851390332e-05
revealed O 0 1.7348479275369755e-07
that O 0 6.282135922575094e-10
BARD1 O 0 0.0005217951256781816
resides O 0 6.339579528003014e-09
within O 0 2.8630586790256984e-09
BRCA1 O 0 1.7440321187223162e-08
nuclear O 0 1.205597072839737e-06
dots O 0 1.0296711039359252e-08
during O 0 2.205713611758142e-09
S O 0 1.2471288890480992e-08
phase O 0 1.2812116700899878e-08
of O 0 1.9299538356332135e-10
the O 0 8.757166519712811e-11
cell O 0 1.1860751270020842e-09
cycle O 0 1.884859157641472e-09
, O 0 3.3661302911713875e-12
but O 0 1.1363561133737043e-11
not O 0 9.850135290756512e-11
during O 0 1.6574728256557592e-09
the O 0 2.4017028366074555e-09
G1 O 0 2.2458154091964388e-07
phase O 0 1.2896452972199768e-06
. O 0 2.8568035048692764e-08

Nevertheless O 0 1.0820148418133613e-05
, O 0 1.9034732900991003e-08
BARD1 O 0 9.428154589841142e-05
polypeptides O 0 3.098778122989643e-08
are O 0 4.2817062395617e-11
found O 0 8.417906996460722e-12
exclusively O 0 1.3158292814716144e-12
in O 0 1.2288456927370128e-12
the O 0 1.234135970501482e-11
nuclear O 0 1.652379033600937e-08
fractions O 0 3.942119519706466e-09
of O 0 3.569785300694406e-10
both O 0 5.1273270351703815e-11
G1 O 0 2.16797158003601e-08
- O 0 3.737424592031857e-09
and O 0 2.1066534627856015e-10
S O 0 2.786073878269235e-07
- O 0 2.636950924284065e-08
phase O 0 3.684550620164373e-07
cells O 0 2.2231882113032952e-08
. O 0 7.509019184226418e-09

Therefore O 0 6.79412323734141e-07
, O 0 2.7386173329091434e-09
progression O 0 8.57665298781285e-08
to O 0 1.8769488185910177e-09
S O 0 3.276203983659798e-07
phase O 0 5.332002501745592e-07
is O 0 2.3049088679338858e-11
accompanied O 0 1.3102325648051139e-11
by O 0 5.543854004336213e-12
the O 0 1.1448565706562164e-10
aggregation O 0 1.0637304370675338e-09
of O 0 1.2099760082762145e-09
nuclear O 0 1.5741350125608733e-06
BARD1 O 0 8.176721166819334e-05
polypeptides O 0 5.11085360699326e-08
into O 0 2.5968315497948424e-08
BRCA1 O 0 8.294927056340384e-08
nuclear O 0 1.9647823137347586e-06
dots O 0 4.912866984341235e-07
. O 0 4.450527413268901e-08

This O 0 4.476135018194327e-08
cell O 0 2.7796409085567575e-07
cycle O 0 1.1250296694242934e-07
- O 0 3.3304297097913604e-09
dependent O 0 6.646280859001763e-09
colocalization O 0 3.554017951046262e-07
of O 0 1.6926225754332336e-08
BARD1 O 0 0.3093957006931305
and O 0 2.8562461285019936e-09
BRCA1 O 0 3.6762351385277725e-08
indicates O 0 1.2761721679410698e-09
a O 0 3.896694078520113e-11
role O 0 3.1842858211339475e-11
for O 0 3.106181978296263e-11
BARD1 O 0 4.422797428560443e-05
in O 0 1.731427268225616e-08
BRCA1 O 0 1.7325921817246126e-06
- O 0 1.3860517356079072e-06
mediated O 0 0.002105036983266473
tumor B-Disease 1 0.9999971389770508
suppression O 0 0.00028521023341454566
. O 0 2.0333803263383743e-07

Ethnic O 0 2.054186325040064e-06
differences O 0 2.6927176577373757e-07
in O 0 2.6364366245701376e-09
the O 0 1.0722294163656443e-08
HFE O 0 2.21184927795548e-05
codon O 0 2.396335503362934e-06
282 O 0 5.202871875553683e-07
( O 0 1.8944149360322626e-08
Cys O 0 0.00016325876640621573
/ O 0 1.7270529497181997e-05
Tyr O 0 9.165352821582928e-06
) O 0 2.0856127935786617e-09
polymorphism O 0 3.917133710729104e-07
. O 0 3.965802264360718e-08

Recent O 0 2.0960264635050407e-08
studies O 0 3.939471804326189e-10
have O 0 5.2858268977107326e-12
shown O 0 1.6984606429626403e-11
that O 0 1.1755394435652988e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 9.24124560697237e-06
HH B-Disease 1 1.0
) O 0 5.240118339244759e-10
is O 0 5.491824703329762e-11
likely O 0 3.307007445663146e-10
to O 0 7.954579356317382e-11
be O 0 9.848594856309845e-11
caused O 0 5.470395803008898e-10
by O 0 8.136769036326541e-12
homozygosity O 0 4.550041765583046e-08
for O 0 3.5084980060107185e-11
a O 0 3.155195271720146e-10
Cys282Tyr O 0 1.7940257635018497e-07
mutation O 0 6.820004117003009e-09
in O 0 1.759063866790811e-10
the O 0 8.08856148726278e-10
HFE O 0 6.147151452751132e-06
gene O 0 1.0264532335213516e-08
located O 0 7.552368508356722e-09
4 O 0 3.0970591069490183e-07
. O 0 5.996691498921791e-08

5 O 0 4.395479663799051e-06
Mb O 0 2.630621202115435e-05
telomeric O 0 2.7737625714507885e-05
to O 0 1.0351136552344542e-06
HLA O 0 0.00017404957907274365
- O 0 1.0065606375064817e-06
A O 0 1.3025546650169417e-06
. O 0 7.027510662283021e-08

Population O 0 2.372038343523286e-09
studies O 0 3.392903458188101e-10
of O 0 5.0815688462657604e-11
this O 0 5.2488759866298196e-12
polymorphism O 0 8.516785054979437e-10
are O 0 2.8556699106091488e-12
facilitated O 0 5.022673249532872e-11
by O 0 5.0212052397913265e-12
the O 0 3.768350562149969e-11
fact O 0 6.869538358295069e-12
that O 0 8.861550273957242e-13
the O 0 4.8881648728738014e-11
Cys282Tyr O 0 2.411343871244753e-07
mutation O 0 1.939513438742324e-08
creates O 0 3.0649538462768078e-09
a O 0 1.6407392111617014e-09
Rsal O 0 1.0125926337423152e-06
restriction O 0 7.447745531408145e-08
site O 0 3.4250923874878936e-08
. O 0 1.2133739346609218e-08

We O 0 8.441580803264515e-07
have O 0 2.0636159447917635e-09
studied O 0 2.0773757825054417e-08
the O 0 1.2507610502865418e-09
codon O 0 9.797721389759317e-08
282 O 0 9.375962406465987e-08
( O 0 1.7610027214232105e-08
Cys O 0 0.0001336239802185446
/ O 0 4.977100616088137e-06
Tyr O 0 4.733777245746751e-07
) O 0 1.468757407363519e-11
polymorphism O 0 2.9121738354120907e-10
in O 0 3.6579793014079875e-12
different O 0 1.0368089850207318e-12
ethnic O 0 1.4393225500342055e-10
groups O 0 1.621276030094876e-11
. O 0 1.6274618319656042e-09

In O 0 1.1944667477337134e-08
agreement O 0 2.0989475046917505e-07
with O 0 9.201185924290201e-10
previous O 0 3.895852529467447e-08
observations O 0 1.0263475402894073e-08
the O 0 7.033243432097436e-10
Tyr O 0 4.723955271401792e-08
allele O 0 5.605350850146351e-09
appeared O 0 3.276419136000186e-10
to O 0 4.222413391152813e-11
be O 0 7.407231772393885e-11
rare O 0 4.4550074740357104e-10
or O 0 1.722888676169987e-08
absent O 0 1.969771403764753e-07
in O 0 7.260240186823808e-10
Asiatic O 0 9.50653067377516e-09
( O 0 6.410192515682311e-11
Indian O 0 1.0258831562026671e-09
, O 0 5.85376053185982e-11
Chinese O 0 6.660690748949705e-11
) O 0 3.173505208620142e-11
populations O 0 4.3159978369011753e-10
. O 0 2.3857411601824197e-09

The O 0 1.90658369092489e-08
highest O 0 1.2354874456832476e-08
allele O 0 5.075914133456649e-10
frequency O 0 3.7557899013052065e-09
( O 0 1.6417017051351124e-11
7 O 0 1.6784633682931371e-09
. O 0 1.4918698221233484e-11
5 O 0 5.174606299007678e-10
% O 0 1.3855988578725942e-10
) O 0 3.612866733213038e-12
was O 0 1.0112235493409116e-09
found O 0 7.458524076131567e-11
in O 0 2.747767013921987e-10
Swedes O 0 1.1631310314896837e-07
. O 0 4.671787579013653e-08

Saamis O 0 0.00012418213009368628
( O 0 8.795173478404195e-09
2 O 0 6.279638000705745e-07
% O 0 1.492111145751096e-08
) O 0 2.2421177761633437e-11
and O 0 1.4003256887384907e-10
Mordvinians O 0 7.070473202475114e-07
( O 0 1.9943036111413903e-10
1 O 0 8.40457516915194e-08
. O 0 2.5177201989912135e-10
8 O 0 7.700546866828972e-09
% O 0 3.307171203559278e-10
) O 0 1.8826071344207884e-12
had O 0 7.979347738107379e-11
significantly O 0 1.0270612832430359e-10
lower O 0 4.575972656351013e-10
frequencies O 0 1.3069841875434918e-09
of O 0 5.799772884174104e-10
the O 0 9.422403968173398e-10
Tyr O 0 9.365020900986565e-07
allele O 0 3.2181694109567616e-07
. O 0 2.1963110441447498e-08

Comparisons O 0 3.080944566136168e-08
with O 0 1.8195219636529814e-11
allele O 0 5.895737786865141e-10
frequencies O 0 4.1602132849760665e-10
based O 0 1.5971210465259844e-11
on O 0 6.269961771998567e-10
prevalence O 0 5.578185913179823e-09
estimates O 0 1.271669769487005e-09
of O 0 6.42486330804104e-09
HH B-Disease 1 0.9982954859733582
showed O 0 8.859729661025995e-08
some O 0 6.518771078489749e-10
disagreements O 0 6.836938126753012e-08
with O 0 2.0233911768308133e-11
the O 0 3.488408450991187e-10
RFLP O 0 5.711473960445801e-08
data O 0 1.1347675021866621e-09
, O 0 5.728156837747633e-11
particularly O 0 4.1019618257642776e-10
in O 0 3.5581086965663644e-09
Finns O 0 1.8846593263788236e-07
. O 0 6.717615974594082e-08

The O 0 2.727885259901086e-07
newly O 0 5.300699612575954e-08
described O 0 3.6186396101811624e-08
HFE O 0 5.7413428294239566e-05
marker O 0 4.3495381873981387e-07
provides O 0 1.4162566952524713e-10
a O 0 8.019124253522136e-11
new O 0 6.4360387679041065e-12
approach O 0 1.0297308838946861e-10
to O 0 1.2249757631865865e-11
the O 0 6.098216549788038e-12
screening O 0 7.105688953901179e-11
of O 0 2.524837561246329e-10
HH B-Disease 0 0.001973692560568452
as O 0 4.805375541927503e-10
well O 0 1.5504354744511062e-11
as O 0 5.041674543126984e-12
studies O 0 9.218109782438422e-12
of O 0 8.527309934558414e-12
the O 0 6.133959225967933e-12
relationship O 0 3.001922321832495e-11
between O 0 3.8302297444836597e-10
the O 0 6.814019348766465e-10
HFE O 0 7.299012736439181e-07
Tyr O 0 7.249204969639322e-08
allele O 0 1.6436835226230073e-09
and O 0 1.3353816316619138e-11
different O 0 5.874497416291646e-11
disorders O 0 1.0166574611503165e-05
including O 0 1.1140450340008101e-08
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999994039535522
dominant I-Disease 1 0.9999973773956299
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999967813491821
associated O 0 1.3585852443043223e-08
with O 0 1.1030360652641846e-11
a O 0 5.84894188637719e-10
missense O 0 4.222234650796963e-08
mutation O 0 2.8939359797419684e-09
encoding O 0 5.30697885636755e-09
Gly23 O 0 1.4678398656542413e-05
- O 0 1.247415298166743e-06
- O 0 5.934333557888749e-07
> O 0 2.487826805008808e-06
Val O 0 1.2184476361198904e-07
in O 0 3.3118379150209876e-09
neurophysin O 0 8.069643627095502e-06
II O 1 0.6935887336730957
. O 0 1.2987800346309086e-06

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 2.4687323296745944e-09
ADNDI B-Disease 1 0.9999940395355225
) O 0 7.182467728211739e-12
is O 0 6.9894398428693716e-12
an O 0 2.857312719761751e-10
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.002356045413762331
by O 0 1.8535217805037973e-09
progressive O 1 0.9999220371246338
degeneration O 1 1.0
of O 0 0.00011843010724987835
the O 0 6.24208098543022e-08
magnocellular O 0 3.5981858559352986e-07
neurons O 0 7.220929632012485e-08
of O 0 1.7991538925343775e-07
the O 0 1.537761917802527e-08
hypothalamus O 0 1.610854525324612e-07
leading O 0 1.2767864987495159e-08
to O 0 1.144346284398523e-09
decreased O 0 5.688075788157221e-09
ability O 0 6.978347066866064e-11
to O 0 4.604901182592158e-10
produce O 0 2.265133858259105e-09
the O 0 4.425630084625709e-09
hormone O 0 1.4742654874666528e-09
arginine O 0 1.1473103356252068e-08
vasopressin O 0 5.344250197936162e-08
( O 0 6.751949221950326e-09
AVP O 0 2.4359555936825927e-06
) O 0 6.529522478260219e-10
. O 0 6.361575710656098e-09

Affected O 0 1.1490935492020071e-07
individuals O 0 5.47521861182787e-10
are O 0 1.3783072773387861e-11
not O 0 1.1149325213066774e-10
symptomatic O 0 1.7118539119564957e-07
at O 0 1.2941254290410598e-08
birth O 0 9.190666006020365e-09
, O 0 7.796168224882827e-12
but O 0 1.491704849920783e-11
usually O 0 3.112161361951138e-10
develop O 0 5.60891464829183e-07
diabetes B-Disease 1 1.0
insipidus I-Disease 1 0.99903404712677
at O 0 2.6978118512488436e-06
1 O 0 5.5473201427957974e-06
- O 0 1.0145604392164387e-06
6 O 0 3.184453589710756e-06
yr O 0 1.0714754353102762e-05
of O 0 3.2872137012418534e-08
age O 0 1.6982437500701053e-07
. O 0 1.7006643204808825e-08

The O 0 7.65405516744977e-09
genetic O 0 5.711296768851071e-09
locus O 0 6.357973258985794e-09
of O 0 7.944030433471028e-10
the O 0 2.920596653410712e-09
disease O 0 0.0005130666540935636
is O 0 5.885895104640326e-10
the O 0 5.641485945062641e-09
AVP O 0 3.111553451162763e-05
- O 0 1.049554953169718e-06
neurophysin O 0 0.0008114429074339569
II O 1 0.9999998807907104
( O 0 1.6731965146732364e-08
NPII O 0 0.17296242713928223
) O 0 2.5659774305353267e-10
gene O 0 6.514520589639972e-10
, O 0 2.4569393394791028e-11
and O 0 5.337803810068209e-11
mutations O 0 4.658207153340754e-09
that O 0 2.438304003149483e-10
cause O 0 5.218781552684959e-06
ADNDI B-Disease 1 0.9999967813491821
have O 0 3.2876572575446517e-09
been O 0 3.7214462067503007e-10
found O 0 6.5607259208677604e-12
in O 0 5.113512152772615e-13
both O 0 3.240676769902112e-13
the O 0 4.7691481840084204e-12
signal O 0 1.8351861696963567e-10
peptide O 0 1.5091576877068746e-09
of O 0 4.881284265678687e-09
the O 0 4.724457269844606e-09
prepro O 0 1.0246212696074508e-05
- O 0 9.539839993522037e-06
AVP O 0 1.2211108696646988e-05
- O 0 2.864388477519242e-07
NPII O 0 1.8590922991279513e-05
precursor O 0 2.1284208173710795e-08
and O 0 2.4512017415823095e-10
within O 0 4.081243787368294e-09
NPII O 0 0.0002863327390514314
itself O 0 1.5015382714977932e-08
. O 0 3.8402109936441775e-08

An O 0 1.5473888836936567e-08
affected O 0 1.1305019143037498e-07
girl O 0 5.8025456439736445e-08
who O 0 1.2698345153161483e-10
presented O 0 1.3969723988704885e-10
at O 0 9.0254043128013e-10
9 O 0 2.1694597229782175e-09
months O 0 6.589903067677483e-10
of O 0 2.0860374538855808e-10
age O 0 1.2083622991099219e-08
and O 0 1.2446840433333328e-11
her O 0 3.4660805042080467e-12
similarly O 0 9.143566112590484e-12
affected O 0 9.262267619547515e-10
younger O 0 1.6455405926762978e-09
brother O 0 8.809561968803337e-09
and O 0 3.8795500145738515e-10
father O 0 5.529373847679153e-09
were O 0 3.467194864548162e-10
all O 0 1.6426696808347074e-11
found O 0 3.802826109566837e-12
to O 0 8.571419615743814e-12
have O 0 1.750143432954765e-12
a O 0 1.9144153276529075e-11
novel O 0 2.755329575609977e-10
missense O 0 1.2536054327938473e-07
mutation O 0 1.801670457268756e-08
( O 0 1.7313199485169406e-10
G1758 O 0 1.3681061545867124e-06
- O 0 6.594272008442204e-07
- O 0 9.930583928507986e-07
> O 0 5.353208507585805e-07
T O 0 3.4263599957284896e-08
) O 0 7.180879155188613e-12
encoding O 0 2.949457691969748e-11
the O 0 2.428158785150458e-10
amino O 0 3.7472658309667395e-10
acid O 0 4.418751128887344e-11
substitution O 0 8.206896273676989e-11
Gly23 O 0 1.4596697894830868e-07
- O 0 4.104235173940651e-08
- O 0 7.545259705921126e-08
> O 0 6.520350552818854e-07
Val O 0 1.0839174535703933e-07
within O 0 2.2637786756263267e-08
NPII O 0 0.00021414669754449278
. O 0 9.537863832065341e-08

The O 0 1.0208889733576143e-07
mutation O 0 2.581650271338276e-08
was O 0 2.1842574415842364e-09
confirmed O 0 7.684385766593138e-11
by O 0 3.43453173887176e-12
restriction O 0 2.924861464137507e-09
endonuclease O 0 1.7151972997453413e-07
analysis O 0 2.18589644163103e-08
. O 0 2.12041015856812e-08

A O 0 0.00026714487466961145
T1 O 0 0.0012376060476526618
- O 0 1.0769094842544291e-06
weighted O 0 1.8158774039989112e-08
magnetic O 0 1.1092701868165022e-08
resonance O 0 3.879108145810051e-09
imaging O 0 2.5647276302720456e-08
of O 0 8.606375168085378e-09
the O 0 2.4387903252431897e-08
fathers O 0 5.394338131736731e-07
pituitary O 0 2.0026049242005683e-05
gland O 0 1.8441024849380483e-06
demonstrates O 0 3.205764098623831e-09
an O 0 3.118959535086674e-10
attenuated O 0 1.667453091158677e-07
posterior O 0 0.00039435489452444017
pituitary O 0 0.07283679395914078
bright O 0 4.914066266792361e-06
spot O 0 7.5139314503758214e-06
. O 0 8.093707748457746e-08

This O 0 1.5537001019083618e-08
mutation O 0 8.049861577319462e-08
may O 0 9.771440545591759e-09
be O 0 4.064446557094925e-10
valuable O 0 4.134612444084418e-11
for O 0 7.875856000358339e-13
developing O 0 9.82180222569573e-12
models O 0 2.592561582082098e-11
of O 0 5.985407169895041e-10
dominantly B-Disease 0 6.948253576410934e-05
inherited I-Disease 1 0.9999977350234985
neurodegeneration I-Disease 1 1.0
, O 0 4.4229525597572206e-10
as O 0 1.871744079173787e-12
the O 0 7.147533433171649e-13
early O 0 1.444046011239708e-11
age O 0 3.8828870674301186e-11
of O 0 7.792585153543197e-12
onset O 0 0.00012510610395111144
of O 0 2.0160371150268475e-07
symptoms O 0 0.04526997730135918
suggests O 0 1.1316529935356812e-09
that O 0 4.653688892575225e-12
this O 0 1.1214668083070478e-11
mutation O 0 2.2261021914715684e-09
may O 0 1.095464052802697e-09
be O 0 1.5674142539445768e-10
particularly O 0 8.553067282202065e-11
deleterious O 0 2.1722604515161947e-07
to O 0 6.355512116584805e-09
the O 0 2.5667721281763534e-09
magnocellular O 0 2.22190422505264e-07
neuron O 0 6.519324529108417e-07
. O 0 1.3882244687124512e-08
. O 0 3.0227486291778405e-08

Frequent O 0 6.734254043294641e-07
inactivation O 0 0.00010428639507154003
of O 0 1.331758767264546e-06
PTEN O 1 0.9998651742935181
/ O 0 0.04826943203806877
MMAC1 O 1 0.9999960660934448
in O 0 1.6332815278019552e-07
primary O 1 1.0
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.554986637434922e-05

Sporadic B-Disease 1 0.9999998807907104
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 6.347625458147377e-06
the O 0 1.0726917132330982e-08
most O 0 2.470076920779718e-11
common O 0 1.1891558848731165e-09
male B-Disease 0 5.539864122994231e-10
cancer I-Disease 0 2.5094275546422296e-09
in O 0 9.670303620368248e-12
the O 0 3.704892989619957e-11
Western O 0 4.664608699300743e-09
world O 0 2.554409461730245e-10
, O 0 6.739201210970158e-12
yet O 0 5.957658671951194e-11
many O 0 3.846359266247018e-13
of O 0 9.406090489827434e-12
the O 0 6.677987589992496e-12
major O 0 1.4237863665833572e-10
genetic O 0 1.7615384151348223e-10
events O 0 1.1550544591967804e-12
involved O 0 4.2417601549271655e-12
in O 0 3.590622590921022e-12
the O 0 2.3453581091126274e-11
progression O 0 5.505064848421171e-09
of O 0 6.971363070151781e-11
this O 0 7.834750903601417e-11
often O 0 7.103320709411776e-10
fatal O 0 0.0010074600577354431
cancer B-Disease 1 0.9705156087875366
remain O 0 3.1476609763103625e-08
to O 0 3.301488193940827e-09
be O 0 2.1616788359324346e-08
elucidated O 0 1.0424691936350428e-05
. O 0 1.1161894519773341e-07

Numerous O 0 7.270487856203545e-08
cytogenetic O 0 1.6568797946092673e-05
and O 0 1.1150569356743745e-08
allelotype O 0 3.421748260734603e-05
studies O 0 1.5000239272922045e-08
have O 0 7.755297792844118e-11
reported O 0 5.106775557983667e-10
frequent O 0 6.764784843404925e-10
loss O 0 2.3687107830738796e-09
of O 0 6.5641150293060946e-09
heterozygosity O 0 8.733740628485975e-07
on O 0 4.3961361484434747e-07
chromosomal O 0 5.988815610180609e-05
arm O 0 4.428158717928454e-06
10q O 0 0.0005626552156172693
in O 0 4.208903447988632e-08
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8838824033737183

Deletion O 0 6.3290017351391725e-06
mapping O 0 2.1578894404683524e-07
studies O 0 3.992165265032099e-09
have O 0 4.329922184687085e-11
unambiguously O 0 3.065281362069072e-09
identified O 0 2.738699267368361e-10
a O 0 6.818071801584225e-11
region O 0 4.427563649045396e-09
of O 0 2.768595797064677e-09
chromosome O 0 1.0400620340078603e-05
10q23 O 0 5.384899395721732e-06
to O 0 6.293637833110211e-10
be O 0 6.46389469727282e-11
the O 0 1.7268964036531997e-11
minimal O 0 6.581817313389138e-09
area O 0 4.038270517980891e-08
of O 0 1.0520201598751555e-08
loss O 0 3.294897510386363e-07
. O 0 2.759235542271199e-07

A O 0 3.6795081541640684e-06
new O 0 1.6187694740210645e-08
tumor B-Disease 0 2.3036634502204834e-06
suppressor O 0 1.2083182809874415e-06
gene O 0 5.4088324930035014e-09
, O 0 2.8881666502833525e-10
PTEN O 0 4.001050183433108e-05
/ O 0 3.063565964112058e-05
MMAC1 O 1 0.9999998807907104
, O 0 1.2027838280914693e-08
was O 0 4.0346986907024984e-07
isolated O 0 1.0600735578236709e-07
recently O 0 1.611775157783768e-09
at O 0 4.0807202061898806e-10
this O 0 1.6679588266121925e-11
region O 0 3.879404353313021e-09
of O 0 3.847393958977818e-09
chromosome O 0 2.2937238099984825e-05
10q23 O 0 6.431954534491524e-05
and O 0 9.510371379306548e-10
found O 0 1.1808422295533916e-10
to O 0 6.356863646583832e-11
be O 0 1.4413108727351354e-11
inactivated O 0 4.6854960883413455e-11
by O 0 3.8227520107736446e-12
mutation O 0 1.3564587231229552e-09
in O 0 9.92425364110261e-10
three O 0 1.9877020918102062e-07
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.05617485195398331
lines O 0 8.438063332505408e-07
. O 0 1.1078644490680745e-07

We O 0 2.330344841539045e-06
screened O 0 2.6988204808731098e-06
80 O 0 4.5251867959450465e-06
prostate B-Disease 1 0.9999951124191284
tumors I-Disease 1 1.0
by O 0 7.400894341813569e-10
microsatellite O 0 3.065411391389716e-08
analysis O 0 8.422797459495257e-10
and O 0 4.020894381340234e-11
found O 0 1.5315256007841782e-10
chromosome O 0 1.3794620201679209e-07
10q23 O 0 4.560128843422717e-07
to O 0 1.3104388685292179e-09
be O 0 5.343022135839703e-10
deleted O 0 1.2774922231173491e-09
in O 0 1.0474460881981784e-10
23 O 0 4.5433012907381e-09
cases O 0 4.322671387502197e-10
. O 0 6.627343562826127e-09

We O 0 1.8338309359933191e-07
then O 0 1.5531304020655057e-09
proceeded O 0 5.069431541215863e-10
with O 0 7.960516604623227e-14
sequence O 0 1.4013743507637622e-12
analysis O 0 5.83102142959202e-13
of O 0 1.4914373555607874e-11
the O 0 6.0964754078352e-11
entire O 0 1.9174001053556822e-08
PTEN O 0 0.00014853777247481048
/ O 0 7.876242307247594e-06
MMAC1 O 0 0.0001652862410992384
coding O 0 2.227522344355748e-07
region O 0 6.738738278500023e-08
and O 0 1.413008182682418e-10
tested O 0 2.223754375085818e-10
for O 0 6.425297793821727e-11
homozygous O 0 1.0622321910958021e-09
deletion O 0 1.0189997290410702e-08
with O 0 2.4932454104759083e-12
new O 0 5.561098109785334e-11
intragenic O 0 6.342780807244708e-07
markers O 0 1.1109005271237038e-08
in O 0 8.181921112848656e-11
these O 0 2.9184875002807864e-12
23 O 0 2.643772145649592e-10
cases O 0 1.2313520862672345e-11
with O 0 4.4006994229239815e-12
10q23 O 0 4.9128488171845675e-05
loss O 0 4.95396875521692e-07
of O 0 2.286959215780371e-06
heterozygosity O 0 0.005880143027752638
. O 0 1.1015050631613121e-06

The O 0 2.133024423756069e-09
identification O 0 5.412111869773639e-10
of O 0 6.869191881975212e-10
the O 0 1.7145078412550419e-10
second O 0 1.3582683866530942e-09
mutational O 0 1.158852711569125e-07
event O 0 3.395242309522928e-09
in O 0 2.3984694785816885e-10
10 O 0 3.1541258493916757e-09
( O 0 1.5689337329316544e-10
43 O 0 3.617125514665531e-07
% O 0 9.502002029648793e-08
) O 0 2.587393233000057e-08
tumors B-Disease 1 1.0
establishes O 0 1.0914093763858546e-05
PTEN O 1 0.9999369382858276
/ O 0 0.009849409572780132
MMAC1 O 1 0.9981959462165833
as O 0 5.83906645257315e-10
a O 0 9.269173623094318e-11
main O 0 2.0705777370455536e-10
inactivation O 0 1.4294087025135127e-09
target O 0 4.122142072127133e-10
of O 0 1.6849224793169526e-10
10q O 0 1.3311389921000227e-05
loss O 0 2.6456370960659115e-07
in O 0 5.561446059232367e-08
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.6720468920539133e-06
. O 0 1.226069628046389e-07

Risk O 0 7.026673847576603e-05
reversals O 0 5.647452780976892e-07
in O 0 1.080361772265448e-10
predictive O 0 3.2925833171049135e-09
testing O 0 3.2166238561615046e-09
for O 0 2.246940411509968e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.5022235351789277e-06

The O 0 3.664089476274057e-08
first O 0 2.8534297147331245e-10
predictive O 0 3.731975173337787e-09
testing O 0 3.985872965017734e-09
for O 0 3.84952247856063e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.4618972699054211e-09
HD B-Disease 0 2.9236468890303513e-06
) O 0 4.590674368420977e-11
was O 0 4.901639094612165e-10
based O 0 1.5393325503154642e-11
on O 0 4.787627516655846e-10
analysis O 0 8.555726960235432e-11
of O 0 1.388143627822913e-10
linked O 0 2.4771706907955604e-09
polymorphic O 0 4.754415083851882e-09
DNA O 0 1.261512050376723e-08
markers O 0 2.1236135072655316e-10
to O 0 2.0268869915796017e-11
estimate O 0 2.593111836368678e-10
the O 0 1.770227367470234e-11
likelihood O 0 2.0079191642707883e-09
of O 0 1.8070246410317736e-09
inheriting O 0 1.8544280777632594e-08
the O 0 2.4448807423027574e-09
mutation O 0 3.7345597725391144e-09
for O 0 1.4455273644742306e-09
HD B-Disease 0 2.1527524950215593e-05
. O 0 2.9689016400880064e-07

Limits O 0 1.0159260455111507e-07
to O 0 1.0813105966178682e-09
accuracy O 0 1.819919437373585e-09
included O 0 1.3244185262384356e-11
recombination O 0 1.0929153415606407e-10
between O 0 8.604580936655282e-10
the O 0 6.87968126911187e-10
DNA O 0 1.6886619880196463e-09
markers O 0 9.49713863107604e-10
and O 0 5.3009135275727814e-11
the O 0 4.2942785438704334e-10
mutation O 0 1.516626468855975e-08
, O 0 1.564922913477318e-10
pedigree O 0 4.569503442297673e-09
structure O 0 1.0589172205754949e-08
, O 0 1.742979510721554e-10
and O 0 2.248258523795954e-11
whether O 0 4.757512439557132e-11
DNA O 0 4.400938780069197e-10
samples O 0 1.8584929602216693e-12
were O 0 3.473901667629814e-13
available O 0 8.443921018126688e-13
from O 0 8.970189868673373e-11
family O 0 8.585953475970243e-11
members O 0 6.384433953732227e-11
. O 0 8.529192463413438e-09

With O 0 7.608172980511085e-10
direct O 0 1.3153952593825124e-08
tests O 0 6.44219844136984e-10
for O 0 4.762506014555079e-11
the O 0 9.36110522431477e-10
HD B-Disease 0 3.3299249935225816e-06
mutation O 0 1.4651172364210652e-07
, O 0 2.4175206281285e-10
we O 0 2.2048081416148335e-10
have O 0 1.677623144569207e-11
assessed O 0 5.52393464303691e-09
the O 0 1.248553205268621e-10
accuracy O 0 1.196018506455232e-09
of O 0 1.1824356771494848e-10
results O 0 1.9042075208308695e-11
obtained O 0 5.1336584289130016e-11
by O 0 1.0711710164701405e-11
linkage O 0 2.556862499503154e-09
approaches O 0 2.9410340829372217e-09
when O 0 1.908494542957051e-11
requested O 0 2.5068763731539434e-10
to O 0 3.6898806232699144e-10
do O 0 1.6970820582162816e-10
so O 0 3.638121054416743e-12
by O 0 1.5357129630466648e-12
the O 0 1.8575830110223457e-11
test O 0 4.432205991111715e-11
individuals O 0 2.1898868135528105e-11
. O 0 1.3802983644950473e-08

For O 0 5.2964721497517075e-09
six O 0 2.5289631500058363e-10
such O 0 6.999512081051762e-12
individuals O 0 9.560308794620553e-11
, O 0 4.939185865859841e-11
there O 0 1.6889090126426254e-10
was O 0 3.7186951296064308e-09
significant O 0 5.579779416287067e-10
disparity O 0 8.790427052929317e-09
between O 0 2.3490762668387788e-09
the O 0 4.920122531615334e-09
tests O 0 3.261382053310058e-09
. O 0 5.8460223328893335e-09

Three O 0 8.065599388373812e-08
went O 0 4.5191132613808804e-08
from O 0 4.595021863007531e-10
a O 0 6.169565414104738e-10
decreased O 0 2.5150349358682433e-08
risk O 0 9.884130180992656e-10
to O 0 1.3954538045923837e-11
an O 0 2.237016344733278e-12
increased O 0 2.9852909033678543e-10
risk O 0 4.134926356869073e-08
, O 0 3.3353021733351085e-11
while O 0 2.0394321648131708e-11
in O 0 6.918730345584212e-12
another O 0 1.0076072615161635e-10
three O 0 1.7386654616036168e-11
the O 0 7.086725650751191e-11
risk O 0 1.8763868236959524e-09
was O 0 1.2943771388052028e-08
decreased O 0 9.805106060412072e-08
. O 0 2.136759569282276e-08

Knowledge O 0 6.498337370430818e-07
of O 0 4.9673658963911294e-08
the O 0 1.5015975129983872e-09
potential O 0 4.7002970404719235e-09
reasons O 0 5.561843763324248e-10
for O 0 1.0783765373723053e-11
these O 0 7.511811268498536e-13
changes O 0 1.3780734366142244e-11
in O 0 3.5108329004412964e-12
results O 0 2.1789705456631836e-11
and O 0 1.0174948557317709e-11
impact O 0 1.167032781523858e-08
of O 0 3.7063507818402286e-10
these O 0 3.550875956118138e-12
risk O 0 4.812750198368576e-10
reversals O 0 1.413273054140518e-09
on O 0 7.218540210018887e-10
both O 0 6.475318545251518e-12
patients O 0 1.299481008909531e-11
and O 0 3.6677882953028984e-12
the O 0 3.9135798768352714e-11
counseling O 0 3.860606972994063e-11
team O 0 1.6319907122745725e-13
can O 0 1.0261517113460683e-12
assist O 0 2.1546325487675766e-11
in O 0 9.512810678069528e-12
the O 0 6.300204108411478e-11
development O 0 2.9843344462321397e-10
of O 0 6.773095279077879e-11
strategies O 0 7.145987274137511e-11
for O 0 3.8822187652109985e-12
the O 0 5.5788935970912945e-11
prevention O 0 2.812119870299057e-09
and O 0 6.6072399287908645e-12
, O 0 2.1120908841321118e-12
where O 0 8.450724495179252e-12
necessary O 0 1.632968538167745e-09
, O 0 3.162544184864835e-11
management O 0 9.194519035027326e-10
of O 0 4.817525822709001e-10
a O 0 7.777669619457583e-10
risk O 0 1.992666653904962e-08
reversal O 0 1.0711230791216053e-09
in O 0 6.566359001675126e-12
any O 0 1.7825468531795785e-11
predictive O 0 8.779677679315867e-11
testing O 0 3.3119292031091874e-11
program O 0 6.658426414396512e-12
. O 0 9.859603584960741e-12
. O 0 7.336384832967724e-10

A O 0 2.8398270046636753e-07
novel O 0 8.850657096104442e-09
common O 0 7.636264953703176e-09
missense O 0 1.8214642523162183e-06
mutation O 0 3.998515865077934e-07
G301C O 0 2.4061621388682397e-06
in O 0 4.47910264433915e-10
the O 0 9.081924101650429e-10
N O 0 2.123474445170359e-07
- O 0 4.8038867106470207e-08
acetylgalactosamine O 0 1.2498707064878545e-06
- O 0 2.1752704526534217e-07
6 O 0 1.907006037527026e-07
- O 0 1.3708216783925309e-08
sulfate O 0 1.990163589482563e-08
sulfatase O 0 2.2760707452107454e-07
gene O 0 5.720910412065905e-10
in O 0 6.663972151876862e-10
mucopolysaccharidosis B-Disease 0 2.2805847038398497e-05
IVA I-Disease 1 0.9999841451644897
. O 0 4.770358827954624e-06

Mucopolysaccharidosis B-Disease 1 0.9931492209434509
IVA I-Disease 1 1.0
( O 0 3.3763110423024045e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 4.2190426152721727e-10
is O 0 1.210474082080637e-10
an O 0 2.8014221498118275e-10
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9845976829528809
by O 0 2.912291519052701e-09
a O 0 1.0402080761195975e-06
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 4.88651288321762e-08
N O 0 1.183265908366593e-06
- O 0 5.298334215808609e-08
acetylgalactosamine O 0 1.3166977623768616e-06
- O 0 4.624944267561659e-07
6 O 0 1.0096533742398606e-06
- O 0 1.0534542838058769e-07
sulfate O 0 3.46354397606774e-07
sulfatase O 0 4.5728461373073515e-06
( O 0 2.078746064171355e-09
GALNS O 0 5.358526686904952e-05
) O 0 1.6593832974365341e-09
. O 0 1.4597164366136894e-08

In O 0 2.781209751390179e-08
previous O 0 1.43656491147226e-08
studies O 0 3.2403992822338523e-09
, O 0 3.2849459263850633e-11
we O 0 9.010280715981978e-11
have O 0 3.691305507785847e-12
found O 0 2.6496302981543485e-12
two O 0 4.0685204229055916e-13
common O 0 2.6367859284892603e-11
mutations O 0 1.2120572323581769e-09
in O 0 2.45874987037098e-10
Caucasians O 0 1.5210355641670503e-08
and O 0 5.284088722135039e-10
Japanese O 0 9.208743279032205e-08
, O 0 1.5506912420804042e-09
respectively O 0 1.305756853753337e-07
. O 0 1.2264742110801308e-07

To O 0 1.9287567454284726e-07
characterize O 0 5.79987784021796e-07
the O 0 5.865859353804126e-09
mutational O 0 2.2592932680254307e-07
spectrum O 0 4.458930646933368e-08
in O 0 1.6001458838510452e-11
various O 0 2.686955258984769e-12
ethnic O 0 9.069525686022928e-11
groups O 0 3.059540685038109e-12
, O 0 5.1007154229509855e-12
mutations O 0 1.540619853912517e-10
in O 0 2.199413914882875e-11
the O 0 1.452156034309482e-10
GALNS O 0 2.9982156775076874e-06
gene O 0 1.3038660429121052e-10
in O 0 6.71877276037236e-11
Colombian O 0 6.510241519208648e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.0139117395956418e-07
were O 0 1.62240987311435e-09
investigated O 0 6.378454742161921e-08
, O 0 1.849205788495567e-10
and O 0 1.6201454067221732e-10
genetic O 0 2.301929136194758e-08
backgrounds O 0 6.885877423812303e-10
were O 0 8.345777541274302e-11
extensively O 0 5.908813369148724e-12
analyzed O 0 5.0048670069413603e-11
to O 0 2.1445180700685462e-11
identify O 0 1.306714320081781e-10
racial O 0 2.639312934871185e-10
origin O 0 1.7438665095292905e-11
, O 0 1.51985509681124e-12
based O 0 6.976985829354465e-12
on O 0 1.527226789477254e-09
mitochondrial O 0 2.7046058725943567e-09
DNA O 0 4.296435651696129e-09
( O 0 7.022006587309448e-11
mtDNA O 0 1.8014496561136184e-09
) O 0 2.63222443841471e-10
lineages O 0 8.22683965395754e-09
. O 0 4.744305392989645e-09

Three O 0 4.245230833532787e-09
novel O 0 6.300006294424065e-09
missense O 0 2.5410886337340344e-06
mutations O 0 3.662556480321655e-07
never O 0 9.820131374738139e-09
identified O 0 2.146942845726585e-09
previously O 0 1.8302434567907255e-10
in O 0 3.909646044408799e-12
other O 0 1.2409901665316747e-12
populations O 0 2.918654467415349e-12
and O 0 1.8167293841173104e-12
found O 0 1.7672382654487784e-11
in O 0 1.2545611251246758e-11
16 O 0 3.8650002642803827e-10
out O 0 1.071119928863773e-11
of O 0 8.075654728267878e-11
19 O 0 2.8753170955297946e-09
Colombian O 0 3.065692339987436e-07
MPS B-Disease 1 0.999987006187439
IVA I-Disease 1 1.0
unrelated O 0 1.0469578093363907e-08
alleles O 0 2.940785948091218e-10
account O 0 4.906154649209071e-11
for O 0 1.1228029617171842e-10
84 O 0 7.234729082483682e-08
. O 0 2.5657257651801046e-08

2 O 0 4.418058665578428e-07
% O 0 4.764191263717521e-09
of O 0 2.3365809287412276e-10
the O 0 1.823893813757138e-10
alleles O 0 2.041277841202671e-10
in O 0 6.200423507962682e-11
this O 0 2.7779356592816384e-10
study O 0 2.904785967317025e-09
. O 0 7.752214870038188e-09

The O 0 7.000967343628872e-07
G301C O 0 6.456443225033581e-05
and O 0 1.8693574688199988e-08
S162F O 0 9.746418072609231e-06
mutations O 0 1.3737976978234201e-08
account O 0 1.5306436673689916e-10
for O 0 7.035765858809384e-10
68 O 0 4.084439240159554e-07
. O 0 3.404627335612531e-08

4 O 0 9.866497748589609e-06
% O 0 3.287126446593902e-07
and O 0 1.0533815597568719e-08
10 O 0 2.1493904966973787e-07
. O 0 7.541446933601037e-08

5 O 0 8.461714173790824e-07
% O 0 2.778351948506952e-08
of O 0 2.767941209569358e-09
mutations O 0 1.867390331256047e-08
, O 0 8.829132563947795e-11
respectively O 0 2.4596189529546564e-09
, O 0 4.791096339107348e-11
whereas O 0 4.627829230940961e-10
the O 0 1.6588833640085454e-09
remaining O 0 2.6361764327020865e-08
F69V O 0 1.5295459888875484e-05
is O 0 7.2610119306038e-11
limited O 0 8.814422282343859e-12
to O 0 4.1177547482895704e-11
a O 0 2.3530527526460787e-10
single O 0 7.155701586825103e-10
allele O 0 4.759715821478494e-08
. O 0 1.6977312000676648e-08

The O 0 2.7897687715494612e-08
skewed O 0 1.1319755799377162e-07
prevalence O 0 9.928143640536291e-08
of O 0 1.8632837495147214e-09
G301C O 0 1.985967855944182e-06
in O 0 4.491747251922362e-10
only O 0 1.114388803458155e-09
Colombian O 0 1.8173956561895466e-07
patients O 0 1.4005695492258496e-09
and O 0 3.530704895116088e-11
haplotype O 0 1.3787925245978272e-09
analysis O 0 1.5558743529653363e-11
by O 0 7.190002716470079e-13
restriction O 0 9.386112026499305e-11
fragment O 0 1.0693532725980504e-09
length O 0 6.987274092651319e-10
polymorphisms O 0 9.688702062859988e-10
in O 0 4.0433972142706054e-11
the O 0 4.761808725106675e-10
GALNS O 0 2.3583948859595694e-05
gene O 0 1.7361155846273846e-09
suggest O 0 6.159383003634389e-10
that O 0 1.8718379277138375e-11
G301C O 0 7.281618508159227e-08
originated O 0 6.759622028784662e-11
from O 0 2.8556169581750446e-11
a O 0 7.143861197045354e-11
common O 0 4.981564605266442e-10
ancestor O 0 4.1856552002172975e-08
. O 0 2.6187167989633053e-08

Investigation O 0 5.414051997831848e-07
of O 0 3.1221770058209586e-08
the O 0 1.8678276703099073e-09
genetic O 0 1.5388643692659798e-09
background O 0 1.0165017265417742e-11
by O 0 3.3743776002570502e-12
means O 0 3.0899589553712303e-09
of O 0 2.656323827565643e-09
mtDNA O 0 2.28683028069554e-09
lineages O 0 5.642986772302905e-11
indicate O 0 3.2685902595641636e-11
that O 0 1.7032934307784076e-12
all O 0 8.791755518045008e-12
our O 0 1.1800040979059734e-11
patients O 0 2.558165918681299e-12
are O 0 1.4851905512716645e-13
probably O 0 4.934498920583508e-10
of O 0 5.366819766372544e-10
native O 0 3.435865481016265e-10
American O 0 4.7776955724998516e-09
descent O 0 1.611445077287499e-05

Low O 0 5.297222855915606e-07
frequency O 0 7.762679388179095e-08
of O 0 1.4182099050685792e-08
BRCA1 O 0 4.0944158286038146e-07
germline O 0 2.6587285901769064e-06
mutations O 0 3.779893731348238e-09
in O 0 1.7915382719002615e-11
45 O 0 4.7743160536128926e-09
German O 1 0.9324326515197754
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.904140951111913e-06
. O 0 2.899927835642302e-07

In O 0 1.948754224656568e-08
this O 0 7.434822757446113e-10
study O 0 2.3517290892449694e-10
we O 0 1.5851032292291123e-11
investigated O 0 4.937078523781224e-10
45 O 0 7.64066498959437e-09
German O 1 0.9302782416343689
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.2686300898678837e-08
for O 0 1.0625543778175484e-09
germline O 0 2.9942788160042255e-07
mutations O 0 4.853534907311996e-09
in O 0 9.072397694209755e-11
the O 0 7.484792230449955e-10
BRCA1 O 0 3.188538855170009e-08
gene O 0 1.3497235329396062e-08
. O 0 7.757051001533455e-09

We O 0 7.530665868671349e-08
identified O 0 3.3076019700928327e-09
four O 0 2.1429980012754868e-10
germline O 0 1.464656236294104e-07
mutations O 0 9.9486126003967e-09
in O 0 1.1997604298930042e-10
three O 0 3.764652478643882e-10
breast B-Disease 1 0.9931468367576599
cancer I-Disease 1 0.9999997615814209
families O 0 1.951855566062477e-09
and O 0 1.8126505851867591e-10
in O 0 3.3355920248112625e-09
one O 0 0.0019769335631281137
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 2.884816922232858e-06
. O 0 1.9191691291720048e-10
among O 0 6.647357360736739e-13
these O 0 2.588689896124152e-13
were O 0 1.0150409159026541e-11
one O 0 9.065923359252714e-12
frameshift O 0 1.4049903462876046e-08
mutation O 0 1.6354629650550123e-08
, O 0 1.2148664019218103e-10
one O 0 1.0249869009104629e-10
nonsense O 0 2.9207319229840323e-08
mutation O 0 3.5003822063117696e-08
, O 0 2.953544700479149e-11
one O 0 5.88665271042399e-12
novel O 0 2.1005055333978007e-11
splice O 0 2.7903952481977967e-09
site O 0 3.133090453744103e-10
mutation O 0 6.381795647492083e-10
, O 0 1.6168476280054023e-11
and O 0 3.9672109347632656e-11
one O 0 2.403700793962571e-09
missense O 0 1.2900725778308697e-05
mutation O 0 6.08947520959191e-05
. O 0 1.119882313105336e-06

The O 0 9.05121950722787e-08
missense O 0 2.2534970867127413e-06
mutation O 0 1.892992429475271e-07
was O 0 2.6758419480188422e-08
also O 0 2.4901337936089618e-11
found O 0 5.6953435023654464e-11
in O 0 1.8174868554599044e-10
2 O 0 3.844784828288539e-07
. O 0 8.187583233620899e-08

8 O 0 1.108888227463467e-06
% O 0 5.959941162814175e-08
of O 0 2.0106976084122152e-09
the O 0 6.053144097073471e-10
general O 0 6.206617442217066e-09
population O 0 6.017948639414072e-11
, O 0 3.3639287102399384e-12
suggesting O 0 7.268800145121546e-11
that O 0 9.736185382219764e-13
it O 0 1.4097978427024538e-12
is O 0 7.588875708397502e-12
not O 0 3.125939507242492e-10
disease O 0 1.5183694301867945e-07
associated O 0 3.0260597583264826e-08
. O 0 1.2657713455155317e-07

The O 0 1.4726635466644211e-09
average O 0 3.298150641484199e-10
age O 0 2.627621231710009e-09
of O 0 3.799320857922339e-10
disease O 0 3.294885027571581e-05
onset O 1 0.6212500333786011
in O 0 2.7254842827062475e-10
those O 0 4.113076546019556e-11
families O 0 1.7145396213891217e-11
harbouring O 0 5.3772120089945474e-09
causative O 0 4.52188730903913e-09
mutations O 0 8.777493398781644e-09
was O 0 5.019211712919969e-09
between O 0 8.847719001892074e-09
32 O 0 2.7854787276737625e-07
. O 0 1.6608217023872385e-08

3 O 0 1.8109083612216637e-05
and O 0 1.17844990654703e-07
37 O 0 3.558603339115507e-06
. O 0 1.8443384419697395e-07

4 O 0 7.471850494766841e-06
years O 0 6.411228525848855e-08
, O 0 1.4244871948676519e-10
whereas O 0 8.504026927091957e-10
the O 0 3.486745336900299e-10
family O 0 6.623696729990414e-11
harbouring O 0 2.801199050495029e-09
the O 0 2.181732988715268e-10
missense O 0 1.6546971792763543e-08
mutation O 0 3.9876066892929884e-09
had O 0 4.0860297784162114e-11
an O 0 4.0591412609619626e-13
average O 0 6.468208347404358e-12
age O 0 1.8345211461046063e-10
of O 0 2.379123842377595e-10
onset O 0 6.218970520421863e-05
of O 0 1.4941294921300141e-06
51 O 0 8.9889726950787e-06
. O 0 1.6974922800727654e-07

2 O 0 4.3011295929318294e-05
years O 0 9.578972139934194e-07
. O 0 1.2696352769125951e-07

These O 0 3.642429136085923e-10
findings O 0 2.1482361722835464e-10
show O 0 6.459651823859103e-12
that O 0 9.149336019712018e-13
BRCA1 O 0 2.4462629255594948e-08
is O 0 2.1325555210616187e-10
implicated O 0 1.4183344276830212e-08
in O 0 2.7330830307259468e-11
a O 0 2.2798771551202357e-11
small O 0 6.5049905566272326e-12
fraction O 0 2.1221975288199246e-09
of O 0 8.41099506487808e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.1892783424727327e-09
suggesting O 0 1.946007244235659e-10
the O 0 1.8646329272287154e-11
involvement O 0 9.966739933364721e-11
of O 0 2.3681482122506203e-11
another O 0 1.0883404420736209e-11
susceptibility O 0 1.6486162435214169e-09
gene O 0 2.404796806132481e-09
( O 0 7.877384855525804e-10
s O 0 9.034692993736826e-07
) O 0 4.379322859904278e-08

Paternal O 0 6.285728886723518e-06
transmission O 0 9.446279727853835e-05
of O 0 0.0007320459117181599
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9954525828361511

We O 0 8.843064733810024e-07
report O 0 1.2138733351818587e-09
a O 0 9.943157408542902e-11
rare O 0 3.646069904328364e-11
case O 0 4.91741813934965e-10
of O 0 7.416522951331217e-10
paternally O 0 0.0024823143612593412
transmitted O 1 0.9999964237213135
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.9706180763896555e-06
DM B-Disease 1 1.0
) O 0 4.0022619884894084e-08
. O 0 1.2298710316827055e-07

The O 0 9.810156598177855e-08
proband O 0 3.32149829773698e-05
is O 0 4.1378100945621554e-10
a O 0 1.21554086240927e-10
23 O 0 6.999038570931759e-10
year O 0 6.468445917784393e-11
old O 0 1.5566486766260823e-08
, O 0 1.5485042137441951e-09
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 4.132964022574015e-05
who O 0 6.293570464777076e-08
suffers O 1 0.999934196472168
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 0 0.2569407820701599

He O 0 6.015490328081796e-08
presented O 0 2.0363488673069696e-08
with O 0 2.6619233484126426e-09
respiratory O 1 0.9995768666267395
and O 0 1.454887552654327e-07
feeding O 0 9.605942068446893e-07
difficulties O 0 3.2481532343808794e-06
at O 0 1.067342395799642e-06
birth O 0 9.915215741784777e-07
. O 0 1.4953683091789571e-07

His O 0 3.820146957878023e-06
two O 0 1.423576492243228e-07
sibs O 1 0.9999980926513672
suffer O 0 0.007730043027549982
from O 0 7.237384807012859e-07
childhood O 1 0.9765191674232483
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 7.045769598335028e-05

Their O 0 8.427494258000934e-09
late O 0 1.5362118119810475e-06
father O 0 1.5810355691314726e-08
had O 0 4.719447055379078e-10
the O 0 1.1614151480821011e-11
adult O 0 8.74848110621329e-12
type O 0 1.8430613979436572e-10
of O 0 7.876036711707002e-09
DM B-Disease 1 1.0
, O 0 2.3623041300879777e-09
with O 0 1.2010609173884745e-10
onset O 1 0.7679018974304199
around O 0 2.5001936521107382e-08
30 O 0 6.049363321380952e-08
years O 0 1.014901140905522e-08
. O 0 5.994344576265576e-09

Only O 0 1.6380509393343345e-08
six O 0 1.799100174393331e-10
other O 0 2.777497199249468e-13
cases O 0 1.0227459070616396e-12
of O 0 6.888602969296054e-12
paternal O 0 6.680443753737109e-09
transmission O 0 4.2069959818036295e-06
of O 0 0.0005497471429407597
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.0376025065779686
been O 0 1.695381968147558e-08
reported O 0 7.335614893300146e-10
recently O 0 1.142603567316769e-09
. O 0 3.221296118738337e-09

We O 0 6.967942312030573e-08
review O 0 4.186595070621024e-09
the O 0 3.01230512755879e-10
sex O 0 3.7876840552897306e-11
related O 0 4.8351059267481844e-11
effects O 0 3.5106506590665276e-09
on O 0 8.582491162201222e-09
transmission O 0 5.828867983836972e-07
of O 0 7.953465228638379e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.09555933624505997

Decreased O 0 4.974589955963893e-06
fertility O 0 9.984220383785214e-08
of O 0 1.761242818254516e-10
males O 0 5.6230861980588465e-12
with O 0 6.16498903793436e-14
adult O 0 2.904330109743114e-10
onset O 0 2.1481342628248967e-05
DM B-Disease 1 1.0
and O 0 4.950360121824815e-08
contraction O 0 1.2562675237859366e-06
of O 0 1.716282937991309e-08
the O 0 5.334804265011428e-10
repeat O 0 5.079652809492075e-10
upon O 0 5.7451828017196505e-11
male O 0 8.61248659195235e-12
transmission O 0 2.5087069574492027e-11
contribute O 0 1.1769201932465556e-11
to O 0 2.45385760322403e-11
the O 0 3.190681399645179e-11
almost O 0 1.269500199407858e-10
absent O 0 1.0933056682205233e-09
occurrence O 0 1.8053769590409274e-10
of O 0 6.73704564357891e-11
paternal O 0 3.871879261652111e-09
transmission O 0 5.210165454627713e-07
of O 0 8.205826702578634e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 9.525191853754222e-05

Also O 0 1.0758717472469925e-08
the O 0 4.618661009203606e-09
fathers O 0 1.5690488908148836e-08
of O 0 1.6774776012695725e-09
the O 0 4.0532677214599744e-10
reported O 0 1.3114947350345574e-08
congenitally O 0 0.000777768378611654
affected O 0 5.789373176412482e-07
children O 0 5.315255346971526e-09
showed O 0 9.126238653678342e-10
, O 0 9.635731795798463e-11
on O 0 2.3965879947240865e-08
average O 0 2.690056399856644e-09
, O 0 2.1289181528771906e-10
shorter O 0 8.697503517396399e-08
CTG O 0 4.100349542568438e-06
repeat O 0 6.219217141278932e-08
lengths O 0 4.887202749159769e-07
and O 0 1.514282796377664e-11
hence O 0 2.2700891166849146e-10
less O 0 3.835522455197804e-10
severe O 0 4.704510558894981e-07
clinical O 0 1.0657155513627004e-07
symptoms O 0 3.4125964276654486e-09
than O 0 4.7950246204186975e-12
the O 0 1.629373545808388e-11
mothers O 0 3.5087575206427246e-12
of O 0 4.7440085713945646e-12
children O 0 1.681409698972569e-11
with O 0 2.3402518811721507e-10
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.6392496228218079

We O 0 2.5122494307083798e-08
conclude O 0 3.2723626475217316e-08
that O 0 1.2668002064009087e-11
paternal O 0 7.1754135966273225e-09
transmission O 0 2.6358907234680373e-07
of O 0 1.7003712855512276e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 4.687329055741429e-05
rare O 0 1.4721132091111144e-09
and O 0 2.378269456371207e-11
preferentially O 0 1.1501575386541063e-10
occurs O 0 2.4978782930951127e-11
with O 0 4.191556227540333e-13
onset O 0 4.684900147822191e-07
of O 0 7.044850036663775e-08
DM B-Disease 1 1.0
past O 0 4.7486307153121743e-07
30 O 0 6.902738824976495e-09
years O 0 4.760108279766584e-11
in O 0 5.32160730412623e-12
the O 0 2.762347642293328e-11
father O 0 6.714829803300404e-10
. O 0 3.6952052528960166e-10
. O 0 8.014376717824234e-09

The O 0 1.1558483947737841e-07
RB1 O 0 2.939190380857326e-06
gene O 0 1.0418674811774054e-09
mutation O 0 1.1874536909317612e-09
in O 0 4.768577546720998e-11
a O 0 6.635372251651006e-10
child O 0 2.3496960821489665e-08
with O 0 1.8566073123338356e-09
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.0004263974551577121

The O 0 2.381705712650728e-07
RB1 O 0 4.257016371411737e-06
gene O 0 1.1681146050435132e-09
mutation O 0 5.218855569921743e-09
was O 0 1.9358092906429647e-09
investigated O 0 4.480574578025198e-09
in O 0 1.687089912216777e-10
a O 0 1.9188050259799638e-08
child O 0 2.7115061129734386e-07
with O 0 3.524478264793629e-09
ectopic B-Disease 1 0.9999997615814209
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 0 2.4170994947780855e-05
using O 0 5.632430077895378e-10
DNA O 0 2.011856237160714e-09
obtained O 0 1.0577493742003341e-10
from O 0 4.8033205884978614e-11
both O 0 5.3641431574380505e-12
the O 0 3.987199459487556e-11
pineal B-Disease 0 6.928204925316095e-07
and I-Disease 0 1.009169636745355e-09
retinal I-Disease 1 0.684939444065094
tumours I-Disease 1 1.0
of O 0 0.01179266907274723
the O 0 1.1503843779792078e-06
patient O 0 6.795322065045184e-07
. O 0 6.255191919990466e-08

A O 0 6.096442120906431e-06
nonsense O 0 8.935314326663502e-06
mutation O 0 1.3063497306120553e-07
in O 0 2.156340883630037e-09
exon O 0 2.60105004201705e-08
17 O 0 1.0718123277797531e-08
( O 0 4.545688825352556e-11
codon O 0 1.1947765443665048e-08
556 O 0 1.9414223562108646e-09
) O 0 1.3868090703583746e-11
of O 0 1.8638407484061759e-10
the O 0 8.378989724278085e-10
RB1 O 0 7.774019081807637e-07
gene O 0 9.140802559315375e-10
was O 0 1.125097237597572e-09
found O 0 3.6239785044384076e-12
to O 0 5.039328763306594e-12
be O 0 1.6117919499070155e-11
present O 0 1.2026632467687648e-10
homozygously O 0 2.2964359231991693e-06
in O 0 8.775613569156349e-10
both O 0 4.147093779494071e-10
the O 0 2.5511921464271836e-09
retinal B-Disease 0 1.9680658169818344e-06
and I-Disease 0 8.796217798590078e-08
the I-Disease 0 9.71761551227246e-07
pineal I-Disease 1 0.9999167919158936
tumours I-Disease 1 1.0
. O 0 1.98067536985036e-05

The O 0 1.2478094113532734e-08
same O 0 8.480507407426785e-10
mutation O 0 1.6387063928036127e-09
was O 0 3.406449289311553e-10
present O 0 6.393512802516099e-11
heterozygously O 0 3.118962865755748e-08
in O 0 3.6428721150727483e-11
the O 0 3.077375160254192e-11
DNA O 0 1.3520720654192075e-10
from O 0 7.434701292108326e-12
the O 0 5.984511063789055e-12
constitutional O 0 9.918575960554676e-10
cells O 0 1.741819743994455e-10
of O 0 9.795951549929072e-11
the O 0 1.1361031559964374e-10
patient O 0 1.9578287879795653e-09
, O 0 1.740015770357317e-11
proving O 0 1.1433972657570735e-09
it O 0 4.75977894251467e-12
to O 0 5.0780223775914735e-11
be O 0 2.406856103309707e-10
of O 0 1.5457185531531081e-09
germline O 0 2.2155995793582406e-06
origin O 0 5.3724374282637655e-08
. O 0 2.7723700668502715e-08

The O 0 9.462968186824128e-09
initial O 0 9.933916800264342e-09
mutation O 0 8.907695914217584e-09
was O 0 1.412076677809182e-09
shown O 0 3.0153501223706414e-11
to O 0 1.1374019087684317e-10
have O 0 1.857249944114958e-11
occurred O 0 3.661474901051065e-09
in O 0 2.581912288135424e-11
the O 0 1.2729287068857786e-10
paternally O 0 3.275397375546163e-08
derived O 0 1.1637274255349439e-08
RB1 O 0 6.677721557935001e-06
allele O 0 9.158224543170945e-07
. O 0 3.795666714268009e-08

The O 0 1.8830778714118424e-08
mutation O 0 1.4323543240379877e-08
is O 0 2.4738253112666087e-11
in O 0 2.7867319996738305e-12
an O 0 2.959424805909494e-12
area O 0 3.090961042673257e-09
of O 0 7.348526787076537e-10
the O 0 4.2575865055738404e-10
gene O 0 6.268296298683751e-11
that O 0 8.84369053683054e-12
encodes O 0 1.0439273577522723e-11
the O 0 1.2751295679069852e-11
protein O 0 6.987804085367699e-11
- O 0 1.152938161608219e-10
binding O 0 1.0880145140390596e-07
region O 0 6.433721864596009e-06
known O 0 2.2749720329784395e-08
as O 0 4.746294468560563e-10
the O 0 4.2893508189756346e-10
pocket O 0 1.072479244612623e-05
region O 0 1.1746802783818566e-06
and O 0 1.7922100470357805e-09
has O 0 1.051987497113771e-09
been O 0 7.211246599858612e-10
detected O 0 2.6899948935010798e-09
in O 0 5.145154701596821e-12
other O 0 8.54014775564238e-13
cases O 0 3.749273114195262e-11
of O 0 8.64012084100807e-10
retinoblastoma B-Disease 0 2.0853015030297684e-06
. O 0 1.4047437879582958e-08
. O 0 9.585994575900258e-08

Low O 0 2.122780870195129e-06
levels O 0 1.1340605787779623e-08
of O 0 6.690437648337877e-10
beta O 0 1.4223688538095303e-07
hexosaminidase O 0 1.2380077123452793e-06
A O 0 8.063042677974863e-09
in O 0 3.771277040653942e-11
healthy O 0 7.287342604356262e-12
individuals O 0 2.3930830190740937e-13
with O 0 1.4704945160842753e-12
apparent O 0 0.00011138522677356377
deficiency O 1 0.9999998807907104
of O 0 0.00019835623970720917
this O 0 9.20839227092074e-08
enzyme O 0 6.454491767726722e-07
. O 0 7.080143404891714e-08

Appreciable O 0 2.6133557184948586e-05
beta O 0 1.0148013643629383e-05
hexosaminidase O 0 0.00010649790783645585
A O 0 1.9397026335354894e-05
( O 0 1.7854144829243523e-08
hex O 0 2.023882643698016e-06
A O 0 3.730753235231532e-07
) O 0 1.2371863256088744e-10
activity O 0 4.48495196536669e-09
has O 0 1.3834862422346106e-10
been O 0 3.3891198181201787e-10
detected O 0 6.858524859154613e-09
in O 0 2.064993176453811e-10
cultured O 0 3.8871682761509874e-08
skin O 0 5.309472612680111e-07
fibroblasts O 0 1.688772925945159e-07
and O 0 8.00505794984474e-09
melanoma B-Disease 0 0.0016750562936067581
tissue O 0 7.774879122735001e-07
from O 0 1.1107140096555668e-08
healthy O 0 3.122578584591196e-10
individuals O 0 1.2445653015114022e-11
previously O 0 4.912580897631358e-10
reported O 0 4.6544038068141447e-10
as O 0 9.189500549400265e-11
having O 0 5.306786565739685e-09
deficiency B-Disease 0 0.00020555277296807617
of I-Disease 0 1.5063407090565306e-06
hex I-Disease 0 3.4417431038491486e-07
A I-Disease 0 4.038299472597373e-09
activity O 0 3.3955446787636845e-10
indistinguishable O 0 8.973270043677317e-11
from O 0 6.820640515055321e-13
that O 0 5.254499770403556e-14
of O 0 9.727126873068648e-13
patients O 0 2.571629107578355e-12
with O 0 2.2773749552840172e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.888275562578201e-07
TSD B-Disease 1 0.9870303273200989
) O 0 1.3463346881792404e-08
. O 0 1.497871693345587e-07

Identification O 0 5.412550763139734e-08
and O 0 4.9661128542766164e-09
quantitation O 0 0.000241184257902205
of O 0 2.7525189580046572e-05
hex O 0 0.00014174128591548651
A O 0 1.0286197721143253e-05
, O 0 4.13849648994713e-10
amounting O 0 2.0027375313702578e-08
to O 0 3.1424420399162045e-08
3 O 0 8.886679552233545e-07
. O 0 6.916989292449216e-08

5 O 0 3.833504706562962e-06
% O 0 6.532144425364095e-07
- O 0 6.661246061412385e-07
6 O 0 3.232476956327446e-06
. O 0 2.034099964021152e-07

9 O 0 1.110482116928324e-06
% O 0 2.282221345240032e-08
of O 0 4.604394199247963e-09
total O 0 2.5997786146092494e-09
beta O 0 8.005365970120693e-08
hexosaminidase O 0 3.8107194200165395e-07
activity O 0 2.4240936369324118e-08
, O 0 7.298613102779683e-11
has O 0 2.864869452778862e-11
been O 0 4.222792254759966e-11
obtained O 0 4.0255315747472764e-10
by O 0 3.810554927152765e-10
cellulose O 0 1.9907564308141446e-07
acetate O 0 1.5808998554689424e-08
gel O 0 1.095511024118423e-07
electrophoresis O 0 2.7486764864192992e-08
, O 0 5.890263832242226e-10
DEAE O 0 6.54278892397997e-06
- O 0 2.547435542510357e-07
cellulose O 0 8.638824624540575e-07
ion O 0 6.545351993736404e-07
- O 0 2.1257877236280365e-08
exchange O 0 6.850119138590571e-09
chromatography O 0 7.145844360678666e-09
, O 0 2.865066170421038e-11
radial O 0 8.27962232108348e-09
immunodiffusion O 0 5.68417455326653e-08
, O 0 4.826205754482338e-11
and O 0 1.7118806372451445e-10
radioimmunoassay O 0 3.3787173379096203e-06
. O 0 1.9008435003797786e-07

Previous O 0 5.995724677632097e-06
family O 0 1.8265441381615233e-09
studies O 0 8.677308177551524e-11
suggested O 0 2.1690944873586915e-10
that O 0 1.3800427814403271e-12
these O 0 2.4158854170647226e-13
individuals O 0 2.0729741707914418e-12
may O 0 6.585819667392911e-10
be O 0 4.2757669627135897e-10
compound O 0 2.6344963988123027e-09
heterozygotes O 0 8.857339306445056e-10
for O 0 8.92802498597689e-12
the O 0 2.1493211724288308e-11
common O 0 2.2705654023624788e-10
mutant O 0 6.164392996055312e-09
TSD B-Disease 0 5.953101549494022e-07
gene O 0 8.022906783367034e-10
and O 0 3.783575536209227e-11
a O 0 3.5728234260012925e-10
rare O 0 4.522566210418688e-10
( O 0 1.2642090707615239e-09
allelic O 0 2.564165981766564e-07
) O 0 1.7083034986598022e-09
mutant O 0 3.6257834068464945e-08
gene O 0 1.597537924169501e-08
. O 0 7.803127033412238e-09

Thus O 0 8.534125299775042e-07
, O 0 1.8161396830862486e-09
the O 0 1.0752475576580878e-09
postulated O 0 5.77134215973274e-08
rate O 0 1.7734777202349505e-08
mutant O 0 2.0500188213645743e-09
gene O 0 5.88123508227234e-11
appears O 0 9.058353026003552e-12
to O 0 2.2530568990347666e-12
code O 0 8.427058963839107e-13
for O 0 1.674837460559353e-12
the O 0 3.3795045754902997e-12
expression O 0 2.3089790496255702e-11
of O 0 6.72772323961901e-11
low O 0 5.854634554935956e-10
amounts O 0 7.312815908377956e-10
of O 0 4.211880622051467e-09
hex O 0 3.4086021969415015e-06
A O 0 1.992455736399279e-06
. O 0 7.583869177096858e-08

Heterozygotes O 0 3.175043093506247e-05
for O 0 3.764570166708836e-08
the O 0 2.022429690384797e-08
rare O 0 2.2618180661737597e-09
mutant O 0 1.0489705992711151e-08
may O 0 1.3907998086537532e-09
be O 0 1.3101732199150007e-10
indistinguishable O 0 5.108918288421194e-10
from O 0 3.244223986675898e-11
heterozygotes O 0 1.7844875577210928e-09
for O 0 7.811055968698355e-11
the O 0 1.1283229905956205e-09
common O 0 2.221458750284455e-08
TSD B-Disease 0 0.00011321590864099562
mutant O 0 1.3366701523409574e-06
. O 0 5.288277904469396e-08

However O 0 1.4375989110249066e-07
, O 0 3.7014619147512917e-10
direct O 0 4.078395843265525e-09
visualization O 0 6.348609105089054e-08
and O 0 3.894409239535435e-09
quantitation O 0 0.00026960045215673745
of O 0 4.868604264629539e-06
hex O 0 2.3515869997936534e-06
A O 0 2.8066020618666698e-08
by O 0 1.1383019526967075e-11
the O 0 2.506114933631398e-11
methods O 0 1.9175701304607884e-10
described O 0 3.994247987915145e-11
may O 0 1.3162246292885982e-10
prevent O 0 2.1623777768375874e-10
false O 0 4.3946812855466533e-10
- O 0 5.020226456764476e-09
positive O 0 1.9437185194703943e-10
prenatal O 0 3.9319541400573144e-08
diagnosis O 0 1.0187143573148205e-07
of O 0 3.3716613945244944e-09
TSD B-Disease 0 7.173484391387319e-06
in O 0 4.120170871146911e-09
fetuses O 0 2.0782714216238674e-08
having O 0 6.276946323824362e-11
the O 0 5.58403531747409e-11
incomplete O 0 4.7388248880508854e-09
hex B-Disease 0 2.319489567526034e-06
A I-Disease 0 2.0903923996229423e-06
deficiency I-Disease 0 0.0011761754285544157
of O 0 3.408695192774758e-08
the O 0 1.6301389405004585e-10
type O 0 5.649292589282595e-09
described O 0 7.02578883959859e-10
in O 0 3.527844336104202e-11
the O 0 3.6716762963351357e-10
four O 0 1.69134289906836e-10
healthy O 0 7.252877187724494e-10
individuals O 0 5.283345760886959e-09

The O 0 4.2433390490259626e-07
tumor B-Disease 0 8.271343176602386e-06
suppressor O 0 1.5007601632532896e-06
gene O 0 1.518548309320522e-08
Smad4 O 0 2.7037901872972725e-06
/ O 0 3.31036204670454e-07
Dpc4 O 0 2.9012658160354476e-06
is O 0 1.3190067094104307e-10
required O 0 1.8467984086445455e-10
for O 0 1.1568634938896594e-10
gastrulation O 0 2.7506695587931063e-08
and O 0 2.424793005273429e-11
later O 0 4.345470372424387e-10
for O 0 2.1839301200810013e-11
anterior O 0 4.526419843386975e-07
development O 0 4.8557691201267517e-08
of O 0 5.4412199190778665e-09
the O 0 6.296843602093816e-10
mouse O 0 2.7911513100775664e-09
embryo O 0 4.084291447270516e-07
. O 0 3.799614489707892e-08

Mutations O 0 3.1471079182665562e-06
in O 0 8.903992210207434e-09
the O 0 2.751656147381709e-08
SMAD4 O 1 0.9998550415039062
/ O 0 0.0983688086271286
DPC4 O 1 0.9986990690231323
tumor B-Disease 0 0.0002876515791285783
suppressor O 0 3.343334128658171e-06
gene O 0 4.077929105505973e-09
, O 0 2.9737018403253046e-11
a O 0 1.6872894748054534e-10
key O 0 8.19923862138694e-09
signal O 0 3.653063984643268e-08
transducer O 0 1.9224908953674458e-07
in O 0 8.907592885520899e-09
most O 0 9.115696530948014e-10
TGFbeta O 0 1.3588331967184786e-05
- O 0 4.155990893650596e-07
related O 0 2.648075394517946e-07
pathways O 0 2.5413152471287503e-08
, O 0 1.6204723327084558e-11
are O 0 2.1350308402733748e-13
involved O 0 4.677930352109394e-12
in O 0 5.649467439000633e-12
50 O 0 4.445924739471252e-10
% O 0 2.9169335835632637e-09
of O 0 3.5320912417091677e-08
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 6.444613973144442e-05

Homozygous O 0 8.151251677190885e-06
Smad4 O 0 0.0003784986038226634
mutant O 0 4.635043296730146e-06
mice O 0 4.258634760390123e-07
die O 0 1.2216186178193311e-06
before O 0 1.3432131851232043e-08
day O 0 2.505936969043887e-08
7 O 0 3.1169651037998847e-07
. O 0 4.793187713403313e-08

5 O 0 6.32327055427595e-06
of O 0 6.17688328929944e-07
embryogenesis O 0 1.638634603295941e-05
. O 0 6.057775294721068e-07

Mutant O 0 1.7796741076381295e-06
embryos O 0 1.1335246341559468e-07
have O 0 2.69545830100526e-10
reduced O 0 2.396989051689502e-09
size O 0 1.1864417226448154e-09
, O 0 1.6379586575965277e-10
fail O 0 8.40435063764744e-08
to O 0 5.474396491678135e-09
gastrulate O 0 9.753735866979696e-06
or O 0 2.861268111331583e-09
express O 0 2.994123837751772e-10
a O 0 4.1203654377319765e-10
mesodermal O 0 2.5693301708429317e-08
marker O 0 2.100580864805579e-08
, O 0 3.5832423833648264e-11
and O 0 7.77868949808358e-11
show O 0 1.265106353010026e-09
abnormal O 0 2.7031321181425483e-08
visceral O 0 1.312091058025544e-06
endoderm O 0 0.00016791719826869667
development O 0 2.8589061912498437e-05
. O 0 3.8405852365031024e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 0.0002436824725009501
the O 0 1.699340373306768e-06
Smad4 O 0 0.026376252993941307
- O 0 9.18131809157785e-06
deficient O 0 6.994920340730459e-07
embryos O 0 3.4544831439831114e-09
results O 0 2.1351563572746812e-10
from O 0 5.102977485016424e-10
reduced O 0 1.433286200835937e-08
cell O 0 7.696450587957315e-09
proliferation O 0 1.9565492337392243e-08
rather O 0 1.2464712595416927e-10
than O 0 7.3747938311719e-11
increased O 0 3.5614560189856093e-09
apoptosis O 0 2.2475788341580483e-07
. O 0 2.2780463737603895e-08

Aggregation O 0 5.987845383970125e-07
of O 0 8.252507655015506e-08
mutant O 0 1.1011294986928988e-07
Smad4 O 0 2.297754144819919e-05
ES O 0 8.164352948369924e-06
cells O 0 1.103639069022222e-09
with O 0 5.834473529309214e-12
wild O 0 7.341321994758232e-11
- O 0 1.4010230475758334e-10
type O 0 5.474364961344236e-09
tetraploid O 0 8.180860277207103e-06
morulae O 0 3.192982330801897e-05
rescues O 0 1.0913145160884596e-06
the O 0 3.104031165435117e-08
gastrulation B-Disease 0 9.419602974958252e-06
defect I-Disease 0 3.140490662190132e-05
. O 0 2.668691649887478e-07

These O 0 7.433790916167027e-09
results O 0 2.454955572162021e-09
indicate O 0 1.8953716374170426e-09
that O 0 3.5871743075954754e-11
Smad4 O 0 7.085060360623174e-08
is O 0 9.675212020443524e-12
initially O 0 1.1915431315234759e-11
required O 0 1.544564649791358e-11
for O 0 2.8941081302302774e-12
the O 0 7.234563208918798e-12
differentiation O 0 2.1791378423952068e-10
of O 0 1.0280882395408142e-10
the O 0 3.709807461227399e-11
visceral O 0 2.0349810725406314e-09
endoderm O 0 1.0659655913514143e-07
and O 0 1.1257171583789471e-10
that O 0 1.193116872660882e-11
the O 0 8.604396362077438e-11
gastrulation B-Disease 0 2.8430399368062353e-08
defect I-Disease 0 2.293138656739302e-08
in O 0 2.461723706825847e-11
the O 0 7.175460225994357e-11
epiblast O 0 2.0444943515940395e-08
is O 0 3.302322304499228e-11
secondary O 0 1.6438967964660378e-09
and O 0 7.627581205538192e-11
non O 0 9.744643136855302e-08
- O 0 4.6102755391075334e-07
cell O 0 2.49953427555738e-06
autonomous O 0 3.018444658664521e-06
. O 0 3.1156869795267994e-07

Rescued O 0 8.641406566312071e-06
embryos O 0 1.0311612186342245e-07
show O 0 3.3158640277974882e-09
severe O 0 1.8416262719256338e-06
anterior O 0 0.0014539582189172506
truncations O 0 0.002545979106798768
, O 0 1.810502192611807e-09
indicating O 0 3.027208350658839e-08
a O 0 1.6937327096400168e-09
second O 0 2.255777786785984e-09
important O 0 8.179455029955207e-11
role O 0 7.617229763612343e-11
for O 0 3.5512030815976203e-11
Smad4 O 0 5.377309662435437e-06
in O 0 1.4362800726530622e-08
anterior O 0 0.0008993509109131992
patterning O 0 0.0041747200302779675
during O 0 2.5327746698167175e-05
embryogenesis O 0 2.286505832671537e-06
. O 0 9.153652058557782e-08

Prevalence O 0 2.641657556523569e-05
of O 0 1.0989976573227977e-07
p16 O 0 1.7087724017983419e-06
and O 0 1.3250800456887646e-08
CDK4 O 1 0.9999409914016724
germline O 0 0.010283946990966797
mutations O 0 7.921453288872726e-07
in O 0 1.0790031090834873e-09
48 O 0 9.022966196425841e-07
melanoma B-Disease 1 0.9999939203262329
- O 0 4.020574124297127e-06
prone O 0 5.381540904636495e-05
families O 0 6.069166835764861e-10
in O 0 2.733346660122038e-09
France O 0 2.037997006709702e-07
. O 0 8.346177651219477e-07

The O 0 1.501318251939665e-07
French O 0 5.629177849186817e-06
Familial B-Disease 1 0.9999932050704956
Melanoma I-Disease 1 1.0
Study O 0 1.1227076583963935e-06
Group O 0 6.265123531079553e-09
. O 0 8.162180265003371e-09

Germline O 0 0.0016829745145514607
mutations O 0 2.849587417586008e-06
in O 0 2.191343106971999e-09
the O 0 2.020978939754059e-09
p16 O 0 4.5086782307635076e-08
and O 0 5.168017125356528e-10
CDK4 O 0 0.00038105735438875854
genes O 0 1.0098555769388895e-08
have O 0 9.947975776469775e-11
been O 0 5.854207396627231e-11
reported O 0 2.985796332399815e-11
in O 0 2.966449134944593e-12
a O 0 6.690919346352686e-11
subset O 0 1.562383467046402e-08
of O 0 1.015981876406613e-08
melanoma B-Disease 0 7.445476512657478e-05
pedigrees O 0 2.27603109692609e-08
, O 0 4.8617020131924704e-11
but O 0 1.4447127522076997e-11
their O 0 4.253183309016473e-12
prevalence O 0 3.3735720883498743e-09
is O 0 3.811932540453977e-12
not O 0 6.660677565051287e-11
well O 0 1.40978312357376e-10
known O 0 1.541603111832046e-08
. O 0 7.265497714570301e-08

We O 0 2.8448499733713106e-07
searched O 0 2.513883856636312e-08
for O 0 1.5771063621716763e-10
such O 0 2.598642134810092e-10
germline O 0 7.790319614287e-06
mutations O 0 5.464613650474348e-08
in O 0 2.1209500822294558e-10
48 O 0 1.3552853062037684e-08
French O 0 5.1839762704730674e-08
melanoma B-Disease 1 0.9999945163726807
- O 0 6.034584316694236e-07
prone O 0 1.010634150588885e-06
families O 0 2.1764453086992042e-11
selected O 0 2.7461242915055584e-12
according O 0 9.412815579062928e-13
to O 0 5.315328472504932e-12
two O 0 3.18758799737473e-13
major O 0 9.727359889799558e-11
criteria O 0 2.064962423276029e-09
families O 0 1.5309458345144633e-12
with O 0 2.4868277467664235e-13
at O 0 1.1125941279388485e-09
least O 0 1.9336975076722496e-10
three O 0 2.0067109432475583e-11
affected O 0 1.9246897131619534e-10
members O 0 1.2509434460517e-11
( O 0 2.838944357375084e-11
n O 0 3.7650278450485075e-09
= O 0 1.8167217730180596e-09
20 O 0 1.4779114598795218e-09
) O 0 2.030170736383452e-12
or O 0 2.5658294933172954e-11
families O 0 2.2986077017478346e-12
with O 0 2.080947718828552e-13
two O 0 4.32139740658144e-12
affected O 0 1.8495550924146897e-10
members O 0 6.554171701894651e-12
, O 0 7.924893380417686e-12
one O 0 1.109979642921477e-11
of O 0 2.6572535838376155e-11
them O 0 2.384162474649426e-13
affected O 0 4.471654383580992e-12
before O 0 3.33682283193415e-11
the O 0 1.7939627214302867e-11
age O 0 7.355454023638686e-10
of O 0 2.2804871879777977e-10
50 O 0 5.948941339539715e-10
( O 0 4.8805626207126807e-11
n O 0 8.552831332053756e-09
= O 0 6.623577686326598e-09
28 O 0 8.853560551358441e-09
) O 0 1.248778858098376e-11
, O 0 1.0761615557020043e-11
and O 0 2.971432344969771e-12
one O 0 3.867666169971029e-12
additional O 0 2.3397105433642373e-11
minor O 0 1.143705308237486e-08
criterion O 0 8.476975381199736e-06
. O 0 5.4979327757109786e-08

Sixteen O 0 1.4953441223042319e-06
different O 0 1.5924384033638717e-09
p16 O 0 6.828296932326339e-07
germline O 0 1.801438997972582e-06
mutations O 0 2.945807686671742e-08
were O 0 1.5638844386156592e-10
found O 0 2.524247521076828e-12
in O 0 1.5648973002851951e-12
21 O 0 4.035248246658796e-10
families O 0 2.1511299685972318e-11
, O 0 1.475226017733089e-11
while O 0 7.789215800135807e-11
one O 0 7.065890650359563e-10
germline O 0 3.5922168990509817e-06
mutation O 0 3.8158833604029496e-07
, O 0 6.318727763243714e-10
Arg24His O 0 9.438640518055763e-06
, O 0 1.0079307388721759e-09
was O 0 3.3275863842163744e-08
detected O 0 1.523474502107547e-08
in O 0 3.0225263958350013e-10
the O 0 3.657210312368875e-09
CDK4 O 0 0.00025365626788698137
gene O 0 3.577979441615753e-07
. O 0 1.3485480110375647e-07

The O 0 1.7419310438526736e-08
frequency O 0 4.3297717411405756e-08
of O 0 3.659966774094414e-09
p16 O 0 1.9450482113825274e-08
gene O 0 2.1865823041089527e-10
mutation O 0 2.99107599799342e-10
in O 0 1.388206390118274e-11
our O 0 1.4321935130900965e-11
sample O 0 4.379898353723544e-12
( O 0 2.7040344789674986e-12
44 O 0 1.0369113345731762e-09
% O 0 4.343216342128642e-10
) O 0 3.294940492323817e-12
is O 0 5.114158662528068e-12
among O 0 2.657332090916925e-13
the O 0 3.1428911122927117e-12
highest O 0 1.1467168326007027e-09
rates O 0 8.044723220912431e-11
yet O 0 8.863215716914397e-11
reported O 0 1.295853008231873e-10
and O 0 1.2350284857298721e-11
the O 0 7.46898792813866e-11
CDK4 O 0 8.5267873828343e-07
mutation O 0 9.920392285422963e-10
is O 0 9.284279074706081e-12
the O 0 1.4114559347688793e-11
second O 0 2.531356790846928e-10
mutation O 0 5.559679938649253e-10
detected O 0 2.060611237197918e-09
in O 0 1.2426060180814602e-11
this O 0 5.922039247874267e-11
gene O 0 1.7089095694089451e-09
worldwide O 0 2.142745758604292e-09
. O 0 2.0591583549389725e-08

In O 0 4.765982275500846e-09
summary O 0 6.299804766740635e-08
, O 0 1.9611914869877012e-10
our O 0 8.411843444022793e-11
results O 0 3.736607898097155e-11
show O 0 8.536031256833887e-12
frequent O 0 7.27889623575173e-12
involvement O 0 7.663399914648039e-10
of O 0 4.801701258827507e-10
the O 0 9.667916467392956e-10
p16 O 0 9.454200977643268e-09
gene O 0 5.294328309091156e-10
in O 0 3.1383659560013655e-10
familial B-Disease 0 0.00016562607197556645
melanoma I-Disease 1 0.9999973773956299
and O 0 3.6107902778859113e-10
confirm O 0 3.6140164194620183e-09
the O 0 2.307355695396751e-10
role O 0 1.0853723475534593e-10
of O 0 1.8254042721821406e-10
the O 0 2.480398664239658e-10
CDK4 O 0 7.502960215788335e-05
gene O 0 1.1861204241014889e-09
as O 0 1.0525931515292797e-10
a O 0 3.579127438868568e-09
melanoma B-Disease 0 0.00016371051606256515
- O 0 2.1320040559658082e-06
predisposing O 0 3.2858897611731663e-06
gene O 0 1.7707197486060977e-08
. O 0 3.7150793552598316e-09
. O 0 2.828711487268265e-08

Progression O 0 0.000178131100255996
of O 0 3.2657212614140008e-06
somatic O 0 0.00010542394738877192
CTG O 0 0.00015217020700220019
repeat O 0 6.513159434007321e-08
length O 0 2.9030855497325092e-09
heterogeneity O 0 1.3570287116237978e-08
in O 0 1.0484130057164531e-11
the O 0 5.312692993864054e-12
blood O 0 1.7221828130242756e-11
cells O 0 2.216741373795017e-10
of O 0 2.1396988625355107e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.0010126790730282664
. O 0 1.3752404584010947e-06

The O 0 2.8411357710922402e-09
genetic O 0 1.765700363698386e-09
basis O 0 2.5695345851062257e-09
of O 0 1.0050363208335966e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.449167482154735e-07
DM B-Disease 1 1.0
) O 0 5.7382175400189084e-11
is O 0 3.3992155878265207e-12
the O 0 7.417760850003674e-12
expansion O 0 7.801262968953893e-10
of O 0 1.080986744561585e-09
an O 0 7.114628886029095e-10
unstable O 0 0.00013144752301741391
CTG O 0 8.062347478698939e-05
repeat O 0 1.0477712208967205e-07
in O 0 3.3697888923711616e-10
the O 0 5.195264773938391e-10
34 O 0 2.5288726668293293e-09
UTR O 0 1.1501189192131278e-06
of O 0 4.593411428999161e-09
the O 0 9.026837943792998e-09
DM B-Disease 1 0.9999990463256836
protein O 0 2.7010502279267712e-08
kinase O 0 1.7231647220228297e-08
gene O 0 2.1851065401534697e-10
on O 0 1.942733529602947e-09
chromosome O 0 2.3919579916764633e-07
19 O 0 2.1591739596260595e-07
. O 0 1.9254260408274604e-08

One O 0 2.2678367628259366e-08
of O 0 2.3449846509038252e-09
the O 0 2.7070609642798615e-10
principal O 0 9.997130900885054e-10
features O 0 1.121162516125318e-12
of O 0 4.659022612152341e-10
the O 0 4.760331240305504e-09
DM B-Disease 1 1.0
mutation O 0 5.35194385520299e-06
is O 0 1.5780994566672035e-10
an O 0 1.4218859596681899e-11
extraordinarily O 0 6.3995706511832395e-09
high O 0 6.279146447241146e-08
level O 0 1.625872982913279e-06
of O 0 3.507370252009423e-07
somatic O 0 0.019954299554228783
mosaicism O 1 0.9999442100524902
, O 0 3.0504085923865887e-09
due O 0 1.0641352332640963e-07
to O 0 4.1608561041073244e-10
an O 0 1.1325717273746871e-11
extremely O 0 3.862625150286014e-11
high O 0 1.188307369170971e-10
degree O 0 5.532116542639187e-09
of O 0 2.2055314519153768e-10
somatic O 0 3.152894691993424e-07
instability O 0 9.621049912311719e-07
both O 0 3.5581794455286087e-11
within O 0 2.548413979841513e-10
and O 0 2.4702074153531983e-12
between O 0 1.1515909059678364e-10
different O 0 9.904506381719358e-11
tissues O 0 6.043341382877543e-09
. O 0 3.5017828636796366e-09

This O 0 2.154963141265398e-07
instability O 0 5.251111360848881e-05
appears O 0 5.057747554104708e-09
to O 0 8.936310025298155e-11
be O 0 1.1871738835045331e-11
biased O 0 9.263093070366324e-11
towards O 0 3.628614422823695e-11
further O 0 4.170123447944096e-12
expansion O 0 3.9636786908214816e-11
and O 0 1.8075044499327175e-12
continuous O 0 3.177977048185454e-10
throughout O 0 5.4707241341211965e-12
the O 0 3.735197220966491e-11
life O 0 1.9311165513902218e-11
of O 0 9.163399206091327e-12
an O 0 1.7541804597440147e-12
individual O 0 8.440345861462917e-13
, O 0 1.2284005193249903e-12
features O 0 9.126115932834439e-14
that O 0 2.1769826880849857e-13
could O 0 3.5558641534733093e-12
be O 0 1.7966978816189028e-12
associated O 0 3.4068030514700087e-12
with O 0 5.2733150826675054e-14
the O 0 1.9682580218449708e-11
progressive O 0 4.782947371495538e-09
nature O 0 1.7718674305555737e-09
of O 0 6.6713394808459725e-09
the O 0 1.772030522317891e-08
disease O 0 8.042293302423786e-06
. O 0 6.73035103204711e-08

Although O 0 2.5963398098127755e-09
increasing O 0 3.4398059400864156e-10
measured O 0 2.773086760221588e-10
allele O 0 6.55002940774807e-10
size O 0 6.370991928461578e-11
between O 0 3.667050274547279e-10
patients O 0 3.871684917111651e-10
clearly O 0 9.952416668568276e-11
correlates O 0 8.122089112383435e-11
with O 0 3.3992767097239945e-14
an O 0 7.737835708548219e-14
increased O 0 3.777567234714008e-12
severity O 0 6.366239801991469e-08
of O 0 2.2569053292897934e-09
symptoms O 0 2.4791903641130375e-08
and O 0 3.1291516686821064e-12
an O 0 6.345010237704396e-13
earlier O 0 1.1466397276116425e-10
age O 0 8.808885287869828e-10
of O 0 2.492777095852716e-10
onset O 0 6.368204594764393e-06
, O 0 3.496493372612264e-11
this O 0 2.7078754169518326e-11
correlation O 0 1.5272820785838803e-09
is O 0 9.755932173227677e-12
not O 0 1.8685419531094816e-11
precise O 0 4.3895795331927445e-10
and O 0 5.670886503439387e-12
measured O 0 1.661168702593585e-10
allele O 0 9.832907821305525e-10
length O 0 9.404413914282372e-10
cannot O 0 3.127120229429181e-10
be O 0 3.173723089888725e-11
used O 0 3.003845002597094e-12
as O 0 2.160585214428315e-13
an O 0 1.6261738320939162e-13
accurate O 0 1.1993508963747956e-10
predictor O 0 1.5602726932684163e-07
of O 0 6.956091813670184e-10
age O 0 5.2333312794417e-08
of O 0 2.3167642027033253e-08
onset O 0 0.009426569566130638
. O 0 2.6945002673528506e-07

In O 0 1.6006703518200993e-08
order O 0 2.386178143964912e-09
to O 0 1.101441493567279e-09
further O 0 1.0198468736177801e-09
characterize O 0 3.383316737881614e-08
the O 0 2.847048818921394e-09
dynamics O 0 1.7412235209235405e-08
of O 0 6.303602617663273e-08
DM B-Disease 1 1.0
CTG O 0 0.0002916107187047601
repeat O 0 4.2366346519884246e-07
somatic O 0 2.365410864513251e-06
instability O 0 6.7308396864973474e-06
, O 0 2.113463154485018e-10
we O 0 9.034787501471797e-11
have O 0 2.8326527321681505e-12
studied O 0 2.6158370608486692e-11
repeat O 0 1.616770606283069e-11
length O 0 6.233503296870779e-12
changes O 0 2.3293255345391284e-12
over O 0 4.548748530619484e-12
time O 0 1.630560964027694e-11
in O 0 7.975418069017248e-12
111 O 0 4.1436592823629326e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.1546823053265598e-08
with O 0 2.9994652595011217e-12
varying O 0 4.946485443468873e-10
clinical O 0 4.892686789048639e-08
severity O 0 1.8138431187253445e-05
and O 0 2.4203177240167406e-09
CTG O 0 6.586051313206553e-07
repeat O 0 1.1619835094123232e-09
size O 0 6.119098977519499e-11
over O 0 1.3383650090958987e-11
time O 0 2.1284703166646324e-11
intervals O 0 1.843430408321467e-10
of O 0 4.4853582653603397e-11
1 O 0 1.0386022708530618e-08
- O 0 1.1495555618523667e-08
7 O 0 1.0086393587016573e-07
years O 0 1.8769819476460725e-08
. O 0 7.301767190881492e-09

We O 0 8.111000937560675e-08
have O 0 3.5321197355830947e-11
found O 0 2.0788223573098286e-12
a O 0 1.4347274453554992e-12
direct O 0 1.3744594351550177e-10
progression O 0 6.06079497700307e-09
of O 0 1.3422310485289302e-10
the O 0 3.295369532807513e-11
size O 0 1.420076278790816e-10
heterogeneity O 0 1.814956362977682e-08
over O 0 1.4134644565899634e-09
time O 0 1.3849917879227291e-09
related O 0 1.3954498667700932e-09
to O 0 1.4129927228268002e-09
initial O 0 1.1552330647646158e-08
CTG O 0 5.43489477422554e-07
repeat O 0 9.869473016621555e-10
size O 0 1.219353784609467e-10
and O 0 8.46398385406788e-12
the O 0 3.4261652542832977e-11
time O 0 9.668556233410897e-11
interval O 0 7.636843935010518e-10
and O 0 4.486913011275684e-12
always O 0 1.6264732616289024e-11
biased O 0 3.304031215289882e-10
towards O 0 2.7697194537879e-10
further O 0 2.807541421567805e-10
expansion O 0 1.5167247013891938e-08
. O 0 3.763385691968324e-08

Attempts O 0 1.6090613996766479e-07
to O 0 3.301890982854161e-09
mathematically O 0 1.9534654782660255e-08
model O 0 8.114057203911784e-10
the O 0 6.112755857046182e-10
dynamics O 0 2.0660666066874e-08
have O 0 1.9301453491049614e-10
proved O 0 2.6091726557098127e-09
only O 0 2.1398762969915275e-11
partially O 0 4.5471743037595047e-10
successful O 0 2.3872955695614095e-11
suggesting O 0 8.186317942970867e-12
that O 0 1.756526646140219e-13
individual O 0 3.1333114136047543e-14
specific O 0 2.4118639377346263e-11
genetic O 0 4.868815128844517e-09
and O 0 9.770945857967561e-11
/ O 0 3.675660593671637e-07
or O 0 3.832659700719887e-08
environmental O 0 5.690644115929899e-07
factors O 0 5.419665161099374e-09
also O 0 4.843253836178674e-12
play O 0 4.105943710031035e-11
a O 0 4.933828345876634e-11
role O 0 1.8683789237972093e-10
in O 0 3.1397906496977157e-10
somatic O 0 1.5171809764069621e-06
mosaicism O 0 9.959506860468537e-05
. O 0 2.0918488274901392e-08
. O 0 5.74898457728068e-08

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 2.703823120953075e-08
Palestinian O 0 7.352847660513362e-06
Arabs O 0 4.5533846559919766e-07
. O 0 4.6298293199242835e-08

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.8196511268615723
AGU B-Disease 1 1.0
) O 0 1.239138303077425e-08
is O 0 6.495834425912506e-10
a O 0 1.6426368043553907e-09
rare O 0 2.4852884195070146e-08
disorder B-Disease 1 0.9995465874671936
of I-Disease 0 1.1390026884328108e-05
glycoprotein I-Disease 0 9.150891128228977e-05
metabolism I-Disease 1 0.955967366695404
caused O 0 1.776779754436575e-07
by O 0 8.26624949046284e-11
the O 0 1.9215042001974325e-08
deficiency B-Disease 0 0.025866655632853508
of I-Disease 0 2.211270157204126e-06
the I-Disease 0 1.3095804263230093e-07
lysosomal I-Disease 0 4.649595211958513e-06
enzyme I-Disease 0 7.990066563934306e-08
aspartylglucosaminidase I-Disease 0 3.5280695556139108e-06
( O 0 1.1237761832205706e-09
AGA O 0 4.688803528551944e-06
) O 0 6.018158749121483e-10
. O 0 8.84805739786998e-09

AGU B-Disease 1 1.0
is O 0 2.0150758928139112e-07
inherited O 0 3.3482351682323497e-06
as O 0 1.2694475470809152e-09
an O 0 4.447553159092621e-10
autosomal O 0 3.574367656256072e-05
recessive O 1 0.990149736404419
trait O 0 1.7852684095487348e-06
and O 0 4.693038735403832e-10
occurs O 0 2.858942804717657e-10
with O 0 2.981115517202565e-13
a O 0 2.6225315322148113e-11
high O 0 2.8278726582620095e-10
frequency O 0 3.7949483555621555e-09
in O 0 9.994914618172146e-11
Finland O 0 1.4563201755635191e-09
because O 0 2.7050842121845164e-10
of O 0 1.7795047657642726e-09
a O 0 2.86678547567476e-09
founder O 0 3.480675303535463e-08
effect O 0 2.590099938970525e-07
. O 0 4.671983688808723e-08

While O 0 7.88490581271617e-07
very O 0 6.988730483215022e-09
few O 0 2.956235922724204e-09
patients O 0 1.1973424474120975e-09
with O 0 7.916497318793958e-11
AGU B-Disease 1 1.0
have O 0 1.3423213651719834e-09
been O 0 9.637808606743903e-11
reported O 0 9.318573690464405e-12
from O 0 2.0993680752146027e-11
non O 0 6.599009672036971e-10
- O 0 1.0663341737382481e-10
Finnish O 0 2.292848577667428e-09
origin O 0 1.1157840207332015e-09
, O 0 7.472578805733932e-11
we O 0 5.363547828096671e-09
diagnosed O 1 0.6721222400665283
the O 0 2.358811279634665e-08
disorder O 0 0.00013269986084196717
in O 0 1.0841791908688947e-09
8 O 0 3.1366813146860295e-08
patients O 0 3.824796035445388e-11
originating O 0 2.2748816719264653e-11
from O 0 1.4591276797926156e-10
3 O 0 3.1593281324404643e-09
unrelated O 0 4.840580158926855e-10
families O 0 1.412365450287334e-12
, O 0 2.1741069773477395e-13
all O 0 3.5976817770559666e-13
Palestinian O 0 2.735806858833456e-10
Arabs O 0 3.5884333698943394e-11
from O 0 1.130935449455972e-11
the O 0 6.786929525326446e-12
region O 0 2.852036662392976e-10
of O 0 3.840368578700293e-10
Jerusalem O 0 1.5003122371126665e-06
. O 0 3.8987366224318976e-08

The O 0 2.617897720824658e-08
clinical O 0 3.460447146608203e-07
diagnosis O 1 0.9060503244400024
of O 0 0.0016300770221278071
AGU B-Disease 1 1.0
is O 0 2.428314758162742e-07
often O 0 4.766342875939245e-10
difficult O 0 1.198519683498489e-08
, O 0 3.0014168234115957e-12
in O 0 3.093397933640052e-12
particular O 0 5.874317698939535e-11
early O 0 1.16047527143337e-09
in O 0 9.028099448582516e-12
the O 0 2.354236770807372e-11
course O 0 8.261524242492158e-10
of O 0 1.2632732360184917e-10
the O 0 1.3801344511676916e-09
disease O 0 1.576340423525835e-06
, O 0 1.507464465755337e-11
and O 0 7.292264014857608e-12
most O 0 4.181529254798644e-12
of O 0 1.030043203509301e-10
the O 0 7.841688409726544e-11
patients O 0 2.9055310241110632e-11
are O 0 1.3491030124643255e-12
diagnosed O 0 4.1043058729428594e-08
after O 0 5.33434629801377e-10
the O 0 6.099103860846e-11
age O 0 9.49949341411127e-10
of O 0 1.95521182577707e-10
5 O 0 4.1366994274483204e-09
years O 0 5.509708245199363e-09
. O 0 8.859269762240274e-09

However O 0 6.942007644283876e-07
, O 0 8.258881578626642e-09
since O 0 2.5941483627889284e-08
these O 0 5.618267517881748e-10
patients O 0 1.0232840130797172e-09
excrete O 0 1.873375676808564e-09
early O 0 1.2391896397900837e-09
large O 0 3.679870644313077e-11
amounts O 0 1.097220647672259e-09
of O 0 5.532506897054645e-09
aspartylglucosamine O 0 1.5576664509353577e-06
in O 0 9.106942755465752e-09
urine O 0 1.0704225283930668e-09
, O 0 9.443697560063136e-12
biochemical O 0 1.6102685851393517e-10
screening O 0 5.595702234906241e-10
is O 0 2.6769916144919748e-11
easy O 0 2.7892976817156523e-10
by O 0 2.362104678521604e-10
urine O 0 3.5519924779237044e-09
chromatography O 0 1.917045366894854e-08
. O 0 3.380986379752926e-09
. O 0 2.217860206599198e-08

Detection O 0 1.826425375384133e-07
of O 0 2.102559903960355e-09
heterozygous O 0 5.852365120295744e-11
carriers O 0 5.2858700055891106e-11
of O 0 3.782300583843323e-10
the O 0 2.5457786989591114e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.895307258972025e-07
ATM O 0 0.1414925754070282
) O 0 4.858320967748853e-10
gene O 0 8.48770498329543e-11
by O 0 5.936334063205706e-11
G2 O 0 1.5621321836079005e-07
phase O 0 1.2744965260935714e-06
chromosomal O 0 2.1697936972486787e-05
radiosensitivity O 0 1.3801036402583122e-05
of O 0 3.3486907113911e-07
peripheral O 0 5.4510313930222765e-05
blood O 0 1.110201446863357e-05
lymphocytes O 0 1.0205011449215817e-06
. O 0 1.0952226858762515e-07

In O 0 9.459594707550423e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.22532448172569275
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.2732699339323972e-08
patients O 0 4.2915729636661126e-08
, O 0 9.922317134591907e-11
mutations O 0 4.968232492075231e-10
in O 0 3.5029819323018074e-11
a O 0 5.3465263466501156e-11
single O 0 5.525551891039093e-11
gene O 0 1.7236091026662237e-11
, O 0 2.2672655853456236e-12
ATM O 0 4.4821319988841424e-08
, O 0 1.2752414575711857e-11
result O 0 1.1015607176423359e-10
in O 0 1.1788349463248693e-10
an O 0 3.508430168608356e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 6.002189365972299e-06
embraces O 0 1.8810784041534134e-08
a O 0 9.738368444978107e-11
variety O 0 3.805040657556269e-11
of O 0 1.1612717731868116e-10
clinical O 0 4.898227934369004e-10
features O 0 9.002748091284374e-13
and O 0 4.323276979467661e-12
manifests O 0 1.6113624323743636e-10
extreme O 0 1.819053352392075e-07
radiosensitivity O 0 4.410415385791566e-06
and O 0 6.961971554808599e-10
a O 0 1.4023925354322841e-09
strong O 0 6.999358870274364e-10
pre O 0 1.3893337609260925e-06
- O 0 1.1151615808557835e-07
disposition O 0 4.129664375795983e-06
to O 0 1.1762082294808351e-06
malignancy B-Disease 0 0.13532012701034546
. O 0 1.8844940541384858e-07

Heterozygotes O 0 2.931660219473997e-06
for O 0 6.103601624118937e-09
the O 0 2.087471528966489e-09
ATM O 0 1.0469676681168494e-06
gene O 0 8.046169286402005e-10
have O 0 2.170881356622356e-11
no O 0 1.5736981162639552e-11
clinical O 0 1.62426669336746e-10
expression O 0 2.2405115263079978e-10
of O 0 5.090753774084078e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 1.538119076549549e-09
may O 0 1.0039978626252832e-08
be O 0 7.432841453436367e-09
cancer B-Disease 0 1.1055526556447148e-06
prone O 0 5.828164617582843e-09
with O 0 6.947356101863478e-13
a O 0 2.1758485291289986e-10
moderate O 0 1.1894336182649567e-07
increase O 0 1.1756162265896819e-08
in O 0 5.780273149014192e-09
in O 0 2.5097349976022088e-08
vitro O 0 2.4777825728961034e-06
radiosensitivity O 0 2.09918634936912e-05
. O 0 3.029230697393359e-07

We O 0 3.2176046715903794e-07
performed O 0 2.0213335449881242e-09
a O 0 3.536100079415405e-09
blind O 0 5.898611732391146e-08
chromosomal O 0 2.991701251175982e-07
analysis O 0 2.2620727513356087e-09
on O 0 1.1425083101812561e-08
G2 O 0 6.382214934319563e-08
- O 0 2.93801782902392e-09
phase O 0 1.2125623527481366e-07
lymphocytes O 0 1.6291691606884484e-10
from O 0 4.371338013786641e-11
7 O 0 2.5645598977774853e-09
unrelated O 0 5.529566848849754e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.845987350814539e-08
, O 0 2.1061381805242974e-11
13 O 0 2.9939184464922164e-10
obligate O 0 1.3930146813834199e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999909400939941
T I-Disease 1 1.0
heterozygotes O 0 9.514334919913381e-08
( O 0 2.9832115944206095e-11
parents O 0 2.3611215413388287e-11
of O 0 7.372670529637304e-11
the O 0 8.824688202402342e-11
patients O 0 4.1287178537130487e-11
) O 0 5.01338640740423e-12
, O 0 2.0348082593879546e-11
and O 0 1.1719211712168942e-10
14 O 0 1.389978443455675e-08
normal O 0 7.306475868773532e-09
controls O 0 1.1898183549519104e-09
following O 0 1.9915780136159356e-10
X O 0 1.6712262151941104e-07
- O 0 1.5189105084800758e-08
irradiation O 0 2.423390910166745e-08
with O 0 3.8330921769968995e-11
1 O 0 6.718115486137322e-08
Gy O 0 9.887815366482755e-08
in O 0 1.6106609102006786e-11
order O 0 2.875840884875025e-11
to O 0 6.863006690727147e-11
evaluate O 0 1.3931991671434218e-10
this O 0 1.306793388777816e-11
cytogenetic O 0 1.9101435100310482e-08
method O 0 2.423574674281781e-09
as O 0 5.503292700020923e-12
a O 0 8.519181020349986e-12
tool O 0 2.732375714575852e-10
for O 0 1.393780663799804e-11
detection O 0 8.417918806458147e-09
of O 0 5.6692512906408865e-09
ATM O 0 3.9456957892980427e-05
carriers O 0 1.2836632379276125e-07
. O 0 3.137962210075784e-07

Both O 0 2.3351969957730034e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 9.704099284135737e-06
and O 0 4.3444592368047097e-10
heterozygotes O 0 5.981633410812037e-09
showed O 0 2.5362755298741213e-11
significantly O 0 4.167788336673084e-11
increased O 0 4.770306025192461e-11
levels O 0 4.932071417940165e-10
of O 0 3.670920234455366e-10
radiation O 0 0.00028418179135769606
- O 0 1.1291824648651527e-06
induced O 0 1.4991369425843004e-05
chromatid O 0 5.808596597489668e-06
damage O 0 2.1073955736028438e-07
relative O 0 2.328778281324162e-09
to O 0 3.630663478193519e-11
that O 0 2.0604705008170354e-12
of O 0 3.057389411087463e-11
normal O 0 2.1294066510080256e-09
controls O 0 1.9969547793152742e-08
. O 0 9.562068470359009e-09

These O 0 2.303096380273928e-09
results O 0 3.16473180994592e-09
show O 0 2.8838509358308784e-10
that O 0 3.166660683673328e-11
the O 0 7.473779373157186e-10
G2 O 0 3.975064544192719e-07
- O 0 9.853588522901191e-08
phase O 0 6.128029781393707e-06
chromosomal O 0 1.1084282959927805e-05
radiosensitivity O 0 8.987617547973059e-07
assay O 0 1.3068751414380131e-08
can O 0 5.184996876295145e-11
be O 0 3.928318174223344e-12
used O 0 5.404985270116014e-13
for O 0 1.102275754938202e-13
the O 0 4.098451721230856e-13
detection O 0 2.796964049256445e-10
of O 0 6.5938547955113336e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 0.00011938139505218714
. O 0 6.907772558406577e-07

In O 0 8.209413238091656e-08
combination O 0 6.072367852993921e-08
with O 0 1.588458364842893e-09
molecular O 0 3.98606601947904e-07
genetic O 0 4.80916746425919e-08
analyses O 0 9.33083610377139e-10
, O 0 1.5946121376467226e-12
this O 0 4.330132715064938e-13
test O 0 5.742506296868566e-12
may O 0 1.2564648974033865e-11
be O 0 5.0921805834491796e-12
of O 0 6.7922906882289524e-12
value O 0 1.3961299998033194e-11
in O 0 1.3278553603890408e-12
studies O 0 1.0048680637586571e-11
of O 0 7.376679128645591e-11
familial B-Disease 0 2.30429257896958e-08
and I-Disease 0 1.1889336182235866e-09
sporadic I-Disease 0 2.42749052858926e-07
cancers I-Disease 0 6.404326995834708e-05
aimed O 0 6.826706755447276e-09
at O 0 5.21169052358772e-10
determination O 0 2.0139130640917102e-10
of O 0 5.3210314626683797e-11
the O 0 9.748101631457118e-12
potential O 0 2.7871904437204442e-11
involvement O 0 2.177783370305164e-10
of O 0 1.5553588972316845e-10
ATM O 0 5.23269306995644e-07
mutations O 0 7.537718005323768e-09
in O 0 6.779946742918597e-11
tumor B-Disease 0 6.410913920262828e-05
risk O 0 1.216695437733506e-07
or O 0 7.335475005199044e-10
development O 0 1.8395475365196035e-08
. O 0 1.614119393700264e-09
. O 0 1.0336103528629792e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 1.1690244328121935e-08
identification O 0 1.5356801386090524e-09
and O 0 1.6684806314337663e-11
detection O 0 2.2220943307615926e-08
of O 0 1.6404271718784003e-08
founder O 0 4.8263970597872685e-08
- O 0 8.662532913206178e-09
effect O 0 4.887556883659272e-07
mutations O 0 2.7108976397016704e-08
in O 0 3.020244332407884e-10
the O 0 1.2887795275418057e-09
ATM O 0 1.4707576383443666e-06
gene O 0 2.808073107374298e-09
in O 0 4.650446139287112e-10
ethnic O 0 5.126588931148035e-09
populations O 0 2.2242558905816168e-09
. O 0 5.0913238069938416e-09

To O 0 1.9862728350972247e-08
facilitate O 0 3.684242466661658e-09
the O 0 4.2190104188044586e-10
evaluation O 0 2.904486651189586e-09
of O 0 1.969777452259791e-09
ATM O 0 3.994771304860478e-06
heterozygotes O 0 5.9577814681688324e-08
for O 0 4.816046450528688e-10
susceptibility O 0 4.7219552357091743e-07
to O 0 4.951547172282744e-09
other O 0 4.5637002510368063e-10
diseases O 0 5.577152478508651e-05
, O 0 3.563946360252146e-11
such O 0 7.97095098259426e-11
as O 0 5.989935658590184e-08
breast B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999998807907104
, O 0 3.67812003077006e-09
we O 0 2.733221649009465e-09
have O 0 2.100441522101537e-11
attempted O 0 1.3749793525974496e-09
to O 0 8.724938826976114e-11
define O 0 1.2380604319517374e-09
the O 0 3.1100295949659795e-11
most O 0 9.710147182845352e-13
common O 0 2.6594797544743365e-11
mutations O 0 2.429344780896514e-10
and O 0 4.066024426874204e-12
their O 0 5.191859312261848e-13
frequencies O 0 3.853958263633217e-10
in O 0 8.030546783110992e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.63564322469756e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.2422429191149007e-10
homozygotes O 0 7.724598738434452e-09
from O 0 2.4931384734472317e-10
10 O 0 2.7068958186049485e-10
ethnic O 0 2.7000482405448167e-10
populations O 0 1.2337413035634626e-10
. O 0 1.8137857882294384e-09

Both O 0 3.0148314067446336e-08
genomic O 0 1.905780635524934e-07
mutations O 0 1.3306753032793495e-07
and O 0 2.222452499811567e-10
their O 0 4.735458553062344e-11
effects O 0 2.606446836139753e-09
on O 0 3.480083110574128e-09
cDNA O 0 1.2622460410227632e-08
were O 0 7.053582717908569e-10
characterized O 0 1.0587192456057437e-08
. O 0 2.0848940351925194e-08

Protein O 0 3.777041612806897e-08
- O 0 7.936023393995129e-09
truncation O 0 5.411683545730739e-08
testing O 0 1.3627863282295039e-09
of O 0 2.686225131220965e-10
the O 0 2.3145138583480218e-10
entire O 0 3.5800831188481652e-09
ATM O 0 1.8424503878122778e-07
cDNA O 0 1.675985039639727e-08
detected O 0 1.361295876023405e-08
92 O 0 4.913182749533007e-09
( O 0 3.758050468039009e-11
66 O 0 1.0834250829816483e-08
% O 0 4.652965512885743e-10
) O 0 1.633427941516441e-11
truncating O 0 2.5715902296497006e-08
mutations O 0 1.8033268212036546e-09
in O 0 9.325423766526342e-11
140 O 0 8.728172629091091e-10
mutant O 0 1.301809215981109e-09
alleles O 0 1.8360308828846428e-09
screened O 0 4.484407156724046e-08
. O 0 7.505182253453313e-09

The O 0 2.8304773991294496e-07
haplotyping O 0 0.02351708710193634
of O 0 1.6780085161371971e-06
patients O 0 1.0898999924791042e-08
with O 0 5.670713464772659e-12
identical O 0 3.5290728117587378e-09
mutations O 0 7.155366006372788e-07
indicates O 0 2.983512459309168e-08
that O 0 2.726897180282961e-11
almost O 0 1.0373638753558012e-10
all O 0 1.4020052480079315e-12
of O 0 8.485526734394733e-13
these O 0 1.8317133224153397e-14
represent O 0 7.039378845455357e-13
common O 0 1.747242454885889e-11
ancestry O 0 3.2626618073905433e-10
and O 0 1.5728219074362393e-11
that O 0 2.97128675830205e-11
very O 0 1.4692680405659075e-10
few O 0 4.275383658214338e-10
spontaneously O 0 8.9019032145643e-09
recurring O 0 6.551082343264625e-09
ATM O 0 1.5022312254586723e-05
mutations O 0 1.1556625167941093e-06
exist O 0 1.8451106598149636e-07
. O 0 6.204572144952181e-08

Assays O 0 7.818802032488747e-07
requiring O 0 7.083492903348088e-08
minimal O 0 3.541333626344567e-07
amounts O 0 2.1735777622211572e-08
of O 0 7.823066638934506e-09
genomic O 0 3.3752003414377896e-09
DNA O 0 1.7572238109053728e-09
were O 0 4.250984980691541e-12
designed O 0 5.349216295608139e-12
to O 0 2.1839969069348264e-11
allow O 0 1.748649315624906e-11
rapid O 0 1.3555424838163077e-10
screening O 0 5.2108234394054875e-11
for O 0 1.6522212200817399e-12
common O 0 2.358152284553938e-10
ethnic O 0 1.4265713943473202e-08
mutations O 0 2.4534548970223113e-07
. O 0 3.331930642502812e-08

These O 0 5.368248068293724e-08
rapid O 0 1.3736004689235415e-07
assays O 0 2.0583462401191355e-07
detected O 0 2.662984002199664e-07
mutations O 0 5.63829072319777e-09
in O 0 6.708246458320133e-11
76 O 0 8.494952297155578e-09
% O 0 1.164795038199884e-09
of O 0 9.022668168157111e-10
Costa O 0 6.174274176373729e-07
Rican O 0 2.6624227302818326e-06
patients O 0 3.0768909642375775e-09
( O 0 3.020847808010707e-11
3 O 0 6.327378621051594e-09
) O 0 8.427802726529432e-12
, O 0 3.0786944174576725e-12
50 O 0 7.963049664105881e-11
% O 0 2.5005379711284803e-11
of O 0 3.660507660874224e-11
Norwegian O 0 4.5255045932890425e-08
patients O 0 3.9349509761699153e-10
( O 0 1.439763933075433e-11
1 O 0 1.918365910569264e-08
) O 0 9.115704718842821e-12
, O 0 7.088263569848818e-12
25 O 0 2.610425764437707e-10
% O 0 8.569412540682109e-11
of O 0 4.6184889246347893e-11
Polish O 0 5.8915841094631105e-08
patients O 0 1.4823579030931455e-09
( O 0 3.555947550304417e-11
4 O 0 1.2358669643219855e-08
) O 0 2.4762752612317307e-11
, O 0 8.02543882044704e-12
and O 0 4.439175155940278e-12
14 O 0 2.1997172139354149e-10
% O 0 8.179923405293721e-11
of O 0 2.875687361847401e-11
Italian O 0 2.1424035878681025e-08
patients O 0 7.108958977042334e-10
( O 0 3.26232409142424e-11
1 O 0 4.457192233076057e-07
) O 0 2.5600135900027965e-10
, O 0 9.714028886831372e-11
as O 0 2.5724644636682115e-11
well O 0 9.00252875718488e-12
as O 0 3.907588228685421e-12
in O 0 5.301254660944332e-12
patients O 0 9.46611278945797e-12
of O 0 1.799052018469638e-10
Amish O 0 1.4181558150028195e-08
/ O 0 8.514584948215997e-08
Mennonite O 0 5.729739527282618e-08
and O 0 3.188827535360872e-10
Irish O 0 2.2931985199647897e-09
English O 0 7.733089724126785e-09
backgrounds O 0 2.3049430808441684e-08
. O 0 2.5124938574094813e-08

Additional O 0 5.461039620513475e-08
mutations O 0 3.6992283014569693e-08
were O 0 1.284965134296101e-09
observed O 0 3.6220679233700537e-10
in O 0 1.402292171270858e-11
Japanese O 0 1.190422205255004e-09
, O 0 8.282441399387608e-11
Utah O 0 3.6685841031669497e-09
Mormon O 0 3.7950328990454807e-10
, O 0 1.7788301213961244e-12
and O 0 2.580266512605678e-12
African O 0 1.4011405924385656e-10
American O 0 3.176632012991121e-10
patients O 0 8.887157121328926e-10
. O 0 7.0271326535475964e-09

These O 0 6.367690819075733e-10
assays O 0 1.1470689953441138e-09
should O 0 3.123464681342725e-11
facilitate O 0 2.6948913586788414e-11
screening O 0 1.4483775290230483e-10
for O 0 2.2395714449618964e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 4.301788578686683e-07
in O 0 2.5950364079818655e-10
the O 0 1.0849894593878417e-10
populations O 0 2.6497935790015248e-11
studied O 0 1.0042999765147442e-09
. O 0 2.833817347447365e-10
. O 0 6.523476425712715e-09

The O 0 1.5536784303549211e-06
von B-Disease 1 0.9999996423721313
Hippel I-Disease 1 0.9999996423721313
- I-Disease 1 0.9999295473098755
Lindau I-Disease 1 0.9992478489875793
tumor I-Disease 0 0.0004960804362781346
suppressor O 0 1.683572605770678e-07
gene O 0 7.510487370909757e-11
is O 0 8.732422337315304e-13
required O 0 1.82590834812979e-11
for O 0 1.2717535358142129e-11
cell O 0 3.2888802792285787e-09
cycle O 0 1.284152428837615e-08
exit O 0 6.178919154109508e-09
upon O 0 4.46057635272723e-10
serum O 0 4.643924356173557e-09
withdrawal O 0 4.36861512298492e-07
. O 0 1.0235992675688976e-07

The O 0 3.2687943019027443e-08
inactivation O 0 6.431262136175064e-06
of O 0 5.139182235325279e-08
the O 0 2.149033484499796e-08
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 6.0381516959751025e-06
VHL I-Disease 1 0.999920129776001
) I-Disease 0 4.37729097413353e-09
tumor I-Disease 0 0.00032454569009132683
suppressor O 0 9.837502148002386e-06
gene O 0 5.4275690608562854e-09
predisposes O 0 6.494266813206195e-08
affected O 0 4.607783044008329e-10
individuals O 0 6.833639990683205e-12
to O 0 4.227146133128912e-10
the O 0 1.8583219407730667e-09
human O 0 6.169489097374026e-07
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 1.3319082503571167e-09
is O 0 9.402830597471379e-11
associated O 0 3.480141175238316e-10
with O 0 1.7863042642285443e-11
sporadic B-Disease 0 2.071768722089473e-05
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 9.621005574445007e-07
RCC B-Disease 1 0.9997867941856384
) O 0 2.2203913374596596e-08
and O 0 8.378310667467304e-08
brain B-Disease 1 0.9999780654907227
hemangioblastomas I-Disease 1 0.8070783615112305
. O 0 5.191989203012781e-06

VHL O 0 0.32409000396728516
- O 0 0.00016983109526336193
negative O 0 6.0395973378035706e-06
786 O 0 6.591024430235848e-06
- O 0 2.1527316675928887e-06
0 O 0 2.2893154039138608e-07
RCC B-Disease 0 1.2380582120385952e-05
cells O 0 1.094802968282238e-07
are O 0 2.0993851101991368e-10
tumorigenic O 0 7.586213996546576e-06
in O 0 4.173450207645146e-08
nude O 0 6.775107408429903e-08
mice O 0 4.661867003541431e-10
which O 0 3.2017509303539082e-12
is O 0 4.049662515048791e-12
suppressed O 0 3.966204448202504e-11
by O 0 4.448821519509316e-12
the O 0 2.941992205407473e-10
reintroduction O 0 5.799757119007154e-08
of O 0 5.531779034839701e-09
VHL B-Disease 0 8.198442083084956e-05
. O 0 5.904109912080457e-07

Remarkably O 0 2.8743429538735654e-06
, O 0 4.665184905050523e-10
this O 0 5.723155283021697e-11
occurs O 0 3.826666206130369e-10
without O 0 1.2014801653581486e-10
affecting O 0 8.974879173173633e-11
the O 0 1.7628953852266704e-11
growth O 0 3.4110894664429736e-11
rate O 0 1.393858500842171e-10
and O 0 9.343257938165817e-12
cell O 0 7.956316494528437e-09
cycle O 0 4.641905082536368e-09
profile O 0 3.871424361645559e-11
of O 0 4.351755067411034e-11
these O 0 2.978997040367637e-12
cells O 0 1.24725132999437e-10
in O 0 4.0005838919388026e-11
culture O 0 1.2230578771976752e-09
. O 0 3.627372624492864e-09

The O 0 8.896363397070672e-07
786 O 0 3.948231551476056e-06
- O 0 3.7784977280352905e-07
0 O 0 5.790814938677613e-08
cell O 0 2.403330690015082e-08
line O 0 4.769403716409215e-08
, O 0 2.885127414753441e-10
like O 0 6.324862855677793e-11
many O 0 5.4275733213371424e-11
cancer B-Disease 0 9.708985260203917e-08
cells O 0 2.647704722136268e-09
, O 0 3.2196217913949e-11
fails O 0 5.393266722109047e-09
to O 0 1.3628227435447116e-09
exit O 0 1.9705373333067655e-08
the O 0 7.640733601377292e-10
cell O 0 3.0718829702180983e-09
cycle O 0 1.758464374113089e-09
upon O 0 1.3454093394926758e-10
serum O 0 1.953762485129573e-09
withdrawal O 0 2.2162220147947664e-07
. O 0 3.839859630261344e-08

Here O 0 3.432620587773272e-07
, O 0 2.0747763229689298e-10
it O 0 9.146234117296537e-12
is O 0 1.5758058920234408e-12
shown O 0 1.1998462119688913e-12
that O 0 1.1638694565399565e-12
reintroduction O 0 2.987975422641398e-09
of O 0 3.302670636973204e-10
the O 0 3.8581504657742016e-10
wild O 0 1.286711404091534e-09
- O 0 4.377591622528598e-09
type O 0 2.842965045601886e-07
VHL B-Disease 0 0.00012421268911566585
gene O 0 2.028866497028048e-08
restores O 0 5.205037290068049e-09
the O 0 1.2677386918014122e-10
ability O 0 1.1039121006195529e-10
of O 0 2.212248384481086e-09
VHL O 0 9.226755355484784e-05
- O 0 4.194620942143956e-06
negative O 0 1.3698817156182486e-06
RCC B-Disease 0 0.0014306566445156932
cancer I-Disease 0 1.8400603948975913e-05
cells O 0 7.74882547016631e-10
to O 0 2.22382209869032e-10
exit O 0 1.169867092087884e-09
the O 0 1.0641763859009501e-10
cell O 0 5.29031096707655e-10
cycle O 0 8.958704889039382e-10
and O 0 1.3477483885859787e-11
enter O 0 1.888970224683817e-08
G0 O 0 0.00017058674711734056
/ O 0 1.2685627552855294e-05
quiescence O 0 1.2939352927787695e-05
in O 0 1.5312497936292857e-08
low O 0 3.3141779454126663e-07
serum O 0 7.405589030895499e-08
. O 0 1.2253000392092872e-08

Both O 0 1.305539399254485e-06
VHL O 0 0.17267252504825592
- O 0 3.945583011955023e-05
positive O 0 2.577773017264917e-08
and O 0 9.181975180183599e-09
VHL O 0 0.0001234257797477767
- O 0 1.2781249552062945e-06
negative O 0 2.3771492863033927e-07
RCC B-Disease 0 2.2867891402711393e-06
cells O 0 3.9074322444321297e-08
exit O 0 3.055301434073954e-08
the O 0 4.0700168235652256e-10
cell O 0 1.4988934537996101e-09
cycle O 0 4.9766168963572e-10
by O 0 1.0429919081178518e-11
contact O 0 5.00111196899411e-09
inhibition O 0 1.393053935316857e-06
. O 0 5.099286113363632e-07

The O 0 2.9473023914761143e-06
cyclin O 0 6.724385002598865e-06
- O 0 4.2382188780720753e-07
dependent O 0 1.4799947223309573e-07
kinase O 0 1.2709253383036412e-07
inhibitor O 0 3.887724915330182e-07
, O 0 8.805021711744132e-10
p27 O 0 1.6013520109936508e-07
, O 0 1.9983995361294582e-11
accumulates O 0 8.007400992271485e-11
upon O 0 3.540299130244673e-12
serum O 0 1.0162691001236457e-11
withdrawal O 0 3.7466172386757535e-09
, O 0 3.691650717757566e-12
only O 0 2.5217065848653908e-12
in O 0 6.574150945848345e-13
the O 0 2.452986164885873e-12
presence O 0 5.239653329269789e-12
of O 0 3.714808183286067e-10
VHL B-Disease 0 4.934042226523161e-05
, O 0 7.791147588198655e-11
as O 0 4.2891749180151706e-12
a O 0 4.198343495770418e-12
result O 0 1.7558383566540492e-11
of O 0 1.7758005135815047e-11
the O 0 6.095890719287622e-12
stabilization O 0 2.925290898403432e-09
of O 0 7.736483453868459e-09
the O 0 6.586375889128249e-09
protein O 0 4.5313694130300064e-08
. O 0 9.672199929866565e-09

We O 0 2.7474708730323982e-08
propose O 0 2.545865918079926e-08
that O 0 1.5535325803561761e-10
the O 0 5.194383256856838e-10
loss O 0 3.2129507943068347e-09
of O 0 2.727357673038e-09
wild O 0 7.309232108454466e-10
- O 0 5.022656179853868e-10
type O 0 4.942322107126529e-08
VHL B-Disease 0 1.1171707228641026e-05
gene O 0 2.5857982421939596e-09
results O 0 1.16619114365335e-09
in O 0 6.350756032169613e-11
a O 0 1.3134635046263554e-10
specific O 0 1.5419022725282616e-09
cellular O 0 3.451389574138375e-08
defect O 0 3.8197867979761213e-07
in O 0 8.987954824846156e-10
serum O 0 4.126834696194237e-08
- O 0 1.4797463165905356e-07
dependent O 0 2.0088323537947872e-07
growth O 0 4.31506164133566e-09
control O 0 7.061447870881921e-09
, O 0 3.3443525726539747e-12
which O 0 1.7241933792169761e-12
may O 0 3.2605343425196054e-10
initiate O 0 2.70704827443069e-08
tumor B-Disease 0 1.4747690784133738e-06
formation O 0 6.304804855972179e-08
. O 0 7.092090470450785e-08

This O 0 1.0290388985367827e-08
is O 0 2.8670299467847826e-10
corrected O 0 1.76596970380416e-09
by O 0 1.090347517135326e-11
the O 0 1.36659628058311e-10
reintroduction O 0 2.534451226665624e-08
of O 0 6.986754508275794e-10
wild O 0 2.7315329997890103e-09
- O 0 1.862644971595273e-08
type O 0 4.0585211536381394e-05
VHL B-Disease 1 0.9999998807907104
, O 0 2.446755900109565e-07
implicating O 0 0.00010044794180430472
VHL B-Disease 1 0.8334874510765076
as O 0 9.365985320641812e-09
the O 0 7.698531256927765e-10
first O 0 1.5794845986683015e-10
tumor B-Disease 0 2.4480177884811383e-08
suppressor O 0 1.1165556657033449e-07
involved O 0 5.024132221365107e-10
in O 0 1.7226756479638006e-11
the O 0 2.1560436769263447e-10
regulation O 0 7.326571349608457e-09
of O 0 5.331277197484496e-09
cell O 0 2.4717113689121106e-08
cycle O 0 1.4803335091073677e-07
exit O 0 6.621976211818037e-08
, O 0 1.432835707720903e-11
which O 0 3.5830151779575603e-12
is O 0 1.573554134215449e-11
consistent O 0 8.791289918264056e-11
with O 0 2.913102430720377e-13
its O 0 1.2165561960597593e-11
gatekeeper O 0 6.262853347038799e-09
function O 0 1.8545145974435684e-10
in O 0 2.4141650484255095e-11
the O 0 4.780099649437375e-10
kidney O 0 2.5638089482526993e-06
. O 0 4.0294820813358e-09
. O 0 2.7298675320253096e-08

Piebaldism B-Disease 1 1.0
with O 1 0.9983413219451904
deafness B-Disease 1 1.0
: O 0 1.0238002801088442e-07
molecular O 0 4.4957971567782806e-08
evidence O 0 2.623153083636254e-10
for O 0 8.419544575422044e-12
an O 0 1.5536264982851655e-11
expanded O 0 2.7150580450552297e-08
syndrome O 1 1.0
. O 0 3.953449777327478e-06

In O 0 5.151368220879249e-09
a O 0 1.8783274935429972e-09
South O 0 4.115709550944757e-09
African O 0 2.6120607898860726e-09
girl O 0 2.828391743037173e-09
of O 0 4.098231198845781e-10
Xhosa O 0 2.00641565584192e-08
stock O 0 1.8966871129233454e-10
with O 0 4.670510397701555e-13
severe O 0 7.085991455824114e-06
piebaldism B-Disease 0 0.3027208745479584
and O 0 7.609689589571644e-08
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 9.380044502904639e-05
identified O 0 2.7596647189653822e-09
a O 0 5.2425449398318946e-11
novel O 0 6.611680647417018e-11
missense O 0 8.056462164063305e-09
substitution O 0 9.803475364833503e-09
at O 0 1.9306407139652038e-08
a O 0 8.150026764575102e-10
highly O 0 1.8136265822477071e-09
conserved O 0 3.731720710220543e-08
residue O 0 6.787265647290042e-07
in O 0 4.692412014506431e-10
the O 0 7.476973484799032e-10
intracellular O 0 1.58987389919929e-09
kinase O 0 4.6602355752156654e-08
domain O 0 1.0590792243192482e-07
of O 0 1.4321712704656875e-08
the O 0 2.722523984033387e-09
KIT O 0 2.392582985066838e-07
proto O 0 7.478744009858929e-06
- O 0 1.2312199260122725e-06
oncogene O 0 3.8353509808075614e-06
, O 0 4.344063775363338e-09
R796G O 0 9.148577191808727e-06
. O 0 6.369567984165769e-08

Though O 0 5.333405965757265e-07
auditory B-Disease 0 0.0031640809029340744
anomalies I-Disease 0 0.09503365308046341
have O 0 6.189086132479815e-09
been O 0 1.6500412147735233e-09
observed O 0 1.8258300427120844e-09
in O 0 3.753608882051118e-11
mice O 0 1.344631905819682e-10
with O 0 3.764835665442945e-12
dominant O 0 8.332492740237285e-08
white O 0 4.13151868272621e-09
spotting O 0 2.80770592553381e-07
( O 0 5.4513376035458805e-09
W O 0 0.0006558315944857895
) O 0 5.664168023500338e-10
due O 0 1.5159358213168161e-07
to O 0 3.150253835570993e-09
KIT O 0 4.778345328304567e-07
mutations O 0 4.6107552407193e-06
, O 0 3.22873489722042e-07
deafness B-Disease 1 1.0
is O 0 2.136673948882617e-08
not O 0 1.1680967304528167e-09
typical O 0 2.481857386271713e-09
in O 0 2.6827998156342403e-10
human O 0 3.200192777441657e-09
piebaldism B-Disease 0 3.2385835311288247e-06
. O 0 1.2607884514181933e-07

Thus O 0 2.4837245149456066e-08
, O 0 1.0752962409377176e-10
the O 0 4.572794573554084e-11
occurrence O 0 2.417301914192649e-08
of O 0 9.628540738049196e-07
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.00045636334107257426
this O 0 3.2529595017649626e-08
patient O 0 1.9617059976440032e-08
extends O 0 6.126856244570433e-10
considerably O 0 1.312043945711494e-10
the O 0 1.4006375920194714e-11
phenotypic O 0 5.51413137372947e-10
range O 0 2.795349285378279e-09
of O 0 8.477079593838255e-10
piebaldism B-Disease 0 4.036588450162526e-07
due O 0 9.516149646060512e-08
to O 0 1.891662604336375e-09
KIT O 0 2.7059384066774328e-08
gene O 0 1.1760192819565418e-09
mutation O 0 5.005473369124047e-09
in O 0 7.270574420292775e-11
humans O 0 2.0879004081209018e-10
and O 0 5.276099696027714e-11
tightens O 0 9.382126187063022e-10
the O 0 2.3479003463666714e-11
clinical O 0 1.9145332541548044e-10
similarity O 0 5.677090395006523e-11
between O 0 1.7040752142705173e-10
piebaldism B-Disease 0 1.7475625213592139e-07
and O 0 2.2405905256150938e-12
the O 0 1.4819315479613904e-12
various O 0 8.469013522156149e-14
forms O 0 2.2496483842449067e-11
of O 0 3.2794591486862146e-09
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.625071253234637e-08
. O 0 5.105154343709728e-08

Cycloheximide O 0 2.2190415620571002e-05
facilitates O 0 1.2231425650099936e-08
the O 0 1.110732505971157e-09
identification O 0 8.857643507553803e-10
of O 0 5.22846033135238e-09
aberrant O 0 1.5837429145904025e-08
transcripts O 0 1.2513081237841561e-08
resulting O 0 7.381246280857567e-09
from O 0 2.7200625085654906e-10
a O 0 5.18561027451625e-11
novel O 0 7.792425732455754e-11
splice O 0 2.764638296071098e-09
- O 0 1.336666610729509e-10
site O 0 7.318798345146149e-11
mutation O 0 1.3175734114856397e-10
in O 0 4.045649926176509e-11
COL17A1 O 1 0.695422887802124
in O 0 1.2074031774389482e-09
a O 0 5.504981359649719e-09
patient O 0 3.15625179325707e-08
with O 0 2.9509897303547916e-10
generalized O 1 0.9632706642150879
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9731284976005554
. O 0 1.5767494687679573e-06

Patients O 0 1.8665591596800368e-06
with O 0 1.556828777005137e-09
generalized O 1 0.9997332692146301
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9154127240180969
often O 0 9.844693948934946e-10
show O 0 5.59482425666058e-11
decreased O 0 6.233533134114566e-10
expression O 0 8.5959649120948e-11
of O 0 4.0729133954364727e-10
type O 0 6.732135204856604e-08
XVII O 0 9.955614223144948e-05
collagen O 0 2.635317514432245e-06
, O 0 4.861280267220991e-09
a O 0 9.342363327391467e-09
transmembrane O 0 2.7962849458162964e-07
hemidesmosomal O 0 2.16647151773941e-07
protein O 0 1.3320962111151857e-09
encoded O 0 3.133106968311594e-11
by O 0 8.68008928622821e-11
COL17A1 O 0 8.79525687196292e-05
. O 0 1.4330379372040625e-07

This O 0 1.7596427426269656e-08
report O 0 3.560815531322703e-10
documents O 0 3.5800473696667723e-10
a O 0 2.718143488067426e-10
novel O 0 2.795395859234162e-10
splice O 0 8.65067839583844e-09
- O 0 2.640491436611825e-10
site O 0 1.250963221899326e-10
mutation O 0 1.2802967019887035e-10
in O 0 3.9752097447109946e-11
COL17A1 O 1 0.9998898506164551
in O 0 2.3402038085151844e-09
a O 0 1.0841527675609086e-08
patient O 0 4.6598444214396295e-08
with O 0 1.9074765378324088e-10
generalized O 1 0.9932886958122253
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999991655349731
bullosa I-Disease 1 0.9741947650909424
, O 0 1.2808396565588964e-09
and O 0 5.565470306834186e-11
applies O 0 1.0448346632330185e-09
a O 0 5.4676183719459814e-11
new O 0 7.965567441758914e-12
methodology O 0 3.504654066954771e-10
to O 0 1.4886698818106225e-10
define O 0 5.817169856925375e-09
and O 0 1.6673139258127634e-10
characterize O 0 5.71531018067617e-08
the O 0 9.083293006639792e-10
resulting O 0 1.879574718088861e-09
mRNA O 0 8.937055184787823e-08
splice O 0 1.1325651172455764e-07
variants O 0 4.512116902333219e-09
. O 0 1.054101073094671e-08

Mutational O 0 7.64865217206534e-06
analysis O 0 1.1275297140400653e-08
of O 0 5.082477727569312e-08
COL17A1 O 1 0.9992303848266602
identified O 0 1.4500962208785495e-07
a O 0 5.345787368327137e-09
maternally O 0 1.7369950455758953e-07
inherited O 0 7.700402306909382e-07
G O 0 3.087367986154277e-06
- O 0 4.2886028950306354e-07
to O 0 8.886154319043271e-07
- O 0 0.00014123994333203882
T O 0 5.112206963531207e-06
transversion O 0 3.4220670386275742e-06
at O 0 1.7385222150778645e-08
the O 0 2.0264087630117444e-10
- O 0 3.584809671330902e-10
1 O 0 1.1248940445796052e-08
position O 0 1.0748380852021455e-08
of O 0 4.965137634371786e-09
exon O 0 4.951077769987933e-08
32 O 0 9.693793856513366e-08
. O 0 1.6777663702782775e-08

This O 0 7.353886388727915e-09
acceptor O 0 6.45489528494636e-09
splice O 0 7.74264208303066e-08
- O 0 6.865187085480784e-09
site O 0 3.832694162042571e-09
mutation O 0 1.3409265919861468e-09
led O 0 1.0020798774101891e-10
to O 0 1.7562377940816276e-10
the O 0 3.5699077027828707e-10
formation O 0 7.766259635388906e-09
of O 0 9.978052872838816e-08
aberrant O 0 1.1735264848766747e-07
transcripts O 0 6.61160228787594e-08
present O 0 6.21709128623138e-09
at O 0 1.9445362653414122e-08
extremely O 0 5.745955711233819e-09
low O 0 3.3767059903766494e-07
levels O 0 1.4841499762496824e-07
. O 0 4.4524124831468725e-08

Based O 0 2.305119117806953e-08
on O 0 1.4059050101877801e-07
our O 0 5.023662597025691e-10
recent O 0 3.424185587852513e-11
finding O 0 1.2462715581751382e-10
that O 0 5.5963796964653145e-12
cycloheximide O 0 2.1516588333270192e-07
stabilized O 0 1.4011828852744657e-06
mutant O 0 7.991727812850513e-08
COL17A1 O 0 3.886144895659527e-06
transcripts O 0 6.076478875627345e-09
in O 0 8.246438254477795e-11
keratinocytes O 0 9.192384631262485e-09
homozygous O 0 3.308458507156331e-10
for O 0 2.438758570089128e-11
a O 0 5.212127951459422e-10
frameshift O 0 1.216919827129459e-06
mutation O 0 1.9042292365156754e-07
, O 0 1.610458988388075e-10
the O 0 3.0594268785044676e-10
effects O 0 7.522024247919035e-08
of O 0 1.28204042937341e-08
the O 0 3.4429914474998213e-09
splice O 0 3.0704789821811573e-08
- O 0 2.15587214746904e-09
site O 0 9.749542284609447e-10
mutation O 0 2.7113603029427225e-10
on O 0 2.1720598653018897e-09
splicing O 0 2.7071245245480213e-09
of O 0 5.0664565875990775e-09
COL17A1 O 0 3.2393093079008395e-06
transcripts O 0 7.141470526050853e-09
were O 0 2.1854315579439287e-10
determined O 0 3.0095487213444017e-10
using O 0 5.673269493078337e-11
reverse O 0 1.9163097775276583e-09
transcriptase O 0 4.3586356746061483e-10
polymerase O 0 1.3809243748497124e-09
chain O 0 2.19633811138209e-10
reaction O 0 6.15681949867053e-11
of O 0 7.568068394192551e-10
total O 0 1.927503850973622e-10
RNA O 0 8.815742580381425e-10
from O 0 1.402908206271647e-10
keratinocytes O 0 5.917506484820478e-09
incubated O 0 5.045530659941733e-09
for O 0 7.532996448844642e-11
2 O 0 6.954466158504147e-08
. O 0 2.1603351996191122e-08

5 O 0 1.0462589443704928e-06
h O 0 1.1390725696003301e-08
in O 0 4.079076312835106e-11
the O 0 8.656513006410904e-11
presence O 0 7.679403640770133e-11
or O 0 3.4602531950866933e-09
absence O 0 5.3943907118991774e-08
of O 0 8.009746643722337e-09
10 O 0 9.713463811067413e-09
microg O 0 3.8426000514846237e-07
cycloheximide O 0 7.335424925258849e-07
per O 0 1.1133975874599855e-07
ml O 0 9.94922061181569e-07
. O 0 1.479206623855589e-08

Using O 0 2.1949404516163895e-09
this O 0 1.649033687378676e-10
approach O 0 9.55240775368793e-09
, O 0 1.19088031103054e-10
an O 0 5.6044793805831716e-11
abnormally O 0 6.013695097450977e-10
spliced O 0 9.263663725000981e-10
transcript O 0 6.236116956159776e-09
was O 0 2.9392508427150688e-09
identified O 0 8.921834104835824e-11
that O 0 1.2029258882398364e-12
contains O 0 1.235008948406724e-12
an O 0 6.047805919257021e-12
extra O 0 4.913815188078985e-11
264 O 0 2.865953030450896e-10
bases O 0 1.0865530697401482e-10
upstream O 0 3.727678166143278e-09
from O 0 4.562795419271737e-10
exon O 0 1.437956864691614e-09
32 O 0 2.330475590284209e-09
, O 0 6.6260187440991825e-12
resulting O 0 1.5599400937649222e-10
in O 0 1.6485555975886967e-10
a O 0 7.461932405306015e-09
premature O 0 6.526054789901536e-07
termination O 0 2.99682938020851e-06
codon O 0 2.230895006505307e-06
27 O 0 8.708797736289853e-07
bp O 0 3.291719110620761e-07
downstream O 0 8.555576158641998e-08
from O 0 3.2267322147561117e-09
the O 0 2.964428924556728e-09
cryptic O 0 6.142236941286683e-08
splice O 0 2.404042049874988e-07
site O 0 4.1116866356105675e-08
. O 0 1.4725913821678205e-08

Three O 0 5.933114000100659e-09
other O 0 4.065824413257424e-11
splice O 0 4.29669766432994e-09
variants O 0 2.535318899266059e-10
, O 0 8.826535856376605e-12
including O 0 6.770582900751665e-13
one O 0 3.2230977869279753e-12
derived O 0 6.87602709145696e-12
from O 0 1.5884212001271436e-10
the O 0 2.936738907610703e-10
skipping O 0 1.658184256569939e-09
of O 0 5.760701360379983e-10
exon O 0 5.710033335049047e-09
32 O 0 1.4331276609880206e-08
, O 0 5.8090147275757786e-11
were O 0 2.7131452640105636e-10
also O 0 1.3067989745874087e-10
identified O 0 1.4067950360185932e-08
. O 0 2.3648658142860768e-08

These O 0 3.2733284971442345e-09
results O 0 1.8307958482566278e-09
indicate O 0 3.4589531239248572e-09
the O 0 3.084716371226648e-10
usefulness O 0 4.300699352199899e-09
of O 0 4.102141681894267e-10
cycloheximide O 0 6.07022627718834e-07
treatment O 0 5.6972289108614405e-09
in O 0 3.4952797600684704e-11
evaluating O 0 2.819938726972282e-10
the O 0 2.782135355428039e-10
abnormal O 0 1.3810244059442311e-09
processing O 0 2.7451596551486546e-09
of O 0 1.7634083082640473e-09
mRNA O 0 1.0266431260674835e-08
due O 0 2.4013511179532543e-08
to O 0 6.015025699745991e-10
splice O 0 1.1593630944162214e-08
- O 0 8.80544137604744e-10
site O 0 3.3966329748835733e-10
mutations O 0 5.598531083172986e-10
, O 0 1.9530826608771257e-11
because O 0 4.3910447500294936e-10
( O 0 9.598976058455833e-10
i O 0 6.054465870874992e-07
) O 0 2.5465238251420885e-10
aberrant O 0 2.3621147260399766e-09
splicing O 0 1.3473925308815637e-09
often O 0 7.484956231207374e-12
generates O 0 1.2020526067579862e-11
a O 0 8.519217969960025e-11
premature O 0 7.605740037774922e-09
termination O 0 4.865642466711506e-08
codon O 0 4.248643392656959e-08
, O 0 2.370915408445029e-10
( O 0 1.0481356060854097e-10
ii O 0 4.415358887399634e-07
) O 0 5.03978581090081e-10
transcripts O 0 2.7416382497591485e-09
with O 0 2.6140666020690873e-11
premature O 0 4.3666531723829394e-08
termination O 0 1.3481572125328967e-07
codons O 0 8.569834619720496e-08
can O 0 1.0208121015153893e-09
occur O 0 1.5361136807001685e-09
at O 0 1.1937827393282419e-09
low O 0 5.150012416521577e-09
or O 0 1.2012379979609022e-09
undetectable O 0 5.50669554399974e-08
levels O 0 5.7076161574798334e-09
due O 0 1.5051684343347915e-08
to O 0 1.1903267260748862e-09
nonsense O 0 5.5043929414466675e-09
- O 0 6.704055088846417e-10
mediated O 0 1.4497469891239234e-08
mRNA O 0 3.1851104864699664e-08
decay O 0 6.581894922419451e-07
, O 0 1.0997086054287397e-11
and O 0 2.2557186153682185e-12
( O 0 1.8995860440185197e-11
iii O 0 7.54813811454369e-08
) O 0 1.6987142248403586e-10
the O 0 6.311717815066231e-10
levels O 0 1.4075645093925004e-09
of O 0 8.836310155801996e-11
these O 0 5.684596456750901e-12
transcripts O 0 1.7151816078531112e-10
can O 0 2.730165572784049e-11
be O 0 5.6539651432929716e-11
increased O 0 1.0657384696965977e-10
by O 0 1.9323187494535432e-10
cycloheximide O 0 5.836660875502275e-06
. O 0 2.3163254070368566e-07

A O 0 5.869297865501721e-07
deletion O 0 3.6175256923343113e-07
mutation O 0 8.607064394539066e-09
in O 0 1.1268449368051492e-10
COL17A1 O 0 3.710038436111063e-05
in O 0 2.0948012768862156e-10
five O 0 1.393531401383541e-10
Austrian O 0 6.219465831236448e-08
families O 0 3.843387552660005e-10
with O 0 1.9880294632734774e-10
generalized O 1 0.9994507431983948
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999873638153076
bullosa I-Disease 0 0.00017833182937465608
represents O 0 1.72413361365642e-09
propagation O 0 2.0715988924280282e-08
of O 0 4.9540695989946926e-09
an O 0 2.062485737752695e-10
ancestral O 0 3.6835416494795936e-08
allele O 0 2.7842438043990114e-07
. O 0 2.9209324736712006e-08

Patients O 0 5.435853722701722e-07
with O 0 1.0299906483268728e-09
generalized O 1 0.5780052542686462
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999688863754272
, O 0 2.342195326576757e-09
a O 0 3.4458474962306695e-10
usually O 0 5.846708533985279e-11
nonlethal O 0 3.448178631515475e-08
form O 0 7.531596679655195e-09
of O 0 8.926057262215181e-07
junctional B-Disease 1 0.9999765157699585
epidermolysis I-Disease 1 0.9999895095825195
bullosa I-Disease 1 0.9920755624771118
, O 0 3.1589422189171046e-09
have O 0 2.6356106186398165e-10
generalized O 0 7.769315146788358e-08
blistering B-Disease 0 5.518352281796979e-06
, O 0 4.858963009723993e-09
nail B-Disease 1 0.9997331500053406
dystrophy I-Disease 1 1.0
, O 0 8.568625162297394e-06
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 3.7976606108713895e-05
and O 0 0.02831754833459854
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.9999958276748657

Skin B-Disease 1 0.9999997615814209
fragility I-Disease 1 0.8729853630065918
in O 0 3.943985138477046e-09
most O 0 2.3769678933471816e-11
cases O 0 5.104942163436377e-11
is O 0 1.2167696537834782e-11
due O 0 5.667478042425955e-09
to O 0 9.936432787682747e-10
mutations O 0 1.9263433070904057e-09
in O 0 7.674278573732707e-11
the O 0 7.600612500491266e-11
gene O 0 2.5746143064719895e-11
encoding O 0 2.264216730774038e-10
type O 0 1.2010099226245075e-07
XVII O 0 9.279291407437995e-05
collagen O 0 7.767263014102355e-06
( O 0 2.3976120644420007e-08
COL17A1 O 0 0.0016860468313097954
) O 0 7.687295244807046e-09
. O 0 3.727545205833849e-08

Recently O 0 6.261983571675955e-07
, O 0 6.078794134722898e-10
we O 0 1.7841055022227437e-10
reported O 0 8.88884729710604e-11
five O 0 9.130651963673575e-12
Austrian O 0 5.21628784611039e-09
families O 0 2.7928952553435415e-11
with O 0 7.255028175445766e-12
generalized O 0 0.20496033132076263
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999392032623291
who O 0 9.752412211128103e-09
share O 0 3.293649519786612e-10
the O 0 7.882871022601989e-10
same O 0 3.512003576844336e-09
COL17A1 O 0 0.001496681710705161
mutation O 0 2.3767190668877447e-06
. O 0 1.2056943887728266e-07

Affected O 0 2.7428302473708754e-07
individuals O 0 7.007587288221373e-10
in O 0 3.4796499015499194e-10
three O 0 4.718796881020282e-11
families O 0 8.166855212932145e-12
are O 0 2.156543390044452e-12
homozygous O 0 2.8999557963316214e-11
for O 0 1.0846599660108147e-11
4003delTC O 0 5.086965515488373e-09
, O 0 2.0811999693060024e-11
whereas O 0 3.734066666982727e-10
those O 0 6.743975516920742e-11
in O 0 8.379768406951982e-11
two O 0 5.417531007134713e-11
others O 0 9.38507396797128e-11
are O 0 8.510800571237542e-12
compound O 0 7.094766552029341e-09
heterozygotes O 0 3.375607704469985e-08
. O 0 3.220615596433163e-08

To O 0 9.171473358549065e-09
determine O 0 1.1828316104356418e-08
if O 0 4.962928956686596e-10
the O 0 8.157985398327128e-11
occurrence O 0 2.477175353732264e-09
of O 0 2.9785626742828697e-10
4003delTC O 0 1.0153445195726363e-08
in O 0 4.3835112623069605e-11
these O 0 2.389713427142226e-12
unrelated O 0 2.49941872754178e-10
families O 0 1.819284957058076e-12
signifies O 0 7.290446024654784e-11
propagation O 0 1.0222934498926861e-08
of O 0 5.877167086332236e-10
an O 0 3.3852479847107375e-11
ancestral O 0 1.03279795826694e-09
allele O 0 7.393505363495478e-09
or O 0 2.033072377116696e-09
a O 0 9.247216326002672e-09
mutational O 0 8.54476365930168e-06
hot O 0 6.465145361289615e-06
spot O 0 2.0606758255325985e-07
, O 0 4.765086242253247e-11
haplotypes O 0 6.3500926739124e-10
were O 0 3.8723697859399664e-11
determined O 0 4.5184878061377276e-10
for O 0 2.7002835731315677e-11
polymorphisms O 0 9.418707591635211e-09
both O 0 3.186085562045804e-10
within O 0 6.434097254981452e-09
and O 0 3.6352110210913224e-10
flanking O 0 1.1317656571918633e-06
COL17A1 O 1 0.9999887943267822
. O 0 1.1679121598717757e-06

Five O 0 3.571100535282312e-07
intragenic O 0 3.524440671753837e-06
polymorphisms O 0 6.483387693378972e-08
were O 0 1.0155298824088277e-09
chosen O 0 3.2052613341271297e-10
based O 0 1.0157677476918536e-10
on O 0 1.5118837737304602e-08
their O 0 2.1393305182915157e-10
informativeness O 0 2.298140316270292e-06
. O 0 1.0486989765468024e-07

One O 0 9.178354787309217e-08
of O 0 1.1446219083666165e-08
these O 0 6.923459722196768e-11
, O 0 3.289360103742034e-11
not O 0 1.6351399401148825e-10
previously O 0 1.4950902738064542e-09
reported O 0 8.851192001557706e-10
, O 0 2.937275075942658e-11
was O 0 8.967137254956015e-09
2988 O 0 2.7114856493426487e-07
A O 0 2.641933178892941e-07
or O 0 6.843915656418176e-09
C O 0 3.2732857562223217e-06
that O 0 3.2178044950814666e-11
introduces O 0 8.510411125817186e-12
a O 0 3.4845477198119923e-12
new O 0 1.0014139040573355e-12
restriction O 0 6.964093191008658e-11
site O 0 6.985165224016043e-11
for O 0 7.321857009578991e-11
Eco0109 O 0 1.632495150261093e-05
I O 0 0.00022922024072613567
. O 0 3.727552666532574e-07

All O 0 7.452403139041053e-09
the O 0 8.951565044768017e-10
4003delTC O 0 1.5157299415591297e-08
alleles O 0 6.385131867681082e-10
showed O 0 3.442337734305134e-11
the O 0 4.517518303881474e-12
same O 0 8.070615356570165e-12
haplotype O 0 1.5795524888062573e-08
for O 0 4.1593484212398835e-10
these O 0 5.506424829992973e-11
five O 0 5.378256173749207e-10
polymorphic O 0 7.834448467747279e-08
markers O 0 5.617249030365201e-07
. O 0 1.4653072355486074e-07

Fourteen O 0 7.644180186616722e-07
microsatellite O 0 6.652668957940477e-07
polymorphisms O 0 4.2888071760671664e-08
were O 0 4.0037997917075074e-10
selected O 0 4.530133212998777e-12
based O 0 7.104167080995705e-12
on O 0 1.5117130880426544e-09
their O 0 1.508540341255138e-11
high O 0 3.1905387221087267e-09
heterozygosity O 0 4.6004376486052934e-07
and O 0 1.2006876048964443e-10
their O 0 6.582008375832782e-12
location O 0 6.856809009470055e-10
within O 0 2.157015455139799e-09
10q23 O 0 4.100568730791565e-06
- O 0 5.633219757328334e-07
q25 O 0 1.026793870551046e-05
near O 0 1.4758664974579006e-06
COL17A1 O 0 0.0005415974301286042
. O 0 2.2859425996557547e-07

Three O 0 6.9161290028318945e-09
families O 0 2.485228967064046e-10
shared O 0 1.075644989745328e-10
microsatellite O 0 1.3571302304171695e-07
polymorphisms O 0 6.567492505382688e-07
covering O 0 1.4771704854865675e-06
at O 0 4.450035007153019e-08
most O 0 2.1517166520768072e-11
19 O 0 7.765396103920352e-10
cM O 0 6.840029698196304e-08
, O 0 8.581741220425876e-12
whereas O 0 2.5685092941429843e-10
the O 0 6.559230936176164e-10
others O 0 1.617761619110425e-10
shared O 0 4.9387147149637656e-11
smaller O 0 8.388260225311583e-11
regions O 0 5.804620673011129e-10
consistent O 0 4.2309852843480655e-10
with O 0 3.4966699132520096e-13
cross O 0 5.254871537907491e-10
- O 0 1.1714434977605492e-09
over O 0 9.461461475401833e-11
events O 0 2.1257511809841256e-12
during O 0 3.3177948235985077e-12
passage O 0 9.048198822136921e-12
of O 0 1.2554125490907286e-12
this O 0 9.149963772769887e-13
mutation O 0 2.6532932101419604e-11
through O 0 1.365558621041485e-11
several O 0 2.21441597697547e-11
generations O 0 7.512854782731893e-10
. O 0 7.261421242077404e-09

These O 0 4.110288998049327e-09
results O 0 2.93760304970192e-09
indicate O 0 2.4208719473506335e-09
that O 0 3.2614532602393e-11
4003delTC O 0 1.2042345787222075e-08
occurs O 0 3.4776329038699316e-10
on O 0 2.6285421061977843e-10
a O 0 4.9375281641061974e-11
single O 0 1.1488113932367483e-10
ancestral O 0 2.25068075287993e-09
allele O 0 1.0199252109543977e-08
. O 0 9.933173172882448e-10
. O 0 1.4465567410582025e-08

The O 0 3.1561677360514295e-07
haptoglobin O 0 5.368000074668089e-06
- O 0 1.377245695266538e-07
gene O 0 7.424534320676912e-10
deletion O 0 2.41565185632453e-08
responsible O 0 7.602085183577856e-09
for O 0 1.2131188276143234e-09
anhaptoglobinemia B-Disease 0 0.00030106320627965033
. O 0 2.109491788360174e-06

We O 0 1.83091785288525e-07
have O 0 8.664789025170094e-11
found O 0 6.1047681666759335e-12
an O 0 9.918675039286007e-13
allelic O 0 1.760605550238381e-09
deletion O 0 4.87385349856595e-08
of O 0 1.4825112693017672e-08
the O 0 7.916082900294441e-09
haptoglobin O 0 3.1898246106720762e-06
( O 0 1.2963827789036486e-09
Hp O 0 3.5611231741228266e-09
) O 0 2.1496041058277626e-11
gene O 0 1.2178237585036555e-11
from O 0 1.918520377286459e-11
an O 0 3.826384955413209e-12
individual O 0 2.2442943770767387e-12
with O 0 1.0389479554451242e-10
anhaptoglobinemia B-Disease 0 0.00875553023070097
. O 0 4.987976808479289e-06

The O 0 1.4692996330722963e-07
Hp O 0 3.573958196056992e-08
gene O 0 2.9460969774852686e-10
cluster O 0 2.2079402750563304e-09
consists O 0 9.708559477183965e-12
of O 0 7.514886629644835e-11
coding O 0 1.6297455829317187e-08
regions O 0 3.45268716728242e-07
of O 0 1.236796947523544e-06
the O 0 1.289058531028786e-07
alpha O 0 1.6484668208249786e-07
chain O 0 7.432482962421716e-10
and O 0 1.1585057566043666e-11
beta O 0 4.576499179620441e-09
chain O 0 3.7086841930822345e-10
of O 0 9.302347087070117e-11
the O 0 6.212189096466147e-11
haptoglobin O 0 8.449544175448409e-09
gene O 0 8.953199293060266e-11
( O 0 7.938448509658969e-12
Hp O 0 1.352159773038153e-10
) O 0 5.319202543707657e-12
and O 0 1.315280349911685e-11
of O 0 4.663698871532063e-10
the O 0 1.1158478585571174e-09
alpha O 0 1.2310557906403119e-08
chain O 0 1.9052329158775194e-10
and O 0 9.322785599064076e-12
beta O 0 5.651286549834822e-09
chain O 0 3.2354197099238036e-10
of O 0 2.979617941267776e-11
the O 0 2.5161204716961372e-11
haptoglobin O 0 1.5518697438210438e-08
- O 0 1.5398744501737838e-09
related O 0 1.2414560490725535e-09
gene O 0 1.4172459039674123e-10
( O 0 1.1421992691940108e-11
Hpr O 0 1.364696267103227e-08
) O 0 4.010707391199908e-11
, O 0 1.7136765964598233e-11
in O 0 9.017261243249308e-11
tandem O 0 4.568806222238209e-09
from O 0 4.982555257271315e-09
the O 0 8.346120239366428e-09
5 O 0 9.888042029615463e-08
side O 0 1.0555761775776773e-07
. O 0 1.5095938010745158e-07

Southern O 0 1.807670514608617e-06
blot O 0 5.7756533351494e-06
and O 0 2.223645045873468e-09
PCR O 0 3.4291303130373763e-09
analyses O 0 1.7447299160977536e-09
have O 0 1.257915646646346e-11
indicated O 0 1.6785842160693676e-10
that O 0 9.993264896146492e-13
the O 0 1.6757034128345172e-12
individual O 0 6.599626037719422e-14
with O 0 1.1311672356174168e-13
anhaptoglobinemia B-Disease 0 1.4140665527406782e-08
was O 0 4.570985367990943e-09
homozygous O 0 6.022024545693228e-11
for O 0 6.418189764378912e-12
the O 0 2.521573227998175e-11
gene O 0 1.6525151039226138e-11
deletion O 0 1.3922968333801578e-09
and O 0 6.094030662040506e-12
that O 0 2.7839215308023135e-12
the O 0 3.923797398108775e-11
gene O 0 3.3325231463265936e-11
deletion O 0 5.868769470396273e-09
was O 0 1.0939190664416287e-09
included O 0 4.912481879615349e-12
at O 0 9.655453520052149e-11
least O 0 8.075927947215344e-12
from O 0 4.3676045419216436e-11
the O 0 1.1356091761394183e-10
promoter O 0 2.32424255841579e-07
region O 0 1.6120625900839514e-07
of O 0 6.111712735901165e-08
Hp O 0 4.453233781731569e-09
to O 0 5.9754641235088e-09
Hpr O 0 8.496139258795665e-08
alpha O 0 2.70540176927625e-08
but O 0 8.005766882757115e-11
not O 0 1.1242366065866705e-10
to O 0 8.741167789594328e-10
Hpr O 0 7.412683089569327e-08
beta O 0 4.976546392754244e-07
( O 0 2.3708441876379993e-09
Hpdel O 0 2.9931190965726273e-06
) O 0 1.9146180196827345e-09
. O 0 1.187078346731596e-08

In O 0 4.9311332794843565e-09
addition O 0 2.676972810089495e-10
, O 0 2.265435061765686e-10
we O 0 1.9219530134062524e-10
found O 0 5.027692671910611e-12
seven O 0 2.005600329910151e-12
individuals O 0 8.260593272781114e-14
with O 0 1.2253670571716474e-13
hypohaptoglobinemia B-Disease 0 1.7901361104577518e-07
in O 0 2.6495927674119457e-10
three O 0 2.6766545577205925e-11
families O 0 1.1216336887054368e-11
, O 0 2.193028961552934e-12
and O 0 2.262737957073324e-12
the O 0 7.96379420742177e-11
genotypes O 0 1.0081850909671175e-08
of O 0 6.5181033903627394e-09
six O 0 3.8530320600749235e-10
of O 0 2.5865568020755347e-10
the O 0 7.611682117936169e-11
seven O 0 9.340459829199066e-12
individuals O 0 1.6055746142329408e-12
were O 0 5.3112670511668014e-11
found O 0 1.586670204944962e-11
to O 0 1.7464769908048794e-10
be O 0 3.682471882981986e-09
Hp2 O 0 0.00010709640628192574
/ O 0 0.0005425621056929231
Hpdel O 0 0.022707141935825348
. O 0 1.7792378912417917e-06

The O 0 4.5374410007070765e-08
phenotypes O 0 1.9945717966152188e-08
and O 0 1.1837851532359167e-10
genotypes O 0 1.1509070141357824e-08
in O 0 2.9796862893727294e-11
one O 0 5.978076540735788e-12
of O 0 1.0334393063526903e-11
these O 0 8.184671338026459e-14
three O 0 2.6747739223162426e-13
families O 0 3.3652423838022305e-13
showed O 0 1.7825808537597077e-11
the O 0 1.561035467556593e-10
father O 0 8.571525711431605e-10
to O 0 8.115930150154327e-10
be O 0 4.913689011232236e-09
hypohaptoglobinemic B-Disease 0 2.4300622953887796e-06
( O 0 2.2045485437161005e-09
Hp2 O 0 1.3889872207073495e-05
) O 0 2.968501278122204e-10
and O 0 7.366306453704397e-10
Hp2 O 0 8.918797902879305e-06
/ O 0 2.415017434032052e-06
Hpdel O 0 0.000712627952452749
, O 0 2.609705118672423e-09
the O 0 7.828843351376236e-09
mother O 0 4.473689474426834e-10
to O 0 5.102919753419144e-10
be O 0 7.670609702969955e-10
Hp2 O 0 2.6614557668835914e-07
- O 0 1.2819351802306755e-08
1 O 0 1.512778879941834e-07
and O 0 3.6267758241059767e-10
Hp1 O 0 6.274603379097243e-07
/ O 0 1.0589337762212381e-07
Hp2 O 0 1.7085002355088363e-06
, O 0 7.581471561657338e-11
one O 0 3.1020023355532444e-11
of O 0 8.322505878899378e-11
the O 0 9.317688981491656e-11
two O 0 8.774433436775642e-12
children O 0 1.4483428562375722e-12
to O 0 4.0093688785658443e-11
be O 0 1.1736709382148547e-09
hypohaptoglobinemic B-Disease 0 2.248034206786542e-06
( O 0 5.3135118527336545e-09
Hp2 O 0 3.544267383404076e-05
) O 0 2.27205573799516e-10
and O 0 3.796958858437449e-10
Hp2 O 0 2.2982478640187765e-06
/ O 0 2.99749302712371e-07
Hpdel O 0 3.4581084037199616e-05
, O 0 5.515246592757705e-10
and O 0 1.152401715720508e-10
the O 0 5.83967874057123e-10
other O 0 1.3836041687365075e-11
child O 0 2.0923854315846313e-10
to O 0 1.0885651408054642e-10
be O 0 1.0351921542195441e-09
Hp1 O 0 1.3158617093722569e-06
and O 0 3.3519507169899043e-09
Hp1 O 0 0.001673914841376245
/ O 0 0.0032090155873447657
Hpdel O 0 0.030745280906558037
, O 0 7.291534043218917e-10
showing O 0 3.2890040690958244e-10
an O 0 2.23429694884425e-11
anomalous O 0 3.154922012527095e-07
inheritance O 0 6.508566457341658e-06
of O 0 8.052185194173944e-07
Hp O 0 1.7891370163169995e-08
phenotypes O 0 4.7792361179688214e-09
in O 0 7.376003974268741e-11
the O 0 4.868088709919505e-10
child O 0 8.59041338063804e-10
with O 0 1.4197992607989374e-11
Hp1 O 0 6.150919944047928e-05
. O 0 8.82987592376594e-07

The O 0 3.2611694678053027e-07
Hp2 O 0 8.25092793093063e-05
/ O 0 8.883748705557082e-06
Hpdel O 0 6.685637345071882e-05
individuals O 0 2.678940624889492e-09
had O 0 8.277553753543998e-09
an O 0 6.08713357497237e-11
extremely O 0 6.651553197123405e-10
low O 0 3.310317708837829e-08
level O 0 1.1035010771820453e-07
of O 0 1.925800852120574e-08
Hp O 0 1.1587816040048438e-08
( O 0 7.91767928998155e-10
mean O 0 3.6484547649706656e-07
+ O 0 3.202166354299152e-08
/ O 0 9.887607888003913e-08
- O 0 9.690521807215191e-08
SD O 0 1.0261536544931005e-06
= O 0 2.1362541957614667e-08
0 O 0 1.9569477149872228e-09
. O 0 4.5591651981480297e-11
049 O 0 1.3486299188514295e-08
+ O 0 2.7227213816871654e-09
/ O 0 2.0205636275250072e-08
- O 0 1.1594980087181739e-08
0 O 0 4.572345613240714e-09
. O 0 1.2421115525018678e-10
043 O 0 9.293967373480427e-09
mg O 0 1.3067854354176234e-08
/ O 0 4.591712343682275e-09
ml O 0 4.594252978051827e-09
; O 0 1.7623506820552137e-11
n O 0 4.5291267958269543e-10
= O 0 2.523094788653424e-10
6 O 0 7.944878643861841e-10
) O 0 1.651402105340427e-12
, O 0 8.105986042984681e-13
compared O 0 7.925589004531552e-12
with O 0 2.4250680673645886e-13
the O 0 6.351700415629935e-11
level O 0 7.922744238442192e-09
( O 0 7.793852369042398e-11
1 O 0 6.176635025667565e-08
. O 0 2.2397937671225776e-10
64 O 0 2.060332127129527e-09
+ O 0 1.0873164590918805e-09
/ O 0 5.286823423489295e-09
- O 0 8.770848936023867e-09
1 O 0 1.9795331596128563e-08
. O 0 1.5730537705760383e-10
07 O 0 4.836556710685613e-10
mg O 0 4.967174227488158e-09
/ O 0 9.917593413177883e-10
ml O 0 3.672509796270873e-10
) O 0 4.376547681119586e-13
obtained O 0 2.0587941074179383e-11
from O 0 1.185794101798976e-10
52 O 0 9.08983111003181e-09
healthy O 0 2.5931153058156298e-11
volunteers O 0 8.698746584157035e-12
having O 0 3.6541318582106186e-11
phenotype O 0 1.552846740082714e-08
Hp2 O 0 1.2642285582842305e-06
, O 0 9.19293668966148e-11
whereas O 0 2.1904142388784464e-10
the O 0 1.150508577296705e-10
serum O 0 2.866302750703653e-10
Hp O 0 8.241123755636792e-11
level O 0 6.972602495380897e-10
of O 0 4.896413483002071e-11
an O 0 2.3497987410026067e-12
individual O 0 4.845875762292395e-13
with O 0 1.080909407119579e-11
Hp1 O 0 1.3515531463781372e-05
/ O 0 1.1457944310677703e-05
Hpdel O 0 6.911431410117075e-05
was O 0 6.163078865029092e-07
0 O 0 1.2914011904285871e-07
. O 0 1.0845995213060178e-08

50 O 0 8.29070188501646e-07
mg O 0 1.8109143411493278e-06
/ O 0 2.1620071777306293e-07
ml O 0 2.944275081517844e-07
, O 0 3.0878820334034884e-11
which O 0 3.894426014311447e-12
was O 0 6.017754350384763e-11
approximately O 0 3.3637105687628344e-12
half O 0 1.9295700454113884e-11
the O 0 6.3768001296038435e-12
level O 0 1.7680020780730388e-09
of O 0 3.0607694156969956e-10
Hp O 0 5.628800203716366e-10
in O 0 2.511398866644754e-10
control O 0 2.2728036341845836e-08
sera O 0 1.665923221594312e-08
from O 0 9.138566292588024e-11
the O 0 5.547876741340829e-11
Hp1 O 0 1.756226275517747e-08
phenotype O 0 1.5216673476814435e-09
( O 0 9.816633617099058e-12
1 O 0 4.9327888440586776e-09
. O 0 5.855056023351679e-11
26 O 0 3.926069247484065e-09
+ O 0 1.3017545930082974e-09
/ O 0 1.3483187011331665e-08
- O 0 1.5259521646271423e-08
0 O 0 2.6966062716127226e-09
. O 0 7.236650167996572e-11
33 O 0 6.298549459771152e-10
mg O 0 3.3505636043429377e-09
/ O 0 1.2767225054943765e-09
ml O 0 1.5872589909093904e-09
; O 0 1.2207540533992756e-11
n O 0 6.01461269678083e-10
= O 0 6.765210058823357e-10
9 O 0 1.3249934482928438e-09
) O 0 3.711150310670153e-12
, O 0 3.8525285392387865e-12
showing O 0 2.6436144939800954e-11
a O 0 2.6486832171990216e-10
gene O 0 1.334562460542088e-10
- O 0 2.310690749851574e-09
dosage O 0 7.274621793840197e-08
effect O 0 2.067715314524321e-07
. O 0 3.156450389951715e-08

The O 0 2.2099214902482345e-08
other O 0 5.6948005339174657e-11
allele O 0 4.236430317661188e-09
( O 0 1.0701156627490604e-10
Hp2 O 0 1.0346093404223211e-06
) O 0 6.592804080440828e-11
of O 0 3.4414465721610554e-10
individuals O 0 2.021940774532549e-11
with O 0 2.641195248620498e-11
Hp2 O 0 0.0002237772714579478
/ O 0 1.057999088516226e-05
Hpdel O 0 0.0001281133299926296
was O 0 3.659940617239954e-08
found O 0 3.2728698223793984e-11
to O 0 1.7507252592086076e-11
have O 0 4.1884256479773896e-12
, O 0 2.7218552932362083e-12
in O 0 1.367889135295286e-11
all O 0 6.038748667780425e-11
exons O 0 9.816385926342264e-09
, O 0 1.0488715451728581e-10
no O 0 5.17949405587359e-10
mutation O 0 1.3065355464192407e-09
, O 0 1.1998033642990347e-11
by O 0 3.447423596592003e-11
DNA O 0 1.8049174599354956e-08
sequencing O 0 5.246484136023355e-08
. O 0 1.6937724112153774e-08

On O 0 9.396784150794701e-08
the O 0 2.2900853435814383e-10
basis O 0 2.262948495257433e-09
of O 0 1.5683233878238667e-10
the O 0 7.528917767007925e-11
present O 0 8.01479646539427e-11
study O 0 7.077864683235902e-11
, O 0 1.7070630933119224e-12
the O 0 1.69235528368894e-11
mechanism O 0 1.1413120448722225e-09
of O 0 7.873854901419008e-10
anhaptoglobinemia B-Disease 0 2.1803255378927133e-07
and O 0 2.624848428889326e-11
the O 0 8.710140941836642e-11
mechanism O 0 6.634207627698174e-10
of O 0 5.577246997567897e-10
anomalous O 0 6.814914854658127e-07
inheritance O 0 2.076167447739863e-06
of O 0 7.541547120126779e-08
Hp O 0 4.225019889503301e-09
phenotypes O 0 2.6019664201015757e-09
were O 0 2.96035335134448e-10
well O 0 6.180822520462925e-11
explained O 0 5.3358348850451875e-09
. O 0 4.232310946150619e-09

However O 0 3.77067124190944e-08
, O 0 1.8025693437895285e-10
the O 0 1.0293499386193616e-10
mechanism O 0 4.162707512023189e-09
of O 0 5.849011941450044e-09
hypohaptoglobinemia B-Disease 0 0.0015244493260979652
remains O 0 1.2666083648582571e-06
unknown O 0 2.151996795873856e-06

ATM O 0 0.00039730724529363215
mutations O 0 1.2740006241074298e-06
and O 0 1.5104997252990415e-09
phenotypes O 0 1.412298900049791e-07
in O 0 1.4095613565245912e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 3.012584386397066e-07
in O 0 2.2908290819856347e-09
the O 0 3.6131325709121143e-10
British O 0 1.0814792117397332e-10
Isles O 0 8.369792858786695e-09
: O 0 1.6589631144509065e-12
expression O 0 1.1747111963722467e-11
of O 0 1.6809864264444307e-11
mutant O 0 1.354606184167384e-11
ATM O 0 5.921029000433009e-09
and O 0 2.460295639092336e-12
the O 0 1.3281068085568837e-11
risk O 0 1.9849162313789748e-09
of O 0 2.3838491181038535e-09
leukemia B-Disease 1 1.0
, O 0 6.208908598637208e-05
lymphoma B-Disease 1 1.0
, O 0 0.015943260863423347
and O 0 0.005138470325618982
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04610520228743553

We O 0 4.959631283441013e-08
report O 0 1.4643943002656812e-10
the O 0 2.6449106793613453e-11
spectrum O 0 8.396751738359853e-09
of O 0 9.194957573122053e-10
59 O 0 1.583214270794997e-08
ATM O 0 9.189353136207501e-07
mutations O 0 1.3809619225924052e-08
observed O 0 2.0283470458792863e-09
in O 0 4.479973891857725e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0932614803314209
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.49941958849098e-09
patients O 0 5.259302993110282e-10
in O 0 2.8783267436160997e-11
the O 0 3.095549372389428e-10
British O 0 1.2058658516167498e-09
Isles O 0 5.680900585502968e-07
. O 0 1.1860084470072252e-07

Of O 0 1.1061453051297576e-06
51 O 0 6.808490979892667e-07
ATM O 0 1.7349801055388525e-05
mutations O 0 1.8169588145156013e-07
identified O 0 5.644607448118677e-09
in O 0 2.048688718669922e-10
families O 0 1.3032644408106364e-10
native O 0 2.8843996635607994e-11
to O 0 1.8803052170834889e-10
the O 0 8.396006806465905e-11
British O 0 1.8780041410870751e-10
Isles O 0 3.907849333018021e-08
, O 0 6.499598775855375e-11
11 O 0 1.0879720457879216e-09
were O 0 1.0162353181186745e-09
founder O 0 1.019938888902061e-08
mutations O 0 4.699059807933281e-09
, O 0 7.667928791921241e-11
and O 0 6.428828303040035e-11
2 O 0 5.391737190052481e-08
of O 0 2.6955522258731435e-09
these O 0 2.017202550830266e-11
11 O 0 4.254923913205033e-10
conferred O 0 4.006208254025978e-09
a O 0 2.3182029906809731e-10
milder O 0 1.4346099419526581e-08
clinical O 0 6.550678888217476e-10
phenotype O 0 3.655667157875797e-10
with O 0 4.721853333680692e-13
respect O 0 9.982378812445347e-11
to O 0 5.398049784943737e-10
both O 0 1.8477610552736223e-09
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 1.718310954856861e-06
cellular O 0 2.014296001107141e-07
features O 0 6.051665835116182e-10
. O 0 1.5134707709307804e-08

We O 0 5.4038650887378026e-08
report O 0 3.412828908366805e-10
, O 0 6.811777270715469e-12
in O 0 6.743495952615808e-12
two O 0 7.46833220266474e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 3.987933983040648e-09
, O 0 4.9787597655726046e-11
an O 0 7.132778395702033e-11
ATM O 0 3.871109583997168e-06
mutation O 0 1.5790607221788378e-07
( O 0 4.3696399276704767e-10
7271T O 0 6.942550498933997e-07
- O 0 9.468966055692363e-08
- O 0 7.473529706203408e-08
> O 0 1.8163282788918877e-07
G O 0 5.0857554612093736e-08
) O 0 1.1981881415865092e-12
that O 0 7.791258415344726e-13
may O 0 3.310565016567679e-11
be O 0 1.1407971789445526e-11
associated O 0 6.096355625179184e-12
with O 0 1.660705840694169e-14
an O 0 1.1200868249398865e-13
increased O 0 1.85946882891308e-11
risk O 0 2.229301632183933e-09
of O 0 2.2571303048835034e-08
breast B-Disease 1 0.999996542930603
cancer I-Disease 1 0.9997294545173645
in O 0 5.417339909996599e-09
both O 0 1.695355189568204e-09
homozygotes O 0 1.1882862338552513e-07
and O 0 2.423088119041239e-10
heterozygotes O 0 9.332834061126505e-09
( O 0 1.6581960804451512e-10
relative O 0 8.10554183772183e-08
risk O 0 1.6649480016894813e-08
12 O 0 4.707759182487337e-10
. O 0 7.877361957175921e-12
7 O 0 6.209349701080669e-10
; O 0 5.6983858603976145e-11
P O 0 1.7277643564739265e-06
= O 0 2.7399025270824495e-09
. O 0 1.0046079246261996e-10
0025 O 0 1.517390302296917e-08
) O 0 1.750190162068399e-12
, O 0 3.548267636741681e-13
although O 0 4.095138670442283e-13
there O 0 1.1439429048118455e-12
is O 0 4.822133903119308e-13
a O 0 5.456946960274989e-12
less O 0 8.701643294806161e-10
severe O 1 0.9999967813491821
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 5.22117504786479e-09
in O 0 1.1981584344469831e-12
terms O 0 1.0028365290959407e-11
of O 0 1.6716172716868538e-12
the O 0 5.836874495020183e-13
degree O 0 2.3315693820080696e-09
of O 0 1.3616014982176239e-09
cerebellar B-Disease 1 0.9999998807907104
degeneration I-Disease 1 1.0
. O 0 6.25607890469837e-06

This O 0 3.358755407134595e-08
mutation O 0 1.7601530899469253e-08
( O 0 5.6835803424748477e-11
7271T O 0 1.5025487698494544e-07
- O 0 3.078835320025064e-08
- O 0 2.6212850556817102e-08
> O 0 1.1597029470067355e-07
G O 0 4.302711431591888e-08
) O 0 1.0900641283714818e-12
also O 0 1.1262114830122572e-13
allows O 0 1.6482637737319505e-13
expression O 0 6.227965192173723e-12
of O 0 2.1432340277516282e-11
full O 0 1.582596033389283e-11
- O 0 3.046288915564688e-11
length O 0 1.040322203382793e-10
ATM O 0 1.6015162529470217e-08
protein O 0 8.010124230573012e-10
at O 0 9.945585327519879e-11
a O 0 1.0776219326602554e-11
level O 0 3.7109060269102656e-10
comparable O 0 1.2233092316904504e-10
with O 0 6.675042463211156e-13
that O 0 2.2983184366082154e-12
in O 0 1.3094380614531165e-11
unaffected O 0 3.695453498764323e-09
individuals O 0 1.5328582847473626e-10
. O 0 2.804697096792097e-08

In O 0 5.791894519546759e-09
addition O 0 8.176745391885731e-10
, O 0 1.9953994012666953e-10
we O 0 2.476314431287818e-10
have O 0 4.9064706290902205e-12
studied O 0 3.5202168957582103e-10
18 O 0 2.2200694616003602e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.282877969468245e-08
, O 0 5.664681397565818e-12
in O 0 6.76635180177354e-12
15 O 0 6.257930840192216e-10
families O 0 7.613221164604056e-11
, O 0 9.18228132418264e-11
who O 0 5.13657005818402e-10
developed O 0 5.41793099273491e-07
leukemia B-Disease 1 1.0
, O 1 0.9775230288505554
lymphoma B-Disease 1 1.0
, O 0 6.59706856822595e-05
preleukemic O 1 0.9987770915031433
T O 0 7.864385406719521e-05
- O 0 5.463200523081468e-07
cell O 0 8.380036575772465e-08
proliferation O 0 5.095250344311353e-06
, O 0 1.2143683281173878e-10
or O 0 2.435695023450535e-07
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 1.6630460777378175e-06
mostly O 0 2.888101979792168e-09
in O 0 7.65858221285498e-09
childhood O 0 2.534761733841151e-06
. O 0 2.2702566582211148e-07

A O 0 2.2696881387673784e-06
wide O 0 7.37939203077076e-08
variety O 0 3.912051793619753e-10
of O 0 1.1308071146132193e-09
ATM O 0 3.473865490377648e-06
mutation O 0 6.44623625589702e-08
types O 0 6.231372751130948e-09
, O 0 8.302022264095044e-11
including O 0 1.0183846821387732e-10
missense O 0 5.909427272854373e-06
mutations O 0 2.989045697177062e-06
and O 0 6.483406589374852e-10
in O 0 3.9529149398198626e-10
- O 0 2.7332422991577232e-09
frame O 0 3.366387346659394e-08
deletions O 0 6.247274342285891e-08
, O 0 7.445750127565987e-10
were O 0 8.590003153230441e-10
seen O 0 1.1099869912101212e-09
in O 0 7.021364045733947e-11
these O 0 1.0932405675179169e-10
patients O 0 1.6348913334240933e-09
. O 0 2.8470283908177407e-08

We O 0 5.980232486990644e-08
also O 0 5.993103929791133e-11
show O 0 5.4744607284884506e-12
that O 0 5.1508341184945336e-14
25 O 0 1.6474420785894672e-11
% O 0 3.1130504424270455e-11
of O 0 6.731317586661234e-11
all O 0 5.6269358061911134e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.613430633540247e-08
carried O 0 1.7466528223764044e-11
in O 0 1.235070812982686e-11
- O 0 1.22265142454836e-10
frame O 0 1.8552479552624845e-09
deletions O 0 6.977754818393578e-09
or O 0 1.2843337060530757e-08
missense O 0 1.1945749065489508e-05
mutations O 0 7.596059731440619e-06
, O 0 6.637305288714757e-11
many O 0 4.689291489834435e-13
of O 0 6.290762615684953e-12
which O 0 9.025786845348605e-13
were O 0 5.499410822562556e-12
also O 0 1.2201109263546006e-12
associated O 0 1.3374462995430214e-11
with O 0 4.2839074843904756e-13
expression O 0 4.869369907289922e-10
of O 0 9.983263993262881e-09
mutant O 0 3.200072029585499e-08
ATM O 0 3.6088290471525397e-06
protein O 0 4.804555828741286e-07
. O 0 2.590775949329327e-08

The O 0 8.005824980727994e-08
DMPK O 0 0.004940673243254423
gene O 0 9.447458815259324e-09
of O 0 6.487888448702961e-09
severely O 0 0.08528532087802887
affected O 1 0.9534898400306702
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9997004270553589
is O 0 1.1432036650660393e-08
hypermethylated O 0 1.3149108326615533e-06
proximal O 0 1.4829159226792399e-05
to O 0 9.885341434312522e-09
the O 0 2.2496078333489322e-09
largely O 0 1.1853198422784317e-09
expanded O 0 2.6072126679821395e-09
CTG O 0 5.607563252851833e-06
repeat O 0 3.018741949745163e-07
. O 0 6.19973405946439e-08

Using O 0 6.69695481292365e-08
methylation O 0 4.02557475354115e-07
- O 0 1.263499171955118e-07
sensitive O 0 7.309908767183515e-08
restriction O 0 1.5169359102173985e-08
enzymes O 0 1.3983992852573124e-09
, O 0 2.26138448244928e-11
we O 0 2.716633862309692e-11
characterized O 0 5.537104108555013e-11
the O 0 3.490949196383042e-11
methylation O 0 1.4869878661727398e-09
pattern O 0 4.641090622925503e-09
on O 0 1.697387119747873e-09
the O 0 5.826202714720452e-11
5 O 0 7.870251117481075e-10
side O 0 1.3199940029906543e-09
of O 0 5.069463071549762e-09
the O 0 1.0907173830787542e-08
CTG O 0 1.0659107829269487e-05
repeat O 0 1.1004487987520406e-08
in O 0 4.4418198286155786e-11
the O 0 8.829166564527924e-11
DMPK O 0 3.9916426430863794e-07
gene O 0 2.551223815538961e-11
of O 0 1.1981932807048068e-11
normal O 0 1.9334467360465624e-10
individuals O 0 3.207080434552978e-12
and O 0 1.1807290388465841e-11
of O 0 3.489180333549058e-10
patients O 0 1.8554699443562583e-10
affected O 0 5.337704722663261e-10
with O 0 8.017675412475e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 2.1175244668825144e-08
showing O 0 9.219526253545496e-10
expansions O 0 8.133135054322338e-09
of O 0 4.605799297507929e-09
the O 0 2.365667661763382e-09
repetitive O 0 5.1879332829685154e-08
sequence O 0 1.1494876162032597e-08
. O 0 4.622556115663201e-09

The O 0 3.699719570704474e-07
gene O 0 6.797770346622656e-09
segment O 0 1.518930758948045e-08
analyzed O 0 1.4731187381045174e-09
corresponds O 0 6.637957739030753e-09
to O 0 3.2730851362572366e-09
the O 0 4.171434753175163e-09
genomic O 0 7.555138381576398e-08
SacI O 0 1.0241318477710593e-06
- O 0 7.755009967524984e-09
HindIII O 0 4.0974228454615513e-08
fragment O 0 8.653946004244517e-09
carrying O 0 1.7189610845846914e-10
exons O 0 5.901545918618467e-09
11 O 0 3.736940090703911e-09
- O 0 8.319402944323429e-09
15 O 0 2.7854939688154445e-08
. O 0 1.2247299174816817e-08

There O 0 3.9447844102369345e-08
is O 0 1.0381798754011129e-09
constitutive O 0 2.178533264896032e-08
methylation O 0 1.1217856155099071e-07
in O 0 4.236802020329833e-09
intron O 0 8.874120567270438e-07
12 O 0 2.1577777786774277e-08
at O 0 9.698797320822905e-10
restriction O 0 5.804166591794058e-10
sites O 0 2.126491482901116e-10
of O 0 3.730877273788735e-10
SacII O 0 5.478012212734029e-07
and O 0 8.253932537449771e-10
HhaI O 0 9.121379662246909e-06
, O 0 6.611003411371996e-10
localized O 0 2.76572421853416e-07
1 O 0 7.200305844889954e-07
, O 0 1.0450454390742436e-10
159 O 0 9.315277438304292e-10
- O 0 6.201635649460968e-09
1 O 0 2.2043651881631376e-07
, O 0 5.398255731314805e-10
232 O 0 3.153265648592196e-09
bp O 0 3.5699112999054705e-08
upstream O 0 2.5702368233737616e-08
of O 0 1.2001134530592594e-09
the O 0 1.5913756978847005e-09
CTG O 0 1.4909737728885375e-06
repeat O 0 1.7673489338676518e-08
, O 0 5.2072464395980234e-11
whereas O 0 2.4946797405611676e-10
most O 0 6.759090249303101e-12
, O 0 1.7962250610514818e-12
if O 0 1.6244828399125666e-11
not O 0 3.518476482389232e-11
all O 0 1.1105640712605336e-11
, O 0 3.774096053038578e-12
of O 0 3.963452135935519e-11
the O 0 1.6070061947814906e-11
other O 0 7.421492890721804e-13
sites O 0 5.397614299962328e-11
of O 0 1.5488076099412496e-10
SacII O 0 9.320809226665006e-07
, O 0 4.5259229697336423e-10
HhaI O 0 9.747478543431498e-06
, O 0 4.0274975021681314e-10
and O 0 1.0192202637426817e-10
HpaII O 0 3.2602567898720736e-06
in O 0 1.6371372313361832e-10
this O 0 1.053975309805999e-10
region O 0 1.2285950035106907e-08
are O 0 2.7069770036636243e-11
unmethylated O 0 6.539886499012937e-08
, O 0 5.951726958497439e-12
in O 0 2.8478643054885566e-12
normal O 0 8.565103071234148e-10
individuals O 0 1.0923082750802227e-11
and O 0 1.2286166008179666e-11
most O 0 1.6848125325430452e-11
of O 0 4.660666297340299e-10
the O 0 1.3916435781524683e-09
patients O 0 8.806365636715441e-10
. O 0 9.469215633828298e-09

In O 0 6.17180484496771e-09
a O 0 1.6591111817731985e-09
number O 0 5.563562388566368e-10
of O 0 4.867273695197127e-09
young O 0 2.5633362099597434e-10
and O 0 2.568719958961907e-10
severely O 1 0.8387112617492676
affected O 0 2.019547355303075e-05
patients O 0 4.525064412064239e-07
, O 0 4.4948236799235985e-10
however O 0 1.4753400723321874e-09
, O 0 3.8518105371920797e-11
complete O 0 7.122150647020931e-10
methylation O 0 7.4306019115510935e-09
of O 0 1.0362075641978663e-09
these O 0 3.3423882151578654e-12
restriction O 0 2.699522827498413e-10
sites O 0 1.4858814179063984e-10
was O 0 2.0071101725083196e-10
found O 0 5.896901456720061e-12
in O 0 3.712460026894515e-12
the O 0 4.128182518048362e-11
mutated O 0 1.4235155276765e-09
allele O 0 1.1245491293720988e-07
. O 0 3.372550594349377e-08

In O 0 3.98408879220824e-08
most O 0 2.838848323083454e-10
of O 0 2.5248952928436097e-10
these O 0 2.758629045682137e-12
patients O 0 1.9747974089323606e-11
, O 0 3.9849758692520054e-13
the O 0 5.195131217577975e-12
onset O 0 6.902721452206606e-07
of O 0 3.757953948024806e-09
the O 0 1.2575384289448266e-08
disease O 1 0.9999339580535889
was O 1 0.6847088932991028
congenital O 1 1.0
. O 0 0.0007384183118119836

Preliminary O 0 1.461672582081519e-05
in O 0 1.6520061763003469e-06
vivo O 0 1.4031140381121077e-05
footprinting O 0 1.089127272280166e-05
data O 0 1.928379900206778e-09
gave O 0 1.3793390041261233e-10
evidence O 0 5.382604431614091e-11
for O 0 8.711498536428941e-12
protein O 0 4.052538860044308e-11
- O 0 1.260075099818181e-10
DNA O 0 6.030948518365165e-10
contact O 0 8.894821545979426e-10
in O 0 1.6710963168797832e-10
normal O 0 3.182372054766347e-08
genes O 0 5.382894685546091e-10
at O 0 3.025704409242991e-10
an O 0 3.9953127611846995e-12
Sp1 O 0 7.816753910816487e-10
consensus O 0 2.709583224458356e-09
binding O 0 2.7833854332470764e-08
site O 0 2.4249954932997753e-08
upstream O 0 3.4698313555736604e-08
of O 0 1.128075632905734e-09
the O 0 9.457875593810172e-10
CTG O 0 1.054205540640396e-06
repeat O 0 3.909010448666095e-09
and O 0 3.612660301119397e-12
for O 0 1.0821197453728115e-12
a O 0 3.4911472584359116e-12
significant O 0 1.1911840437639487e-11
reduction O 0 4.814083798265756e-09
of O 0 1.3691740796684115e-10
this O 0 2.832702475363824e-11
interaction O 0 9.970638203959936e-11
in O 0 3.881213406220496e-11
cells O 0 8.29798521562175e-11
with O 0 1.3239026845288104e-12
a O 0 6.182923617537028e-10
hypermethylated O 0 9.547471790938289e-07
DMPK O 0 9.828151814872399e-05
gene O 0 1.2101289748045474e-08
. O 0 2.0921151477892863e-09
. O 0 1.0165769559478122e-08

The O 0 1.7319813196081668e-05
hemochromatosis B-Disease 1 1.0
gene O 0 5.52851169288715e-08
product O 0 9.48606349027159e-09
complexes O 0 1.0378770065599952e-09
with O 0 6.0646709008904676e-12
the O 0 6.58774201856005e-10
transferrin O 0 1.7950715403003414e-07
receptor O 0 4.689616446285072e-07
and O 0 2.843514312900197e-10
lowers O 0 1.0259144644919616e-09
its O 0 9.696493608046808e-12
affinity O 0 5.874407904560286e-11
for O 0 2.6263357807976284e-11
ligand O 0 6.128075380473774e-09
binding O 0 2.624580304200208e-07
. O 0 4.6715737056501894e-08

We O 0 4.7651892032263277e-07
recently O 0 4.162866051871106e-09
reported O 0 6.663768981063356e-10
the O 0 4.761397873198625e-11
positional O 0 9.520970678522644e-10
cloning O 0 3.4861999398394516e-10
of O 0 1.2428667470198995e-11
a O 0 9.830311911707135e-12
candidate O 0 7.174903449147507e-10
gene O 0 9.518138499586826e-10
for O 0 1.1927318688265132e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999998807907104
HFE O 1 0.9999997615814209
. O 0 5.036259153712308e-06

The O 0 1.2708945895667512e-08
gene O 0 8.601180184752977e-11
product O 0 1.4161029293635607e-10
, O 0 2.8753128350489376e-12
a O 0 9.696128622227462e-11
member O 0 7.912304700319339e-10
of O 0 3.728595654450828e-09
the O 0 1.568120744366297e-09
major O 0 2.417126765408284e-08
histocompatibility O 0 6.888655207148986e-06
complex O 0 1.2306196595091023e-07
class O 0 2.195744475130823e-09
I O 0 1.1176886118846596e-06
- O 0 6.88735202203361e-09
like O 0 5.173853359630165e-11
family O 0 4.168328529563503e-11
, O 0 5.764762365384479e-12
was O 0 3.8760958331884865e-10
found O 0 1.7937745039331432e-11
to O 0 1.2809978078287543e-10
have O 0 4.4529831211281845e-11
a O 0 5.498346222765349e-10
mutation O 0 1.0824212637317032e-08
, O 0 8.022539299545883e-10
Cys O 0 1.5363862075901125e-06
- O 0 6.215806820364378e-07
282 O 0 7.371050259052936e-08
- O 0 9.925906852004118e-07
- O 0 7.41643077617482e-07
> O 0 1.1848716212625732e-06
Tyr O 0 1.8901181420005742e-06
( O 0 1.2738710086779292e-10
C282Y O 0 2.255099929016069e-07
) O 0 3.4688979119734675e-12
, O 0 1.1353828033994207e-12
in O 0 2.576440579979411e-12
85 O 0 7.030641624439227e-10
% O 0 2.580057556489379e-10
of O 0 3.360199896107474e-10
patient O 0 3.91157826129529e-08
chromosomes O 0 5.590143814515613e-07
. O 0 1.4214765542419627e-07

This O 0 1.2873012877889778e-08
mutation O 0 2.588770442457644e-08
eliminates O 0 3.211629007182637e-08
the O 0 3.0711141962846966e-10
ability O 0 1.0703851693882882e-10
of O 0 1.2615690714312677e-09
HFE O 0 1.6562511518714018e-05
to O 0 1.3073861993007085e-08
associate O 0 2.193132786487695e-09
with O 0 4.2574685096830045e-12
beta2 O 0 3.4250970202265307e-06
- O 0 1.6036732404245413e-06
microglobulin O 0 1.1592774171731435e-05
( O 0 1.813979411124933e-09
beta2m O 0 1.0320922228856944e-05
) O 0 2.030556417453866e-10
and O 0 1.3751202954104258e-10
prevents O 0 8.268795426147335e-09
cell O 0 8.141711305142962e-07
- O 0 6.607756830590006e-08
surface O 0 2.9721697956119897e-06
expression O 0 4.4668900045508053e-07
. O 0 2.2606187144447176e-07

A O 0 2.1597538761852775e-06
second O 0 9.18516676051695e-08
mutation O 0 4.940434283895456e-09
that O 0 1.669005905702292e-11
has O 0 7.405433904983383e-12
no O 0 1.0185045515309632e-11
effect O 0 1.7898428295026747e-09
on O 0 5.610174991232952e-09
beta2m O 0 1.1275338920313516e-06
association O 0 8.104406035158718e-10
, O 0 3.332747411377568e-10
H63D O 0 0.0022333019878715277
, O 0 1.547298816850784e-10
was O 0 2.3182835651169853e-09
found O 0 1.154762049870861e-11
in O 0 2.321873596167201e-12
eight O 0 4.775747505791905e-12
out O 0 9.047193333042158e-13
of O 0 9.202896257554105e-12
nine O 0 3.862772601781472e-11
patients O 0 2.020675293756824e-12
heterozygous O 0 1.5195834174308587e-11
for O 0 3.5340265436278884e-11
the O 0 4.658118335498784e-09
C282Y O 0 1.1281016668363009e-05
mutant O 0 5.364000799090718e-07
. O 0 6.075125469351406e-08

In O 0 1.6089623855464197e-08
this O 0 6.179033396058742e-10
report O 0 6.843403066447706e-10
, O 0 1.221786560812177e-10
we O 0 4.945664988653675e-10
demonstrate O 0 5.013668924469528e-10
in O 0 7.783872990607676e-10
cultured O 0 7.015123060227779e-08
293 O 0 3.5904452744262016e-08
cells O 0 2.7435435256961682e-08
overexpressing O 0 1.0333545219509688e-07
wild O 0 8.755918212699498e-10
- O 0 1.6019849335968672e-10
type O 0 1.3319082503571167e-09
or O 0 2.9249898059191537e-09
mutant O 0 2.6257174212673817e-09
HFE O 0 5.714808537504723e-08
proteins O 0 3.149413889402819e-12
that O 0 6.361490110726176e-13
both O 0 1.0346221492388286e-12
the O 0 3.0621578189782284e-11
wild O 0 9.84123477154597e-11
- O 0 1.839051133600833e-10
type O 0 8.157464037594764e-09
and O 0 5.333026464882096e-09
H63D O 0 0.0013358242576941848
HFE O 0 1.6050187696237117e-05
proteins O 0 6.844604327760351e-10
form O 0 5.814947967586193e-10
stable O 0 5.714435147297081e-09
complexes O 0 1.336291910458698e-10
with O 0 2.258051601602973e-12
the O 0 2.1989368659269815e-10
transferrin O 0 7.998207962600645e-08
receptor O 0 2.3728502185349498e-07
( O 0 7.399398316287886e-10
TfR O 0 1.1108500785894648e-07
) O 0 1.1140439959422821e-10
. O 0 4.260082508977803e-09

The O 0 5.135566993885732e-07
C282Y O 0 4.4229160266695544e-05
mutation O 0 5.930752422500518e-08
nearly O 0 1.1348563200286321e-09
completely O 0 3.5498096129238377e-10
prevents O 0 5.2581369813786694e-11
the O 0 1.4876587808854147e-11
association O 0 2.0482110799080466e-11
of O 0 6.864869783740346e-10
the O 0 1.0302323438793337e-09
mutant O 0 5.958210813616915e-09
HFE O 0 5.990335694150417e-07
protein O 0 1.7078178871088312e-09
with O 0 8.962524299105379e-12
the O 0 1.242996039430011e-09
TfR O 0 1.423768253516755e-06
. O 0 4.91571618965736e-08

Studies O 0 1.1126206089784318e-07
on O 0 5.605268071917635e-08
cell O 0 3.345941479437897e-08
- O 0 5.271216352298325e-09
associated O 0 3.095385725515598e-09
transferrin O 0 3.4708713769759925e-07
at O 0 4.175050349886078e-08
37 O 0 2.0027595137861454e-09
degrees O 0 1.0458504817734138e-07
C O 0 1.8761949149848078e-07
suggest O 0 3.634365308702314e-10
that O 0 1.7278683692167895e-11
the O 0 2.654995667761284e-10
overexpressed O 0 3.9729459899717767e-07
wild O 0 6.379352601726396e-09
- O 0 1.5003349673747834e-09
type O 0 1.4423415350961477e-08
HFE O 0 3.0949709071137477e-06
protein O 0 4.951112853035511e-09
decreases O 0 4.477701542882073e-10
the O 0 6.439231526461642e-12
affinity O 0 9.517080179488602e-11
of O 0 2.8235017102140603e-10
the O 0 2.2620456896493835e-10
TfR O 0 2.892772776874608e-08
for O 0 2.4811699916860164e-10
transferrin O 0 9.670429790276103e-07
. O 0 1.201078703161329e-07

The O 0 2.081518459817744e-06
overexpressed O 0 5.202455213293433e-05
H63D O 0 0.011253162287175655
protein O 0 4.907481638838362e-07
does O 0 4.857802493596353e-10
not O 0 4.7422558935306114e-11
have O 0 1.100448616779548e-12
this O 0 8.596874297508994e-13
effect O 0 4.3748268896415254e-10
, O 0 8.734621099321105e-13
providing O 0 1.1266911882634734e-12
the O 0 3.5033941893358733e-12
first O 0 1.7068254361957136e-12
direct O 0 8.4202193828542e-12
evidence O 0 7.146487394915635e-12
for O 0 6.012309248550063e-13
a O 0 9.423545277442713e-12
functional O 0 1.6036612038305975e-09
consequence O 0 1.4341339671375408e-08
of O 0 6.749113490300829e-10
the O 0 6.58806842412929e-10
H63D O 0 1.542023164802231e-05
mutation O 0 1.695243696531179e-07
. O 0 1.4393735980888778e-08

Addition O 0 7.50378177372113e-08
of O 0 1.3973649402032606e-06
soluble O 0 3.344941433169879e-05
wild O 0 2.802727010475792e-07
- O 0 5.7284935905954626e-08
type O 0 2.5285230549343396e-06
HFE O 1 0.9949020147323608
/ O 0 0.00045449958997778594
beta2m O 0 0.00010701167047955096
heterodimers O 0 2.486906396370614e-06
to O 0 4.476903470163052e-08
cultured O 0 1.9932786088361354e-08
cells O 0 8.391992656342495e-10
also O 0 6.76021174803032e-12
decreased O 0 2.633530338247425e-10
the O 0 1.1192700412332446e-11
apparent O 0 6.315173384230377e-10
affinity O 0 1.0377165793329368e-09
of O 0 7.379103439397738e-10
the O 0 2.0877331807778177e-10
TfR O 0 1.4815749738161799e-09
for O 0 7.639949328556994e-13
its O 0 3.099550509918364e-13
ligand O 0 5.53556263327426e-11
under O 0 9.031414505145108e-10
steady O 0 2.2062394133826047e-09
- O 0 1.7737566970765783e-10
state O 0 3.042440743783459e-10
conditions O 0 2.3358309420018486e-07
, O 0 1.1625615747856699e-10
both O 0 4.0593930994425875e-11
in O 0 2.847720670384746e-10
293 O 0 7.011518032840058e-10
cells O 0 8.056781908294397e-10
and O 0 1.4500027567532214e-10
in O 0 1.7166584820316189e-09
HeLa O 0 4.041453394165728e-07
cells O 0 4.020409960503457e-08
. O 0 2.2731201809733648e-08

Furthermore O 0 2.1131995708856266e-07
, O 0 6.779872219198069e-10
at O 0 1.6311287875936387e-09
4 O 0 3.375103752034647e-09
degrees O 0 5.891162686566531e-07
C O 0 1.3301339549798286e-06
, O 0 1.532805687931571e-10
the O 0 8.744035495666935e-10
added O 0 6.942879604565633e-09
soluble O 0 4.2255216214925895e-08
complex O 0 5.6414428684092854e-09
of O 0 5.534934732764896e-09
HFE O 0 2.449087332934141e-05
/ O 0 7.558524544037937e-07
beta2m O 0 3.6175913464830955e-07
inhibited O 0 2.521152620005296e-09
binding O 0 7.710467819777023e-09
of O 0 1.9430153042065967e-09
transferrin O 0 1.2048782593865326e-07
to O 0 2.5505416445525952e-08
HeLa O 0 7.910227850516094e-07
cell O 0 2.0026725167099357e-08
TfR O 0 3.671855353104547e-08
in O 0 5.1987220084370733e-11
a O 0 3.449306396063889e-10
concentration O 0 3.482701060875115e-08
- O 0 9.05135433271198e-09
dependent O 0 1.7725545475855142e-08
manner O 0 4.6166199751951353e-08
. O 0 5.2909214787177916e-08

Scatchard O 0 8.492328925058246e-05
plots O 0 1.8420724927636911e-06
of O 0 1.0021634011536662e-07
these O 0 5.897961286027709e-11
data O 0 4.1998374222806945e-10
indicate O 0 1.512159952810066e-09
that O 0 3.047166685643532e-11
the O 0 1.9850891763706358e-10
added O 0 3.2459523957584224e-10
heterodimer O 0 9.100899589498113e-09
substantially O 0 2.602815296626204e-09
reduced O 0 2.4284840804966734e-09
the O 0 8.219805391895818e-11
affinity O 0 1.2597248799650629e-09
of O 0 2.4617263783e-09
TfR O 0 4.311361934128399e-08
for O 0 3.8702083204888993e-10
transferrin O 0 9.641514679969987e-07
. O 0 9.082035745677786e-08

These O 0 3.742275378471049e-09
results O 0 2.5997837216351627e-09
establish O 0 4.768091255158424e-09
a O 0 1.0721920018497144e-09
molecular O 0 2.2023798340597978e-09
link O 0 1.6821297688096593e-09
between O 0 5.075607045768038e-09
HFE O 0 0.0001012897482723929
and O 0 9.778110543479102e-10
a O 0 1.088602985532816e-09
key O 0 3.4851115326972604e-09
protein O 0 9.469499628877998e-10
involved O 0 1.3370235474319259e-10
in O 0 8.031415116294127e-11
iron O 0 7.691919279295689e-08
transport O 0 3.562984796090518e-09
, O 0 5.752946036219342e-11
the O 0 3.5376568341405346e-10
TfR O 0 3.081414590155873e-08
, O 0 1.110890286010191e-11
and O 0 2.311471760524375e-12
raise O 0 1.9193302502884535e-10
the O 0 1.4815318416516732e-10
possibility O 0 2.146181454776297e-09
that O 0 2.3315582103888843e-11
alterations O 0 3.7857939005903063e-10
in O 0 1.1249240471425392e-12
this O 0 3.7072713063475426e-13
regulatory O 0 2.6295049471158904e-10
mechanism O 0 1.6201339159138683e-09
may O 0 8.862290346023372e-10
play O 0 6.753590742203386e-11
a O 0 2.3819468966679302e-11
role O 0 1.103339034719264e-11
in O 0 1.5183657282868968e-12
the O 0 2.790009542841254e-11
pathogenesis O 0 1.3884687177778687e-07
of O 0 1.0994778421036244e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 3.85374623874668e-05
. O 0 3.717087508903205e-07

Genomic O 0 5.201120529818581e-07
organization O 0 3.546159277334482e-08
of O 0 2.274685861891612e-08
the O 0 2.2714946368296296e-08
UBE3A O 0 0.00033064090530388057
/ O 0 1.6454227079520933e-05
E6 O 0 6.150004628580064e-05
- O 0 3.815333911916241e-06
AP O 0 8.752493272368156e-07
gene O 0 1.4127900238580793e-10
and O 0 8.821335155395627e-12
related O 0 2.3599442400268344e-09
pseudogenes O 0 9.124790949499584e-07
. O 0 1.0081257784122499e-07

The O 0 2.113924210789264e-06
UBE3A O 0 9.446406329516321e-05
gene O 0 1.080748290860356e-08
encodes O 0 8.509592475114403e-10
the O 0 1.194311094465661e-09
E6 O 0 9.292602953792084e-07
- O 0 1.8199868634383165e-07
AP O 0 3.89571567893654e-07
ubiquitin O 0 5.073448328118957e-09
- O 0 1.7087694592632374e-09
protein O 0 1.8919647792881022e-10
ligase O 0 2.7454344353472493e-11
and O 0 2.2026463986080103e-11
has O 0 4.831249983405783e-12
recently O 0 1.0549602857956586e-11
been O 0 1.6980256176829522e-12
shown O 0 1.1317585323772361e-13
to O 0 1.2934540591369448e-12
be O 0 2.70172491149967e-12
mutated O 0 3.756927269282784e-10
in O 0 7.15720682720189e-09
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9773443341255188
who O 0 2.5451473817383885e-08
lack O 0 2.7603408625509473e-07
15q11 O 0 9.395505912834778e-06
- O 0 2.8896940307276964e-07
q13 O 0 1.72372892848216e-06
deletions O 0 1.491678602860702e-08
or O 0 6.226929194497188e-09
chromosome O 0 2.372018116147956e-06
15 O 0 1.0916605219790654e-07
paternal O 0 1.8385219391348073e-06
uniparental B-Disease 0 0.002254330087453127
disomy I-Disease 0 0.0028927179519087076
. O 0 3.915179149771575e-06

Previous O 0 2.9406705834844615e-06
UBE3A O 0 1.390584384353133e-05
cDNA O 0 2.1708927988584037e-08
analysis O 0 2.0530620259417987e-10
has O 0 5.774203597902483e-12
shown O 0 2.388679098269675e-12
a O 0 2.0682322174336853e-11
coding O 0 4.344610449180664e-09
region O 0 2.7612246711328226e-08
of O 0 4.762946925751521e-09
approximately O 0 4.291128785638421e-09
2 O 0 4.2933416466439667e-07
. O 0 4.840114442572485e-08

6 O 0 4.8121451982297e-05
kb O 0 5.195464109419845e-05
and O 0 7.325146711423258e-09
a O 0 4.399474207161802e-08
3 O 0 2.7196222163183847e-06
- O 0 6.485973358394403e-07
untranslated O 0 0.00013751452206633985
region O 0 5.856437610418652e-07
( O 0 1.908452951226991e-09
UTR O 0 1.2429583875928074e-05
) O 0 3.749832666599673e-10
of O 0 9.333065875694047e-09
< O 0 5.16926820637309e-06
50 O 0 4.076842330391628e-08
bp O 0 5.207979825172515e-08
, O 0 3.911945420376206e-11
whereas O 0 1.5723668200795515e-10
Northern O 0 4.873793035820029e-10
analysis O 0 7.614180119741576e-11
has O 0 1.0714918535770224e-11
indicated O 0 5.524666488176955e-11
mRNA O 0 1.4743772869252325e-10
sizes O 0 4.304404055410771e-11
of O 0 1.180155556612661e-10
5 O 0 1.6302742267271242e-08
- O 0 5.404174174827858e-08
8 O 0 4.638942812107416e-07
kb O 0 4.335575340519426e-06
. O 0 1.2594676945809624e-07

We O 0 1.3875594504497712e-06
have O 0 8.941770657244774e-10
analyzed O 0 4.0262992939688047e-10
additional O 0 3.5085920280231164e-11
cDNA O 0 1.0199174838021463e-08
clones O 0 3.215458344030253e-09
and O 0 5.2878439474324246e-12
provide O 0 2.8367455953692833e-12
evidence O 0 3.410198512465712e-11
for O 0 7.868352670803436e-12
an O 0 1.579604502754961e-11
additional O 0 4.257619257153067e-10
0 O 0 1.468408612481653e-07
. O 0 4.321777069549171e-08

5 O 0 8.704233550815843e-06
kb O 0 1.948172939592041e-05
of O 0 4.355872533778893e-07
5 O 0 1.3835755225954927e-06
- O 0 3.7966955801493896e-07
UTR O 0 9.544384374748915e-05
and O 0 6.5074701183220895e-09
> O 0 4.5791645675308246e-07
2 O 0 1.8589969386084704e-07
kb O 0 4.6247677687460964e-07
of O 0 3.165137840710486e-08
3 O 0 5.907850209041499e-07
- O 0 6.626789286201529e-07
UTR O 0 0.00014033714251127094
. O 0 1.1793797227710456e-07

We O 0 4.614190274310204e-08
have O 0 2.0047675325374215e-11
established O 0 3.1936040617575046e-11
the O 0 4.3419859721560705e-12
genomic O 0 1.0630606117612018e-10
organization O 0 2.7621054748960816e-11
of O 0 2.198106696660318e-10
UBE3A O 0 1.4031927548785461e-06
and O 0 1.5861323365840008e-10
the O 0 2.622737860225044e-10
sequence O 0 3.5059513625590455e-10
of O 0 8.69059657571114e-10
intron O 0 1.800870563783974e-07
- O 0 2.3221998901590268e-07
exon O 0 1.4202001352714433e-07
borders O 0 2.960995573175751e-07
. O 0 2.1967827024127473e-07

We O 0 3.683991963043809e-06
have O 0 2.4474844373401083e-09
also O 0 1.9746966561928758e-10
mapped O 0 1.1333599836405028e-08
two O 0 6.078991199309769e-10
highly O 0 4.554500110387494e-10
homologous O 0 1.9940991080602544e-09
processed O 0 1.2959779915888703e-08
pseudogenes O 0 6.045880240890256e-08
, O 0 3.18825577050319e-10
UBE3AP1 O 0 3.1875850254436955e-05
and O 0 6.88909951307437e-09
UBE3AP2 O 0 0.003822946920990944
, O 0 7.130401824539945e-10
to O 0 1.465686016999257e-09
chromosomes O 0 8.677925045219581e-10
2 O 0 3.7618912429593365e-09
and O 0 2.0979591328074143e-11
21 O 0 2.1514849901649313e-09
, O 0 1.940409638523377e-11
respectively O 0 4.844635248524298e-10
, O 0 1.2526243063637477e-11
and O 0 1.3541231504154982e-11
determined O 0 1.051048914568753e-09
their O 0 2.7000828656253972e-11
genomic O 0 2.042591207285227e-09
organization O 0 1.4323507935287694e-09
. O 0 1.0404719752443725e-08

These O 0 6.382768757973167e-10
results O 0 2.8174979016526436e-10
will O 0 1.2891936650161195e-11
form O 0 5.716867951255367e-12
the O 0 6.8602810064655184e-12
basis O 0 2.2970136209776726e-11
for O 0 2.275361160337247e-13
studies O 0 1.7616173277057445e-12
of O 0 4.364404670997857e-12
mutation O 0 2.2009749925389066e-11
and O 0 3.4923210157078444e-11
imprinting O 0 1.752790126374748e-07
of O 0 2.589000871466851e-07
UBE3A O 0 0.00136551761534065
. O 0 3.247557174290705e-07

Mutation O 0 1.2041768968629185e-06
spectrum O 0 1.9160056581313256e-06
and O 0 3.6477565412695867e-09
genotype O 0 1.207889681609231e-06
- O 0 1.3873449233869906e-07
phenotype O 0 1.625657120030155e-08
analyses O 0 7.72757247080591e-10
in O 0 3.2696376855989584e-11
Cowden B-Disease 0 0.00032509563607163727
disease I-Disease 0 2.8034994556946913e-06
and O 0 1.4013016302882875e-09
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.329779220071714e-08
two O 0 8.799855066854434e-09
hamartoma B-Disease 1 0.9999905824661255
syndromes I-Disease 1 0.9993537068367004
with O 0 6.774906751161325e-07
germline O 1 0.9999948740005493
PTEN O 1 0.9999849796295166
mutation O 0 0.0005277223535813391
. O 0 8.4792844745607e-07

The O 0 4.599542990035843e-06
tumour B-Disease 1 1.0
suppressor O 0 0.006662335246801376
gene O 0 3.03384422295494e-06
PTEN O 0 0.0006007017800584435
, O 0 2.7279492553766715e-10
which O 0 1.580279310187116e-11
maps O 0 1.6599150942653296e-09
to O 0 4.922415186570106e-08
10q23 O 0 0.0005529783666133881
. O 0 6.127435199232423e-07

3 O 0 3.430464630582719e-06
and O 0 1.2029260254564633e-08
encodes O 0 3.0055402611139925e-09
a O 0 8.081810776161547e-09
403 O 0 3.9912819715937076e-09
amino O 0 6.696185383958664e-09
acid O 0 1.7128743978744865e-09
dual O 0 7.892469455761386e-10
specificity O 0 4.6056786828785334e-08
phosphatase O 0 3.2101714168675244e-05
( O 0 5.555018667280365e-09
protein O 0 2.1226032487220436e-08
tyrosine O 0 2.476043015064988e-08
phosphatase O 0 1.1364428331717136e-07
; O 0 5.552068874092875e-11
PTPase O 0 8.76969892260604e-08
) O 0 1.2655684659967914e-11
, O 0 4.126605741144873e-12
was O 0 2.6650412432438486e-10
shown O 0 1.2344797059582469e-11
recently O 0 6.116508688425171e-11
to O 0 5.240515660309697e-11
play O 0 4.531276395769446e-11
a O 0 3.623772809602244e-11
broad O 0 2.216953953748657e-09
role O 0 4.316318968911048e-10
in O 0 1.277079830774852e-10
human O 0 2.1829215768320864e-08
malignancy B-Disease 0 0.00022878157324157655
. O 0 6.415044850882623e-08

Somatic O 0 0.0005890992470085621
PTEN O 0 0.000620791397523135
deletions O 0 6.137910304460092e-07
and O 0 3.3382521191782644e-09
mutations O 0 8.490335545729977e-09
were O 0 3.018343908145482e-10
observed O 0 1.33697775073216e-10
in O 0 1.103680081354641e-11
sporadic B-Disease 0 2.438958404127334e-07
breast I-Disease 1 0.9999996423721313
, I-Disease 0 1.4485067367786542e-07
brain I-Disease 1 1.0
, I-Disease 0 2.9086046197335236e-05
prostate I-Disease 1 1.0
and I-Disease 1 0.9999914169311523
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.8672072887420654
lines O 0 1.1807133404317938e-07
and O 0 2.4259461106623803e-10
in O 0 6.600366087017306e-11
several O 0 4.233954159493791e-11
primary O 0 4.263641244506289e-07
tumours B-Disease 1 1.0
such O 0 1.0220142510064534e-09
as O 0 1.060656060758447e-07
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.999990701675415
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999936819076538
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9951152801513672

In O 0 1.9253524996543092e-08
addition O 0 8.676816487529493e-10
, O 0 2.348682137665037e-09
PTEN O 0 0.25435876846313477
was O 0 2.1525805493638472e-07
identified O 0 6.847085121108876e-10
as O 0 6.041349712160304e-12
the O 0 5.379871461513863e-12
susceptibility O 0 1.0344973766507337e-09
gene O 0 1.054751563867029e-10
for O 0 4.0390038535953465e-11
two O 0 1.4966823336237667e-09
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 8.257775019337998e-10
CD B-Disease 0 2.9609830107801827e-06
; O 0 3.1837622316288616e-08
MIM O 0 0.00019615345809143037
158350 O 0 2.748336555669084e-06
) O 0 7.382844335879213e-11
and O 0 5.254630619511147e-10
Bannayan B-Disease 0 0.3658379316329956
- I-Disease 1 0.8562657833099365
Zonana I-Disease 1 0.7224204540252686
( I-Disease 0 1.6111734169044212e-08
BZS I-Disease 0 7.145955169107765e-05
) I-Disease 0 5.066490282867875e-11
or I-Disease 0 2.4581967017489603e-10
Ruvalcaba I-Disease 0 2.8198402901580266e-07
- I-Disease 0 5.5309484991994395e-08
Riley I-Disease 0 2.0345863660509167e-08
- I-Disease 0 8.683537998877e-06
Smith I-Disease 0 3.0079019779805094e-05
syndrome I-Disease 1 1.0
( O 0 1.7827305498485657e-07
MIM O 1 0.5830847024917603
153480 O 0 5.866981882718392e-05
) O 0 4.225334304663875e-09
. O 0 1.1699216173610694e-07

Constitutive O 0 1.946254712947848e-07
DNA O 0 4.214767912458228e-08
from O 0 1.0077980672207332e-09
37 O 0 3.5501297457329883e-09
CD B-Disease 0 1.0904198433081547e-08
families O 0 2.2193687165827924e-10
and O 0 3.7095049254531887e-10
seven O 0 5.075200260051815e-09
BZS B-Disease 0 2.1601807020488195e-05
families O 0 1.4888063004647734e-10
was O 0 1.9213677315832456e-09
screened O 0 3.2587952336626813e-09
for O 0 1.5131236263954406e-09
germline O 0 0.00017520514666102827
PTEN O 0 0.016102442517876625
mutations O 0 3.779733015107922e-05
. O 0 2.032133892271304e-07

PTEN O 0 0.0007910067797638476
mutations O 0 4.645530395919195e-07
were O 0 3.4639049406592903e-09
identified O 0 3.1110633513797836e-10
in O 0 4.3231303953339406e-11
30 O 0 2.4799930997687625e-09
of O 0 9.175318282927947e-10
37 O 0 7.315805294894062e-09
( O 0 1.0318718796087367e-10
81 O 0 4.468985892458477e-08
% O 0 4.924072261047741e-10
) O 0 3.2919127493369338e-12
CD B-Disease 0 5.1235784503944615e-09
families O 0 1.3789575037392865e-10
, O 0 4.50849947652987e-11
including O 0 2.595183616616037e-11
missense O 0 7.155202297326468e-07
and O 0 4.916979712277225e-09
nonsense O 0 2.186306574003538e-06
point O 0 1.6754372609284474e-06
mutations O 0 7.189935757878629e-09
, O 0 6.572878352706368e-11
deletions O 0 7.070369623107808e-09
, O 0 6.578325106865179e-10
insertions O 0 2.210553873283061e-08
, O 0 5.147063886212777e-10
a O 0 5.313937290196691e-09
deletion O 0 5.454189704323653e-07
/ O 0 5.576507646765094e-07
insertion O 0 2.721075134104467e-07
and O 0 1.2521724102043663e-08
splice O 0 3.4538206818979234e-06
site O 0 3.1432816172127787e-07
mutations O 0 3.418410017275164e-07
. O 0 4.47145893645029e-08

These O 0 2.3943673710391522e-08
mutations O 0 7.081533937025597e-08
were O 0 1.255124781884831e-09
scattered O 0 5.054293095163587e-10
over O 0 5.2655640264687165e-11
the O 0 1.64673205627075e-11
entire O 0 9.267087097697413e-11
length O 0 4.583893681298079e-11
of O 0 2.4872776061002355e-10
PTEN O 0 1.744699716255127e-06
, O 0 1.28272574853594e-11
with O 0 1.902931344400713e-13
the O 0 2.155055821295715e-11
exception O 0 6.116555179014327e-11
of O 0 1.628939205744473e-10
the O 0 6.352245812690782e-11
first O 0 3.2195499044540554e-10
, O 0 3.6612195913887646e-11
fourth O 0 3.42464634428552e-09
and O 0 1.5887241522349882e-10
last O 0 6.17720061768523e-08
exons O 0 3.1958686577127082e-06
. O 0 2.1480668976892048e-07

A O 0 0.00033804451231844723
hot O 0 3.8704893086105585e-05
spot O 0 5.7756852811508e-07
for O 0 1.148590667021665e-09
PTEN O 0 1.983541005756706e-05
mutation O 0 2.3136026428005607e-08
in O 0 4.1685135898639203e-10
CD B-Disease 0 4.3631811053046476e-08
was O 0 4.4054111469904456e-08
identified O 0 1.4057078834284198e-09
in O 0 1.267970867191437e-10
exon O 0 2.1057948718095076e-09
5 O 0 4.0966701142508555e-09
that O 0 4.627577401133953e-12
contains O 0 5.422790255033005e-12
the O 0 2.0838027137148885e-10
PTPase O 0 3.2817516171235184e-07
core O 0 1.683279649000724e-08
motif O 0 3.8286665504649875e-10
, O 0 2.4592634786241296e-12
with O 0 1.2607199084604254e-13
13 O 0 6.433958921192584e-10
of O 0 3.2385807924306675e-10
30 O 0 2.405815324735272e-09
( O 0 7.017133402120734e-11
43 O 0 1.2306637486858563e-08
% O 0 1.8940625456931315e-10
) O 0 5.5283954497609145e-12
CD B-Disease 0 6.813607011935119e-09
mutations O 0 5.688856941077347e-09
identified O 0 9.627891817132195e-10
in O 0 9.259596561728145e-11
this O 0 1.041656871869634e-09
exon O 0 3.3931081588889356e-07
. O 0 7.523157563582572e-08

Seven O 0 9.71682112549388e-08
of O 0 1.101881164089491e-08
30 O 0 6.650364259286334e-09
( O 0 9.066584982786452e-11
23 O 0 1.2554534301045805e-08
% O 0 8.113361094075344e-10
) O 0 2.3755574330569518e-12
were O 0 2.5666517522449084e-11
within O 0 5.146001333389272e-11
the O 0 2.0294052896496773e-11
core O 0 1.1070370314891775e-10
motif O 0 1.7410746455670534e-11
, O 0 4.0999921014674146e-13
the O 0 1.0808862485611748e-12
majority O 0 7.990717462713626e-13
( O 0 7.04304930349009e-12
five O 0 1.881575173445782e-10
of O 0 3.0636429504404816e-10
seven O 0 3.836003389934284e-11
) O 0 2.017909710855248e-12
of O 0 2.3728052508942277e-11
which O 0 8.50359626464181e-12
were O 0 3.761910505328814e-10
missense O 0 6.178108833410079e-07
mutations O 0 5.081576546217548e-07
, O 0 1.9808153728373412e-10
possibly O 0 1.5105175776852775e-08
pointing O 0 9.90066251205235e-09
to O 0 3.108341084523403e-10
the O 0 7.494731918411546e-11
functional O 0 1.7582698630391747e-09
significance O 0 5.210716857995124e-10
of O 0 2.282741357051421e-10
this O 0 2.4720955837942427e-10
region O 0 7.270890023391985e-08
. O 0 5.054201679399739e-08

Germline O 0 0.0031033726409077644
PTEN O 0 0.00017048853624146432
mutations O 0 5.0519464167564365e-08
were O 0 2.427570644503163e-10
identified O 0 3.171798934609171e-11
in O 0 2.6617059251110575e-12
four O 0 3.230970395742827e-12
of O 0 1.2219986134098804e-10
seven O 0 2.6234633909716365e-10
( O 0 8.38541250325342e-11
57 O 0 1.650154501930956e-07
% O 0 1.759934953327047e-08
) O 0 1.4150586258310227e-09
BZS B-Disease 0 0.0009023052407428622
families O 0 5.991167117969098e-09
studied O 0 1.6663943824823946e-07
. O 0 6.271940833357803e-08

Interestingly O 0 3.1783188205736224e-06
, O 0 4.1521452942561154e-09
none O 0 1.8457780859293393e-09
of O 0 6.775230931843623e-10
these O 0 2.7092704815712132e-11
mutations O 0 4.5932804226822554e-09
was O 0 6.364185178853177e-09
observed O 0 1.0390792670733617e-09
in O 0 8.027924158771071e-11
the O 0 1.199390364803321e-09
PTPase O 0 6.116393251431873e-06
core O 0 7.726708872723975e-07
motif O 0 1.4440846030083776e-07
. O 0 3.2090451185240454e-08

It O 0 2.8580500188724045e-09
is O 0 3.46595009637074e-11
also O 0 1.8087459698404307e-12
worthy O 0 8.512302529517513e-10
of O 0 1.0935638505848999e-10
note O 0 4.196952854695901e-11
that O 0 3.028062826523903e-12
a O 0 2.384892457130139e-11
single O 0 4.2048049070375626e-11
nonsense O 0 7.985081040828845e-09
point O 0 2.1871350952551438e-08
mutation O 0 1.0896291646744771e-09
, O 0 2.972528126421459e-11
R233X O 0 1.2936005759911495e-06
, O 0 1.6885644271713574e-10
was O 0 1.1030945046286433e-08
observed O 0 1.0030823949236378e-09
in O 0 3.507313883766017e-11
the O 0 1.707256974681215e-10
germline O 0 2.884849692463831e-08
DNA O 0 5.785258938573179e-09
from O 0 1.3319532976563409e-10
two O 0 2.1465056294911466e-12
unrelated O 0 9.811359363842698e-11
CD B-Disease 0 8.465934620005555e-09
families O 0 1.45765066683623e-10
and O 0 2.6894189653070555e-10
one O 0 1.6665461899378897e-08
BZS B-Disease 0 0.2843271493911743
family O 0 3.9732977796802516e-08
. O 0 5.97925122747256e-08

Genotype O 0 6.1016999097773805e-06
- O 0 3.1141689760261215e-07
phenotype O 0 2.197823789629183e-08
studies O 0 7.237068722076856e-10
were O 0 2.1155754231783064e-11
not O 0 1.931507037644664e-11
performed O 0 1.3908301593756889e-11
on O 0 9.069179435217123e-11
this O 0 3.310260269021037e-12
small O 0 2.7209847222597894e-11
group O 0 4.06765524041397e-11
of O 0 4.210234383350553e-09
BZS B-Disease 1 0.9960359930992126
families O 0 3.6999413310923046e-08
. O 0 2.6152682153224305e-07

However O 0 2.5127869207608455e-07
, O 0 2.0576420567408604e-09
genotype O 0 7.965749659888388e-08
- O 0 8.844243559735787e-09
phenotype O 0 4.103074768835313e-09
analysis O 0 1.1048199854979401e-10
inthe O 0 5.465103569690655e-08
group O 0 8.137809003050389e-12
of O 0 2.8377427144232747e-11
CD B-Disease 0 8.8009626253438e-09
families O 0 3.376967802615205e-11
revealed O 0 2.5808943870941903e-10
two O 0 4.2709352764472297e-13
possible O 0 1.4086696219217654e-11
associations O 0 5.102388997424434e-12
worthy O 0 1.0357590340959177e-09
of O 0 1.5520879026453827e-09
follow O 0 9.44397671176489e-10
- O 0 1.1830115775879335e-09
up O 0 2.423347078561733e-10
in O 0 2.431638050637286e-11
independent O 0 5.422485793715737e-10
analyses O 0 1.2675609895040907e-08
. O 0 1.9860227240542372e-08

The O 0 2.5480471066430255e-08
first O 0 8.444529520090782e-10
was O 0 1.4231354983351707e-09
an O 0 1.3926193531688114e-11
association O 0 5.878913328372093e-11
noted O 0 4.322968094605528e-10
in O 0 6.431869620238118e-11
the O 0 1.03737768375467e-10
group O 0 3.3933398625729527e-12
of O 0 2.511666048754524e-11
CD B-Disease 0 3.778843193913417e-08
families O 0 4.07960748516345e-10
with O 0 3.0993261290745977e-09
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.599493589310441e-05

A O 0 3.2926675430644536e-07
correlation O 0 2.8396096141136695e-08
was O 0 1.4571176487621074e-09
observed O 0 5.657330853781062e-11
between O 0 1.3234085702307219e-11
the O 0 4.3599800853000303e-11
presence O 0 1.7591678114214915e-10
/ O 0 1.8682347899812157e-06
absence O 0 1.0073031120327869e-07
of O 0 4.2766337138289146e-09
a O 0 1.558257745060132e-09
PTEN O 0 2.5851618374872487e-06
mutation O 0 2.156719247636829e-09
and O 0 1.59147640812346e-12
the O 0 1.1210898745797615e-12
type O 0 3.9222128322968786e-10
of O 0 3.683560789724538e-09
breast O 0 2.973889422719367e-05
involvement O 0 2.0265440525690792e-06
( O 0 8.46109138308293e-09
unaffected O 0 3.6333826756163035e-06
versus O 0 1.0218605893896893e-05
benign O 0 0.08414028584957123
versus O 0 0.0002371617592871189
malignant O 1 0.9999951124191284
) O 0 5.557562410274386e-09
. O 0 1.9955953334260812e-08

Specifically O 0 4.213208626424603e-08
and O 0 1.5463783031854916e-10
more O 0 2.529867374617689e-12
directly O 0 2.0726008409521768e-10
, O 0 1.6498004351550577e-11
an O 0 9.464200256825706e-12
association O 0 2.1515166037655575e-10
was O 0 1.7401543317419055e-08
also O 0 2.002520371746641e-11
observed O 0 6.302403737779017e-11
between O 0 2.3824466705013592e-11
the O 0 3.163346667944822e-11
presence O 0 4.623907159939655e-12
of O 0 2.678268197497946e-11
a O 0 2.4273530407903365e-10
PTEN O 0 0.0003410605131648481
mutation O 0 9.976897672459017e-06
and O 0 8.313378430102603e-08
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.3146011497155996e-06

Secondly O 0 0.0007988323923200369
, O 0 6.498541438304528e-08
there O 0 1.7442540745093993e-09
appeared O 0 4.671809605838462e-10
to O 0 5.330153332594456e-11
be O 0 5.686280266092858e-11
an O 0 2.6893971424857277e-11
interdependent O 0 1.5473741399318897e-08
association O 0 4.2573269909418343e-10
between O 0 2.4688566213626473e-07
mutations O 0 7.0737705755163915e-06
upstream O 0 7.221066198326298e-07
and O 0 8.162047426818475e-11
within O 0 9.139721757200903e-10
the O 0 4.283668697535603e-10
PTPase O 0 2.7212206532567507e-07
core O 0 2.156802736408281e-08
motif O 0 6.050096534870875e-10
, O 0 6.1091830379222944e-12
the O 0 8.62456894096253e-12
core O 0 5.901056032708851e-11
motif O 0 3.8512504817178606e-12
containing O 0 2.4909103100469177e-13
the O 0 1.5120077499070073e-12
majority O 0 2.1719405787767876e-12
of O 0 8.230472553494295e-11
missense O 0 2.2333335891744355e-07
mutations O 0 6.938196861483448e-08
, O 0 1.3772510042142638e-11
and O 0 1.2743290580749522e-12
the O 0 8.024383241211908e-12
involvement O 0 1.874969957071926e-09
of O 0 4.542640708038448e-10
all O 0 7.915587456330808e-12
major O 0 3.3229916041044305e-10
organ O 0 3.0629192337983113e-07
systems O 0 3.1453557767235907e-06
( O 0 2.0523515331660747e-08
central O 1 0.9999939203262329
nervous O 1 0.5709028840065002
system O 0 0.005338214337825775
, O 0 1.861817935377985e-07
thyroid O 1 1.0
, O 0 2.916059202107135e-06
breast O 1 1.0
, O 0 1.3527150258596521e-05
skin O 1 1.0
and O 0 0.0005427653668448329
gastrointestinal O 1 1.0
tract O 1 0.9999998807907104
) O 0 5.527467692445498e-07
. O 0 2.3640238850930473e-06

However O 0 1.6076041902124416e-06
, O 0 3.956280636430165e-09
these O 0 4.8489774695514853e-11
observations O 0 2.7036206606823043e-09
would O 0 7.571894777846921e-10
need O 0 5.552346360460092e-10
to O 0 2.388020892141185e-10
be O 0 1.3194872972022154e-10
confirmed O 0 5.494926041960113e-11
by O 0 1.5233637918818377e-12
studying O 0 3.3464214038714246e-11
a O 0 2.586356909889398e-12
larger O 0 2.6598178954478913e-12
number O 0 4.385164974196609e-12
of O 0 5.887239307167391e-11
CD B-Disease 0 6.22310878384269e-08
families O 0 1.8209750374253986e-09
. O 0 9.430772962559786e-08

Molecular O 0 0.09451783448457718
defects O 1 0.9999998807907104
leading O 0 8.253436334371145e-08
to O 0 5.342756792536818e-10
human O 0 9.435060371876247e-11
complement B-Disease 0 8.392952999258796e-10
component I-Disease 0 0.0025246136356145144
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 8.023763875542045e-10
an O 0 1.5716764695250518e-11
African O 0 1.0103497205538048e-10
- O 0 2.9382404842515086e-10
American O 0 1.4327818098625045e-10
family O 0 2.1511636916216048e-10
. O 0 3.5874243575761966e-09

Complement B-Disease 0 7.75619639625802e-08
component I-Disease 0 0.00012860831338912249
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 6.402033347896463e-10
C6D B-Disease 0 5.5639677157159895e-05
) O 0 3.385880811834774e-11
was O 0 1.673381611055902e-08
diagnosed O 0 5.887326892661804e-07
in O 0 2.6143807604905867e-11
a O 0 6.217713149903048e-11
16 O 0 3.5946828846888934e-10
- O 0 6.275283070955595e-11
year O 0 2.3174689944838178e-10
- O 0 1.390062620565402e-09
old O 0 6.403819696743085e-09
African O 0 1.74956105158941e-10
- O 0 1.7987225597870804e-10
American O 0 2.9055365752261864e-11
male O 0 3.930073627644859e-11
with O 0 2.842150560039558e-12
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 5.1152501328033395e-06

The O 0 1.5774817541114317e-07
patients O 0 2.1360715152241028e-07
father O 0 6.134884245057037e-08
and O 0 9.357499219930787e-10
two O 0 2.8372354465844296e-10
brothers O 0 3.3104754493251676e-08
also O 0 2.065859844302409e-10
had O 0 2.0326702099282556e-08
C6D B-Disease 1 0.9999626874923706
, O 0 1.089566353806859e-10
but O 0 1.469174781831839e-11
gave O 0 2.4531977144137684e-11
no O 0 3.552422592201232e-11
history O 0 2.2160554641326158e-11
of O 0 2.8512753269538393e-10
meningitis B-Disease 1 1.0
or O 0 1.0714444442783133e-08
other O 0 4.930180708129228e-10
neisserial B-Disease 0 6.238988862605765e-05
infection I-Disease 0 0.00018243964586872607
. O 0 3.8135408431116957e-07

By O 0 4.334347103451819e-09
using O 0 1.931096393903431e-09
exon O 0 8.856955169278535e-09
- O 0 1.791697457065311e-09
specific O 0 1.7093586268668304e-10
polymerase O 0 8.228252745823283e-09
chain O 0 1.3815460997435025e-09
reaction O 0 1.7844799249377985e-10
( O 0 1.971383993548681e-11
PCR O 0 4.081272819700388e-10
) O 0 8.948261402685898e-12
/ O 0 4.439458800575835e-10
single O 0 6.712597838687273e-11
- O 0 1.7242413052898087e-10
strand O 0 2.187182934765275e-10
conformation O 0 8.426392916760506e-11
polymorphism O 0 4.860098087866582e-11
as O 0 2.6978523581799863e-12
a O 0 5.3860626895996244e-12
screening O 0 1.675582762816763e-11
step O 0 1.94173233047934e-10
and O 0 2.348154439987815e-12
nucleotide O 0 5.1160641695302544e-11
sequencing O 0 4.8031554428229484e-11
of O 0 5.0266790729835975e-11
target O 0 2.511055363640935e-09
exons O 0 5.759297927454554e-09
, O 0 1.5475223533178983e-11
we O 0 1.2984700988039055e-11
determined O 0 1.71852504449177e-10
that O 0 2.5334213893390967e-12
the O 0 2.8801443868742282e-11
proband O 0 3.7229050064979674e-08
was O 0 1.6054055862468886e-09
a O 0 7.476912838866312e-11
compound O 0 4.402029851746647e-10
heterozygote O 0 1.0410788897630141e-09
for O 0 5.4073828748002484e-11
two O 0 1.60029933748973e-10
C6 O 0 1.0346623639634345e-05
gene O 0 1.6678475844855711e-07
mutations O 0 1.0364392437622882e-06
. O 0 1.1616023698479694e-07

The O 0 1.6107026112877065e-07
first O 0 1.1130468102749091e-08
, O 0 2.053813924485226e-10
1195delC O 0 2.8619245640015833e-08
located O 0 2.2904360630349174e-09
in O 0 5.081775000803646e-10
exon O 0 2.0821678603510918e-08
7 O 0 2.153997371578953e-07
, O 0 4.2859143317697246e-11
is O 0 6.757027229409296e-12
a O 0 1.2558467286927222e-11
novel O 0 4.10633541059191e-11
mutation O 0 3.0946520346297746e-10
, O 0 6.737427889896841e-12
while O 0 1.2940987691167916e-11
the O 0 4.845288753552168e-11
second O 0 1.3676869636825018e-09
, O 0 3.050661459558235e-11
1936delG O 0 3.6656815360913697e-09
in O 0 3.7568556598976954e-10
exon O 0 2.187300784939339e-09
12 O 0 1.5806978836963026e-08
, O 0 1.50475274601769e-11
has O 0 7.114757567816543e-12
been O 0 1.269535952058698e-11
described O 0 1.1832089995278405e-11
before O 0 5.901742289315948e-11
to O 0 6.512280992243547e-11
cause O 0 3.447021157398922e-08
C6D B-Disease 0 0.0034551583230495453
in O 0 1.4807069459443767e-10
an O 0 1.4580196425195702e-11
unrelated O 0 7.941999835558988e-10
African O 0 3.032296636007459e-10
- O 0 3.229648770641802e-10
American O 0 1.776817859511226e-10
individual O 0 1.5235687711445678e-10
. O 0 3.917700652777967e-08

Both O 0 1.894129475488171e-08
mutations O 0 8.472108703472259e-08
result O 0 3.062985598489831e-08
in O 0 7.029760329402279e-09
premature O 0 1.849657451202802e-06
termination O 0 8.162157428159844e-06
codons O 0 3.5836217193718767e-06
and O 0 2.568046397755097e-08
C6 O 0 1.2395764315442648e-05
null O 0 8.189617801690474e-06
alleles O 0 4.510966178372655e-08
. O 0 6.708867683613562e-09

Allele O 0 4.000246889290793e-08
- O 0 5.758635790442668e-10
specific O 0 1.8051867292645518e-11
PCR O 0 2.337222915205217e-10
indicated O 0 2.738970994453638e-10
that O 0 2.3347075141233464e-12
the O 0 2.9559903136355814e-11
probands O 0 3.1491987328990945e-07
two O 0 3.785562696645428e-10
brothers O 0 1.0062659150378295e-08
also O 0 6.582338146765565e-11
inherited O 0 8.001256546208424e-09
the O 0 1.201114319115959e-09
1195delC O 0 4.3197641019787625e-09
mutation O 0 1.606263122511109e-09
from O 0 1.6074913622432518e-10
their O 0 1.7988726827566914e-11
heterozygous O 0 8.172063720168765e-11
mother O 0 1.2343267033476657e-11
and O 0 6.411702223839411e-13
the O 0 1.0408853466647994e-11
1936delG O 0 6.645073935551693e-10
mutation O 0 5.371161848621853e-10
from O 0 3.501113010617729e-10
their O 0 5.573501382638568e-11
homozygous O 0 8.407132767729308e-10
father O 0 2.5379909285305757e-09
. O 0 5.965519189743418e-10
. O 0 5.920984147422814e-09

PAX6 O 0 0.008368969894945621
mutations O 0 2.390357622061856e-05
reviewed O 0 3.2681639368092874e-06
. O 0 3.8246272993092134e-07

Mutations O 0 2.7105725166620687e-06
in O 0 6.421751130858411e-09
PAX6 O 0 6.016663974151015e-05
are O 0 1.820821271536488e-10
responsible O 0 2.529128462214203e-09
for O 0 1.4307773021915438e-10
human O 0 2.4509050788878994e-08
aniridia B-Disease 1 1.0
and O 0 1.5336466319126885e-08
have O 0 3.8483169428893405e-10
also O 0 2.7756887066576752e-11
been O 0 2.920760855396054e-11
found O 0 1.8892257550029434e-12
in O 0 3.840318633843015e-13
patients O 0 4.735797257821028e-13
with O 0 7.001378101410827e-13
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 2.678625889984687e-07
with O 0 0.0003161477216053754
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 9.296055941376835e-05
with O 0 1.0992237342577482e-08
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 2.0761005359304363e-08
and O 0 1.5363070815510582e-09
with O 0 2.0176895709766995e-09
isolated B-Disease 1 1.0
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9999703168869019

No O 0 6.593832324597315e-08
locus O 0 1.4250267632576197e-08
other O 0 6.0539802337888915e-12
than O 0 4.853675621141473e-12
chromosome O 0 3.043482621478688e-08
11p13 O 0 2.013792027355521e-06
has O 0 6.27111904072386e-11
been O 0 9.979447129770946e-11
implicated O 0 3.4050351427339365e-09
in O 0 8.532101691827165e-10
aniridia B-Disease 1 1.0
, O 0 1.2257582504560105e-08
and O 0 1.0323882859708533e-09
PAX6 O 1 0.9177964329719543
is O 0 2.0740413830822035e-09
clearly O 0 1.6493679755313906e-09
the O 0 3.532438230813284e-10
major O 0 7.331744100724791e-09
, O 0 2.7220435974695256e-11
if O 0 7.636082738349259e-11
not O 0 4.840642470194112e-11
only O 0 5.7489315391512363e-11
, O 0 1.8266955656431882e-11
gene O 0 4.344011816925786e-10
responsible O 0 3.387578573210703e-08
. O 0 1.3654778285854263e-07

Twenty O 0 2.416303004793008e-06
- O 0 1.0022035468182366e-07
eight O 0 3.890726851807358e-09
percent O 0 3.6564082872558856e-09
of O 0 1.638642971313331e-10
identified O 0 4.516146567823398e-09
PAX6 O 0 5.2802333811996505e-06
mutations O 0 6.55469705179712e-08
are O 0 4.401509434703854e-10
C O 0 2.9860239010304213e-05
- O 0 5.213970780459931e-06
T O 0 1.4685181213280885e-06
changes O 0 6.292020238163332e-09
at O 0 1.0752439827399485e-08
CpG O 0 2.4609484228221845e-08
dinucleotides O 0 1.2039778596317774e-07
, O 0 1.1692062595880515e-10
20 O 0 1.5493845095804204e-09
% O 0 2.6832297495005264e-10
are O 0 4.731917115086137e-12
splicing O 0 6.405798558262177e-09
errors O 0 1.8483795827251015e-07
, O 0 6.289830462025137e-11
and O 0 3.665955993631398e-12
more O 0 4.073505313444137e-13
than O 0 1.0560897642508671e-11
30 O 0 7.771145393853374e-10
% O 0 1.6058335217117303e-10
are O 0 2.801654524695052e-12
deletion O 0 1.1292164980858388e-09
or O 0 4.983798373991988e-10
insertion O 0 1.5216768289860738e-08
events O 0 9.859144611823467e-10
. O 0 1.0878107303824436e-08

There O 0 6.16858173430046e-08
is O 0 1.0566448827020736e-09
a O 0 8.469984158487875e-10
noticeably O 0 3.6620356524963427e-08
elevated O 0 3.640057855136547e-08
level O 0 2.527981912692212e-08
of O 0 1.4289126548661102e-09
mutation O 0 3.080860677684427e-09
in O 0 1.1352475209891466e-10
the O 0 6.932775881152153e-11
paired O 0 1.3145129949820866e-11
domain O 0 3.3454405912181073e-10
compared O 0 1.4162047402843658e-11
with O 0 1.9607060387175773e-13
the O 0 4.879427070725306e-11
rest O 0 1.8645626709279384e-10
of O 0 1.7142462449548646e-10
the O 0 6.189165291381471e-10
gene O 0 3.076116250610994e-09
. O 0 7.152116676678588e-09

Increased O 0 3.115484901172749e-07
mutation O 0 5.583692086474912e-08
in O 0 2.393899245500819e-10
the O 0 3.8565539650647906e-10
homeodomain O 0 5.915703482628487e-08
is O 0 1.0373382014483568e-10
accounted O 0 2.2957884204810597e-10
for O 0 4.392279942533328e-12
by O 0 3.291876840560981e-11
the O 0 4.518403873277066e-09
hypermutable O 0 1.8352810684518772e-06
CpG O 0 1.5196731055766577e-06
dinucleotide O 0 5.041118242843368e-07
in O 0 1.5943781406235757e-08
codon O 0 2.7295871518617787e-07
240 O 0 3.324668185200608e-08
. O 0 8.83392559103413e-09

Very O 0 1.8902388987385166e-08
nearly O 0 4.698396782742975e-09
all O 0 1.2561372775277135e-10
mutations O 0 7.593878303957524e-10
appear O 0 3.019714478469382e-10
to O 0 4.044973245243e-10
cause O 0 2.545626216488017e-07
loss O 0 1.8069911789098114e-08
of O 0 1.610134248153372e-09
function O 0 3.341346366259046e-10
of O 0 8.552430985631077e-11
the O 0 1.8308743410244688e-11
mutant O 0 5.463031763075499e-11
allele O 0 9.05924280036885e-10
, O 0 3.8941063915109986e-12
and O 0 6.141987417794537e-13
more O 0 1.5971528570177251e-13
than O 0 1.2874833144049802e-11
80 O 0 3.237073942230495e-10
% O 0 2.3198838683402556e-10
of O 0 2.2356920481581e-10
exonic O 0 1.0096344738030893e-07
substitutions O 0 1.0430863950361413e-09
result O 0 2.453719893935613e-09
in O 0 1.1292703439025331e-09
nonsense O 0 3.1019453672342934e-07
codons O 0 1.0299488621967612e-06
. O 0 3.920974833704349e-08

In O 0 4.001345743631646e-08
a O 0 9.87563542054204e-09
gene O 0 2.968852386153742e-10
with O 0 3.464547008655283e-12
such O 0 6.316303036157933e-11
extraordinarily O 0 1.4476890441983414e-07
high O 0 7.936647250517126e-08
sequence O 0 1.9441646070816887e-09
conservation O 0 7.564792681158394e-10
throughout O 0 1.0429958979818466e-11
evolution O 0 2.766366857809288e-10
, O 0 7.0595248397031796e-12
there O 0 4.291779084897307e-11
are O 0 9.80866499133981e-11
presumed O 0 1.91010349226417e-06
undiscovered O 0 4.9624781240709126e-05
missense O 0 6.563142960658297e-06
mutations O 0 1.1239856121392222e-06
, O 0 6.409153763264896e-11
these O 0 3.3059948008340445e-12
are O 0 4.535320469872817e-12
hypothesized O 0 5.005329928309266e-09
to O 0 5.483181686471994e-10
exist O 0 2.3988595554413905e-09
in O 0 1.410315614291946e-10
as O 0 1.6173666572694145e-10
- O 0 1.2219386613665506e-09
yet O 0 1.1674752276036315e-09
unidentified O 0 2.2572281821453544e-09
phenotypes O 0 1.2681311556406172e-09
. O 0 4.380036888740335e-10
. O 0 6.929094631402677e-09

Genetic O 0 1.032765612762887e-05
heterogeneity O 0 2.6653140139387688e-06
and O 0 1.020710960197846e-09
penetrance O 0 1.1496897656115834e-07
analysis O 0 5.33263710966736e-10
of O 0 2.390624143089326e-09
the O 0 1.6626433563260434e-09
BRCA1 O 0 7.28687012951923e-08
and O 0 1.194374932289577e-09
BRCA2 O 0 2.0210691786815005e-07
genes O 0 7.171391036564501e-09
in O 0 2.5471613707139795e-09
breast B-Disease 1 0.9998563528060913
cancer I-Disease 1 0.9999997615814209
families O 0 6.885515517751628e-07
. O 0 1.4348679542308673e-06

The O 0 0.00013225467409938574
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.00012786898878403008
Consortium O 0 2.6577652079140535e-06
. O 0 1.7657222883826762e-07

The O 0 7.084678621538387e-09
contribution O 0 8.630473224968682e-09
of O 0 5.326175056552529e-09
BRCA1 O 0 1.8640832877281355e-07
and O 0 2.5087767419051943e-09
BRCA2 O 0 8.293917744595092e-06
to O 0 2.7654587029246613e-05
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 9.301846876041964e-05
assessed O 0 1.3880237759167358e-07
by O 0 9.65552776621692e-11
linkage O 0 1.0803731242958747e-08
and O 0 4.2197807748056704e-11
mutation O 0 5.8180519429962274e-11
analysis O 0 3.6175281520334224e-12
in O 0 3.0198784011642443e-12
237 O 0 3.564639555753146e-11
families O 0 3.4371793605769696e-12
, O 0 1.290336977891049e-12
each O 0 8.088749938947593e-13
with O 0 2.885629018720137e-13
at O 0 3.757586464203655e-10
least O 0 3.279518323573427e-11
four O 0 2.6898472598596568e-12
cases O 0 4.43993938836762e-11
of O 0 3.971523110379849e-09
breast B-Disease 0 0.141671285033226
cancer I-Disease 0 0.0005078081740066409
, O 0 9.306393156105486e-11
collected O 0 2.8019229297848725e-11
by O 0 5.062674585110116e-11
the O 0 2.277582069609707e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 7.116994765965501e-06
Consortium O 0 2.747456164797768e-07
. O 0 4.964837074794559e-08

Families O 0 9.654432808758884e-09
were O 0 2.936156318078531e-10
included O 0 2.257600530131132e-11
without O 0 3.8963093862420806e-10
regard O 0 2.0671457878762567e-09
to O 0 9.106863180230462e-11
the O 0 5.7038446882318183e-11
occurrence O 0 6.319153200706751e-09
of O 0 6.528856033582997e-08
ovarian B-Disease 1 1.0
or I-Disease 1 0.5160254836082458
other I-Disease 0 3.375882897671545e-06
cancers I-Disease 1 1.0
. O 0 3.757458398467861e-05

Overall O 0 0.0001092151360353455
, O 0 7.15740071655091e-08
disease O 0 0.0495157316327095
was O 0 2.5544687787260045e-07
linked O 0 7.605336804772378e-08
to O 0 3.2646944703174086e-08
BRCA1 O 0 5.0901512338441535e-08
in O 0 8.170567694643083e-11
an O 0 4.760532679864982e-12
estimated O 0 1.3908309226540183e-10
52 O 0 4.467217706860538e-10
% O 0 1.9104112736201273e-10
of O 0 2.472991533775115e-10
families O 0 8.587804078974415e-11
, O 0 2.7056246132417527e-11
to O 0 2.2405384214607693e-09
BRCA2 O 0 2.2781243558256392e-08
in O 0 1.7207620051085115e-10
32 O 0 1.6003123270991182e-09
% O 0 2.7857779971718344e-10
of O 0 7.670795942882336e-11
families O 0 2.050689305865827e-11
, O 0 1.0943853462341835e-11
and O 0 7.877963038860347e-12
to O 0 3.8169636895624137e-10
neither O 0 8.624841396631666e-10
gene O 0 7.883934477481702e-11
in O 0 9.441037535085073e-11
16 O 0 1.4637751011292721e-09
% O 0 3.4401539950046356e-10
( O 0 2.055850975568596e-11
95 O 0 1.5494739713517447e-08
% O 0 1.1837546942672361e-08
confidence O 0 2.000462018258986e-08
interval O 0 1.9090768432761251e-07
[ O 0 1.2412132832650968e-07
CI O 0 4.077226549270563e-06
] O 0 6.804542262983659e-09
6 O 0 3.5357292649251804e-09
% O 0 1.8364817999660943e-10
- O 0 3.537400372621846e-10
28 O 0 2.7640054689470617e-09
% O 0 3.8282868541905657e-10
) O 0 4.272566675456169e-12
, O 0 1.3206197420345678e-11
suggesting O 0 1.014430317525239e-09
other O 0 2.6381807849418237e-10
predisposition O 0 2.500609480193816e-05
genes O 0 3.132138033379306e-07
. O 0 3.0278840768005466e-08

The O 0 2.9758057351614298e-08
majority O 0 6.815032982387947e-10
( O 0 1.5742994408096678e-10
81 O 0 3.239239276808803e-08
% O 0 8.416823349399749e-10
) O 0 2.0784973134985174e-12
of O 0 1.7502420346371395e-10
the O 0 3.949836013816821e-08
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.448696948131328e-08
were O 0 7.446786520759474e-10
due O 0 2.0085520802126666e-08
to O 0 1.3196188586306334e-09
BRCA1 O 0 9.531150979569247e-09
, O 0 4.409277630512687e-12
with O 0 3.9822935530772763e-13
most O 0 1.5669352967928596e-11
others O 0 2.0978789885828242e-11
( O 0 2.950312563698709e-11
14 O 0 1.255973192115789e-08
% O 0 1.2505010360541746e-09
) O 0 3.5143585958019585e-11
due O 0 1.349103655456929e-07
to O 0 2.425257434879313e-07
BRCA2 O 0 3.2908556022448465e-05
. O 0 4.6294849198602606e-07

Conversely O 0 1.4594528465750045e-06
, O 0 3.6558345239967593e-10
the O 0 1.3920622987662057e-10
majority O 0 2.319396064098811e-11
of O 0 1.4528264702384774e-10
families O 0 8.871887599570805e-12
with O 0 3.1868362115883286e-12
male B-Disease 0 1.5109807849356116e-09
and I-Disease 0 2.1816665141116687e-10
female I-Disease 0 4.750190907287788e-09
breast I-Disease 0 0.0007687422330491245
cancer I-Disease 1 0.674441397190094
were O 0 3.2987138354201306e-08
due O 0 5.328181487129768e-06
to O 0 2.656640276654798e-07
BRCA2 O 0 1.0111103847521008e-06
( O 0 2.501900242535271e-09
76 O 0 8.293342830256734e-07
% O 0 1.4634576217531503e-08
) O 0 4.1547892903892603e-10
. O 0 1.6438537642216033e-08

The O 0 5.343536813029459e-08
largest O 0 1.3821424893478707e-08
proportion O 0 5.454954266070899e-10
( O 0 1.175580813250754e-11
67 O 0 4.394188568568325e-09
% O 0 1.9110307780678681e-10
) O 0 1.2346250324174468e-12
of O 0 9.091590674747962e-11
families O 0 1.9067625950386358e-11
due O 0 1.9559111663625117e-08
to O 0 1.0367214864359653e-09
other O 0 8.228930557796499e-12
genes O 0 1.4761773400873146e-11
was O 0 4.7271925956993144e-11
found O 0 6.792986854443905e-13
in O 0 3.252876483797462e-13
families O 0 2.0696230916116692e-13
with O 0 6.069871981342206e-14
four O 0 3.0791994388296162e-12
or O 0 3.3128264020909626e-11
five O 0 6.0975881462088655e-12
cases O 0 9.819929591703414e-12
of O 0 1.1455538739824078e-09
female O 0 1.6259043000843576e-09
breast B-Disease 0 0.00012384132423903793
cancer I-Disease 0 0.3478164076805115
only O 0 1.5999934532828775e-07
. O 0 5.025162863603327e-07

These O 0 8.023814501711968e-09
estimates O 0 2.170627944053649e-08
were O 0 1.9542573115316486e-10
not O 0 4.055770996824748e-11
substantially O 0 5.440967676406672e-10
affected O 0 3.591021924265192e-11
either O 0 1.851301056898791e-11
by O 0 4.7334605852988876e-12
changing O 0 1.9869111911319237e-10
the O 0 2.256687718638073e-11
assumed O 0 1.342814887062005e-10
penetrance O 0 1.9754274604988353e-10
model O 0 1.276034659880576e-11
for O 0 2.777966225109285e-11
BRCA1 O 0 2.3448325503494516e-09
or O 0 5.5550768846002185e-11
by O 0 7.114839099819914e-12
including O 0 9.96679128117961e-12
or O 0 1.71864722453563e-09
excluding O 0 1.5875807335419267e-08
BRCA1 O 0 3.4761018241624697e-07
mutation O 0 1.0919062987113648e-07
data O 0 1.5130435571109047e-08
. O 0 2.1425506702144048e-08

Among O 0 1.3115064589896974e-09
those O 0 1.003198565885377e-10
families O 0 1.1312336484214924e-10
with O 0 9.502424541674159e-11
disease O 0 0.0005166964256204665
due O 0 1.9648534362204373e-05
to O 0 1.5495618299610214e-07
BRCA1 O 0 6.018198916990514e-08
that O 0 2.373286289714116e-10
were O 0 3.7059601915023777e-11
tested O 0 9.381186799606311e-12
by O 0 1.6340658210226011e-12
one O 0 1.649586370278122e-11
of O 0 2.0689344334967608e-11
the O 0 3.489216728047584e-12
standard O 0 1.882159358923552e-11
screening O 0 1.6435909924727987e-11
methods O 0 2.5152482874268856e-10
, O 0 1.4651982752078574e-11
mutations O 0 1.1656173803942238e-09
were O 0 5.400005997913127e-10
detected O 0 3.6985492446461876e-09
in O 0 2.3651419364667525e-11
the O 0 1.7594958476307987e-11
coding O 0 1.0924797871902925e-10
sequence O 0 3.216368837932748e-11
or O 0 9.368883273352946e-12
splice O 0 8.178399069080911e-10
sites O 0 2.2306562846852174e-11
in O 0 1.2392965343180351e-12
an O 0 1.40838415148975e-12
estimated O 0 1.0377972786690393e-10
63 O 0 1.9843786613904513e-09
% O 0 2.2038916525080054e-10
( O 0 3.8914947653179155e-11
95 O 0 5.5352963101995556e-08
% O 0 1.7874929980621346e-08
CI O 0 7.845467280276353e-07
51 O 0 8.942013351997957e-09
% O 0 7.052909922755646e-10
- O 0 1.657434856028317e-09
77 O 0 4.169032674639084e-09
% O 0 8.590789746243388e-10
) O 0 8.857808236895082e-11
. O 0 7.860084139110768e-09

The O 0 5.084261900378806e-08
estimated O 0 1.2699518769920815e-08
sensitivity O 0 9.733902572861552e-09
was O 0 2.4641408913339546e-09
identical O 0 1.348028546427349e-11
for O 0 4.9146940857280885e-12
direct O 0 5.382576606649536e-10
sequencing O 0 1.1653217280027661e-09
and O 0 5.6828645955686596e-11
other O 0 2.668233863023506e-11
techniques O 0 5.734054564499047e-09
. O 0 1.2633468493561395e-08

The O 0 1.6543380354505643e-07
penetrance O 0 5.9920544117630925e-06
of O 0 6.034485977579607e-07
BRCA2 O 0 1.0604471754049882e-06
was O 0 9.367039588425996e-09
estimated O 0 1.0747077533457272e-10
by O 0 4.35309774338144e-12
maximizing O 0 3.85147602699476e-09
the O 0 7.398269774583355e-10
LOD O 0 2.4317720090039074e-05
score O 0 1.7867354262790514e-09
in O 0 5.6622210392598404e-11
BRCA2 O 0 7.152048731029481e-09
- O 0 5.592781349150755e-09
mutation O 0 3.976146523143598e-09
families O 0 4.114669716059893e-11
, O 0 5.100695907311881e-12
over O 0 1.3940817944479988e-10
all O 0 5.700930005847482e-11
possible O 0 1.1379042597070566e-08
penetrance O 0 1.3214566934038885e-06
functions O 0 1.3932325515497723e-08
. O 0 1.784556502570922e-08

The O 0 5.088110821560576e-09
estimated O 0 2.042306990190923e-09
cumulative O 0 1.794742310323727e-08
risk O 0 3.438871587491121e-08
of O 0 2.5861844221708452e-08
breast B-Disease 0 0.0005953778745606542
cancer I-Disease 0 6.195434980327263e-05
reached O 0 3.299631543995929e-06
28 O 0 2.5784697754716035e-07
% O 0 1.1829618395964303e-09
( O 0 9.440779755176543e-12
95 O 0 6.938775776177408e-09
% O 0 1.9396901862478444e-09
CI O 0 6.654934026073533e-08
9 O 0 1.750920630705366e-09
% O 0 6.160507520780456e-11
- O 0 7.933033396856359e-11
44 O 0 1.0278373291372489e-10
% O 0 5.029419155450077e-12
) O 0 2.4440913770390656e-14
by O 0 5.165407489758633e-13
age O 0 6.095280391527069e-10
50 O 0 2.9650493171828884e-10
years O 0 7.221800935042211e-11
and O 0 1.2173499187861925e-11
84 O 0 3.208198595672229e-09
% O 0 3.249817914774411e-10
( O 0 2.4305715426442553e-11
95 O 0 1.642625235831474e-08
% O 0 5.47230838421342e-09
CI O 0 3.0790093319410516e-07
43 O 0 3.560579830974575e-09
% O 0 5.30139890320136e-11
- O 0 4.4570534762922165e-11
95 O 0 2.0683436907642516e-10
% O 0 2.6574716385785457e-11
) O 0 2.6066900916422997e-13
by O 0 4.50179477029522e-12
age O 0 6.491379433981592e-09
70 O 0 8.89689655281245e-09
years O 0 6.576145406000933e-09
. O 0 1.4895747746379584e-08

The O 0 5.288147804094478e-07
corresponding O 1 0.9959748387336731
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.999057948589325
were O 0 1.2018715267458902e-07
0 O 0 9.674160139638843e-08
. O 0 6.573411592825096e-09

4 O 0 5.3654102885047905e-06
% O 0 9.492130459420878e-08
( O 0 7.222065723233584e-10
95 O 0 1.4164884021283797e-07
% O 0 1.8475683205565474e-08
CI O 0 5.86316048156732e-07
0 O 0 2.254169295667907e-09
% O 0 1.4435262707390706e-10
- O 0 8.486911173832823e-11
1 O 0 1.5402444875078913e-09
% O 0 1.6482057038635922e-11
) O 0 3.000423463828637e-14
by O 0 5.55301572953415e-13
age O 0 4.252636021107037e-10
50 O 0 1.529388837795409e-10
years O 0 1.6316436049490513e-11
and O 0 2.33934334577246e-12
27 O 0 8.059686251726816e-10
% O 0 1.6941001379500165e-10
( O 0 1.716774812587918e-11
95 O 0 5.295916594150185e-09
% O 0 1.1513739961444003e-09
CI O 0 4.4799786991234214e-08
0 O 0 4.4449241509703086e-10
% O 0 4.378673118532461e-11
- O 0 8.248954991296742e-11
47 O 0 2.0850192405941215e-10
% O 0 7.024911034825276e-12
) O 0 4.793264242008814e-14
by O 0 2.510907931227435e-12
age O 0 4.706738554460799e-09
70 O 0 2.333250925801167e-09
years O 0 4.335405812128101e-09
. O 0 1.1293354695851576e-08

The O 0 1.5990469393045714e-08
lifetime O 0 1.4679787341265182e-07
risk O 0 1.2367555655146134e-06
of O 0 1.9317881196911912e-06
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 1.4352997013133972e-08
similar O 0 7.764563297874005e-11
to O 0 1.942555671874402e-09
the O 0 1.1043087555506759e-09
risk O 0 4.419800969657217e-09
in O 0 6.511212402582345e-11
BRCA1 O 0 2.007938260106812e-09
carriers O 0 1.8713855465257723e-10
, O 0 2.613632921200093e-11
but O 0 1.9188314132057016e-11
there O 0 2.5235267001044726e-11
was O 0 2.0518679810788143e-10
some O 0 2.2825727310875343e-13
suggestion O 0 1.2988075892561568e-10
of O 0 7.101068344450567e-11
a O 0 1.314593850443302e-10
lower O 0 1.5049847590375975e-08
risk O 0 3.5594525105153707e-09
in O 0 6.195363666527953e-11
BRCA2 O 0 1.4818322124909855e-09
carriers O 0 6.076832093082629e-11
< O 0 1.0401132755077924e-07
50 O 0 1.321371789764214e-09
years O 0 1.393135468097384e-10
of O 0 1.09376820101037e-10
age O 0 1.527448922900021e-08
. O 0 5.505338407374438e-09

Eye B-Disease 1 0.9997333884239197
movement I-Disease 0 2.830373887263704e-06
abnormalities I-Disease 0 1.9948854514950654e-06
correlate O 0 1.5765779792786816e-09
with O 0 1.9099283786461196e-12
genotype O 0 3.9335592560973964e-08
in O 0 1.0233659475389345e-09
autosomal O 1 0.9909413456916809
dominant O 1 0.9998193383216858
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 2.708802412598743e-06

We O 0 3.3922992770385463e-07
compared O 0 7.13978423050321e-08
horizontal O 0 7.168423962866655e-06
eye O 0 4.553435792331584e-05
movements O 0 4.048589374860967e-08
( O 0 7.641375310285525e-10
visually O 0 5.382935763798002e-10
guided O 0 1.2975157615002786e-09
saccades O 0 2.26900993993695e-07
, O 0 2.0357411589788654e-10
antisaccades O 0 2.0805508427201858e-07
, O 0 9.159908942457662e-11
and O 0 2.680455683801153e-11
smooth O 0 1.1464085236667643e-09
pursuit O 0 5.635066191445048e-09
) O 0 1.78607927059371e-11
in O 0 4.810820838918595e-11
control O 0 1.2602463517197293e-09
subjects O 0 3.070452225806264e-10
( O 0 6.74296903035998e-12
n O 0 8.710244747689444e-10
= O 0 4.418121146709808e-10
14 O 0 2.7144236858234194e-10
) O 0 7.673597542980082e-13
and O 0 6.206356500775001e-13
patients O 0 7.387485263278537e-13
with O 0 1.70239544710531e-14
three O 0 3.235933385397488e-13
forms O 0 2.300108888075858e-11
of O 0 1.2122768344724477e-09
autosomal O 0 8.23743685032241e-05
dominant O 0 0.00016602737014181912
cerebellar B-Disease 1 0.9999998807907104
ataxias I-Disease 1 0.994306743144989
type I-Disease 1 0.9682599306106567
I I-Disease 0 0.015550842508673668
spinocerebellar B-Disease 0 7.053628360154107e-05
ataxias I-Disease 0 6.430655048461631e-06
1 I-Disease 0 8.2386662825229e-07
and I-Disease 0 3.12123299428535e-10
2 I-Disease 0 6.813480268874628e-08
( O 0 6.001286134704742e-10
SCA1 B-Disease 0 0.00035311171086505055
, O 0 1.2925582826284199e-09
n O 0 7.926931111512658e-09
= O 0 4.1120924443305285e-09
11 O 0 6.801670893175071e-10
; O 0 5.045044243479069e-11
SCA2 B-Disease 0 8.648256880405825e-06
, O 0 2.6963631327703297e-10
n O 0 2.553314448761057e-09
= O 0 2.303887081112066e-09
10 O 0 4.14069167842257e-10
) O 0 5.4820887412931896e-12
and O 0 2.316664776680355e-10
SCA3 B-Disease 1 1.0
/ O 0 0.00024643601500429213
Machado B-Disease 0 4.5191475805950176e-07
- I-Disease 0 3.66853676325718e-08
Joseph I-Disease 0 3.9522896599919477e-07
disease I-Disease 0 3.971449132222915e-06
( O 0 9.865709360568076e-10
MJD B-Disease 1 1.0
) O 0 3.4607416932175283e-09
( O 0 6.749872882849672e-10
n O 0 8.296271403196442e-08
= O 0 3.422826111432187e-08
16 O 0 1.4513822144124333e-08
) O 0 5.252707158120984e-10
. O 0 1.1173904468364526e-08

In O 0 5.976401098450879e-07
SCA1 B-Disease 0 0.26188352704048157
, O 0 5.775203870683754e-09
saccade O 0 1.8613670249578718e-07
amplitude O 0 1.3110345697953107e-08
was O 0 3.59654833692602e-10
significantly O 0 8.355366398760111e-11
increased O 0 9.039751586170652e-11
, O 0 8.492638883805803e-12
resulting O 0 8.192012068697352e-10
in O 0 1.5437680023211442e-09
hypermetria B-Disease 0 8.05552554083988e-06
. O 0 2.734016391059413e-07

The O 0 1.3422456390799198e-07
smooth O 0 6.969963095571075e-08
pursuit O 0 3.242645618684037e-07
gain O 0 2.8630446990973724e-07
was O 0 2.1483619150330924e-07
decreased O 0 1.8611646623867273e-07
. O 0 2.3909539237365607e-08

In O 0 1.1700929007929517e-06
SCA2 B-Disease 0 0.0036903484724462032
, O 0 1.8548806934859385e-08
saccade O 0 8.220959557547758e-07
velocity O 0 8.469893373330706e-07
was O 0 2.6754440440868166e-08
markedly O 0 1.356087437898168e-07
decreased O 0 1.9294706987693644e-07
. O 0 1.49268615246001e-08

The O 0 1.7730998536080733e-07
percentage O 0 6.043205758032855e-07
of O 0 2.7083446596520844e-08
errors O 0 4.924551831209101e-05
in O 0 5.164396199575094e-08
antisaccades O 0 0.08261512964963913
was O 0 9.156462965620449e-08
greatly O 0 2.730088655145124e-10
increased O 0 2.2268525912139125e-10
and O 0 3.622188920332503e-12
was O 0 8.391492362092023e-11
significantly O 0 1.0493612923045958e-11
correlated O 0 1.3603048375221416e-11
with O 0 3.4216555912409963e-13
age O 0 3.6986760321156e-09
at O 0 1.6151764370420096e-08
disease O 0 9.429124361304275e-07
onset O 0 6.952873809495941e-05
. O 0 2.0855888749338192e-07

In O 0 2.442500424137961e-08
addition O 0 9.842591186526306e-10
, O 0 2.1404202021901853e-10
a O 0 4.3468795229983925e-10
correlation O 0 1.2438545748949537e-09
between O 0 6.559556231522379e-10
smooth O 0 3.7096412608406126e-09
pursuit O 0 8.903007220339987e-09
gain O 0 7.717206429447288e-09
and O 0 9.380434796979475e-12
the O 0 3.957167232782055e-11
number O 0 9.292645819503065e-11
of O 0 9.737852746383169e-10
trinucleotide O 0 7.345688004534168e-07
repeats O 0 1.2802785498422509e-08
was O 0 1.3656284991725443e-08
found O 0 1.869149945932236e-09
. O 0 3.5531038111713542e-09

In O 0 5.046205842518248e-06
SCA3 B-Disease 1 1.0
, O 0 9.82528490567347e-07
gaze B-Disease 0 0.00016068165132310241
- I-Disease 0 2.6078859605149773e-07
evoked I-Disease 0 2.5171848605509695e-08
nystagmus I-Disease 0 7.065518730087206e-07
was O 0 3.87055010264703e-09
often O 0 7.734892587540898e-12
present O 0 1.2919679215350754e-11
as O 0 5.532097783339518e-12
was O 0 4.963175426198063e-10
saccade O 0 2.8330312318303186e-08
hypometria O 0 9.592413618975115e-08
and O 0 1.807944211007495e-10
smooth O 0 1.2712242813961439e-08
pursuit O 0 7.06643561443343e-08
gain O 0 1.910278939476484e-07
was O 0 9.357649588537242e-08
markedly O 0 1.0354774815368728e-07
decreased O 0 1.8507007837342826e-07
. O 0 1.3398278930765173e-08

Three O 0 7.820723624263337e-09
major O 0 1.6814858838642976e-08
criteria O 0 4.885338711346776e-08
, O 0 8.048744309929745e-11
saccade O 0 5.3723866244581586e-08
amplitude O 0 8.419172026208344e-09
, O 0 2.8412737440586255e-11
saccade O 0 1.746105660060948e-08
velocity O 0 2.3796306436452141e-07
, O 0 7.242698801812608e-11
and O 0 2.3343436558742603e-11
presence O 0 3.5244562823777414e-10
of O 0 6.674355734759274e-09
gaze B-Disease 0 2.124755837940029e-06
- I-Disease 0 1.7806160101940804e-08
evoked I-Disease 0 3.6124039315410528e-09
nystagmus I-Disease 0 6.4455085713177596e-09
, O 0 1.4824686617176397e-12
permitted O 0 8.145946590876196e-12
the O 0 1.9844891788883823e-12
correct O 0 7.228980608564584e-11
assignment O 0 3.481839122576602e-11
of O 0 6.432553708440869e-12
90 O 0 1.9430586306601327e-10
% O 0 6.693012116754105e-11
of O 0 3.78795848854363e-11
the O 0 1.16776865954904e-10
SCA1 B-Disease 0 1.0701488463382702e-05
, O 0 6.364045401774376e-11
90 O 0 1.7338521729470813e-09
% O 0 1.6003084968296832e-10
of O 0 4.489466784440843e-11
the O 0 1.3268768028762423e-10
SCA2 B-Disease 0 7.5515172284212895e-06
, O 0 2.830698869749071e-11
and O 0 7.71691564815935e-12
93 O 0 1.969896606945909e-10
% O 0 6.977814853703634e-11
of O 0 3.652173702350936e-11
the O 0 5.38698981256136e-11
patients O 0 8.504866255698573e-11
with O 0 8.742392226812612e-12
SCA3 B-Disease 1 1.0
to O 0 7.169096249981521e-08
their O 0 4.528580635487778e-11
genetically O 0 6.387686213304988e-11
confirmed O 0 6.80984879597446e-10
patient O 0 1.8481992825059024e-08
group O 0 4.232113270941085e-11
and O 0 5.2298311514764606e-11
, O 0 1.7428564147436987e-10
therefore O 0 8.151635455533324e-08
, O 0 9.183232507758987e-10
may O 0 9.536245215713279e-08
help O 0 8.164312781389071e-09
orient O 0 3.0242449611250777e-06
diagnoses O 0 3.144211007111153e-07
of O 0 5.4576759112023865e-08
SCA1 B-Disease 0 0.03040453977882862
, O 0 7.473779373157186e-10
SCA2 B-Disease 0 0.0006430675275623798
, O 0 4.303544187678199e-10
and O 0 2.2498052310027106e-09
SCA3 B-Disease 1 1.0
at O 0 4.892122547062172e-07
early O 0 1.0415144302555746e-08
clinical O 0 3.5782332652445348e-09
stages O 0 1.8259564527056682e-08
of O 0 1.6995544971365462e-09
the O 0 1.0421820739736631e-08
diseases O 0 8.477694791508839e-06
. O 0 5.774036360151058e-09
. O 0 2.9920489197365896e-08

Genetic O 0 9.271149536971279e-08
basis O 0 3.0223896718695187e-09
and O 0 2.0715802337423206e-11
molecular O 0 1.1516090303587134e-09
mechanism O 0 1.981883102075699e-08
for O 0 5.184886120446208e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9997228980064392

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 1 0.9998350143432617
more O 0 1.0949543494120917e-09
than O 0 6.458845125401069e-10
300 O 0 2.667456810989677e-10
, O 0 1.3579069292612989e-11
000 O 0 1.202929977850431e-09
sudden O 0 2.674855892337291e-09
deaths O 0 2.980540259045483e-10
each O 0 9.110959382774286e-12
year O 0 3.5938807485536017e-10
in O 0 1.6247067580188457e-10
the O 0 2.2237680585845965e-09
USA O 0 4.5705693452191554e-08
alone O 0 2.698465095818392e-08
. O 0 3.240957369143871e-08

In O 0 1.3273870891339357e-08
approximately O 0 1.1355362206089126e-09
5 O 0 3.2575895314579384e-09
- O 0 1.4192375052957118e-09
12 O 0 2.237147800343564e-09
% O 0 3.583770502579853e-10
of O 0 7.986348561639378e-12
these O 0 4.530528242060322e-13
cases O 0 9.838132912498576e-12
, O 0 1.4873912648413756e-12
there O 0 3.070285345407875e-12
are O 0 4.236728426854769e-13
no O 0 3.546018340072621e-11
demonstrable O 0 6.987852998463495e-07
cardiac O 0 0.00017935172945726663
or O 0 1.3906253926165846e-08
non O 0 0.020576156675815582
- O 0 0.0008821124210953712
cardiac O 1 0.9999997615814209
causes O 0 1.9851505328460917e-07
to O 0 2.9551575075892345e-10
account O 0 3.436104265702733e-12
for O 0 6.042732720451527e-12
the O 0 7.288736281196861e-11
episode O 0 1.0195002481117044e-10
, O 0 6.413118191876677e-14
which O 0 3.892268180937658e-14
is O 0 8.364154231417856e-14
therefore O 0 4.8111024712749195e-12
classified O 0 1.8046332483923067e-10
as O 0 5.624531951298195e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 4.238805195200257e-05
IVF B-Disease 1 1.0
) O 0 1.27242021363827e-08
. O 0 4.703491995883269e-08

A O 0 4.0652497546034283e-07
distinct O 0 1.597710741485514e-09
group O 0 2.9823826741548487e-10
of O 0 4.119348062658901e-08
IVF B-Disease 1 1.0
patients O 0 4.8853289627004415e-06
has O 0 6.331573459972262e-11
been O 0 1.4535188157249745e-11
found O 0 6.630844961649784e-13
to O 0 1.2742779921526282e-12
present O 0 1.1006564583360134e-12
with O 0 1.6345450925929483e-13
a O 0 1.4590748054210678e-10
characteristic O 0 5.518837387086251e-09
electrocardiographic O 0 2.377494411121006e-06
pattern O 0 3.826790816674475e-06
. O 0 1.4936436798507202e-07

Because O 0 4.3025968921028834e-07
of O 0 5.262900870661724e-08
the O 0 7.81672337968331e-10
small O 0 2.6023509736017303e-11
size O 0 1.735247362466552e-10
of O 0 2.9026686609867625e-10
most O 0 1.542636331175462e-11
pedigrees O 0 1.3904304096978848e-10
and O 0 9.157405736481827e-12
the O 0 3.645826349152337e-11
high O 0 2.8315709776904896e-09
incidence O 0 7.346921506723447e-07
of O 0 6.0023301884370994e-09
sudden B-Disease 0 4.6983547008494497e-07
death I-Disease 0 4.619319611265382e-07
, O 0 8.317142113911657e-11
however O 0 3.126702785571922e-10
, O 0 6.059667351232534e-11
molecular O 0 1.7993962986295742e-09
genetic O 0 9.505312092983331e-10
studies O 0 1.2763858026065833e-10
of O 0 1.0805641936784127e-09
IVF B-Disease 1 1.0
have O 0 1.09833406258808e-10
not O 0 5.111879669561503e-11
yet O 0 1.0487535145875526e-10
been O 0 7.565105486495582e-11
done O 0 2.395662279663924e-10
. O 0 3.023277628244614e-09

Because O 0 8.279053872684017e-06
IVF B-Disease 1 1.0
causes O 1 0.9999985694885254
cardiac O 1 1.0
rhythm O 1 0.9999972581863403
disturbance O 1 0.9988740086555481
, O 0 1.745555477938865e-09
we O 0 1.612583844234905e-09
investigated O 0 7.473298424542918e-09
whether O 0 3.5365048667301835e-09
malfunction O 0 1.859945314208744e-06
of O 0 3.6746541920429365e-10
ion O 0 8.425114828014557e-09
channels O 0 3.7730218949150185e-09
could O 0 1.0233620617583483e-09
cause O 0 4.264905939521668e-08
the O 0 6.606969416012021e-10
disorder O 0 4.25555901628627e-09
by O 0 7.308221736113119e-12
studying O 0 1.2937366455911814e-10
mutations O 0 3.190403219388571e-10
in O 0 9.535722211850839e-11
the O 0 8.775864479559914e-10
cardiac O 0 4.146749432720753e-08
sodium O 0 2.091677231419453e-08
channel O 0 1.7909181337927293e-07
gene O 0 3.0396133610111065e-08
SCN5A O 0 5.4157560953171924e-05
. O 0 1.0211168444129726e-07

We O 0 3.5050965152549907e-07
have O 0 1.262328991336048e-10
now O 0 6.015642151080414e-11
identified O 0 6.604824326350567e-11
a O 0 9.57143808655303e-11
missense O 0 5.390790747128449e-08
mutation O 0 1.354081202720181e-08
, O 0 1.6895752158463395e-11
a O 0 4.54993091814071e-11
splice O 0 3.614195609458193e-09
- O 0 1.0303267128364269e-09
donor O 0 6.205623126476212e-09
mutation O 0 9.373029996595506e-08
, O 0 8.212940744156683e-11
and O 0 3.4144811977832035e-11
a O 0 6.754135029041208e-10
frameshift O 0 4.5036463802716753e-07
mutation O 0 7.325370088295813e-09
in O 0 4.0488227354140705e-11
the O 0 1.946050785794906e-11
coding O 0 7.20151493993626e-10
region O 0 7.563324189163723e-09
of O 0 4.463430069989727e-09
SCN5A O 0 0.0002576455590315163
in O 0 2.296779211263811e-09
three O 0 2.613605776247141e-09
IVF B-Disease 1 1.0
families O 0 1.4217625965429193e-09
. O 0 1.1845972203161637e-08

We O 0 1.4279602567057736e-07
show O 0 3.518250135670087e-10
that O 0 4.899475356673344e-12
sodium O 0 6.096289445478575e-11
channels O 0 4.8808977692882394e-11
with O 0 9.37697727625142e-13
the O 0 1.0816132017810176e-10
missense O 0 3.128710943656188e-07
mutation O 0 9.143303714154172e-08
recover O 0 4.358157568162824e-08
from O 0 8.97218022100077e-10
inactivation O 0 4.057402804846788e-07
more O 0 5.339176149810054e-12
rapidly O 0 4.4944187260753665e-11
than O 0 4.3986346683067e-12
normal O 0 2.6569002553600285e-10
and O 0 1.2391877888401348e-12
that O 0 1.6247981692724123e-12
the O 0 4.194215807995505e-11
frameshift O 0 1.382361887181105e-07
mutation O 0 1.3457520431359171e-08
causes O 0 1.6214756204391279e-09
the O 0 6.27669513586504e-11
sodium O 0 5.661886237628977e-11
channel O 0 1.9526515127044064e-10
to O 0 7.75139327724439e-11
be O 0 5.344693576603277e-10
non O 0 5.2020133978203376e-08
- O 0 4.557233523883042e-08
functional O 0 3.641058299308497e-07
. O 0 4.086636096189977e-08

Our O 0 1.7291542064867826e-07
results O 0 4.265579001128117e-09
indicate O 0 4.741708803379652e-09
that O 0 2.763761441926249e-10
mutations O 0 2.0785082543994804e-09
in O 0 2.939574417215596e-10
cardiac O 0 5.963670446362812e-08
ion O 0 1.293929727808063e-07
- O 0 2.1212109402313217e-08
channel O 0 3.3163576329542366e-09
genes O 0 3.779399709857856e-11
contribute O 0 6.333382169404489e-12
to O 0 5.959155911783309e-12
the O 0 7.316841577065247e-12
risk O 0 1.751564449037346e-10
of O 0 2.09145978313785e-10
developing O 0 4.555686317075924e-08
IVF B-Disease 1 1.0
. O 0 7.6542594484863e-09
. O 0 1.950531647310072e-08

Molecular O 0 2.6562929633655585e-06
heterogeneity O 0 2.6637892460712465e-06
in O 0 4.8380903727718305e-09
mucopolysaccharidosis B-Disease 0 0.022797096520662308
IVA I-Disease 1 1.0
in O 0 5.429362914810554e-08
Australia O 0 1.1180416314982011e-10
and O 0 1.0037722389388826e-11
Northern O 0 3.728438890959751e-09
Ireland O 0 1.3815645294457113e-09
: O 0 2.6225814922509194e-11
nine O 0 1.5387698060198574e-10
novel O 0 6.055577567165571e-11
mutations O 0 1.749063810452256e-10
including O 0 1.1192146168181871e-11
T312S O 0 3.5248071981186513e-06
, O 0 1.3981766265602769e-11
a O 0 1.571478537576443e-11
common O 0 9.122579081033422e-11
allele O 0 1.940437588388022e-09
that O 0 2.6164358873925764e-11
confers O 0 3.995738406814553e-09
a O 0 2.67325939162788e-09
mild O 0 3.0975722893344937e-06
phenotype O 0 6.098982703406364e-05
. O 0 9.762593435880262e-07

Mucopolysaccharidosis B-Disease 1 0.9465663433074951
IVA I-Disease 1 1.0
( O 0 3.572279183572391e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 8.412971430615812e-10
is O 0 1.7246819250527068e-10
an O 0 2.635469897871445e-10
autosomal B-Disease 1 0.9999910593032837
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9988085031509399
by O 0 1.5677857900797676e-09
a O 0 1.2777118172380142e-06
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.2230771950783037e-08
N O 0 3.1796693633623363e-07
- O 0 1.8108346822032217e-08
acetylgalactosamine O 0 4.3597751187007816e-07
- O 0 1.0971127295533734e-07
6 O 0 2.1387008075635094e-07
- O 0 1.6907511835029254e-08
sulfate O 0 7.519872724515153e-08
sulfatase O 0 6.810464583395515e-07
( O 0 4.925218011209154e-10
GALNS O 0 2.3166987375589088e-05
) O 0 6.925920392752971e-10
. O 0 7.2077299684281115e-09

Previous O 0 4.4498058571207366e-08
studies O 0 6.768166027626421e-10
of O 0 3.549613381004235e-10
patients O 0 5.4509993741014284e-11
from O 0 8.0681685291073e-12
a O 0 9.24413236930155e-12
British O 0 5.896094029678167e-11
- O 0 6.538845020997996e-10
Irish O 0 1.8961951453455583e-10
population O 0 2.2345855634625655e-12
showed O 0 6.491439872614857e-13
that O 0 1.3699191249699066e-13
the O 0 1.4123122810127953e-11
I113F O 0 1.3150797428806982e-07
mutation O 0 1.9817507634911635e-08
is O 0 2.1491695575970304e-11
the O 0 2.8821927483546617e-12
most O 0 4.0030434885927543e-14
common O 0 8.492473217713847e-13
single O 0 4.221404909660054e-12
mutation O 0 4.3582112918549853e-10
among O 0 5.042600711990808e-11
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.629665575819672e-07
and O 0 5.399303226738539e-11
produces O 0 1.600812260527107e-10
a O 0 1.4557063332532039e-09
severe O 0 5.519994829228381e-06
clinical O 0 6.29373346328066e-07
phenotype O 0 3.3984686069743475e-06
. O 0 3.014170246729009e-08

We O 0 4.2734967564683757e-07
studied O 0 6.644280858836282e-08
mutations O 0 5.306280748129666e-09
in O 0 7.554550734978349e-11
the O 0 2.0926767263507173e-10
GALNS O 0 2.5147385258605937e-06
gene O 0 1.274403221840359e-10
from O 0 3.6954640736386324e-11
23 O 0 1.6589711548942176e-10
additional O 0 2.325958314841614e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.2799596877121076e-07
( O 0 8.976385607040172e-11
15 O 0 3.4685989636074055e-09
from O 0 1.3619748384652297e-10
Australia O 0 2.8311944802461575e-12
, O 0 3.1288456526189223e-13
8 O 0 3.6613455323131205e-11
from O 0 9.019871655135958e-12
Northern O 0 3.357727151875878e-10
Ireland O 0 2.4067364767788035e-10
) O 0 6.771877763406264e-12
, O 0 1.6642652967552296e-12
with O 0 4.43407619378066e-14
various O 0 2.236640777100729e-12
clinical O 0 3.6474365749938897e-09
phenotypes O 0 7.399645340910865e-08
( O 0 1.313286257520474e-09
severe O 1 0.9997434020042419
, O 0 5.994227336714175e-10
16 O 0 5.589803064864896e-10
cases O 0 1.0250410763246176e-11
; O 0 5.026177824635214e-12
intermediate O 0 2.079611682859195e-08
, O 0 1.9436358772439988e-11
4 O 0 5.150670556730574e-09
cases O 0 3.7143121911498156e-10
; O 0 3.4415123528752645e-10
mild O 0 5.4306128731695935e-06
, O 0 2.496794548889625e-09
3 O 0 1.020326436673713e-07
cases O 0 2.9628122177882688e-09
) O 0 9.337993711611148e-10
. O 0 3.2266413541037764e-08

We O 0 3.1466589689443936e-07
found O 0 8.371193738199167e-10
two O 0 1.3607693964690082e-11
common O 0 9.061087297146386e-11
mutations O 0 3.840434359414502e-10
that O 0 2.5812806753178208e-12
together O 0 8.85621057825775e-13
accounted O 0 2.677492082214794e-11
for O 0 1.9959455095641676e-12
32 O 0 1.0152626517268004e-09
% O 0 2.9848185034708763e-10
of O 0 1.1459882348630046e-10
the O 0 1.4731152409019899e-10
44 O 0 1.3149857869265702e-09
unrelated O 0 3.845228024879077e-10
alleles O 0 3.273969984007863e-10
in O 0 4.256334174002063e-11
these O 0 7.297569493136535e-11
patients O 0 7.330062112842484e-10
. O 0 1.286373407793917e-08

One O 0 2.1748880030258988e-08
is O 0 2.1133704508624618e-10
the O 0 8.378541749287649e-10
T312S O 0 1.2959850437255227e-06
mutation O 0 2.0768370134760517e-08
, O 0 1.2232666268818804e-11
a O 0 8.84198703837713e-12
novel O 0 4.851882437484356e-11
mutation O 0 1.9803769735204924e-10
found O 0 6.489933156855754e-12
exclusively O 0 1.0231698301110814e-11
in O 0 2.2241264385769455e-11
milder O 0 6.3337238316307776e-06
patients O 0 3.2595434618087893e-07
. O 0 3.5323682823218405e-07

The O 0 7.343390961978002e-08
other O 0 5.6890464561476506e-11
is O 0 2.063425125209406e-11
the O 0 1.6111926029460655e-11
previously O 0 1.809140164066303e-11
described O 0 8.115538796538146e-11
I113F O 0 1.177059445467421e-07
that O 0 8.445665174161565e-12
produces O 0 1.0137992528802542e-10
a O 0 1.933255777686327e-09
severe O 0 0.00012414991215337068
phenotype O 0 8.592678932473063e-05
. O 0 1.0706517059588805e-06

The O 0 6.707257966809266e-07
I113F O 0 9.016149124363437e-05
and O 0 1.1148102885272237e-08
T312S O 0 5.584151040238794e-06
mutations O 0 8.916925864355107e-09
accounted O 0 6.745303759991828e-10
for O 0 1.381634303493362e-11
8 O 0 1.92705629231682e-09
( O 0 1.7344689920428813e-11
18 O 0 7.135574797700883e-09
% O 0 1.979259395268329e-10
) O 0 1.7106320700233102e-12
and O 0 1.1913022651688365e-11
6 O 0 3.996202924128056e-09
( O 0 5.3587568410451425e-11
14 O 0 5.725519169885729e-09
% O 0 1.1203427768835539e-10
) O 0 1.0189276722707974e-12
of O 0 6.921902634404731e-11
44 O 0 4.563648070554649e-10
unrelated O 0 1.896954815450158e-10
alleles O 0 1.939404192796701e-10
, O 0 9.05386668414998e-11
respectively O 0 1.2377587843559468e-08
. O 0 2.579947278036343e-08

The O 0 5.479141123032605e-07
relatively O 0 2.870348936312439e-08
high O 0 7.262725887358101e-08
residual O 0 7.254291995195672e-05
GALNS O 1 0.9695790410041809
activity O 0 3.0284016361292743e-07
seen O 0 2.1461978860770614e-09
when O 0 7.782533645306344e-11
the O 0 1.1989118031685564e-10
T312S O 0 1.9528023642578773e-08
mutant O 0 6.299702426382225e-10
cDNA O 0 4.0280681012916375e-09
is O 0 2.78300976014334e-11
overexpressed O 0 5.748103770741864e-09
in O 0 1.461525171719824e-11
mutant O 0 1.409761613002658e-10
cells O 0 7.345072466913294e-12
provides O 0 7.481893522700428e-14
an O 0 1.1746539071294526e-13
explanation O 0 3.0255763172615247e-11
for O 0 1.0033416805721451e-11
the O 0 1.206504757211846e-10
mild O 0 3.518687208270421e-07
phenotype O 0 2.331167252123123e-06
in O 0 2.203279114709744e-09
patients O 0 2.1401140581911449e-10
with O 0 1.750170104328208e-12
this O 0 3.6061373331897073e-10
mutation O 0 7.166908488898116e-08
. O 0 3.3535702215203855e-08

The O 0 1.0301326902606434e-08
distribution O 0 1.9681625218481713e-09
and O 0 1.1530255916714083e-11
relative O 0 1.6079430009696694e-09
frequencies O 0 2.6306501421657913e-09
of O 0 4.744927228905738e-10
the O 0 3.501039735898104e-10
I113F O 0 1.5860908320064482e-07
and O 0 6.186545720154868e-10
T312S O 0 1.4647332591266604e-06
mutations O 0 2.685975442062727e-09
in O 0 1.8664011308677786e-11
Australia O 0 7.079639608928434e-13
corresponded O 0 6.897990425386302e-12
to O 0 3.0512665311066556e-11
those O 0 1.2637400674531118e-11
observed O 0 4.002623787968673e-10
in O 0 7.951632408076392e-12
Northern O 0 8.956244634816812e-10
Ireland O 0 4.776025686048513e-10
and O 0 3.5841038470429964e-11
are O 0 2.415637785288527e-12
unique O 0 1.9885659958973623e-12
to O 0 8.436298881697724e-11
these O 0 6.791876522999063e-12
two O 0 1.0163389227435538e-11
populations O 0 1.5283907819907405e-11
, O 0 2.153591974890512e-12
suggesting O 0 1.372232882879132e-10
that O 0 1.7559823387025553e-11
both O 0 4.614993109886001e-11
mutations O 0 2.2515653785859513e-09
were O 0 6.573730448877768e-11
probably O 0 1.641608654567861e-10
introduced O 0 7.964336655452708e-12
to O 0 3.9474801899475054e-11
Australia O 0 7.69308878753594e-13
by O 0 8.782130296418333e-13
Irish O 0 2.614252425647834e-10
migrants O 0 1.685661749073475e-10
during O 0 4.70179867262388e-11
the O 0 2.383901062663618e-11
19th O 0 2.409245469792154e-09
century O 0 8.044428057019104e-08
. O 0 5.7363223504580674e-08

Haplotype O 0 1.0478253898327239e-05
analysis O 0 5.5948113697468216e-08
using O 0 8.232145631836829e-09
6 O 0 3.7398513086372986e-07
RFLPs O 0 9.536888683214784e-07
provides O 0 2.363076748168602e-11
additional O 0 2.2600822255358644e-11
data O 0 2.258022588352837e-11
that O 0 1.9310529737748272e-12
the O 0 3.744941856620443e-11
I113F O 0 3.5460303138279414e-08
mutation O 0 1.1295239743525087e-10
originated O 0 2.691859105410921e-12
from O 0 5.215573632699755e-12
a O 0 2.1996992768946733e-11
common O 0 8.996422357077094e-11
ancestor O 0 1.8752427166646157e-08
. O 0 2.5224622390851437e-08

The O 0 1.4677044646305148e-07
other O 0 3.4774139123783243e-10
9 O 0 7.03976965610309e-09
novel O 0 3.4766114986872765e-10
mutations O 0 4.791155472361197e-09
identified O 0 2.7115362732921255e-10
in O 0 1.0378244270914383e-11
these O 0 4.356702932445389e-12
23 O 0 1.6199980246156542e-09
patients O 0 2.990002342939668e-11
were O 0 4.058106281568108e-12
each O 0 1.3795849228628865e-12
limited O 0 5.001581180469339e-12
to O 0 5.617268108992768e-11
a O 0 5.415994319690753e-10
single O 0 6.257336870874042e-09
family O 0 1.7460149992487572e-09
. O 0 1.7201204016714655e-08

These O 0 3.3998108772692603e-09
data O 0 3.248466773353442e-10
provide O 0 2.3895095971337987e-11
further O 0 1.1502145763619964e-10
evidence O 0 1.2277059924237221e-10
for O 0 8.411390507723215e-12
extensive O 0 6.159453502796453e-10
allelic O 0 2.7881835507059805e-08
heterogeneity O 0 1.3988166358558374e-07
in O 0 4.561109712142297e-09
MPS B-Disease 1 0.9999994039535522
IVA I-Disease 1 1.0
in O 0 1.5303613931649807e-09
British O 0 1.4351236865550732e-09
- O 0 1.7595658263758196e-08
Irish O 0 2.1975794517459235e-09
patients O 0 1.519184222864567e-10
and O 0 4.043835145212116e-12
provide O 0 7.29440639835044e-12
evidence O 0 6.115018491570368e-10
for O 0 1.7255735729193589e-10
their O 0 4.486384874713423e-11
transmission O 0 4.426168043192291e-10
to O 0 3.9680508878703336e-11
Australia O 0 2.2343456566268488e-13
by O 0 2.437556450088363e-13
British O 0 1.3907248963551666e-10
- O 0 5.5685758226786675e-09
Irish O 0 2.4607029747159004e-09
migrants O 0 1.4489253130633983e-09
. O 0 7.637888238543056e-11
. O 0 1.9696835273919078e-09

Identification O 0 4.3577255581794816e-08
of O 0 1.020454476474697e-08
constitutional O 0 2.147973873434239e-06
WT1 O 0 0.0040638935752213
mutations O 0 9.818747457757127e-06
, O 0 3.700622031033163e-10
in O 0 5.894632698622004e-11
patients O 0 2.5608926090825435e-10
with O 0 8.600356538046583e-12
isolated O 0 5.26954245287925e-05
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 4.494148608813475e-09
and O 0 2.6788918305875598e-11
analysis O 0 6.369862276534022e-11
of O 0 4.594390978773788e-10
genotype O 0 8.538231099919358e-08
/ O 0 2.691079998839996e-07
phenotype O 0 7.960475834067893e-09
correlations O 0 2.755856431946313e-09
by O 0 5.431858522003674e-12
use O 0 4.6898419175933626e-11
of O 0 2.0174655002147546e-10
a O 0 2.574085389284164e-10
computerized O 0 1.1611644090692153e-08
mutation O 0 5.386741008805984e-08
database O 0 2.548392252776921e-08
. O 0 2.8055424650119676e-08

Constitutional O 0 5.034472451370675e-06
mutations O 0 4.395138262225373e-07
of O 0 7.757586928391902e-08
the O 0 1.5379203688326015e-08
WT1 O 0 4.0391209950030316e-06
gene O 0 1.8923591582620247e-09
, O 0 2.415883118556117e-11
encoding O 0 2.2705004543155383e-10
a O 0 1.2176165853361454e-08
zinc O 0 4.721694324416603e-07
- O 0 6.291435283856117e-08
finger O 0 1.3561961509367393e-07
transcription O 0 1.7103329241763277e-07
factor O 0 2.458921422032745e-08
involved O 0 2.1913168501974667e-10
in O 0 2.742871207939146e-10
renal O 1 0.9999867677688599
and O 0 3.025552075541782e-08
gonadal O 1 0.9997298121452332
development O 0 0.000501323607750237
, O 0 5.568679406486865e-10
are O 0 1.7033886454131952e-11
found O 0 4.944247442018046e-11
in O 0 8.137901810756354e-12
most O 0 2.506854532985381e-12
patients O 0 3.4804496524404316e-12
with O 0 1.390649206033101e-12
Denys B-Disease 1 0.9999923706054688
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.9149642866977956e-06
DDS B-Disease 1 1.0
) O 0 2.1998274313261845e-09
, O 0 1.7646187289166448e-10
or O 0 1.0655305260343084e-07
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 2.430035976885847e-07
DMS B-Disease 0 0.00014281985932029784
) O 0 2.679423002915904e-11
associated O 0 2.642713547995612e-10
with O 0 3.156644390323038e-11
pseudohermaphroditism B-Disease 1 1.0
and O 0 9.677368097982253e-07
/ O 0 0.46224722266197205
or O 0 2.662345468706917e-05
Wilms B-Disease 1 0.9999992847442627
tumor I-Disease 1 0.9999936819076538
( O 0 4.431248967762258e-08
WT B-Disease 1 1.0
) O 0 2.535552212634684e-09
. O 0 2.2418859657591383e-08

Most O 0 2.0608558415347034e-08
mutations O 0 1.5421038312979363e-07
in O 0 3.55970541932038e-08
DDS B-Disease 1 1.0
patients O 0 0.0009904135949909687
lie O 0 5.194914047024213e-05
in O 0 2.8928541784267736e-09
exon O 0 1.9990659794189014e-08
8 O 0 2.968051404650396e-08
or O 0 2.6579609624377554e-09
exon O 0 3.024467076784276e-08
9 O 0 1.9358994052254275e-07
, O 0 4.237745432345008e-10
encoding O 0 2.4452086577753107e-08
zinc O 0 1.0836114597623236e-05
finger O 0 7.45365468901582e-05
2 O 0 6.420647878258023e-06
or O 0 2.636546696521691e-07
zinc O 0 3.983614078606479e-06
finger O 0 2.1535302039410453e-06
3 O 0 2.1216284551428544e-07
, O 0 1.7338379343367905e-10
respectively O 0 1.1520022713540357e-09
, O 0 1.607763575051102e-11
with O 0 4.067001509872048e-12
a O 0 7.50744444388829e-09
hot O 0 6.617556209675968e-07
spot O 0 1.346408424751644e-07
( O 0 3.869448095272787e-10
R394W O 0 1.0080140100399149e-06
) O 0 1.5635116812351413e-10
in O 0 8.462911482709501e-10
exon O 0 4.344894577457126e-08
9 O 0 1.9255166705534066e-07
. O 0 2.4077307259062763e-08

We O 0 5.7692396637776255e-08
analyzed O 0 2.308285784735631e-09
a O 0 1.0146040257952293e-10
series O 0 1.462671303520402e-11
of O 0 2.5237385098408893e-11
24 O 0 1.885110734178852e-09
patients O 0 1.257647597174838e-10
, O 0 3.80063792937424e-11
10 O 0 5.6513944635128155e-09
with O 0 4.4419493083758255e-10
isolated B-Disease 0 0.0045172953978180885
DMS I-Disease 1 0.9999727010726929
( O 0 1.4713495488649642e-07
IDMS B-Disease 1 0.9003807306289673
) O 0 7.418857750352004e-10
, O 0 1.1375950181857775e-10
10 O 0 4.477838100314102e-10
with O 0 2.1751421844240504e-11
DDS B-Disease 1 1.0
, O 0 3.4508806923128077e-09
and O 0 1.7000365004626872e-10
4 O 0 1.1660092447129955e-08
with O 0 6.32991853377618e-11
urogenital B-Disease 0 0.00014248986553866416
abnormalities I-Disease 1 0.9999243021011353
and O 0 6.34614480077289e-07
/ O 0 0.07904094457626343
or O 0 0.13805389404296875
WT B-Disease 1 1.0
. O 0 7.56231713694433e-07

We O 0 2.973443713472079e-07
report O 0 3.931157621650527e-09
WT1 O 0 3.7178608636168065e-06
heterozygous O 0 6.163969334949115e-09
mutations O 0 6.3827236829183676e-09
in O 0 1.2437401109011148e-10
16 O 0 5.607414532704524e-09
patients O 0 3.3610206284784283e-10
, O 0 1.662473630981154e-11
4 O 0 1.1670216792936117e-08
of O 0 5.062245289622069e-09
whom O 0 1.7217903769406462e-09
presented O 0 4.8710258049311506e-09
with O 0 1.5354691962343736e-09
IDMS B-Disease 1 0.999640941619873
. O 0 4.031431672046892e-06

One O 0 1.0287409679676784e-07
male O 0 1.5384887808167491e-09
and O 0 2.3594647069469232e-11
two O 0 4.957817142936527e-11
female O 0 6.469966229438739e-10
IDMS B-Disease 0 0.00029335214640013874
patients O 0 9.977838999475352e-09
with O 0 8.871998691262206e-10
WT1 O 0 0.022965703159570694
mutations O 0 0.0030621939804404974
underwent O 0 0.023886188864707947
normal O 0 0.0006245967233553529
puberty O 0 0.0007363797631114721
. O 0 4.035236855770563e-08

Two O 0 4.918679863408215e-08
mutations O 0 1.1479084349730329e-07
associated O 0 3.5113740803893734e-09
with O 0 4.002957687543329e-11
IDMS B-Disease 1 0.9570930004119873
are O 0 2.966043383123562e-11
different O 0 1.8572136016581364e-12
from O 0 8.223553088493318e-11
those O 0 7.743764830758781e-12
described O 0 1.6551973680556387e-10
in O 0 1.3617782457231442e-09
DDS B-Disease 1 1.0
patients O 0 2.973456957988674e-06
. O 0 2.7542404268388054e-07

No O 0 2.5601345896575367e-06
WT1 O 0 5.3350315283751115e-05
mutations O 0 4.929076453663583e-07
were O 0 4.362854522099724e-09
detected O 0 1.2998993881296883e-08
in O 0 1.0798385102761543e-10
the O 0 6.830962462345269e-10
six O 0 1.0241002490474216e-09
other O 0 1.9752052771160322e-10
IDMS B-Disease 1 1.0
patients O 0 4.5803872694705206e-07
, O 0 1.242580621729772e-10
suggesting O 0 2.771332496820378e-09
genetic O 0 8.307799248541414e-08
heterogeneity O 0 3.40948247412598e-07
of O 0 1.1691581924822003e-08
this O 0 7.1000734180870495e-09
disease O 0 9.866792242974043e-05
. O 0 7.118354261592685e-08

We O 0 8.305254937113205e-07
analyzed O 0 1.4709806350765575e-07
genotype O 0 1.0702780173232895e-06
/ O 0 8.537788858120621e-07
phenotype O 0 1.9524373229273806e-08
correlations O 0 1.0588687260337792e-08
, O 0 3.971804656e-12
on O 0 1.4067472013656879e-11
the O 0 6.824075809638841e-13
basis O 0 1.7920371783719524e-11
of O 0 2.274282108125081e-12
the O 0 2.474480039274529e-12
constitution O 0 1.4928261751756544e-11
of O 0 1.6531054303214887e-10
a O 0 7.193635132018983e-10
WT1 O 0 3.806487995916541e-07
mutation O 0 3.4138203375277953e-09
database O 0 3.636549394947508e-10
of O 0 1.127662518918271e-09
84 O 0 2.8164691912024864e-08
germ O 0 2.0871555534540676e-05
- O 0 3.7947622786305146e-06
line O 0 5.629843599308515e-06
mutations O 0 5.754314997830079e-07
, O 0 8.827111958042977e-11
to O 0 1.3319177705195528e-10
compare O 0 2.2328582038877443e-10
the O 0 9.032340153591889e-11
distribution O 0 1.2054512943393547e-10
and O 0 5.817402224002344e-13
type O 0 1.035642460678332e-09
of O 0 4.688567312172154e-09
mutations O 0 4.6862966840421905e-09
, O 0 4.960794795783041e-12
according O 0 4.5177598641255035e-12
to O 0 8.072451734841835e-11
the O 0 5.370441938379322e-11
different O 0 2.3666774096042786e-10
symptoms O 0 9.387957220496901e-07
. O 0 4.23291872664322e-08

This O 0 9.497577835304583e-09
demonstrated O 0 4.741193215807016e-09
( O 0 1.9450388522024298e-10
1 O 0 7.765374476775833e-08
) O 0 2.249785774344204e-11
the O 0 7.200440244048423e-11
association O 0 6.947827035919119e-11
between O 0 2.5306192696916696e-09
mutations O 0 7.433720305982661e-09
in O 0 3.399912573698316e-10
exons O 0 6.619271353258682e-09
8 O 0 5.717269768723554e-09
and O 0 3.5000766174242415e-11
9 O 0 1.3836723766758041e-08
and O 0 2.402883725327598e-10
DMS B-Disease 0 8.872343073562661e-07
; O 0 3.2485475420784837e-10
( O 0 3.183947272500376e-10
2 O 0 1.765732378089524e-07
) O 0 7.828029197076702e-11
among O 0 3.121814959317071e-11
patients O 0 6.675265201705471e-11
with O 0 9.021351374260966e-12
DMS B-Disease 0 2.1442692741402425e-06
, O 0 7.607763030659243e-11
a O 0 5.681932702117365e-11
higher O 0 1.6938804525690188e-10
frequency O 0 5.530109148388362e-10
of O 0 6.252796891370593e-11
exon O 0 2.8054539247257537e-10
8 O 0 3.2111007186585994e-09
mutations O 0 8.179958932430509e-10
among O 0 1.0932421634635148e-11
46 O 0 1.6936195779138075e-09
, O 0 1.726650211697489e-10
XY O 0 5.830616646562703e-05
patients O 0 1.4441349505123213e-10
with O 0 1.4633207839898077e-12
female O 0 9.42124416675183e-12
phenotype O 0 3.103080847832729e-10
than O 0 3.898611988795153e-11
among O 0 1.0135976259706414e-11
46 O 0 7.2869088540983284e-09
, O 0 7.163895587858349e-10
XY O 1 0.8448613286018372
patients O 0 5.518624446310127e-10
with O 0 1.2248093164690665e-12
sexual O 0 2.1513280046292493e-10
ambiguity O 0 1.2651891090342815e-08
or O 0 1.2440942720459702e-09
male O 0 3.7137435487943904e-11
phenotype O 0 2.1624273205400613e-10
; O 0 5.103673560158395e-12
and O 0 4.7676501635507407e-11
( O 0 1.2135115134981334e-10
3 O 0 1.4357601685333066e-07
) O 0 5.4072284844108864e-11
statistically O 0 9.524525612647494e-11
significant O 0 1.2556143624831151e-11
evidence O 0 8.636887038893093e-11
that O 0 1.4919209964658897e-11
mutations O 0 6.476633673813126e-10
in O 0 1.5386847351805955e-10
exons O 0 1.817859640595998e-08
8 O 0 1.3881608751376007e-08
and O 0 4.631606556615431e-11
9 O 0 6.686766695906954e-09
preferentially O 0 3.376410928623841e-09
affect O 0 2.0771420139453767e-08
amino O 0 4.257905583671118e-09
acids O 0 4.480894474911956e-11
with O 0 4.696306074602509e-14
different O 0 2.162811623589514e-13
functions O 0 1.8003694021717642e-11
. O 0 4.6232306177840243e-11
. O 0 1.7603234425678238e-09

The O 0 1.5192892988125095e-07
185delAG O 0 5.297293910189182e-07
BRCA1 O 0 3.203211207392087e-08
mutation O 0 9.630977126917628e-10
originated O 0 8.183008957940441e-12
before O 0 7.469197135789862e-12
the O 0 1.065109480648252e-12
dispersion O 0 1.2368566171261364e-09
of O 0 2.0982962589677356e-10
Jews O 0 3.4119179703751e-10
in O 0 1.2527915337068318e-11
the O 0 1.7401385887794163e-11
diaspora O 0 8.452340910514167e-11
and O 0 6.284238754372673e-12
is O 0 9.89524955030685e-12
not O 0 5.889418119853218e-11
limited O 0 1.688483936002072e-10
to O 0 1.6085634158002904e-08
Ashkenazim O 0 2.72058678092435e-05
. O 0 4.49328581453301e-07

The O 0 2.466681436885665e-08
185delAG O 0 4.1747480850062857e-07
mutation O 0 2.900435625008413e-08
in O 0 1.2841517849082607e-09
BRCA1 O 0 5.956770365855846e-08
is O 0 5.05675883111234e-11
detected O 0 4.180385204666237e-10
in O 0 8.197287466871206e-12
Ashkenazi O 0 9.357485453165282e-09
Jews O 0 8.121381345205236e-10
both O 0 1.7332476599796198e-12
in O 0 5.525688587249e-11
familial B-Disease 0 0.2836274802684784
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 8.940788376321507e-08
in O 0 5.190897156559515e-10
the O 0 5.772624045441432e-10
general O 0 8.764958203677509e-10
population O 0 4.181228280275562e-11
. O 0 7.93223542405741e-10

All O 0 5.8471183450592434e-08
tested O 0 5.488353771454513e-09
Ashkenazi O 0 1.6089501286842278e-08
mutation O 0 3.374561463598269e-10
carriers O 0 7.870933939335689e-12
share O 0 2.926672446057488e-11
the O 0 1.303805761271315e-11
same O 0 2.4950307445092967e-11
allelic O 0 6.584956135924358e-09
pattern O 0 1.1004865463348779e-08
at O 0 3.73276520804211e-09
the O 0 6.359389681520611e-10
BRCA1 O 0 4.569087508343728e-08
locus O 0 2.394436648955889e-07
. O 0 1.2545941174835207e-08

Our O 0 4.4516951902551227e-07
previous O 0 1.8635761378504867e-08
study O 0 1.551939132760083e-10
showed O 0 6.741618548133932e-12
that O 0 3.4373545676480433e-13
this O 0 3.343988931245323e-12
Ashkenazi O 0 2.2618094064341676e-09
mutation O 0 3.983446628108567e-10
also O 0 1.5215314902103372e-12
occurs O 0 1.4224068103918519e-11
in O 0 2.6123059878452315e-12
Iraqi O 0 1.3394390041554516e-09
Jews O 0 3.6645192436068896e-10
with O 0 5.08711074567042e-13
a O 0 5.830583238441989e-11
similar O 0 1.2130627058404286e-10
allelic O 0 2.481071419424552e-07
pattern O 0 4.834560058952775e-07
. O 0 2.9601702422610288e-08

We O 0 1.6002222480437922e-07
extended O 0 1.7971608201605704e-08
our O 0 3.232163148236822e-10
analysis O 0 3.176266888393897e-11
to O 0 1.217387718410734e-10
other O 0 2.0241476897386868e-11
non O 0 9.855031457561836e-09
- O 0 6.887904024921454e-09
Ashkenazi O 0 7.534441515133494e-09
subsets O 0 2.3402217941281833e-09
354 O 0 1.9465901113235873e-10
of O 0 2.0928274738207797e-11
Moroccan O 0 3.9330170231721695e-09
origin O 0 3.7502331795558064e-10
, O 0 4.960333185866084e-11
200 O 0 5.461770966053159e-11
Yemenites O 0 5.664171354169412e-09
and O 0 2.256554491875118e-11
150 O 0 3.8761033271939027e-10
Iranian O 0 7.587500761019328e-08
Jews O 0 6.002218810863269e-08
. O 0 2.4424958056101786e-08

Heteroduplex O 0 4.0235296182800084e-05
analysis O 0 1.5786127960382146e-08
complemented O 0 1.4521374103182438e-09
by O 0 1.461539049507632e-11
direct O 0 1.3472691851035279e-09
DNA O 0 6.8463572588939314e-09
sequencing O 0 3.4381482105771966e-09
of O 0 2.1651851422888058e-09
abnormally O 0 4.585690938085918e-09
migrating O 0 7.342554342315566e-11
bands O 0 2.5181429164078395e-10
were O 0 1.86618512310055e-10
employed O 0 3.3376028607534636e-09
. O 0 9.918618815163427e-09

Four O 0 8.868112466586808e-09
of O 0 2.0706063530440133e-09
Moroccan O 0 1.7603318269721058e-07
origin O 0 1.9431263265090593e-09
( O 0 1.901198989906483e-11
1 O 0 2.9847628812973426e-09
. O 0 9.977386104809138e-12
1 O 0 2.673789856189046e-09
% O 0 1.400782545513124e-10
) O 0 1.24033465789819e-12
and O 0 5.27988200035856e-12
none O 0 1.768921953360092e-10
of O 0 2.3835569629149234e-10
the O 0 2.9990279704072975e-10
Yemenites O 0 1.256298975960135e-08
or O 0 3.097693490605735e-10
Iranians O 0 1.9273649343176658e-09
was O 0 2.5353480426204555e-10
a O 0 8.324597088049668e-12
carrier O 0 1.7773863977832427e-11
of O 0 5.2386768534251615e-11
the O 0 8.747501334394059e-11
185delAG O 0 3.0220107305467536e-08
mutation O 0 1.722271605331116e-07
. O 0 5.736300323633259e-08

BRCA1 O 0 1.4069286180529161e-06
allelic O 0 1.0127454430630678e-07
patterns O 0 8.985263644234465e-10
were O 0 1.9075919663325003e-11
determined O 0 8.728400641144773e-11
for O 0 4.297658583174435e-12
four O 0 1.9758552433080112e-12
of O 0 9.827011600294089e-12
these O 0 2.9678738850194564e-13
individuals O 0 1.491695547466143e-12
and O 0 8.330982605164738e-12
for O 0 6.374371169792781e-11
12 O 0 1.1939285116113751e-09
additional O 0 1.4844678264402944e-10
non O 0 3.445298801807439e-08
- O 0 4.3850043596194155e-09
Ashkenazi O 0 8.466898848702442e-10
185delAG O 0 3.3788104258913876e-11
mutation O 0 8.866881187619136e-12
carriers O 0 3.4154695131155544e-12
who O 0 5.979254591448324e-11
had O 0 1.1114413922541644e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9503195881843567

Six O 0 7.115504274679552e-08
non O 0 1.5129792529933184e-07
- O 0 2.751561645197853e-08
Ashkenazi O 0 2.788874908787875e-08
individuals O 0 7.47415671020768e-12
shared O 0 1.8754975003587582e-11
the O 0 4.1899383268484414e-11
common O 0 2.2362507678952426e-10
Ashkenazi O 0 2.4592402780854172e-08
haplotype O 0 4.5825851202607737e-07
, O 0 6.850560119175952e-10
four O 0 8.50230372217986e-11
had O 0 4.4397047149757896e-10
a O 0 2.643130506130298e-11
closely O 0 1.2030343735092153e-11
related O 0 5.961219851080557e-10
pattern O 0 7.088601705618203e-08
, O 0 6.457757939504205e-11
and O 0 1.1171165381629322e-10
the O 0 4.995715841005222e-09
rest O 0 3.253853009255181e-08
( O 0 6.712934652597369e-10
n O 0 2.6530753416409425e-07
= O 0 1.303037464595036e-07
6 O 0 6.471885427572488e-08
) O 0 8.955824797041156e-12
displayed O 0 1.9894624142535733e-11
a O 0 1.7520823680783337e-10
distinct O 0 3.5243621909764045e-10
BRCA1 O 0 1.1752826623023793e-07
allelic O 0 3.5334329595571035e-07
pattern O 0 3.7073698422318557e-07
. O 0 3.665067893621199e-08

We O 0 1.313648283485236e-07
conclude O 0 3.644907735633751e-07
that O 0 9.594101901821972e-11
the O 0 9.788405502808573e-11
185delAG O 0 1.8928220768543724e-08
BRCA1 O 0 5.5055092929023886e-08
mutation O 0 5.643251199671795e-09
occurs O 0 3.2407065919670686e-10
in O 0 2.0136188723374193e-12
some O 0 4.9484244826758506e-12
non O 0 5.5204196769409464e-08
- O 0 7.911980048902478e-08
Ashkenazi O 0 1.7663487028585223e-07
populations O 0 7.242201977009088e-11
at O 0 2.922042816044801e-11
rates O 0 6.7139007027539055e-12
comparable O 0 1.2660682398302203e-11
with O 0 3.5544790309878505e-13
that O 0 2.8419568781634652e-11
of O 0 3.1298128533308045e-09
Ashkenazim O 0 1.651686375225836e-06
. O 0 5.0851248545313865e-08

The O 0 5.088520538265584e-08
majority O 0 5.442368777863749e-10
of O 0 1.1834176971703414e-09
Jewish O 0 6.556057474682575e-09
185delAG O 0 1.751736533606163e-08
mutation O 0 1.827220041938915e-09
carriers O 0 3.196590214749051e-11
have O 0 2.923897669121489e-12
a O 0 4.180173568402168e-12
common O 0 1.1734906449345495e-11
allelic O 0 3.862835384893515e-09
pattern O 0 5.7083564541926535e-09
, O 0 3.6061065158271566e-12
supporting O 0 3.3292195389389434e-11
the O 0 2.9108684906908877e-10
founder O 0 9.411555978999786e-10
effect O 0 3.289208194701132e-08
notion O 0 1.0316330012472008e-08
, O 0 1.151979206470699e-11
but O 0 4.530305817984637e-12
dating O 0 2.8903362342402872e-11
the O 0 1.5449006657286546e-11
mutations O 0 2.9489737041199504e-11
origin O 0 5.2885100812472e-12
to O 0 5.646903517703139e-12
an O 0 4.0324568770927494e-13
earlier O 0 1.834149498947113e-11
date O 0 3.199021048061468e-09
than O 0 4.463731814730032e-11
currently O 0 5.030956901075356e-11
estimated O 0 2.8130211493504476e-09
. O 0 2.3251223169040713e-08

However O 0 9.12217501536361e-08
, O 0 3.930877845448322e-10
the O 0 7.498106302517016e-11
different O 0 7.953998570897625e-12
allelic O 0 3.2798297411318345e-08
pattern O 0 3.093911615792422e-08
at O 0 2.6001902853067804e-09
the O 0 1.205460453679308e-10
BRCA1 O 0 1.0188442089997807e-08
locus O 0 2.030895274174327e-08
even O 0 2.7034631477906856e-11
in O 0 1.5488385313872088e-12
some O 0 6.878463727419404e-13
Jewish O 0 2.375994678782689e-10
mutation O 0 4.287003529945821e-10
carriers O 0 1.7445085306877495e-11
, O 0 4.857815538716892e-12
might O 0 5.857736518066758e-11
suggest O 0 2.1536188110626853e-10
that O 0 5.862259896266542e-12
the O 0 4.272096565394179e-11
mutation O 0 1.7920553929684502e-10
arose O 0 2.5144186732717344e-10
independently O 0 6.589551682090189e-10
. O 0 5.42859091012815e-10
. O 0 9.154451419135512e-09

Crystal O 0 4.103087576368125e-06
structure O 0 4.455080215848284e-07
of O 0 2.9871448532503564e-06
the O 0 2.113299387929146e-06
hemochromatosis B-Disease 1 1.0
protein O 0 0.0006031204247847199
HFE O 0 0.0021793043706566095
and O 0 6.834350863016425e-10
characterization O 0 3.1387280330363865e-08
of O 0 1.043932851274576e-08
its O 0 1.603678717598811e-10
interaction O 0 8.936314466190254e-10
with O 0 2.0614069479174546e-11
transferrin O 0 3.072764229727909e-07
receptor O 0 1.2426362445694394e-06
. O 0 8.891827718571221e-08

HFE O 1 0.9994975328445435
is O 0 3.786541213912642e-08
an O 0 1.6500097954619264e-09
MHC O 0 1.0785183803818654e-05
- O 0 1.4291199477156624e-06
related O 0 8.928179084932708e-08
protein O 0 1.9106245474631578e-08
that O 0 5.695644476888528e-12
is O 0 1.1135542358001183e-12
mutated O 0 7.618911578022303e-12
in O 0 8.445278330826422e-12
the O 0 6.195389756769032e-10
iron B-Disease 0 0.3078548312187195
- I-Disease 1 0.9999802112579346
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9899186491966248

HFE O 0 0.0004716143012046814
binds O 0 2.0428539926342637e-07
to O 0 1.6585202544661115e-08
transferrin O 0 3.5105125562040485e-07
receptor O 0 1.7763865400866052e-07
( O 0 7.953885328149113e-10
TfR O 0 6.147042341808628e-08
) O 0 2.625549430645968e-11
and O 0 1.1128816618244386e-11
reduces O 0 3.056149222580018e-10
its O 0 2.136589169476899e-11
affinity O 0 4.53407061895561e-10
for O 0 5.229046085020173e-10
iron O 0 1.4640779966157424e-07
- O 0 6.4923946219153095e-09
loaded O 0 2.6224725169221585e-10
transferrin O 0 3.069366272256957e-08
, O 0 1.8680297586559647e-10
implicating O 0 2.69705520139496e-08
HFE O 0 2.7828931706608273e-05
in O 0 1.5230740757488093e-07
iron O 0 0.0001369212695863098
metabolism O 0 0.00015598443860653788
. O 0 3.845246965283877e-07

The O 0 6.853703325759852e-06
2 O 0 2.6755373255582526e-05
. O 0 4.2120277043977694e-07

6 O 0 8.886101568350568e-05
A O 0 2.6704638003138825e-06
crystal O 0 1.2588700428750599e-06
structure O 0 5.529133773052308e-07
of O 0 1.07682012639998e-06
HFE O 1 0.9842490553855896
reveals O 0 1.0582469123221472e-08
the O 0 5.489562276972393e-11
locations O 0 2.1470072941731644e-10
of O 0 5.259727320350294e-09
hemochromatosis B-Disease 1 1.0
mutations O 1 0.8311620950698853
and O 0 4.615175797084703e-08
a O 0 2.121994668868865e-07
patch O 1 0.9719111323356628
of O 0 2.891904478019569e-05
histidines O 0 0.00021765126439277083
that O 0 1.8396624223981917e-09
could O 0 1.2760512646536881e-08
be O 0 5.750206422128201e-10
involved O 0 2.451590042085172e-10
in O 0 1.9803694795150761e-10
pH O 0 2.506466262275353e-05
- O 0 2.6760928903968306e-06
dependent O 0 1.4670622476842254e-06
interactions O 0 3.48585189158257e-07
. O 0 2.1768600788618642e-07

We O 0 2.6073291792272357e-06
also O 0 3.934097492219735e-09
demonstrate O 0 1.0427666730095098e-08
that O 0 9.224099262183927e-10
soluble O 0 4.0151763869289425e-07
TfR O 0 5.897801429455285e-07
and O 0 2.8498942095112056e-10
HFE O 0 6.47953072530072e-07
bind O 0 7.074875352230947e-09
tightly O 0 2.5049131657794987e-09
at O 0 6.591638346264972e-10
the O 0 2.8503057553086464e-11
basic O 0 2.825667477779348e-10
pH O 0 3.5038155488109624e-08
of O 0 1.322743581333441e-09
the O 0 5.364343413916117e-10
cell O 0 6.568248167582169e-09
surface O 0 4.7963702343167824e-08
, O 0 1.4584682073159883e-10
but O 0 1.5994174040745435e-10
not O 0 8.745170143598102e-10
at O 0 1.463248189281785e-08
the O 0 1.3652267094599324e-09
acidic O 0 4.2607189243426546e-07
pH O 0 2.676021267689066e-06
of O 0 1.3208727978053503e-07
intracellular O 0 1.1470417149439527e-07
vesicles O 0 1.899377025438298e-06
. O 0 1.5434368094702222e-07

TfR O 0 0.0007954270113259554
HFE O 0 0.0010199676034972072
stoichiometry O 0 2.58370564552024e-05
( O 0 4.249380936016678e-08
2 O 0 1.8458005115462583e-06
1 O 0 6.473607641055423e-07
) O 0 7.536733737101287e-11
differs O 0 3.9211653368731447e-10
from O 0 7.507783839066917e-10
TfR O 0 2.1569425356915417e-08
transferrin O 0 1.7268167340489526e-08
stoichiometry O 0 1.5754004323298432e-08
( O 0 8.633428694171386e-11
2 O 0 1.4426882799511986e-08
2 O 0 8.845526089373834e-09
) O 0 1.5390742499898913e-11
, O 0 9.218004831668125e-12
implying O 0 1.5179560386435753e-10
a O 0 1.0703826713864828e-11
different O 0 3.91415036233439e-13
mode O 0 3.196620398937533e-11
of O 0 8.373613434586868e-12
binding O 0 1.4534813352895526e-09
for O 0 5.410604186906198e-10
HFE O 0 2.6011002773884684e-06
and O 0 4.696172895002348e-10
transferrin O 0 3.9223962744472374e-08
to O 0 6.40493125203534e-09
TfR O 0 7.770811549789869e-08
, O 0 3.4584814179172696e-11
consistent O 0 2.138277888086293e-10
with O 0 5.67988960985949e-13
our O 0 3.390262723335091e-11
demonstration O 0 1.4821366356443377e-10
that O 0 1.3099676725303322e-11
HFE O 0 6.216684482751589e-07
, O 0 1.328568505210015e-10
transferrin O 0 3.1291875757233356e-08
, O 0 1.8642497268128722e-10
and O 0 8.286202279883526e-11
TfR O 0 7.15545933616113e-09
form O 0 9.044407583980174e-11
a O 0 1.0352988466522106e-09
ternary O 0 9.083144902888307e-08
complex O 0 1.6845264383391623e-07
. O 0 5.903249089556084e-08

Identification O 0 2.920955033403061e-08
of O 0 9.764249853105866e-09
three O 0 3.848638074899213e-11
novel O 0 4.4307205127047666e-10
mutations O 0 1.8369801235706973e-09
and O 0 1.3541825646945505e-11
a O 0 3.221077918280635e-11
high O 0 2.2234616925409512e-10
frequency O 0 1.3976233503854019e-09
of O 0 1.4981353657628205e-10
the O 0 5.568007860334845e-11
Arg778Leu O 0 1.5614992321388854e-07
mutation O 0 1.1799113686095097e-08
in O 0 1.1738629512869636e-10
Korean O 0 1.0948297379798078e-08
patients O 0 5.854921408809943e-11
with O 0 3.5695908034982793e-12
Wilson B-Disease 0 1.464633783143654e-07
disease I-Disease 0 8.489256288157776e-06
. O 0 5.451028428637983e-08

Four O 0 4.463636216200939e-08
mutations O 0 6.758355652891623e-08
- O 0 4.661284691565015e-08
- O 0 1.3545080435051204e-07
R778L O 0 1.4510836990666576e-05
, O 0 7.399765800109037e-10
A874V O 0 1.2542743661470013e-06
, O 0 1.8986415217803199e-10
L1083F O 0 4.61369722870586e-07
, O 0 3.9342962915300816e-11
and O 0 1.5231350902755736e-11
2304delC O 0 7.27316162851821e-09
- O 0 6.405361574479684e-08
- O 0 7.573923710424424e-08
in O 0 2.075470817430869e-08
the O 0 5.620159626573695e-08
copper O 0 2.1473663025517453e-07
- O 0 2.1274672690196894e-08
transporting O 0 2.7555411286073195e-09
enzyme O 0 2.9257374301039363e-09
, O 0 1.9170982856753227e-10
P O 0 7.711087732786837e-07
- O 0 3.1180271697905937e-09
type O 0 4.474340009608113e-09
ATPase O 0 4.480696347286539e-08
( O 0 7.983184252546849e-11
ATP7B O 0 2.7778755793406162e-06
) O 0 9.582393038776171e-12
, O 0 1.7836817092775625e-12
were O 0 4.5864189182620585e-12
identified O 0 1.7301635818478545e-11
in O 0 3.6619513844871054e-12
Korean O 0 1.583648434611007e-09
Patients O 0 1.0236778785754908e-10
with O 0 9.54226801741509e-12
Wilson B-Disease 0 8.868468626133108e-07
disease I-Disease 0 0.0012393040815368295
. O 0 3.9793695805201423e-07

Arg778Leu O 1 0.9135112166404724
, O 0 6.818913789174985e-08
the O 0 3.022343708636299e-09
most O 0 2.6634035255046484e-11
frequently O 0 8.98110752434178e-12
reported O 0 3.435345757862862e-11
mutation O 0 1.4391908498279093e-10
of O 0 5.8140471603795874e-11
this O 0 4.861152279322933e-12
enzyme O 0 1.6307484529409777e-10
, O 0 2.8887419799977776e-12
was O 0 1.464807719564476e-10
found O 0 1.758220305458913e-12
in O 0 1.36015114102217e-12
six O 0 9.512375262477057e-12
of O 0 5.82353609779318e-11
eight O 0 1.738772459347615e-10
unrelated O 0 6.302205424191243e-09
patients O 0 1.1878155403710622e-10
studied O 0 5.148340087579584e-10
, O 0 2.4909972088510424e-12
an O 0 1.8224803177008253e-12
allele O 0 1.7893331261120693e-10
frequency O 0 1.1241883868251534e-08
of O 0 4.758406557670014e-09
37 O 0 1.3828430667217617e-07
. O 0 1.8446247196379773e-08

5 O 0 1.3130827028362546e-05
% O 0 4.929349302074115e-07
, O 0 4.801982769753188e-11
which O 0 3.0731209677697935e-12
is O 0 3.656751550867865e-12
considerably O 0 6.9889233289544e-11
higher O 0 1.644149955071228e-10
than O 0 1.4028860538528587e-11
those O 0 5.001638860024915e-12
in O 0 2.135008489445589e-11
other O 0 1.880160784006879e-11
Asian O 0 8.012843721871832e-10
populations O 0 5.773527211871965e-10
. O 0 3.1407265677074747e-09

The O 0 2.3576870233910086e-08
novel O 0 1.2996854703573035e-09
single O 0 2.3835658446991204e-10
nucleotide O 0 1.9802761652698564e-09
deletion O 0 1.6039251704569324e-08
, O 0 1.5881174847409696e-11
2304delC O 0 3.309490637093404e-08
, O 0 2.0550522394913173e-10
was O 0 8.277301510872803e-09
found O 0 1.249787495716248e-10
in O 0 6.664147012003241e-11
one O 0 6.081913861422095e-10
patient O 0 4.361800165497698e-08
. O 0 8.102666981812945e-08

Since O 0 5.033829779677035e-07
a O 0 2.1328952826138448e-08
mutation O 0 8.047524424625863e-09
at O 0 9.163500180875417e-09
cDNA O 0 2.6235861483314693e-08
nucleotide O 0 1.1549470713134724e-07
2302 O 0 2.3037446226226166e-06
( O 0 5.759226082147073e-11
2302insC O 0 2.1749130496573343e-08
) O 0 6.452857692629266e-11
had O 0 8.235219173258201e-10
been O 0 1.2207057586977044e-10
previously O 0 1.251144465808096e-10
described O 0 1.0783606646525001e-10
, O 0 1.4099699055872272e-12
this O 0 3.1409495230422246e-12
region O 0 7.148720726490865e-09
of O 0 4.163740019436091e-09
the O 0 4.1962202601553145e-09
ATP7B O 1 0.7240021824836731
gene O 0 1.075994848775963e-08
may O 0 7.957333458818994e-09
be O 0 9.485878749160293e-10
susceptible O 0 2.8847340516335862e-08
to O 0 3.3502440821564505e-09
gene O 0 1.0069820532976337e-08
rearrangements O 0 0.00031309513724409044
causing O 1 0.9528339505195618
Wilson B-Disease 0 3.658318746602163e-05
disease I-Disease 1 0.7993205189704895
. O 0 6.026469350217667e-07

Disruption O 0 0.00013521990331355482
of O 0 3.4951324323628796e-07
splicing O 0 1.7158965803787396e-08
regulated O 0 9.46123068779059e-10
by O 0 6.375012497061849e-12
a O 0 3.1150176882377423e-10
CUG O 0 1.8203007812189753e-06
- O 0 1.8865640161180863e-09
binding O 0 2.0244597109808637e-08
protein O 0 1.0649007720076042e-07
in O 0 4.93985963245791e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 9.483662870479748e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.246926775726024e-06
DM B-Disease 1 1.0
) O 0 1.1217338169444702e-08
is O 0 7.982488003932531e-10
caused O 0 8.21697643260677e-09
by O 0 1.1801712385128837e-10
a O 0 6.525119111699951e-09
CTG O 0 2.6996390261047054e-06
expansion O 0 6.909984140435199e-09
in O 0 1.2695632045645056e-10
the O 0 2.190940762147875e-10
3 O 0 7.2651897831121914e-09
untranslated O 0 1.3704266166314483e-06
region O 0 2.0892807484074183e-08
of O 0 1.2905931434659124e-08
the O 0 4.062009395511268e-08
DM B-Disease 1 1.0
gene O 0 5.070887709734961e-07
. O 0 3.1474083783678e-08

One O 0 1.8103364363142305e-09
model O 0 1.2683826211556948e-09
of O 0 3.8198663787625264e-08
DM B-Disease 1 1.0
pathogenesis O 1 0.9991294741630554
suggests O 0 5.381151968464337e-09
that O 0 1.6648725800760822e-11
RNAs O 0 4.1260750371918675e-10
from O 0 9.912860116090272e-11
the O 0 8.334288120748212e-12
expanded O 0 4.357192991827352e-12
allele O 0 1.0386448645594015e-10
create O 0 6.272922285777138e-12
a O 0 6.337686625501604e-11
gain O 0 5.581005879662371e-09
- O 0 3.4778602220342236e-09
of O 0 1.3875619542247364e-09
- O 0 1.8417233293988033e-09
function O 0 1.3648875085703338e-10
mutation O 0 1.3030649476108991e-11
by O 0 3.5968312204516517e-13
the O 0 3.6142866043781252e-12
inappropriate O 0 3.622100536171402e-11
binding O 0 3.6481602183613404e-09
of O 0 2.1350554657573184e-09
proteins O 0 1.341534088677987e-11
to O 0 3.3620206618678594e-10
the O 0 1.323255838237003e-09
CUG O 0 0.00017192642553709447
repeats O 0 1.7057944887710619e-06
. O 0 1.1624479157035239e-07

Data O 0 2.4155321298735544e-08
presented O 0 1.1852458570160707e-08
here O 0 5.3974855696026225e-09
indicate O 0 3.9176688559905415e-09
that O 0 9.440388748505057e-11
the O 0 1.0278280448972055e-09
conserved O 0 2.5391058144919043e-08
heterogeneous O 0 9.256888944264574e-08
nuclear O 0 0.00014146137982606888
ribonucleoprotein O 0 1.94784406630788e-05
, O 0 2.8145021868652975e-09
CUG O 0 2.4114181087497855e-06
- O 0 3.171185092298856e-09
binding O 0 2.833350087882991e-08
protein O 0 8.496734871243916e-09
( O 0 2.3531189149994525e-11
CUG O 0 3.280729515608982e-06
- O 0 4.864752156663599e-08
BP O 0 1.1792080840677954e-06
) O 0 4.194327871132053e-11
, O 0 1.861967524607877e-11
may O 0 1.4079699628410935e-09
mediate O 0 1.7468609314619243e-07
the O 0 5.215461840180069e-09
trans O 0 6.151945086685373e-08
- O 0 1.0622388302294894e-08
dominant O 0 5.6374309664875e-09
effect O 0 1.0640151870688896e-08
of O 0 1.595496845752109e-09
the O 0 1.067433585966171e-09
RNA O 0 6.104523464500744e-08
. O 0 7.478460517518215e-09

CUG O 1 0.9225588440895081
- O 0 0.000313960132189095
BP O 0 0.0009756181389093399
was O 0 1.417450619101146e-07
found O 0 5.789999382721511e-11
to O 0 3.093753725424975e-11
bind O 0 7.031496218612432e-11
to O 0 3.5263794662121484e-10
the O 0 1.6663610491463032e-09
human O 0 2.5074957221704608e-08
cardiac O 0 0.0003726316208485514
troponin O 0 0.00044906814582645893
T O 0 4.442534191184677e-05
( O 0 1.9475863144435834e-09
cTNT O 0 3.22986807077541e-07
) O 0 6.398026553000591e-11
pre O 0 2.0151599500195516e-08
- O 0 9.258718236537788e-10
messenger O 0 7.736918050671449e-11
RNA O 0 5.544113501620984e-10
and O 0 4.114518187964267e-12
regulate O 0 2.3669562837502767e-11
its O 0 4.035906157884295e-12
alternative O 0 5.543542291874815e-10
splicing O 0 7.415636105179146e-09
. O 0 3.3567426616087914e-09

Splicing O 0 1.5137889874949906e-07
of O 0 2.742486593376725e-08
cTNT O 0 1.5124617675610352e-05
was O 0 5.927268489358539e-07
disrupted O 0 5.655235213453125e-07
in O 0 3.3109976982359512e-09
DM B-Disease 1 1.0
striated O 0 2.756965386652155e-06
muscle O 0 1.4939442962713656e-06
and O 0 5.2895265945096526e-09
in O 0 4.0496686004587445e-09
normal O 0 6.555897016369272e-07
cells O 0 7.540565505337327e-09
expressing O 0 5.773527211871965e-10
transcripts O 0 4.7908819134079295e-09
that O 0 1.2954329275949306e-10
contain O 0 4.056355695780667e-09
CUG O 0 5.710045661544427e-05
repeats O 0 1.113800635721418e-06
. O 0 7.065936813432927e-08

Altered O 0 1.443130486222799e-07
expression O 0 4.25489581346028e-08
of O 0 3.08586116659626e-08
genes O 0 2.1993240562068195e-09
regulated O 0 3.0185123289783178e-09
posttranscriptionally O 0 9.518564070276625e-08
by O 0 1.5921407525709697e-09
CUG O 1 0.900956928730011
- O 0 6.82561585563235e-06
BP O 0 9.90788157650968e-06
therefore O 0 5.944656766843082e-09
may O 0 2.009072241904164e-09
contribute O 0 1.38729205900745e-09
to O 0 4.1526224237031784e-08
DM B-Disease 1 1.0
pathogenesis O 0 0.00013932219007983804
. O 0 1.1861708060223464e-08
. O 0 1.9975491483137375e-08

Identification O 0 3.354824329449002e-08
of O 0 4.757580995828903e-09
a O 0 4.942486975245686e-10
novel O 0 6.910573779883578e-10
nonsense O 0 4.8164100263647924e-08
mutation O 0 2.1135204697486643e-09
and O 0 2.2881894296000738e-11
a O 0 7.544830732397756e-11
missense O 0 1.7003886298994075e-08
substitution O 0 3.879996324229751e-09
in O 0 1.908014995999352e-10
the O 0 3.710290408243111e-10
vasopressin O 0 6.387254281037258e-09
- O 0 3.087350819441781e-08
neurophysin O 0 1.079427647709963e-06
II O 0 0.0004289654898457229
gene O 0 6.947167840998247e-10
in O 0 2.8725844619659213e-11
two O 0 2.4055913511178417e-12
Spanish O 0 4.966622113578012e-10
kindreds O 0 4.412567733425021e-08
with O 0 1.9571174542099e-11
familial B-Disease 0 0.003431294346228242
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999995231628418
. O 0 2.5156357423838926e-06

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 6.182599321391535e-08
FNDI B-Disease 1 1.0
) O 0 1.8519590028187594e-10
is O 0 3.8170855365393663e-11
an O 0 7.039896443572502e-11
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999946355819702
by O 0 2.0191157545923488e-07
deficiency O 1 1.0
in O 0 1.6643545677652583e-05
the O 0 2.554461616455228e-06
antidiuretic O 0 5.27439283359854e-07
hormone O 0 4.127794994701617e-08
arginine O 0 1.535215972126025e-07
vasopressin O 0 1.7138890484602598e-07
( O 0 1.154902062872054e-09
AVP O 0 1.2694390250089782e-07
) O 0 1.1723715531361534e-12
encoded O 0 1.0363444043898218e-12
by O 0 9.402449305251359e-12
the O 0 8.16522793822827e-10
AVP O 0 1.066535446625494e-06
- O 0 1.1224490492622863e-07
neurophysin O 0 7.25404970580712e-06
II O 1 0.9958540201187134
( O 0 1.004509613267146e-07
AVP O 0 2.7606074581854045e-05
- O 0 2.7295430982121616e-07
NPII O 0 1.3868059795640875e-05
) O 0 6.501532645586394e-11
gene O 0 2.0388264687642987e-10
on O 0 5.118674817339297e-09
chromosome O 0 7.181068667705404e-06
20p13 O 0 0.00012366606097202748
. O 0 2.486505366050551e-07

In O 0 1.9447810473138816e-08
this O 0 1.0458296451076876e-09
study O 0 1.502276525400248e-09
, O 0 5.1527584282728967e-11
we O 0 1.9277390794769644e-10
analyzed O 0 7.412507274651148e-10
two O 0 2.6287713325579e-11
families O 0 2.0544517476128732e-11
with O 0 7.44959580134541e-11
FNDI B-Disease 1 1.0
using O 0 8.600204992603722e-09
direct O 0 2.5069123665844018e-08
automated O 0 2.753063021998514e-08
fluorescent O 0 1.1119773546397482e-08
, O 0 1.628852192014918e-10
solid O 0 7.335125284946287e-10
phase O 0 5.528153579348327e-08
, O 0 1.9738445253270065e-11
single O 0 1.6817502945798424e-10
- O 0 5.106969847012977e-10
stranded O 0 1.3640598373054758e-10
DNA O 0 2.0636336389712184e-11
sequencing O 0 2.0490236243841942e-11
of O 0 7.58706986125901e-11
PCR O 0 5.71005553950954e-09
- O 0 9.163783687426985e-08
amplified O 0 4.7387911195073684e-07
AVP O 0 8.227271791838575e-06
- O 0 2.62130839701058e-07
NPII O 0 2.9958298910059966e-05
DNA O 0 9.395077995577594e-07
. O 0 3.676115767348165e-08

In O 0 6.823386744514437e-09
one O 0 2.217472871990367e-10
of O 0 2.3023835615809674e-10
the O 0 7.524524059387971e-11
families O 0 8.161062971245858e-12
, O 0 2.9270390364960486e-12
affected O 0 3.5360426392516686e-11
individuals O 0 1.2639570813599565e-11
presented O 0 1.1038411296127038e-09
a O 0 4.3814404881992175e-10
novel O 0 7.86700926624917e-10
nonsense O 0 7.518420552798943e-09
mutation O 0 5.334549468827277e-10
in O 0 3.154369473956642e-11
exon O 0 5.433926086872987e-10
3 O 0 1.5380310358636962e-09
of O 0 3.200764930877398e-10
the O 0 1.3825365852149218e-10
gene O 0 3.112070670607814e-11
, O 0 3.627602341779723e-12
consisting O 0 3.683885661798225e-12
in O 0 8.579061766544882e-11
a O 0 1.2082032263549536e-08
G O 0 1.7396885141351959e-06
to O 0 5.742638222727692e-07
T O 0 7.253171133925207e-06
transition O 0 3.504351013816631e-07
at O 0 2.5897879396552526e-08
nucleotide O 0 1.960984086224471e-08
2101 O 0 4.0832438230609114e-07
, O 0 9.684664528664122e-12
which O 0 1.6081920951177553e-12
produces O 0 1.342094577833075e-11
a O 0 1.6134474312146097e-10
stop O 0 2.597781101343344e-09
signal O 0 6.342046443563731e-09
in O 0 7.291562353906045e-10
codon O 0 1.1051229620306913e-07
82 O 0 1.293119282763655e-07
( O 0 2.1846240372269676e-09
Glu O 0 2.858264736005367e-07
) O 0 3.6500094613423073e-10
of O 0 1.3517331254320197e-08
NPII O 0 0.0018809341127052903
. O 0 3.9486090486207104e-07

The O 0 4.601174623530824e-07
premature O 0 3.3673686630208977e-06
termination O 0 2.2035719666746445e-06
eliminates O 0 1.5050628121571208e-07
part O 0 4.637984662991812e-09
of O 0 8.09041722504844e-09
the O 0 1.7648316141816167e-09
C O 0 5.515304337677662e-07
- O 0 5.7327973479459615e-09
terminal O 0 2.2740740845961227e-08
domain O 0 7.389557410419911e-09
of O 0 1.7395694884569934e-09
NPII O 0 1.0559811016719323e-05
, O 0 1.4633529110685828e-10
including O 0 1.9606295753593628e-11
a O 0 3.024994699174499e-10
cysteine O 0 3.4001851334508615e-10
residue O 0 5.6899452260950056e-08
in O 0 1.1431981056242435e-10
position O 0 2.5682851401143125e-09
85 O 0 2.4246982199827016e-09
, O 0 3.1369021963323362e-12
which O 0 1.7321505558012817e-12
could O 0 8.588131594766679e-11
be O 0 1.6663410928874356e-10
involved O 0 2.667064902261984e-10
in O 0 2.503654228380725e-11
the O 0 7.982925431804233e-11
correct O 0 8.595465672556202e-09
folding O 0 6.617516312701355e-09
of O 0 1.4839647288766855e-09
the O 0 4.700817068936658e-09
prohormone O 0 2.203438816650305e-05
. O 0 9.79430225811484e-08

In O 0 5.904833955128197e-09
the O 0 2.0752204399343555e-09
second O 0 2.648635444302272e-08
family O 0 2.3515003833018966e-10
, O 0 1.5813256953878252e-11
a O 0 2.1970042451968652e-10
G279A O 0 4.8657536666496526e-08
substitution O 0 1.0332121824774276e-08
at O 0 1.2993342402012331e-08
position O 0 4.44197700844029e-09
- O 0 7.16988246551864e-10
1 O 0 1.7062852464277967e-08
of O 0 2.568235069055902e-10
the O 0 1.9460100197932206e-11
signal O 0 1.0433267444431849e-10
peptide O 0 1.0623978086155006e-10
was O 0 5.867534791370588e-10
observed O 0 1.931632111207282e-11
in O 0 1.4825025972456385e-12
all O 0 8.776370472377004e-13
affected O 0 5.007215475583138e-11
individuals O 0 5.934896324388816e-11
. O 0 2.1639973368792198e-08

This O 0 4.602552650112557e-08
missense O 0 1.079193225450581e-05
mutation O 0 9.614575446903473e-07
, O 0 1.3361416140167393e-10
which O 0 4.659650790217462e-11
replaces O 0 2.3703570661837148e-08
Ala O 0 9.352760343972477e-08
with O 0 5.8116633033789e-11
Thr O 0 1.9282322227809345e-06
, O 0 1.135132821072915e-10
is O 0 4.21900812896947e-11
frequent O 0 2.9390362366044087e-10
among O 0 9.291339919670349e-10
FNDI B-Disease 1 1.0
patients O 0 0.0004834071733057499
and O 0 3.1817635193220895e-09
is O 0 1.4931667013939887e-09
thought O 0 9.394303113197111e-10
to O 0 5.548451142978195e-10
reduce O 0 4.744522552613262e-09
the O 0 2.852183766943739e-10
efficiency O 0 8.381035310200957e-10
of O 0 2.3282883954145461e-10
cleavage O 0 1.869374433027815e-09
by O 0 8.33739258188082e-11
signal O 0 1.3561520972871222e-07
peptidases O 0 4.2014926293632016e-07
. O 0 2.506920671052626e-09
. O 0 9.33785582191149e-09

Genetic O 0 1.099026690098981e-06
heterogeneity O 0 1.6207487760766526e-06
of O 0 2.57021781635558e-07
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.3730119263755114e-08
due O 0 4.864807578996988e-06
to O 0 2.032577128829871e-08
TWIST O 0 1.9606979549280368e-05
and O 0 6.1125722261579085e-09
FGFR O 1 0.9831935167312622
mutations O 0 1.5999328752513975e-05
. O 0 3.2109954872794333e-07

Thirty O 0 1.358452300337376e-05
- O 0 4.1811867390606494e-07
two O 0 3.500178480386751e-10
unrelated O 0 2.3229768331134437e-08
patients O 0 4.6390332547607827e-11
with O 0 4.2448798653633296e-14
features O 0 9.839385166007797e-13
of O 0 1.535996441148768e-09
Saethre B-Disease 1 0.9999978542327881
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 8.613875168705931e-10
a O 0 3.3621874728773093e-10
common O 0 2.189439030075846e-08
autosomal B-Disease 1 0.9978949427604675
dominant I-Disease 1 0.999992847442627
condition I-Disease 1 1.0
of O 1 0.9984087347984314
craniosynostosis B-Disease 1 1.0
and O 1 0.7699434757232666
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999996423721313
, O 0 1.1072086580909968e-09
were O 0 2.5428689709450225e-10
screened O 0 1.810053329442951e-09
for O 0 1.450843750694375e-10
mutations O 0 2.8848756716826074e-09
in O 0 8.048134381155592e-10
TWIST O 0 1.7958376702154055e-05
, O 0 2.5863111652313364e-09
FGFR2 O 1 0.9874243140220642
, O 0 5.879301046007868e-09
and O 0 1.0880680356706307e-08
FGFR3 O 1 0.9995701909065247
. O 0 2.3128584416554077e-06

Nine O 0 3.1309016890190833e-07
novel O 0 7.802487544950054e-09
and O 0 9.236916231891712e-10
three O 0 4.715334789295866e-10
recurrent O 0 3.6572615158547706e-07
TWIST O 0 6.476735052274307e-06
mutations O 0 1.5704958400419855e-07
were O 0 7.662990797463465e-10
found O 0 1.6190448287600745e-11
in O 0 2.2778300079462355e-11
12 O 0 1.4260075342775735e-09
families O 0 2.1162180341427472e-10
. O 0 2.2287414580546283e-08

Seven O 0 2.401436631771503e-07
families O 0 1.8223230702218984e-09
were O 0 1.0398762961827401e-09
found O 0 1.418341000203327e-10
to O 0 1.8493186149104446e-10
have O 0 2.8727378115211977e-11
the O 0 1.7197940294089165e-10
FGFR3 O 0 6.429734639823437e-06
P250R O 0 1.5767825516377343e-06
mutation O 0 2.3491134371056432e-08
, O 0 2.0120920554700383e-11
and O 0 3.860207726386067e-12
one O 0 5.641423959923397e-12
individual O 0 1.7027835304966876e-12
was O 0 1.4034468032164682e-09
found O 0 2.0252136773146745e-11
to O 0 8.414475366480545e-11
have O 0 2.0283759047390326e-11
an O 0 1.060901436145123e-10
FGFR2 O 0 8.103777508949861e-05
VV269 O 0 1.3205811228544917e-05
- O 0 5.399547262641136e-07
270 O 0 1.085274590195695e-07
deletion O 0 5.584042810369283e-07
. O 0 5.863065766220643e-08

To O 0 1.2660900949867937e-07
date O 0 3.563187874533469e-06
, O 0 4.338314985030678e-10
our O 0 6.057899321065818e-11
detection O 0 8.751644409166204e-10
rate O 0 8.233958653791618e-11
for O 0 2.4750464264894356e-12
TWIST O 0 5.854193219079207e-08
or O 0 2.726140646558406e-09
FGFR O 0 0.00012028297351207584
mutations O 0 1.8538054646910496e-08
is O 0 5.723592086392948e-11
68 O 0 1.5927845709029498e-09
% O 0 1.2469801580206052e-10
in O 0 5.605545541631507e-12
our O 0 1.4664962300070528e-10
Saethre B-Disease 1 0.5114330053329468
- I-Disease 1 0.9999526739120483
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 4.3626616275105334e-07
, O 0 5.422585991343709e-11
including O 0 1.967334802011056e-11
our O 0 2.997708303809077e-09
five O 0 2.8965188580976076e-10
patients O 0 1.6314196521483026e-11
elsewhere O 0 3.3714524227956844e-11
reported O 0 7.681630331823897e-11
with O 0 1.2180351345592033e-11
TWIST O 0 5.01374506711727e-06
mutations O 0 2.755679815891199e-06
. O 0 1.6474280073452974e-07

More O 0 1.1697064428162207e-09
than O 0 1.1540866873271938e-10
35 O 0 3.281409588495876e-10
different O 0 7.169981297051875e-13
TWIST O 0 1.0289524787765458e-08
mutations O 0 2.6133764041702534e-09
are O 0 2.975845047811787e-12
now O 0 3.81423798795355e-12
known O 0 3.4763958205175083e-12
in O 0 4.209352484629836e-12
the O 0 1.6566492969105617e-11
literature O 0 3.3442282276752167e-10
. O 0 1.768909463351065e-09

The O 0 2.110138552779972e-07
most O 0 1.3363352091566583e-10
common O 0 4.359589078628545e-11
phenotypic O 0 2.854073422042802e-09
features O 0 1.0914899192804306e-11
, O 0 6.551272111604556e-12
present O 0 1.9844447265993104e-11
in O 0 5.849516183931147e-12
more O 0 1.8984504723471018e-13
than O 0 3.1025685492958033e-12
a O 0 8.103535897863168e-11
third O 0 1.508935976168857e-09
of O 0 6.086974257968336e-10
our O 0 1.4375611812056377e-10
patients O 0 4.854758955952221e-12
with O 0 1.106841723309826e-12
TWIST O 0 1.6475487427669577e-06
mutations O 0 1.2686296031461097e-06
, O 0 1.9292914488211466e-10
are O 0 3.790611227683094e-11
coronal B-Disease 0 0.0002609672665130347
synostosis I-Disease 0 5.833592149429023e-05
, O 0 1.5704673117511447e-09
brachycephaly B-Disease 0 5.637020876747556e-06
, O 0 7.462426787618881e-10
low B-Disease 0 4.597495262714801e-06
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 3.1067028771758487e-07
facial B-Disease 1 0.9999209642410278
asymmetry I-Disease 1 0.9999995231628418
, O 0 7.736471729913319e-08
ptosis B-Disease 1 0.9999853372573853
, O 0 7.184616901412255e-09
hypertelorism B-Disease 0 2.950726957351435e-05
, O 0 1.7442675082079973e-09
broad B-Disease 0 2.4808545276755467e-05
great I-Disease 0 0.44354987144470215
toes I-Disease 1 0.9997751116752625
, O 0 8.127180706196668e-09
and O 0 9.7261816378591e-09
clinodactyly B-Disease 1 0.557950496673584
. O 0 2.517466236895416e-05

Significant O 0 9.482351742917672e-06
intra O 0 0.005804397165775299
- O 0 5.082922598376172e-06
and O 0 3.4410481131175175e-09
interfamilial O 0 1.3928971611676388e-06
phenotypic O 0 2.595173214103852e-07
variability O 0 1.747127157614159e-06
is O 0 2.2343651234768558e-11
present O 0 1.1641719706301235e-11
for O 0 7.164817350524544e-12
either O 0 6.093618387659205e-10
TWIST O 0 1.575648980178812e-06
mutations O 0 2.665992724359967e-07
or O 0 4.47763781608046e-08
FGFR O 0 0.0038671453949064016
mutations O 0 3.872313300234964e-06
. O 0 7.400124957257503e-08

The O 0 1.389083195135754e-07
overlap O 0 1.5832360134027113e-07
in O 0 3.6001790437723e-10
clinical O 0 7.273258884055167e-09
features O 0 8.154527400550116e-12
and O 0 2.0925521732051422e-11
the O 0 1.4254983304873292e-10
presence O 0 8.166018555799681e-11
, O 0 6.567549021979646e-12
in O 0 4.000483104504848e-12
the O 0 6.078382588925457e-12
same O 0 1.3598379366985824e-11
genes O 0 2.1275125758335456e-11
, O 0 1.961571096525949e-12
of O 0 7.943692925671542e-11
mutations O 0 2.2244839303908748e-10
for O 0 1.1097044290420133e-11
more O 0 6.955603627789575e-13
than O 0 2.0005198886341446e-11
one O 0 3.528005665387468e-11
craniosynostotic B-Disease 0 2.317136136298359e-07
condition I-Disease 0 3.506237362671527e-06
- O 0 9.395274780388263e-09
such O 0 3.036369419784357e-11
as O 0 1.8784841737673474e-10
Saethre B-Disease 0 2.6273224307260534e-07
- I-Disease 0 2.0895756236427587e-08
Chotzen I-Disease 0 2.07938751373149e-06
, I-Disease 0 3.2332853061589617e-10
Crouzon I-Disease 0 1.863469515228644e-05
, I-Disease 0 2.7282629488922794e-09
and I-Disease 0 1.499240198654661e-08
Pfeiffer I-Disease 0 0.03929196670651436
syndromes I-Disease 1 0.9807448387145996
- O 0 7.40990162739763e-06
support O 0 5.075222020423098e-08
the O 0 4.1286779151050723e-07
hypothesis O 0 4.114762930385041e-07
that O 0 1.924120723861833e-10
TWIST O 0 1.436327181636443e-07
and O 0 1.006439515061075e-10
FGFRs O 0 9.585939153566869e-08
are O 0 5.931328345143427e-12
components O 0 2.4510615759254506e-10
of O 0 3.955192562354881e-10
the O 0 9.578341592098027e-11
same O 0 9.720645122168747e-11
molecular O 0 1.5737537939486401e-09
pathway O 0 1.96381266803769e-09
involved O 0 7.891980471907978e-12
in O 0 3.233027452524684e-13
the O 0 7.042602178514157e-13
modulation O 0 3.060494913054157e-10
of O 0 6.892500459265705e-10
craniofacial O 1 0.9889240860939026
and O 0 5.270927516676238e-08
limb O 1 1.0
development O 0 3.4168397178291343e-06
in O 0 6.257647733320937e-09
humans O 0 5.248242729294361e-09
. O 0 7.510705390956218e-10
. O 0 8.002859708255983e-09

Mutation O 0 1.6069320096789852e-08
analysis O 0 9.313589899306862e-10
of O 0 6.451067235957453e-09
UBE3A O 1 0.9999977350234985
in O 0 0.00022924340737517923
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9942227005958557
. O 0 2.649130919962772e-06

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.00016306772886309773
AS B-Disease 1 1.0
) O 0 2.6107556116983233e-09
is O 0 1.7161043419644528e-10
caused O 0 2.2599206950246753e-09
by O 0 1.4014560345554372e-10
chromosome O 0 9.762707122717984e-06
15q11 O 0 4.964626714354381e-05
- O 0 2.4497933281963924e-07
q13 O 0 7.011992124716926e-07
deletions O 0 4.60615057207292e-09
of O 0 1.3534867671083362e-09
maternal O 0 1.47903174152475e-08
origin O 0 7.968219417620048e-10
, O 0 1.012820816798099e-11
by O 0 2.8232093746138887e-11
paternal O 0 1.5587422694807174e-06
uniparental B-Disease 0 0.00898502953350544
disomy I-Disease 0 0.17643316090106964
( O 0 1.0159143926102843e-07
UPD B-Disease 1 1.0
) O 0 4.402164466288383e-10
15 O 0 3.6037326456295204e-09
, O 0 2.3801470776935174e-12
by O 0 3.77592679345895e-11
imprinting O 0 0.0003291489265393466
defects O 1 1.0
, O 0 5.069141217894924e-10
and O 0 4.6849777529667236e-11
by O 0 1.0331441258060181e-10
mutations O 0 2.3279177696622355e-08
in O 0 2.898133955042681e-09
the O 0 5.8037628036800015e-08
UBE3A O 0 6.218774797162041e-05
gene O 0 1.2444240837794496e-07
. O 0 8.067199530614744e-08

UBE3A O 0 0.0034576451871544123
encodes O 0 9.804227119047937e-08
a O 0 1.4808806625410398e-08
ubiquitin O 0 8.09293609904671e-08
- O 0 3.5647129692506496e-08
protein O 0 1.0823567597739725e-09
ligase O 0 1.8809938329145126e-10
and O 0 1.6747529751892642e-10
shows O 0 6.119498796586242e-10
brain O 0 5.082570169179235e-07
- O 0 1.5178244439084665e-08
specific O 0 2.0326003991044672e-08
imprinting O 0 1.1519497093104292e-05
. O 0 1.798807431896421e-07

Here O 0 1.4731806459167274e-06
we O 0 3.090431732744037e-08
describe O 0 4.885226800865894e-08
UBE3A O 0 3.004315476573538e-05
coding O 0 1.7841194903667201e-06
- O 0 8.61821149555908e-07
region O 0 4.354776024229068e-07
mutations O 0 5.879595477153998e-08
detected O 0 3.2993476839493496e-09
by O 0 1.2656071503303057e-11
SSCP O 0 1.5028037978481734e-06
analysis O 0 8.245934490780371e-11
in O 0 1.157485392255797e-11
13 O 0 1.4814138804553068e-09
AS B-Disease 1 0.9844498038291931
individuals O 0 3.6444704892835134e-11
or O 0 2.0748642803880557e-09
families O 0 9.09901987089512e-10
. O 0 1.3889818184509295e-08

Two O 0 2.936949172749337e-08
identical O 0 2.3010247929278194e-08
de O 0 1.3108640359860146e-06
novo O 0 1.8958131477120332e-05
5 O 0 4.8454439820488915e-06
- O 0 8.142185379256262e-07
bp O 0 7.551657859039551e-07
duplications O 0 6.822296683139939e-08
in O 0 2.6939999120401126e-09
exon O 0 2.1832171626101626e-08
16 O 0 9.039691661882898e-09
were O 0 3.8262498724961347e-10
found O 0 4.1235731496058747e-10
. O 0 6.199412094787249e-09

Among O 0 1.832274598712047e-08
the O 0 1.5252821228273206e-09
other O 0 2.920070435452615e-11
11 O 0 4.70854966128087e-10
unique O 0 1.596021752259258e-11
mutations O 0 6.351803527593347e-09
, O 0 1.795031484563836e-10
8 O 0 2.5359502942023937e-08
were O 0 5.21525045371618e-10
small O 0 1.6653498025043234e-10
deletions O 0 3.4639908719213963e-09
or O 0 1.0705578645797686e-08
insertions O 0 4.06308657829868e-08
predicted O 0 7.701195841036679e-07
to O 0 2.132065546334161e-08
cause O 0 4.018488652945962e-06
frameshifts O 0 4.472122964216396e-05
, O 0 5.696563221135875e-10
1 O 0 6.348112435716757e-08
was O 0 5.64415536530305e-09
a O 0 1.3692680322918704e-10
mutation O 0 8.280640062530154e-11
to O 0 1.5037206202439535e-10
a O 0 4.134220465967786e-10
stop O 0 2.929512188387662e-09
codon O 0 7.857925865550897e-09
, O 0 1.0035373920747048e-10
1 O 0 1.34536444207356e-08
was O 0 4.125761954298923e-09
a O 0 5.084750953621153e-10
missense O 0 4.554956589686299e-08
mutation O 0 1.1517919951131717e-08
, O 0 3.523473179889436e-11
and O 0 1.4426777480980313e-11
1 O 0 3.2628580726168366e-08
was O 0 2.0943160095043822e-08
predicted O 0 2.774083895928925e-08
to O 0 3.48520934334573e-10
cause O 0 1.7676985430981063e-09
insertion O 0 2.634928497613487e-09
of O 0 4.478609039182402e-09
an O 0 3.792905711730299e-10
isoleucine O 0 5.111389782541664e-07
in O 0 1.2871427534921764e-10
the O 0 3.714014651379216e-10
hect O 0 1.1888869977383365e-07
domain O 0 4.3928000792448074e-08
of O 0 1.375370839440393e-08
the O 0 6.998468471408614e-09
UBE3A O 0 5.595132734015351e-06
protein O 0 2.861395209663442e-08
, O 0 1.8478262323040617e-11
which O 0 3.8790802167620875e-12
functions O 0 2.842574786665608e-11
in O 0 4.077240281508132e-11
E2 O 0 2.498067708245344e-08
binding O 0 2.0282243440306047e-08
and O 0 6.578525502121124e-10
ubiquitin O 0 2.6569841438117692e-08
transfer O 0 1.1068142384829116e-06
. O 0 1.0955862705941399e-07

Eight O 0 1.0534080274737789e-07
of O 0 1.939416405249972e-09
the O 0 2.1922699766641074e-10
cases O 0 7.367510768130359e-11
were O 0 1.886483885771284e-10
familial O 0 1.9691178465564008e-07
, O 0 1.228331991676157e-09
and O 0 5.019878956957768e-10
five O 0 7.04457436828676e-10
were O 0 1.1026543011993795e-09
sporadic O 0 9.680601920081244e-08
. O 0 1.2375987523682852e-07

In O 0 3.680577975728738e-08
two O 0 1.0294426422419178e-09
familial O 0 2.58810973718937e-06
cases O 0 8.601619327919252e-08
and O 0 1.8486494557379274e-09
one O 0 9.815650514610752e-10
sporadic O 0 1.6937077518264232e-08
case O 0 4.909557649313001e-09
, O 0 4.929604988102021e-11
mosaicism O 0 1.0035155355581082e-06
for O 0 1.9565817854783063e-09
UBE3A O 0 3.4947368021676084e-06
mutations O 0 1.172168140328722e-08
was O 0 7.139532853805974e-10
detected O 0 1.6479206887964892e-10
in O 0 1.0742497386431737e-12
the O 0 6.382640943547457e-12
mother O 0 3.8772088838123775e-12
of O 0 4.373122697298726e-11
three O 0 4.175068277212368e-11
AS B-Disease 1 1.0
sons O 0 3.268345238893744e-08
, O 0 4.9826141476638774e-12
in O 0 2.4963861273291643e-12
the O 0 4.399308348168596e-11
maternal O 0 5.505401023953027e-09
grandfather O 0 1.0880929934842243e-08
of O 0 1.6298296046102223e-08
two O 0 7.017297853906257e-10
AS B-Disease 1 1.0
first O 0 3.4647373858831543e-09
cousins O 0 5.605800268426719e-09
, O 0 6.2601208938861674e-12
and O 0 1.227147615294466e-12
in O 0 1.030482817132583e-11
the O 0 2.18426887688139e-10
mother O 0 5.494087476631826e-11
of O 0 1.1019521961586065e-09
an O 0 7.903797616393149e-10
AS B-Disease 1 1.0
daughter O 0 1.0255050256091636e-05
. O 0 5.210260383137211e-07

The O 0 3.648162305580627e-08
frequencies O 0 5.92132254340072e-09
with O 0 6.2815065648980095e-12
which O 0 3.6508157608139413e-11
we O 0 1.5590417845601223e-10
detected O 0 3.278594618016939e-10
mutations O 0 9.571949483033748e-11
were O 0 1.06368681224156e-11
5 O 0 1.807361482697445e-10
( O 0 9.448670144907023e-12
14 O 0 1.1105334429828417e-09
% O 0 9.997565275643439e-11
) O 0 2.4845060904443717e-12
of O 0 8.014918589926978e-11
35 O 0 1.277750460992877e-09
in O 0 1.8772582446868746e-11
sporadic O 0 2.675259125339835e-09
cases O 0 4.457640159771792e-11
and O 0 1.1969439328574083e-11
8 O 0 1.3333367743229019e-09
( O 0 1.5536382944048022e-11
80 O 0 8.106091353710099e-10
% O 0 6.961330817345512e-11
) O 0 1.7284870366604532e-12
of O 0 6.962366794205366e-11
10 O 0 1.9084300806326837e-10
in O 0 2.843919717776533e-11
familial O 0 2.0873848427527264e-08
cases O 0 4.64894922558301e-09
. O 0 1.857910825187048e-09
. O 0 2.290446055042139e-08

The O 0 1.733858880470507e-05
hemochromatosis B-Disease 1 0.9999998807907104
845 O 0 1.793323826859705e-05
G O 0 2.0289710391807603e-06
- O 0 1.3520842401248956e-07
- O 0 5.8672050329278136e-08
> O 0 7.302021742816578e-08
A O 0 3.5134323894681074e-08
and O 0 3.8631705473468614e-11
187 O 0 1.753954759209364e-10
C O 0 1.3106019380870748e-08
- O 0 4.728730296221784e-09
- O 0 7.53990381241465e-09
> O 0 1.0136189132481377e-07
G O 0 1.6706063377114333e-07
mutations O 0 4.346773607721843e-09
: O 0 3.953182399485389e-12
prevalence O 0 4.697050526303315e-10
in O 0 1.8285746181123663e-11
non O 0 2.4307469814743854e-08
- O 0 4.966588917909576e-08
Caucasian O 0 2.4008528498598025e-07
populations O 0 1.560161955183048e-08
. O 0 1.1885759043650523e-08

Hemochromatosis B-Disease 1 0.9708101153373718
, O 0 1.7217978154349112e-08
the O 0 3.5470051784614043e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 1.0230039038106042e-07
leads O 0 2.1945443506865558e-07
, O 0 1.643382652183334e-09
if O 0 5.17180751558044e-06
untreated O 1 0.9999963045120239
, O 0 3.398147735422796e-11
to O 0 5.1183626226247725e-09
progressive O 0 0.13341182470321655
iron B-Disease 1 0.9999402761459351
overload I-Disease 1 0.996553897857666
and O 0 3.7096543792358716e-07
premature B-Disease 0 0.0062353829853236675
death I-Disease 0 3.2592954084975645e-05
. O 0 3.8617184827671736e-07

The O 0 6.975201813474996e-06
hemochromatosis B-Disease 1 1.0
gene O 0 1.5528800076936022e-06
, O 0 5.164432881343828e-09
HFE O 1 0.9997792840003967
, O 0 9.115665555725627e-09
recently O 0 5.99770721976256e-09
has O 0 6.32295674152239e-11
been O 0 6.467791580089255e-11
identified O 0 2.0095808350717448e-10
, O 0 4.617949252161413e-12
and O 0 4.83241138077295e-12
characterization O 0 4.316675461524255e-09
of O 0 2.3657669157017835e-09
this O 0 1.993352843898677e-10
gene O 0 1.9751450475169463e-10
has O 0 6.426740216392002e-12
shown O 0 9.029367965124324e-13
that O 0 3.0809602373678413e-13
it O 0 4.4135412013458775e-13
contains O 0 5.099175747445839e-13
two O 0 3.767507573276818e-12
mutations O 0 1.6316072104505253e-10
that O 0 4.5886610483547585e-11
result O 0 3.148349803083761e-09
in O 0 5.6790132596518106e-09
amino O 0 4.744144632695679e-08
acid O 0 7.784620059680947e-09
substitutions O 0 3.479663224226215e-10
- O 0 1.24238463961035e-09
cDNA O 0 3.007197602045153e-09
nucleotides O 0 2.356991823937449e-10
845 O 0 1.2496521595295462e-09
G O 0 1.0140763784249884e-09
- O 0 6.566441279609592e-10
- O 0 1.662304072169718e-09
> O 0 1.494344026298222e-08
A O 0 4.016730770217691e-08
( O 0 1.1390062504279541e-10
C282Y O 0 7.372019439344513e-08
) O 0 3.92434869322944e-12
and O 0 3.1551441147248394e-12
187 O 0 1.3171989887705848e-10
C O 0 1.451792019935283e-08
- O 0 7.971720172861296e-09
- O 0 2.2616207573378233e-08
> O 0 2.516264032692561e-07
G O 0 5.532155569198949e-07
( O 0 1.7579747657592293e-09
H63D O 0 9.152881102636456e-05
) O 0 5.1381210397494215e-09
. O 0 4.45914309921136e-08

Although O 0 1.399888560627005e-06
hemochromatosis B-Disease 1 1.0
is O 0 5.8438182293230057e-08
common O 0 1.7699059995379685e-08
in O 0 4.263431829798492e-09
Caucasians O 0 6.072201017559564e-07
, O 0 3.8113764921909876e-10
affecting O 0 2.9371212129092328e-09
> O 0 8.410331986397068e-08
= O 0 1.2138601235278657e-08
1 O 0 1.0678459005930563e-07
/ O 0 3.8337688579304086e-09
300 O 0 9.925720835524121e-12
individuals O 0 4.487681114304781e-13
of O 0 4.020693066680847e-12
northern O 0 2.7670145688607484e-11
European O 0 1.0597283467417284e-10
origin O 0 2.9862307071581995e-10
, O 0 5.624394613240602e-12
it O 0 5.545564550103743e-13
has O 0 2.2151784529952923e-13
not O 0 6.801439836681689e-13
been O 0 2.1552111224149018e-12
recognized O 0 3.349868125945843e-12
in O 0 1.2715085061232312e-11
other O 0 6.913638498501351e-12
populations O 0 5.76193204260278e-10
. O 0 4.796111063853914e-09

The O 0 1.9252649963164004e-07
present O 0 5.408172576437664e-09
study O 0 1.7564522059032583e-10
used O 0 1.6192517812707585e-11
PCR O 0 2.1879423273141185e-10
and O 0 4.362375738420354e-11
restriction O 0 1.3552226008073376e-09
- O 0 1.1575946867736775e-09
enzyme O 0 1.5421192101072734e-10
digestion O 0 8.05980948648255e-10
to O 0 7.885242458982589e-11
analyze O 0 5.22544368886102e-11
the O 0 6.1233223352941124e-12
frequency O 0 3.0901695091678505e-10
of O 0 5.3528927818069505e-11
the O 0 4.6010622395398215e-11
845 O 0 2.5362731914668757e-09
G O 0 5.572592609581761e-09
- O 0 3.4496765444202993e-09
- O 0 3.73726782854078e-09
> O 0 6.5315441943880614e-09
A O 0 7.395183132530292e-09
and O 0 1.8785405522803167e-11
187 O 0 7.256443362857468e-11
C O 0 4.8487973636213155e-09
- O 0 1.9698449538196883e-09
- O 0 5.810472547551626e-09
> O 0 6.930815743544372e-08
G O 0 8.807952411871156e-08
mutations O 0 3.2003757421961154e-09
in O 0 3.392819358793986e-10
HLA O 0 1.1042923908632929e-08
- O 0 3.1465530181407075e-10
typed O 0 6.398880730840162e-11
samples O 0 3.709395204193333e-12
from O 0 4.898297913114025e-12
non O 0 1.5025687361003293e-09
- O 0 9.270097467428684e-10
Caucasian O 0 6.833129173600128e-09
populations O 0 1.313015113302285e-10
, O 0 6.252146695327754e-13
comprising O 0 1.0793184922197607e-12
Australian O 0 1.1547604539252632e-10
Aboriginal O 0 1.9014466390299134e-10
, O 0 5.8130683426582674e-12
Chinese O 0 3.2433455227076635e-11
, O 0 7.610375524214064e-11
and O 0 6.876348934703458e-10
Pacific O 0 2.8670831397903385e-07
Islanders O 0 4.736572520869231e-07
. O 0 9.512611143236427e-08

Results O 0 4.46138102461191e-07
showed O 0 5.337667197125029e-09
that O 0 7.919018912838638e-11
the O 0 2.8930624562661933e-10
845 O 0 4.88873830306602e-09
G O 0 1.3928339370750109e-08
- O 0 3.847797636069572e-09
- O 0 2.663731457630547e-09
> O 0 7.720828421042825e-09
A O 0 5.948989745263589e-09
mutation O 0 1.103887536935133e-09
was O 0 3.8460348794622234e-10
present O 0 2.2659266823987778e-11
in O 0 9.48550699791939e-12
these O 0 2.6312179431803306e-12
populations O 0 4.820940088107184e-12
( O 0 2.2375155114134904e-12
allele O 0 1.791436859965856e-10
frequency O 0 1.9819879071292235e-09
0 O 0 4.0674091872361373e-10
. O 0 4.880057729444998e-12
32 O 0 2.1424094442945574e-10
% O 0 9.88561454917658e-11
) O 0 5.558582240328125e-12
, O 0 1.1977819777686527e-11
and O 0 9.365739087052738e-12
, O 0 6.7530980807362084e-12
furthermore O 0 1.455633391600486e-10
, O 0 8.683480150206702e-12
it O 0 5.711603932867515e-12
was O 0 2.3715227559506502e-09
always O 0 3.044076102298732e-11
seen O 0 1.9595677511197174e-11
in O 0 1.0121984630670489e-12
conjunction O 0 1.1597084403902613e-11
with O 0 5.396708427363173e-11
HLA O 0 8.637822247692384e-06
haplotypes O 0 6.596423673954632e-08
common O 0 1.0647033477084733e-08
in O 0 2.4684214672276994e-09
Caucasians O 0 9.354401697692083e-08
, O 0 8.925646333146631e-11
suggesting O 0 8.258625450174861e-10
that O 0 1.2729092779828477e-10
845 O 0 2.4719755131741294e-08
G O 0 2.8185445444250945e-07
- O 0 1.8733557283212576e-07
- O 0 1.4381213020442374e-07
> O 0 5.44064107543818e-07
A O 0 5.720751232729526e-07
may O 0 1.080585398938183e-08
have O 0 1.1940184084513472e-11
been O 0 4.5434073170369516e-12
introduced O 0 2.1687736242309574e-12
into O 0 4.668482180697486e-12
these O 0 9.079342773487056e-14
populations O 0 7.123824100063736e-13
by O 0 2.5034956746550208e-12
Caucasian O 0 4.112015972168592e-08
admixture O 0 9.278133461521065e-07
. O 0 3.1048722348714364e-07

187 O 0 2.762985218396352e-07
C O 0 5.835174761159578e-07
- O 0 3.4126177439475214e-08
- O 0 1.530487736545183e-08
> O 0 1.0162825958559552e-07
G O 0 6.009802433482037e-08
was O 0 7.805579516073635e-10
present O 0 5.4003329585938786e-11
at O 0 9.654643751133563e-11
an O 0 1.2391263145769549e-12
allele O 0 7.01895416788112e-11
frequency O 0 5.073370612507233e-09
of O 0 3.046222385449937e-09
2 O 0 9.13810595193354e-07
. O 0 1.642444118488129e-07

68 O 0 6.756460606993642e-06
% O 0 6.050078837915862e-08
in O 0 2.3248626634941871e-10
the O 0 5.532462266089055e-10
two O 0 2.966948561833327e-11
populations O 0 3.590008151865831e-11
analyzed O 0 1.509752739492498e-10
( O 0 6.435379312774714e-11
Australian O 0 2.998726156278053e-09
Aboriginal O 0 6.382050998787747e-10
and O 0 3.756538483057348e-11
Chinese O 0 1.3057575853903103e-10
) O 0 4.415956211811789e-10
. O 0 1.4722852270665499e-08

In O 0 7.123352929738758e-08
the O 0 8.806134488281714e-09
Australian O 0 2.3932476000965153e-09
Aboriginal O 0 1.2878696720175498e-10
samples O 0 5.891021611498237e-12
, O 0 3.6359820319506464e-13
187 O 0 2.1008422432244878e-11
C O 0 8.639153392664412e-09
- O 0 3.3166482893420834e-09
- O 0 1.5103390538229178e-08
> O 0 1.1755954432146609e-07
G O 0 8.189395828139823e-08
was O 0 1.512719727259082e-09
found O 0 1.1485910963657253e-12
to O 0 3.883499424817138e-12
be O 0 1.055211907435849e-11
associated O 0 1.7031004384548964e-10
with O 0 4.0823608382645205e-11
HLA O 0 4.571204408421181e-05
haplotypes O 0 9.435649417355307e-08
common O 0 6.600221702512954e-09
in O 0 4.912150131097803e-10
Caucasians O 0 2.54117953346622e-08
, O 0 1.9803155643094428e-11
suggesting O 0 5.5122881953417746e-11
that O 0 3.4317162826702496e-12
it O 0 2.1732747979702483e-12
was O 0 2.411132404844807e-11
introduced O 0 1.852635449564599e-12
by O 0 7.674743653096616e-12
recent O 0 3.7115929774067524e-10
admixture O 0 1.0908321712577163e-07
. O 0 9.121131228084778e-08

In O 0 1.5762698524213192e-07
the O 0 2.744684479694115e-08
Chinese O 0 9.242502874151626e-10
samples O 0 7.534634721695355e-11
analyzed O 0 1.1873398098050103e-10
, O 0 2.8252981551513123e-12
187 O 0 5.115605508643206e-11
C O 0 2.2827164603000938e-09
- O 0 4.004517828448684e-10
- O 0 8.976818732797653e-10
> O 0 7.03263003387633e-09
G O 0 8.21887269353283e-09
was O 0 1.4236098411224418e-10
present O 0 7.585633510220902e-12
in O 0 6.9056782861509625e-12
association O 0 9.013370778909735e-12
with O 0 2.0891652123544713e-12
a O 0 6.454313195014549e-10
wide O 0 7.307661142874622e-09
variety O 0 7.802840595871885e-10
of O 0 1.9268956208406962e-08
HLA O 0 2.43787530962436e-06
haplotypes O 0 3.255647129662975e-08
, O 0 3.783452717787128e-11
showing O 0 1.5889295088000743e-11
this O 0 1.0084643189967046e-11
mutation O 0 1.3942147436551977e-10
to O 0 1.145680009195793e-10
be O 0 2.1220102064400947e-10
widespread O 0 2.3388562198078944e-09
and O 0 8.294883530046704e-11
likely O 0 1.5259841390502515e-08
to O 0 7.792136713646869e-09
predate O 0 5.650571779369784e-07
the O 0 1.7340769931095679e-09
more O 0 1.1339982772251567e-11
genetically O 0 1.8611019669823037e-10
restricted O 0 2.416644662162071e-10
845 O 0 8.023508080157171e-09
G O 0 9.391749244969105e-08
- O 0 7.351645336939328e-08
- O 0 1.0309016573728513e-07
> O 0 1.965020715033461e-07
A O 0 4.994480491404829e-07
mutation O 0 1.0219976331882208e-07
. O 0 1.2987692699084619e-08

Genotype O 0 2.2458192688645795e-05
- O 0 1.763396198839473e-06
phenotype O 0 3.2400242844232707e-07
correlations O 0 6.606458669011772e-07
in O 0 3.3154105238963893e-08
attenuated B-Disease 1 0.9699459075927734
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 3.699873559526168e-05

Germ O 0 0.0005147630581632257
- O 0 3.282290890638251e-06
line O 0 3.301269941857754e-07
mutations O 0 3.2289008800034935e-08
of O 0 4.985005186419755e-10
the O 0 6.132745700160314e-11
tumor B-Disease 0 1.9264840389610072e-08
suppressor O 0 2.4177268187486334e-07
APC O 0 9.86277903791688e-09
are O 0 9.066787251543751e-12
implicated O 0 7.346834696164706e-09
in O 0 2.908411511626241e-09
attenuated B-Disease 1 0.9999688863754272
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 1.3612215070679667e-06
AAPC B-Disease 1 1.0
) O 0 4.7773625333480396e-11
, O 0 1.258745386568949e-12
a O 0 4.540375020400944e-12
variant O 0 4.2636287389541394e-08
of O 0 0.014255810528993607
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 8.788299510342767e-07
FAP B-Disease 0 1.4620509318774566e-06
) O 0 7.726805306695894e-10
. O 0 7.821172154365286e-09

AAPC B-Disease 1 1.0
is O 0 1.7132315122125874e-08
recognized O 0 6.469916824514144e-10
by O 0 3.888334099144686e-11
the O 0 4.771036343775847e-10
occurrence O 0 7.121053968717206e-09
of O 0 1.7853123424060868e-08
< O 0 2.8578759156516753e-05
100 O 0 5.3372421149333604e-08
colonic B-Disease 0 2.674014467629604e-05
adenomas I-Disease 0 2.4457249310216866e-06
and O 0 2.510200380889671e-11
a O 0 3.08370308454986e-11
later O 0 6.960166332170559e-10
onset O 0 3.0485507522826083e-05
of O 0 8.202093340514693e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 5.314877427053943e-10
age O 0 1.2098502111257403e-07
> O 0 3.615231491949089e-08
40 O 0 4.887628524130605e-09
years O 0 4.0733716399898867e-10
) O 0 9.655067023661701e-11
. O 0 5.211872267096851e-09

The O 0 3.443479101861158e-08
aim O 0 1.6105228439755592e-07
of O 0 5.644994693909666e-09
this O 0 1.8868724638299028e-10
study O 0 1.9199232481614814e-10
was O 0 3.5338934556428114e-10
to O 0 9.513541343597609e-11
assess O 0 4.52668524886235e-09
genotype O 0 1.7633612969802925e-07
- O 0 3.501578191844601e-07
phenotype O 0 2.1046881215625035e-07
correlations O 0 1.7212040575032006e-06
in O 0 5.375963851861343e-08
AAPC B-Disease 1 1.0
families O 0 1.4718800400714827e-07
. O 0 1.5618090287716768e-07

By O 0 1.4449573981778485e-08
protein O 0 3.394971770376287e-08
- O 0 7.230573473293589e-09
truncation O 0 9.197123063131585e-08
test O 0 1.6173961725485242e-08
( O 0 1.735174504080561e-10
PTT O 0 1.9272084728072514e-07
) O 0 9.570812892212288e-12
assay O 0 5.322526308582098e-10
, O 0 2.193965929070396e-12
the O 0 4.229552905826717e-12
entire O 0 1.092834017724087e-10
coding O 0 9.507360454463765e-10
region O 0 9.356022623308036e-09
of O 0 2.586439507012983e-09
the O 0 1.2445143804384884e-09
APC B-Disease 0 5.096103983248668e-09
gene O 0 6.168538596584838e-11
was O 0 6.836067822924008e-11
screened O 0 8.419709374152262e-11
in O 0 1.8043217744553863e-12
affected O 0 3.788919525349321e-11
individuals O 0 2.4135389867230295e-11
from O 0 3.297575190686075e-08
11 O 0 5.867266736458987e-06
AAPC B-Disease 1 1.0
kindreds O 0 4.364312917459756e-05
, O 0 4.571663048125174e-10
and O 0 3.522263730681985e-11
their O 0 1.71135744464479e-11
phenotypic O 0 7.081409236775471e-09
differences O 0 4.066769321298125e-08
were O 0 4.787693796970416e-09
examined O 0 1.233559316915489e-07
. O 0 2.4785803631743875e-08

Five O 0 2.8876737445671097e-08
novel O 0 2.0888175633615447e-09
germ O 0 5.128630959916336e-07
- O 0 1.4665704206606733e-08
line O 0 1.2815685401790233e-08
APC B-Disease 0 6.151965603606868e-09
mutations O 0 7.087567754915369e-10
were O 0 3.604877160667819e-11
identified O 0 1.8393142564576692e-10
in O 0 1.2608804278446684e-10
seven O 0 1.6543648673206235e-09
kindreds O 0 3.2227501378656598e-06
. O 0 1.424811131300885e-07

Mutations O 0 5.890600505153998e-07
were O 0 5.972452532532202e-10
located O 0 2.0455651061901392e-10
in O 0 6.989639336069109e-12
three O 0 1.146610150576377e-12
different O 0 3.9660191363671826e-13
regions O 0 1.676977723352735e-10
of O 0 4.74256578453236e-10
the O 0 6.75725364551738e-10
APC B-Disease 0 2.0535095845986007e-09
gene O 0 1.8064516549287646e-10
( O 0 1.694771580018628e-11
1 O 0 3.947222637634695e-08
) O 0 3.628586667248079e-11
at O 0 3.390369318623243e-09
the O 0 9.36417193786454e-11
5 O 0 8.14342260291312e-10
end O 0 4.421234489626613e-09
spanning O 0 3.845178397909876e-09
exons O 0 4.461752745044123e-09
4 O 0 2.4999016190463408e-09
and O 0 2.5049774754482e-11
5 O 0 2.5417599136545732e-09
, O 0 5.216780132877297e-11
( O 0 3.641718870905919e-11
2 O 0 3.974053974786784e-09
) O 0 4.686808233178574e-12
within O 0 1.2434103746628011e-10
exon O 0 2.771923246491781e-10
9 O 0 2.8721161005051954e-09
, O 0 1.5155252053311585e-11
and O 0 1.5002648429129906e-11
( O 0 1.25538510142853e-10
3 O 0 3.2658405757501896e-08
) O 0 7.586852673879818e-11
at O 0 2.300830637125273e-09
the O 0 1.1180800035814897e-10
3 O 0 2.687420508351579e-09
distal O 0 1.00165699734589e-07
end O 0 2.5005038040148975e-08
of O 0 2.239555652039371e-09
the O 0 2.367708029638038e-09
gene O 0 4.6971426748143585e-09
. O 0 5.7688844812275875e-09

Variability O 0 7.675177039345726e-05
in O 0 2.405324384113783e-09
the O 0 3.378038959667151e-10
number O 0 1.3232173690091997e-10
of O 0 1.1817541434311352e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 4.566564166452736e-05
most O 0 3.155073424743193e-11
apparent O 0 2.3478130550813603e-09
in O 0 9.78160781539561e-12
individuals O 0 4.3312168088172065e-12
with O 0 3.4670723323554364e-12
mutations O 0 1.0047836696003287e-07
in O 0 6.258817464299682e-09
region O 0 7.480070053134114e-05
1 O 1 0.9998806715011597
, O 0 9.69632285574562e-09
and O 0 6.031802612938009e-09
upper O 1 0.9973393082618713
- O 0 0.00028541748179122806
gastrointestinal O 0 4.796479970536893e-06
manifestations O 0 9.816078818403184e-05
were O 0 4.638736506024088e-09
more O 0 2.0484884621918553e-11
severe O 0 9.9630668159989e-08
in O 0 3.993534114510311e-10
them O 0 1.5271851838694062e-10
. O 0 4.720260182722313e-09

In O 0 4.819973309366787e-09
individuals O 0 1.9466049605565416e-10
with O 0 2.3190555378804767e-11
mutations O 0 7.272162871885257e-09
in O 0 5.201353237005435e-10
either O 0 5.031979277703158e-09
region O 0 2.8438000754249515e-07
2 O 0 5.956679274277121e-07
or O 0 1.2411393690570094e-08
region O 0 2.193182382370651e-07
3 O 0 2.237456584452957e-07
, O 0 7.628439546714105e-11
the O 0 1.3731754622270387e-10
average O 0 6.276674735516963e-10
number O 0 2.2635000818116424e-10
of O 0 2.544088051337212e-09
adenomas B-Disease 0 1.8208634173788596e-06
tended O 0 3.5072238446787196e-09
to O 0 2.480076977118273e-10
be O 0 6.635988286651795e-11
lower O 0 6.527430818081825e-10
than O 0 2.0631298752737948e-11
those O 0 1.6470453473305113e-12
in O 0 9.509522076039945e-13
individuals O 0 1.2629394058327748e-12
with O 0 4.025558098669224e-12
mutations O 0 3.744088594714867e-09
in O 0 2.101191859393836e-10
region O 0 1.861700127392396e-08
1 O 0 1.8645827992713748e-07
, O 0 1.501060560571421e-11
although O 0 2.791877840024881e-11
age O 0 3.3580873637362174e-09
at O 0 1.3180366797982401e-09
diagnosis O 0 3.030402950798816e-08
was O 0 6.787441164668451e-10
similar O 0 2.4665192110973067e-10
. O 0 1.9550757457409418e-08

In O 0 2.9336860052353586e-07
all O 0 1.0326748167699407e-07
AAPC B-Disease 1 1.0
kindreds O 0 5.280659388517961e-05
, O 0 1.0048301773979418e-10
a O 0 1.7212969938285028e-10
predominance O 0 8.343641155761361e-08
of O 0 2.669160039658891e-07
right O 1 0.9999979734420776
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9992043375968933
rectal B-Disease 1 1.0
polyp I-Disease 1 0.9998514652252197
sparing O 0 1.4082360166867147e-06
was O 0 1.5903940209227585e-07
observed O 0 2.263256249079859e-08
. O 0 7.1021317715747045e-09

No O 0 0.00014806179387960583
desmoid B-Disease 1 0.9999995231628418
tumors I-Disease 1 1.0
were O 0 8.640920157176879e-08
found O 0 1.0297608321607754e-09
in O 0 2.0055755667325315e-10
these O 0 3.162135553402834e-10
kindreds O 0 2.4582213882240467e-06
. O 0 6.814428843426867e-08

Our O 0 1.3397672660175886e-07
data O 0 2.2242812036665782e-09
suggest O 0 1.5129447694661735e-09
that O 0 5.888148996158193e-11
, O 0 7.146177399830478e-11
in O 0 1.6406641600852367e-09
AAPC B-Disease 1 1.0
families O 0 3.5605050019427154e-09
, O 0 3.473136708787017e-11
the O 0 4.2265472371960655e-11
location O 0 1.0400865724236041e-09
of O 0 8.345240609664017e-10
the O 0 1.1468831440097915e-09
APC B-Disease 0 5.159847660252126e-08
mutation O 0 7.851202354913767e-08
may O 0 1.0021841134744136e-08
partially O 0 4.501177031102088e-08
predict O 0 2.110890839901458e-08
specific O 0 6.424651366465639e-10
phenotypic O 0 2.2747296668512718e-07
expression O 0 1.6421904547314625e-07
. O 0 7.635044596554508e-08

This O 0 7.368080368053143e-09
should O 0 4.583330159846355e-09
help O 0 8.715391602853728e-11
in O 0 5.362987397922181e-12
the O 0 1.688775204747306e-12
design O 0 2.8101118654255686e-11
of O 0 1.7213716563269088e-11
tailored O 0 5.839263794715777e-11
clinical O 0 6.331413260340923e-08
- O 0 9.044037518890491e-09
management O 0 1.3560060851958156e-09
protocols O 0 1.2601027776781848e-08
in O 0 7.460516232571379e-11
this O 0 3.380112509332456e-11
subset O 0 4.393040597960862e-09
of O 0 1.2156341488989142e-09
FAP B-Disease 0 4.2804551014796743e-08
patients O 0 1.0285026164069677e-09
. O 0 6.451433276488672e-10
. O 0 1.1826106316448204e-08

Wilms B-Disease 1 0.9999977350234985
' I-Disease 0 0.00013155849592294544
tumor I-Disease 0 0.0007319280412048101
1 O 0 5.198162398301065e-06
and O 0 1.9479477586514804e-08
Dax O 0 7.04369304003194e-05
- O 0 4.80243045331008e-07
1 O 0 9.528915256851178e-07
modulate O 0 2.6892575277770447e-08
the O 0 3.4005243065848845e-09
orphan O 0 1.7028877863367597e-08
nuclear O 0 4.4762205675397126e-07
receptor O 0 2.8053023015672807e-07
SF O 0 6.641367508564144e-05
- O 0 7.763330245325051e-08
1 O 0 1.0389350713069234e-08
in O 0 2.982301558485112e-11
sex O 0 1.2666576988673572e-11
- O 0 5.383258509100708e-12
specific O 0 8.154294080242597e-12
gene O 0 8.164460080228864e-11
expression O 0 8.613563751147524e-10
. O 0 6.669647056867234e-09

Products O 0 1.3475710147758946e-07
of O 0 5.4751925659957124e-08
steroidogenic O 0 1.9621531464508735e-05
factor O 0 1.679383956343372e-07
1 O 0 1.1717215642192969e-07
( O 0 3.9142758478938333e-10
SF O 0 0.0025918397586792707
- O 0 3.7999445794412168e-06
1 O 0 1.8473766658644308e-06
) O 0 2.709592550331763e-10
and O 0 7.543769497964092e-10
Wilms B-Disease 0 7.781973545206711e-05
tumor I-Disease 0 3.886460035573691e-05
1 O 0 3.561669075224927e-07
( O 0 2.3674179283617036e-10
WT1 O 0 1.8925663880509092e-07
) O 0 3.153436886615957e-11
genes O 0 2.9037250035002238e-11
are O 0 6.429091200382819e-13
essential O 0 1.6923230178322868e-11
for O 0 7.063511234250974e-12
mammalian O 0 4.449150381446998e-09
gonadogenesis O 0 7.036778981728276e-08
prior O 0 4.664430619527593e-09
to O 0 1.868551091632753e-09
sexual O 0 2.4288548949868982e-09
differentiation O 0 1.6954182058270817e-07
. O 0 1.7677196595400346e-08

In O 0 7.50285167328002e-08
males O 0 2.1211057799064292e-08
, O 0 8.400720119539073e-10
SF O 0 0.0008651088573969901
- O 0 5.648762908094795e-06
1 O 0 2.6706470634962898e-06
participates O 0 5.958400439709521e-10
in O 0 2.058526960002638e-11
sexual O 0 1.45672710005762e-11
development O 0 8.273658667901085e-12
by O 0 8.744589796196023e-13
regulating O 0 3.639575030245368e-10
expression O 0 1.8006551805171966e-10
of O 0 6.534680574432628e-10
the O 0 5.181282070054749e-10
polypeptide O 0 2.0504929310050102e-08
hormone O 0 4.4327663761833946e-10
Mullerian O 0 7.515295052940019e-09
inhibiting O 0 2.860788050895735e-09
substance O 0 1.0711644016225819e-08
( O 0 6.594379486912771e-10
MIS O 0 3.1195424526231363e-05
) O 0 1.3004591847831648e-09
. O 0 1.230513380079401e-08

Here O 0 2.006731165238307e-06
, O 0 8.519454475219845e-09
we O 0 3.258298075792254e-09
show O 0 2.3162317897007512e-10
that O 0 6.741544822386203e-11
WT1 O 0 6.04221850153408e-06
- O 0 2.285431037307717e-06
KTS O 0 0.00034087474341504276
isoforms O 0 1.1033642977054114e-07
associate O 0 7.06950675777307e-09
and O 0 2.490608934369032e-11
synergize O 0 1.003293448320619e-08
with O 0 3.167216489075031e-11
SF O 0 9.524146298645064e-05
- O 0 2.1140058947821672e-07
1 O 0 1.2267480542504927e-07
to O 0 2.7910180833146114e-09
promote O 0 1.089139445298315e-08
MIS O 0 6.968418892938644e-05
expression O 0 6.268257379815623e-08
. O 0 3.7136995700848274e-08

In O 0 2.0716068860338055e-08
contrast O 0 1.1535332689049937e-08
, O 0 9.228186215182177e-09
WT1 O 0 9.009162022266537e-05
missense O 0 2.4415687221335247e-05
mutations O 0 8.408613894062e-07
, O 0 4.5941608156629954e-11
associated O 0 1.1334064242696229e-10
with O 0 3.859942747375111e-12
male B-Disease 0 2.44077136279941e-09
pseudohermaphroditism I-Disease 1 1.0
in O 0 4.7619952425748124e-08
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.865872150119685e-06
fail O 0 5.0818831368815154e-05
to O 0 2.5781818635550735e-07
synergize O 0 3.814697265625e-06
with O 0 4.494714822556034e-09
SF O 1 0.999983549118042
- O 0 0.00016585300909355283
1 O 0 3.8703230529790744e-05
. O 0 1.372166877899872e-07

Additionally O 0 1.3220385142176383e-07
, O 0 3.1216138007827965e-10
the O 0 2.306572433052878e-10
X O 0 1.3327305168786552e-05
- O 0 1.2525709962574183e-06
linked O 0 3.0607495205003943e-07
, O 0 4.618815052648273e-11
candidate O 0 7.874725871381827e-10
dosage O 0 2.7043475370192027e-07
- O 0 1.6281704873222225e-08
sensitive O 0 6.145798892021048e-08
sex O 0 9.56766443849233e-10
- O 0 1.2892811263043313e-09
reversal O 0 9.989873817062289e-09
gene O 0 5.802273661537072e-10
, O 0 1.7423246179149032e-10
Dax O 0 2.2226658984436654e-06
- O 0 2.1879826306303585e-07
1 O 0 9.967426194634754e-06
, O 0 1.585129028036647e-09
antagonizes O 0 5.5122441722232907e-08
synergy O 0 3.3651659236966225e-09
between O 0 1.718785824778024e-08
SF O 0 0.00011073191126342863
- O 0 1.1660008425451451e-07
1 O 0 7.922097466916966e-08
and O 0 1.75476452812795e-10
WT1 O 0 2.9952070690342225e-07
, O 0 2.2960499820867675e-11
most O 0 1.966733633590456e-12
likely O 0 6.568266069928441e-11
through O 0 2.0844565223193667e-12
a O 0 1.5084770238482648e-11
direct O 0 1.030078591868211e-10
interaction O 0 8.082670088782606e-10
with O 0 2.5132676495509543e-10
SF O 0 0.08055413514375687
- O 0 1.7501857655588537e-05
1 O 0 1.408249772794079e-05
. O 0 1.1669931154756341e-07

We O 0 6.425337346627202e-07
propose O 0 3.8977933058959024e-07
that O 0 4.485508409146632e-09
WT1 O 0 2.0017456336063333e-05
and O 0 2.8007091756876434e-08
Dax O 0 1.3593101357400883e-05
- O 0 2.5485087817855856e-08
1 O 0 7.589324013679288e-08
functionally O 0 5.246521439516982e-09
oppose O 0 2.0707919823337306e-09
each O 0 2.350696373665251e-11
other O 0 3.707301392957829e-12
in O 0 4.2252576437640244e-11
testis O 0 8.712711974112608e-08
development O 0 1.1839280666947616e-09
by O 0 6.783425904322016e-11
modulating O 0 6.378065364742724e-08
SF O 0 0.00012577259622048587
- O 0 6.601394488825463e-07
1 O 0 5.14240809934563e-07
- O 0 1.5707438905110394e-08
mediated O 0 3.6279075743550493e-07
transactivation O 0 2.3060770217853133e-06
. O 0 1.9861734479320603e-09
. O 0 3.2356683998813196e-09

A O 0 1.3058590297987394e-07
mouse O 0 1.776923719276624e-09
model O 0 9.387460808696346e-10
for O 0 3.3186733361389997e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9999881982803345
centre O 0 3.0848761525703594e-05
mutations O 0 2.991455403389409e-06
. O 0 9.018081925660226e-08

Imprinting O 0 2.476655936334282e-05
in O 0 1.8168510251825865e-08
the O 0 1.358932522066425e-08
15q11 O 0 2.8468348318710923e-05
- O 0 5.318067337611865e-07
q13 O 0 8.706515473022591e-06
region O 0 2.6548260478875818e-08
involves O 0 5.445203732357129e-10
an O 0 5.6796359282351716e-11
imprinting O 0 1.0499318392476198e-07
centre O 0 2.4544323906638965e-08
( O 0 6.458595463998407e-11
IC O 0 1.3933462241766392e-06
) O 0 2.1106512371193986e-10
, O 0 2.6373391318057493e-11
mapping O 0 5.267294378441534e-10
in O 0 2.1382689022186874e-11
part O 0 3.932773204318174e-11
to O 0 3.033025497423125e-10
the O 0 2.617575323160537e-10
promoter O 0 1.5825899879473582e-07
and O 0 1.3189639658239827e-10
first O 0 1.0636330705082742e-09
exon O 0 1.51879753218509e-08
of O 0 6.750483549922137e-08
SNRPN O 0 0.04964212700724602
. O 0 7.05280797319574e-07

Deletion O 0 1.0321591616957448e-05
of O 0 3.856580121919251e-08
this O 0 7.278556646284073e-10
IC O 0 5.530575435841456e-06
abolishes O 0 8.425454893767892e-07
local O 0 1.263543714102866e-09
paternally O 0 2.3378750046987307e-09
derived O 0 4.050220922535708e-11
gene O 0 8.102527329634235e-12
expression O 0 5.380055775883186e-12
and O 0 2.4736010223631866e-13
results O 0 5.977426886794035e-12
in O 0 5.339089725886481e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 8.810567669570446e-05
PWS B-Disease 1 1.0
) O 0 3.985943308748574e-08
. O 0 1.3639524354402965e-07

We O 0 1.2045153141571063e-07
have O 0 5.94367610684543e-11
created O 0 1.0724533067163478e-10
two O 0 1.0888517171236956e-10
deletion O 0 7.412725722133473e-08
mutations O 0 6.90440131734249e-08
in O 0 7.400033363857972e-10
mice O 0 1.941415028738902e-09
to O 0 2.1855492970956902e-09
understand O 0 1.9215268309835665e-07
PWS B-Disease 1 1.0
and O 0 4.865491565197999e-09
the O 0 9.172640980104063e-10
mechanism O 0 4.7512509482317e-09
of O 0 5.420272564116146e-10
this O 0 4.3982117947649613e-10
IC O 0 1.9144410543958656e-05
. O 0 2.2710058544817002e-07

Mice O 0 7.98347537056543e-06
harbouring O 0 3.906403435394168e-06
an O 0 2.96751778705584e-09
intragenic O 0 8.774098205321934e-06
deletion O 0 2.0123770809732378e-06
in O 0 5.539518177499758e-09
Snrpn O 0 0.003769057337194681
are O 0 1.7772898708301454e-09
phenotypically O 0 9.058255272975657e-06
normal O 0 8.857497277858783e-07
, O 0 3.105240370393503e-11
suggesting O 0 1.3625776895676012e-10
that O 0 1.9741533061057304e-11
mutations O 0 5.154769056048281e-09
of O 0 4.800064790089209e-09
SNRPN O 0 0.000258454994764179
are O 0 5.2263412347874905e-11
not O 0 2.9294214276553987e-10
sufficient O 0 3.104645207585577e-09
to O 0 6.7895551403296395e-09
induce O 0 9.96338712866418e-06
PWS B-Disease 1 1.0
. O 0 1.7914948330144398e-05

Mice O 0 5.904082058805216e-07
with O 0 5.637242408984555e-11
a O 0 3.8328165641310363e-10
larger O 0 6.264140872680457e-10
deletion O 0 5.7967046274143286e-08
involving O 0 1.0274614492544742e-09
both O 0 3.8520620027071573e-10
Snrpn O 0 6.282540653046453e-06
and O 0 4.718853086060903e-10
the O 0 6.022708998187909e-09
putative O 0 4.842671842197888e-06
PWS O 1 1.0
- O 0 6.9037487264722586e-06
IC O 0 0.00015138280286919326
lack O 0 6.915129091566996e-08
expression O 0 1.5443040179974332e-09
of O 0 7.844174754190192e-10
the O 0 1.6291193394302184e-10
imprinted O 0 1.5856219670595806e-09
genes O 0 1.6344112729882454e-09
Zfp127 O 0 1.9549271712548943e-07
( O 0 5.078158032967295e-11
mouse O 0 1.7827934684078173e-09
homologue O 0 4.194462519535591e-07
of O 0 2.0399175681973247e-08
ZNF127 O 0 0.008853244595229626
) O 0 6.238163319238765e-09
, O 0 4.907039219403941e-09
Ndn O 0 1.2652016266656574e-05
and O 0 1.54431649690423e-08
Ipw O 0 3.065300688831485e-07
, O 0 2.425515621684582e-10
and O 0 6.326816848201133e-11
manifest O 0 1.015336259513333e-09
several O 0 2.697087171654733e-11
phenotypes O 0 4.0937644385508065e-09
common O 0 1.7046546396670692e-09
to O 0 4.229811736422562e-07
PWS B-Disease 1 1.0
infants O 1 0.8293279409408569
. O 0 1.0344514294047258e-06

These O 0 2.6286522958329783e-10
data O 0 5.58366269887145e-11
demonstrate O 0 5.116493340118211e-11
that O 0 1.4545773439900156e-12
both O 0 1.645811199997571e-12
the O 0 8.901465502197947e-12
position O 0 3.441433527040516e-10
of O 0 4.0683612728686924e-11
the O 0 1.0919417280097488e-11
IC O 0 7.736811369341012e-08
and O 0 2.2824355253026063e-11
its O 0 8.400359401139479e-12
role O 0 1.357238973986874e-11
in O 0 1.4266418992339713e-12
the O 0 1.3883805129871751e-12
coordinate O 0 1.591204078221775e-11
expression O 0 1.6945655989530906e-10
of O 0 8.943271123662555e-10
genes O 0 3.0176763865519263e-10
is O 0 3.9197707579763374e-12
conserved O 0 4.452235802254734e-11
between O 0 4.9131025636750536e-11
mouse O 0 3.5546879328940406e-10
and O 0 3.8798960572128394e-11
human O 0 2.0980241155488244e-10
, O 0 7.543747744531704e-12
and O 0 2.4311314680142138e-12
indicate O 0 2.2885439376896244e-10
that O 0 1.078195605713761e-11
the O 0 4.428149860680186e-11
mouse O 0 7.937180079853334e-11
is O 0 1.7573216102781397e-12
a O 0 1.6721435434213783e-12
suitable O 0 6.10075531759513e-11
model O 0 1.3615586089144038e-11
system O 0 7.390169726173568e-11
in O 0 1.4450434772383947e-11
which O 0 4.305370730067759e-12
to O 0 9.118125698925894e-11
investigate O 0 3.3836941581988356e-10
the O 0 6.09482395108607e-11
molecular O 0 4.3943457206374603e-10
mechanisms O 0 8.193918321630633e-10
of O 0 1.2157357065500918e-10
imprinting O 0 7.3381096754587816e-09
in O 0 9.573660440798104e-12
this O 0 4.186125838329113e-12
region O 0 8.819022179196168e-10
of O 0 2.267674381606355e-10
the O 0 9.293497221785074e-11
genome O 0 2.577799917968804e-10
. O 0 2.881310745550536e-10
. O 0 3.9083096758929514e-09

Mutations O 0 4.030837601476378e-07
of O 0 3.0299581510462303e-08
the O 0 5.373818723342083e-09
ATM O 0 1.5623347280779853e-05
gene O 0 3.799148995398127e-09
detected O 0 1.528375648263136e-08
in O 0 9.532576811244198e-11
Japanese O 0 2.3897468054201454e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.22803515195846558
: O 0 4.4034973584183845e-11
possible O 0 6.391080997758536e-09
preponderance O 0 8.725966438305477e-08
of O 0 7.474250107719627e-10
the O 0 1.3750363347941885e-10
two O 0 1.4932107633702785e-11
founder O 0 2.560366585413476e-09
mutations O 0 9.112085308515816e-09
4612del165 O 0 2.5342612843815004e-06
and O 0 7.946655777857359e-09
7883del5 O 0 0.0002954693918582052
. O 0 6.631891551478475e-07

The O 0 8.089309488923391e-08
ATM O 0 0.015779634937644005
( O 0 3.241426156819216e-06
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 4.193996261392385e-09
mutated O 0 9.402746359299385e-10
) O 0 1.0894120675009056e-11
gene O 0 3.890975389109208e-11
on O 0 1.6112956524594324e-09
human O 0 2.203741411577198e-09
chromosome O 0 3.325013312860392e-05
11q22 O 0 0.00013709816266782582
. O 0 4.2985035975107166e-07

3 O 0 9.381234121974558e-06
has O 0 1.377247094147549e-09
recently O 0 4.0729677963646793e-10
been O 0 3.701114414944584e-11
identified O 0 1.682962449955916e-11
as O 0 1.6717886569452695e-13
the O 0 1.0051065746840768e-13
gene O 0 1.6548538255868606e-13
responsible O 0 4.159947126353147e-12
for O 0 9.171525301374106e-13
the O 0 5.93348148392181e-11
human O 0 1.2597567433658696e-08
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9850678443908691
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.337340773323376e-08
. O 0 2.0493206420724164e-07

In O 0 3.0053857180689647e-09
order O 0 1.9592284739022858e-10
to O 0 6.466410046312987e-11
define O 0 9.35293176240748e-10
the O 0 8.511239456276964e-12
types O 0 1.1677619982108922e-10
of O 0 5.405302871963613e-10
disease O 0 3.851897645290592e-07
- O 0 7.525651213313722e-09
causing O 0 4.369935879822151e-08
ATM O 0 2.4401501832471695e-06
mutations O 0 1.4037635054364728e-08
in O 0 2.6404159414461503e-10
Japanese O 0 9.378749723509827e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.9704477810810204e-07
as O 0 1.1618522810508125e-10
well O 0 1.6808067090923196e-11
as O 0 8.863448169860177e-12
to O 0 3.984827398606505e-11
look O 0 1.4785218188650973e-11
for O 0 2.0984793763778598e-11
possible O 0 1.3331213466472036e-08
mutational O 0 1.6960050288616912e-06
hotspots O 0 1.8875877572099853e-07
, O 0 1.585965941908185e-10
reverse O 0 2.7651338996292907e-09
- O 0 3.24774845905651e-10
transcribed O 0 1.4085817234832376e-10
RNA O 0 2.1595009114250274e-10
derived O 0 5.7344506747269985e-12
from O 0 4.009206161503798e-12
ten O 0 8.93717478495093e-12
patients O 0 1.092457721507678e-12
belonging O 0 1.9021047757694642e-12
to O 0 2.252559597182291e-11
eight O 0 4.227837177572802e-11
unrelated O 0 9.798311051412156e-10
Japanese O 0 2.8763480486304616e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 3.2264981797425207e-09
was O 0 6.829298015986751e-09
analyzed O 0 8.711839583064318e-10
for O 0 3.289905847747576e-11
mutations O 0 2.049056063713195e-10
by O 0 1.1141645765710972e-11
the O 0 7.535554819027013e-11
restriction O 0 3.2487953993687313e-10
endonuclease O 0 1.8778413490849744e-08
fingerprinting O 0 4.461778502218294e-09
method O 0 9.180714855006045e-09
. O 0 2.179338487451332e-09

As O 0 3.3219553330354756e-08
has O 0 1.4719299390453244e-10
been O 0 4.09388564714952e-11
reported O 0 9.0358848875427e-12
by O 0 2.121785386277608e-12
others O 0 7.552591885229276e-11
, O 0 1.96027812038313e-11
mutations O 0 6.819636522159556e-10
that O 0 4.0307099324898843e-10
lead O 0 1.4347349974741519e-09
to O 0 8.20424439496037e-09
exon O 0 1.4795544700518803e-07
skipping O 0 4.015490162601054e-07
or O 0 3.203724219247306e-08
premature O 0 2.9131444989616284e-07
protein O 0 7.524417533488759e-09
truncation O 0 2.8255956863176834e-07
were O 0 9.755960483914805e-10
also O 0 2.3646412952715856e-11
predominant O 0 3.262912606771806e-09
in O 0 2.4646756857649166e-10
our O 0 2.2481920769479302e-09
mutants O 0 1.1119498211087375e-08
. O 0 7.498829113217198e-09

Six O 0 1.4004313264592838e-08
different O 0 1.650939975006427e-11
mutations O 0 2.84489765078888e-10
were O 0 1.854927669797668e-11
identified O 0 5.910382600005093e-11
on O 0 7.6554090844283e-10
12 O 0 3.1973720893141433e-10
of O 0 9.851375964986531e-11
the O 0 1.8493681586129185e-10
16 O 0 4.415975585203569e-09
alleles O 0 6.1349281210709705e-09
examined O 0 2.073819445058689e-07
. O 0 6.156992071737477e-08

Four O 0 7.660057477210103e-09
were O 0 1.7046352107641383e-09
deletions O 0 2.769759177567721e-08
involving O 0 2.3978579122285737e-09
a O 0 2.837377666153884e-09
loss O 0 2.313655578234375e-08
of O 0 4.1606931233673095e-08
a O 0 3.517903301997194e-09
single O 0 1.4907165502009434e-09
exon O 0 5.6789484226271725e-09
exon O 0 1.5021052846009297e-08
7 O 0 1.7542602392950357e-07
, O 0 4.4316841862901413e-10
exon O 0 2.9392074551992664e-08
16 O 0 7.823069836376817e-08
, O 0 1.4996083264051663e-09
exon O 0 8.105417492743072e-08
33 O 0 1.4095942901803937e-07
or O 0 2.895438910854864e-08
exon O 0 7.273386017914163e-07
35 O 0 1.6025619515858125e-06
. O 0 6.103743999119615e-08

The O 0 5.005991283724143e-07
others O 0 1.4612987264683852e-08
were O 0 2.9504734211371897e-09
minute O 0 2.3710721563929837e-07
deletions O 0 7.55044240463576e-08
, O 0 1.3820415922793927e-09
4649delA O 0 7.832984039168878e-08
in O 0 2.973750135026876e-09
exon O 0 1.2633184098831407e-07
33 O 0 7.671435753309197e-08
and O 0 7.878827035234792e-10
7883del5 O 0 3.2430464216304244e-06
in O 0 3.2493378654407934e-08
exon O 0 5.026528810958553e-07
55 O 0 8.976516028269543e-07
. O 0 6.07994792289901e-08

The O 0 7.896495048953511e-07
mutations O 0 4.982187533641991e-07
4612del165 O 0 4.969061592419166e-06
and O 0 1.356494916393558e-09
7883del5 O 0 3.612975206124247e-06
were O 0 1.4525389779862508e-09
found O 0 9.013783643097018e-12
in O 0 1.0519217875232245e-12
more O 0 5.720123945904612e-14
than O 0 8.312851275393829e-13
two O 0 3.387731447365011e-13
unrelated O 0 1.8383312233583027e-11
families O 0 3.7117710164139006e-13
; O 0 2.380737534196653e-12
44 O 0 1.2123554382625912e-09
% O 0 3.994265473927783e-10
( O 0 1.7035022698008717e-11
7 O 0 2.495491280285478e-08
of O 0 1.4210415066884252e-09
16 O 0 8.988177979674106e-10
) O 0 1.7094578790705084e-12
of O 0 9.553831684105951e-12
the O 0 6.776969176808256e-12
mutant O 0 1.9290770369995158e-11
alleles O 0 1.2110715208457634e-11
had O 0 2.0892777091718884e-11
one O 0 1.9424527090972088e-12
of O 0 1.761705538394498e-11
the O 0 4.9001504243140204e-11
two O 0 6.605176822160885e-11
mutations O 0 2.572895319019608e-08
. O 0 4.600603986659735e-08

The O 0 1.845526043098289e-07
4612del165 O 0 1.8016547983279452e-05
mutations O 0 2.0477649798067432e-08
in O 0 4.2154689461337824e-11
three O 0 9.70559244951874e-13
different O 0 1.9666725387980366e-13
families O 0 1.778640169175505e-12
were O 0 1.7266559709794294e-11
all O 0 6.03545295338459e-12
ascribed O 0 5.950802628440499e-10
to O 0 1.4672683901206796e-10
the O 0 1.1274813027650765e-10
same O 0 3.9072048374499957e-10
T O 0 1.3866102044346462e-08
- O 0 7.229263410124531e-09
- O 0 9.697173730671693e-09
> O 0 2.1988467935329936e-08
A O 0 1.548614214641475e-08
substitution O 0 1.0877645451046192e-09
at O 0 2.7436036775796424e-10
the O 0 4.6162583304532046e-12
splice O 0 3.830755712641576e-10
donor O 0 1.5751674964370466e-10
site O 0 1.0573767417199065e-09
in O 0 4.120797592044312e-10
intron O 0 3.0369126307050465e-06
33 O 0 1.792833586478082e-06
. O 0 1.0465289079775175e-07

Microsatellite O 0 3.09433089569211e-05
genotyping O 0 3.513613933137094e-07
around O 0 3.135978143831153e-10
the O 0 8.247004468220354e-11
ATM O 0 1.352842673441046e-07
locus O 0 1.6831060989375146e-08
also O 0 6.038319583928642e-12
indicated O 0 9.459133476497072e-11
that O 0 7.754505588000726e-13
a O 0 1.5171912337574867e-11
common O 0 7.564240206425765e-11
haplotype O 0 5.65091227144876e-08
was O 0 2.3179831387665217e-09
shared O 0 1.318376614475869e-12
by O 0 7.012229338854148e-13
the O 0 1.2384133649123719e-11
mutant O 0 3.208771096052665e-11
alleles O 0 5.572119501917605e-11
in O 0 1.988127197594114e-11
both O 0 1.0149872609055421e-10
mutations O 0 1.4458871078204538e-07
. O 0 1.1972566937856755e-07

This O 0 6.335844293658965e-09
suggests O 0 2.393772735587163e-09
that O 0 1.7924920228673535e-11
these O 0 5.581391685632875e-12
two O 0 1.6236713362705046e-11
founder O 0 2.751917138610338e-09
mutations O 0 4.8906687588612385e-09
may O 0 4.473478476541004e-09
be O 0 1.1037906144650833e-09
predominant O 0 1.0993075783005679e-08
among O 0 1.2697466342248553e-11
Japanese O 0 1.1063304716785183e-09
ATM O 0 3.4533260873104155e-07
mutant O 0 4.166331635246934e-08
alleles O 0 6.053033274611153e-08
. O 0 1.3900129047783594e-08

W474C O 0 0.000554701138753444
amino O 0 1.3196519148550578e-06
acid O 0 2.407850097085884e-08
substitution O 0 3.742546272889058e-09
affects O 0 7.310960725703808e-10
early O 0 6.779872219198069e-10
processing O 0 8.698922138172804e-10
of O 0 2.6583601986374106e-10
the O 0 5.458302906879986e-11
alpha O 0 7.938422141862134e-11
- O 0 3.3531797130614827e-12
subunit O 0 1.675487006080889e-11
of O 0 2.3847651284270022e-11
beta O 0 1.3024897826952042e-09
- O 0 1.5566112288034617e-10
hexosaminidase O 0 6.406800867608808e-09
A O 0 7.153259096170927e-10
and O 0 9.9078980696915e-13
is O 0 1.53465001123676e-12
associated O 0 2.550216635088809e-11
with O 0 6.9497324561851315e-12
subacute O 0 0.00021282907982822508
G B-Disease 0 6.274268525885418e-05
( I-Disease 0 1.8433189419297946e-09
M2 I-Disease 0 1.2743779734591953e-05
) I-Disease 0 4.5423220740303805e-09
gangliosidosis I-Disease 0 5.883543781237677e-05
. O 0 5.216922431827697e-07

Mutations O 0 8.146379855134001e-07
in O 0 2.9450366589856003e-09
the O 0 7.874669805119083e-09
HEXA O 0 7.582893886137754e-06
gene O 0 3.4239003299241233e-10
, O 0 4.140987466122459e-12
encoding O 0 6.431351545072017e-12
the O 0 5.5328071985050187e-11
alpha O 0 1.37139827272037e-10
- O 0 4.361766156590896e-12
subunit O 0 1.0372946251946402e-10
of O 0 1.3578403679215256e-10
beta O 0 5.968618044249752e-09
- O 0 1.7129724305675609e-09
hexosaminidase O 0 9.546473478394546e-08
A O 0 1.4185513919073856e-07
( O 0 6.934115504009242e-10
Hex O 0 2.0934797362315294e-07
A O 0 5.765378929822873e-08
) O 0 4.5536029807946576e-11
, O 0 1.2227020611266237e-11
that O 0 1.295887095548176e-11
abolish O 0 7.601305185289675e-08
Hex O 0 1.4451977392582194e-07
A O 0 4.107224782501362e-09
enzyme O 0 6.205181923846226e-10
activity O 0 4.520610552560811e-09
cause O 0 0.030089007690548897
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 5.74781910955835e-09
TSD B-Disease 0 0.000670509587507695
) O 0 3.0368690895343775e-10
, O 0 7.710665439475406e-11
the O 0 1.2968229823329125e-09
fatal O 0 3.4404049529257463e-06
infantile B-Disease 0 5.866148057975806e-06
form I-Disease 0 4.4595090287202765e-08
of I-Disease 0 7.5177445069130044e-06
G I-Disease 0 4.3038213334511966e-05
( I-Disease 0 5.76793557360844e-10
M2 I-Disease 0 2.1231192022241885e-06
) I-Disease 0 3.8896638687724305e-10
gangliosidosis I-Disease 0 7.2934182071549e-07
, I-Disease 0 2.279734873100736e-10
Type I-Disease 0 1.072209343533359e-07
1 I-Disease 0 1.3496121027856134e-05
. O 0 1.4176561080603278e-07

Less O 0 1.3908575056120753e-05
severe O 1 0.9996929168701172
, O 0 1.7248680705961306e-08
subacute O 1 0.6588634252548218
( O 0 1.493229206950275e-09
juvenile O 0 1.840004370023962e-05
- O 0 3.26884190826604e-07
onset O 1 1.0
) O 0 5.331104446781865e-09
and O 0 2.314578608775264e-07
chronic O 1 1.0
( O 0 1.956626638488501e-09
adult O 0 1.093721380129864e-06
- O 0 8.475454649214953e-08
onset O 0 0.00028478525928221643
) O 0 1.3937939344343953e-11
variants O 0 1.909398472665913e-10
are O 0 5.327995857007384e-12
characterized O 0 8.460696032663861e-11
by O 0 7.565751844462731e-12
a O 0 6.804664470783095e-11
broad O 0 2.4800403952696115e-09
spectrum O 0 5.2880967160717773e-08
of O 0 1.2299309348762222e-09
clinical O 0 1.1338875616218047e-08
manifestations O 0 1.731856613673699e-08
and O 0 1.8953734415294576e-11
are O 0 8.049380931761385e-13
associated O 0 2.144059756126193e-11
with O 0 1.680453194131959e-12
residual O 0 1.07290861706133e-06
levels O 0 7.788410272269175e-08
of O 0 2.9522537303705576e-08
Hex O 0 3.4352078159827215e-07
A O 0 3.2328198784625783e-08
enzyme O 0 4.569189915315519e-09
activity O 0 2.8796653950280415e-08
. O 0 8.92245477501774e-09

We O 0 3.8855753814459604e-07
identified O 0 9.375869858274655e-09
a O 0 3.137002657638277e-09
1422 O 0 1.7476587572673452e-06
G O 0 7.284506864380091e-07
- O 0 2.4346149984921794e-07
- O 0 1.6167675198630604e-07
> O 0 2.5662453140284924e-07
C O 0 1.1402407835703343e-06
( O 0 2.775658314302376e-10
amino O 0 2.409410893022823e-09
acid O 0 3.3051594794386574e-10
W474C O 0 8.088515413007258e-10
) O 0 4.8728812732925716e-14
substitution O 0 3.0420720196350226e-12
in O 0 7.003955792075911e-13
the O 0 1.827506678972468e-12
first O 0 8.475777371619309e-12
position O 0 2.0023151192649635e-10
of O 0 7.11112557727489e-11
exon O 0 5.057552709963886e-10
13 O 0 6.279369246797728e-10
of O 0 2.0160267899527184e-10
HEXA O 0 3.3298360904154833e-06
of O 0 1.139767502600364e-09
a O 0 1.4100096645819349e-09
non O 0 6.276273012417732e-08
- O 0 1.8157527037487853e-08
Jewish O 0 3.767925420561369e-07
proband O 0 0.048322033137083054
who O 0 2.3539696858421166e-09
manifested O 0 6.768540727897232e-10
a O 0 2.0012995427531877e-10
subacute O 0 4.85821942675102e-07
variant O 0 3.709062923462625e-08
of O 0 5.099177542433608e-06
G B-Disease 0 0.0001342528557870537
( I-Disease 0 4.395454666905607e-09
M2 I-Disease 0 4.721694131148979e-05
) I-Disease 0 7.803976131981472e-09
gangliosidosis I-Disease 0 0.00017672624380793422
. O 0 1.2194641385576688e-06

On O 0 2.3985558073036373e-06
the O 0 7.497484411089772e-09
second O 0 9.126000399817258e-09
maternally O 0 4.755786520149741e-08
inherited O 0 1.0822689944234298e-07
allele O 0 8.250540872722922e-08
, O 0 4.4642088636859256e-11
we O 0 2.742503446562239e-11
identified O 0 3.7632438831813886e-11
the O 0 2.755822132993746e-11
common O 0 3.193523667732734e-08
infantile O 1 1.0
disease O 1 1.0
- O 0 0.0009641827782616019
causing O 0 0.02696521393954754
4 O 0 3.944032869185321e-05
- O 0 4.147478307459096e-07
bp O 0 2.70838143023866e-07
insertion O 0 8.720359545577594e-08
, O 0 1.3700839351926675e-09
+ O 0 1.765357815486368e-08
TATC O 0 1.5261612134054303e-05
1278 O 0 1.2403357914081425e-06
, O 0 3.0206706580493403e-10
in O 0 5.095809330057932e-10
exon O 0 6.949255038080082e-08
11 O 0 6.591481138684685e-08
. O 0 1.558752060759616e-08

Pulse O 0 0.0001515763287898153
- O 0 5.617334863927681e-07
chase O 0 7.996298734269658e-09
analysis O 0 4.9761205572762535e-11
using O 0 1.0520712773187668e-10
proband O 0 4.649652680654981e-07
fibroblasts O 0 3.1797082300499824e-08
revealed O 0 7.768719001433055e-09
that O 0 4.722272226032054e-11
the O 0 2.45160391987298e-10
W474C O 0 2.0990029270251398e-08
- O 0 5.285167303803462e-10
containing O 0 1.628167912992584e-11
alpha O 0 5.228826260861297e-10
- O 0 3.224587610817231e-11
subunit O 0 4.3092529544708214e-10
precursor O 0 1.8045241967357128e-09
was O 0 1.5585490675817937e-09
normally O 0 4.596141522927866e-11
synthesized O 0 2.2794348353283311e-10
, O 0 2.4215067451205385e-11
but O 0 1.2216344255633338e-11
not O 0 3.696225270299891e-11
phosphorylated O 0 5.957957460722696e-10
or O 0 1.0267131589358769e-09
secreted O 0 3.421902206035554e-10
, O 0 3.005967350033778e-11
and O 0 2.412245576899341e-11
the O 0 3.895269107268007e-10
mature O 0 7.164992155139771e-09
lysosomal O 0 6.950501330038605e-08
alpha O 0 5.8894693566458045e-09
- O 0 2.6194832414283553e-10
subunit O 0 3.762099076709546e-09
was O 0 3.406463999766629e-09
not O 0 1.654582693078055e-09
detected O 0 3.711844343001758e-08
. O 0 9.156197577908642e-09

When O 0 1.5832073074761865e-07
the O 0 1.5717507295676114e-08
W474C O 0 5.95704307215783e-07
- O 0 4.485174454060825e-09
containing O 0 6.893732806823039e-11
alpha O 0 7.752166131247407e-10
- O 0 2.221421484260855e-11
subunit O 0 4.929475716508591e-10
was O 0 4.925302943270538e-10
transiently O 0 7.27956006585373e-09
co O 0 1.2016383721391577e-10
- O 0 1.0754193369155729e-10
expressed O 0 4.114379323350015e-11
with O 0 4.867099345079451e-12
the O 0 1.319985787340272e-10
beta O 0 1.1138533428933783e-09
- O 0 2.923140896005094e-11
subunit O 0 1.516902575771084e-10
to O 0 1.6428959581649138e-10
produce O 0 5.250342938190045e-10
Hex O 0 7.222898545933276e-08
A O 0 7.35746681357341e-08
( O 0 6.94416080193605e-10
alphabeta O 0 1.0032380259872298e-06
) O 0 2.0894462549048143e-10
in O 0 1.76032011189875e-09
COS O 0 2.604652536319918e-06
- O 0 1.4162021955144155e-07
7 O 0 1.0075510203932936e-07
cells O 0 2.304286983445536e-09
, O 0 2.767917145485299e-11
the O 0 6.309391897829641e-11
mature O 0 1.7217434422622802e-10
alpha O 0 5.6953435023654464e-11
- O 0 3.1516074472381916e-12
subunit O 0 5.933119273660026e-11
was O 0 1.8828173742324594e-10
present O 0 2.4096290934805253e-11
, O 0 2.0535064534227265e-12
but O 0 2.181518637608959e-12
its O 0 2.003979013981416e-12
level O 0 1.6025909488348589e-09
was O 0 8.698308184840187e-10
much O 0 9.152277546942145e-11
lower O 0 6.736072255542069e-10
than O 0 1.796116380625712e-11
that O 0 4.29408635385653e-12
from O 0 1.7175190436535814e-10
normal O 0 1.0613937506676052e-09
alpha O 0 2.2617564765514686e-10
- O 0 1.192211433742596e-11
subunit O 0 1.0472703260155924e-10
transfections O 0 4.525096741758716e-09
, O 0 5.667293349019553e-13
although O 0 3.201871276795054e-13
higher O 0 3.735824150030709e-11
than O 0 7.645857905136388e-12
in O 0 7.15072792645266e-12
those O 0 1.153252059821197e-11
cells O 0 1.0083994750331726e-10
transfected O 0 3.2193900323385094e-10
with O 0 2.634812669693315e-13
an O 0 4.19219823785677e-12
alpha O 0 2.842278079562277e-10
- O 0 4.154161389879896e-11
subunit O 0 1.628697732236617e-09
associated O 0 1.338353650126578e-09
with O 0 2.7881860709122464e-10
infantile O 0 0.0008892505429685116
TSD B-Disease 0 0.0018437285907566547
. O 0 5.708456569664122e-07

Furthermore O 0 8.283667511932435e-07
, O 0 1.662821103032286e-09
the O 0 4.903706329884017e-10
precursor O 0 1.1365377972083479e-08
level O 0 1.280117913893264e-07
of O 0 2.44185160980237e-09
the O 0 9.308350201742144e-10
W474C O 0 2.944077515110166e-08
alpha O 0 5.574971040367416e-10
- O 0 1.0831362716456905e-11
subunit O 0 1.280157507776991e-10
was O 0 2.8068988799923034e-10
found O 0 2.921673319944418e-12
to O 0 2.2521557535570835e-11
accumulate O 0 1.0835830843713978e-10
in O 0 5.839661653544992e-12
comparison O 0 4.799110553399544e-10
to O 0 1.5445867918018052e-09
the O 0 3.0213982427085284e-09
normal O 0 1.831299734078584e-08
alpha O 0 8.210694346644232e-09
- O 0 5.085508125723948e-10
subunit O 0 3.0137894402315624e-09
precursor O 0 1.0820869533745281e-08
levels O 0 9.37923250177164e-09
. O 0 2.4221373795541012e-09

We O 0 3.669153443297546e-07
conclude O 0 5.566836875914305e-07
that O 0 3.472370169177452e-10
the O 0 9.786357280106017e-10
1422 O 0 6.532748670906585e-07
G O 0 3.722522308180487e-07
- O 0 5.8839926708742496e-08
- O 0 2.0389684607380332e-08
> O 0 2.849168723173534e-08
C O 0 1.017392037283571e-07
mutation O 0 1.7551260445003436e-10
is O 0 9.370523020718613e-13
the O 0 1.5876684732532564e-12
cause O 0 5.56676760243846e-10
of O 0 3.0753655178017425e-09
Hex B-Disease 0 7.3969599725387525e-06
A I-Disease 0 0.00020933110499754548
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.997408105580689e-08
the O 0 2.296903112153359e-08
proband O 0 1.2722506653517485e-05
. O 0 1.682574293226935e-07

The O 0 1.6111542322505557e-07
resulting O 0 9.523775901243425e-08
W474C O 0 4.404341325425776e-06
substitution O 0 9.400440603712923e-08
clearly O 0 8.363378434239621e-09
interferes O 0 2.069852289565688e-09
with O 0 7.996193984727284e-12
alpha O 0 6.378971795228949e-10
- O 0 1.913502689632196e-11
subunit O 0 2.6815821785319827e-10
processing O 0 5.664081981215929e-10
, O 0 3.062658199964874e-12
but O 0 1.2349406436698573e-12
because O 0 3.1196466850763604e-12
the O 0 1.6943764100108005e-12
base O 0 1.0117163183609446e-11
substitution O 0 1.3821147004655643e-10
falls O 0 5.410958348051054e-09
at O 0 3.7943309605381614e-10
the O 0 2.5351195101497304e-11
first O 0 6.945442831973736e-11
position O 0 2.7897832932666233e-09
of O 0 9.746642382069126e-10
exon O 0 3.773518386651631e-09
13 O 0 4.606854009381323e-09
, O 0 3.043849547412769e-11
aberrant O 0 2.8051111433669007e-10
splicing O 0 9.857319405170983e-10
may O 0 4.109236284577378e-10
also O 0 7.062945714397806e-12
contribute O 0 9.446044640926132e-11
to O 0 3.932484560209559e-09
Hex B-Disease 0 7.199243555078283e-05
A I-Disease 0 0.0018629726255312562
deficiency I-Disease 0 0.03727966174483299
in O 0 1.20830856431553e-09
this O 0 2.6757693838419527e-09
proband O 0 1.9951862668676767e-06
. O 0 4.546638621150123e-09
. O 0 1.9655074012803198e-08

Two O 0 5.566834548886845e-09
frequent O 0 8.523485028888445e-09
missense O 0 1.0729273526521865e-05
mutations O 0 7.142983577068662e-06
in O 0 9.645073077990673e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.002368903486058116

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.1649821551884543e-08
an O 0 7.042807226298464e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 6.331920303637162e-07
by O 0 2.743048843623086e-10
early O 0 0.0013373938854783773
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 1.0
goiter B-Disease 1 1.0
. O 1 0.8867374658584595

A O 0 2.2736107041509968e-07
century O 0 1.812199457162933e-08
after O 0 6.03598837578545e-10
its O 0 1.9863370930711666e-12
recognition O 0 3.855117614026682e-11
as O 0 3.1227558733304406e-11
a O 0 1.90076954176277e-09
syndrome O 0 6.7428791226120666e-06
by O 0 4.924163507502577e-11
Vaughan O 0 2.096822093733408e-08
Pendred O 0 1.7670458873908501e-06
, O 0 7.080375868939726e-11
the O 0 8.961302810917005e-10
disease O 0 2.1113614820933435e-06
gene O 0 1.6998178864469082e-08
( O 0 3.779734747411112e-09
PDS O 0 1.8747956346487626e-05
) O 0 6.48232786892855e-11
was O 0 2.1652843962272073e-09
mapped O 0 3.6197700392648358e-09
to O 0 1.6063927077425433e-08
chromosome O 0 0.00010110149742104113
7q22 O 0 0.0015103314071893692
- O 0 2.3487482394557446e-05
q31 O 0 0.00018630018166732043
. O 0 4.146536980442761e-07

1 O 0 9.368111204821616e-05
and O 0 2.987657765629592e-08
, O 0 3.238335599675679e-09
recently O 0 2.2541703614820108e-08
, O 0 2.5287219540537365e-10
found O 0 9.373588710781533e-11
to O 0 5.784615564330409e-10
encode O 0 1.6090259125078887e-09
a O 0 8.759597491803106e-09
putative O 0 5.82477241550805e-07
sulfate O 0 1.5805327393536572e-06
transporter O 0 2.6564841391518712e-05
. O 0 1.7598249257844145e-07

We O 0 9.386644705955405e-08
performed O 0 1.4458492736402206e-10
mutation O 0 5.716773235353578e-11
analysis O 0 1.3147360804210972e-11
of O 0 1.8123393064062299e-10
the O 0 1.3552846622744141e-09
PDS B-Disease 0 6.717892392771319e-05
gene O 0 2.1769290814432907e-09
in O 0 1.2086837086755509e-10
patients O 0 7.297583370924343e-11
from O 0 1.3891633676710313e-10
14 O 0 7.269552182442851e-10
Pendred B-Disease 0 2.6660099905484458e-08
families O 0 1.5131559200076694e-12
originating O 0 7.175128980546619e-12
from O 0 1.7188290721281696e-11
seven O 0 6.52726223765443e-12
countries O 0 5.679824557729141e-13
and O 0 5.7563680384842275e-12
identified O 0 1.4492320676851023e-09
all O 0 7.613369934489356e-10
mutations O 0 2.643386487477528e-08
. O 0 3.2999349031115344e-08

The O 0 2.1346988887671614e-07
mutations O 0 2.149992894828756e-08
include O 0 1.223276618889102e-10
three O 0 5.743013356540594e-11
single O 0 2.348322647449663e-10
base O 0 3.797822945017515e-09
deletions O 0 3.119599512046989e-08
, O 0 7.300036686253009e-10
one O 0 3.150324168199603e-10
splice O 0 2.571423429742481e-08
site O 0 2.2353903172955825e-09
mutation O 0 2.0260813027306313e-09
and O 0 6.765739635206103e-10
10 O 0 5.53870762587394e-08
missense O 0 3.87372710974887e-05
mutations O 0 5.793791206087917e-05
. O 0 1.2527835906439577e-06

One O 0 8.288363062547432e-08
missense O 0 9.299819794250652e-07
mutation O 0 9.608454831777635e-08
( O 0 1.4843150319965304e-10
L236P O 0 5.204226454225136e-07
) O 0 3.3690161771460225e-11
was O 0 1.0045528853197538e-09
found O 0 1.0948489510831383e-11
in O 0 3.679910542953024e-12
a O 0 5.885936876781628e-11
homozygous O 0 6.381159489698973e-11
state O 0 2.678482956264272e-11
in O 0 1.6690759885307216e-11
two O 0 3.663732945496934e-12
consanguineous O 0 3.3505307328596245e-07
families O 0 1.46007692047867e-10
and O 0 2.2485759781920578e-11
in O 0 6.353760573230005e-11
a O 0 2.593497361313979e-10
heterozygous O 0 1.2784324987524798e-10
state O 0 3.108339280410988e-11
in O 0 5.552807345876598e-12
five O 0 1.9277151489666133e-12
additional O 0 1.0610262668464543e-11
non O 0 2.7192559315381004e-08
- O 0 1.8477308572073525e-07
consanguineous O 0 4.496098426898243e-06
families O 0 2.733951287581249e-09
. O 0 4.016041188492636e-08

Another O 0 1.7275355901347211e-07
missense O 0 3.701611149153905e-06
mutation O 0 2.217680901139829e-07
( O 0 4.892606875195327e-10
T416P O 0 7.477150347767747e-07
) O 0 1.724417830750724e-11
was O 0 5.485744636324341e-10
found O 0 4.343062801753783e-12
in O 0 2.4016396510395666e-12
a O 0 3.203377493821158e-11
homozygous O 0 1.5400117292507787e-10
state O 0 8.036441651038118e-11
in O 0 1.1575213010317498e-10
one O 0 9.815551843539438e-11
family O 0 9.513771714875219e-12
and O 0 1.2502177028014816e-12
in O 0 3.848371708109477e-12
a O 0 3.3094856716209264e-11
heterozygous O 0 7.800991796980128e-11
state O 0 7.499936782728867e-11
in O 0 5.360546034838265e-11
four O 0 4.7039334233334174e-11
families O 0 1.8306832438863552e-10
. O 0 9.701632386338588e-09

Pendred B-Disease 0 0.409600168466568
patients O 0 8.213890509978228e-07
in O 0 2.826682221623855e-09
three O 0 8.785125960031337e-10
non O 0 1.3283373334616044e-07
- O 0 6.06896435328963e-08
consanguineous O 0 4.184588306088699e-06
families O 0 4.0265990541854535e-10
were O 0 1.21435445032958e-10
shown O 0 1.2218021733234607e-11
to O 0 1.0016135837398465e-10
be O 0 7.677031232944387e-11
compound O 0 6.299642474338896e-10
heterozygotes O 0 1.6069159336495886e-09
for O 0 9.1914982569552e-11
L236P O 0 2.1465116333274636e-06
and O 0 6.533861451885059e-09
T416P O 0 4.39103132521268e-05
. O 0 1.7469460544816684e-07

In O 0 2.3057742382093238e-08
total O 0 1.8008183388928956e-08
, O 0 1.657263354326588e-10
one O 0 5.614665329889412e-11
or O 0 1.3893594608127557e-10
both O 0 2.5896059602237287e-11
of O 0 1.2729479970108315e-10
these O 0 2.5189906584233146e-12
mutations O 0 1.332573357215594e-10
were O 0 3.451845059787573e-11
found O 0 5.353584763001518e-12
in O 0 2.0263641025558554e-12
nine O 0 4.2139576550415114e-11
of O 0 4.606673376095216e-11
the O 0 1.4422300853578207e-10
14 O 0 2.867277526519274e-09
families O 0 5.400065117289188e-11
analyzed O 0 3.4822825512037525e-08
. O 0 4.6208310067186176e-08

The O 0 5.737763597579715e-09
identification O 0 2.200376991723374e-09
of O 0 3.553320526705761e-09
two O 0 1.6927693968771251e-10
frequent O 0 5.119690449362224e-09
PDS B-Disease 0 1.9496557797538117e-05
mutations O 0 3.968904849216415e-08
will O 0 7.664741064061786e-11
facilitate O 0 4.0964026615242233e-10
the O 0 2.9366156728549697e-10
molecular O 0 2.612874183682834e-08
diagnosis O 0 3.0540886655217037e-05
of O 0 2.3287009298655903e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 6.372969801304862e-05

Insertional O 0 4.561771493172273e-05
mutation O 0 1.958942874580316e-08
by O 0 1.0391045662805354e-10
transposable O 0 3.1683032375440234e-07
element O 0 1.8373005161720357e-07
, O 0 1.5209477011168815e-09
L1 O 0 4.077802077517845e-05
, O 0 2.7828622739534126e-10
in O 0 2.4355523153829495e-10
the O 0 1.0313456755284278e-08
DMD B-Disease 1 1.0
gene O 0 1.3113146124510422e-08
results O 0 5.711185413481701e-10
in O 0 1.2272213800734733e-10
X B-Disease 1 0.99956876039505
- I-Disease 0 0.008579950779676437
linked I-Disease 1 0.7090394496917725
dilated I-Disease 1 0.9928352236747742
cardiomyopathy I-Disease 1 1.0
. O 0 4.811351391253993e-05

X B-Disease 1 0.5794681310653687
- I-Disease 0 0.0005583066958934069
linked I-Disease 0 0.0033047429751604795
dilated I-Disease 1 0.999994158744812
cardiomyopathy I-Disease 1 1.0
( O 0 2.5982194529206026e-07
XLDCM B-Disease 1 1.0
) O 0 2.9427046910335264e-10
is O 0 3.254381833461828e-11
a O 0 4.667273859060295e-11
clinical O 0 2.922056596688094e-09
phenotype O 0 7.099575327629282e-08
of O 0 2.192205350581844e-08
dystrophinopathy B-Disease 0 1.4122604625299573e-05
which O 0 8.256920147609037e-11
is O 0 7.50253678627466e-12
characterized O 0 1.0325762814233919e-11
by O 0 1.4825903092013926e-12
preferential O 0 2.6611735037818107e-08
myocardial B-Disease 0 0.00027994741685688496
involvement I-Disease 0 5.086444332391693e-08
without O 0 2.443816815578259e-10
any O 0 4.1970188435769273e-10
overt O 0 5.670657277079272e-09
clinical O 0 4.024476396580212e-08
signs O 0 5.095063926319199e-09
of O 0 1.9041566190480808e-07
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.000147807746543549

To O 0 1.029168394950375e-08
date O 0 2.79840293160305e-07
, O 0 1.0181400167397214e-10
several O 0 1.057797252568271e-11
mutations O 0 1.994730602916661e-09
in O 0 1.386598197372635e-10
the O 0 1.9698985553873172e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9420522451400757
, O 0 6.738905540260021e-07
DMD O 1 1.0
, O 0 9.562086233927403e-09
have O 0 1.448311193197327e-10
been O 0 1.500397167619738e-10
identified O 0 1.3739222259889772e-10
in O 0 1.1447729916791438e-11
patients O 0 1.9689113187060236e-11
with O 0 9.832449091029538e-12
XLDCM B-Disease 1 0.9999995231628418
, O 0 2.3968429463394614e-09
but O 0 1.1977438485466507e-10
a O 0 6.288318477043475e-11
pathogenic O 0 3.674191506597424e-10
correlation O 0 5.5685758226786675e-09
of O 0 1.2243415170587468e-09
these O 0 4.4046145203369136e-11
cardiospecific O 0 5.126973405822355e-07
mutations O 0 4.6344766246875224e-08
in O 0 2.3825035277980078e-09
DMD O 1 1.0
with O 0 2.907544760510916e-10
the O 0 1.0203611289227865e-08
XLDCM B-Disease 0 0.0017677961150184274
phenotype O 0 1.5233224530675216e-06
has O 0 5.877301978429728e-10
remained O 0 6.22148887963192e-10
to O 0 1.2021472706180703e-10
be O 0 1.3838352685979771e-09
elucidated O 0 9.374081741952978e-07
. O 0 5.617084042341958e-08

We O 0 1.0180870191334179e-07
report O 0 2.505920193573985e-10
here O 0 1.634328609945168e-11
the O 0 5.395419354348174e-12
identification O 0 1.840583588319511e-11
of O 0 1.0190647631302951e-10
a O 0 2.120909559089057e-10
unique O 0 5.4850617103863186e-11
de O 0 4.848781642863287e-08
novo O 0 8.603225296610617e-07
L1 O 0 9.344083196083375e-07
insertion O 0 1.5805802888735343e-08
in O 0 3.034830997616922e-10
the O 0 1.690304424206701e-10
muscle O 0 1.9846310705950998e-10
exon O 0 4.367775030544863e-09
1 O 0 3.556468186616257e-08
in O 0 5.121816859521289e-10
DMD O 1 1.0
in O 0 7.901330256743222e-09
three O 0 7.771085996921556e-10
XLDCM B-Disease 0 0.17628756165504456
patients O 0 1.5034632427912697e-09
from O 0 1.7743725932994892e-10
two O 0 1.2795832102230342e-11
unrelated O 0 1.3715846236550533e-09
Japanese O 0 2.2904360630349174e-09
families O 0 1.5490173033150256e-10
. O 0 8.857141686746672e-09

The O 0 1.417425732341826e-08
insertion O 0 1.6121756374332108e-08
was O 0 1.0765737634699235e-08
a O 0 2.553595945808951e-10
5 O 0 8.587775490731531e-10
- O 0 1.4165324468962126e-10
truncated O 0 4.4769671303512837e-10
form O 0 2.321791786608074e-10
of O 0 8.246914262599603e-10
human O 0 2.475917804112271e-10
L1 O 0 4.2569492819666266e-08
inversely O 0 2.1933178828703603e-08
integrated O 0 2.445664337713538e-09
in O 0 5.975298034144316e-11
the O 0 1.0945696432562713e-10
5 O 0 4.464136171833388e-09
- O 0 7.773832244595269e-09
untranslated O 0 4.528424597083358e-06
region O 0 3.6529666402884686e-08
in O 0 5.161682747889529e-10
the O 0 4.455092406097094e-10
muscle O 0 2.544542909710401e-10
exon O 0 1.231360347020427e-09
1 O 0 1.967645424372222e-08
, O 0 1.989890240430836e-12
which O 0 8.841088668457009e-13
affected O 0 1.3240952605186873e-11
the O 0 5.763332953240274e-12
transcription O 0 3.835278969410716e-11
or O 0 1.3736149370724426e-11
the O 0 1.517859796185128e-11
stability O 0 3.5603742176704145e-10
of O 0 1.26417959434022e-10
the O 0 5.710430392436017e-11
muscle O 0 4.782769319477964e-11
form O 0 5.1966798919611534e-11
of O 0 6.731525892256229e-10
dystrophin O 0 5.20835152784116e-10
transcripts O 0 2.3658108805335587e-10
but O 0 4.530755111364915e-12
not O 0 5.912082455539203e-12
that O 0 1.1329469263784975e-12
of O 0 4.1679312778875044e-11
the O 0 1.6756093734748845e-10
brain O 0 1.615528475440442e-07
or O 0 6.95263313588157e-09
Purkinje O 0 3.113185357506154e-06
cell O 0 4.980529411113821e-07
form O 0 4.838025979836402e-09
, O 0 5.505503275493595e-10
probably O 0 9.792486821424973e-09
due O 0 4.102849970877287e-08
to O 0 2.5048163543317514e-10
its O 0 9.06516181564676e-12
unique O 0 2.0952508391486324e-12
site O 0 2.259764458889535e-10
of O 0 4.307280643267575e-10
integration O 0 8.124967365574776e-08
. O 0 8.106562177090382e-08

We O 0 3.0567534281544795e-07
speculate O 0 1.384821359806665e-07
that O 0 1.7827201520548286e-11
this O 0 5.5831381184923146e-12
insertion O 0 7.750732278211103e-10
of O 0 2.507770657800279e-10
an O 0 2.430159025401668e-11
L1 O 0 1.0836363628641266e-07
sequence O 0 7.395504209029014e-10
in O 0 2.421595979296143e-10
DMD O 1 1.0
is O 0 1.1069531957730305e-09
responsible O 0 8.81243134021048e-10
for O 0 6.702819722870235e-12
some O 0 1.628720053790944e-12
of O 0 1.921065216625717e-11
the O 0 2.7061911739290068e-12
population O 0 3.911448801571099e-13
of O 0 2.651571670564401e-12
Japanese O 0 3.3830230283804497e-10
patients O 0 3.001172227401483e-11
with O 0 9.398325867548962e-12
XLDCM B-Disease 0 0.004322191700339317
. O 0 3.0540252993205286e-08
. O 0 7.053360207009973e-08

Severe O 1 0.9990463852882385
early O 1 0.9771754741668701
- O 1 0.8827366828918457
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 8.910453470889479e-05
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 1.4952776837162673e-05
red O 0 1.7970902263186872e-05
hair O 0 0.0010270454222336411
pigmentation O 0 0.0002729386033024639
caused O 0 1.5415847656186088e-06
by O 0 2.524994080488341e-08
POMC O 0 0.007666701916605234
mutations O 0 3.1692204629507614e-06
in O 0 1.2704292728926703e-08
humans O 0 4.3652459424947665e-08
. O 0 1.8143541780091255e-08

Sequential O 0 4.121557140024379e-07
cleavage O 0 1.9687490748765413e-06
of O 0 6.965245802348363e-08
the O 0 1.7544308228423233e-09
precursor O 0 1.6569544625255617e-09
protein O 0 9.648646326354537e-10
pre O 0 1.587572313610508e-07
- O 0 8.319295119463277e-08
pro O 0 3.4464497389308235e-07
- O 0 5.047997433393903e-07
opiomelanocortin O 0 7.555896900157677e-06
( O 0 7.708688798402363e-09
POMC O 0 5.225609129411168e-06
) O 0 1.0894873891942325e-10
generates O 0 1.9301969744756065e-10
the O 0 3.17111087388966e-10
melanocortin O 0 1.1707274438776949e-07
peptides O 0 7.006294655553802e-09
adrenocorticotrophin O 0 7.326266882046184e-07
( O 0 1.0031436792345971e-09
ACTH O 0 2.9973188020449015e-07
) O 0 1.045555864109815e-10
, O 0 1.802920035487432e-10
melanocyte O 0 2.792383497762785e-07
- O 0 2.2717270553584967e-07
stimulating O 0 3.1709205927654693e-08
hormones O 0 8.087440050985606e-09
( O 0 5.5123090120234863e-11
MSH O 0 2.3523870140707004e-07
) O 0 4.467581860012615e-11
alpha O 0 7.905214816084083e-10
, O 0 4.5215697505596175e-12
beta O 0 1.3701910717145438e-09
and O 0 6.071734781620819e-11
gamma O 0 8.522623495821335e-09
as O 0 4.750176987866617e-11
well O 0 2.0712284318213925e-11
as O 0 1.823204434647785e-11
the O 0 3.580899118893477e-11
opioid O 0 4.283254195769359e-09
- O 0 1.386818437865145e-09
receptor O 0 1.579292696618495e-09
ligand O 0 1.1580591596782597e-08
beta O 0 6.299191568359674e-07
- O 0 4.143682019730477e-08
endorphin O 0 5.649197873935918e-07
. O 0 9.198891426365208e-09

While O 0 3.0192566669029475e-08
a O 0 7.546518410173064e-10
few O 0 1.2196793575114384e-10
cases O 0 1.6057845331207687e-10
of O 0 3.043086449494581e-09
isolated O 0 2.2073696527513675e-05
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 5.328712973096117e-07
been O 0 1.3358727457557507e-08
reported O 0 3.451131158627163e-09
( O 0 3.2747757283679846e-10
OMIM O 0 1.1276842997176573e-05
201400 O 0 5.458393843582598e-07
) O 0 2.1863977642255783e-11
, O 0 1.2107874598765722e-11
an O 0 1.0515095738572455e-10
inherited O 1 0.7336332201957703
POMC O 1 1.0
defect O 1 0.9999996423721313
has O 0 9.65168833744201e-09
not O 0 1.6516596978988218e-09
been O 0 4.1989564603106544e-10
described O 0 5.168342420702743e-10
so O 0 8.147442442929531e-11
far O 0 1.7635798377213519e-09
. O 0 7.077925801013407e-09

Recent O 0 2.586162963780225e-07
studies O 0 3.335922649227996e-09
in O 0 3.494480052546045e-11
animal O 0 7.730513278125795e-12
models O 0 2.5497193332363333e-12
elucidated O 0 2.9513627097799144e-09
a O 0 3.9126691470103836e-11
central O 0 6.576493238874548e-10
role O 0 4.677328524493873e-10
of O 0 2.1344324085958988e-09
alpha O 0 4.045887536108239e-08
- O 0 1.654132297801425e-08
MSH O 0 2.855139427992981e-06
in O 0 2.5368182554608154e-10
the O 0 1.8710392957199673e-10
regulation O 0 9.795171340698516e-10
of O 0 6.23437482194511e-11
food O 0 6.43945227002396e-12
intake O 0 6.896039728837566e-13
by O 0 4.987819917290012e-14
activation O 0 3.528128345031689e-10
of O 0 4.001458275837422e-09
the O 0 3.605066467571305e-09
brain O 0 1.5794823866599472e-06
melanocortin O 0 3.3219603210454807e-06
- O 0 2.2965227230997698e-07
4 O 0 1.0403395123148584e-07
- O 0 8.885211677522875e-09
receptor O 0 5.205474273850541e-09
( O 0 1.4418780058811365e-10
MC4 O 0 1.6460144252050668e-06
- O 0 2.7921961631705017e-08
R O 0 9.393017030845385e-09
; O 0 2.6125960769785017e-11
refs O 0 1.45007550411691e-09
3 O 0 6.749190095689528e-10
- O 0 1.2310522046199424e-10
5 O 0 1.3290957223688338e-10
) O 0 5.684821645542126e-13
and O 0 1.175670021405506e-12
the O 0 1.8062924420081394e-11
linkage O 0 1.3896814365921273e-08
of O 0 2.029283407978255e-09
human O 0 5.500617561438048e-08
obesity B-Disease 1 1.0
to O 0 6.040460132084036e-09
chromosome O 0 9.117675290326588e-07
2 O 0 1.157508506821614e-07
in O 0 1.3083029104521415e-10
close O 0 5.764209998204706e-09
proximity O 0 2.9078790486636308e-09
to O 0 8.538548201819651e-10
the O 0 1.0354193058503824e-09
POMC O 0 6.996441470619175e-07
locus O 0 2.7429836180203893e-08
, O 0 1.8235520732323707e-11
led O 0 3.985053606547773e-12
to O 0 1.9516740654146325e-12
the O 0 3.9995654357860566e-13
proposal O 0 1.5935487304719054e-11
of O 0 1.84181628282154e-11
an O 0 1.2540293239590716e-12
association O 0 2.1144216585944342e-11
of O 0 4.983591317397895e-09
POMC O 0 0.0004860176704823971
with O 0 8.784858396282402e-10
human O 0 7.198663297458552e-06
obesity B-Disease 1 1.0
. O 0 4.926346264255699e-07

The O 0 3.308291240955441e-08
dual O 0 8.383745608853133e-08
role O 0 6.031885391166725e-08
of O 0 3.427242916131945e-07
alpha O 0 4.5333936213864945e-06
- O 0 1.2584630439960165e-06
MSH O 0 9.88436586339958e-05
in O 0 4.093866134979862e-09
regulating O 0 1.8833436143950166e-08
food O 0 1.0466897348848647e-09
intake O 0 4.5142323212843394e-10
and O 0 1.1536964959757423e-11
influencing O 0 2.8722601186359498e-08
hair O 0 8.765732673055027e-07
pigmentation O 0 1.4577724414266413e-06
predicts O 0 7.017783687501833e-09
that O 0 3.489176612567202e-12
the O 0 2.281800096093356e-11
phenotype O 0 3.431825934541166e-09
associated O 0 1.8625437303576575e-10
with O 0 8.475093456888905e-13
a O 0 1.171050256765227e-09
defect O 0 5.455526093101071e-07
in O 0 6.728855805882006e-10
POMC O 0 2.4402106646448374e-06
function O 0 1.775463553954637e-09
would O 0 2.9216654096053674e-10
include O 0 8.592723199640773e-10
obesity B-Disease 1 1.0
, O 0 9.924556731988332e-10
alteration O 0 4.6487384679494426e-05
in O 0 5.903665396544966e-07
pigmentation O 1 0.9999285936355591
and O 0 3.772995114559308e-05
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 1.5756335415062495e-05

The O 0 1.3736850767998021e-08
observation O 0 3.5337461667950265e-07
of O 0 4.662226871232633e-08
these O 0 1.958945672342338e-09
symptoms O 0 5.333882654667832e-05
in O 0 2.6268793806849544e-09
two O 0 4.660390962030192e-10
probands O 0 8.348223445864278e-07
prompted O 0 3.8132910162858025e-09
us O 0 1.7509599326004377e-10
to O 0 3.556288596939794e-10
search O 0 1.1321921178364391e-10
for O 0 4.471953189699729e-12
mutations O 0 3.1642349851424e-10
within O 0 1.624447354409142e-09
their O 0 9.84582082530494e-10
POMC O 0 6.5543613345653284e-06
genes O 0 5.327122565290665e-08
. O 0 1.502578150791578e-08

Patient O 0 3.054452463402413e-05
1 O 0 1.4101698297963594e-06
was O 0 2.8371569982255096e-08
found O 0 3.4173476548549075e-11
to O 0 3.9504854248972876e-11
be O 0 5.058234733845701e-11
a O 0 4.923741275808524e-11
compound O 0 1.1059148041780986e-09
heterozygote O 0 8.581880206470771e-10
for O 0 3.390301234196258e-11
two O 0 2.0266201911089965e-11
mutations O 0 3.779545842963472e-10
in O 0 2.255832742825703e-10
exon O 0 9.903439845970752e-09
3 O 0 2.531301959152188e-07
( O 0 1.2129521831383272e-09
G7013T O 0 1.9677487216540612e-05
, O 0 9.239048415210505e-10
C7133delta O 0 1.5974227096648974e-07
) O 0 1.7257473228227127e-11
which O 0 1.0655854670860165e-11
interfere O 0 2.5796589864235386e-10
with O 0 5.926259374726406e-13
appropriate O 0 9.5424911028541e-11
synthesis O 0 1.7767916027366937e-09
of O 0 6.2050315996486916e-09
ACTH O 0 1.099972450901987e-06
and O 0 1.6319075868409527e-08
alpha O 0 1.4209522305463906e-06
- O 0 6.881799663460697e-07
MSH O 0 4.5753993617836386e-05
. O 0 5.4683148675849225e-08

Patient O 0 9.107202458835673e-06
2 O 0 1.2648108338453312e-07
was O 0 1.0548210305216799e-08
homozygous O 0 2.4117086105945873e-10
for O 0 3.1658696497682826e-11
a O 0 1.4299424144770256e-10
mutation O 0 9.282464796811496e-10
in O 0 1.767421209386555e-10
exon O 0 1.3462371661887573e-08
2 O 0 3.636311021182337e-07
( O 0 1.1602051541714786e-09
C3804A O 0 2.150970658476581e-06
) O 0 1.0356537849531833e-10
which O 0 2.1289302265525833e-10
abolishes O 0 2.5765621103346348e-06
POMC O 0 1.1469324817880988e-05
translation O 0 1.9448187060788769e-07
. O 0 1.2657881143240957e-07

These O 0 1.0466337796444236e-09
findings O 0 8.06894551175219e-10
represent O 0 4.005302686738155e-11
the O 0 2.0505564260475673e-11
first O 0 2.774057242596606e-12
examples O 0 3.967852522240856e-12
of O 0 5.7674264669627107e-11
a O 0 2.2192807591636665e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 3.057427644392874e-09
the O 0 9.1828994408516e-10
POMC O 0 4.72210814450591e-07
gene O 0 1.0742179368250504e-10
and O 0 4.588851434256247e-12
define O 0 5.712982864558569e-10
a O 0 8.413817559338455e-11
new O 0 2.0910728704137682e-10
monogenic B-Disease 1 0.9999778270721436
endocrine I-Disease 1 1.0
disorder I-Disease 1 0.9943597912788391
resulting O 0 8.005790697040993e-09
in O 0 7.499493387408407e-11
early O 0 1.5388804968097247e-06
- O 0 3.4145041354349814e-06
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 1.0849308637261856e-05
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 3.4641523143363884e-06
red O 0 1.41272607834253e-06
hair O 0 1.729799078020733e-05
pigmentation O 0 2.9173135771998204e-05
. O 0 4.5727841069265196e-08
. O 0 7.53401394604225e-08

A O 0 8.922099254959903e-07
European O 0 1.3423634470655088e-07
multicenter O 0 5.9612550103338435e-05
study O 0 1.177436672605836e-07
of O 0 4.1006387618836015e-06
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 6.776901706473382e-09
classification O 0 2.9044326055327474e-08
of O 0 4.3405378846728127e-08
105 O 0 4.223603866648773e-08
mutations O 0 8.620076208387673e-09
and O 0 5.1014963087236964e-11
a O 0 2.8174548805104394e-10
general O 0 4.2905046182539763e-10
system O 0 2.5641283540878135e-10
for O 0 4.1604650280469e-11
genotype O 0 1.2948661698430897e-08
- O 0 1.9847041787812714e-09
based O 0 2.3666774096042786e-10
prediction O 0 5.174700135057719e-08
of O 0 1.0655708315709944e-08
metabolic O 0 2.9476645067916252e-05
phenotype O 0 5.379597951105097e-06
. O 0 7.67979599913815e-08

Phenylketonuria B-Disease 1 0.9243243932723999
( O 0 2.88026512862416e-07
PKU B-Disease 0 0.031006889417767525
) O 0 2.520272657235978e-09
and O 0 1.6714891692970468e-09
mild B-Disease 1 0.9999994039535522
hyperphenylalaninemia I-Disease 1 1.0
( O 0 0.0960528776049614
MHP B-Disease 1 1.0
) O 0 1.8522884337457413e-09
are O 0 2.898082607227792e-10
allelic B-Disease 0 3.9717710023978725e-05
disorders I-Disease 1 0.7524023056030273
caused O 0 3.680585223264643e-07
by O 0 2.1325229082602704e-10
mutations O 0 2.5129573977267228e-09
in O 0 1.9025421515994623e-10
the O 0 5.329261476560987e-10
gene O 0 2.927823816722963e-10
encoding O 0 2.8421887066087947e-08
phenylalanine O 0 3.8259022403508425e-05
hydroxylase O 0 6.800686969654635e-05
( O 0 4.938891962069647e-08
PAH O 0 0.0002618226280901581
) O 0 1.0242374059998838e-08
. O 0 6.23556033474415e-08

Previous O 0 3.099842729170632e-07
studies O 0 4.042923329450332e-09
have O 0 1.588402326335725e-11
suggested O 0 7.903175336387847e-11
that O 0 9.403179190153876e-13
the O 0 6.5798620892121296e-12
highly O 0 1.2555713413409109e-11
variable O 0 2.5593621444386372e-08
metabolic O 0 0.0027985561173409224
phenotypes O 0 5.6597850743855815e-06
of O 0 0.000127051753224805
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 1.5146168152568862e-05
with O 0 7.823039993581915e-08
PAH O 1 0.9935387969017029
genotypes O 0 0.00010204975114902481
. O 0 3.1512928444499266e-07

We O 0 1.109850416014524e-07
identified O 0 1.522323267444392e-09
both O 0 3.67112139298964e-11
causative O 0 8.74454020305393e-09
mutations O 0 4.685063004217227e-09
in O 0 1.0477697875987957e-10
686 O 0 1.9073553403359256e-07
patients O 0 1.602960875146664e-09
from O 0 1.422174933374265e-09
seven O 0 1.381714742620943e-09
European O 0 1.0223364377281996e-08
centers O 0 6.596672541547832e-09
. O 0 9.906462317132991e-09

On O 0 1.5030862243747833e-07
the O 0 4.6555934107850305e-10
basis O 0 1.2396246251711318e-09
of O 0 9.066429551563004e-11
the O 0 1.030872175816766e-11
phenotypic O 0 1.6190651042080617e-09
characteristics O 0 2.3387880521141824e-10
of O 0 1.9548948571035396e-10
297 O 0 7.434765580960345e-10
functionally O 0 9.111098364655845e-08
hemizygous O 0 3.863393885694677e-06
patients O 0 3.1368652120278284e-09
, O 0 1.0523116232563634e-11
105 O 0 9.492537866861994e-10
of O 0 9.60283519368943e-11
the O 0 9.729252126167154e-11
mutations O 0 5.444702674828328e-11
were O 0 8.473854430646188e-12
assigned O 0 5.471308302251732e-12
to O 0 8.673912282874952e-12
one O 0 4.90598360547434e-12
of O 0 1.691974511885963e-11
four O 0 6.351915521340956e-12
arbitrary O 0 7.626843601116207e-10
phenotype O 0 5.970920113895772e-08
categories O 0 1.1947651756827327e-08
. O 0 8.836420484215068e-09

We O 0 1.5922969964776712e-07
proposed O 0 2.876723037559259e-08
and O 0 4.5831002881691063e-10
tested O 0 4.979636147872668e-10
a O 0 1.860384242491353e-11
simple O 0 4.24741101665016e-12
model O 0 8.958866634656282e-12
for O 0 2.5347263350739002e-12
correlation O 0 8.004438778463907e-11
between O 0 4.5999326570012045e-10
genotype O 0 3.393800085405019e-08
and O 0 1.4507828272058987e-10
phenotypic O 0 1.532854696506547e-07
outcome O 0 2.458441713315551e-06
. O 0 1.1008229705566919e-07

The O 0 6.565845467321196e-08
observed O 0 6.265362451074452e-09
phenotype O 0 1.0629076285795236e-08
matched O 0 7.867789753035481e-10
the O 0 1.9164109188452016e-10
predicted O 0 1.1567455437955232e-08
phenotype O 0 1.530626958512471e-09
in O 0 1.0185828569486688e-10
79 O 0 6.2026295211126126e-09
% O 0 1.2658835091272636e-09
of O 0 2.3257941406118476e-10
the O 0 1.0174332903956085e-10
cases O 0 2.66250077540775e-10
, O 0 3.228723538528655e-11
and O 0 1.7616987729729416e-11
in O 0 3.099577539078524e-11
only O 0 6.681010605857907e-11
5 O 0 3.1983682369229882e-09
of O 0 4.861667179945073e-10
184 O 0 2.5861928154569114e-09
patients O 0 2.6824364951494317e-10
was O 0 8.774291848645532e-10
the O 0 6.975844901724315e-11
observed O 0 1.719095421570671e-10
phenotype O 0 2.560692491382355e-10
more O 0 1.957260850789233e-13
than O 0 9.195452559118689e-13
one O 0 1.381633631288015e-12
category O 0 1.1788034437465456e-10
away O 0 8.58538032333378e-11
from O 0 2.1807208816504442e-11
that O 0 1.0859226712289782e-11
expected O 0 1.4497167022398116e-08
. O 0 2.7351994447144534e-08

Among O 0 8.836319231875223e-09
the O 0 4.14644540924769e-10
seven O 0 6.546903297266482e-11
contributing O 0 7.500151194550497e-11
centers O 0 1.4222656906370812e-11
, O 0 1.043254024835072e-12
the O 0 1.11618735088026e-11
proportion O 0 1.8908320742472284e-10
of O 0 1.8342868890464104e-10
patients O 0 9.25482884772677e-11
for O 0 2.8731215323540837e-11
whom O 0 5.892500376525334e-10
the O 0 7.676829727465417e-10
observed O 0 7.217603736897615e-10
phenotype O 0 1.0730845545481316e-08
did O 0 5.440874972784115e-10
not O 0 1.93007901327924e-10
match O 0 6.712653211060626e-10
the O 0 1.009650418826169e-10
predicted O 0 2.0538777345535664e-09
phenotype O 0 4.235410078212709e-10
was O 0 7.803674373363378e-10
4 O 0 1.337687516311803e-09
% O 0 4.124234009861283e-10
- O 0 1.3918081132047178e-09
23 O 0 1.3115947439246156e-08
% O 0 1.8344241681234053e-09
( O 0 2.748385408146703e-10
P O 0 3.1941624456521822e-06
< O 0 5.265712843538495e-07
. O 0 5.54709611577664e-10
0001 O 0 2.0588763050000125e-07
) O 0 7.423649368842877e-12
, O 0 6.0304127143251396e-12
suggesting O 0 1.3426022793527892e-10
that O 0 1.6966863677914112e-11
differences O 0 5.23115051276335e-10
in O 0 3.286236907595885e-11
methods O 0 2.2167583046961425e-10
used O 0 1.0804848335488337e-11
for O 0 1.6870248253919584e-11
mutation O 0 3.510059742861671e-10
detection O 0 8.285862662660293e-09
or O 0 2.725801251379778e-10
phenotype O 0 2.157699796612178e-08
classification O 0 6.932293405981227e-09
may O 0 2.363357287649137e-10
account O 0 3.0405753869561236e-12
for O 0 1.9398794636610317e-12
a O 0 8.219628103156573e-12
considerable O 0 6.387320533596252e-11
proportion O 0 1.0618528972772268e-10
of O 0 1.486825385033086e-10
genotype O 0 2.0246342558039032e-07
- O 0 1.261015995623893e-06
phenotype O 0 1.0245177008982864e-06
inconsistencies O 0 3.902219134488405e-07
. O 0 2.2016166667526704e-08

Our O 0 4.5148567551223096e-07
data O 0 7.815549096790164e-09
indicate O 0 4.62516691612791e-09
that O 0 9.400338146781095e-11
the O 0 7.925717304679836e-10
PAH O 0 5.087286808702629e-06
- O 0 5.441025408003952e-08
mutation O 0 1.0022562779710142e-09
genotype O 0 2.9842677218283598e-09
is O 0 2.2557745602003187e-12
the O 0 2.148381516089981e-12
main O 0 6.703846505695665e-11
determinant O 0 2.534667364884058e-09
of O 0 1.4361169198284784e-10
metabolic O 0 5.144591455064074e-07
phenotype O 0 7.974429649948434e-08
in O 0 2.2369929519872045e-10
most O 0 7.572988069970421e-11
patients O 0 4.186259783267587e-09
with O 0 1.875049626676173e-08
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.00102909782435745

In O 0 2.326621739712209e-08
the O 0 1.7608674518498901e-09
present O 0 1.125427750992003e-09
study O 0 6.575803235264743e-10
, O 0 7.321811559823921e-12
the O 0 2.738886201170132e-11
classification O 0 5.940667069381789e-09
of O 0 2.753735373062227e-08
105 O 0 1.0774169822980184e-06
PAH O 0 0.0001015989255392924
mutations O 0 8.516208538367209e-08
may O 0 2.4470363513273696e-09
allow O 0 1.516810010926406e-10
the O 0 7.715491440185573e-11
prediction O 0 3.1902100960934376e-09
of O 0 1.8342623253619905e-10
the O 0 5.404867178815387e-11
biochemical O 0 5.949009063144217e-10
phenotype O 0 6.016818598908458e-09
in O 0 2.355257378017228e-10
> O 0 8.679638341391183e-08
10 O 0 7.463711426680675e-09
, O 0 5.8132710450964353e-11
000 O 0 1.015475703525226e-09
genotypes O 0 1.9404236439868328e-08
, O 0 7.997750031685236e-12
which O 0 2.3454374293435665e-12
may O 0 8.482913677054782e-11
be O 0 1.8254208908330405e-11
useful O 0 2.8168193472177805e-11
for O 0 4.590409649618543e-12
the O 0 2.1785342627089754e-11
management O 0 1.7493707871185649e-10
of O 0 1.1145291356484677e-09
hyperphenylalaninemia B-Disease 1 1.0
in O 0 3.293590680186753e-07
newborns O 0 3.1379502729578235e-07
. O 0 1.9589950994713945e-08

Somatic O 0 0.0005808020359836519
instability O 1 0.8676386475563049
of O 0 2.446986036375165e-05
the O 0 4.840834208152955e-06
CTG O 1 0.6594660878181458
repeat O 0 3.7858844734728336e-06
in O 0 2.6187751966944006e-09
mice O 0 7.466043339121597e-10
transgenic O 0 6.037266242486794e-10
for O 0 1.481480216281028e-11
the O 0 2.3071677901498333e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.28334760665893555
is O 0 7.895424758430636e-09
age O 0 1.855545939122294e-08
dependent O 0 1.1044307690610822e-09
but O 0 7.130094691748523e-12
not O 0 1.5150629015248107e-11
correlated O 0 1.0549447426733138e-10
to O 0 6.29067006818751e-11
the O 0 2.5694389324537603e-11
relative O 0 1.5170045220003203e-09
intertissue O 0 3.740271736774048e-08
transcription O 0 6.412669062427767e-09
levels O 0 7.9199944380548e-09
and O 0 5.063633401469758e-10
proliferative O 0 1.6585318007855676e-05
capacities O 0 4.389550554151356e-07
. O 0 8.65393303683959e-08

A O 0 0.00033879480906762183
( O 0 2.701316077491356e-07
CTG O 0 0.00014569285849574953
) O 0 1.0388275795136792e-09
nexpansion O 0 1.2574648735608207e-06
in O 0 2.5835392158946036e-10
the O 0 7.105027677312137e-10
3 O 0 6.387853801470555e-08
- O 0 4.917272633520042e-08
untranslated O 0 4.7094985347939655e-05
region O 0 6.555809477504226e-07
( O 0 1.1651750675412131e-09
UTR O 0 2.988975029438734e-05
) O 0 1.811509969806835e-10
of O 0 3.563745964996201e-09
the O 0 1.3359390926837023e-08
DM O 1 1.0
protein O 0 1.741896937801357e-07
kinase O 0 1.0372762204724495e-07
gene O 0 6.950693354212945e-10
( O 0 9.298350284181467e-12
DMPK O 0 6.01351666773553e-06
) O 0 2.6175927744787053e-12
is O 0 1.6722775508098975e-12
responsible O 0 1.2837690632760967e-10
for O 0 6.32040045300819e-11
causing O 0 2.8200060114613734e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.703726062871283e-06
DM B-Disease 1 1.0
) O 0 2.1048441212201396e-08
. O 0 3.9503408544305785e-08

Major O 0 0.02629268355667591
instability O 1 0.9999998807907104
, O 0 2.3856879138861586e-08
with O 0 5.0304389126454296e-11
very O 0 3.274332471825403e-10
large O 0 1.9039761434136437e-10
expansions O 0 4.7683097470496705e-09
between O 0 1.0230971625446728e-08
generations O 0 1.7850969591393095e-09
and O 0 2.3857023995210724e-11
high O 0 2.311184577052927e-09
levels O 0 1.0920260251623404e-09
of O 0 3.9140740648591077e-10
somatic O 0 3.3796086995607766e-07
mosaicism O 0 1.0422404557175469e-05
, O 0 8.824318359357264e-11
is O 0 4.1472578843348984e-11
observed O 0 5.35148758640247e-10
in O 0 1.538822541613527e-10
patients O 0 1.2554671746656254e-09
. O 0 2.430413204024262e-08

There O 0 6.684155096081668e-08
is O 0 1.0894568580610553e-09
a O 0 8.363533199329254e-10
good O 0 3.66150082475869e-10
correlation O 0 8.266946571744427e-10
between O 0 6.864686596941283e-10
repeat O 0 6.31062535561e-09
size O 0 2.61535593182316e-09
( O 0 2.4722746072569635e-10
at O 0 1.0835656816254868e-08
least O 0 1.9085756586267877e-10
in O 0 3.08165090667778e-11
leucocytes O 0 4.263035080498412e-08
) O 0 2.9188006178682e-11
, O 0 7.256218629431155e-12
clinical O 0 4.564326971934207e-10
severity O 0 5.238085165615303e-08
and O 0 3.1314877774191174e-11
age O 0 6.1745129009693756e-09
of O 0 1.0947545092676592e-08
onset O 0 0.00011286914377706125
. O 0 2.1957627893698373e-07

The O 0 1.0555360859143548e-05
trinucleotide O 1 0.9170991778373718
repeat O 0 2.6548746063781437e-06
instability O 0 1.1689479833876248e-05
mechanisms O 0 2.589588632417872e-07
involved O 0 4.46478365390135e-09
in O 0 2.4970614465047447e-09
DM B-Disease 1 1.0
and O 0 5.605083508442021e-09
other O 0 4.055417390791405e-10
human O 0 1.9784354776675173e-07
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 5.568517869036782e-11
unknown O 0 1.606340660487149e-08
. O 0 4.335405812128101e-09

We O 0 8.64503022057761e-07
studied O 0 5.633939395011112e-07
somatic O 0 4.81638244309579e-06
instability O 0 3.2191405807679985e-06
by O 0 8.620926750246838e-10
measuring O 0 1.4333976423586137e-06
the O 0 1.6653006085221023e-08
CTG O 0 1.3088066452837666e-06
repeat O 0 4.9193156215210365e-09
length O 0 1.1594574189643936e-09
at O 0 1.0135053907234237e-10
several O 0 8.009699132248416e-13
ages O 0 7.573797144999617e-11
in O 0 3.2428181234028797e-12
various O 0 9.762558816905909e-12
tissues O 0 8.454876243568776e-10
of O 0 2.7470976604604402e-09
transgenic O 0 1.2839222129912287e-08
mice O 0 5.661619506547311e-10
carrying O 0 5.618007448138229e-11
a O 0 9.153329205702221e-10
( O 0 1.752250455844262e-09
CTG O 0 5.511715244210791e-06
) O 0 2.257145303996566e-10
55expansion O 0 3.6401067404767673e-07
surrounded O 0 3.262506376167096e-10
by O 0 4.373721437106459e-12
45 O 0 1.9188004518611024e-09
kb O 0 7.607120977581872e-08
of O 0 2.8984932232134497e-09
the O 0 3.966715844683222e-09
human O 0 1.783121490461781e-07
DM B-Disease 1 1.0
region O 0 2.731281529122498e-05
, O 0 4.166184897069769e-10
using O 0 3.8117400902315524e-10
small O 0 1.6954652126699443e-09
- O 0 8.31442203974575e-09
pool O 0 1.1992737913857354e-09
PCR O 0 7.18294446144796e-09
. O 0 9.74765157479851e-09

These O 0 9.210060625264305e-08
mice O 0 2.0973541126068085e-08
have O 0 4.372205028579934e-11
been O 0 5.034124853087185e-11
shown O 0 5.837512331158257e-12
to O 0 2.2131662821833764e-11
reproduce O 0 9.505869008608059e-11
the O 0 4.406614656504715e-11
intergenerational O 0 3.0890041635700527e-09
and O 0 1.3094712814076814e-10
somatic O 0 2.7245857836533105e-06
instability O 0 0.00596215995028615
of O 0 4.020870676413324e-07
the O 0 4.405696785170221e-08
55 O 0 3.281128613252804e-07
CTG O 0 3.3441569939896e-06
repeat O 0 9.085082020021673e-09
suggesting O 0 4.894231131480353e-10
that O 0 9.136680127752594e-12
surrounding O 0 4.4651622677083225e-11
sequences O 0 5.641498986713733e-12
and O 0 3.738578999330777e-13
the O 0 1.731258582673978e-12
chromatin O 0 2.481458649672419e-10
environment O 0 3.2781566350337243e-10
are O 0 1.0335333934172186e-12
involved O 0 2.158882100866677e-11
in O 0 9.436481457347767e-11
instability O 0 7.027335300335835e-07
mechanisms O 0 1.067180619429564e-06
. O 0 7.139580304738047e-08

As O 0 2.887255234895747e-08
observed O 0 7.426323112014188e-09
in O 0 2.6458441340637684e-11
some O 0 2.4313725945773745e-12
of O 0 8.426520592408338e-11
the O 0 2.3067077761784738e-11
tissues O 0 1.2051201703222603e-10
of O 0 3.295963946214897e-09
DM B-Disease 1 1.0
patients O 0 1.564746071380796e-06
, O 0 7.303933152735809e-11
there O 0 7.669626045370137e-11
is O 0 1.7453505654629886e-11
a O 0 3.069724682780439e-11
tendency O 0 1.2756265488356178e-10
for O 0 1.58878396550044e-11
repeat O 0 6.404573538176805e-10
length O 0 6.571690969181532e-10
and O 0 1.2821270434226761e-10
somatic O 0 1.0530765592875468e-07
mosaicism O 0 9.10850644686434e-07
to O 0 4.582593193802609e-10
increase O 0 7.99217289570997e-11
with O 0 7.323119975005676e-13
the O 0 6.448083733623378e-11
age O 0 2.6072424219591994e-09
of O 0 4.524956520590706e-10
the O 0 5.313376960636162e-10
mouse O 0 3.34100569432394e-08
. O 0 2.7527059742737947e-08

Furthermore O 0 1.3182745988160605e-06
, O 0 8.834263098833617e-09
we O 0 2.4729642777998606e-09
observed O 0 1.099575430707489e-09
no O 0 3.970314355061788e-11
correlation O 0 8.6554229061786e-11
between O 0 4.449892537783384e-11
the O 0 1.1527556686985463e-10
somatic O 0 1.428354767796236e-08
mutation O 0 1.8877456042787344e-08
rate O 0 1.6787907952675596e-08
and O 0 3.108103774351889e-10
tissue O 0 9.880877627210793e-08
proliferation O 0 1.3290638889884576e-05
capacity O 0 1.1193682780685776e-07
. O 0 7.66102488114484e-08

The O 0 3.56475112539556e-07
somatic O 0 2.5801052743190667e-06
mutation O 0 1.7354088299725845e-07
rates O 0 2.5466708741817e-09
in O 0 1.6209917089171633e-11
different O 0 4.8196351423723804e-12
tissues O 0 2.751752992136147e-10
were O 0 4.591357849470512e-11
also O 0 9.247055161518136e-13
not O 0 2.4698400876571602e-12
correlated O 0 3.192605207980037e-11
to O 0 3.113857782732765e-11
the O 0 1.1536992888805386e-10
relative O 0 6.943306374296299e-08
inter O 0 0.00020076321379747242
- O 0 5.017673174734227e-07
tissue O 0 8.629571368601319e-08
difference O 0 1.6536708669079303e-09
in O 0 5.058743354768858e-12
transcriptional O 0 1.4693800343135166e-10
levels O 0 1.5669091024683723e-10
of O 0 2.567024023902853e-11
the O 0 1.1303056580980186e-11
three O 0 2.6143796329203273e-12
genes O 0 1.5027220787167117e-11
( O 0 1.1251197890027598e-11
DMAHP O 0 1.8700422515394166e-05
, O 0 5.428280602792768e-10
DMPK O 0 7.04774574842304e-05
and O 0 5.861662266681833e-10
59 O 0 1.5514197926336237e-08
) O 0 1.2006159087751822e-11
surrounding O 0 3.3228012008557073e-10
the O 0 3.464458164792461e-10
repeat O 0 6.867937329957385e-09
. O 0 8.592723199640773e-10
. O 0 1.2697968898578438e-08

A O 0 1.3181320923649764e-07
novel O 0 7.4497452651201e-09
missense O 0 2.4221330932050478e-06
mutation O 0 1.1415132661340976e-07
in O 0 6.840401578500632e-10
patients O 0 5.315657913840255e-10
from O 0 3.514614987931708e-10
a O 0 1.369953261942669e-09
retinoblastoma B-Disease 0 5.263641469355207e-06
pedigree O 0 7.332865692433188e-08
showing O 0 7.947849045564226e-10
only O 0 1.570730212563376e-10
mild O 0 3.174715246245796e-08
expression O 0 1.3359542805346791e-08
of O 0 2.1811734640664326e-08
the O 0 3.609607501786627e-09
tumor B-Disease 0 4.160928313012846e-07
phenotype O 0 2.999789217028592e-07
. O 0 2.4058854464215074e-08

We O 0 2.1238916758647974e-07
have O 0 1.0687796481168022e-10
used O 0 3.3355120748757017e-11
single O 0 6.20780718496583e-11
strand O 0 1.4667535241930096e-10
conformation O 0 3.172500456782856e-11
polymorphism O 0 8.260196693310462e-11
analysis O 0 1.4099168881009927e-11
to O 0 5.4135331634119765e-11
study O 0 4.040151893591748e-11
the O 0 2.506583308969912e-11
27 O 0 1.5531836927706877e-09
exons O 0 7.324853168455547e-09
of O 0 2.0673182610231322e-10
the O 0 8.09709313487339e-11
RB1 O 0 3.857094910131309e-08
gene O 0 9.295867894887344e-12
in O 0 4.4633695068900525e-13
individuals O 0 6.830378276867499e-13
from O 0 1.372945090949429e-10
a O 0 8.519335792378513e-10
family O 0 2.914772936901677e-11
showing O 0 3.2561762314253784e-11
mild O 0 1.381075254158759e-08
expression O 0 9.169025538824371e-09
of O 0 5.9587023315543775e-08
the O 0 5.370765165935154e-09
retinoblastoma B-Disease 0 1.924046046042349e-06
phenotype O 0 5.006067112844903e-06
. O 0 7.747768648869169e-08

In O 0 1.0406664863182868e-08
this O 0 4.643470330467636e-10
family O 0 3.033550494135895e-11
affected O 0 2.371230815867431e-11
individuals O 0 1.5850361387986789e-12
developed O 0 1.144584693690831e-08
unilateral B-Disease 1 1.0
tumors I-Disease 1 1.0
and O 0 3.007982343206095e-07
, O 0 1.8554344172194703e-10
as O 0 1.071700280602661e-11
a O 0 3.483526314629337e-11
result O 0 4.4092901552161834e-10
of O 0 7.165808502129778e-10
linkage O 0 7.851364003386152e-09
analysis O 0 2.3277911542773921e-10
, O 0 1.456382583975291e-11
unaffected O 0 4.5216433375294685e-10
mutation O 0 6.718234302205417e-11
carriers O 0 2.656654410349013e-12
were O 0 7.954423578149239e-12
also O 0 6.809565389863381e-13
identified O 0 4.3451863634969e-11
within O 0 2.0519815013830822e-10
the O 0 3.533610626327288e-10
pedigree O 0 1.2343733146735758e-08
. O 0 2.6064334690545365e-08

A O 0 3.471696572887595e-06
single O 0 3.603177844979655e-08
band O 0 4.039979017989026e-09
shift O 0 5.979496342511936e-10
using O 0 7.853497713261604e-11
SSCP O 0 6.115686119301245e-05
was O 0 1.9587112376484583e-08
identified O 0 6.085092985053109e-10
in O 0 7.253274370011553e-11
exon O 0 7.7290462918711e-10
21 O 0 4.1126080319031644e-10
which O 0 1.7785350015647738e-12
resulted O 0 2.016272843130551e-10
in O 0 3.113703392343403e-11
a O 0 1.469151023059112e-09
missense O 0 5.34982916633453e-07
mutation O 0 8.596846612363152e-08
converting O 0 2.1624130042141587e-08
a O 0 8.139591223255138e-09
cys O 0 1.0376973023085156e-06
- O 0 3.3421341072426003e-07
- O 0 2.711942954647384e-07
> O 0 1.7239378280464734e-07
arg O 0 2.310660995874514e-08
at O 0 3.32526295387936e-09
nucleotide O 0 9.076815410402617e-10
position O 0 1.073108601978845e-09
28 O 0 1.102898328220192e-09
in O 0 4.078220400272059e-11
the O 0 1.0851866072414396e-09
exon O 0 8.851825583633399e-08
. O 0 5.671525116213161e-08

The O 0 4.2379926412650093e-07
mutation O 0 5.8852162254652285e-08
destroyed O 0 1.0204198730434655e-07
an O 0 3.0615401880318416e-10
NdeI O 0 5.153489155418356e-07
restriction O 0 4.5019756811370826e-08
enzyme O 0 1.829547180420832e-08
site O 0 2.210385297019002e-08
. O 0 6.5000271831650025e-09

Analysis O 0 6.021021015101269e-09
of O 0 2.1103232938912697e-08
all O 0 2.496383932903967e-10
family O 0 3.589857230923421e-11
members O 0 6.30382736028362e-13
demonstrated O 0 6.4972159596887735e-12
that O 0 1.093404230004258e-12
the O 0 5.525119944893575e-11
missense O 0 2.154015277255894e-08
mutation O 0 7.210909558352796e-08
co O 0 7.111024213912742e-09
- O 0 3.55971216947637e-08
segregated O 0 2.536653942453171e-10
with O 0 6.964378618072586e-13
patients O 0 2.7627022891607567e-10
with O 0 6.580056499672082e-10
tumors B-Disease 1 1.0
or O 1 0.9999998807907104
who O 0 4.547622665995732e-06
, O 0 8.391460443180065e-11
as O 0 1.4389101021805573e-11
a O 0 3.871335890748284e-11
result O 0 2.92456447947842e-10
of O 0 9.867026085075281e-10
linkage O 0 3.248109337050664e-09
analysis O 0 5.336615593876104e-10
had O 0 6.105438377090877e-10
been O 0 1.0180001980275577e-10
predicted O 0 1.4124241776158897e-09
to O 0 6.94928559141772e-11
carry O 0 5.719837797846239e-11
the O 0 1.9806489781615255e-10
predisposing O 0 4.844251932922816e-08
mutation O 0 9.561306058003538e-08
. O 0 2.414491007129982e-08

These O 0 3.907534296132553e-09
observations O 0 3.172632645487283e-08
point O 0 1.9160694364472874e-08
to O 0 7.2908637460678e-11
another O 0 7.459847323199043e-11
region O 0 3.645030499654922e-09
of O 0 1.6849683870390209e-09
the O 0 1.69142766459629e-09
RB1 O 0 9.531260047879186e-07
gene O 0 1.190571974341026e-09
where O 0 2.9983071581085596e-10
mutations O 0 5.025033167349591e-10
only O 0 1.355355584709006e-11
modify O 0 2.0756549257150425e-10
the O 0 6.992763312840822e-11
function O 0 2.506488905318349e-10
of O 0 1.6443443828784154e-10
the O 0 8.398889916882979e-11
gene O 0 3.43089341658942e-11
and O 0 1.674875841316259e-12
raise O 0 4.4356143757973143e-11
important O 0 1.541365646229309e-11
questions O 0 4.6097320405280584e-11
for O 0 1.2094026301257e-11
genetic O 0 5.366781685722799e-09
counseling O 0 1.665102083991954e-10
in O 0 1.1169790136225655e-12
families O 0 6.768826493232238e-13
with O 0 1.1134261644184934e-13
these O 0 2.578785709278497e-12
distinctive O 0 6.470345786935283e-11
phenotypes O 0 7.590696071702041e-09
. O 0 2.6288140553276662e-09
. O 0 2.1743696621001618e-08

Maternal B-Disease 0 5.4282587370835245e-05
disomy I-Disease 0 0.00043494050623849034
and O 0 6.0339898482197896e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 1.3160864000383299e-05
with O 0 6.517773126768489e-11
gamete O 0 6.963425391859346e-08
complementation O 0 4.306186383473687e-06
in O 0 1.0672660671895429e-10
a O 0 1.5946015341494757e-10
case O 0 3.3387488329594817e-09
of O 0 4.895727379050641e-09
familial O 0 5.610802986666386e-07
translocation O 0 2.301576932950411e-05
( O 0 3.5225813932449057e-10
3 O 0 3.141986582022582e-08
; O 0 7.81657100157318e-11
15 O 0 6.711836864070619e-09
) O 0 3.1220172280743697e-11
( O 0 6.818800385444135e-11
p25 O 0 1.9364460968063213e-07
; O 0 1.7768991833477799e-10
q11 O 0 5.65145569453307e-07
. O 0 5.94047144808485e-10
2 O 0 2.732837067753735e-08
) O 0 5.239119138522597e-10
. O 0 1.2904380675138327e-08

Maternal B-Disease 0 0.06843670457601547
uniparental I-Disease 1 0.9987809062004089
disomy I-Disease 1 0.9911704063415527
( I-Disease 0 6.558848326676525e-07
UPD I-Disease 1 1.0
) I-Disease 0 4.045675461306075e-10
for I-Disease 0 1.4847396923034495e-10
chromosome I-Disease 0 3.6194234098729794e-07
15 I-Disease 0 5.253210311195744e-09
is O 0 5.546805202649718e-12
responsible O 0 1.2384850089919297e-10
for O 0 2.6520573931376745e-12
an O 0 2.4917145170083588e-12
estimated O 0 8.96803534211621e-11
30 O 0 1.4505338596926265e-10
% O 0 1.073357288466914e-11
of O 0 1.6228282823452234e-12
cases O 0 1.6770791352871406e-11
of O 0 2.8439783861244905e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.0001208711983053945
PWS B-Disease 1 1.0
) O 0 8.246183114124506e-08
. O 0 3.3188084103130677e-07

We O 0 2.1587169385384186e-07
report O 0 2.0861490312995556e-10
on O 0 4.200302328172256e-10
an O 0 8.506803659928674e-13
unusual O 0 7.621716625882957e-12
case O 0 2.337508242522546e-10
of O 0 3.310345886298194e-10
maternal B-Disease 0 4.015987897787454e-08
disomy I-Disease 0 5.180357220524456e-06
15 I-Disease 0 1.5136907904889085e-07
in O 0 4.3938452876091105e-09
PWS B-Disease 1 1.0
that O 0 6.078855196989252e-09
is O 0 2.4400859111040063e-10
most O 0 3.435770114593173e-12
consistent O 0 1.2635665083693404e-11
with O 0 5.6200673319772507e-14
adjacent O 0 2.523325715042546e-10
- O 0 1.8096391052324634e-09
1 O 0 4.790720140590565e-07
segregation O 0 1.1935830102061118e-08
of O 0 6.341096397965984e-11
a O 0 1.6618657838751716e-10
paternal O 0 1.079543032744823e-08
t O 0 2.8197411072738987e-09
( O 0 6.30469981777182e-11
3 O 0 1.302930208169073e-08
; O 0 1.2279004202309096e-10
15 O 0 8.987702138085751e-09
) O 0 5.5144864369305324e-11
( O 0 1.4916087809346834e-10
p25 O 0 2.3671071858188952e-07
; O 0 2.154481454352819e-10
q11 O 0 2.6877404479819234e-07
. O 0 8.044968857756629e-11
2 O 0 9.300417103119685e-10
) O 0 1.5562772424926319e-12
with O 0 5.318489247098379e-13
simultaneous O 0 8.198327572372932e-10
maternal O 0 6.774344996074433e-08
meiotic O 0 9.836769550020108e-07
nondisjunction O 0 9.345999387733173e-07
for O 0 3.7929077656428944e-09
chromosome O 0 5.420880370365921e-06
15 O 0 3.8398309243348194e-07
. O 0 2.345791116908913e-08

The O 0 4.4519541120280337e-07
patient O 0 2.4450949354104523e-07
( O 0 5.793647783747247e-10
J O 0 1.1997499314020388e-06
. O 0 7.196476192738999e-10
B O 0 5.6447714058549536e-08
. O 0 2.119153463819856e-11
) O 0 4.887901281641627e-12
, O 0 4.435315829887099e-12
a O 0 6.394927642983106e-11
17 O 0 2.737352011727978e-10
- O 0 1.6038684269581438e-10
year O 0 1.8801447065897037e-09
- O 0 2.499421292156967e-08
old O 0 5.574062100777155e-08
white O 0 1.921758863154821e-10
male O 0 1.7553394501823583e-11
with O 0 1.6365423556249925e-12
PWS B-Disease 1 1.0
, O 0 5.05637798298153e-09
was O 0 6.741232283502541e-08
found O 0 1.781106651055353e-10
to O 0 5.962004778758967e-10
have O 0 7.546716723760838e-11
47 O 0 4.9672026491975885e-09
chromosomes O 0 9.383843702082117e-10
with O 0 2.1574896817005973e-12
a O 0 4.5123130232305186e-10
supernumerary O 0 2.62802416273189e-07
, O 0 7.004430369050851e-11
paternal O 0 6.385551643006693e-08
der O 0 1.131633689510636e-05
( O 0 2.279774008462354e-10
15 O 0 3.5533747055893627e-09
) O 0 1.4442491256747014e-12
consisting O 0 1.8611499060655623e-12
of O 0 2.9293643899475086e-11
the O 0 7.38852173887139e-11
short O 0 3.3110467145824884e-10
arm O 0 3.231659384539398e-09
and O 0 4.13876294347304e-11
the O 0 1.2550601669047978e-09
proximal O 0 1.542661448183935e-05
long O 0 1.064520560589699e-08
arm O 0 1.1120325105196116e-08
of O 0 3.202476506203311e-09
chromosome O 0 6.477887382061454e-07
15 O 0 1.5537480635430256e-07
, O 0 1.0599426197854811e-10
and O 0 4.002227160793126e-10
distal O 0 2.0720710381283425e-05
chromosome O 0 0.0017829345306381583
arm O 0 8.404138498008251e-05
3p O 0 0.0018845837330445647
. O 0 1.1884986861332436e-06

The O 0 1.8877331058320124e-06
t O 0 8.65527027826829e-08
( O 0 3.539600557100897e-10
3 O 0 9.299535363993527e-09
; O 0 4.083388835396384e-11
15 O 0 1.5945659237459608e-09
) O 0 2.4700330756438627e-12
was O 0 3.280683502637771e-10
present O 0 4.52956292265605e-12
in O 0 2.3017052673546257e-12
the O 0 6.004428291378483e-12
balanced O 0 4.346131440846612e-11
state O 0 2.333880658178522e-11
in O 0 2.089676348626668e-11
the O 0 1.6197376773163796e-10
patients O 0 3.6709832396120134e-10
father O 0 6.045920986075259e-10
and O 0 1.0917298315371582e-10
a O 0 8.606670043320719e-09
sister O 0 2.0225557761932578e-07
. O 0 1.0309468478908457e-07

Fluorescent O 0 3.56182908944902e-06
in O 0 3.954532346028827e-08
situ O 0 2.2528128340582043e-07
hybridization O 0 6.84718948207319e-10
analysis O 0 2.867362076941493e-11
demonstrated O 0 1.2746190387880052e-11
that O 0 8.37859295832466e-13
the O 0 1.279061717651686e-10
PWS B-Disease 1 1.0
critical O 0 1.2685982255788986e-06
region O 0 2.793102567011374e-07
resided O 0 2.0333215999812637e-08
on O 0 2.5849895557428226e-09
the O 0 4.819306412273683e-11
derivative O 0 4.5104800450168625e-10
chromosome O 0 6.509182970404481e-09
3 O 0 1.784126846260392e-09
and O 0 2.3804376438757435e-12
that O 0 1.7056407284818387e-12
there O 0 8.007427186595972e-12
was O 0 2.951704436426894e-10
no O 0 5.5875939292127086e-11
deletion O 0 2.003370580538899e-09
of O 0 2.2338633720586643e-10
the O 0 6.668854912739164e-10
PWS B-Disease 1 1.0
region O 0 6.801799372624373e-07
on O 0 9.792415767151397e-08
the O 0 6.492391069201631e-10
normal O 0 2.7493831655789336e-09
pair O 0 2.6971695710198418e-11
of O 0 7.401088769620756e-11
15s O 0 1.0425960539350854e-07
present O 0 1.168036556364882e-09
in O 0 4.94169682951906e-09
J O 0 6.829979247413576e-05
. O 0 1.3360261164052645e-07

B O 0 0.0017356665339320898
. O 0 1.1038564480259083e-06

Methylation O 0 4.6529129349437426e-07
analysis O 0 1.6259670942986304e-08
at O 0 2.3671676174785716e-08
exon O 0 1.2175283004012272e-08
alpha O 0 4.053650215496418e-08
of O 0 1.7428707366207163e-09
the O 0 3.3939906440849654e-10
small O 0 3.119149938335397e-10
nuclear O 0 1.8970599739986937e-06
ribonucleoprotein O 0 4.534937488642754e-06
- O 0 4.891212483926211e-07
associated O 0 2.1455848653317844e-08
polypeptide O 0 1.5205531553874607e-06
N O 0 2.572922994659166e-07
( O 0 3.132814146988849e-11
SNRPN O 0 7.29112343833549e-07
) O 0 8.96397713001651e-12
gene O 0 4.66228878420738e-12
showed O 0 8.661690071784522e-13
a O 0 1.9072490982374735e-12
pattern O 0 2.4675825271991414e-10
characteristic O 0 1.29515134728031e-10
of O 0 8.25299967255333e-11
only O 0 4.235068892799454e-11
the O 0 1.2787300385230793e-10
maternal O 0 1.399566151860654e-08
chromosome O 0 1.227845245921344e-06
15 O 0 2.4439245294161083e-07
in O 0 7.587960482169365e-09
J O 0 0.00013595697237178683
. O 0 3.709855889155733e-07

B O 0 0.0016655956860631704
. O 0 8.700122862137505e-07

Maternal B-Disease 0 0.0003605170059017837
disomy I-Disease 0 0.00021446812024805695
was O 0 4.202686625376373e-07
confirmed O 0 2.0838593073335687e-09
by O 0 6.475445180065265e-11
polymerase O 0 9.643684073523673e-09
chain O 0 3.928681824305613e-10
reaction O 0 2.229597062530786e-11
analysis O 0 2.6961252674873037e-11
of O 0 4.5610895615944003e-10
microsatellite O 0 9.181926685641884e-08
repeats O 0 1.6241042288811514e-08
at O 0 4.0308196780358685e-09
the O 0 1.703451268930678e-10
gamma O 0 4.745031745301276e-08
- O 0 1.9915002980042118e-08
aminobutyric O 0 2.1215575429778255e-07
acid O 0 6.382505191027121e-09
receptor O 0 3.3449572001131855e-09
beta3 O 0 2.1666073379833506e-08
subunit O 0 3.106445989331519e-09
( O 0 2.994168107894879e-11
GABRB3 O 0 7.116494202819013e-07
) O 0 1.1668668808972882e-10
locus O 0 1.9611597679158876e-08
. O 0 1.3830753209376212e-09

A O 0 2.735189082159195e-05
niece O 0 4.019500465801684e-06
( O 0 2.4737947246222802e-09
B O 0 2.444164692860795e-07
. O 0 8.633625758758257e-11
B O 0 6.8931482744005734e-09
. O 0 5.532108191680374e-12
) O 0 7.652288091380965e-13
with O 0 2.0022826712623454e-12
45 O 0 4.55781323793758e-09
chromosomes O 0 1.01427166665502e-09
and O 0 9.535936276727774e-12
the O 0 1.71755092787107e-11
derivative O 0 2.4357477146352835e-10
3 O 0 1.8360475639855878e-10
but O 0 1.575102786914584e-12
without O 0 5.436214325915678e-11
the O 0 2.690383749115455e-10
der O 0 7.534357564509264e-07
( O 0 1.680913325197153e-10
15 O 0 6.840979338562647e-09
) O 0 8.339074222818432e-12
demonstrated O 0 1.4977373508084924e-11
a O 0 7.903036731982116e-12
phenotype O 0 2.0230296604584197e-10
consistent O 0 2.922722827647384e-11
with O 0 3.910850050921344e-14
that O 0 8.277253123363526e-13
reported O 0 1.6453224199741712e-11
for O 0 1.0439790525118564e-11
haploinsufficiency O 0 3.209489420896716e-07
of O 0 1.2336747090557765e-07
distal O 0 0.00023562056594528258
3 O 0 6.485341145889834e-05
p O 0 0.00012329721357673407
. O 0 2.3177948094144085e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999997615814209
associated O 0 4.3019977624680905e-07
with O 0 7.317503825099436e-10
unbalanced O 0 5.9421789046609774e-05
segregation O 0 7.768542218400398e-07
of O 0 1.1570147506745343e-08
non O 0 3.485511967937782e-08
- O 0 4.629200134331768e-09
Robertsonian O 0 9.659295301389648e-07
translocations O 0 1.2076039865860366e-06
has O 0 8.58492610333883e-10
been O 0 6.761349813366735e-11
reported O 0 3.4964201672815776e-11
previously O 0 2.783014964313768e-11
but O 0 6.6429123486699826e-12
has O 0 4.743610452356828e-12
not O 0 1.6016358378445616e-11
, O 0 2.2016036996946875e-12
to O 0 6.539415536854776e-11
our O 0 9.915922943859456e-11
knowledge O 0 4.732490510583887e-10
, O 0 2.201017146319373e-11
been O 0 5.877321546110537e-11
observed O 0 8.870285062023697e-11
in O 0 2.652027035476845e-12
a O 0 2.976153351541555e-11
case O 0 1.4909837808829707e-09
of O 0 6.054532875054974e-09
PWS B-Disease 1 1.0
. O 0 3.332304459036095e-06

Furthermore O 0 1.8655642634257674e-05
, O 0 1.8437908977375628e-08
our O 0 2.3056807574306504e-09
findings O 0 2.600357706938894e-10
are O 0 3.3595301020261648e-12
best O 0 4.396471034451288e-12
interpreted O 0 3.259164813029791e-11
as O 0 5.753272424441347e-12
true O 0 4.0669568407425416e-11
gamete O 0 1.171193808602311e-08
complementation O 0 1.3766180018137675e-07
resulting O 0 1.3081538074999344e-09
in O 0 5.892657473083318e-10
maternal B-Disease 0 1.1898780030605849e-05
UPD I-Disease 1 1.0
15 I-Disease 0 9.999512985814363e-05
and O 0 1.0978585578413913e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999809265136719
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 1.3326325642992742e-05
2 I-Disease 0 7.166231625888031e-07
and O 0 9.63507496010152e-10
Stuve B-Disease 1 0.9999992847442627
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 6.83385514843593e-10
a O 0 4.820191468191126e-10
case O 0 9.884337792698261e-10
for O 0 7.02090885429385e-11
" O 0 3.320142161200579e-09
lumping O 0 1.09430775552255e-08
" O 0 2.789609254705283e-08
. O 0 1.3274047638844877e-08

Recent O 0 1.3614361193958757e-08
studies O 0 6.469571545153485e-10
demonstrated O 0 2.2997415083381156e-10
the O 0 1.0357920771086881e-10
existence O 0 7.631412723974051e-10
of O 0 3.192235364934959e-10
a O 0 2.0890077168100873e-10
genetically O 0 7.975502480661589e-10
distinct O 0 1.47015316587229e-11
, O 0 1.0065977999046405e-12
usually O 0 9.804577939462322e-13
lethal O 0 5.2726288612969796e-11
form O 0 7.68259414418715e-12
of O 0 2.920194364097739e-10
the O 0 2.0736130867948788e-10
Schwartz B-Disease 0 0.00018311673193238676
- I-Disease 1 0.9991911053657532
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.9758625664253486e-08
SJS B-Disease 1 0.9976019263267517
) O 0 2.2040848313142902e-10
of O 0 1.0591034538265376e-07
myotonia B-Disease 1 0.9999998807907104
and O 0 3.323000419186428e-05
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 7.51247398511623e-07
which O 0 9.123705524416437e-08
we O 0 3.546129221376759e-07
called O 0 9.954175084203598e-07
SJS B-Disease 0 0.4524382948875427
type I-Disease 0 1.68438764376333e-05
2 I-Disease 0 2.418446274532471e-05
. O 0 2.3931994519443833e-07

This O 0 6.0350937580722075e-09
disorder O 0 0.001049146754667163
is O 0 4.5289778871637765e-11
reminiscent O 0 2.152564571034077e-09
of O 0 2.4292809985837494e-09
another O 0 4.256539287705863e-10
rare O 0 6.100456251267872e-10
condition O 0 0.00024187099188566208
, O 0 6.803781843478518e-11
the O 0 1.200587407268472e-09
Stuve B-Disease 1 0.9999209642410278
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.335668588988483e-05
SWS B-Disease 1 0.9999969005584717
) O 0 3.219463862169647e-10
, O 0 1.0943269727892169e-11
which O 0 4.583533205759771e-12
comprises O 0 1.4314316225394474e-11
campomelia B-Disease 0 8.51852973937639e-07
at O 0 1.843738743900758e-07
birth O 0 4.21249346516106e-08
with O 0 3.4500563517170235e-10
skeletal B-Disease 1 0.9997630715370178
dysplasia I-Disease 1 1.0
, O 0 6.585863161490124e-07
contractures B-Disease 1 0.9103914499282837
, O 0 8.090556669060334e-09
and O 0 1.3759500205878794e-09
early B-Disease 0 1.6494621377205476e-05
death I-Disease 0 2.0680696252384223e-05
. O 0 3.0285775665106485e-07

To O 0 3.583253027628075e-09
test O 0 7.241897359566707e-11
for O 0 9.849618950313888e-13
possible O 0 1.928746884427568e-10
nosologic O 0 2.3470049654861214e-06
identity O 0 6.916629935460605e-09
between O 0 2.1579385389713934e-08
these O 0 1.4425114436278363e-09
disorders O 0 2.5728084438014776e-05
, O 0 9.015283658486695e-11
we O 0 1.359602569417362e-10
reviewed O 0 5.616295761790013e-10
the O 0 2.431308973593893e-11
literature O 0 5.66845355376433e-12
and O 0 3.2448582666308456e-13
obtained O 0 3.758937605624624e-12
a O 0 3.817505773301422e-12
follow O 0 5.750244464614029e-12
- O 0 1.91577413655164e-11
up O 0 1.6426226698285085e-11
of O 0 1.810748946617924e-11
the O 0 4.5435630084689205e-12
only O 0 2.9393696678037262e-12
two O 0 3.6034315722272003e-12
surviving O 0 1.4549791371720744e-09
patients O 0 1.6311653416867244e-10
, O 0 3.1998355354279084e-11
one O 0 6.784887929267569e-11
with O 0 1.8518768116204676e-11
SJS B-Disease 0 1.1609150760705234e-06
type I-Disease 0 4.8227715154780526e-08
2 I-Disease 0 2.51777152016075e-07
at O 0 8.742872203981733e-09
age O 0 1.6599119856408606e-09
10 O 0 2.2265299326473809e-10
years O 0 7.786869066217506e-11
and O 0 3.039868053458794e-12
another O 0 3.6176544399024735e-11
with O 0 1.5070446626741507e-11
SWS B-Disease 0 3.7868630897719413e-06
at O 0 1.3554766198353718e-08
age O 0 7.490251974218154e-09
7 O 0 3.5155707678313775e-08
years O 0 5.638624678283577e-09
. O 0 1.308930741572567e-08

Patients O 0 2.763712245723582e-06
reported O 0 7.093954756953735e-09
as O 0 6.344653274981127e-11
having O 0 1.48982326475533e-10
either O 0 1.1809898836645516e-08
neonatal O 1 0.9999749660491943
SJS B-Disease 1 0.9999964237213135
or O 0 2.612326852613478e-07
SWS B-Disease 0 6.3170741668727715e-06
presented O 0 3.3940798088716306e-11
a O 0 5.123775969478883e-12
combination O 0 4.4196951654029704e-11
of O 0 1.5262824337725078e-10
a O 0 2.2393537024711918e-10
severe O 0 4.105005700694164e-06
, O 0 4.268254083505951e-10
prenatal O 0 3.2831144380907062e-06
- O 0 1.1639292551990366e-06
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 2.3905879498187232e-09
with O 0 6.141088704225695e-08
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999943971633911
respiratory O 1 1.0
and O 1 0.9240896701812744
feeding O 1 0.979082465171814
difficulties O 1 0.9075499176979065
, O 0 4.476662152086419e-09
tendency O 0 5.995079277454352e-08
to O 0 8.718630084558754e-08
hyperthermia B-Disease 1 0.9999933242797852
, O 0 4.1257602889643863e-10
and O 0 1.9594032993341948e-11
frequent O 0 4.186593294264185e-10
death O 0 4.365778494275219e-08
in O 0 1.0421139506888721e-09
infancy O 0 2.0940011324910301e-07
) O 0 2.3487683152578764e-12
with O 0 3.08788449454242e-13
a O 0 1.343660183117379e-10
distinct O 0 1.5271859332699478e-09
campomelic B-Disease 0 8.613434329163283e-05
- I-Disease 0 0.0001999032829189673
metaphyseal I-Disease 1 0.9964140057563782
skeletal I-Disease 1 0.9999421834945679
dysplasia I-Disease 1 1.0
. O 0 5.413039980339818e-05

The O 0 1.4050966967715794e-07
similarity O 0 6.999471935387191e-08
of O 0 7.638031007672907e-08
the O 0 5.2642237236000256e-09
clinical O 0 1.784532699389274e-08
and O 0 2.5741136652768226e-11
radiographic O 0 3.889571331683328e-08
findings O 0 2.5863226227329505e-08
is O 0 1.529429777269442e-10
so O 0 2.46417014397593e-12
extensive O 0 1.3286648170574011e-10
that O 0 2.239296942319058e-11
these O 0 6.156302551074688e-11
disorders O 0 1.18428647510882e-06
appear O 0 1.8069005180976205e-09
to O 0 3.8145692160540534e-10
be O 0 6.317989881265973e-11
a O 0 6.303112892735996e-11
single O 0 6.976111355250225e-11
entity O 0 3.068710796583218e-08
. O 0 2.3867670506660943e-07

The O 0 3.098695344760927e-08
follow O 0 5.668883584775131e-09
- O 0 1.3687569966336355e-09
up O 0 9.289137514745249e-11
observation O 0 1.266224014528916e-09
of O 0 3.9780085475671356e-11
an O 0 9.255666979374189e-13
identical O 0 4.6976372444773595e-12
and O 0 1.6892382132850658e-13
unique O 0 3.267931986215139e-13
pattern O 0 1.6082158937891222e-09
of O 0 6.661980744837592e-09
progressive O 1 0.9999457597732544
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 6.013643769620103e-07
the O 0 1.6538206182303838e-07
two O 0 1.5831802535615225e-09
patients O 0 5.786381374051075e-10
( O 0 1.4153702515562472e-11
one O 0 1.4251014257560257e-10
with O 0 1.0934047937893876e-11
SJS B-Disease 0 8.848202242006664e-07
type I-Disease 0 1.1207461625417636e-07
2 I-Disease 0 2.1764064968010643e-06
, O 0 3.1034833036791554e-10
one O 0 1.5307750900195316e-10
with O 0 2.608980913254566e-11
SWS B-Disease 0 8.292683560284786e-06
) O 0 2.4829072131637986e-10
surviving O 0 5.7432412603475314e-08
beyond O 0 1.8816903093465953e-06
infancy O 0 4.20273067902599e-07
adds O 0 4.9426730069912495e-11
to O 0 2.5174310552822377e-11
the O 0 6.659366200839623e-12
evidence O 0 2.682275191887018e-12
in O 0 3.692381415811713e-13
favor O 0 6.811416708440987e-11
of O 0 7.880702340701262e-11
identity O 0 3.4154989947410286e-10
. O 0 3.0988178689739243e-09

The O 0 4.3829413698404096e-07
hypothesis O 0 1.6546739516343223e-06
that O 0 7.057246342867529e-09
SWS B-Disease 0 0.0016533068846911192
and O 0 5.321019358461854e-08
SJS B-Disease 0 0.0019523572409525514
type I-Disease 0 5.556684641305765e-07
2 I-Disease 0 2.815632171859761e-07
are O 0 1.2369663453248858e-11
the O 0 3.555079494677038e-11
same O 0 5.461200380807441e-10
disorder O 0 7.647812338973381e-08
should O 0 3.176268414950556e-10
be O 0 1.8341154983669838e-10
testable O 0 2.7485074216571093e-09
by O 0 1.0627883989533515e-11
molecular O 0 3.4132718873536305e-10
methods O 0 5.876663045079056e-10
. O 0 9.649820525980957e-11
. O 0 2.1723747245516734e-09

A O 0 8.632486014903407e-08
mouse O 0 6.387421147557859e-10
model O 0 7.883603492242486e-11
of O 0 6.881908931610781e-11
severe O 0 0.1753855049610138
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9203486442565918
defects O 1 1.0
in O 0 5.287580279400572e-06
hemostasis O 1 0.999950647354126
and O 0 6.907917395437835e-06
thrombosis B-Disease 1 1.0
. O 0 0.010612252168357372

von B-Disease 1 0.9953776597976685
Willebrand I-Disease 1 0.9999955892562866
factor I-Disease 0 0.003150414675474167
( I-Disease 0 4.3226425106013266e-08
vWf I-Disease 1 0.9999088048934937
) I-Disease 0 2.330261850147508e-07
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.99996018409729
humans O 0 0.003427987452596426
. O 0 1.48955405165907e-06

We O 0 1.8826042946784582e-07
generated O 0 5.094536459360199e-10
a O 0 6.217808212749532e-11
mouse O 0 2.3866944878769836e-11
model O 0 9.769115204283363e-12
for O 0 2.801942922472933e-12
this O 0 2.3359649284349082e-11
disease O 0 3.293285366634535e-10
by O 0 2.0090461412547445e-12
using O 0 8.4917364806536e-11
gene O 0 1.4066574571813817e-09
targeting O 0 1.40235583145909e-08
. O 0 1.9024062325456725e-08

vWf B-Disease 0 0.29226362705230713
- I-Disease 1 0.9999536275863647
deficient I-Disease 1 0.8240681290626526
mice O 0 2.2272674016221572e-07
appeared O 0 1.7116963846319777e-08
normal O 0 4.526963692796926e-08
at O 0 3.3686724520975986e-09
birth O 0 3.5059780079116365e-10
; O 0 6.1849466520547125e-12
they O 0 4.096806921483065e-11
were O 0 2.449953850902631e-10
viable O 0 3.503802048498983e-08
and O 0 1.374612201843206e-09
fertile O 0 2.4489459065080155e-06
. O 0 1.7377487893099897e-07

Neither O 0 6.213825690792874e-05
vWf O 0 0.003367132507264614
nor O 0 9.449738718103617e-05
vWf O 0 0.0020153680816292763
propolypeptide O 0 0.0009102329495362937
( O 0 1.756943213138129e-08
von B-Disease 0 0.0003635987523011863
Willebrand I-Disease 0 3.815899617620744e-05
antigen O 0 9.148569688477437e-07
II O 1 0.9886887669563293
) O 0 1.1554748269304582e-09
were O 0 2.8230937587636618e-09
detectable O 0 1.4868473385831749e-07
in O 0 5.153095172794053e-10
plasma O 0 9.075334617136832e-08
, O 0 1.8087548125933495e-10
platelets O 0 5.449653617262129e-09
, O 0 4.014641397098728e-11
or O 0 9.986568516584526e-11
endothelial O 0 5.959523152743174e-11
cells O 0 5.40138350713093e-11
of O 0 1.029728941004393e-10
the O 0 3.987947194694641e-10
homozygous O 0 2.445030178321872e-09
mutant O 0 4.604993719681261e-08
mice O 0 4.908633144395935e-08
. O 0 7.445952743267981e-09

The O 0 2.627305093483301e-06
mutant O 0 4.892881861451315e-06
mice O 0 1.7561298193413677e-07
exhibited O 0 5.2578140952164176e-08
defects O 0 0.0019017227459698915
in O 0 3.007633475604621e-09
hemostasis O 0 7.1603617470827885e-06
with O 0 1.2733439302969884e-10
a O 0 9.296023506522033e-09
highly O 0 3.701606843264926e-08
prolonged O 1 1.0
bleeding O 1 0.9999998807907104
time O 0 5.167838480701903e-06
and O 0 9.37354460717188e-09
spontaneous O 0 2.3359609713224927e-06
bleeding O 0 4.7153716877801344e-05
events O 0 3.9831710846316426e-11
in O 0 4.006706424974915e-12
approximately O 0 1.9158400560437272e-11
10 O 0 1.5020866495074614e-10
% O 0 3.1288982516031183e-10
of O 0 4.0823630587105697e-10
neonates O 0 3.7603010127895686e-07
. O 0 9.147525759090058e-08

As O 0 1.9227544001410024e-08
in O 0 6.229717852690442e-10
the O 0 1.43408929176303e-09
human O 0 6.272584673894244e-09
disease O 0 1.8331805051730043e-07
, O 0 2.725710282480698e-12
the O 0 2.3980109564725183e-11
factor O 0 1.4728819552889405e-10
VIII O 0 2.6437945052748546e-05
level O 0 0.00153810263145715
in O 0 3.471630316553842e-09
these O 0 8.083252123203266e-11
mice O 0 2.659891751299881e-10
was O 0 2.0911125608868986e-10
reduced O 0 4.1361056246635997e-10
strongly O 0 2.467839994857446e-11
as O 0 1.3670616288291582e-12
a O 0 2.7583974600980943e-12
result O 0 4.247283427738502e-11
of O 0 2.9601994466776915e-11
the O 0 2.2830275864249572e-11
lack O 0 3.4285660421851105e-10
of O 0 8.833276471387208e-11
protection O 0 8.220259889446524e-11
provided O 0 7.756033662542627e-12
by O 0 2.9598623552118397e-10
vWf O 0 2.1398036551545374e-06
. O 0 5.926387558474744e-08

Defective O 0 0.005799927748739719
thrombosis B-Disease 1 0.9084544777870178
in O 0 2.807170176311047e-07
mutant O 0 2.329199730866094e-07
mice O 0 5.98121108197347e-09
was O 0 6.480711522982574e-10
also O 0 3.4431897437403602e-12
evident O 0 1.236110935831647e-10
in O 0 1.1686302966995576e-11
an O 0 5.022047881719782e-12
in O 0 7.781994666722358e-12
vivo O 0 3.343941512579107e-10
model O 0 5.2594512078840694e-11
of O 0 3.474929455293818e-09
vascular B-Disease 1 0.9999971389770508
injury I-Disease 1 1.0
. O 0 1.850083026511129e-05

In O 0 5.834905003609947e-09
this O 0 6.143516945167349e-11
model O 0 4.65324084819585e-10
, O 0 3.3321928549767676e-11
the O 0 1.76217693215186e-10
exteriorized O 0 5.511765266419388e-07
mesentery O 0 1.3763938113697805e-06
was O 0 1.151128046217309e-07
superfused O 0 7.909503665359807e-07
with O 0 1.1305569813657712e-09
ferric O 0 4.079669452039525e-06
chloride O 0 2.2765961205095664e-07
and O 0 3.843846130280326e-08
the O 0 1.016565676081882e-07
accumulation O 0 3.438964768065489e-06
of O 0 2.3788771841282141e-07
fluorescently O 0 8.171917329491407e-07
labeled O 0 3.308285201342187e-08
platelets O 0 1.5818800491729235e-08
was O 0 3.014933636080741e-09
observed O 0 2.868145720924531e-10
by O 0 3.218436975260808e-11
intravital O 0 2.037357660356065e-07
microscopy O 0 6.036972877154767e-07
. O 0 2.0092002728233638e-07

We O 0 5.941043355051079e-07
conclude O 0 3.6497044675343204e-06
that O 0 1.916127034817805e-09
these O 0 2.3033236429270687e-10
mice O 0 3.067082365859619e-09
very O 0 2.75549617845261e-11
closely O 0 3.8502406818352597e-10
mimic O 0 3.420444727453287e-07
severe O 1 0.9991756081581116
human O 0 0.000377747172024101
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 5.303543730406091e-06
will O 0 5.1630568265181864e-08
be O 0 2.2425135082215775e-09
very O 0 4.830236471214944e-12
useful O 0 8.281979269053608e-12
for O 0 3.441388883931862e-13
investigating O 0 3.242856677632133e-11
the O 0 2.5187275876081827e-11
role O 0 4.539173897866178e-11
of O 0 9.714139909133834e-11
vWf O 0 7.808282020960178e-08
in O 0 3.726439157247796e-10
normal O 0 1.0732876631891486e-07
physiology O 0 7.1475754204186615e-09
and O 0 1.2722241662932454e-11
in O 0 5.691998608559068e-11
disease O 0 4.618678772772e-09
models O 0 8.401854212358728e-11
. O 0 5.739315134256628e-10
. O 0 1.7139864638693325e-08

Oral O 0 2.0244757251930423e-05
contraceptives O 0 4.536741471383721e-06
and O 0 1.0287513202422716e-10
the O 0 1.428955426208134e-10
risk O 0 7.766677612153217e-08
of O 0 2.190330405937857e-06
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9779009222984314

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9771997332572937
Study O 0 3.283714420376782e-07
Group O 0 4.131274433660792e-09
. O 0 3.6987890528195067e-09

BACKGROUND O 0 5.676953605870949e-06
Women O 0 2.659861220166704e-10
with O 0 1.5145245084099979e-12
mutations O 0 6.053952339435398e-10
in O 0 1.6979034497821566e-11
either O 0 6.42593811495118e-10
the O 0 1.475396360639536e-09
BRCA1 O 0 3.114575619633797e-08
or O 0 1.3985728131160613e-09
the O 0 1.0228821123448029e-09
BRCA2 O 0 8.901682946316214e-09
gene O 0 4.6104266238078395e-11
have O 0 1.0116193906867244e-12
a O 0 2.8256214642391475e-12
high O 0 6.278706721207783e-11
lifetime O 0 9.884468799015167e-10
risk O 0 7.052969408505305e-07
of O 0 0.00829825084656477
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.781460251659155e-05

Oral O 0 0.0005394853069446981
contraceptives O 0 0.013645163737237453
protect O 0 1.524955041531939e-05
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.013560006394982338
general O 0 6.3819443312240764e-06
, O 0 1.9866876199703398e-10
but O 0 1.2131777353541207e-11
it O 0 2.224952860840901e-12
is O 0 7.031194203255264e-13
not O 0 1.2196130607169953e-12
known O 0 6.702794569379833e-12
whether O 0 3.270386045306495e-11
they O 0 4.34525028805699e-12
also O 0 9.008072066052364e-13
protect O 0 2.7045811337028658e-12
against O 0 1.2030326734802088e-10
hereditary B-Disease 0 8.340078056789935e-05
forms I-Disease 0 6.921166641404852e-05
of I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.3900353224016726e-05

METHODS O 0 2.0747841062984662e-06
We O 0 4.027776334680766e-09
enrolled O 0 5.032226302326137e-10
207 O 0 1.3984040314607427e-10
women O 0 7.44068435337697e-13
with O 0 9.85715935958309e-12
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.823276818413433e-08
161 O 0 1.529547266621023e-09
of O 0 1.6932707458394702e-09
their O 0 5.2896825808446124e-11
sisters O 0 6.118165002400033e-11
as O 0 7.691244342800108e-12
controls O 0 4.3448072917229297e-10
in O 0 2.1114072296102293e-11
a O 0 1.7757471881818532e-10
case O 0 7.143186930846923e-09
- O 0 1.2583110553521237e-08
control O 0 3.818351146378518e-08
study O 0 3.5243907792192886e-09
. O 0 4.2874477301779734e-09

All O 0 8.117532956930518e-08
the O 0 2.708105739657185e-09
patients O 0 1.270658162022542e-10
carried O 0 3.172972648513017e-11
a O 0 1.6248299580801095e-11
pathogenic O 0 2.3091388523521772e-10
mutation O 0 1.0609828571261914e-09
in O 0 7.262507956129483e-11
either O 0 2.7015536474550572e-09
BRCA1 O 0 5.21438074940761e-08
( O 0 1.1266342719862266e-10
179 O 0 2.630479389864604e-09
women O 0 3.1253821145688088e-12
) O 0 8.074599474293398e-13
or O 0 2.690352662870765e-10
BRCA2 O 0 4.712193302225387e-08
( O 0 2.379423325038488e-10
28 O 0 2.489701387276e-07
women O 0 1.2188282327851852e-10
) O 0 1.7185479428416528e-10
. O 0 8.415190322352828e-09

The O 0 1.1596918625400576e-07
control O 0 1.4054759844839282e-07
women O 0 1.0083066326327383e-11
were O 0 7.93069949989178e-12
enrolled O 0 3.183119740013396e-11
regardless O 0 1.0261761579366535e-10
of O 0 4.037555706437601e-11
whether O 0 4.5976059764862853e-11
or O 0 2.848394575760693e-10
not O 0 7.032384674587888e-10
they O 0 3.6659293656260417e-11
had O 0 3.727448905088693e-10
either O 0 6.861203827313034e-10
mutation O 0 4.5170100548830305e-08
. O 0 5.05545507678562e-08

Lifetime O 0 5.570311259361915e-06
histories O 0 3.6036595929545e-07
of O 0 4.0186549199461297e-07
oral O 0 4.1697748542901536e-07
- O 0 9.222502761474516e-09
contraceptive O 0 8.70028216137797e-10
use O 0 2.035666080146825e-11
were O 0 2.9086401256289696e-12
obtained O 0 4.0946330527591446e-12
by O 0 2.030015912313221e-12
interview O 0 1.1273995625948885e-10
or O 0 6.212138442540649e-12
by O 0 4.760902501226016e-13
written O 0 1.1567387672717366e-12
questionnaire O 0 7.856625072744094e-12
and O 0 2.9749143686669255e-12
were O 0 6.0256300817018715e-12
compared O 0 1.4083310906354285e-11
between O 0 4.2200243299816975e-10
patients O 0 2.6486832171990216e-10
and O 0 1.3578914902223627e-11
control O 0 9.755965812985323e-09
women O 0 6.469956406567057e-13
, O 0 1.9131941311149175e-13
after O 0 4.24218082537009e-12
adjustment O 0 2.0460722005566367e-10
for O 0 5.127197711535247e-12
year O 0 1.6719889361915818e-10
of O 0 2.9453720018501883e-10
birth O 0 1.3863846737294239e-09
and O 0 2.9760865993821994e-10
parity O 0 2.5146903226413997e-07
. O 0 1.2743612387566827e-07

RESULTS O 0 1.5928483207972022e-06
The O 0 6.3843796915818984e-09
adjusted O 0 3.677474547103543e-09
odds O 0 8.796900985430511e-09
ratio O 0 5.955594351014781e-10
for O 0 1.1900277208098942e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 4.578596701776405e-08
with O 0 1.601067889378527e-11
any O 0 1.7540393582038405e-09
past O 0 1.0855571996870594e-09
use O 0 7.133349466670325e-11
of O 0 1.4518901358950842e-10
oral O 0 7.179028038706292e-09
contraceptives O 0 3.2062306587476996e-08
was O 0 1.0297928731972661e-08
0 O 0 5.828723459444518e-08
. O 0 1.2751874223226878e-08

5 O 0 7.544222171418369e-07
( O 0 1.3292384970498006e-09
95 O 0 1.6892755638764356e-07
percent O 0 5.364625010884083e-08
confidence O 0 5.561729743419619e-09
interval O 0 2.857266601097308e-08
, O 0 1.5038152667568028e-10
0 O 0 1.736274568564511e-09
. O 0 3.8153240983218595e-11
3 O 0 1.1209781991539103e-09
to O 0 7.47874207007726e-10
0 O 0 3.124915659569183e-09
. O 0 2.1006509032250875e-10
8 O 0 1.8137519930405688e-08
) O 0 1.4440308948593383e-09
. O 0 2.3643426771968734e-08

The O 0 1.463869949702712e-07
risk O 0 2.624960586672387e-07
decreased O 0 7.949308766797003e-09
with O 0 1.6510965771682207e-12
increasing O 0 3.0779107040856957e-10
duration O 0 1.8094604925522617e-08
of O 0 4.2911019182412247e-10
use O 0 4.0767061948443484e-10
( O 0 1.0262080074596724e-09
P O 0 2.0844521714025177e-05
for O 0 5.032939398574854e-09
trend O 0 3.741299181569957e-08
, O 0 1.1592313220454287e-10
< O 0 6.700519605828958e-08
0 O 0 1.6887038434276747e-09
. O 0 2.90045921308435e-11
001 O 0 1.1342195238572828e-10
) O 0 1.848557656773664e-13
; O 0 2.253038521807943e-13
use O 0 4.548609319060537e-12
for O 0 1.2262193864465143e-11
six O 0 2.1504489161605633e-11
or O 0 1.8822384623140564e-11
more O 0 2.1539452079583077e-12
years O 0 4.886542559479068e-11
was O 0 1.4575060602872725e-10
associated O 0 1.5365897790275973e-11
with O 0 2.889804010235836e-13
a O 0 5.4015281830688266e-11
60 O 0 4.810419285128376e-10
percent O 0 3.6414427029285434e-10
reduction O 0 4.105180195779212e-09
in O 0 2.0508947873310035e-09
risk O 0 5.670081918651704e-06
. O 0 6.365444278344512e-07

Oral O 0 2.6039495423901826e-05
- O 0 4.364242727206147e-07
contraceptive O 0 7.79814612883456e-08
use O 0 1.2197148846482264e-09
protected O 0 2.9626846753672e-07
against O 1 0.999431312084198
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 3.142774651632152e-10
for O 0 9.033025195892552e-12
carriers O 0 2.6916435660190308e-12
of O 0 1.1600231886177426e-10
the O 0 1.2906434254666976e-10
BRCA1 O 0 1.46318890337227e-09
mutation O 0 1.5575802869705058e-09
( O 0 1.6316094308965745e-11
odds O 0 1.1527721888171527e-08
ratio O 0 3.003475801399702e-10
, O 0 6.4947500502676725e-12
0 O 0 3.182903107745716e-10
. O 0 1.545386908718971e-11
5 O 0 6.527853813054207e-10
; O 0 1.4738141262959914e-11
95 O 0 9.658466026962742e-09
percent O 0 1.1464702964758544e-08
confidence O 0 1.746211508724116e-09
interval O 0 4.617841664611433e-09
, O 0 8.534799256221248e-11
0 O 0 8.265401696405661e-10
. O 0 3.94580167151215e-11
3 O 0 1.1345663297746e-09
to O 0 4.46691933442267e-10
0 O 0 1.1898955154521218e-09
. O 0 3.68904837233508e-11
9 O 0 1.7680560349120356e-09
) O 0 1.7769107582901733e-12
and O 0 7.229428644270341e-13
for O 0 1.002424814162961e-12
carriers O 0 3.711582256815671e-12
of O 0 9.130343009422504e-11
the O 0 2.4062821180059757e-10
BRCA2 O 0 1.0314971987668287e-08
mutation O 0 3.829471850735899e-09
( O 0 6.336647873084189e-11
odds O 0 4.3560881124449224e-08
ratio O 0 6.764422910698897e-10
, O 0 1.5119162866117364e-11
0 O 0 5.323338991836124e-10
. O 0 2.6293430974155818e-11
4 O 0 1.0852528875560097e-09
; O 0 2.3308821886502962e-11
95 O 0 6.439339728103732e-09
percent O 0 7.303327720364905e-09
confidence O 0 1.4337147025145214e-09
interval O 0 8.557922370755477e-09
, O 0 9.435816017422383e-11
0 O 0 1.5692037669268188e-09
. O 0 4.963872715646467e-11
2 O 0 8.77511230346073e-10
to O 0 3.7697828192406746e-10
1 O 0 2.1163373276067432e-08
. O 0 2.337633142612816e-10
1 O 0 1.0491331181583519e-07
) O 0 1.5960325283614907e-09
. O 0 3.628066380656492e-08

CONCLUSIONS O 0 0.00010801308962982148
Oral O 0 8.956028977991082e-06
- O 0 4.964429578535601e-08
contraceptive O 0 4.513339479927936e-09
use O 0 1.4179264533342728e-11
may O 0 3.107628043785837e-11
reduce O 0 1.8935279733067745e-10
the O 0 5.380079368122459e-11
risk O 0 7.405235891155826e-08
of O 0 2.6015815819846466e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.1843152236679089e-07
women O 0 7.736236130873042e-12
with O 0 1.1219662894058902e-13
pathogenic O 0 2.7400408331157422e-11
mutations O 0 2.4407376120194613e-10
in O 0 3.261839062740357e-11
the O 0 5.059810348484461e-10
BRCA1 O 0 9.555326130339381e-08
or O 0 2.303502242284594e-07
BRCA2 O 0 2.3477135982830077e-05
gene O 0 5.481187145051081e-06

A O 0 2.577429768280126e-06
Japanese O 0 4.4509013719107315e-07
family O 0 3.356793953912529e-09
with O 0 1.9374483961609457e-10
adrenoleukodystrophy B-Disease 1 1.0
with O 0 7.735903584382697e-10
a O 0 1.3319394476241087e-08
codon O 0 2.3096791323951038e-07
291 O 0 1.897336687761708e-08
deletion O 0 2.577896509592392e-07
: O 0 1.2216491707128796e-10
a O 0 5.621675902567347e-10
clinical O 0 2.8177373323501342e-08
, O 0 1.0728993388164909e-10
biochemical O 0 8.510346560797188e-08
, O 0 3.5293485911580547e-09
pathological O 1 0.9933131337165833
, O 0 4.29717328387369e-09
and O 0 1.633837731773724e-09
genetic O 0 4.231909827012714e-07
report O 0 6.698510190972229e-09
. O 0 3.17335882016323e-08

We O 0 2.962802447825652e-08
report O 0 8.436781134824045e-11
a O 0 3.831543068932852e-11
Japanese O 0 4.177826140594476e-10
family O 0 1.8091955017451866e-11
with O 0 4.4431923418297714e-11
adrenoleukodystrophy B-Disease 1 1.0
( O 0 5.6333019529120065e-06
ALD B-Disease 1 1.0
) O 0 7.599558204951506e-10
with O 0 3.4256621844752644e-11
a O 0 1.8529209278028702e-09
three O 0 1.4044261587020657e-10
base O 0 1.2406725646840755e-09
pair O 0 3.425141004154142e-10
deletion O 0 3.257653347077394e-08
( O 0 2.816724353760236e-10
delGAG O 0 1.0256810583086917e-06
291 O 0 3.4644731528032935e-09
) O 0 2.5232042150102885e-11
in O 0 7.239332466824067e-10
the O 0 9.622814900467347e-08
ALD B-Disease 1 1.0
gene O 0 8.037762199819554e-06
. O 0 5.251129664429754e-07

A O 0 2.8475560043261794e-07
variety O 0 5.518392409697981e-10
of O 0 8.589806643755082e-10
phenotypes O 0 1.642671221269154e-09
were O 0 5.819694379183282e-11
observed O 0 1.0105712794361565e-10
within O 0 9.440964676699082e-11
this O 0 1.4277296012110696e-10
family O 0 7.294190806916845e-10
. O 0 4.899108674294439e-09

While O 0 3.70334412025386e-08
the O 0 4.343152504304726e-09
proband O 0 7.210887360997731e-06
( O 0 2.52350984553118e-09
patient O 0 2.781956141006958e-07
1 O 0 2.2123008136532007e-07
) O 0 5.548066867033796e-11
was O 0 1.3695515832523597e-08
classified O 0 4.433138023340888e-10
as O 0 3.588351490946273e-11
having O 0 5.529463345532726e-11
a O 0 2.037585378200646e-11
rare O 0 4.961078423071363e-12
intermediate O 0 2.805507492986692e-10
type O 0 4.4060957660185807e-10
of O 0 4.5191431152780126e-10
adult O 0 8.538405538160987e-09
cerebral O 0 7.22010008757934e-06
and O 0 2.6426389965195085e-09
cerebello O 0 0.0022889103274792433
- O 0 1.820907164074015e-05
brain O 0 0.00016281602438539267
stem O 0 1.1584969428213299e-07
forms O 0 3.45504980181488e-09
, O 0 6.548327158295564e-11
his O 0 1.3373908924751987e-10
younger O 0 7.175286476091003e-10
brother O 0 1.9999688571914476e-09
( O 0 3.3067847071688306e-11
patient O 0 7.277102476166419e-09
2 O 0 1.5244831175209583e-08
) O 0 2.3163365323042306e-11
and O 0 1.176687497439488e-10
nephew O 0 2.1146674100691598e-07
( O 0 2.336340565456396e-10
patient O 0 6.688733833470906e-08
3 O 0 6.453839063169653e-08
) O 0 4.745567133701556e-11
had O 0 6.258698004302232e-09
a O 0 1.2117041592318856e-08
childhood O 0 4.437140160007402e-05
ALD B-Disease 1 1.0
type O 0 0.0008641552412882447
. O 0 2.8374224712024443e-06

Another O 0 1.4002237094246084e-06
nephew O 0 2.3107941160560586e-05
( O 0 8.962059538930589e-09
patient O 0 1.2877759445473203e-06
4 O 0 2.8321514378149004e-07
) O 0 7.441259414209256e-11
of O 0 1.1758629625546746e-08
patient O 0 9.183765570242031e-08
1 O 0 5.434889658317843e-07
was O 0 5.3184017190233135e-08
classified O 0 3.418131888643927e-10
as O 0 3.1866551064574367e-11
having O 0 6.592288520623768e-11
an O 0 6.455935092075649e-11
adolescent O 0 5.131852720552388e-09
form O 0 1.360659140914322e-09
. O 0 5.9300287347241465e-08

The O 0 2.3853564812270633e-07
tau O 0 4.4572047386282065e-07
level O 0 6.757787929245751e-08
in O 0 8.056919575949451e-10
the O 0 2.353722550196835e-09
cerebrospinal O 0 2.5217892130058317e-07
fluid O 0 4.6479854631797934e-07
( O 0 1.1715914460808108e-08
CSF O 0 0.02978385239839554
) O 0 4.579308043872743e-10
in O 0 3.422777061778959e-10
patient O 0 1.3280506472312936e-08
1 O 0 5.1436149561823186e-08
was O 0 7.979325644669188e-09
as O 0 2.0427761912578113e-11
high O 0 8.911017757018413e-11
as O 0 2.4335890832886953e-13
that O 0 7.85625701321159e-14
of O 0 4.448439446663732e-12
patients O 0 2.295218008707689e-11
with O 0 6.119005302451797e-11
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.8064073920249939
( O 0 1.8702650539381693e-10
AD B-Disease 0 2.0530524125206284e-06
) O 0 6.3821761209226224e-09
. O 0 8.246607308137754e-08

His O 0 2.2480306142824702e-05
brain O 0 3.631904110079631e-05
magnetic O 0 2.5574602204869734e-06
resonance O 0 9.395777169629582e-07
image O 0 4.196182601390319e-08
( O 0 5.777228695436065e-10
MRI O 0 2.0486945686570834e-06
) O 0 1.4406106862985268e-10
showed O 0 6.651121875478339e-10
abnormalities B-Disease 0 2.5477410403595968e-08
in I-Disease 0 2.3749604713407813e-11
the I-Disease 0 5.498511368440262e-11
bilateral I-Disease 0 8.080456268544367e-07
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9998142123222351
and O 0 1.0350193235808547e-07
brain O 0 0.00020895779016427696
stem O 0 2.1394188820522686e-07
, O 0 2.7558417787371114e-12
but O 0 1.1587128825873982e-12
not O 0 5.2081975884799014e-12
in O 0 2.7574349054093616e-12
the O 0 7.970191173711783e-11
cerebral O 0 9.894482900563162e-06
white O 0 8.030489162536014e-09
matter O 0 5.289468418823162e-08
, O 0 1.156536411778264e-11
where O 0 1.7851112298419847e-12
marked O 0 1.1382498242562544e-11
reductions O 0 2.7315536499372683e-09
of O 0 6.474521474508776e-10
the O 0 8.174874110977726e-10
cerebral O 0 6.514849246741505e-07
blood O 0 1.7021474008060977e-08
flow O 0 1.544861483182558e-08
and O 0 5.280401116358746e-10
oxygen O 0 2.0590396054842586e-09
metabolism O 0 6.798081209069551e-09
were O 0 3.113133362209197e-11
clearly O 0 3.8372621052884526e-11
demonstrated O 0 4.767975077257791e-12
by O 0 1.3073942102537206e-11
positron O 0 5.496369936963674e-08
emission O 0 6.420621048164321e-07
tomography O 0 3.0617090942541836e-06
( O 0 4.044205681452695e-08
PET O 0 2.6118136702280026e-06
) O 0 3.797395731197639e-09
. O 0 2.4650587349128728e-08

In O 0 4.766166341596545e-07
patients O 0 1.1853084203039543e-07
2 O 0 2.9184832328610355e-07
and O 0 1.501288315886029e-09
3 O 0 2.0265969169486198e-07
, O 0 2.1117543824722418e-10
the O 0 5.754090537379852e-10
autopsy O 0 3.155991246117651e-09
findings O 0 1.252806608453838e-10
showed O 0 8.284147673398579e-11
massive O 0 5.887989829034268e-08
demyelination B-Disease 1 1.0
of I-Disease 0 1.4149604794511106e-05
the I-Disease 0 2.519683448554133e-07
cerebral I-Disease 1 0.9968374967575073
white I-Disease 0 1.555906514738581e-08
matter I-Disease 0 5.295987204334551e-09
with O 0 1.3867925904853529e-12
sparing O 0 8.131657569521167e-10
of O 0 9.507346909742864e-09
the O 0 1.3295890610720562e-08
U O 0 4.143398109590635e-05
- O 0 2.5681794113552314e-07
fibers O 0 3.796868952576915e-08
, O 0 3.130789030802994e-11
compatible O 0 1.238536911918331e-10
with O 0 1.541035636772048e-12
the O 0 1.1342238259715032e-10
findings O 0 4.037003509260728e-10
of O 0 8.346359159361327e-09
childhood O 0 7.034658483462408e-05
ALD B-Disease 1 1.0
. O 0 6.800847131671617e-06

Oleic O 0 0.0022807710338383913
and O 0 6.5218137024203315e-06
erucic O 0 0.004989726468920708
acids O 0 4.297239229344996e-06
( O 0 1.5863813596084242e-09
Lorenzos O 0 1.1400026096453075e-06
Oil O 0 3.917753588211781e-07
) O 0 3.463742834219907e-11
were O 0 3.220494010358621e-11
administered O 0 7.570186144612023e-11
to O 0 4.078907211990668e-10
patients O 0 1.3100383278175087e-10
1 O 0 1.2814121319593141e-08
and O 0 1.0872869271594254e-10
4 O 0 1.1213958650557743e-08
, O 0 1.2120304759832834e-11
but O 0 3.563251256555322e-12
sufficient O 0 5.836524319402514e-11
effectiveness O 0 8.27161117378239e-11
was O 0 1.543985078678034e-10
not O 0 3.2119119863782686e-11
obtained O 0 2.1568962171869543e-09
. O 0 6.970026777963767e-09

The O 0 7.820101188826811e-08
findings O 0 4.613994075697292e-09
in O 0 6.646274502974947e-11
this O 0 3.8895803244898275e-11
family O 0 1.0293357312340934e-11
suggest O 0 1.3814314275828465e-11
that O 0 7.749921581215458e-13
delGAG291 O 0 1.7592962642254406e-09
is O 0 6.396949376458183e-12
part O 0 3.68485728041712e-11
of O 0 1.807361482697445e-10
the O 0 1.711913388824371e-10
cause O 0 5.874304065400793e-08
of O 0 7.135903956623224e-08
Japanese O 0 1.765427100508532e-06
ALD B-Disease 1 1.0
with O 0 5.87125126294552e-10
phenotypic O 0 2.99609837384196e-07
variations O 0 2.39470153928778e-07
. O 0 2.842194213314997e-08

Moreover O 0 5.715712632081704e-07
, O 0 1.4870127351684914e-10
although O 0 8.801234914479483e-12
the O 0 9.284137694742789e-12
scale O 0 3.8761647225271645e-09
of O 0 1.196106963474719e-10
the O 0 1.914714740924861e-11
study O 0 7.548929363554446e-12
is O 0 6.45951282914059e-13
limited O 0 1.0208617805262943e-11
, O 0 9.944859172272835e-12
there O 0 3.0178186338769564e-11
is O 0 4.404513559430612e-11
a O 0 3.9549963304352787e-10
possibility O 0 8.256286321284279e-08
that O 0 3.2027636098774792e-09
PET O 0 9.134472520599957e-07
can O 0 1.7058126022817532e-09
detect O 0 2.6780841722029436e-07
an O 0 1.8324134432035066e-09
insidious B-Disease 0 7.390106475213543e-06
lesion I-Disease 1 0.9184027314186096
which O 0 1.1636624996924638e-09
is O 0 1.9887803903717582e-10
undetectable O 0 7.30870253207172e-10
by O 0 1.28248600975156e-11
computed O 0 1.9725604261111584e-08
tomogram O 0 3.5694358757609734e-06
( O 0 3.0419258223446377e-09
CT O 0 6.147999374661595e-05
) O 0 5.910374967221799e-10
or O 0 1.0304485043022282e-09
MRI O 0 4.78139021709012e-08
analysis O 0 1.2122670922654066e-10
, O 0 2.4359401214896215e-12
and O 0 2.674927065873106e-13
that O 0 1.737814942946378e-13
the O 0 2.310237721611652e-12
higher O 0 1.1508773101187586e-10
level O 0 4.3566822371943204e-10
of O 0 5.150753781824058e-11
tau O 0 7.319752026724302e-10
reflects O 0 2.7841923645050004e-12
the O 0 1.6601216928924245e-12
process O 0 1.4138384907269597e-10
of O 0 8.482929636510761e-11
neuronal B-Disease 0 6.504742486868054e-07
degeneration I-Disease 1 0.9999986886978149
in O 0 9.098713462663e-07
ALD B-Disease 1 1.0
. O 0 3.0009391593921464e-06

Lorenzos O 0 9.37665463425219e-05
Oil O 0 1.2299923355385545e-06
should O 0 2.6687712040285305e-09
be O 0 4.7650678541844016e-11
given O 0 6.131303798007082e-12
in O 0 3.1776831600077715e-12
the O 0 1.0211850462460426e-11
early O 0 1.134116245360417e-09
stage O 0 1.6417660564371772e-09
. O 0 1.5982494494526378e-10
. O 0 5.256918900187202e-09

Nonsense O 0 2.789924110402353e-05
mutation O 0 8.13540381727762e-08
in O 0 4.577945800221528e-10
exon O 0 1.1753471973463547e-08
4 O 0 1.3977814461441085e-08
of O 0 2.327160686377283e-10
human O 0 6.912007077808369e-11
complement O 0 1.3915261998231898e-10
C9 O 0 4.827156772080343e-06
gene O 0 2.0954046831000994e-10
is O 0 3.879709487702998e-12
the O 0 4.66979146324098e-12
major O 0 2.831677670123156e-10
cause O 0 5.208075748441843e-09
of O 0 4.4562331602548966e-09
Japanese O 0 3.73957256272206e-08
complement B-Disease 0 3.17004435146373e-07
C9 I-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999984502792358
. O 0 2.408843783996417e-06

Deficiency B-Disease 1 0.9993700385093689
of I-Disease 0 8.803920536593068e-06
the I-Disease 0 2.625248782806011e-07
ninth I-Disease 0 3.386280695849564e-07
component I-Disease 0 2.9026827164102542e-08
of I-Disease 0 1.1539182942499338e-08
human I-Disease 0 2.2997677373570724e-10
complement I-Disease 0 2.3034685270317823e-10
( O 0 1.1653011888768106e-10
C9 O 0 0.0002196452987845987
) O 0 4.585039292681614e-11
is O 0 6.7337277247225824e-12
the O 0 4.315697538920249e-12
most O 0 3.501909320250546e-13
common O 0 3.142726634486337e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.9864243583356256e-08
Japan O 0 4.165336520145502e-09
but O 0 6.038426703103283e-11
is O 0 1.4048327605375999e-11
rare O 0 6.833157737556883e-12
in O 0 9.105730058855954e-12
other O 0 2.382118157243096e-12
countries O 0 1.0359955254779507e-10
. O 0 2.557419875870437e-08

We O 0 5.122271673485557e-08
studied O 0 2.004593602222826e-09
the O 0 5.4375413893748004e-11
molecular O 0 2.5040472473314423e-10
basis O 0 1.9107619930736064e-09
of O 0 3.2676332750725123e-09
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999971389770508
in O 0 4.253562835287994e-09
four O 0 1.7469367619149523e-10
Japanese O 0 1.1880636918704113e-08
C9 B-Disease 1 0.9848084449768066
- I-Disease 0 1.7610816939850338e-05
deficient I-Disease 0 2.3519871319876984e-05
patients O 0 4.575078804691657e-08
who O 0 7.903044330070941e-10
had O 0 9.973767589599447e-09
suffered O 0 9.015740829454444e-07
from O 0 1.9252466643138177e-07
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 5.254237748886226e-06

Direct O 0 1.606638591056253e-07
sequencing O 0 6.687572806640674e-08
of O 0 3.8813748659549674e-08
amplified O 0 9.71530269566756e-08
C9 O 0 1.2637821782846004e-05
cDNA O 0 6.982976685776521e-08
and O 0 8.504545956355969e-10
DNA O 0 1.0034197472919004e-08
revealed O 0 2.441870261549184e-09
a O 0 5.054254237357725e-10
nonsense O 0 2.3830320827755713e-08
substitution O 0 1.345651856610175e-08
( O 0 2.525791242824482e-10
CGA O 0 5.802091607165494e-08
- O 0 3.2867941968106607e-07
- O 0 8.535349138583115e-08
> O 0 7.98825254832991e-08
TGA O 0 7.329202844630345e-08
) O 0 2.6937710742580556e-11
at O 0 5.421368909352964e-10
codon O 0 4.3793019210980333e-10
95 O 0 2.7293753368518026e-10
in O 0 1.6301909475102683e-11
exon O 0 1.4230214784305417e-09
4 O 0 3.7193474966557005e-09
in O 0 1.025299706247651e-10
the O 0 7.554093461870082e-10
four O 0 1.3610718108125752e-09
C9 B-Disease 0 0.002341073239222169
- I-Disease 0 1.1635359442152549e-05
deficient I-Disease 0 1.32206537273305e-06
individuals O 0 1.5530532415652942e-09
. O 0 5.489999921337585e-08

An O 0 1.040571273591695e-08
allele O 0 2.5949599802288503e-08
- O 0 4.676893539112825e-09
specific O 0 6.045736133941659e-10
polymerase O 0 1.95734433106054e-08
chain O 0 2.7553834769378227e-09
reaction O 0 2.381466412959554e-10
system O 0 9.544785101178732e-11
designed O 0 1.2495610102192245e-10
to O 0 5.123712565335836e-10
detect O 0 1.901744983712206e-09
exclusively O 0 1.2672110756561938e-11
only O 0 7.050320830620516e-12
one O 0 5.9904724410142496e-12
of O 0 8.103052950847456e-12
the O 0 1.558779320898207e-11
normal O 0 1.285538203665837e-10
and O 0 2.3288990094044726e-12
mutant O 0 3.5828801731030424e-11
alleles O 0 2.5071285325584114e-11
indicated O 0 7.469443119578756e-11
that O 0 2.1916741425181963e-12
all O 0 4.943820092889739e-12
the O 0 1.1790097544095435e-11
four O 0 3.173261566707941e-12
patients O 0 1.3124879872164485e-12
were O 0 8.222058450746417e-12
homozygous O 0 1.726359506737385e-11
for O 0 2.4093258638169246e-11
the O 0 7.657259548654594e-11
mutation O 0 1.7693843612498483e-10
in O 0 1.2381519420845422e-10
exon O 0 8.137941431840545e-10
4 O 0 8.377411653270883e-09
and O 0 4.414065467306383e-12
that O 0 2.1924558522845583e-12
the O 0 4.987846594084466e-11
parents O 0 2.099484301687493e-11
of O 0 2.9226460140918675e-10
patient O 0 4.0995935535192984e-09
2 O 0 6.038457911472506e-08
were O 0 6.292560250642509e-09
heterozygous O 0 1.6789220680379913e-08
. O 0 2.687068345608168e-08

The O 0 1.5845381540202652e-07
common O 0 3.0668264372479825e-08
mutation O 0 4.829896482760887e-08
at O 0 9.570936043701295e-09
codon O 0 1.0168581532354892e-08
95 O 0 6.960913179199224e-09
in O 0 1.3564994960635346e-10
exon O 0 2.9364044529245348e-09
4 O 0 2.5392885572017576e-09
might O 0 1.86373069754886e-10
be O 0 7.565249815488784e-11
responsible O 0 6.441867039796989e-10
for O 0 3.06778144554265e-11
most O 0 5.81740836058664e-11
Japanese O 0 9.478723939082556e-08
C9 B-Disease 1 0.9999731779098511
deficiency I-Disease 1 0.9311434626579285
. O 0 8.206423274259578e-08
. O 0 1.1097424135186884e-07

BRCA1 O 0 2.9366222520366136e-07
required O 0 9.188387828373834e-09
for O 0 3.4214978072988345e-10
transcription O 0 3.7038809352907265e-08
- O 0 4.4599257620348e-08
coupled O 0 3.6568703620787346e-08
repair O 0 3.664946780190803e-05
of O 0 8.765164238866419e-07
oxidative O 0 1.5294906916096807e-05
DNA O 0 7.595131319249049e-05
damage O 1 0.9971922039985657
. O 0 9.382462167195627e-07

The O 0 2.06952536245808e-05
breast B-Disease 1 1.0
and I-Disease 1 0.9999992847442627
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 1.0
gene O 0 1.454873881812091e-06
BRCA1 O 0 7.861719950597035e-07
encodes O 0 4.959184174424536e-09
a O 0 1.4904378842217625e-09
zinc O 0 5.73228646771895e-08
finger O 0 2.4496666028994696e-08
protein O 0 9.97820048809217e-09
of O 0 2.119648900844595e-09
unknown O 0 1.8233810905599057e-08
function O 0 1.2806106397533767e-08
. O 0 3.4587090969040446e-09

Association O 0 8.593944755830307e-08
of O 0 1.418537749486859e-07
the O 0 2.281712063734176e-08
BRCA1 O 0 1.7824168807578644e-08
protein O 0 9.403087197767945e-10
with O 0 2.414587410223823e-12
the O 0 1.4894481481508848e-10
DNA O 0 5.715852235965713e-09
repair O 0 1.612254720839701e-07
protein O 0 7.057303719193442e-08
Rad51 O 0 7.942022506313151e-08
and O 0 1.3264467302320782e-10
changes O 0 2.0763794850164885e-10
in O 0 4.658682467573172e-11
the O 0 4.316382667957086e-11
phosphorylation O 0 4.6038997614239463e-10
and O 0 8.30867527557011e-11
cellular O 0 5.526145097078938e-10
localization O 0 1.7513022143589296e-08
of O 0 2.723282266359206e-09
the O 0 4.2731254645822503e-10
protein O 0 5.50638534768666e-10
after O 0 4.571907574746348e-10
exposure O 0 9.533399625283323e-10
to O 0 1.30057506431136e-10
DNA O 0 1.9090788949682747e-09
- O 0 6.33960051121818e-10
damaging O 0 3.0888509527926544e-09
agents O 0 2.5397607628097063e-11
are O 0 6.724688080689267e-13
consistent O 0 4.493627692170321e-12
with O 0 1.2155615666050064e-14
a O 0 3.343740215266955e-12
role O 0 5.88659633191102e-12
for O 0 1.2420847336769292e-11
BRCA1 O 0 4.801475217419693e-09
in O 0 1.2506561342107148e-09
DNA O 0 1.2252519354660762e-06
repair O 0 0.0010946366237476468
. O 0 1.5193210174402338e-06

Here O 0 7.823247187843663e-07
, O 0 4.713869294903361e-10
it O 0 1.6488378370982382e-11
is O 0 4.557728326692878e-12
shown O 0 4.8384061514250565e-12
that O 0 3.775521128374093e-12
mouse O 0 1.1498948460086922e-09
embryonic O 0 5.441274453232836e-08
stem O 0 1.1713371605992506e-07
cells O 0 6.9001853120198575e-09
deficient B-Disease 0 2.429272960569051e-08
in I-Disease 0 2.8737145996160507e-10
BRCA1 I-Disease 0 1.6231876287520208e-08
are O 0 3.21109736023395e-11
defective O 0 1.6295560456569547e-08
in O 0 3.8737976715275124e-10
the O 0 2.6050042678527063e-10
ability O 0 2.1329002800052344e-11
to O 0 2.2920343401011678e-10
carry O 0 1.0987739884615877e-10
out O 0 2.0767151887035595e-11
transcription O 0 7.037953553279408e-10
- O 0 1.5721965951343009e-09
coupled O 0 7.64996777036231e-09
repair O 0 2.88208889287489e-06
of O 0 1.1553193957070107e-07
oxidative O 0 3.366558303241618e-07
DNA O 0 4.536178948910674e-06
damage O 1 0.9878907203674316
, O 0 1.0491021384950727e-09
and O 0 1.7891831072258668e-10
are O 0 7.459178413826706e-11
hypersensitive O 0 3.5037831480622117e-07
to O 0 1.6770102320151636e-06
ionizing O 0 0.0003080515598412603
radiation O 0 0.0001600281393621117
and O 0 6.3909224579106194e-09
hydrogen O 0 1.9557171881956492e-08
peroxide O 0 3.11142315467805e-07
. O 0 2.873876780995488e-08

These O 0 3.767700373913385e-09
results O 0 3.6492180388592033e-09
suggest O 0 2.9804623213891546e-09
that O 0 3.939178983003444e-10
BRCA1 O 0 2.2741029681583314e-07
participates O 0 7.883607655578828e-10
, O 0 4.933740915813445e-12
directly O 0 1.1568083990720623e-10
or O 0 6.536463037498663e-10
indirectly O 0 2.0185606075528995e-08
, O 0 1.224738088723143e-10
in O 0 1.5044149259679784e-10
transcription O 0 1.7455128897836403e-08
- O 0 1.7701017540616704e-08
coupled O 0 1.283927097972537e-08
repair O 0 1.3398072269410477e-06
of O 0 7.59498632874056e-08
oxidative O 0 5.985093594063073e-07
DNA O 0 2.1351661416701972e-06
damage O 0 7.852874114178121e-05
. O 0 1.3445742297335528e-08
. O 0 1.094485213570806e-08

Truncation O 0 3.805782034760341e-05
mutations O 0 4.51940593393374e-07
in O 0 3.086140509811486e-10
the O 0 2.310090174706403e-10
transactivation O 0 6.476015528278367e-07
region O 0 1.3161411516193766e-07
of O 0 4.6253365582060724e-08
PAX6 O 0 0.0008805479155853391
result O 0 1.485161078562669e-07
in O 0 3.616043686704984e-09
dominant O 0 1.8836783510778332e-07
- O 0 2.1255445403767226e-08
negative O 0 1.6329382290791727e-08
mutants O 0 1.086749001899534e-08
. O 0 1.209943700786198e-09

PAX6 O 0 0.002211647341027856
is O 0 9.099805353685042e-09
a O 0 1.3914790431002189e-09
transcription O 0 6.641237337845496e-09
factor O 0 3.023195305207338e-10
with O 0 1.0486158789164632e-13
two O 0 1.8561441446351967e-12
DNA O 0 1.9920719240840157e-10
- O 0 1.7155743492480724e-10
binding O 0 1.1155041335086935e-07
domains O 0 7.285798915290798e-07
( O 0 1.750171813030832e-10
paired O 0 2.9267852030834263e-10
box O 0 1.5121945917684343e-09
and O 0 1.9862290978611696e-10
homeobox O 0 1.8168474724689077e-08
) O 0 9.985387516842081e-11
and O 0 2.0982002246761056e-10
a O 0 6.938048358051674e-09
proline O 0 9.567015979428106e-08
- O 0 9.792509558792517e-08
serine O 0 1.3923032327056717e-07
- O 0 2.797562501655193e-07
threonine O 0 1.1382513775970438e-06
( O 0 1.4745270560112544e-09
PST O 0 2.1468111299327575e-05
) O 0 7.644917476845592e-10
- O 0 1.9565343123417733e-08
rich O 0 2.200344617619976e-08
transactivation O 0 5.443294867291115e-06
domain O 0 2.600472726044245e-06
. O 0 8.238212956257485e-08

PAX6 O 1 0.9899120926856995
regulates O 0 4.763151446240954e-05
eye O 0 0.48715779185295105
development O 0 3.623941893238225e-06
in O 0 9.557983737806808e-09
animals O 0 1.9661804129267324e-10
ranging O 0 1.8094604925522617e-08
from O 0 5.384848567047129e-09
jellyfish O 0 8.777756854705387e-10
to O 0 3.812381965673239e-09
Drosophila O 0 6.4572227564951845e-09
to O 0 1.2002394633725544e-09
humans O 0 3.224627898035237e-09
. O 0 7.956772130057743e-09

Heterozygous O 0 5.14196699441527e-07
mutations O 0 6.136288277502899e-08
in O 0 1.0109935805191483e-10
the O 0 3.586697328028521e-10
human O 0 7.42555406052503e-10
PAX6 O 0 5.9947983572783414e-06
gene O 0 1.0701999286766295e-09
result O 0 6.311994815710875e-10
in O 0 1.4089545502526946e-11
various O 0 4.855666650011026e-12
phenotypes O 0 1.951423689305898e-09
, O 0 3.67828250497082e-12
including O 0 9.371958070714115e-12
aniridia B-Disease 1 1.0
, O 0 4.846654988455157e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.0717223553058375e-08
autosomal B-Disease 0 0.00021172239212319255
dominant I-Disease 0 0.009481794200837612
keratitis I-Disease 1 0.999998927116394
, O 0 1.1968886326485517e-08
and O 0 1.1573745517523548e-08
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9842086434364319

It O 0 4.206389458971671e-09
is O 0 1.8720817951400903e-10
believed O 0 2.8411614727552603e-10
that O 0 3.2538711308705004e-12
the O 0 1.0894619408008399e-11
mutated O 0 4.332012179530942e-11
allele O 0 3.862202113680269e-09
of O 0 3.608712662028779e-09
PAX6 O 0 3.027996626769891e-06
produces O 0 5.203149022747766e-10
an O 0 3.266047501893077e-11
inactive O 0 8.531775841369438e-10
protein O 0 2.1389316984254947e-09
and O 0 2.844594004791645e-10
aniridia B-Disease 1 1.0
is O 0 4.500310168964461e-08
caused O 0 6.798557024012553e-07
due O 0 2.1859605112695135e-06
to O 0 6.113892681014477e-08
genetic O 0 7.136257522688538e-07
haploinsufficiency O 0 6.407606633729301e-06
. O 0 1.2439909369277302e-07

However O 0 1.5701932909450989e-07
, O 0 4.978895629115243e-10
several O 0 6.555588016876612e-11
truncation O 0 7.835658522026279e-08
mutations O 0 3.279022919855379e-08
have O 0 1.6222109766594883e-10
been O 0 5.0389664663086364e-11
found O 0 5.164011145780689e-12
to O 0 1.9536190373758977e-11
occur O 0 1.737578969596143e-10
in O 0 1.4474764269134521e-11
the O 0 1.4247969470915223e-10
C O 0 4.712534860118467e-07
- O 0 2.6536213226791006e-08
terminal O 0 3.5259733976999996e-07
half O 0 3.17734838439776e-09
of O 0 1.0292307006665169e-09
PAX6 O 0 2.0079564819752704e-06
in O 0 2.7683408343470717e-10
patients O 0 8.746166291206947e-11
with O 0 1.9406871942795334e-11
Aniridia B-Disease 1 1.0
resulting O 0 1.5783936646585062e-07
in O 0 1.1687563139517465e-09
mutant O 0 6.099362681588616e-10
proteins O 0 8.954835137298112e-12
that O 0 1.0253007210608844e-12
retain O 0 7.258156315553821e-12
the O 0 4.405166769555491e-12
DNA O 0 4.322413260648972e-11
- O 0 1.93889661270763e-11
binding O 0 4.524785879311821e-09
domains O 0 3.9032681087292076e-08
but O 0 5.656287660471548e-10
have O 0 1.3911970186963885e-10
lost O 0 3.02407365815327e-09
most O 0 4.087797374902058e-12
of O 0 2.7771080574057194e-11
the O 0 4.1152581342629446e-11
transactivation O 0 2.7440466965344967e-07
domain O 0 4.709641530098452e-07
. O 0 4.123600660932425e-08

It O 0 1.8165451365348417e-09
is O 0 8.989476524279283e-11
not O 0 5.713535547458015e-11
clear O 0 1.2664970183706714e-09
whether O 0 1.340342975497677e-10
such O 0 1.5424544974607102e-10
mutants O 0 2.9388439770627883e-07
really O 0 1.8312858784952368e-08
behave O 0 1.816999106729611e-09
as O 0 2.2136696642416354e-10
loss O 0 4.039516721121572e-09
- O 0 2.9448415261867922e-08
of O 0 1.314259776563631e-07
- O 0 6.840538446795108e-08
function O 0 9.517525434432628e-09
mutants O 0 3.0955199514792753e-10
as O 0 5.199532644717397e-12
predicted O 0 1.3836267687139525e-09
by O 0 1.7706335009304297e-10
haploinsufficiency O 0 1.3589420632342808e-05
. O 0 2.3956471295605297e-07

Contrary O 0 1.7384499528816377e-07
to O 0 1.7783341466071079e-09
this O 0 1.784585396125138e-10
theory O 0 9.813933665725472e-09
, O 0 3.397123901627275e-11
our O 0 1.6314663162098064e-11
data O 0 2.867099613279578e-11
showed O 0 2.384565114810222e-11
that O 0 5.370623650663431e-12
these O 0 7.370683924312615e-12
mutants O 0 3.629225531209812e-10
are O 0 1.1048216161380076e-11
dominant O 0 1.0756235013786863e-08
- O 0 7.199047136197123e-09
negative O 0 4.792270580367131e-09
in O 0 3.435649265082219e-10
transient O 0 1.1278394218550147e-08
transfection O 0 2.4030957224141503e-09
assays O 0 4.001845521628411e-10
when O 0 4.3104179947572874e-11
they O 0 7.524578182760422e-12
are O 0 5.788315248118903e-13
coexpressed O 0 1.1372360830819161e-08
with O 0 4.73343621243405e-11
wild O 0 8.031912912542793e-09
- O 0 2.0606751860441364e-08
type O 0 1.538466676720418e-06
PAX6 O 0 0.012037856504321098
. O 0 7.030660640339192e-07

We O 0 1.3794515041354316e-07
found O 0 2.342726013182528e-10
that O 0 6.223880352068667e-12
the O 0 1.8884352415149408e-10
dominant O 0 1.4549299542920835e-08
- O 0 4.033742229125892e-09
negative O 0 4.081952109658005e-09
effects O 0 1.541633309898316e-07
result O 0 2.2165522750583477e-09
from O 0 3.3668334786796095e-10
the O 0 3.5359146166591415e-11
enhanced O 0 9.774781678517641e-12
DNA O 0 9.817799351274914e-11
binding O 0 8.171662790878997e-10
ability O 0 8.469834555935307e-11
of O 0 2.3165144802383963e-10
these O 0 6.375319716589445e-11
mutants O 0 1.7660067852531824e-09
. O 0 1.6385064416368778e-09

Kinetic O 0 6.025199468240316e-07
studies O 0 1.6360643950719123e-09
of O 0 6.731166735107763e-10
binding O 0 1.0816453510642532e-08
and O 0 1.1400566046759764e-09
dissociation O 0 8.388528272007534e-08
revealed O 0 5.8188565077443855e-09
that O 0 1.0573696432314428e-11
various O 0 1.1970465417510123e-11
truncation O 0 4.634140893244876e-08
mutants O 0 2.1672303951447702e-09
have O 0 9.401714649859283e-12
3 O 0 2.8661223394621516e-10
- O 0 3.1598204608407343e-10
5 O 0 1.2652512371147395e-09
- O 0 7.576286265020826e-10
fold O 0 9.770877440473669e-10
higher O 0 4.736798175919432e-10
affinity O 0 5.841246236704123e-11
to O 0 2.7449842746052333e-11
various O 0 7.638245504842933e-13
DNA O 0 1.7807389243729155e-11
- O 0 6.7237044924783884e-12
binding O 0 7.075866281791576e-11
sites O 0 1.6114106576869958e-11
when O 0 1.5662112448980303e-12
compared O 0 5.339715648811083e-12
with O 0 4.795663107078074e-13
the O 0 1.6219912912784906e-10
wild O 0 7.081811248532688e-10
- O 0 6.062598867373481e-09
type O 0 4.6398321273954934e-07
PAX6 O 0 0.0016962981317192316
. O 0 6.049871785762662e-07

These O 0 1.5383421203551961e-09
results O 0 9.634265607516568e-10
provide O 0 6.502934302154983e-11
a O 0 2.654853559214132e-10
new O 0 6.481301606520162e-11
insight O 0 6.829968535182473e-11
into O 0 1.8318140407314054e-11
the O 0 8.081752281285937e-12
role O 0 2.0721807950097038e-11
of O 0 3.9231985715648676e-11
mutant O 0 3.59972096575234e-09
PAX6 O 0 6.764229965483537e-06
in O 0 1.1005741873404418e-09
causing O 0 1.950423893504194e-06
aniridia B-Disease 1 1.0
. O 0 1.67518663829469e-07
. O 0 1.4392298908205703e-07

Reversal O 0 3.3006260764523176e-06
of O 0 1.36411642870371e-07
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 0.00010752823436632752
excellent O 0 1.5537332842541218e-07
neuropsychologic O 0 0.048307083547115326
outcome O 1 0.9999805688858032
in O 0 8.402282958286378e-08
very B-Disease 0 7.780793254141827e-08
- I-Disease 0 3.573631772724184e-07
long I-Disease 0 5.152451620915599e-08
- I-Disease 0 8.206090917894926e-09
chain I-Disease 0 1.44917966515834e-09
acyl I-Disease 0 2.1233148572719074e-09
- I-Disease 0 1.24058079364886e-08
coenzyme I-Disease 0 6.140875807858492e-09
A I-Disease 0 4.019669177068863e-06
dehydrogenase I-Disease 0 0.0007995085907168686
deficiency I-Disease 1 0.9999892711639404
. O 0 1.4663210095022805e-06

Very B-Disease 0 2.696747060326743e-06
- I-Disease 0 2.1757423382950947e-06
long I-Disease 0 1.646477869599039e-07
- I-Disease 0 9.12119713092352e-09
chain I-Disease 0 7.536938295693574e-10
acyl I-Disease 0 4.980567069878816e-10
- I-Disease 0 6.39757746778713e-10
coenzyme I-Disease 0 2.0274641687745287e-10
A I-Disease 0 3.115215641003033e-09
dehydrogenase I-Disease 0 4.956470345263142e-09
( I-Disease 0 9.98138863228526e-11
VLCAD I-Disease 0 0.01968781277537346
) I-Disease 0 3.552073746249107e-09
deficiency I-Disease 0 0.0001151680335169658
is O 0 1.2148368977449309e-09
a O 0 2.6279030507225798e-08
disorder O 1 0.5446974039077759
of O 0 8.638233703095466e-05
fatty O 0 1.4960550288378727e-05
acid O 0 1.0044174132417538e-06
beta O 0 2.4022634192988335e-07
oxidation O 0 7.771048871063613e-08
that O 0 2.5632529432328965e-10
reportedly O 0 5.096784327918158e-09
has O 0 1.4562882150181977e-11
high O 0 9.01227495408996e-11
rates O 0 9.006156931334885e-11
of O 0 6.284146120139056e-11
morbidity O 0 6.011992326193649e-08
and O 0 1.7675131358529939e-09
mortality O 0 7.476729706468177e-07
. O 0 3.3557327583366714e-08

We O 0 2.3512829017136028e-08
describe O 0 1.7812740171763153e-09
the O 0 9.58108176130068e-11
outcome O 0 4.205835679726988e-09
of O 0 1.0935805039302693e-10
a O 0 2.196378842689306e-11
5 O 0 2.4778404328351655e-10
- O 0 1.1043396752619117e-10
year O 0 4.215214011171753e-10
- O 0 7.483497377336334e-09
old O 0 2.054411574192727e-08
girl O 0 4.906026140893971e-10
with O 0 1.971587129667718e-11
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.00013128093269187957
was O 0 2.2031818502910028e-07
first O 0 2.662648157514269e-10
seen O 0 7.715373478989207e-11
at O 0 1.5983339651803874e-11
5 O 0 2.2291548815167594e-11
months O 0 1.6458402349317502e-11
of O 0 8.52074053675489e-12
age O 0 2.620892669558117e-10
with O 0 3.398768246010153e-12
severe O 1 0.9996373653411865
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 0 0.09192432463169098
hepatomegaly B-Disease 1 1.0
, O 1 0.7054070830345154
encephalopathy B-Disease 1 1.0
, O 0 1.255319148185663e-06
and O 0 2.319821533092181e-06
hypotonia B-Disease 1 0.9998910427093506
. O 0 0.0027848812751471996

Biochemical O 0 1.5208663626253838e-06
studies O 0 7.767091858568165e-08
indicated O 0 0.0020695598796010017
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.8863282799720764
by O 0 1.4162979677934118e-09
a O 0 7.401914636773199e-09
stable O 0 5.816639969680182e-08
yet O 0 7.821440384248035e-09
inactive O 0 2.8722929812374787e-08
enzyme O 0 7.122659440028656e-08
. O 0 3.5039960266658454e-08

Molecular O 0 1.6671556295477785e-06
genetic O 0 1.693995343998722e-08
analysis O 0 4.431379707625638e-10
of O 0 4.005811238272372e-09
her O 0 1.0861640475923195e-09
VLCAD O 1 0.5320941805839539
gene O 0 1.402660831928415e-08
revealed O 0 2.5641407219723078e-08
a O 0 5.4885735956133885e-09
T1372C O 0 7.202344022516627e-06
( O 0 2.6753201876061894e-09
F458L O 0 1.3496404790203087e-05
) O 0 1.846816921613481e-09
missense O 0 1.5266369928212953e-06
mutation O 0 2.2039763791781297e-07
and O 0 7.594413986566906e-10
a O 0 1.3568683066012e-08
1668 O 0 3.2110470783663914e-05
ACAG O 0 0.005886582657694817
1669 O 0 2.5613440811866894e-05
splice O 0 3.8181437957973685e-06
site O 0 6.765539239950158e-08
mutation O 0 4.5591807662503925e-08
. O 0 1.9681035468011032e-08

After O 0 1.5588746293815348e-07
initial O 0 7.056428330542985e-08
treatment O 0 6.059826063165019e-08
with O 0 1.4981552109993856e-10
intravenous O 0 2.1260960991753564e-08
glucose O 0 1.8972335737998947e-06
and O 0 5.80906156510963e-10
carnitine O 0 1.3969871481833707e-08
, O 0 5.047296608440277e-11
the O 0 3.8600789231679755e-10
patient O 0 4.966794975302946e-09
has O 0 2.5202751344211016e-11
thrived O 0 7.07272629352218e-10
on O 0 5.30652077834759e-10
a O 0 3.901917122739462e-10
low O 0 1.8509020094370499e-07
- O 0 2.6105379191676548e-08
fat O 0 4.7862258156783355e-08
diet O 0 6.954406495118803e-10
supplemented O 0 5.6116430946495655e-12
with O 0 1.1784605409570492e-12
medium O 0 2.3551699257495784e-08
- O 0 3.3151195566460956e-08
chain O 0 1.0926517468590191e-08
triglyceride O 0 5.778887413043776e-08
oil O 0 2.3470136056857882e-07
and O 0 3.547102334078289e-10
carnitine O 0 1.3972022427921615e-09
and O 0 2.4696246783695308e-11
avoidance O 0 5.36642374981966e-09
of O 0 1.1115532494443414e-08
fasting O 0 2.135106029754752e-07
. O 0 4.910766016053003e-09

Her O 0 4.956066277372884e-07
ventricular O 0 0.0023394546005874872
hypertrophy O 1 0.9718985557556152
resolved O 0 0.0001706433540675789
significantly O 0 2.4353457916959087e-08
over O 0 1.8560796233302312e-09
1 O 0 3.978272644644676e-08
year O 0 1.43403744434778e-09
, O 0 3.56758476927066e-11
and O 0 1.366082941212099e-10
cognitively O 0 1.7694572989057633e-06
, O 0 3.171050366734818e-10
she O 0 6.410412478619065e-11
is O 0 3.873084578748243e-12
in O 0 1.6363551139098043e-12
the O 0 7.220681084302294e-12
superior O 0 3.0227914615821305e-10
range O 0 2.7698738858106253e-09
for O 0 4.8860232526593e-10
age O 0 5.468387485052517e-07
. O 0 5.984077233733842e-08

Clinical O 0 5.624861501019041e-07
recognition O 0 4.024599604690593e-07
of O 1 0.9988489151000977
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.9295755919301882e-05
important O 0 3.5933960251810504e-09
because O 0 4.605689440939642e-11
it O 0 6.568497373619919e-13
is O 0 4.1568360082192e-13
one O 0 5.485694364038007e-13
of O 0 3.3247885781323427e-12
the O 0 1.924295141633725e-12
few O 0 2.700390475465775e-12
directly O 0 3.629419265127609e-10
treatable O 1 0.9994279742240906
causes O 0 1.1896621572304866e-06
of O 0 8.94847198651405e-06
cardiomyopathy B-Disease 1 1.0
in O 0 0.0015037673292681575
children O 0 2.7887102405088626e-08
. O 0 6.98956670319717e-10
. O 0 8.761468883733414e-09

Cloning O 0 5.291648363936474e-08
of O 0 3.7344369263614396e-10
a O 0 3.6169921224793455e-11
novel O 0 4.76301428853354e-11
member O 0 7.731400936128452e-11
of O 0 1.3988440961121285e-10
the O 0 2.4606641724211897e-10
low O 0 9.40822530992591e-08
- O 0 8.688861186101349e-09
density O 0 1.3687211364299401e-08
lipoprotein O 0 1.9681747289723717e-05
receptor O 0 0.04731713980436325
family O 0 2.8508765126389335e-07
. O 0 1.2468177601476782e-07

A O 0 6.548324336108635e-07
gene O 0 9.515996879372324e-10
encoding O 0 1.2264077531298767e-09
a O 0 5.992066842708255e-10
novel O 0 1.6834168503621072e-09
transmembrane O 0 4.1841865083824814e-08
protein O 0 2.6419184617765268e-09
was O 0 1.754215800398029e-10
identified O 0 2.6639101081277206e-12
by O 0 2.2160786118489983e-13
DNA O 0 1.380699114067463e-11
sequence O 0 2.2529966173939764e-12
analysis O 0 3.387014247627912e-13
within O 0 1.1331464412622783e-11
the O 0 5.089212037900914e-11
insulin B-Disease 0 6.614543053728994e-06
- I-Disease 0 0.001752360607497394
dependent I-Disease 1 0.9989727735519409
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 1.0856053833663282e-08
IDDM B-Disease 0 3.3435509976698086e-05
) O 0 6.342112252033516e-11
locus O 0 6.57970877782077e-09
IDDM4 O 0 8.327787668349629e-07
on O 0 1.3328848247340375e-08
chromosome O 0 2.1062473933852743e-06
11q13 O 0 2.212661820522044e-05
. O 0 1.1312675951558049e-07

Based O 0 9.063896300176566e-09
on O 0 7.951522995597315e-09
its O 0 7.820775971278948e-11
chromosomal O 0 8.242454327955784e-07
position O 0 1.2158207596257853e-07
, O 0 5.058878663199984e-12
this O 0 4.25138223236754e-12
gene O 0 7.648060136589141e-12
is O 0 1.015274669891042e-12
a O 0 3.724964781071094e-12
candidate O 0 1.1103486186048173e-10
for O 0 8.751168192877579e-12
conferring O 0 5.911279465919961e-09
susceptibility O 0 1.3190153367759194e-05
to O 0 3.2522914352739463e-06
diabetes B-Disease 1 1.0
. O 0 1.7738753740559332e-05

The O 0 3.691000642902509e-07
gene O 0 2.0953988766336806e-08
, O 0 5.725320217919716e-10
termed O 0 7.872165497246897e-08
low O 0 8.724918188818265e-06
- O 0 5.9529654095058504e-08
density O 0 8.183770106029442e-09
lipoprotein O 0 1.7894036830057303e-07
receptor O 0 1.7546800279433228e-07
related O 0 2.968368306710545e-08
protein O 0 1.5994677582398253e-08
5 O 0 6.616708958517847e-09
( O 0 2.5713950066452718e-11
LRP5 O 0 2.3202219381346367e-06
) O 0 2.9034203860578423e-11
, O 0 7.905931118101783e-12
encodes O 0 7.925618494830644e-12
a O 0 6.477396397031043e-11
protein O 0 7.189479012126299e-10
of O 0 1.6346918263465682e-09
1615 O 0 1.1631570941972313e-06
amino O 0 1.2023323847643042e-07
acids O 0 1.813640460035515e-09
that O 0 3.229140479316106e-12
contains O 0 2.7563569916094766e-12
conserved O 0 2.977243451773859e-11
modules O 0 1.1389100600112112e-11
which O 0 3.558060421814113e-13
are O 0 2.3869743529837673e-13
characteristic O 0 1.4246820737029431e-11
of O 0 9.978775618313396e-12
the O 0 1.5231177430408138e-11
low O 0 1.1283020739938365e-08
- O 0 6.524073725699964e-09
density O 0 6.829246057549199e-09
lipoprotein O 0 9.059195917870966e-07
( O 0 6.166203991853081e-09
LDL O 0 3.296629074611701e-05
) O 0 2.156340883630037e-09
receptor O 0 5.923980097577441e-07
family O 0 6.744973024552792e-09
. O 0 1.5399015396155846e-08

These O 0 1.702309582185535e-08
modules O 0 2.475480975761002e-08
include O 0 8.248361438312202e-10
a O 0 8.07424616056096e-09
putative O 0 1.3741180282522691e-07
signal O 0 2.4744757354255853e-08
peptide O 0 3.719702101889766e-09
for O 0 2.6414584408662733e-10
protein O 0 8.447863519833732e-10
export O 0 1.9258878936057044e-09
, O 0 1.1763591836744247e-11
four O 0 1.92143904953479e-11
epidermal O 0 6.456729817472251e-09
growth O 0 7.421843695176733e-10
factor O 0 8.911124060873021e-10
( O 0 1.1540293720635475e-10
EGF O 0 9.939758172095026e-08
) O 0 3.078983942805813e-11
repeats O 0 3.5571703915771025e-10
with O 0 5.437785096339132e-13
associated O 0 2.9315677663177553e-10
spacer O 0 4.9106933630582716e-08
domains O 0 1.3152677524885803e-07
, O 0 2.9896385367322864e-10
three O 0 1.7537941932044276e-10
LDL O 0 1.3341307294467697e-06
- O 0 2.7516989575815387e-07
receptor O 0 4.610689074979746e-07
( O 0 1.2860513765033943e-09
LDLR O 0 4.9612950533628464e-05
) O 0 1.9427547071071416e-10
repeats O 0 2.1026882457420015e-09
, O 0 1.1117891329792684e-11
a O 0 9.233776243622316e-11
single O 0 6.693066656460189e-10
transmembrane O 0 5.673656744420441e-08
spanning O 0 7.918531963468922e-08
domain O 0 1.3184236991037324e-07
, O 0 2.42163733510381e-10
and O 0 1.4943139781120607e-10
a O 0 5.277896786282099e-09
cytoplasmic O 0 7.806389135112113e-07
domain O 0 1.8076826791002532e-06
. O 0 6.941584729247552e-08

The O 0 2.564928180959214e-08
encoded O 0 7.588216721643448e-10
protein O 0 5.395334845559319e-09
has O 0 4.683331847332717e-12
a O 0 4.569566513373813e-12
unique O 0 3.1585400527694985e-12
organization O 0 2.584189806587034e-10
of O 0 3.2565710128551473e-09
EGF O 0 1.0362186912971083e-05
and O 0 8.134406925819349e-09
LDLR O 1 0.9996647834777832
repeats O 0 1.3867747838958167e-07
; O 0 3.9360150555500795e-11
therefore O 0 8.23220380752332e-10
, O 0 4.0879161167239886e-11
LRP5 O 0 0.00012575976143125445
likely O 0 4.511058637746146e-09
represents O 0 1.264699803216196e-11
a O 0 4.114643955416275e-12
new O 0 5.868287084563606e-13
category O 0 4.6718164059544875e-11
of O 0 9.624160496324308e-11
the O 0 8.58355053701132e-10
LDLR O 0 0.2180599570274353
family O 0 1.1932348442655893e-08
. O 0 2.0169672154679574e-08

Both O 0 2.685352740172675e-07
human O 0 3.556054650744045e-08
and O 0 8.83965178832824e-10
mouse O 0 4.32136495476243e-08
LRP5 O 0 0.09814535826444626
cDNAs O 0 0.00010609711898723617
have O 0 9.550694457516329e-09
been O 0 9.55462997609402e-09
isolated O 0 2.539314181149166e-08
and O 0 6.553575043755089e-11
the O 0 1.8141965707485497e-10
encoded O 0 3.203953213848365e-10
mature O 0 2.5100115319531824e-09
proteins O 0 1.6486303641705113e-11
are O 0 6.8675566535642e-13
95 O 0 2.386140451893226e-10
% O 0 7.127257117822694e-11
identical O 0 1.749630301750571e-11
, O 0 5.310555380860782e-12
indicating O 0 2.3783253144671335e-10
a O 0 9.868037637028593e-11
high O 0 1.248365744110913e-09
degree O 0 2.6093234239965568e-08
of O 0 5.354631738008209e-10
evolutionary O 0 4.4751682359844835e-09
conservation O 0 5.938556868478884e-10
. O 0 1.0929382399105236e-10
. O 0 3.138774351540974e-09

The O 0 2.8568041443577386e-07
APC B-Disease 0 1.004777914204169e-07
variants O 0 8.108971272235976e-09
I1307K O 0 6.520489023387199e-06
and O 0 5.153832360882404e-10
E1317Q O 0 2.0345960365375504e-06
are O 0 3.511658325239253e-11
associated O 0 3.9753444980306085e-08
with O 0 1.7954540453501977e-05
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 8.078085045326588e-08
but O 0 1.189568166193311e-10
not O 0 6.621158482600364e-11
always O 0 2.465970786943994e-12
with O 0 4.015699516077449e-14
a O 0 3.794654868105596e-11
family O 0 4.887120222396568e-11
history O 0 9.966745206924088e-10
. O 0 6.929451679127396e-09

Classical O 0 0.0025924535002559423
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.8014648617281637e-07
FAP B-Disease 0 3.1941272027324885e-07
) O 0 1.467055123216543e-11
is O 0 5.128361277306759e-12
a O 0 1.7916008954177443e-10
high O 0 5.563965146393457e-07
- O 0 0.00032294561970047653
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
that O 0 4.326253133513092e-09
predisposes O 0 2.7681755909725325e-07
to O 0 1.897035417641746e-09
hundreds O 0 7.358719189554108e-11
or O 0 1.9128540418300588e-10
thousands O 0 1.0420479062966947e-10
of O 0 1.1843648906051385e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 2.1425061902391462e-07
that O 0 6.842568178733188e-10
results O 0 6.902090010640904e-10
from O 0 1.2745570154848451e-09
truncating O 0 8.700887832446824e-08
mutations O 0 2.4064807924162324e-09
in O 0 2.127732851020525e-10
the O 0 2.0896981922646773e-09
APC B-Disease 0 2.3854513031551505e-08
gene O 0 9.240533671572848e-09
. O 0 1.5302015654583556e-08

A O 0 5.2532026728613346e-08
variant O 0 3.72450337238206e-08
of O 0 5.748085385448576e-08
FAP B-Disease 0 3.609304258134216e-06
is O 0 2.4803064491152327e-08
attenuated B-Disease 0 0.07379741966724396
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999996423721313
coli I-Disease 1 1.0
, O 0 2.3769930468375833e-09
which O 0 4.246667947849225e-11
results O 0 7.702551790833567e-11
from O 0 2.06626271648247e-09
germ O 0 3.7665924992325017e-06
- O 0 2.795233555730192e-08
line O 0 2.8066395429959812e-08
mutations O 0 2.498905304904042e-09
in O 0 2.7421792267445788e-11
the O 0 5.2085873808449534e-11
5 O 0 4.601757863653688e-10
and O 0 6.9976698047202746e-12
3 O 0 1.6082128961869557e-09
regions O 0 1.9562163000585997e-09
of O 0 2.558267375718515e-09
the O 0 2.809192878316935e-09
APC B-Disease 0 4.664984487590118e-08
gene O 0 8.75031336278198e-09
. O 0 5.963827209853889e-09

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 0.0015186554519459605
have O 0 7.0967560716894695e-09
" O 0 1.0709907627415305e-08
multiple O 0 7.373257915332943e-08
" O 0 0.2592093050479889
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 6.215775005813384e-09
typically O 0 1.3227839934515373e-09
fewer O 0 1.9896749178793804e-11
than O 0 8.365121095810224e-12
100 O 0 2.2033189508996465e-11
) O 0 3.124778268168843e-13
without O 0 1.5639432457414948e-11
the O 0 3.3779791464016995e-11
florid O 0 4.921492990916931e-09
phenotype O 0 4.768655248454934e-09
of O 0 2.2456552173366617e-09
classical O 0 6.225412363392024e-08
FAP B-Disease 0 4.7352537535516603e-07
. O 0 3.6758915911150325e-08

Another O 0 5.056458007857145e-08
group O 0 7.223608933237813e-10
of O 0 2.057163328572642e-09
patients O 0 7.699500481628263e-10
with O 0 1.105340124984977e-11
multiple O 0 2.1254558646432997e-07
adenomas B-Disease 1 0.9999946355819702
has O 0 5.857097562511626e-08
no O 0 8.626063419114871e-09
mutations O 0 2.3875803556450137e-09
in O 0 1.8250075062287152e-10
the O 0 4.782808038505948e-10
APC B-Disease 0 2.04412287097e-09
gene O 0 2.353811312527654e-10
, O 0 1.0832086096146387e-11
and O 0 5.0617452937440355e-12
their O 0 7.31759531441556e-12
phenotype O 0 3.0537383732820444e-09
probably O 0 4.001511566542604e-09
results O 0 9.740268591684753e-10
from O 0 6.643742778145167e-10
variation O 0 3.682865346021913e-09
at O 0 3.7211336789688687e-10
a O 0 6.6613984293917294e-12
locus O 0 9.081988633363736e-11
, O 0 1.0846345523118917e-12
or O 0 3.0495560937593424e-11
loci O 0 8.87296724982889e-09
, O 0 2.3681754474091932e-11
elsewhere O 0 1.1353883111464569e-10
in O 0 4.994063149132977e-11
the O 0 9.687186608431375e-10
genome O 0 1.4833542394399046e-08
. O 0 9.433036574080234e-09

Recently O 0 1.4610822063332307e-06
, O 0 1.7538386298809883e-09
however O 0 1.2266651028269848e-09
, O 0 4.578659673626362e-11
a O 0 8.78222286559982e-11
missense O 0 1.8364168852258445e-08
variant O 0 1.6273322245297095e-08
of O 0 9.822267657000339e-07
APC B-Disease 0 4.2085744667019753e-07
( O 0 9.46401068624425e-10
I1307K O 0 3.8158563256729394e-05
) O 0 8.208462382031101e-11
was O 0 8.683736507641981e-10
described O 0 1.607558010319199e-11
that O 0 3.77551966470116e-13
confers O 0 1.1616345038656384e-11
an O 0 7.620187033458015e-13
increased O 0 2.9156752012760023e-10
risk O 0 1.3013366242375923e-06
of O 1 0.8763629198074341
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 2.3431131523921067e-07
including O 0 1.5929904617628665e-10
multiple O 0 2.772655882665731e-08
adenomas B-Disease 0 0.020860275253653526
, O 0 3.6545952930566727e-09
in O 0 1.9551352536950617e-08
Ashkenazim O 0 5.053207132732496e-05
. O 0 7.520079634559806e-07

We O 0 3.494179452445678e-07
have O 0 3.0295044251005265e-10
studied O 0 7.797142376197996e-10
a O 0 9.659801430972337e-11
set O 0 2.8446425770489725e-10
of O 0 2.6123719507054055e-11
164 O 0 6.270859387313976e-10
patients O 0 1.544072682213571e-11
with O 0 4.757419284906472e-12
multiple O 0 0.00014812505105510354
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999827146530151
/ I-Disease 1 1.0
or I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 1.664731257733365e-06
analyzed O 0 2.1993507459683315e-07
codons O 0 4.2616292716957105e-07
1263 O 0 1.6662401094436063e-06
- O 0 4.4587096681425464e-08
1377 O 0 3.8474112784570025e-07
( O 0 1.0681138196133588e-09
exon O 0 8.999130329812033e-08
15G O 0 5.67676295304409e-07
) O 0 1.996563157857789e-11
of O 0 2.8857657929926006e-10
the O 0 2.9679123048076406e-10
APC B-Disease 0 5.4586624109731474e-09
gene O 0 2.565498091744445e-10
for O 0 2.69247818485141e-10
germ O 0 2.4655771539983107e-06
- O 0 2.3917345970403403e-07
line O 0 1.339179647175115e-07
variants O 0 6.081386061396188e-08
. O 0 1.3884182692436298e-07

Three O 0 1.36072785039687e-07
patients O 0 1.8110064559095918e-09
with O 0 4.5314468323509605e-12
the O 0 7.746963626154013e-10
I1307K O 0 9.016035562581237e-08
allele O 0 2.4287436506398308e-09
were O 0 8.121748412692753e-11
detected O 0 3.562996564454579e-10
, O 0 1.327786947231957e-12
each O 0 4.214655100615028e-12
of O 0 4.76813477590099e-10
Ashkenazi O 0 1.8025750136985152e-07
descent O 0 4.268871180101996e-06
. O 0 1.6545241976473335e-07

Four O 0 3.3091563977905025e-07
patients O 0 3.77121089911725e-08
had O 0 9.795438238313636e-09
a O 0 6.018058495982359e-09
germ O 0 5.234831860434497e-06
- O 0 1.3324455494512222e-07
line O 0 7.160486603652316e-08
E1317Q O 0 5.239154461378348e-07
missense O 0 1.9385961280704578e-08
variant O 0 2.86032975083117e-09
of O 0 3.270627857432373e-08
APC O 0 3.4296927520216514e-09
that O 0 1.2293947977692898e-11
was O 0 1.7800538820722522e-10
not O 0 1.2335193630419461e-11
present O 0 1.044741983896591e-11
in O 0 5.703090777409159e-12
controls O 0 1.451552350539842e-10
; O 0 6.7619139454411226e-12
one O 0 2.514594608926668e-11
of O 0 5.284176568531862e-11
these O 0 8.818016304125431e-13
individuals O 0 1.0461797227134806e-11
had O 0 2.075133398449225e-09
an O 0 2.579460950391521e-11
unusually O 0 2.078154454077108e-10
large O 0 7.830090048566163e-11
number O 0 6.532434315698055e-11
of O 0 2.0966810510003597e-09
metaplastic B-Disease 0 3.9227717934409156e-05
polyps I-Disease 0 1.687499320723873e-06
of I-Disease 0 5.2653106763500546e-08
the I-Disease 0 2.706361712512262e-08
colorectum I-Disease 0 2.020828287641052e-05
. O 0 2.2593039261664671e-07

There O 0 9.703353676115967e-09
is O 0 6.95294447017325e-11
increasing O 0 4.615979126709746e-11
evidence O 0 2.7785810111091713e-11
that O 0 1.6088547594855784e-12
there O 0 7.876851081112246e-12
exist O 0 1.2691563078259804e-10
germ O 0 9.605134465573428e-09
- O 0 1.9495627334720211e-10
line O 0 1.6978202177497792e-10
variants O 0 3.800492906491648e-11
of O 0 1.2962708684227664e-10
the O 0 5.605463315738746e-11
APC B-Disease 0 5.475677689048553e-10
gene O 0 5.5874844681613745e-12
that O 0 5.969892549056999e-13
predispose O 0 1.0814714679341364e-09
to O 0 9.740207251862643e-11
the O 0 5.231826430418529e-11
development O 0 5.463826058260679e-10
of O 0 7.869200291388267e-10
multiple O 0 0.4911934733390808
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 1.8036233839779925e-08
but O 0 3.3760291784368235e-10
without O 0 3.190512853912253e-10
the O 0 7.978465110802802e-11
florid O 0 7.388430312005312e-09
phenotype O 0 4.6299595268806115e-09
of O 0 1.9561192665662475e-09
classical O 0 1.5159727695390757e-08
FAP B-Disease 0 5.430419136587261e-08
, O 0 1.2105541395690533e-11
and O 0 4.954390305129952e-13
possibly O 0 2.221743448937996e-11
with O 0 1.422313059429997e-13
importance O 0 7.790275091679177e-10
for O 0 1.1526489060997847e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9999940395355225
in O 0 8.777823468086865e-10
the O 0 1.2219381062550383e-10
general O 0 1.1468847399553894e-10
population O 0 2.694540554223912e-12
. O 0 3.1401842931488844e-11
. O 0 2.3892476885833958e-09

Genomic O 0 1.0175391196298733e-08
structure O 0 2.323817582805532e-09
of O 0 4.760022154215449e-09
the O 0 1.2492953338494317e-08
human O 0 9.054713700606953e-06
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 0.0001259209238924086
CLD B-Disease 1 0.9999995231628418
) O 0 6.442177458154674e-09
gene O 0 2.4143345100924307e-08
. O 0 3.606209730833143e-08

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 0.00020748704264406115
CLD B-Disease 1 1.0
) O 0 3.9578787469629617e-10
is O 0 8.351414698681836e-11
caused O 0 3.3047831138333095e-09
by O 0 7.492258896624193e-11
mutations O 0 7.190909201426621e-09
in O 0 2.272961541205376e-10
a O 0 2.160077533508442e-10
gene O 0 2.410700285226941e-11
which O 0 1.0018003787637397e-11
encodes O 0 6.809780517258446e-11
an O 0 1.0010348799882607e-10
intestinal O 0 1.894940737656725e-06
anion O 0 1.449689875698823e-06
transporter O 0 1.8778391677187756e-05
. O 0 2.2505065544464742e-07

We O 0 1.7491665005309187e-07
report O 0 6.475225355906389e-10
here O 0 3.64947204400945e-11
the O 0 3.710980307769507e-12
complete O 0 1.7175934285962313e-11
genomic O 0 2.578960378585293e-10
organization O 0 4.202584114043617e-11
of O 0 1.0470785349880884e-10
the O 0 2.986298985874214e-10
human O 0 3.50461615283848e-09
CLD B-Disease 0 0.00011406167323002592
gene O 0 4.487859528445881e-10
which O 0 9.83109860880349e-12
spans O 0 7.835920246002104e-10
approximately O 0 1.7369328197958112e-10
39kb O 0 2.983871354445e-07
, O 0 1.6296290705763994e-10
and O 0 1.6499522581536752e-10
comprises O 0 1.4250252367009608e-10
21 O 0 5.2039087705679776e-08
exons O 0 8.253781516032177e-07
. O 0 6.508415850703386e-08

All O 0 1.2364502026684931e-06
exon O 0 1.5414465224239393e-06
/ O 0 6.405496151273837e-07
intron O 0 2.5947034032469674e-07
boundaries O 0 9.468799966327879e-09
conform O 0 2.923439268442962e-09
to O 0 2.6189650448316115e-09
the O 0 4.762974015193322e-09
GT O 0 1.3935961078459513e-06
/ O 0 1.9554694517864846e-05
AG O 0 0.0682206079363823
rule O 0 9.492900971963536e-06
. O 0 4.3111896275149775e-07

An O 0 7.328412876539403e-10
analysis O 0 7.443364258286067e-10
of O 0 1.824378426107387e-09
the O 0 1.4872147957589732e-09
putative O 0 6.094072091400449e-07
promoter O 0 1.1917507436010055e-05
region O 0 1.085703118519632e-07
sequence O 0 1.160276674738725e-08
shows O 0 3.037164408858928e-10
a O 0 2.013979427673007e-09
putative O 0 2.155165475414833e-06
TATA O 0 5.6447308452334255e-05
box O 0 2.177399416325443e-08
and O 0 3.6441524797758973e-10
predicts O 0 5.7776277095911155e-09
multiple O 0 1.2043296915287272e-10
transcription O 0 2.672596588482179e-09
factor O 0 4.4082978933879247e-10
binding O 0 5.77835557180606e-09
sites O 0 3.206756460372162e-08
. O 0 9.692995739385424e-09

The O 0 5.4830827878049604e-08
genomic O 0 2.405922039372399e-08
structure O 0 1.8117768396663791e-09
was O 0 5.3098214713998e-10
determined O 0 8.524159156308997e-11
using O 0 3.4207372177907924e-12
DNA O 0 1.1113486519942484e-10
from O 0 5.179300998497949e-12
several O 0 6.160148888385841e-13
sources O 0 3.112408941685629e-11
including O 0 1.0141231387636451e-12
multiple O 0 3.990219960003927e-11
large O 0 2.1370967218103942e-09
- O 0 2.6752195125823164e-08
insert O 0 3.892547439932059e-08
libaries O 0 8.937956863519503e-07
and O 0 3.313706531393734e-10
genomic O 0 4.6497388161981235e-09
DNA O 0 1.1133143296149228e-08
from O 0 1.0450639242876036e-09
Finnish O 0 1.2140787475800607e-05
CLD B-Disease 1 0.9999960660934448
patients O 0 1.0338552414168589e-07
and O 0 3.3591893711104603e-09
controls O 0 1.1010092748620082e-06
. O 0 1.3293308143147442e-07

Exon O 0 1.9501118231346481e-07
- O 0 1.1305833602648363e-08
specific O 0 6.753517189928004e-10
primers O 0 9.916311327629046e-09
developed O 0 4.733068381668204e-10
in O 0 2.4406572249335845e-11
this O 0 9.334155844087366e-12
study O 0 5.912285418185892e-12
will O 0 7.492294003090538e-13
facilitate O 0 6.226824611488269e-12
mutation O 0 9.605124334788329e-11
screening O 0 6.193071749871493e-11
studies O 0 1.0179686087130602e-11
of O 0 1.01973308269665e-11
patients O 0 1.2352757705613726e-11
with O 0 8.339833272759389e-13
the O 0 7.356510067779709e-09
disease O 0 1.516688189440174e-05
. O 0 1.564379061846921e-07

Genomic O 0 4.171818801523841e-08
sequencing O 0 1.6873233477099348e-08
of O 0 1.0865748301114309e-08
a O 0 9.412350010506998e-09
BAC O 0 0.0005845768610015512
clone O 0 1.3530941942008212e-05
H O 1 1.0
_ O 0 8.909665893952479e-09
RG364P16 O 0 1.1888502058354788e-06
revealed O 0 1.73270831016481e-09
the O 0 3.228551107015143e-11
presence O 0 1.3746370361444882e-11
of O 0 1.622984663329774e-10
another O 0 1.8786597277831163e-10
, O 0 1.161144878164544e-11
highly O 0 1.4509012047358993e-11
homologous O 0 1.4080900334612068e-10
gene O 0 5.605166331079658e-10
3 O 0 8.398577833190757e-09
of O 0 2.1187596122018704e-09
the O 0 7.602984020138592e-09
CLD B-Disease 0 0.10750450193881989
gene O 0 3.725768138451713e-08
, O 0 4.0734936257447174e-11
with O 0 3.631248676316118e-13
a O 0 1.6622770868113257e-11
similar O 0 7.1934086291747246e-12
genomic O 0 1.174564445705073e-09
structure O 0 9.091179475895217e-10
, O 0 3.904169088714271e-12
recently O 0 7.592032037762042e-12
identified O 0 1.4057655213506326e-11
as O 0 1.379548059989022e-12
the O 0 2.884445182704809e-10
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 3.289795245109417e-07
( O 0 1.1988117165628864e-09
PDS B-Disease 0 3.953065515815979e-06
) O 0 1.0285942930732261e-10
. O 0 8.418460928361071e-10
. O 0 1.4522572477915219e-08

The O 0 3.3625948248072746e-08
APCI1307K O 0 0.0003207297413609922
allele O 0 1.4815680060564773e-06
and O 0 1.3209239924094618e-08
cancer B-Disease 1 0.998633086681366
risk O 0 1.179732680611778e-05
in O 0 1.6047925488482662e-10
a O 0 2.2122009779579344e-10
community O 0 2.738494327136909e-11
- O 0 7.763378134795218e-11
based O 0 3.2689080609049626e-11
study O 0 6.827910459250575e-11
of O 0 2.3568211271474127e-10
Ashkenazi O 0 2.889624184376771e-08
Jews O 0 7.1808901047631934e-09
. O 0 7.579050276262933e-09

Mutations O 0 9.982580877476721e-07
in O 0 1.7715970912490775e-09
APC O 0 2.6662235086405417e-08
are O 0 8.966439569990658e-12
classically O 0 5.259546576041885e-09
associated O 0 3.8730014750854025e-09
with O 0 4.2717260839708615e-09
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 5.49663212723317e-08
FAP B-Disease 0 7.779517119388402e-08
) O 0 3.6246489750618727e-12
, O 0 4.654379095678229e-13
a O 0 1.5123026095298364e-11
highly O 0 1.3280074817600962e-08
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 0.0010230301413685083
by O 0 8.198221657096383e-09
multiple O 0 8.410141163039953e-06
intestinal O 1 1.0
polyps B-Disease 0 0.10734120011329651
and O 0 2.404962007318545e-09
, O 0 3.966081369571883e-12
without O 0 2.835491910713195e-11
surgical O 0 1.5868124592088861e-07
intervention O 0 1.2129247579650837e-06
, O 0 9.798811068106872e-11
the O 0 5.795880442249768e-10
development O 0 6.820461067036376e-07
of O 1 0.9839905500411987
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.3185122043068986e-05
CRC B-Disease 0 0.0011662913020700216
) O 0 3.357005118331813e-09
. O 0 5.191852636698968e-08

APC B-Disease 0 6.533055966428947e-06
is O 0 3.6182721263600115e-09
a O 0 7.26792004357435e-09
tumour O 1 1.0
- O 0 2.6569060196379723e-07
suppressor O 0 2.692489147193555e-07
gene O 0 7.51752771144254e-10
, O 0 3.786456218013434e-11
and O 0 1.9717460997270564e-10
somatic O 0 5.985937605146319e-05
loss O 0 0.0024536498822271824
occurs O 0 1.5157410416577477e-05
in O 0 1.4400676491277409e-06
tumours B-Disease 1 1.0
. O 0 1.2704064829449635e-05

The O 0 1.3227514727987e-06
germline O 0 3.602682409109548e-05
T O 0 3.7409927244880237e-07
- O 0 4.223053906571295e-09
to O 0 1.3180114777355811e-09
- O 0 2.051254721635587e-09
A O 0 9.420019431161109e-09
transversion O 0 8.030661291513752e-08
responsible O 0 1.4668690706542975e-09
for O 0 1.305533459117214e-10
the O 0 1.1168358460267314e-09
APC O 0 8.738254564377712e-09
I1307K O 0 1.7022861698023917e-07
allele O 0 5.481009868191222e-09
converts O 0 7.693775616601783e-10
the O 0 1.1065155736122989e-10
wild O 0 4.827033911469769e-11
- O 0 1.721204255511477e-11
type O 0 2.6254556861893263e-10
sequence O 0 1.685019068720095e-10
to O 0 1.6277806880182766e-10
a O 0 1.2398989612805167e-09
homopolymer O 0 4.8292422434315085e-05
tract O 0 2.4867000320227817e-05
( O 0 9.12048303547408e-09
A8 O 0 2.3678374418523163e-05
) O 0 4.5623577832332174e-11
that O 0 2.5435809708485024e-11
is O 0 2.1495068225352298e-10
genetically O 0 2.84082286583498e-08
unstable O 0 9.47704684222117e-05
and O 0 1.7763518656011e-08
prone O 0 5.034549394622445e-05
to O 0 5.87815384278656e-06
somatic O 0 0.0008147543994709849
mutation O 0 7.245899178087711e-05
. O 0 4.977647449777578e-07

The O 0 1.6753207887632016e-07
I1307K O 0 3.4540346405265154e-06
allele O 0 5.585769713434274e-08
was O 0 8.789807104392366e-09
found O 0 7.164246973445643e-11
in O 0 1.657048387393445e-10
6 O 0 2.802793801492953e-07
. O 0 4.227472416573619e-08

1 O 0 9.502302418695763e-06
% O 0 9.291985492154708e-08
of O 0 8.132204243338492e-09
unselected O 0 4.6341716370079666e-05
Ashkenazi O 0 5.69739427191962e-07
Jews O 0 2.0098349651220815e-09
and O 0 1.975938076353989e-12
higher O 0 6.90929188862377e-11
proportions O 0 2.7162674887115656e-10
of O 0 9.283894486511457e-11
Ashkenazim O 0 3.952405691620697e-08
with O 0 1.5272564029417124e-12
family O 0 2.5629876693189502e-11
or O 0 7.344472946479996e-11
personal O 0 1.8299291248968785e-10
histories O 0 2.084877159802545e-09
of O 0 1.356425400445005e-06
CRC B-Disease 0 4.139283191761933e-05
( O 0 1.4297987238620635e-09
ref O 0 2.893176088036853e-06
. O 0 2.475918803312993e-09
2 O 0 4.633628236661025e-08
) O 0 5.348732012855351e-10
. O 0 1.4542197668276913e-08

To O 0 2.3245945612870855e-08
evaluate O 0 7.1838219817266236e-09
the O 0 2.472529403441115e-10
role O 0 5.154844884280863e-10
of O 0 3.2018290241353498e-09
I1307K O 0 0.0011658996809273958
in O 0 7.217830955141835e-08
cancer B-Disease 1 0.9987926483154297
, O 0 2.730965231734217e-09
we O 0 7.920538003247657e-09
genotyped O 0 4.727858140540775e-06
5 O 0 5.567123366745363e-07
, O 0 4.718123669533725e-10
081 O 0 1.2658995274250628e-06
Ashkenazi O 0 6.932177143426088e-08
volunteers O 0 5.173863421026326e-11
in O 0 2.1878577075029604e-11
a O 0 2.7893509724208343e-10
community O 0 1.2056909914903713e-09
survey O 0 7.947247304684879e-09
. O 0 3.592294461896017e-08

Risk O 0 0.00013417541049420834
of O 0 1.065444621417555e-06
developing O 1 0.9934180974960327
colorectal B-Disease 1 1.0
, I-Disease 1 0.9556653499603271
breast I-Disease 1 1.0
and I-Disease 0 7.234775694087148e-05
other I-Disease 0 1.5184504036369617e-06
cancers I-Disease 1 1.0
were O 0 2.4299177425746166e-07
compared O 0 1.4116519508888814e-08
between O 0 1.8738983698085576e-08
genotyped O 0 6.049271519259491e-07
I1307K O 0 4.4813116772957073e-08
carriers O 0 3.3005778665717855e-11
and O 0 1.815590559839375e-11
non O 0 4.607580705862091e-10
- O 0 1.5911707715310364e-11
carriers O 0 1.9659608142819085e-12
and O 0 5.957621548868808e-12
their O 0 1.52995335584577e-12
first O 0 3.3133697174836385e-11
- O 0 2.3620863598416975e-10
degree O 0 4.5364455303342766e-08
relatives O 0 4.529466135494431e-09
. O 0 7.402535917577779e-09

Sperm O 0 2.7297010873894578e-08
DNA O 0 4.640320572235623e-09
analysis O 0 1.4312685758799404e-10
in O 0 4.523694266400646e-11
a O 0 6.071682712160964e-09
Friedreich B-Disease 0 0.2589639723300934
ataxia I-Disease 1 0.9966081380844116
premutation O 0 0.0017907489091157913
carrier O 0 1.9746050838875817e-07
suggests O 0 2.1215427636889217e-08
both O 0 1.9626432423702767e-10
meiotic O 0 1.7206593838636763e-07
and O 0 1.8028728510088854e-09
mitotic O 0 3.8391274159721434e-08
expansion O 0 6.8661066165987e-08
in O 0 9.794929312079148e-10
the O 0 3.984603758055982e-09
FRDA B-Disease 0 4.723081656266004e-05
gene O 0 2.7971641003432524e-08
. O 0 1.1280331335683513e-08

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 1.2134466942370636e-06
usually O 0 6.8034906597347344e-09
caused O 0 3.5966807310217064e-09
by O 0 4.3603189635310624e-12
an O 0 5.607844917598914e-12
expansion O 0 6.844398381389283e-09
of O 0 3.478551846569644e-08
a O 0 5.050978302278963e-07
GAA O 1 0.9996496438980103
trinucleotide O 1 0.9721800088882446
repeat O 0 8.068450938480964e-07
in O 0 4.859917357435961e-09
intron O 0 3.477262282558513e-07
1 O 0 1.8589118155887263e-07
of O 0 7.006682345434001e-09
the O 0 5.309742867609657e-09
FRDA B-Disease 0 0.00018176472804043442
gene O 0 9.914537457689221e-08
. O 0 3.115882662996228e-08

Occasionally O 0 1.599012534825306e-06
, O 0 1.2718129882571816e-09
a O 0 4.2613643169708837e-10
fully O 0 5.927998092403186e-10
expanded O 0 1.5011243637008675e-10
allele O 0 4.641727890941638e-09
has O 0 5.207673875462504e-11
been O 0 2.131200250998777e-11
found O 0 2.139385456984e-12
to O 0 1.7082592285166953e-11
arise O 0 8.994625599889616e-10
from O 0 1.522409698306859e-10
a O 0 2.3031390683492248e-10
premutation O 0 1.1138754985040578e-07
of O 0 4.1436325481925e-09
100 O 0 8.376736526649609e-10
or O 0 2.5075888587799966e-10
less O 0 1.029600404933717e-08
triplet O 0 5.249769856163766e-06
repeats O 0 3.437086206758977e-06
. O 0 1.6039777506193786e-07

We O 0 3.3274221777901403e-07
have O 0 2.2639447261330048e-10
examined O 0 1.7932700879796926e-09
the O 0 1.5646842155270235e-10
sperm O 0 2.2233385965630958e-10
DNA O 0 6.410110220400611e-10
of O 0 1.2656536929611661e-10
a O 0 5.848875272995713e-10
premutation O 0 1.3148593325240654e-06
carrier O 0 2.7898573762286105e-07
. O 0 2.225685591383808e-07

This O 0 1.9990354260812637e-08
mans O 0 3.2167363883672806e-07
leucocyte O 0 1.3834775813847955e-07
DNA O 0 6.25873353143902e-09
showed O 0 1.3776220442185405e-10
one O 0 4.034751699411032e-12
normal O 0 8.699613945895024e-11
allele O 0 1.5972559386234764e-10
and O 0 3.677118071837571e-12
one O 0 7.385263407766463e-12
allele O 0 9.557067359722282e-10
of O 0 5.872315411714624e-10
approximately O 0 8.56994031295244e-10
100 O 0 6.2678728873777345e-09
repeats O 0 4.575925061089947e-08
. O 0 2.323375625223889e-08

His O 0 4.924716563436959e-07
sperm O 0 4.542619436165296e-08
showed O 0 4.4216030836707887e-10
an O 0 4.195302091836162e-12
expanded O 0 5.833419164380516e-11
allele O 0 3.686393190704962e-09
in O 0 1.9774029635932777e-10
a O 0 1.7000505447839487e-09
tight O 0 1.0924849469517994e-08
range O 0 2.4763641803815517e-08
centering O 0 1.0270861849903667e-07
on O 0 3.170217199865988e-09
a O 0 1.6411703940288902e-10
size O 0 3.6368338895975683e-10
of O 0 4.5138362492203044e-10
approximately O 0 3.305835827305259e-09
320 O 0 1.2622803069461952e-07
trinucleotide O 0 6.592246063519269e-05
repeats O 0 1.387200995850435e-06
. O 0 1.4844232509858557e-07

His O 0 8.11113841336919e-06
affected O 0 2.6186518880422227e-05
son O 0 9.650810170569457e-06
has O 0 7.899608189809726e-10
repeat O 0 3.2563720608891344e-09
sizes O 0 1.7834463905685993e-09
of O 0 4.226470728951881e-09
1040 O 0 1.6792591850389726e-07
and O 0 6.707946198503123e-09
540 O 0 2.1673685068890336e-07
. O 0 4.204129666618428e-08

These O 0 1.6426869864361038e-09
data O 0 3.181397645324324e-10
suggest O 0 1.5127420149863013e-10
that O 0 4.269153607017184e-12
expansion O 0 6.663744001045302e-10
occurs O 0 1.0709876041570254e-10
in O 0 6.041084733149349e-12
two O 0 2.3566973025856974e-12
stages O 0 5.189768059743471e-10
, O 0 3.831036616414041e-12
the O 0 3.5740754106283745e-11
first O 0 6.420005499441217e-11
during O 0 1.951713096692842e-10
meiosis O 0 1.6782160383588263e-10
followed O 0 2.5534583128483668e-11
by O 0 9.235709419463944e-12
a O 0 5.968421312729788e-10
second O 0 5.749024811763093e-09
mitotic O 0 5.591120100234548e-08
expansion O 0 2.9387234690148034e-07
. O 0 2.3317423369917378e-07

We O 0 4.546832030882797e-07
also O 0 1.0040701603486468e-09
show O 0 2.159933482070997e-10
that O 0 3.6785565912800244e-12
in O 0 4.2588085835681966e-12
all O 0 1.5419941799127423e-12
informative O 0 5.911273553982355e-11
carrier O 0 2.175989666231004e-10
father O 0 3.3195324267154547e-10
to O 0 2.6462593227805087e-10
affected O 0 4.458367008908226e-09
child O 0 1.2606333754661136e-09
transmissions O 0 7.852558048249136e-10
, O 0 4.57727735922453e-12
with O 0 1.509373274153139e-13
the O 0 1.2205700859746482e-11
notable O 0 3.5197500296291206e-12
exception O 0 1.937869725798791e-10
of O 0 4.860851721133486e-10
the O 0 1.2608347699227807e-10
premutation O 0 1.4267210524110396e-08
carrier O 0 6.440761257664462e-10
, O 0 1.9206402093741026e-11
the O 0 3.607147219808482e-11
expansion O 0 7.644305188847511e-10
size O 0 1.132719695817741e-09
decreases O 0 1.7753290393329735e-08
. O 0 1.4311273277556325e-09
. O 0 2.9422812630741646e-08

The O 0 7.784192490589703e-08
R496H O 0 1.2118403901695274e-05
mutation O 0 5.5491018002840065e-08
of O 0 8.656686922847712e-09
arylsulfatase O 0 5.6740467698546126e-05
A O 0 1.4821573586232262e-06
does O 0 3.5669285303185916e-09
not O 0 5.202992703345899e-09
cause O 0 2.4072860469459556e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 4.155763235758059e-06

Deficiency B-Disease 1 0.9999996423721313
of I-Disease 0 0.00042523510637693107
arylsulfatase I-Disease 1 0.9999996423721313
A I-Disease 1 0.9998481273651123
( O 0 2.750249805671956e-08
ARSA O 0 0.00016528309788554907
) O 0 1.369680896479153e-10
enzyme O 0 1.3108063523503688e-09
activity O 0 7.812315239164036e-09
causes O 0 6.319239673757693e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 4.2576562009344343e-07
MLD B-Disease 1 1.0
) O 0 9.31217325472744e-09
. O 0 3.2514460457377936e-08

A O 0 1.9733449789782753e-06
number O 0 5.864673635613826e-09
of O 0 7.33524085916315e-09
ARSA O 0 3.2200809073401615e-05
gene O 0 3.1613776041439223e-09
mutations O 0 1.3310302193758616e-08
responsible O 0 8.251575422946189e-09
for O 0 8.487292646464084e-09
MLD B-Disease 1 1.0
have O 0 5.9144852571080264e-08
been O 0 7.30734051046511e-09
identified O 0 9.783263976714807e-09
. O 0 5.162522409563053e-09

Recently O 0 1.5967419813023298e-06
, O 0 2.364787921038669e-09
the O 0 1.797351822929727e-09
R496H O 0 1.3269424243844696e-06
mutation O 0 1.1503518138056279e-08
of O 0 4.017548516088709e-09
ARSA O 0 8.122710823954549e-06
was O 0 1.8517478661550513e-09
proposed O 0 4.932843022942279e-10
to O 0 1.4884088406219576e-10
be O 0 7.760313919247253e-11
a O 0 2.136981425149287e-10
cause O 0 4.716212487210214e-08
of O 0 7.741210339418103e-08
MLD B-Disease 1 1.0
( O 0 5.576143546903722e-09
Draghia O 0 7.136460226320196e-06
et O 0 2.0575454584559338e-07
al O 0 1.0943978878685812e-07
. O 0 2.376665531045319e-10
, O 0 8.059129058546333e-11
1997 O 0 1.0779438452956924e-09
) O 0 5.455651486130364e-10
. O 0 3.920152380487707e-08

We O 0 3.4584675745463755e-07
have O 0 5.789351220641947e-10
investigated O 0 5.134163316711238e-09
the O 0 1.5190596003300527e-10
R496H O 0 2.8223306358654554e-08
mutation O 0 2.5258201086231225e-10
and O 0 3.1630130372523046e-12
found O 0 2.009628791502238e-12
this O 0 3.000724235063812e-12
mutation O 0 9.413454044038261e-11
at O 0 1.655462572580646e-10
a O 0 9.672073905675482e-12
relatively O 0 4.601998903480675e-12
high O 0 2.6204413638986068e-11
frequency O 0 1.264300053538392e-10
in O 0 3.969093716887917e-12
an O 0 3.4167529916473427e-12
African O 0 5.015445350697867e-11
American O 0 1.4062696319927515e-11
population O 0 3.073947346665662e-12
( O 0 2.039961082000996e-11
f O 0 4.9991310646646525e-08
= O 0 6.538274366363339e-09
0 O 0 2.632486895137731e-09
. O 0 9.413993196094594e-11
09 O 0 3.780946222775583e-09
, O 0 1.3644502194765096e-10
n O 0 8.117822858366708e-09
= O 0 3.4450231112259644e-08
61 O 0 1.7596763157712303e-08
subjects O 0 6.05265082498363e-09
) O 0 6.231179461302361e-10
. O 0 1.070218935694811e-08

The O 0 2.8387520956130174e-07
ARSA O 0 1.3666201994055882e-05
enzyme O 0 7.140980251563178e-09
activity O 0 4.110477291874304e-09
in O 0 3.5982345575336083e-11
subjects O 0 3.11520198525983e-10
with O 0 5.874289227790486e-13
and O 0 5.7692279772925126e-12
without O 0 1.5444033552025616e-10
the O 0 2.456068959322266e-10
R496H O 0 2.468319415527276e-08
mutation O 0 2.6249147300205777e-10
was O 0 4.182219293102918e-10
determined O 0 4.614167659067192e-10
and O 0 7.822681738489656e-12
found O 0 7.453756362130193e-12
to O 0 1.58469612432377e-10
be O 0 1.5028381872284058e-09
normal O 0 1.5281838727787544e-07
. O 0 4.0345749852122026e-08

It O 0 4.220944038735297e-09
is O 0 1.4087402078200029e-10
therefore O 0 5.498042576768114e-10
concluded O 0 1.0066282252196856e-09
that O 0 7.306437573018076e-12
the O 0 9.148995450125597e-11
R496H O 0 3.1833468483455363e-07
mutation O 0 1.0188208499073426e-08
of O 0 2.538523391493186e-09
ARSA O 0 0.00011906682630069554
does O 0 1.5519983909140223e-10
not O 0 2.688555801599879e-11
negatively O 0 1.2656441172875788e-10
influence O 0 4.1372652526128206e-10
the O 0 1.2634556595392255e-11
activity O 0 5.2524238430828873e-11
of O 0 7.267302731817082e-11
ARSA O 0 8.131787012644054e-07
and O 0 1.7335063939860618e-11
is O 0 1.0998763531888667e-11
not O 0 6.123489215692501e-11
a O 0 9.550580326589397e-10
cause O 0 9.198295742862683e-07
of O 0 2.1606706468446646e-06
MLD B-Disease 1 1.0

Down O 0 1.385029736411525e-05
- O 0 1.0875788092334915e-07
regulation O 0 5.6466348041794845e-08
of O 0 1.498734114591116e-08
transmembrane O 0 2.2255526346270926e-06
carbonic O 0 0.0007367257494479418
anhydrases O 0 0.04888809844851494
in O 0 1.0183485983361606e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999957084655762
lines O 0 1.825044648740004e-07
by O 0 1.9147605723190964e-09
wild O 0 4.888840887673496e-09
- O 0 1.565992557850393e-09
type O 0 1.6367930300020817e-07
von B-Disease 1 0.9999902248382568
Hippel I-Disease 1 0.9999574422836304
- I-Disease 1 0.7387245893478394
Lindau I-Disease 1 0.9335537552833557
transgenes O 0 0.00023054584744386375
. O 0 7.217754500743467e-07

To O 0 1.1325101212378286e-07
discover O 0 1.127645887777362e-08
genes O 0 4.972499079158865e-10
involved O 0 1.778723418555117e-10
in O 0 1.529733145710921e-10
von B-Disease 1 0.9999792575836182
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( O 0 2.0473672179832647e-07
VHL B-Disease 0 0.0011350655695423484
) O 0 2.2414272660142842e-09
- O 0 8.340936119566322e-08
mediated O 0 0.0012727766297757626
carcinogenesis O 1 1.0
, O 0 3.4043480923173774e-08
we O 0 2.210714100669975e-08
used O 0 1.5383669449420267e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999994039535522
lines O 0 3.513535193633288e-05
stably O 0 6.402879807865247e-05
transfected O 0 7.860189725761302e-07
with O 0 1.0621100526853056e-10
wild O 0 3.668640058407391e-09
- O 0 4.773660577939154e-09
type O 0 4.2420964518896653e-07
VHL O 0 0.0009173925500363111
- O 0 3.422563395361067e-06
expressing O 0 8.348909830147022e-08
transgenes O 0 2.645585482241586e-05
. O 0 2.878392137972696e-07

Large O 0 2.5056317554117413e-07
- O 0 9.90085595731216e-08
scale O 0 1.0618953183438862e-06
RNA O 0 3.547695541783469e-07
differential O 0 7.336908680599663e-08
display O 0 1.9285739671914826e-10
technology O 0 1.262209337049569e-09
applied O 0 1.2622284328855926e-09
to O 0 1.0152486490389023e-10
these O 0 3.290626018198628e-12
cell O 0 4.456528757135203e-10
lines O 0 2.279390218240529e-11
identified O 0 1.912721890595659e-11
several O 0 4.080908516928411e-13
differentially O 0 2.027782386448962e-09
expressed O 0 1.6999134044848319e-10
genes O 0 5.976725780953984e-10
, O 0 1.656693532359199e-11
including O 0 5.9263076217230815e-12
an O 0 9.329586408979296e-11
alpha O 0 4.028469646755184e-08
carbonic O 0 6.30331385309546e-07
anhydrase O 0 1.2249340670678066e-06
gene O 0 7.222317854882476e-09
, O 0 1.571191787785864e-10
termed O 0 1.3506975449217862e-07
CA12 O 0 0.009132987819612026
. O 0 7.376083885901608e-07

The O 0 1.1817473932751454e-07
deduced O 0 2.9301228110512056e-08
protein O 0 7.126662593393007e-10
sequence O 0 8.071897317218912e-11
was O 0 7.616678121546983e-11
classified O 0 1.3384262448346007e-11
as O 0 5.701666135754513e-12
a O 0 2.3059520959378688e-10
one O 0 1.3136821630510553e-09
- O 0 1.1356129192563458e-07
pass O 0 2.0121506167924963e-06
transmembrane O 1 0.7511281371116638
CA O 0 0.018163640052080154
possessing O 0 3.088322131361565e-08
an O 0 5.170264771869881e-10
apparently O 0 7.34288363446467e-09
intact O 0 9.88552573133461e-10
catalytic O 0 1.9461383615748673e-09
domain O 0 6.194733970232846e-08
in O 0 2.440492030686414e-09
the O 0 1.1796008614339826e-08
extracellular O 0 4.308568804844981e-06
CA O 0 0.002031708136200905
module O 0 1.2699873877863865e-05
. O 0 9.546273105343062e-08

Reintroduced O 0 7.39505549063324e-06
wild O 0 3.922329483430076e-07
- O 0 7.403188106991365e-08
type O 0 5.394487629928335e-07
VHL B-Disease 0 5.8282090321881697e-05
strongly O 0 1.3887778926857663e-08
inhibited O 0 7.488480058270852e-09
the O 0 4.4387560294012474e-10
overexpression O 0 2.937491139221038e-09
of O 0 7.185311790003368e-10
the O 0 5.973865291331037e-10
CA12 O 0 8.910985343391076e-06
gene O 0 2.4449542390669876e-10
in O 0 2.4565268222365155e-11
the O 0 4.945900911046408e-10
parental O 0 2.6871457521338016e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 4.87517609144561e-05
. O 0 1.5003379303379916e-06

Similar O 0 5.22946752568032e-09
results O 0 4.658224916909148e-09
were O 0 1.306504904263761e-10
obtained O 0 1.761608914296886e-10
with O 0 8.354023202372662e-12
CA9 O 0 3.033415850950405e-05
, O 0 1.2041781460858658e-10
encoding O 0 1.3979113422379896e-09
another O 0 2.3915147195907593e-08
transmembrane O 0 2.2386087948689237e-05
CA O 0 5.386784323491156e-06
with O 0 3.317151067716573e-11
an O 0 3.598552011929712e-10
intact O 0 7.419753256243666e-09
catalytic O 0 2.9186827177341e-08
domain O 0 6.287967835305608e-07
. O 0 2.9578110627426213e-08

Although O 0 1.3764521078485359e-08
both O 0 6.918473571815298e-10
domains O 0 4.1872603162573796e-08
of O 0 1.3881344074206936e-08
the O 0 4.112060913996629e-09
VHL B-Disease 0 3.04840995113409e-07
protein O 0 1.3626355599427598e-09
contribute O 0 2.2546842171067283e-10
to O 0 1.3832646139633198e-10
regulation O 0 2.524637743306357e-08
of O 0 8.618876279342658e-09
CA12 O 1 0.9946087598800659
expression O 0 4.920350349379987e-08
, O 0 9.050085680861741e-11
the O 0 7.229752907456088e-11
elongin O 0 4.250456431265093e-09
binding O 0 1.2750197342370484e-08
domain O 0 3.2515327319515563e-08
alone O 0 9.615944707164203e-10
could O 0 2.648142538586029e-10
effectively O 0 6.616027725669937e-09
regulate O 0 3.315910035439629e-08
CA9 O 0 0.0003137483145110309
expression O 0 4.585566557580023e-07
. O 0 1.3442888757708715e-07

We O 0 9.103929414777667e-07
mapped O 0 1.9118022009934066e-06
CA12 O 0 0.01949389837682247
and O 0 1.7637228211242473e-07
CA9 O 0 0.0034006419591605663
loci O 0 1.500838834544993e-06
to O 0 5.54810739572531e-08
chromosome O 0 1.041395080392249e-06
bands O 0 9.893908980984634e-08
15q22 O 0 5.277328455122188e-06
and O 0 7.548278446734003e-09
17q21 O 0 8.972800424089655e-05
. O 0 2.5323549834865844e-07

2 O 0 6.374991698976373e-06
respectively O 0 3.267093404701882e-07
, O 0 3.720610486368514e-09
regions O 0 1.589790485923004e-07
prone O 0 2.339197635592427e-06
to O 0 3.611578947015914e-08
amplification O 0 3.763608731333079e-07
in O 0 7.935720525154011e-09
some O 0 1.6039731765005172e-09
human O 0 4.1400329564567073e-07
cancers B-Disease 0 0.4245803952217102
. O 0 2.2806685251453018e-07

Additional O 0 1.0726000709837535e-07
experiments O 0 5.630781885201941e-08
are O 0 2.1779900799545615e-11
needed O 0 3.2822233819729263e-10
to O 0 5.7637644657049236e-11
define O 0 3.105723234142488e-09
the O 0 1.1069778427241772e-10
role O 0 2.373096164021149e-10
of O 0 8.369533399665841e-10
CA O 0 2.177969918193412e-06
IX O 0 0.07630716264247894
and O 0 4.467281655706756e-08
CA O 0 6.062675311113708e-06
XII O 0 2.565971044532489e-06
enzymes O 0 6.492898441123884e-10
in O 0 3.577963272882734e-11
the O 0 5.4364634322068284e-11
regulation O 0 8.871812173794069e-10
of O 0 8.881327340226619e-10
pH O 0 2.7876259878212295e-07
in O 0 1.0313904175163202e-09
the O 0 2.57214338716949e-09
extracellular O 0 1.3326666703505907e-07
microenvironment O 0 6.694368153148389e-07
and O 0 1.410576516702733e-10
its O 0 5.795479721126817e-11
potential O 0 6.466289725892693e-10
impact O 0 2.6420256205028636e-08
on O 0 2.015783309161634e-07
cancer B-Disease 0 1.027539292408619e-05
cell O 0 1.7541290162625955e-06
growth O 0 5.33473851760391e-08
. O 0 3.271189186193624e-08

A O 0 3.500776983855758e-07
gene O 0 8.070177304198012e-10
encoding O 0 8.558359021471063e-10
a O 0 1.6009228387403596e-09
transmembrane O 0 1.7436835264561523e-07
protein O 0 6.374742955728152e-09
is O 0 5.1241962062409385e-12
mutated O 0 5.928572216484795e-11
in O 0 8.850777749591643e-12
patients O 0 2.3171420338030657e-10
with O 0 2.5173121920296637e-10
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.5496348142623901
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 0.0032476175110787153
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 3.702261830440534e-09
. O 0 2.0133082756501608e-08

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.6867768408701522e-06
WFS B-Disease 0 0.0386664979159832
; O 0 6.811033959053248e-09
OMIM O 0 8.510918269166723e-05
222300 O 0 3.606100165143289e-07
) O 0 4.555016953899926e-12
is O 0 8.949097539401318e-12
an O 0 2.0021548308157833e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 2.1482835066422012e-08
by O 0 1.7846024658041415e-10
young O 0 1.4295341577152954e-09
- O 0 1.146252159855976e-07
onset O 1 1.0
non O 1 1.0
- O 1 0.9945399165153503
immune O 0 0.0008042138069868088
insulin B-Disease 1 1.0
- I-Disease 1 0.9999827146530151
dependent I-Disease 1 0.9711362719535828
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 4.851094104196818e-07
progressive O 0 0.4973624050617218
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999942779541016
. O 0 1.2354858881735709e-05

Linkage O 0 1.776839781086892e-05
to O 0 2.9697501346959143e-08
markers O 0 1.3579428248533532e-08
on O 0 9.446377902122549e-09
chromosome O 0 3.0580156362702837e-07
4p O 0 0.00011492855264805257
was O 0 3.741632781384396e-09
confirmed O 0 5.075236342300116e-10
in O 0 2.7096011198657344e-11
five O 0 9.410797141562455e-11
families O 0 1.7121419559895656e-10
. O 0 1.8742628782320025e-08

On O 0 1.7263036511394603e-07
the O 0 4.991941859877613e-10
basis O 0 6.2499418973516185e-09
of O 0 6.627314808049789e-10
meiotic O 0 2.936842429335229e-05
recombinants O 1 0.9999226331710815
and O 0 3.279830309566023e-07
disease O 1 0.9929866194725037
- O 0 2.112776513740755e-07
associated O 0 1.6808613167995645e-07
haplotypes O 0 9.295288236899069e-07
, O 0 8.781775862054531e-10
the O 0 7.2217662960838425e-09
WFS B-Disease 0 3.3458286452514585e-06
gene O 0 2.328049752975403e-09
was O 0 5.495770061259009e-09
localized O 0 1.3571715840043908e-07
to O 0 4.8094698001932557e-08
a O 0 1.47245998505241e-07
BAC O 0 0.001396276755258441
/ O 0 8.16750616650097e-06
P1 O 0 0.0001764274202287197
contig O 0 7.081343028403353e-06
of O 0 6.863013712887778e-09
less O 0 2.3979083163538917e-09
than O 0 5.886063303428557e-10
250 O 0 4.878594417334625e-09
kb O 0 2.030254336204962e-06
. O 0 8.522367522800778e-08

Mutations O 0 3.646979962468322e-07
in O 0 5.51569900864024e-10
a O 0 4.1929543170837746e-10
novel O 0 9.39372912789338e-10
gene O 0 7.245977151626448e-10
( O 0 9.763010538899053e-11
WFS1 O 0 1.9673658243846148e-05
) O 0 1.5174696221809114e-10
encoding O 0 8.294840370126622e-10
a O 0 6.515095574144425e-09
putative O 0 8.352365910013759e-08
transmembrane O 0 3.316858965263236e-08
protein O 0 6.997520785034794e-09
were O 0 4.1800004429992654e-11
found O 0 2.4263321386774894e-12
in O 0 6.655959420773239e-13
all O 0 6.809825598384778e-13
affected O 0 1.1517506566527391e-11
individuals O 0 3.4143100673122984e-12
in O 0 1.763400675480753e-10
six O 0 1.732887611183287e-08
WFS B-Disease 0 0.00851807277649641
families O 0 9.113470533783641e-10
, O 0 3.7066669178464906e-11
and O 0 5.969519583509664e-12
these O 0 2.5072229448835914e-12
mutations O 0 2.488311778847674e-10
were O 0 1.7982827033025117e-11
associated O 0 4.7003550357471724e-11
with O 0 3.158310852430235e-12
the O 0 2.230296836103207e-09
disease O 0 4.3859185439032444e-07
phenotype O 0 1.9147487364534754e-06
. O 0 3.021022791926953e-07

WFS1 O 1 0.9960824251174927
appears O 0 1.5580735635012388e-07
to O 0 2.526062248264793e-09
function O 0 1.8594423778495184e-09
in O 0 7.255502448844098e-11
survival O 0 7.72993402620159e-09
of O 0 1.5885249782243704e-09
islet O 0 1.6462325902466546e-06
beta O 0 3.026633567060344e-05
- O 0 2.1659593585354742e-07
cells O 0 1.25363197600592e-09
and O 0 5.7053244073568266e-11
neurons O 0 1.4194818653834318e-08
. O 0 6.213333403337629e-09
. O 0 2.475542437707645e-08

Stable O 0 3.86514475394506e-05
interaction O 0 3.525428127204577e-08
between O 0 1.07437481133843e-08
the O 0 1.5562796606971574e-09
products O 0 5.377886469482007e-10
of O 0 2.9053606742657223e-10
the O 0 2.2407935229562526e-10
BRCA1 O 0 9.266955203202087e-09
and O 0 5.683800097244784e-10
BRCA2 O 0 4.81628141812962e-08
tumor B-Disease 0 2.3063950038704206e-07
suppressor O 0 7.312112160207107e-08
genes O 0 4.355394378485755e-10
in O 0 3.600458819974506e-11
mitotic O 0 5.3921866971506915e-09
and O 0 2.1890786960909736e-09
meiotic O 0 1.5678120689699426e-05
cells O 0 6.551661954290466e-06
. O 0 3.2076565048555494e-07

BRCA1 O 0 1.0993538126058411e-05
and O 0 6.638628757826837e-09
BRCA2 O 0 5.4668131355128935e-08
account O 0 5.1943411377708415e-11
for O 0 9.508112179534844e-12
most O 0 1.8808628699656937e-12
cases O 0 1.9014312693799162e-11
of O 0 1.798341892067512e-10
familial O 0 1.3089587014292192e-07
, O 0 1.7524900974841273e-10
early O 0 1.9909235504655953e-07
onset O 1 0.9999995231628418
breast B-Disease 1 0.9999995231628418
and I-Disease 0 4.094823088962585e-05
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.4160313810407388e-08
encode O 0 2.7628549448266426e-10
products O 0 5.1684483082237165e-11
that O 0 1.9225964136698748e-12
each O 0 4.91139507535765e-12
interact O 0 1.7117883499562225e-11
with O 0 7.249827040783918e-12
hRAD51 O 0 2.971524395434244e-07
. O 0 9.603324002682712e-08

Results O 0 3.1805697631170915e-08
presented O 0 1.0526182592229816e-08
here O 0 1.2908140112344313e-09
show O 0 5.2230025859856255e-11
that O 0 3.9245212982153e-12
BRCA1 O 0 2.2253168197039486e-09
and O 0 5.547032833064236e-10
BRCA2 O 0 1.1087095117545687e-06
coexist O 0 4.583227308785354e-08
in O 0 1.9611988422152393e-10
a O 0 6.99527491487828e-10
biochemical O 0 1.5436981470884348e-08
complex O 0 1.1682709910587619e-08
and O 0 1.703545360332015e-10
colocalize O 0 5.070307338428393e-07
in O 0 7.610118091250229e-10
subnuclear O 0 2.5156284664262785e-06
foci O 0 1.579303159360279e-07
in O 0 3.6571454198330855e-10
somatic O 0 1.3312789981512196e-08
cells O 0 1.0784928505813696e-09
and O 0 2.1488007553860378e-11
on O 0 3.523750458089836e-10
the O 0 8.392928713130132e-12
axial O 0 1.574443631024991e-10
elements O 0 1.0523121263261714e-10
of O 0 5.444892314798722e-10
developing O 0 5.334898300901614e-09
synaptonemal O 0 4.783602889801841e-06
complexes O 0 1.415593118281322e-07
. O 0 6.842796551609354e-08

Like O 0 1.475400722483755e-06
BRCA1 O 0 4.994145911041414e-06
and O 0 7.951678071549395e-08
RAD51 O 0 0.00041007669642567635
, O 0 5.1231900499715266e-08
BRCA2 O 0 5.138065262144664e-07
relocates O 0 6.070098379495903e-08
to O 0 6.206143599030156e-09
PCNA O 0 2.5417497795388044e-07
+ O 0 4.246299756260896e-09
replication O 0 4.428895861163795e-10
sites O 0 5.722544313413458e-11
following O 0 6.812768404973468e-11
exposure O 0 2.0820406732013907e-08
of O 0 5.851500173292834e-09
S O 0 1.205492480949033e-06
phase O 0 1.8109610664396314e-06
cells O 0 6.492790749490496e-09
to O 0 1.5286699905914247e-08
hydroxyurea O 0 7.599477385156206e-07
or O 0 1.4866715503103478e-07
UV O 0 0.0009009597706608474
irradiation O 0 1.446568603569176e-05
. O 0 7.52450688423778e-08

Thus O 0 2.260944285126243e-07
, O 0 2.2253252573989357e-09
BRCA1 O 0 1.0823799634351872e-08
and O 0 2.0045774762333934e-10
BRCA2 O 0 1.341658961706571e-08
participate O 0 1.8982153626723175e-09
, O 0 5.061892918711841e-11
together O 0 1.2200603374812324e-11
, O 0 4.581120639085556e-12
in O 0 1.2838370123946508e-11
a O 0 6.354078374570804e-10
pathway O 0 2.8375847449524372e-08
( O 0 1.1370981933822577e-10
s O 0 4.532334951790062e-09
) O 0 4.070680424683726e-12
associated O 0 5.923463108903348e-11
with O 0 4.1653361532514865e-13
the O 0 1.1297539292964842e-11
activation O 0 2.4514076879533775e-10
of O 0 1.258375181834026e-09
double O 0 2.2245263964215667e-10
- O 0 2.6134210351358433e-09
strand O 0 6.770002780598361e-09
break O 0 1.0111121717670812e-08
repair O 0 7.278424618561985e-08
and O 0 1.9028625342087935e-09
/ O 0 1.6274633196644572e-07
or O 0 1.8792922773513965e-08
homologous O 0 3.102444523506165e-08
recombination O 0 4.69718060003288e-08
. O 0 3.050561403483698e-08

Dysfunction O 1 0.9989905953407288
of O 0 7.205478027572099e-07
this O 0 2.6120108298499645e-09
pathway O 0 9.993117799922402e-08
may O 0 8.552173969000876e-10
be O 0 3.091075659322762e-11
a O 0 2.1648774786720004e-11
general O 0 2.3477494948132005e-10
phenomenon O 0 6.130889684818897e-10
in O 0 1.0273579946831757e-12
the O 0 1.3468919989739758e-12
majority O 0 1.885035232291124e-13
of O 0 2.2700001600650666e-12
cases O 0 8.484123126262233e-12
of O 0 5.823061477450153e-10
hereditary B-Disease 1 0.9999954700469971
breast I-Disease 1 1.0
and I-Disease 0 0.4089885354042053
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.457869636098621e-06
. O 0 2.2355497719672712e-07

A O 0 6.096710762903967e-07
novel O 0 1.964458107295286e-08
Arg362Ser O 0 3.5499633668223396e-06
mutation O 0 6.2003104872587755e-09
in O 0 9.207290485591102e-11
the O 0 2.600972770494536e-10
sterol O 0 2.051701741834222e-08
27 O 0 2.3907082891128084e-07
- O 0 1.0571074682275139e-07
hydroxylase O 0 5.116189072396082e-07
gene O 0 1.9284620123016794e-08
( O 0 1.3513095087347438e-09
CYP27 O 1 0.9019494652748108
) O 0 2.086189665462257e-09
: O 0 7.523146688948046e-11
its O 0 2.673431476196697e-10
effects O 0 1.2397056714519294e-08
on O 0 1.0051283361178776e-08
pre O 0 2.9502610132681184e-08
- O 0 1.2530126936027841e-09
mRNA O 0 3.804558446063311e-09
splicing O 0 5.74686243037803e-10
and O 0 4.519862348978387e-12
enzyme O 0 6.899480986533035e-11
activity O 0 1.9155530495140738e-09
. O 0 2.421777223204913e-09

A O 0 2.807036594276724e-07
novel O 0 1.0632644986685591e-08
C O 0 3.6349933907331433e-07
to O 0 7.405808744032072e-10
A O 0 1.3625063743916144e-08
mutation O 0 1.4706705853129165e-09
in O 0 8.3825182906061e-11
the O 0 1.21382875972742e-10
sterol O 0 3.3193522597230185e-08
27 O 0 1.8274656099492859e-07
- O 0 1.003820173650638e-07
hydroxylase O 0 3.4795678516275075e-07
gene O 0 9.49388301307863e-09
( O 0 1.7148805986355597e-10
CYP27 O 0 0.000137411494506523
) O 0 5.922830281779312e-11
was O 0 7.699940685057527e-10
identified O 0 1.799497183208043e-11
by O 0 1.6758632242347415e-12
sequencing O 0 1.3626479111739087e-10
amplified O 0 6.843899336139714e-10
CYP27 O 0 3.929986576167721e-07
gene O 0 3.1866918825951274e-11
products O 0 7.868322313142606e-12
from O 0 1.2693251831563668e-11
a O 0 1.5949726261954567e-10
patient O 0 9.624128161078715e-10
with O 0 8.509587479110792e-11
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 6.925741757868309e-08
CTX B-Disease 0 0.00020414979371707886
) O 0 5.650596435202715e-09
. O 0 3.699157957726129e-08

The O 0 1.4117844671091007e-07
mutation O 0 2.7006793246187044e-08
changed O 0 2.392795739325493e-09
the O 0 1.7370255234183674e-10
adrenodoxin O 0 3.1648301757059016e-08
cofactor O 0 1.884420619546745e-09
binding O 0 1.524881376724352e-08
residue O 0 9.771257936108668e-08
362Arg O 0 9.240550546962822e-09
to O 0 1.0986823673064805e-09
362Ser O 0 1.0283368112595781e-07
( O 0 2.9340303520086763e-09
CGT O 0 5.21190804647631e-06
362Arg O 0 7.285076719654171e-08
to O 0 8.800324913238455e-09
AGT O 0 1.0861811006179778e-06
362Ser O 0 1.3580903512888653e-08
) O 0 3.033463757962096e-11
, O 0 6.819031016930266e-12
and O 0 3.5547248738304615e-12
was O 0 2.7825826087735095e-09
responsible O 0 1.8541520319104166e-08
for O 0 1.5931469476981874e-08
deficiency O 1 0.971486508846283
in O 0 1.4074262821850425e-07
the O 0 6.679987052393699e-08
sterol O 0 3.919427911114326e-07
27 O 0 1.0269956192132668e-06
- O 0 5.392097079948144e-08
hydroxylase O 0 8.012179364413896e-08
activity O 0 2.381267449891311e-07
, O 0 1.8910366328395156e-11
as O 0 3.0931028138087013e-12
confirmed O 0 9.405875384116413e-12
by O 0 1.0732891355183516e-12
expression O 0 9.854345117688013e-11
of O 0 4.0148653845939464e-10
mutant O 0 5.389633739305566e-10
cDNA O 0 2.367811724468538e-09
into O 0 2.2724728765410873e-09
COS O 0 2.2191945845406735e-06
- O 0 1.4658998281902313e-07
1 O 0 5.444409225674463e-07
cells O 0 1.913002023457011e-08
. O 0 7.476350205593008e-09

Quantitative O 0 4.243079843035957e-08
analysis O 0 8.7789792102555e-10
showed O 0 7.468133056409698e-11
that O 0 9.296644400483278e-13
the O 0 5.530546940551995e-12
expression O 0 3.024681893837311e-11
of O 0 3.377433333007218e-10
CYP27 O 0 2.9092518616380403e-07
gene O 0 5.48993940585607e-11
mRNA O 0 4.207968418157293e-10
in O 0 4.563852334243945e-12
the O 0 1.9123206490556655e-11
patient O 0 4.5360515343872976e-10
represented O 0 7.343944896653909e-10
52 O 0 6.073040594856138e-07
. O 0 9.966925063054077e-08

5 O 0 4.7397492153322673e-07
% O 0 2.285828593073802e-08
of O 0 3.5876708270876634e-09
the O 0 5.281471260332182e-09
normal O 0 6.712274398523732e-07
level O 0 4.50053448730614e-06
. O 0 1.6535146585283655e-07

As O 0 2.134352250493521e-08
the O 0 2.76769829277157e-09
mutation O 0 2.147606537050706e-09
occurred O 0 2.0478859497075064e-08
at O 0 3.509189328010365e-10
the O 0 5.374294759219467e-11
penultimate O 0 4.022033817108195e-09
nucleotide O 0 6.312933509278196e-10
of O 0 7.558042525168673e-10
exon O 0 1.3031159484810928e-09
6 O 0 1.4091931177517836e-08
( O 0 7.697808362960856e-11
- O 0 1.2754039602214107e-08
2 O 0 5.9555095077712394e-08
position O 0 3.0080020252398754e-08
of O 0 3.1611424589073067e-09
exon O 0 2.537332788321578e-09
6 O 0 1.640051650042551e-08
- O 0 5.763539423497832e-09
intron O 0 2.8975163601785425e-08
6 O 0 7.720092121132893e-09
splice O 0 3.424972971899365e-09
site O 0 1.309818503658633e-10
) O 0 2.5677964528986186e-12
of O 0 1.160027629509841e-10
the O 0 6.938454255589477e-10
gene O 0 1.1150096401735254e-09
, O 0 1.3092239792289462e-10
we O 0 1.2148229089348206e-09
hypothesized O 0 1.964330742509901e-08
that O 0 6.537195784694916e-11
the O 0 2.619123529168377e-10
mutation O 0 2.2846156078060176e-09
may O 0 1.8245177590969774e-09
partially O 0 8.84115713972733e-09
affect O 0 8.010281327130997e-09
the O 0 8.125471961939468e-10
normal O 0 2.2262591770072504e-09
splicing O 0 3.1008856593572887e-10
efficiency O 0 2.1174657860445478e-10
in O 0 1.2027681801918266e-11
exon O 0 1.9871272682880914e-10
6 O 0 1.336906918503189e-09
and O 0 7.920450753595709e-12
cause O 0 2.6710969547316665e-10
alternative O 0 1.2558455386724177e-09
splicing O 0 5.350058729369778e-10
elsewhere O 0 4.460957298002555e-11
, O 0 2.4396682048698215e-13
which O 0 8.963541172322953e-14
resulted O 0 3.001624643284018e-11
in O 0 5.4664684237537564e-12
decreased O 0 6.845243816222535e-10
transcript O 0 7.102806121039862e-10
in O 0 5.896746285705134e-11
the O 0 4.541497178323084e-10
patient O 0 8.654605920810354e-09
. O 0 1.5021829113948115e-08

Transfection O 0 1.0914687663898803e-05
of O 0 5.147481374478957e-08
constructed O 0 3.1676322009843716e-08
minigenes O 0 6.884504728077445e-06
, O 0 9.415680041202634e-11
with O 0 1.0131448631434115e-12
or O 0 2.1107558756394695e-10
without O 0 1.673738370122635e-09
the O 0 1.20865661923375e-09
mutation O 0 4.872084957696643e-09
, O 0 9.098009151609077e-11
into O 0 1.3363206097238844e-09
COS O 0 9.804068213270511e-06
- O 0 3.708412634750857e-07
1 O 0 3.6388018997968175e-07
cells O 0 6.603970703622508e-10
confirmed O 0 8.071866092196345e-11
that O 0 8.41473971665424e-13
the O 0 6.1809841099547125e-12
mutant O 0 3.546464510950642e-11
minigene O 0 2.0275812140369e-09
was O 0 9.438876763523396e-11
responsible O 0 1.0342778716809775e-10
for O 0 1.0645554750221553e-11
a O 0 2.687803590806226e-10
mRNA O 0 4.360167338290921e-09
species O 0 1.0285604833126794e-11
alternatively O 0 1.3679374299968572e-09
spliced O 0 2.2807808974789623e-08
at O 0 1.335116284195692e-08
an O 0 9.755886098972155e-10
activated O 0 2.1467234034844296e-07
cryptic O 0 2.535196585995436e-07
5 O 0 1.5051345769734326e-07
splice O 0 2.2094332052802201e-07
site O 0 4.455793600754987e-08
88 O 0 2.4099545470335215e-08
bp O 0 3.519146218877722e-08
upstream O 0 1.900636270590894e-08
from O 0 4.800117525682879e-10
the O 0 2.860317260822143e-10
3 O 0 6.6761258743497365e-09
end O 0 2.785685282447048e-08
of O 0 6.641541538954243e-09
exon O 0 9.670063860767186e-08
6 O 0 3.4396003911751905e-07
. O 0 4.185750768215257e-08

Our O 0 1.2053070008732902e-07
data O 0 1.6880759012849467e-09
suggest O 0 9.777102460972742e-10
that O 0 1.6903553209934863e-11
the O 0 9.848820370361722e-11
C O 0 2.866655712807642e-08
to O 0 2.7456031892469923e-10
A O 0 1.1831994939370816e-08
mutation O 0 1.4841373685570147e-09
at O 0 9.268859568756227e-10
the O 0 5.747594067351258e-11
penultimate O 0 3.3845544145094664e-09
nucleotide O 0 4.0665715239640576e-10
of O 0 2.3348348254792484e-10
exon O 0 5.901160671228922e-10
6 O 0 2.646624031044098e-09
of O 0 8.149773217391854e-11
the O 0 4.1217151219852255e-11
CYP27 O 0 1.9087127611783217e-07
gene O 0 3.3398537407913764e-11
not O 0 1.4274292685356738e-11
only O 0 1.3760326211809115e-11
causes O 0 7.2087753544280986e-09
the O 0 3.585625574231699e-09
deficiency B-Disease 0 3.176588734277175e-06
in I-Disease 0 2.5238131584615076e-09
the I-Disease 0 4.966785649429539e-09
sterol I-Disease 0 4.006691867175505e-08
27 I-Disease 0 5.934010971486714e-08
- I-Disease 0 6.119700302065212e-09
hydroxylase I-Disease 0 1.6470925956468818e-08
activity I-Disease 0 1.3971515500088572e-07
, O 0 7.350092756652771e-11
but O 0 9.16443518295118e-11
also O 0 5.888609044824022e-11
partially O 0 1.0892184043598263e-08
leads O 0 4.3633579388524524e-11
to O 0 4.5664232811715166e-11
alternative O 0 5.117481438610127e-10
pre O 0 2.599149118154287e-09
- O 0 1.3509635077291193e-10
mRNA O 0 4.125114971831323e-10
splicing O 0 1.4629426836609838e-10
of O 0 1.826657228254369e-11
the O 0 3.411200488745436e-11
gene O 0 1.4581122420587178e-10
. O 0 1.1800885824087004e-09

To O 0 3.600848685891833e-08
our O 0 2.5778896795003448e-09
knowledge O 0 4.615030579913082e-10
, O 0 1.301855064722579e-11
this O 0 3.793596513312902e-12
is O 0 1.0413857276514449e-11
the O 0 1.0555963221581255e-11
first O 0 2.645854195459929e-11
report O 0 1.502249366569508e-11
regarding O 0 3.170064766244707e-10
effects O 0 7.818487191002532e-09
on O 0 2.288470968281331e-09
pre O 0 4.369591799502359e-09
- O 0 1.2563144968780193e-10
mRNA O 0 2.8278673847026425e-10
splicing O 0 1.0612657280750781e-10
of O 0 1.2002702651225938e-11
a O 0 1.0083642254521408e-11
mutation O 0 6.642953548352537e-11
at O 0 1.8079061858689016e-10
the O 0 2.5917308230094527e-11
- O 0 2.613883554047902e-10
2 O 0 2.38135982044696e-08
position O 0 4.3281698225428045e-08
of O 0 2.757076345005771e-09
a O 0 5.044106021756534e-09
5 O 0 8.656013505969895e-08
splice O 0 2.05387564733428e-07
site O 0 2.6394870289436767e-08
. O 0 7.755453168556414e-09

ATM O 0 0.0020952916238456964
germline O 0 0.00046850688522681594
mutations O 0 2.725409729009698e-07
in O 0 1.1352588868973612e-09
classical O 0 0.00017074069182854146
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.14877057075500488
in O 0 3.565935324800762e-09
the O 0 1.5162437971838472e-09
Dutch O 0 5.1323837624295265e-08
population O 0 6.411687292207091e-10
. O 0 3.4496372425252275e-09

Germline O 0 0.0013749590143561363
mutations O 0 3.697281840686628e-07
in O 0 2.3075316657461542e-10
the O 0 1.0262466570987172e-10
ATM O 0 2.9143658153429897e-08
gene O 0 1.3262285367132698e-11
are O 0 2.375908443510294e-14
responsible O 0 2.004024767313095e-12
for O 0 1.919189199922622e-12
the O 0 1.8653825151204728e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.00036476284731179476
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 7.876145247109889e-08
. O 0 3.643420143362164e-07

In O 0 3.948032656353462e-07
our O 0 3.7559207299864283e-08
study O 0 1.8592827277785773e-09
, O 0 4.1722184734860335e-11
we O 0 2.7479804889929405e-11
have O 0 9.191893123386419e-13
determined O 0 2.13401119691925e-11
the O 0 6.711980363865999e-12
ATM O 0 1.2007575378447655e-08
mutation O 0 4.6149600807510183e-10
spectrum O 0 9.255120225759583e-09
in O 0 3.48928490268019e-11
19 O 0 9.983773807675789e-10
classical O 0 1.8989447880812804e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.1998792476551898e-07
, O 0 1.131449014341035e-11
including O 0 3.455846719901956e-13
some O 0 2.7459096194754062e-12
immigrant O 0 5.627061594459803e-10
populations O 0 3.40236311346942e-11
, O 0 2.2138660262654986e-12
as O 0 4.18071610316928e-12
well O 0 3.675891188659186e-12
as O 0 7.85326838281808e-12
12 O 0 1.650896641613997e-10
of O 0 3.3822146472406445e-11
Dutch O 0 3.664800463099027e-09
ethnic O 0 1.922119130526312e-09
origin O 0 4.798957231599843e-09
. O 0 6.382736117416243e-09

Both O 0 1.954971295958785e-08
the O 0 6.972393773452268e-09
protein O 0 1.8954042779739666e-09
truncation O 0 4.011279841620308e-08
test O 0 1.0668927075130341e-08
( O 0 8.330308109982809e-10
PTT O 0 1.7028963839038624e-06
) O 0 1.0611320849784889e-10
and O 0 2.8960256068244483e-11
the O 0 7.614281427592573e-11
restriction O 0 7.417004233012392e-10
endonuclease O 0 2.6320565282844655e-08
fingerprinting O 0 1.7434233612334538e-08
( O 0 1.59207313998877e-10
REF O 0 1.2976653351870482e-07
) O 0 9.320510509225333e-12
method O 0 1.251650588729447e-10
were O 0 8.603932670492309e-12
used O 0 6.4865916457601536e-12
and O 0 4.253004632498447e-12
compared O 0 1.0718152754218835e-10
for O 0 3.849394067390044e-11
their O 0 1.74555699755663e-11
detection O 0 1.6164053429079672e-09
efficiency O 0 5.9075572211853e-10
, O 0 1.3122283641642252e-11
identifying O 0 3.0499416880935826e-10
76 O 0 4.623129878922327e-09
% O 0 1.332456367464374e-10
and O 0 4.871817359253239e-12
60 O 0 6.391711049325011e-10
% O 0 1.59048885173263e-10
of O 0 8.31903018694291e-11
the O 0 3.863201980536246e-10
mutations O 0 7.686386638283693e-09
, O 0 4.4859421732823535e-10
respectively O 0 3.752447952365401e-08
. O 0 4.401186259883616e-08

Most O 0 3.5177976087652496e-08
patients O 0 5.589134488559466e-09
were O 0 2.946838606465718e-10
found O 0 5.666640073842544e-11
to O 0 1.9820056706976175e-10
be O 0 7.292925152668772e-10
compound O 0 4.407360876257371e-08
heterozygote O 0 5.323404934642895e-07
. O 0 3.6903276878774705e-08

Seventeen O 0 1.8355366364630754e-06
mutations O 0 4.586953039620312e-08
were O 0 4.6101125694697487e-10
distinct O 0 4.291189972804865e-11
, O 0 8.594468886569118e-12
of O 0 3.781980978390109e-11
which O 0 8.301906037622153e-12
10 O 0 2.0527878008547162e-10
were O 0 2.0038042405912115e-11
not O 0 1.2123131665209286e-10
reported O 0 9.59110679765729e-10
previously O 0 5.967650817950698e-09
. O 0 9.622444174794964e-09

Mutations O 0 1.7773703802959062e-05
are O 0 7.966365345168924e-10
small O 0 2.4197630010824867e-10
deletions O 0 2.933192710941057e-08
or O 0 2.81510580180111e-07
point O 0 1.3741308976022992e-05
mutations O 0 7.128979717663242e-08
frequently O 0 8.970879039615909e-10
affecting O 0 3.520520985844655e-09
splice O 0 1.190371037296245e-07
sites O 0 2.4268139497962693e-08
. O 0 1.3278047994447206e-08

Moreover O 0 2.19156322600611e-06
, O 0 1.2283467576423845e-08
a O 0 4.687684551640814e-08
16 O 0 5.806685976494919e-07
. O 0 5.198531738415113e-08

7 O 0 1.1931074368476402e-05
- O 0 3.295815247383871e-07
kb O 0 6.355144819281122e-07
genomic O 0 4.842774004032435e-08
deletion O 0 1.1906128349892242e-07
of O 0 2.9636149090350727e-09
the O 0 1.8686213687502118e-10
3 O 0 1.9539601048279565e-09
end O 0 5.1553588065189615e-09
of O 0 3.5269173692675793e-10
the O 0 8.826001041128961e-11
gene O 0 3.7391249818607974e-11
, O 0 1.348393076881782e-12
most O 0 4.689049712749971e-13
likely O 0 9.362564890036396e-11
a O 0 3.5808578324747486e-11
result O 0 3.045593499617638e-10
of O 0 4.956458576899081e-10
recombination O 0 4.4340999622027866e-11
between O 0 5.057301799560321e-10
two O 0 2.8104334831580147e-11
LINE O 0 1.475723543364893e-08
elements O 0 5.942658587443361e-10
, O 0 2.5810159565153867e-11
was O 0 2.681660227210614e-09
identified O 0 2.8972497734258695e-09
. O 0 5.521901158545006e-09

The O 0 9.611240159301815e-08
most O 0 3.270872461769159e-11
frequently O 0 1.4665628086940607e-11
found O 0 3.869296810038447e-12
mutation O 0 6.201794633398094e-11
, O 0 9.997459674351838e-13
identified O 0 2.1082682474804493e-11
in O 0 2.7913812754298828e-12
three O 0 2.1531647992345526e-12
unrelated O 0 1.212132894057305e-10
Turkish O 0 4.432753897276598e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 2.7720303830136572e-09
, O 0 8.049665101150794e-11
was O 0 2.368087503867855e-09
previously O 0 3.290182015724952e-11
described O 0 2.568952646095357e-12
to O 0 2.1853124778509203e-12
be O 0 1.6206290866585538e-12
a O 0 5.861644936794308e-12
Turkish O 0 1.761587320459057e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 5.962293471384328e-06
mutation O 0 4.902280466012598e-07
. O 0 3.986186669635572e-08

The O 0 1.1676918099112754e-08
presence O 0 4.980320045255837e-10
of O 0 1.125213144881343e-09
a O 0 1.982433994740518e-09
founder O 0 7.645930821809088e-08
mutation O 0 7.284715763944405e-08
among O 0 1.1027351774772765e-11
relatively O 0 2.3166194657031625e-11
small O 0 7.001395123384935e-12
ethnic O 0 7.73237446294317e-11
population O 0 9.922535883222228e-13
groups O 0 2.739531149674457e-13
in O 0 3.5508015798491055e-12
Western O 0 6.412995690041612e-10
Europe O 0 2.293408574161049e-09
could O 0 4.862244828984785e-09
indicate O 0 2.7026874072078044e-09
a O 0 1.628491924643427e-10
high O 0 1.2103262836404838e-10
carrier O 0 5.234718908342373e-12
frequency O 0 5.880867459673311e-10
in O 0 8.84331930600668e-12
such O 0 8.856147586111529e-12
communities O 0 1.053196085898378e-09
. O 0 1.9573928256022555e-08

In O 0 2.900114992598901e-08
patients O 0 2.7569710958630367e-09
of O 0 1.592997289634468e-09
Dutch O 0 5.097069077919514e-08
ethnic O 0 2.7589175388698095e-09
origin O 0 1.3683002508813047e-09
, O 0 1.4658718683335792e-11
however O 0 1.478389910491984e-10
, O 0 2.6408829983948223e-11
no O 0 1.8562486270301548e-10
significant O 0 1.055879272904292e-09
founder O 0 7.618909059203816e-09
effect O 0 3.7245602158009206e-08
could O 0 1.1674023525642951e-08
be O 0 3.432644168910315e-09
identified O 0 2.4356106465006633e-08
. O 0 1.1663073173906469e-08

The O 0 4.678029341675938e-08
observed O 0 1.876251687349395e-08
genetic O 0 1.0595677224500832e-08
heterogeneity O 0 2.8120568984491e-08
including O 0 1.2209309084576514e-11
the O 0 4.5384573876816603e-10
relative O 0 5.859745400016436e-08
high O 0 2.416131295035484e-08
percentage O 0 7.1360921616303585e-09
of O 0 9.196658434795779e-10
splice O 0 2.6079202797291146e-08
- O 0 1.306072672235814e-08
site O 0 2.8071573954235873e-09
mutations O 0 3.258316727539068e-09
had O 0 1.812194949657453e-09
no O 0 2.841524793240069e-10
reflection O 0 7.545859936897159e-09
on O 0 1.730502852126392e-08
the O 0 3.8923451128880515e-09
phenotype O 0 7.450827297361684e-07
. O 0 8.010345453612899e-08

All O 0 8.859473155098385e-09
patients O 0 7.733824136657574e-10
manifested O 0 1.4392684821729063e-09
classical O 0 8.213091859943233e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
and O 0 3.078340915507738e-09
increased O 0 9.691293989533278e-09
cellular O 0 1.6099939159630594e-08
radioresistant O 0 2.0124333843796194e-07
DNA O 0 3.0047225152429746e-08
synthesis O 0 2.4572521795107605e-08
. O 0 9.18789666570774e-09

Determination O 0 1.5169018752203556e-06
of O 0 2.0489720142791157e-08
the O 0 6.666833196611321e-10
genomic O 0 1.3996134251570425e-09
structure O 0 9.774343556756548e-10
of O 0 4.319506419214747e-10
the O 0 2.0198409611538182e-10
COL4A4 O 0 3.522654151311144e-05
gene O 0 1.321766862627527e-10
and O 0 3.5666168369391515e-12
of O 0 3.428839157049168e-11
novel O 0 7.021394576867124e-10
mutations O 0 7.768579735056846e-07
causing O 0 7.086894038366154e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.024881992489099503

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 9.077274398805457e-08
a O 0 1.7050034273324854e-08
progressive O 0 0.000608048343565315
hematuric B-Disease 1 0.9999995231628418
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.0002628523507155478
by O 0 6.98779984986686e-08
glomerular B-Disease 1 0.9999368190765381
basement I-Disease 1 0.9999110698699951
membrane I-Disease 0 0.0008118690457195044
abnormalities I-Disease 1 0.9986822009086609
and O 0 1.4675911597095137e-09
associated O 0 1.3263367293347983e-08
with O 0 9.207958007184658e-11
mutations O 0 6.501988991658436e-08
in O 0 1.1936871491258216e-09
either O 0 3.3316878145228657e-09
the O 0 2.8695534837197556e-09
COL4A3 O 0 0.0005229241796769202
or O 0 8.665078432557038e-09
the O 0 5.883305398413086e-09
COL4A4 O 0 2.9678431019419804e-05
gene O 0 1.36550792895207e-09
, O 0 4.5039935323010205e-12
which O 0 8.443759472002987e-13
encode O 0 3.97952608366392e-11
the O 0 4.4161918566487657e-10
alpha3 O 0 2.0415140511431673e-07
and O 0 7.105542820795563e-10
alpha4 O 0 1.0727038670665934e-06
type O 0 4.812305860468769e-07
IV O 1 0.9672455191612244
collagen O 0 1.0159285920963157e-05
chains O 0 4.0521982214158925e-07
, O 0 1.7505734639655657e-09
respectively O 0 1.762908219404835e-08
. O 0 2.9328681705464987e-08

To O 0 4.882059556621243e-08
date O 0 1.4315217811144976e-07
, O 0 3.111590152204968e-11
mutation O 0 3.720642197113655e-11
screening O 0 1.0274060768811211e-10
in O 0 8.374826873658314e-12
the O 0 3.726046554630713e-11
two O 0 1.0198886873924451e-11
genes O 0 7.473376778532881e-11
has O 0 2.795675800235098e-12
been O 0 6.36396968109465e-12
hampered O 0 1.0234734171277182e-09
by O 0 4.951860969881761e-12
the O 0 1.687933265381858e-10
lack O 0 8.451280786303528e-10
of O 0 9.211119367247278e-11
genomic O 0 2.2998028481602262e-10
structure O 0 6.454387024845687e-10
information O 0 4.2492145913008983e-10
. O 0 4.451119473003473e-09

We O 0 1.1826335821751854e-07
report O 0 3.378992363689548e-10
here O 0 9.186240657044209e-11
the O 0 1.2865702427033998e-11
complete O 0 6.361969978607718e-11
characterization O 0 1.113793723916956e-09
of O 0 4.009707288421538e-10
the O 0 1.7933102225420328e-10
48 O 0 2.9508673282663267e-09
exons O 0 7.010866998058418e-09
of O 0 2.2869786064916298e-09
the O 0 2.779903640615089e-09
COL4A4 O 0 0.1978960484266281
gene O 0 1.6484346332390487e-08
, O 0 5.966893645847904e-11
a O 0 1.3644502194765096e-10
comprehensive O 0 4.695825506217943e-09
gene O 0 1.142980710078234e-09
screen O 0 9.375404452782732e-09
, O 0 1.0578179998610437e-10
and O 0 7.35901010268103e-12
the O 0 2.054545769625271e-11
subsequent O 0 2.743225611945288e-11
detection O 0 6.839214750087308e-10
of O 0 1.8025476944405483e-11
10 O 0 4.729300284722626e-12
novel O 0 2.334480482188428e-12
mutations O 0 4.087877258918127e-11
in O 0 2.159259750167397e-12
eight O 0 5.0333757994902584e-11
patients O 0 1.7356446835314898e-10
diagnosed O 0 4.142902525927639e-06
with O 0 1.4093859412867005e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.001121083158068359

Furthermore O 0 4.14476016885601e-06
, O 0 2.4219078298415297e-08
we O 0 1.5722903867754212e-08
identified O 0 4.744105996934422e-09
a O 0 1.6373442601747001e-09
glycine O 0 7.773135912714224e-09
to O 0 2.6748303572077248e-09
alanine O 0 1.1867387961217446e-08
substitution O 0 2.5185055818610635e-08
in O 0 5.163258154361472e-10
the O 0 3.2926819604206514e-10
collagenous O 0 6.067111968377503e-08
domain O 0 2.2907766794588724e-09
that O 0 3.933881866091671e-12
is O 0 3.4360255526250105e-12
apparently O 0 4.176095927399537e-11
silent O 0 9.554912416831485e-11
in O 0 3.292779243713184e-12
the O 0 1.1836625429806347e-11
heterozygous O 0 1.138152159324557e-11
carriers O 0 2.2970136209776726e-11
, O 0 3.468290932229223e-11
in O 0 3.2548053141567834e-10
11 O 0 5.6968733730400345e-08
. O 0 3.084695876509613e-08

5 O 0 5.33916647782462e-07
% O 0 1.6279935621810182e-08
of O 0 7.30856319908213e-10
all O 0 4.740374759393262e-11
control O 0 1.4418513050173942e-09
individuals O 0 5.2189693539039794e-11
, O 0 2.6825014431963723e-11
and O 0 9.917676922766017e-12
in O 0 4.039697049096347e-11
one O 0 2.4160860812028062e-11
control O 0 1.1990558546060015e-10
individual O 0 7.620331774448041e-13
homozygous O 0 2.2823659628912196e-11
for O 0 1.0132264818829562e-11
this O 0 8.17724013502108e-11
glycine O 0 1.9356292568772915e-08
substitution O 0 1.4442498752487154e-07
. O 0 5.374467093588464e-08

There O 0 5.4481180455923095e-08
has O 0 3.3626301743083786e-10
been O 0 8.822634983696176e-11
no O 0 3.327403977348986e-11
previous O 0 1.266639015895521e-10
finding O 0 1.417875816756009e-10
of O 0 2.5973525413780507e-11
a O 0 1.7816357764099955e-11
glycine O 0 2.1761516200147213e-10
substitution O 0 9.425028535403612e-10
that O 0 8.717165878024957e-12
is O 0 2.661609647958141e-12
not O 0 5.220480298051555e-12
associated O 0 1.6446415410098503e-11
with O 0 1.127204273389075e-13
any O 0 8.392805200818643e-11
obvious O 0 2.0318463578306023e-10
phenotype O 0 8.854265098889869e-10
in O 0 7.474659780015713e-11
homozygous O 0 7.274698066161989e-10
individuals O 0 9.505800591114166e-10
. O 0 3.6447957540985954e-08

Founder O 0 2.4972161554615013e-05
BRCA1 O 0 2.2622930373472627e-06
and O 0 5.013595316682995e-09
BRCA2 O 0 1.2975429797279503e-07
mutations O 0 9.098777287164239e-10
in O 0 5.269097658189281e-12
French O 0 1.070022404014992e-09
Canadian O 0 1.1303929881023578e-07
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.1137664589332417e-05
. O 0 7.669898423046106e-07

We O 0 6.684805242684888e-08
have O 0 7.949119140704397e-11
identified O 0 2.0968880798388767e-10
four O 0 4.054871889647149e-12
mutations O 0 3.58911789177796e-11
in O 0 1.6821817376555526e-12
each O 0 4.901550519631481e-12
of O 0 1.1321127368901784e-09
the O 0 5.442800699029249e-08
breast B-Disease 1 0.9999938011169434
cancer I-Disease 1 0.999998927116394
- O 0 0.001216647564433515
susceptibility O 0 0.3886836767196655
genes O 0 3.4928336845041486e-07
, O 0 8.05095934364175e-10
BRCA1 O 0 6.133924301821025e-08
and O 0 2.353462535964468e-09
BRCA2 O 0 7.577361316180031e-07
, O 0 1.361870251986863e-11
in O 0 4.315763024731467e-12
French O 0 1.8185072336862618e-09
Canadian O 0 7.989608974412477e-08
breast B-Disease 1 0.9982038736343384
cancer I-Disease 1 0.9999538660049438
and O 0 1.7031599782058038e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.369593741808785e-07
from O 0 1.2930895820773003e-07
Quebec O 0 7.813345632712299e-07
. O 0 1.1219204054668808e-07

To O 0 2.2061578874854604e-06
identify O 0 5.815719305246603e-06
founder O 0 1.8033857486443594e-05
effects O 0 0.47389644384384155
, O 0 5.178558026841529e-09
we O 0 1.3991837688465125e-09
examined O 0 5.303859573757563e-10
independently O 0 7.91104820541122e-11
ascertained O 0 9.374724996291661e-09
French O 0 1.0656698856692515e-09
Canadian O 0 7.770764476333625e-09
cancer B-Disease 0 8.103160809014298e-08
families O 0 1.5839843542711507e-12
for O 0 3.4135790982076086e-13
the O 0 2.943465133090073e-12
distribution O 0 2.9295541686957804e-11
of O 0 2.452781380779534e-11
these O 0 6.952808120908038e-12
eight O 0 1.2367269430768602e-09
mutations O 0 3.740107601402087e-08
. O 0 5.243242995334185e-08

Mutations O 0 1.933601879500202e-06
were O 0 7.3869506067580915e-09
found O 0 1.501860441566194e-10
in O 0 7.812337582402407e-11
41 O 0 6.564490728777628e-09
of O 0 1.2819638683936319e-09
97 O 0 5.0093440506771e-08
families O 0 1.8392029010882993e-09
. O 0 6.396327023594495e-08

Six O 0 1.511157989853018e-07
of O 0 1.9636415160562137e-08
eight O 0 3.381025015514183e-09
mutations O 0 4.890911231569817e-09
were O 0 1.110014524741132e-09
observed O 0 3.5695555400394596e-09
at O 0 3.2708884489807133e-09
least O 0 1.1877142602756408e-09
twice O 0 1.920709102876117e-08
. O 0 2.8923148320814107e-08

The O 0 4.280871621631377e-07
BRCA1 O 0 1.7450606719648931e-06
C4446T O 0 9.693683750811033e-06
mutation O 0 8.736692080901776e-08
was O 0 2.166523627167294e-09
the O 0 2.2853019823743104e-11
most O 0 2.96129196468084e-13
common O 0 8.126920143791683e-12
mutation O 0 1.0031149244582593e-09
found O 0 5.240445230536572e-11
, O 0 1.7892903955360473e-12
followed O 0 1.0247518111849985e-11
by O 0 1.9964451966614227e-11
the O 0 1.8741763696539238e-09
BRCA2 O 0 1.624256782406519e-07
8765delAG O 0 5.391735840021283e-07
mutation O 0 1.164504510597908e-06
. O 0 8.750100022325569e-08

Together O 0 1.661578785672191e-08
, O 0 3.2684671635863083e-10
these O 0 1.244114360143822e-11
mutations O 0 6.891645587536743e-10
were O 0 1.0778999914862197e-10
found O 0 8.098324962013681e-12
in O 0 2.6421816123889386e-12
28 O 0 7.945530344777296e-10
of O 0 1.1150048245811561e-10
41 O 0 8.483840852058222e-10
families O 0 1.2005718684829358e-12
identified O 0 3.0424916058757745e-11
to O 0 1.4097346900943108e-10
have O 0 3.841494830569836e-11
a O 0 2.94869573203016e-09
mutation O 0 2.9840333581887535e-07
. O 0 9.868070804941453e-08

The O 0 4.772288164645033e-08
odds O 0 1.0480130896439732e-07
of O 0 4.762054084395118e-10
detection O 0 4.640781092746238e-09
of O 0 4.881663406841596e-10
any O 0 8.721915412124304e-10
of O 0 2.059947101784587e-09
the O 0 2.6276950060299953e-10
four O 0 2.6988624876600475e-11
BRCA1 O 0 3.6579983486717538e-09
mutations O 0 2.257931086546705e-08
was O 0 3.88414456153896e-08
18 O 0 5.891988763551126e-08
. O 0 1.8875800478213023e-08

7x O 0 0.0007693424704484642
greater O 0 2.9562724535026064e-07
if O 0 8.445213950381003e-08
one O 0 2.3904225820992053e-10
or O 0 1.401268164002989e-11
more O 0 1.9686089238780957e-13
cases O 0 2.116132269414095e-11
of O 0 2.064837545390219e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 9.261936995130782e-09
also O 0 1.8523385950097726e-12
present O 0 9.007183887632664e-12
in O 0 2.1374695416409573e-11
the O 0 3.5511232843177254e-10
family O 0 3.40987516000979e-10
. O 0 8.357239345002654e-09

The O 0 7.397542844955751e-08
odds O 0 1.318269085004431e-07
of O 0 3.516707203221614e-10
detection O 0 6.482396397444745e-09
of O 0 2.2481654038397636e-10
any O 0 4.738442971330414e-10
of O 0 1.6856467333070668e-09
the O 0 1.653707865090226e-10
four O 0 3.157680020238196e-11
BRCA2 O 0 1.1641160035935627e-08
mutations O 0 1.426663942538653e-08
was O 0 5.971911321012158e-08
5 O 0 1.5196847868992336e-07
. O 0 2.991757952486296e-08

3x O 0 5.496359881362878e-05
greater O 0 3.6301989325693285e-07
if O 0 6.445559819212576e-08
there O 0 6.798856477807647e-10
were O 0 1.1488989620778156e-10
at O 0 3.523567201901834e-11
least O 0 2.704168486356018e-12
five O 0 4.34167784189865e-13
cases O 0 8.573098285967473e-13
of O 0 1.490135792536762e-10
breast B-Disease 0 0.003489537164568901
cancer I-Disease 0 0.009676272980868816
in O 0 1.0124050930926387e-08
the O 0 9.991421734412143e-08
family O 0 1.4950396476365313e-08
. O 0 4.20117984845092e-08

Interestingly O 0 4.2373216047053575e-07
, O 0 4.484898563639206e-10
the O 0 5.5787017366748515e-11
presence O 0 4.121463934025904e-11
of O 0 6.223886406253598e-10
a O 0 5.42122897684294e-08
breast B-Disease 1 0.9605722427368164
cancer I-Disease 0 0.014576766639947891
case O 0 1.5142251186262e-07
< O 0 2.4524433683836833e-05
36 O 0 2.7985411321651554e-08
years O 0 2.856043457288848e-10
of O 0 5.701103825139775e-11
age O 0 5.509852574192564e-10
was O 0 2.5768448139174005e-11
strongly O 0 2.0854945374793044e-12
predictive O 0 1.1613027900425621e-10
of O 0 1.834159907287969e-11
the O 0 2.4530562043462156e-12
presence O 0 1.240942786896737e-12
of O 0 4.598524252358294e-12
any O 0 4.817413135072002e-11
of O 0 9.711416393276551e-11
the O 0 1.0976679981622439e-10
eight O 0 1.4838479056589193e-10
mutations O 0 9.787962662599625e-10
screened O 0 1.117226311464492e-08
. O 0 9.879271622992292e-09

Carriers O 0 1.8373444987673793e-09
of O 0 5.255432200534926e-10
the O 0 2.5947875792464714e-11
same O 0 2.2726093576452833e-11
mutation O 0 2.2985925662855067e-10
, O 0 7.673861546209082e-13
from O 0 2.963921209159226e-12
different O 0 8.672435599516026e-13
families O 0 7.881630244288562e-12
, O 0 3.630412376970371e-12
shared O 0 4.233096078526399e-12
similar O 0 2.0016497140340483e-11
haplotypes O 0 7.435478455164457e-09
, O 0 2.3252162348330607e-11
indicating O 0 4.0478442819846805e-10
that O 0 7.889782577263915e-12
the O 0 3.559428446431312e-11
mutant O 0 2.4418399593995055e-11
alleles O 0 2.1788210124995544e-11
were O 0 2.8859607845849178e-12
likely O 0 1.1892135713675867e-11
to O 0 3.617666279390197e-12
be O 0 1.3379661961687717e-12
identical O 0 3.3511447740039446e-13
by O 0 8.860131053313458e-13
descent O 0 1.078418798705627e-09
for O 0 4.547846040731107e-12
a O 0 4.405690048892019e-11
mutation O 0 6.924282258680137e-10
in O 0 6.727312457099899e-11
the O 0 4.980804102494574e-10
founder O 0 1.3943463272880763e-08
population O 0 2.0134674483252013e-10
. O 0 3.3851872416335027e-09

The O 0 6.511989614210734e-09
identification O 0 2.2618309447608453e-09
of O 0 3.20406479126234e-09
common O 0 2.2799154564268065e-08
BRCA1 O 0 3.6021174310008064e-06
and O 0 6.135398677997728e-08
BRCA2 O 0 3.2418311093351804e-06
mutations O 0 8.790078709353111e-08
will O 0 1.5581559653643495e-10
facilitate O 0 1.3218501293543738e-10
carrier O 0 3.60359173057212e-11
detection O 0 2.1759161139556227e-09
in O 0 1.1328698396040338e-11
French O 0 1.8478033547708606e-09
Canadian O 0 6.035878641341696e-08
breast B-Disease 1 0.6172499060630798
cancer I-Disease 1 0.6589429974555969
and O 0 2.491739905963186e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.5200398593151476e-06
. O 0 2.7669932478602277e-07

Are O 0 7.141282765132928e-08
Dp71 O 0 0.0003053820983041078
and O 0 9.9440057965694e-08
Dp140 O 0 0.008610153570771217
brain O 0 1.3584729458671063e-05
dystrophin O 0 3.170902687088528e-07
isoforms O 0 4.551845123046405e-09
related O 0 4.5265446946274324e-10
to O 0 1.150284797968304e-10
cognitive B-Disease 0 1.7795042595025734e-06
impairment I-Disease 1 0.9396924376487732
in O 0 2.0449876956263324e-06
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9994813799858093

Molecular O 0 3.3449925922468537e-06
study O 0 8.72667893503376e-09
and O 0 6.678487624034446e-11
neuropsychological O 0 3.4531374981661145e-10
analysis O 0 6.097568283625066e-11
were O 0 2.1539997216435403e-11
performed O 0 1.3998168943429867e-12
concurrently O 0 5.669696483134867e-12
on O 0 8.480066648886009e-11
49 O 0 2.8290663145469352e-09
patients O 0 4.1522126015269833e-11
with O 0 3.296526246421294e-11
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.620718467165716e-05
DMD B-Disease 1 1.0
) O 0 1.6248803691443214e-10
in O 0 5.6055271535626616e-11
order O 0 6.305734406852892e-11
to O 0 8.281304114676757e-11
find O 0 6.868362822931573e-11
a O 0 1.9650397628523386e-11
molecular O 0 2.5736190956138216e-10
explanation O 0 3.7776410471979105e-11
for O 0 3.367286050687257e-12
the O 0 3.3234335422571704e-11
cognitive B-Disease 0 1.3891599337512162e-07
impairment I-Disease 0 7.1114045567810535e-06
observed O 0 3.728462161234347e-08
in O 0 3.8668435120570166e-10
most O 0 1.7321266643222089e-09
DMD B-Disease 1 1.0
patients O 0 5.474659587889619e-07
. O 0 8.410685126136741e-08

Complete O 0 6.724769008314979e-08
analysis O 0 2.2912836072919163e-09
of O 0 5.3997926130477936e-09
the O 0 1.2037746355275658e-09
dystrophin O 0 5.98605183199652e-08
gene O 0 4.5246308921775835e-09
was O 0 1.3620230276956136e-08
performed O 0 6.965435173089674e-11
to O 0 1.6620560483460167e-10
define O 0 5.4701065899109835e-09
the O 0 5.39920275155481e-10
localization O 0 6.918703832070605e-08
of O 0 2.042253299805452e-08
deletions O 0 2.9384898070361487e-08
and O 0 7.780844857308011e-10
duplications O 0 3.359300038141555e-08
in O 0 1.7902139493042313e-10
relation O 0 5.711307871081317e-09
to O 0 3.9321526590363476e-10
the O 0 1.1983539160986822e-10
different O 0 4.160284894361155e-10
DMD B-Disease 1 1.0
promoters O 0 5.215687269810587e-05
. O 0 2.2791508058617183e-07

Qualitative O 0 2.2106472385985398e-07
analysis O 0 6.3402927352740335e-09
of O 0 1.2543715399715438e-08
the O 0 5.7111879669946575e-09
Dp71 O 0 5.038786525801697e-07
transcript O 0 1.2021622808333632e-08
and O 0 4.06740682801221e-11
testing O 0 2.2407837738103176e-11
for O 0 7.883159728293287e-13
the O 0 4.301578624549274e-12
specific O 0 3.664125947100416e-11
first O 0 1.847312719460703e-10
exon O 0 2.2603088289940843e-09
of O 0 7.54902718114181e-09
Dp140 O 0 8.233567996285274e-07
were O 0 7.143905467188461e-10
also O 0 3.954745211864896e-11
carried O 0 2.1980563202905756e-10
out O 0 1.2734749366138942e-10
. O 0 7.211357067049562e-10

Neuropsychological O 0 3.87793352274457e-06
analysis O 0 6.337236868603213e-08
assessed O 0 9.676703029981581e-07
verbal O 0 6.353175194817595e-07
and O 0 1.229903379140751e-08
visuospatial O 0 1.8149929701394285e-06
intelligence O 0 7.739021867791962e-09
, O 0 3.27501942232189e-10
verbal O 0 2.0513856213710824e-07
memory O 0 3.829738489002921e-05
, O 0 1.4227610201089647e-09
and O 0 2.9013844105030273e-10
reading O 0 6.109147676625071e-08
skills O 0 3.684019489469392e-08
. O 0 2.0763934571732534e-08

Comparison O 0 1.8988844203704502e-06
of O 0 4.5878280729994003e-07
molecular O 0 2.6108523343282286e-07
and O 0 5.925974155829294e-10
psychometric O 0 2.2355114026595402e-07
findings O 0 5.425115912061074e-09
demonstrated O 0 2.987917135932605e-10
that O 0 2.6115696410977662e-11
deletions O 0 1.7960154474749856e-09
and O 0 8.300945347761157e-11
duplications O 0 7.08384106928861e-09
that O 0 1.4689541250056948e-10
were O 0 1.199497307036168e-10
localized O 0 3.9070592094958556e-08
in O 0 1.8877292784491573e-10
the O 0 3.1867541938623845e-10
distal O 0 1.378816477881628e-06
part O 0 4.202291403743175e-09
of O 0 5.453025053725469e-08
the O 0 6.06787375900808e-09
gene O 0 1.3465806247836554e-09
seemed O 0 4.402198050534878e-10
to O 0 1.1325025119079957e-11
be O 0 6.645814541045292e-12
preferentially O 0 1.716958936137658e-10
associated O 0 6.193995316650103e-10
with O 0 7.219679715175786e-11
cognitive B-Disease 0 0.0001777780125848949
impairment I-Disease 1 0.9989933371543884
. O 0 5.4402016758103855e-06

Two O 0 5.632221089513223e-08
altered O 0 2.926956881310616e-07
Dp71 O 0 1.7664073311607353e-05
transcripts O 0 1.690342514848453e-07
and O 0 2.2174022618060008e-09
two O 0 2.650310526597366e-10
deleted O 0 1.0897497348949514e-09
Dp140 O 0 9.071507101054976e-09
DNA O 0 1.352992995418134e-10
sequences O 0 4.702244670029554e-12
were O 0 1.3020680453973421e-12
found O 0 2.2634707151115985e-13
in O 0 1.6273218666693068e-13
four O 0 5.56726919339473e-13
patients O 0 6.35881278188144e-12
with O 0 6.0862942290185185e-12
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 0.20716406404972076

These O 0 9.343877671597056e-09
findings O 0 3.5707610201995976e-09
suggest O 0 1.3908263429840417e-09
that O 0 5.184460499796373e-12
some O 0 1.1843778995740406e-12
sequences O 0 3.3171115593894074e-12
located O 0 7.422076842011904e-12
in O 0 4.515623118483969e-12
the O 0 2.3459083633992073e-11
distal O 0 5.560216109756766e-08
part O 0 2.7264304702789843e-10
of O 0 1.2483039046884414e-09
the O 0 2.8358179693377394e-10
gene O 0 6.359834880953485e-11
and O 0 2.8218042485983474e-11
, O 0 2.721512685349703e-12
in O 0 3.6776584382003374e-12
particular O 0 3.3525052178795534e-10
, O 0 9.468876203955201e-12
some O 0 5.6616785912289025e-12
DMD B-Disease 1 1.0
isoforms O 0 3.7033654365359325e-08
expressed O 0 5.544938397328281e-10
in O 0 2.128528325817669e-10
the O 0 3.8017416992275344e-10
brain O 0 6.661665707952125e-08
may O 0 1.9315926635954384e-10
be O 0 9.063813935505927e-12
related O 0 1.5539109929352257e-11
to O 0 1.1552577471041214e-11
the O 0 2.061359763438908e-11
cognitive B-Disease 0 4.889067284352677e-08
impairment I-Disease 0 3.6518696333587286e-07
associated O 0 3.218251620751289e-08
with O 0 1.638153168670442e-09
DMD B-Disease 1 1.0
. O 0 1.8852814775982552e-07
. O 0 5.939197222915027e-08

I1307K O 0 0.00013949236017651856
APC O 0 3.3708661817399843e-07
and O 0 4.971000833187134e-10
hMLH1 O 0 4.282186338855354e-08
mutations O 0 2.5281348126071634e-09
in O 0 6.265759178863961e-12
a O 0 4.986629165149026e-11
non O 0 9.83212622429619e-09
- O 0 1.3288227185270785e-09
Jewish O 0 1.0494608737587896e-08
family O 0 1.1374554943766046e-11
with O 0 1.991754634486642e-12
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9997324347496033

We O 0 1.9285648633626806e-08
describe O 0 7.439007188025926e-10
a O 0 5.689849633117028e-11
French O 0 2.2851822656377863e-09
Canadian O 0 5.753152265697281e-08
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.5007934962341096e-05
HNPCC B-Disease 1 1.0
) O 0 6.633182891846445e-10
kindred O 0 7.971217463875746e-09
which O 0 1.2905148304154235e-11
carries O 0 1.5472980535724545e-11
a O 0 1.1563599904007571e-11
novel O 0 1.1223361823242683e-10
truncating O 0 2.391838727078266e-08
mutation O 0 4.752547244635252e-09
in O 0 4.293697064561286e-10
hMLH1 O 0 5.844788120157318e-07
. O 0 2.112192305503413e-07

Interestingly O 0 8.684918952894805e-07
, O 0 1.7772796567783189e-09
the O 0 1.2857693798551395e-09
I1307K O 0 1.912581240048894e-07
APC O 0 5.165851746369299e-09
polymorphism O 0 7.093683862535727e-09
, O 0 1.8750003286105432e-11
associated O 0 1.2719864224408628e-11
with O 0 3.24787837954494e-14
an O 0 2.1727763902315567e-13
increased O 0 8.076393720468644e-11
risk O 0 4.1324199173686793e-07
of O 1 0.9683597683906555
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.963604828210009e-08
is O 0 4.602633552064361e-11
also O 0 6.352323723458897e-13
present O 0 3.773332774709148e-12
in O 0 7.400124783785156e-12
this O 0 1.3885567695659518e-10
family O 0 3.6849151507922784e-10
. O 0 1.068371169310467e-08

The O 0 1.1334132921092532e-07
I1307K O 0 3.1668639621784678e-06
polymorphism O 0 1.4852403751319798e-07
has O 0 1.5429046928971957e-10
previously O 0 1.1688933675146895e-11
only O 0 1.4501507633601918e-12
been O 0 1.231196459887396e-12
identified O 0 1.206917920638928e-12
in O 0 8.690711182385985e-14
individuals O 0 6.043720211790227e-13
of O 0 7.406030649859119e-11
self O 0 8.793327843648058e-09
- O 0 1.4105161483257689e-08
reported O 0 3.6435010564161985e-09
Ashkenazi O 0 3.12018251236168e-08
Jewish O 0 4.486834459527245e-09
origins O 0 9.869666861561655e-09
. O 0 4.858888846825948e-09

In O 0 2.5519124591255604e-09
addition O 0 1.332420840327586e-10
, O 0 4.459519559185665e-11
in O 0 2.7833972973678733e-11
this O 0 1.080376135775829e-10
family O 0 6.719207829020135e-11
, O 0 2.0008777620872387e-12
there O 0 3.037978289072152e-12
appears O 0 1.505708752125301e-11
to O 0 1.870139286486161e-11
be O 0 1.2865095100345059e-10
no O 0 1.596768550715666e-10
relationship O 0 8.8526727615168e-11
between O 0 2.5906446432522046e-10
the O 0 1.2415643513286057e-10
I1307K O 0 1.498807744582109e-09
polymorphism O 0 1.8409497537508202e-10
and O 0 3.1921774251708612e-12
the O 0 6.0174868560247674e-12
presence O 0 5.820457397304191e-12
or O 0 8.156993414054625e-10
absence O 0 2.5454191643348167e-08
of O 0 9.737319395242139e-09
cancer B-Disease 0 6.398090590664651e-07
. O 0 1.8413369717862338e-09
. O 0 1.1902820062914543e-08

Identification O 0 4.349571014472531e-08
of O 0 1.7195849189022283e-09
a O 0 2.720550174029057e-10
novel O 0 2.604984283838263e-10
mutation O 0 3.5892040450846707e-09
of O 0 3.989227170819731e-09
the O 0 3.4075429145019598e-09
CPO O 0 6.267478056543041e-06
gene O 0 1.129870849658765e-10
in O 0 8.627958590634588e-12
a O 0 3.07287806311507e-10
Japanese O 0 6.511395866937164e-08
hereditary B-Disease 1 0.9999996423721313
coproporphyria I-Disease 1 0.9999995231628418
family O 0 3.0078763302299194e-07
. O 0 9.43032318900805e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999997615814209
( O 0 3.8668261481689115e-07
HCP B-Disease 1 0.9999973773956299
) O 0 2.3775814650406346e-10
is O 0 6.629713444894492e-11
an O 0 5.191114760272342e-10
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 2.389322446560982e-07
by O 0 1.648506109397374e-09
a O 0 2.5989774599111115e-07
deficiency B-Disease 1 0.9999639987945557
of I-Disease 1 0.8848695158958435
coproporphyrinogen I-Disease 0 0.0012889341451227665
oxidase I-Disease 0 2.5871127036225516e-06
( O 0 1.6725129059480537e-09
CPO O 0 1.2783931424564798e-06
) O 0 5.064903357832051e-12
caused O 0 2.3942006710520047e-10
by O 0 5.178036818764831e-12
a O 0 1.3845158353120723e-10
mutation O 0 3.906727441549407e-10
in O 0 2.2082928541333757e-10
the O 0 9.759147268084689e-09
CPO O 0 1.2699594662990421e-05
gene O 0 2.3137392446415106e-08
. O 0 1.9052386335260962e-08

Only O 0 4.954563692649572e-08
11 O 0 1.7493960058345692e-08
mutations O 0 2.096153250974453e-09
of O 0 4.228121741611801e-10
the O 0 1.6488700682604218e-10
gene O 0 1.1946317546307483e-10
have O 0 2.6161016061787556e-11
been O 0 9.59992363380735e-11
reported O 0 2.366587203983528e-10
in O 0 5.895771648667392e-10
HCP B-Disease 1 0.9999997615814209
patients O 0 3.042518756046775e-06
. O 0 1.80781705694244e-06

We O 0 4.4459799397600364e-08
report O 0 1.5932336006052594e-10
another O 0 1.5380478834980948e-10
mutation O 0 5.496647581537673e-10
in O 0 2.1632182156672286e-11
a O 0 4.8723985957011e-10
Japanese O 0 5.151390780611109e-08
family O 0 1.6701666716301133e-09
. O 0 2.077819694079608e-08

Polymerase O 0 1.1137815363326808e-06
chain O 0 4.1657756355562015e-08
reaction O 0 1.0280769568993264e-09
- O 0 2.1316051146413884e-09
single O 0 7.517811373425332e-11
strand O 0 5.098483302212742e-10
conformational O 0 1.9174019316725577e-10
polymorphism O 0 1.7175975919325737e-10
and O 0 3.6185496873203382e-12
direct O 0 1.442692215691821e-10
sequence O 0 1.6420689807894462e-10
analyses O 0 7.451627509480474e-11
demonstrated O 0 5.505259442761812e-11
a O 0 5.057022023358115e-10
C O 0 1.8591707373616373e-07
to O 0 2.1730999222313585e-09
T O 0 7.936129087227073e-09
substitution O 0 5.731919383578088e-10
in O 0 8.050924510394353e-11
exon O 0 6.28983309880482e-10
1 O 0 1.10892743876434e-08
of O 0 8.610541168962982e-10
the O 0 2.430991408175487e-09
CPO O 0 3.691715164677589e-07
gene O 0 4.270108919235405e-11
at O 0 1.077863076570651e-10
nucleotide O 0 2.2772533858628208e-10
position O 0 7.760480591478824e-10
85 O 0 1.3901207962518924e-09
, O 0 2.8170382693204488e-12
which O 0 9.542705167731036e-12
lies O 0 6.2381153576041015e-09
in O 0 1.4459097807950627e-10
the O 0 1.5051215829231523e-09
putative O 0 5.325182073079304e-08
presequence O 0 1.4698811412472423e-07
for O 0 3.6423666860407877e-10
targeting O 0 2.462055004315289e-09
to O 0 1.6964106563932546e-08
mitochondria O 0 2.2764420748444536e-07
. O 0 4.6636323247639666e-08

This O 0 7.363500476031959e-09
mutation O 0 2.8529849593894596e-09
changes O 0 5.483767884228996e-10
the O 0 1.7833842735903715e-10
codon O 0 3.1441189651815193e-09
for O 0 1.6555383453020767e-10
glutamine O 0 3.9271833007781254e-10
to O 0 6.165706833982654e-10
a O 0 1.3402925436167834e-09
termination O 0 2.255151514418685e-07
codon O 0 4.329078251430474e-07
at O 0 1.2399875970459107e-07
amino O 0 1.1072957661895089e-08
acid O 0 2.4526434216909365e-09
position O 0 6.3374998582332864e-09
29 O 0 1.3114251373735897e-07
. O 0 1.1716741354916849e-08

MaeI O 0 1.549072658235673e-05
restriction O 0 5.191872887166937e-08
analysis O 0 2.200687632125664e-09
showed O 0 1.401268961975788e-10
two O 0 8.781728599513428e-13
other O 0 1.737907777757397e-13
carriers O 0 2.3744881928744466e-12
in O 0 1.3338594118117442e-11
the O 0 7.756780773249261e-10
family O 0 9.969635117457187e-10
. O 0 1.0517513082675123e-08

The O 0 2.0816047197058651e-07
C O 0 0.0001226506137754768
- O 0 8.469509339192882e-06
T O 0 1.1766524039558135e-06
mutation O 0 7.200035678778249e-09
is O 0 9.967096592511382e-12
located O 0 4.479954601732672e-11
within O 0 1.5097499639349365e-10
a O 0 1.1768894192520918e-10
recently O 0 1.568556673436916e-10
proposed O 0 9.13564279780843e-10
putative O 0 4.177804768801252e-09
alternative O 0 8.078739899275433e-10
translation O 0 3.117805458252576e-10
initiation O 0 6.366962512771579e-10
codon O 0 2.663695930493759e-09
( O 0 1.2384606361270922e-11
TIC O 0 1.7090041604106432e-09
- O 0 1.0390579952002099e-08
1 O 0 3.9858978340134854e-08
) O 0 1.3552161129415374e-11
, O 0 4.8000392723068774e-12
supporting O 0 2.305819077341731e-11
that O 0 1.582321426663036e-11
TIC O 0 7.557988013218164e-09
- O 0 1.2786971481659748e-08
1 O 0 7.20281292387881e-08
is O 0 1.6849804884699893e-10
the O 0 6.125267515422195e-10
real O 0 6.573777966423222e-08
TIC O 0 1.294896350145791e-07
rather O 0 2.7600437491059893e-09
than O 0 1.5396864894157147e-09
TIC O 0 4.265515940460318e-08
- O 0 5.5565688938941094e-08
2 O 0 6.93007535801371e-08
. O 0 1.6024197524444617e-09
. O 0 8.17749779002952e-09

Human B-Disease 0 3.294995831737424e-09
complement I-Disease 0 5.517826640044632e-09
factor I-Disease 0 1.673094971010869e-06
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999971389770508
associated O 0 8.099003139250271e-07
with O 0 1.1380588205156528e-07
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999986886978149

This O 0 3.369263534835909e-09
study O 0 1.1037205871478051e-10
reports O 0 7.523572910506093e-12
on O 0 1.9376183990615914e-10
six O 0 1.9339252421701758e-11
cases O 0 4.6579358425891115e-11
of O 0 3.982977503369511e-09
deficiency B-Disease 1 0.9997170567512512
in I-Disease 0 4.088320082473729e-08
the I-Disease 0 2.955622946387848e-08
human I-Disease 0 4.5166442808053375e-10
complement I-Disease 0 6.644651495690823e-11
regulatory I-Disease 0 3.135112613961155e-09
protein I-Disease 0 1.2618801115138467e-08
Factor I-Disease 0 2.33419559236836e-08
H I-Disease 0 0.022712426260113716
( O 0 3.7290327076222596e-11
FH O 0 7.985084238271156e-08
) O 0 1.881766091690537e-13
in O 0 4.108460127010341e-14
the O 0 2.6626577258694918e-14
context O 0 6.103845727467583e-13
of O 0 2.1831128484833817e-12
an O 0 3.0015673974093104e-11
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.1098140021204017e-05

Five O 0 5.167657946003601e-08
of O 0 1.1918603881611034e-09
the O 0 1.0554800783380003e-10
cases O 0 2.410235899752422e-11
were O 0 2.400601245566847e-11
observed O 0 3.40943107079994e-11
in O 0 1.309879613629883e-12
children O 0 9.46071237843682e-13
presenting O 0 1.5479917694904977e-11
with O 0 1.0022423863054186e-10
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.0002691153495106846
HUS B-Disease 1 1.0
) O 0 9.552684332447825e-08
. O 0 1.1018055374734104e-06

Two O 0 1.7266049701092356e-09
of O 0 3.257937697398461e-09
the O 0 7.607796059794225e-10
children O 0 1.8627347928013016e-11
exhibited O 0 1.1001811961453001e-10
a O 0 4.404837827820529e-09
homozygous O 0 1.5760939504616545e-06
deficiency O 1 0.9999939203262329
characterized O 0 1.2330155563233802e-08
by O 0 2.450023794953182e-10
the O 0 2.2359115448011835e-08
absence O 0 1.0247263304563603e-07
of O 0 6.289908593970495e-09
the O 0 2.3247208325027913e-10
150 O 0 5.0358821279683497e-11
- O 0 1.3493199613190399e-11
kD O 0 1.9739135326268809e-10
form O 0 6.628231383892791e-12
of O 0 6.180836398250733e-10
Factor O 0 7.756074893450204e-09
H O 1 0.9999037981033325
and O 0 2.0820139015609307e-11
the O 0 3.4301343015963326e-11
presence O 0 4.779137589144833e-12
, O 0 6.959597828593012e-13
upon O 0 2.502981155672046e-11
immunoblotting O 0 3.096544531899781e-08
, O 0 3.363904640951709e-11
of O 0 4.038990530919051e-10
the O 0 3.4855085484508663e-10
42 O 0 3.616733357247881e-09
- O 0 1.8148792468863917e-09
kD O 0 6.154620990628246e-08
Factor O 0 2.6426203447726948e-08
H O 1 0.9808961153030396
- O 0 1.4452831464950577e-07
like O 0 6.533210084036511e-10
protein O 0 9.414989676770347e-09
1 O 0 2.8185327849428177e-08
( O 0 5.1283248481137633e-11
FHL O 0 2.7270061764284037e-07
- O 0 3.156035077722663e-08
1 O 0 9.297995262613767e-08
) O 0 2.2215571396366762e-11
and O 0 2.8100688442833643e-11
other O 0 2.989238023776153e-11
FH O 0 4.512523901212262e-07
- O 0 3.956929894854966e-09
related O 0 4.068047232408389e-09
protein O 0 8.815411511875482e-09
( O 0 6.997486617921211e-11
FHR O 0 4.7579237616446335e-06
) O 0 3.608669474353121e-10
bands O 0 1.8775834220718934e-08
. O 0 1.8444101357317777e-08

Southern O 0 7.231403742480325e-07
blot O 0 1.357458131678868e-06
and O 0 4.134565259605871e-11
PCR O 0 7.440181110096589e-11
analysis O 0 2.915066191905291e-12
of O 0 3.5853394905749347e-12
DNA O 0 4.476708934109119e-11
of O 0 1.4370669584873319e-11
one O 0 2.4435158757496467e-12
patient O 0 3.299772607934237e-11
with O 0 1.182161681913263e-12
homozygous O 0 3.665263648144901e-08
deficiency O 1 0.9999988079071045
ruled O 0 0.009987737983465195
out O 0 1.9647830029612123e-09
the O 0 1.0814337619846626e-10
presence O 0 2.236872319316685e-11
of O 0 9.454894506211176e-11
a O 0 1.1016777767824948e-11
large O 0 2.4201585180350094e-11
deletion O 0 1.742485156164264e-09
of O 0 3.738636511485538e-09
the O 0 9.828389213595301e-10
FH O 0 7.038214562271605e-07
gene O 0 1.3332368542506856e-10
as O 0 2.5948557538790773e-12
the O 0 1.2596250431595735e-11
underlying O 0 8.622674130265295e-09
defect O 0 2.6608668690641935e-07
for O 0 1.7440412447555786e-09
the O 0 2.1076850487133925e-07
deficiency O 1 0.9999996423721313
. O 0 3.890371954184957e-05

The O 0 3.57346756629795e-08
other O 0 3.4563778922303e-11
four O 0 7.632933347878623e-12
children O 0 6.497423042303718e-13
presented O 0 8.72247239713797e-12
with O 0 1.141195384718463e-11
heterozygous O 0 7.040301852612174e-07
deficiency O 1 1.0
and O 0 6.513231731730684e-09
exhibited O 0 3.2388667303706598e-09
a O 0 3.8969210081063466e-09
normal O 0 9.09496762346862e-08
immunoblotting O 0 4.1248762272516615e-07
pattern O 0 8.646983573612488e-09
of O 0 5.511218703624365e-10
proteins O 0 1.9337776172023702e-11
of O 0 1.5815465603807866e-10
the O 0 9.179064175413032e-10
FH O 0 3.3907399483723566e-05
family O 0 1.3768688411630592e-09
. O 0 7.101441212853388e-09

Factor B-Disease 1 0.9978936314582825
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
is O 0 5.355265120243757e-10
the O 0 1.5316366230866407e-10
only O 0 2.986572378294028e-10
complement B-Disease 1 0.9999710321426392
deficiency I-Disease 1 1.0
associated O 0 6.9091561272216495e-06
with O 0 2.4716406699099025e-08
HUS B-Disease 1 1.0
. O 0 1.227860320796026e-05

These O 0 7.498742959910487e-09
observations O 0 1.2585367414885695e-08
suggest O 0 2.0561785607497995e-09
a O 0 3.8357489406948275e-10
role O 0 1.3691582589903106e-10
for O 0 6.380720951604246e-11
FH O 0 1.168353992397897e-05
and O 0 1.0719063858743993e-08
/ O 0 2.6679460916056996e-06
or O 0 5.70659572929344e-08
FH O 0 1.6324578609783202e-05
receptors O 0 7.238784238694507e-09
in O 0 8.199105283601682e-11
the O 0 1.2452545938845816e-10
pathogenesis O 0 5.35335047402441e-08
of O 0 2.1153594431666534e-09
idiopathic O 1 0.9522035717964172
HUS B-Disease 1 1.0
. O 0 1.1767967578180105e-07
. O 0 9.433256309421267e-08

Further O 0 1.1472315541993794e-08
evidence O 0 1.2826292250522897e-09
for O 0 3.0161210334833655e-11
a O 0 6.549026598801078e-11
major O 0 1.5908953321375208e-10
ancient O 0 2.1237106517801863e-10
mutation O 0 4.552316212880214e-08
underlying O 0 2.0181783838779666e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 2.490689610112895e-07
linkage O 0 5.756807013312937e-07
disequilibrium O 0 1.515454414402484e-06
studies O 0 1.9692654451564096e-10
in O 0 2.1515064035915188e-12
the O 0 4.484448836578059e-12
Japanese O 0 1.0244356751787365e-10
population O 0 8.0436603558387e-12
. O 0 7.255533951422422e-10

The O 0 6.022589332133066e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 3.735741245236568e-07
DM B-Disease 1 1.0
) O 0 8.210564450550351e-10
mutation O 0 5.985570261657358e-09
is O 0 1.538130040001917e-10
an O 0 2.9411897917164254e-10
unstable O 0 2.9877783163101412e-05
( O 0 1.910639113589241e-08
CTG O 0 1.8163547792937607e-05
) O 0 5.576619166447472e-10
n O 0 1.3861236602963345e-08
repeat O 0 2.3035191532017052e-08
, O 0 3.3979530994487916e-11
present O 0 4.366538033928613e-11
at O 0 1.5733447877863682e-10
a O 0 2.6473873006999105e-12
copy O 0 2.2036508035006008e-11
number O 0 5.493477200912977e-12
of O 0 1.8148982317001128e-11
5 O 0 8.959490926940816e-10
- O 0 1.6023709026313782e-09
37 O 0 2.9932805123422668e-09
repeats O 0 7.332425777661911e-10
on O 0 1.0378379045050679e-08
normal O 0 9.975993364719216e-09
chromosomes O 0 1.2539786986565105e-09
but O 0 1.331333654430722e-10
amplified O 0 6.571277411104859e-10
to O 0 7.399835744159589e-10
50 O 0 3.4184790553837274e-09
- O 0 1.2998986331780316e-09
3000 O 0 1.4204960818720025e-10
copies O 0 1.1102892216729998e-10
on O 0 4.2439378233893876e-08
DM B-Disease 1 0.9999995231628418
chromosomes O 0 2.079899104501237e-06
. O 0 4.763785099726192e-08

Previous O 0 4.5113623059478414e-07
findings O 0 8.112621685540944e-09
in O 0 2.7734145535696086e-10
Caucasian O 0 1.1322195803131763e-07
populations O 0 5.69426006347129e-10
of O 0 2.0087685681513534e-10
a O 0 2.6263599295361928e-08
DM B-Disease 1 1.0
founder O 0 9.681193660071585e-06
chromosome O 0 4.58883550891187e-06
raise O 0 7.044054228799723e-09
a O 0 1.8264700862857808e-10
question O 0 2.949234190197103e-10
about O 0 2.9778892025877912e-12
the O 0 3.846346418451274e-12
molecular O 0 2.892133928178442e-11
events O 0 5.063664331589335e-13
involved O 0 6.275350898643506e-12
in O 0 3.676725590651131e-12
the O 0 1.1843338809658377e-10
expansion O 0 2.267832321933838e-08
mutation O 0 2.6720837809079967e-07
. O 0 1.1006549271996846e-07

To O 0 3.1930365906873703e-08
investigate O 0 1.409787220296721e-08
whether O 0 7.146863101326062e-10
a O 0 7.737674390106974e-10
founder O 0 1.5558165866735862e-09
chromosome O 0 3.330010711621867e-09
for O 0 3.342287904772867e-11
the O 0 9.570128023383973e-10
DM B-Disease 1 1.0
mutation O 0 1.4792496472182393e-07
exists O 0 4.491995664324122e-10
in O 0 3.5021915922861524e-12
the O 0 3.6847569266640345e-12
Japanese O 0 1.243154329477747e-10
population O 0 5.703167105242102e-12
, O 0 5.689032578359843e-12
we O 0 2.072711446921005e-10
genotyped O 0 1.2417034156442242e-07
families O 0 1.897706471132299e-11
using O 0 7.379381133931773e-11
polymorphic O 0 1.568654006689485e-08
markers O 0 2.5797010749784022e-08
near O 0 1.831209601732553e-07
the O 0 5.7013811449735385e-09
( O 0 2.6266591124368688e-09
CTG O 0 3.616222329583252e-06
) O 0 6.194468271658593e-10
n O 0 3.182881869179255e-08
repeat O 0 1.8647813959660198e-08
region O 0 1.5078866155704418e-08
and O 0 1.8812737478945962e-10
constructed O 0 2.5271718939734455e-08
haplotypes O 0 9.62764033829444e-07
. O 0 1.3197093551298167e-07

Six O 0 1.4123360259077344e-08
different O 0 2.970589746409402e-11
haplotypes O 0 6.7496443989512045e-09
were O 0 5.885176235231881e-10
found O 0 9.386452726189987e-11
and O 0 1.441053248951718e-10
DM B-Disease 1 1.0
alleles O 0 2.0653654786428888e-08
were O 0 1.0516203463595275e-09
always O 0 4.381515983364892e-10
haplotype O 0 5.465014396577317e-07
A O 0 2.0857967228948837e-06
. O 0 1.403739844363372e-07

To O 0 1.1378261888239649e-08
find O 0 7.796443490803995e-10
an O 0 4.660937434619594e-12
origin O 0 2.0347667994968788e-10
of O 0 5.915607448336857e-10
the O 0 1.2970950979962481e-09
( O 0 1.7207562041932079e-09
CTG O 0 5.103283001517411e-06
) O 0 5.551880621901262e-10
n O 0 6.300498789357789e-09
repeat O 0 5.758880483597295e-09
mutation O 0 4.969654687769776e-10
and O 0 3.173794126815066e-12
to O 0 1.9079630236840117e-11
investigate O 0 3.979647861251934e-11
the O 0 1.1125570083259095e-11
mechanism O 0 1.2301695773153654e-10
of O 0 1.0833785257791106e-10
the O 0 2.45096703349601e-11
expansion O 0 6.822732379063723e-10
mutation O 0 4.1058045852082614e-10
in O 0 1.697162028968524e-11
the O 0 1.2615726172060526e-11
Japanese O 0 6.84663714611844e-11
population O 0 3.9136376431270214e-12
we O 0 1.2874294512410511e-11
have O 0 2.672847403475953e-12
studied O 0 3.5158889688524653e-10
90 O 0 1.4056356079095167e-09
Japanese O 0 3.6241223355659713e-09
DM B-Disease 1 1.0
families O 0 1.066598614984926e-10
comprising O 0 7.320219083672974e-12
190 O 0 2.7404761793192733e-10
affected O 0 1.4838903716896112e-10
and O 0 1.4511918576542993e-11
130 O 0 2.018259337432937e-09
unaffected O 0 5.81335726224097e-08
members O 0 5.061875918421777e-10
. O 0 1.0058744059904257e-08

The O 0 4.9601329266124594e-08
results O 0 3.3517781883318776e-09
suggest O 0 3.4933504977630037e-09
that O 0 2.9796633910228465e-11
a O 0 1.9950073537611246e-10
few O 0 3.738104964456923e-11
common O 0 9.468519718280888e-11
ancestral O 0 2.1223673929426923e-09
mutations O 0 1.8856431971414622e-09
in O 0 6.195209623083286e-11
both O 0 8.957402181097862e-11
Caucasian O 0 1.8115640898486163e-07
and O 0 2.1894869250971283e-10
Japanese O 0 1.982142894263461e-09
populations O 0 9.7651843208868e-12
have O 0 1.6540713026688691e-13
originated O 0 5.061076341003612e-13
by O 0 4.2852966184239727e-13
expansion O 0 9.255575195155075e-10
of O 0 3.379430901784275e-10
an O 0 7.55103618521602e-11
ancestral O 0 9.600990003022503e-10
n O 0 4.035758394138611e-09
= O 0 5.605618191850681e-09
5 O 0 5.808610925583935e-09
repeat O 0 4.485533722231594e-09
to O 0 2.8518531980381567e-09
n O 0 8.747509383510987e-09
= O 0 8.028238518420494e-09
19 O 0 1.3576241464363648e-08
- O 0 5.113931944578098e-09
37 O 0 1.9077759372265746e-09
copies O 0 9.761134123209558e-10
. O 0 5.7520850305081694e-09

These O 0 1.057064102916172e-09
data O 0 6.828978355022386e-11
support O 0 2.632373832800461e-11
multistep O 0 3.1303759584488944e-08
models O 0 2.056123715732383e-09
of O 0 9.662021405176802e-09
triplet O 0 1.3930844033893663e-06
repeat O 0 7.76047315298456e-08
expansion O 0 9.762554320502659e-09
that O 0 9.640836740043568e-12
have O 0 1.0417546816507417e-12
been O 0 4.995248464000068e-13
proposed O 0 8.884961343047504e-12
for O 0 4.982176997347931e-12
both O 0 1.7285943509914858e-10
DM B-Disease 1 1.0
and O 0 1.0999224997476631e-07
Friedreichs B-Disease 1 0.754645586013794
ataxia I-Disease 1 0.963636040687561
. O 0 4.499992769524397e-07
. O 0 4.155788815296546e-07

The O 0 5.963781468665275e-09
molecular O 0 4.469623338110296e-09
basis O 0 1.886867373457335e-08
of O 0 3.371702348431427e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.8277945318677666e-08
the O 0 6.936893282016854e-10
western O 0 1.184302877987875e-09
Cape O 0 1.9005057083631982e-08
, O 0 4.069548517615651e-11
South O 0 7.07927216847537e-10
Africa O 0 8.765593251247594e-10
. O 0 1.2777261471086376e-09

Deficiency B-Disease 1 0.9987013339996338
of I-Disease 0 1.784239793778397e-05
the I-Disease 0 3.5852855262419325e-07
sixth I-Disease 0 6.136265255918261e-07
component I-Disease 0 6.380596317967502e-08
of I-Disease 0 1.2697775275682943e-08
human I-Disease 0 3.7869926639011453e-10
complement I-Disease 0 2.6196630975583446e-10
( O 0 9.410833223810755e-11
C6 O 0 6.118978035374312e-06
) O 0 5.520821994009495e-11
has O 0 2.057847815761793e-11
been O 0 1.089451532459984e-11
reported O 0 8.144920501940156e-12
in O 0 3.8345582677005996e-13
a O 0 1.076448392228757e-12
number O 0 9.50391891921254e-13
of O 0 2.784293412147476e-12
families O 0 3.3557626621071035e-13
from O 0 1.5391682720022892e-11
the O 0 4.2508007530583924e-11
western O 0 1.0791431082068925e-09
Cape O 0 2.294468615104961e-08
, O 0 1.0419545087847482e-10
South O 0 1.1508822783667938e-09
Africa O 0 2.177784397261462e-09
. O 0 4.057430835757714e-09

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 2.3315791963796073e-08
endemic O 0 1.4314139873405907e-09
in O 0 5.320909685080366e-11
the O 0 3.8434316840252336e-10
Cape O 0 6.85924472776378e-09
and O 0 2.347600412677675e-11
almost O 0 4.564655597949496e-11
all O 0 1.875682551985558e-12
pedigrees O 0 1.911854702330018e-10
of O 0 5.421647575332145e-10
total O 0 5.809022809444286e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 5.533871316742989e-08
C6Q0 O 0 0.05560966581106186
) O 0 1.3726641351352598e-11
have O 0 1.2942857506234584e-12
been O 0 1.788495458503181e-12
ascertained O 0 1.0527603233612126e-09
because O 0 1.1979487714308679e-11
of O 0 1.3995647696329883e-10
recurrent O 0 0.00029822648502886295
disease O 1 0.9912559986114502
. O 0 4.161877029673633e-07

We O 0 1.4274469606334605e-07
have O 0 2.049020814132163e-10
sequenced O 0 5.450544460217088e-10
the O 0 6.041307037962795e-11
expressed O 0 4.039065262806396e-11
exons O 0 1.1267213828602962e-08
of O 0 2.5278648063675746e-09
the O 0 7.026539350363237e-10
C6 O 0 2.963040799386363e-07
gene O 0 9.844463438879458e-11
from O 0 2.2388826903529946e-11
selected O 0 1.3967045835866498e-12
cases O 0 2.9628077335280834e-12
and O 0 1.3039444740972628e-12
have O 0 5.6741755391498394e-12
found O 0 2.3333909457412538e-11
three O 0 1.1378525725802557e-11
molecular O 0 6.462276758156804e-08
defects O 0 0.0009209740674123168
leading O 0 9.486208263354001e-09
to O 0 4.985150514613679e-09
total O 0 8.859223044055398e-08
deficiency O 1 0.570574164390564
879delG O 0 4.112121132493485e-06
, O 0 6.052909562459519e-11
which O 0 1.1114074938145535e-11
is O 0 1.2195461654429529e-11
the O 0 6.37699754113541e-11
common O 0 2.841699542344145e-09
defect O 0 1.4334768820845056e-06
in O 0 4.119660168555583e-09
the O 0 1.1429791335615391e-08
Cape O 0 1.3417171373930614e-07
and O 0 2.035470458849886e-09
hitherto O 0 1.5067487879605324e-07
unreported O 0 1.2406783866936166e-07
, O 0 2.1193555591048074e-11
and O 0 1.319738329036424e-11
1195delC O 0 6.689943266025011e-09
and O 0 1.771207763789917e-10
1936delG O 0 5.669859604040539e-08
, O 0 2.437828411361309e-11
which O 0 5.567718595195226e-12
have O 0 5.629803914719567e-12
been O 0 1.594333172427742e-11
previously O 0 1.724056140905983e-11
reported O 0 1.1573794006514149e-11
in O 0 1.1800897065095128e-11
African O 0 8.16237855083557e-10
- O 0 5.153431903437422e-09
Americans O 0 1.0541064687785706e-09
. O 0 2.773316865045672e-08

We O 0 1.2555166222227854e-06
also O 0 2.8490682035808845e-10
show O 0 2.533345408450849e-11
that O 0 8.133739450195965e-13
the O 0 8.748564372940137e-12
879delG O 0 3.181472196800428e-09
and O 0 5.947009551476867e-11
1195delC O 0 4.412140242493479e-06
defects O 1 0.9999960660934448
are O 0 2.836488544044613e-10
associated O 0 9.909882692227256e-09
with O 0 2.8232108317816085e-10
characteristic O 0 5.925578534515807e-06
C6 O 1 0.9999998807907104
/ O 1 0.9998816251754761
C7 O 0 0.008162345737218857
region O 0 7.360975473602593e-07
DNA O 0 1.2037321539537515e-07
marker O 0 3.2044393805108484e-08
haplotypes O 0 8.666367179444023e-09
, O 0 8.37179284229883e-12
although O 0 7.185427600142624e-12
small O 0 2.2548808306654955e-11
variations O 0 1.1025764745653532e-09
were O 0 1.9163828302026786e-09
observed O 0 1.8386915101586965e-08
. O 0 2.8904398874374237e-08

The O 0 4.7065970676385405e-08
1936delG O 0 6.020110276949708e-07
defect O 0 4.931887815473601e-06
was O 0 6.409528907624917e-08
observed O 0 3.4157416894942116e-09
only O 0 1.044202641020675e-10
once O 0 2.386472686133345e-10
in O 0 1.6280624418052447e-11
the O 0 1.1968144530971614e-10
Cape O 0 1.713751096588112e-08
, O 0 1.9875432896721e-11
but O 0 9.407166885744278e-12
its O 0 2.164320112019169e-11
associated O 0 6.457009371629852e-10
haplotype O 0 1.378709697519298e-07
could O 0 2.1464609645249766e-08
be O 0 1.2752240152735794e-08
deduced O 0 3.605801168760081e-07
. O 0 2.9307209103990317e-08

The O 0 4.495179695140905e-08
data O 0 1.452311937377715e-09
from O 0 2.374019592021881e-10
the O 0 4.543983800342488e-10
haplotypes O 0 7.040414473635792e-09
indicate O 0 1.0468874656055505e-09
that O 0 8.448613336708988e-12
these O 0 3.3616197932934133e-12
three O 0 1.6816725095791796e-11
molecular O 0 9.581475168829456e-09
defects O 0 1.4818816396200418e-07
account O 0 1.0396928110112391e-11
for O 0 3.53847819101194e-11
the O 0 1.1419135859114249e-08
defects O 1 0.9993258714675903
in O 0 3.042360807725686e-09
all O 0 2.2189537707273388e-10
the O 0 2.0527408939319258e-10
38 O 0 1.2910971181057107e-09
unrelated O 0 3.3310379454754013e-10
C6Q0 O 0 9.610994311515242e-06
individuals O 0 8.296169307087098e-10
we O 0 5.800905089614616e-09
have O 0 1.219637585370137e-10
studied O 0 1.887139777778657e-09
from O 0 5.140020076233043e-10
the O 0 7.941545754341917e-10
Cape O 0 5.4221189316194796e-08
. O 0 7.44485895154412e-09

We O 0 2.4057689529399795e-07
have O 0 2.51403481366097e-10
also O 0 1.1973846393564802e-11
observed O 0 1.0534246391857849e-10
the O 0 1.5902786032473415e-11
879delG O 0 1.0789707793890102e-08
defect O 0 7.350874398071028e-08
in O 0 6.91129931063017e-10
two O 0 9.385275889783884e-10
Dutch O 0 0.002689819084480405
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 6.957728328416124e-05
, O 0 5.327835742030551e-11
but O 0 1.0542442786809492e-11
the O 0 2.6669720251670803e-11
879delG O 0 8.745807633658842e-09
defect O 0 1.812709911064303e-07
in O 0 3.245884394598164e-10
the O 0 7.901793108722188e-10
Cape O 0 1.1006124900347913e-08
probably O 0 1.945451577611834e-09
did O 0 1.7692020071180536e-10
not O 0 7.138657720506814e-11
come O 0 4.4708806101745324e-11
from O 0 4.525419969314548e-11
The O 0 1.0432191915876743e-10
Netherlands O 0 1.2591025999597605e-09
. O 0 7.329014062307238e-10
. O 0 2.6681870934908147e-08

Complement B-Disease 1 0.9993084669113159
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 4.6592223412744715e-08
seven O 0 5.1673394452222965e-09
further O 0 9.681244250714371e-09
molecular O 0 4.438343694346258e-06
defects O 0 0.0019539822824299335
and O 0 2.897624085118622e-10
their O 0 9.365851150189286e-11
associated O 0 3.1956668422594703e-09
marker O 0 3.545564482010377e-07
haplotypes O 0 2.330331653865869e-06
. O 0 1.678420176176587e-07

Seven O 0 4.10612237544683e-08
further O 0 2.7041826555773696e-09
molecular O 0 2.8828308629158528e-08
bases O 0 1.5726143942629278e-08
of O 0 3.666309794425615e-06
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.411201537848683e-07
described O 0 1.461332885810407e-07
. O 0 5.134166158882181e-08

All O 0 1.2403916116454639e-08
these O 0 8.231006848324895e-11
new O 0 2.080569883045058e-10
molecular O 0 9.471115447468037e-08
defects O 0 1.3573853152593074e-07
involve O 0 5.197594021844054e-10
single O 0 2.5284468962993856e-10
- O 0 1.7004915253693298e-09
nucleotide O 0 6.608182889777936e-09
events O 0 1.6253266788002207e-10
, O 0 2.0518317947471054e-11
deletions O 0 4.705694722773046e-10
and O 0 2.1898963198374588e-10
substitutions O 0 1.0457379406858536e-09
, O 0 2.8872286506054223e-11
some O 0 2.0098816274488618e-12
of O 0 4.483604806870822e-11
which O 0 5.5066949264381826e-12
alter O 0 7.458944573102144e-09
splice O 0 1.5422502386286396e-08
sites O 0 2.515590402651924e-09
, O 0 2.8940157562051816e-11
and O 0 9.552762053610664e-11
others O 0 1.3194678682992844e-09
codons O 0 4.805119715456385e-07
. O 0 1.0497035418666201e-07

They O 0 7.512601207793068e-09
are O 0 1.1026846970241255e-11
distributed O 0 1.2561509991904085e-11
along O 0 1.6992131313120495e-10
the O 0 7.291812154086585e-10
C7 O 0 8.682221960043535e-06
gene O 0 1.130587179432041e-09
, O 0 9.708374729133773e-12
but O 0 4.103264169413867e-12
predominantly O 0 4.3833504534407375e-12
towards O 0 1.1333371741084619e-10
the O 0 7.758049064277017e-11
3 O 0 4.9814079972065883e-08
end O 0 7.643465664841642e-07
. O 0 1.283550545849721e-07

All O 0 3.4000329662831064e-08
were O 0 5.490444765499092e-10
found O 0 3.696288761179112e-11
in O 0 9.845960852183921e-12
compound O 0 8.776183113567981e-10
heterozygous O 0 5.092846144805208e-10
individuals O 0 5.212864029324749e-10
. O 0 2.7622256482118246e-08

The O 0 3.6078465200262144e-05
C6 O 1 0.8156736493110657
/ O 0 0.01817597821354866
C7 O 0 0.0003623885859269649
marker O 0 2.6894122129306197e-07
haplotypes O 0 9.050166482893474e-08
associated O 0 3.242760948651835e-09
with O 0 1.5380186013658204e-10
most O 0 1.5177317180814498e-08
C7 B-Disease 1 1.0
defects I-Disease 1 1.0
are O 0 2.148402522550441e-08
tabulated O 0 1.3038579993462918e-07
. O 0 5.149246362634585e-09
. O 0 3.49645894459627e-08

A O 0 2.0724071418953827e-06
genome O 0 3.183239982718078e-08
- O 0 5.138160119599888e-09
wide O 0 9.557686864170023e-10
search O 0 2.8170948906947046e-10
for O 0 7.414563754637449e-12
chromosomal O 0 1.5617435167314397e-07
loci O 0 3.430159551953693e-07
linked O 0 1.1988200867563137e-06
to O 0 7.295673043472561e-08
mental O 1 1.0
health O 0 0.0012458544224500656
wellness O 0 0.0028570026624947786
in O 0 5.28325472259894e-09
relatives O 0 5.066051134150484e-09
at O 0 9.620311214320054e-10
high O 0 1.6782040201945847e-09
risk O 0 1.577035924071879e-08
for O 0 3.258695757679675e-09
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 2.3710160501622113e-09
the O 0 2.85995871429634e-09
Old O 0 1.013479344891266e-08
Order O 0 2.3054871345351557e-09
Amish O 0 4.22455457282922e-08
. O 0 9.227517416832143e-09

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 8.783644034338067e-08
BPAD B-Disease 1 1.0
; O 0 0.0016216965159401298
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 3.5879583748510413e-09
is O 0 2.614277405665888e-10
characterized O 0 1.4244791457507233e-10
by O 0 3.1721014703833816e-11
episodes O 0 5.5841047341687045e-09
of O 0 1.3289755074197274e-08
mania B-Disease 0 5.318767080098041e-07
and O 0 1.1410643985243496e-08
/ O 0 1.0807051694428083e-05
or O 0 5.547894375013129e-07
hypomania B-Disease 0 0.0006184192025102675
interspersed O 0 1.5232760608441254e-09
with O 0 2.5821176793949796e-12
periods O 0 1.3969792433954353e-08
of O 0 1.2770666302230893e-08
depression B-Disease 0 9.204522211803123e-05
. O 0 1.0074184331188007e-07

Compelling O 0 2.2250085862651758e-07
evidence O 0 4.704180600612062e-09
supports O 0 8.041597387986599e-10
a O 0 6.349256675974857e-10
significant O 0 1.6518424406086751e-09
genetic O 0 7.323385897706203e-09
component O 0 3.811531090747167e-09
in O 0 4.388848659497846e-11
the O 0 5.879409736841978e-10
susceptibility O 0 1.994804534888317e-07
to O 0 3.461139286287107e-08
develop O 0 3.9181173633551225e-05
BPAD B-Disease 1 1.0
. O 0 0.00028807835769839585

To O 0 4.1805488848467576e-08
date O 0 1.3872048612029175e-06
, O 0 8.603908141502359e-10
however O 0 1.350840550529142e-09
, O 0 5.838108330102898e-10
linkage O 0 1.3721721359161165e-07
studies O 0 2.2850994430001492e-09
have O 0 2.7740997433217673e-12
attempted O 0 1.0373742975744449e-09
only O 0 9.473916443014652e-12
to O 0 1.8891331207693263e-11
identify O 0 8.93024404424736e-11
chromosomal O 0 5.439541155283223e-07
loci O 0 1.6358535503968596e-07
that O 0 1.2014367278823102e-10
cause O 0 2.4087320582566463e-08
or O 0 2.2638628471849387e-10
increase O 0 5.451158413549706e-10
the O 0 1.9940715745292437e-10
risk O 0 3.2406588523770097e-09
of O 0 2.8033477761368886e-09
developing O 0 1.2876961363872397e-06
BPAD B-Disease 1 1.0
. O 0 6.8415824898693245e-06

To O 0 7.902252008307187e-08
determine O 0 6.88493813072455e-08
whether O 0 2.721641578773415e-09
there O 0 8.4344808914949e-11
could O 0 2.4760310468607827e-10
be O 0 4.216401880419163e-11
protective O 0 1.1239643243898811e-10
alleles O 0 3.9973958171346524e-11
that O 0 1.0437117749922953e-12
prevent O 0 4.78579884055641e-11
or O 0 3.715330820774909e-11
reduce O 0 2.012827238218051e-09
the O 0 2.8143934405200355e-10
risk O 0 1.3549958488567881e-08
of O 0 3.769943024423128e-09
developing O 0 5.369367045204854e-06
BPAD B-Disease 1 1.0
, O 0 1.7931904572332513e-10
similar O 0 3.744797007210199e-12
to O 0 2.388169870193302e-11
what O 0 6.987023264647119e-13
is O 0 2.457311697873221e-13
observed O 0 2.732769089144882e-12
in O 0 8.24517158107968e-13
other O 0 7.976973942502852e-11
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 2.087311157250582e-10
we O 0 4.357353020068011e-11
used O 0 2.0950810530884212e-10
mental O 0 4.484519195102621e-06
health O 0 2.2525961096420133e-09
wellness O 0 1.2064646170983906e-08
( O 0 1.7479382741561467e-12
absence O 0 1.5233515560097999e-09
of O 0 3.766103540137067e-10
any O 0 4.996061520046169e-08
psychiatric B-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9980278611183167
) O 0 1.1276226480338991e-11
as O 0 2.522814596117584e-11
the O 0 1.1364543334169142e-10
phenotype O 0 4.695288158274025e-09
in O 0 1.642974367666028e-10
our O 0 5.358187227244571e-10
genome O 0 1.1844519809400822e-09
- O 0 1.2261955006920289e-08
wide O 0 4.4215738626007806e-08
linkage O 0 5.166140226720017e-07
scan O 0 2.4955188564490527e-06
of O 0 3.280086247059444e-08
several O 0 4.519192312035791e-11
large O 0 1.6414959669308615e-10
multigeneration O 0 4.793928383151069e-07
Old O 0 1.8611606478202702e-08
Order O 0 1.5818552023816324e-09
Amish O 0 1.1274437383690383e-08
pedigrees O 0 2.1481021406088985e-09
exhibiting O 0 1.4862754083022622e-10
an O 0 1.2178423200448485e-11
extremely O 0 1.6838664906870804e-09
high O 0 7.52674580439816e-08
incidence O 0 0.0009799014078453183
of O 0 1.1511556294863112e-05
BPAD B-Disease 1 1.0
. O 0 0.00019389341468922794

We O 0 6.705517989757936e-07
have O 0 2.1123025550906505e-10
found O 0 1.8521770922541592e-11
strong O 0 1.7275510449249465e-12
evidence O 0 1.1417419093495695e-11
for O 0 2.7704776407039278e-12
a O 0 5.106042325064841e-11
locus O 0 1.8191350648066873e-09
on O 0 3.1813871537167415e-09
chromosome O 0 2.7026328552892664e-07
4p O 0 0.00026434543542563915
at O 0 7.722318429159714e-08
D4S2949 O 0 2.8651314210037526e-07
( O 0 5.955989174077914e-11
maximum O 0 1.1046720516105779e-07
GENEHUNTER O 0 8.20733475848101e-06
- O 0 4.1127769634385913e-08
PLUS O 0 2.038027524520203e-08
nonparametric O 0 5.113408363399685e-08
linkage O 0 1.8629933151714795e-08
score O 0 1.880359867811876e-09
= O 0 4.699057809531837e-10
4 O 0 1.4003398440820547e-09
. O 0 2.447813306216684e-11
05 O 0 1.2298517759745664e-08
, O 0 2.2447461944796743e-10
P O 0 7.112830076039245e-07
= O 0 3.2537954552935844e-09
5 O 0 1.1706705604908052e-09
. O 0 8.34311526115572e-12
22 O 0 6.832313881321994e-11
x O 0 1.4507173240474458e-09
10 O 0 1.649301806239123e-09
( O 0 5.981159317824947e-11
- O 0 2.2223190399017767e-08
4 O 0 3.1795448052207576e-08
) O 0 5.254748372540696e-11
; O 0 1.9577379994917266e-10
SIBPAL O 0 5.592171874013729e-06
Pempirical O 0 1.3081898941891268e-07
value O 0 7.541280933054395e-10
< O 0 9.675152234933648e-09
3 O 0 2.6159882593468353e-10
x O 0 6.344160752291828e-10
10 O 0 3.070674825522701e-10
( O 0 1.2606104528301021e-11
- O 0 2.5672663994669165e-09
5 O 0 5.38378053249744e-09
) O 0 5.105389722093179e-11
) O 0 2.5996026511987402e-11
and O 0 9.77650183031642e-11
suggestive O 0 1.252850156951979e-09
evidence O 0 1.3126220943515676e-10
for O 0 1.1087946533150372e-11
a O 0 1.9266953310559387e-10
locus O 0 1.2846228081286881e-08
on O 0 1.651093661791947e-08
chromosome O 0 1.0469144399394281e-05
4q O 0 1.0076592843688559e-05
at O 0 1.9023699948661488e-08
D4S397 O 0 2.006391355280357e-07
( O 0 7.942420332529565e-11
maximum O 0 1.0965040075916477e-07
GENEHUNTER O 0 9.695809239929076e-06
- O 0 2.8074266467115194e-08
PLUS O 0 7.620667652474822e-09
nonparametric O 0 1.8837855719766594e-08
linkage O 0 4.327194158548764e-09
score O 0 4.510566087301271e-10
= O 0 2.898453144162261e-10
3 O 0 4.219139204675315e-10
. O 0 1.9913681814642814e-11
29 O 0 3.6586056406662237e-09
, O 0 8.579879862136153e-11
P O 0 5.554755944103817e-07
= O 0 2.3668185189507085e-09
2 O 0 1.9370207660074357e-09
. O 0 1.6095123497872343e-11
57 O 0 1.9839307974223175e-10
x O 0 1.3496430639747814e-09
10 O 0 1.9142092355650675e-09
( O 0 1.994242687652914e-10
- O 0 4.594150126990826e-08
3 O 0 5.7916871298857586e-08
) O 0 8.672742385362753e-11
; O 0 2.8619434599974625e-10
SIBPAL O 0 1.1055156392103527e-05
Pempirical O 0 3.0630212677351665e-07
value O 0 1.6629890797759117e-09
< O 0 1.6469982710987097e-08
1 O 0 1.8029278070486043e-09
x O 0 3.4680034399769966e-09
10 O 0 9.798647448988618e-10
( O 0 3.2307934105801905e-11
- O 0 2.6380360118594126e-09
3 O 0 1.6134730218553273e-09
) O 0 1.4082874406559642e-12
) O 0 4.0681165575963407e-13
that O 0 3.684529894729116e-13
are O 0 5.583251959720426e-13
linked O 0 1.6787514711680274e-09
to O 0 8.879807111839e-09
mental O 0 0.040519267320632935
health O 0 1.1733200153685175e-06
wellness O 0 3.702486765178037e-06
. O 0 7.075026786651506e-08

These O 0 3.0638140913197276e-09
findings O 0 2.440184942997803e-09
are O 0 7.466932454291975e-12
consistent O 0 6.70619948461848e-11
with O 0 2.7156621677966453e-13
the O 0 8.441284130022986e-12
hypothesis O 0 5.697972996210332e-11
that O 0 2.4477970106580316e-13
certain O 0 1.7840603994123683e-11
alleles O 0 4.020037636109919e-10
could O 0 1.0794601879027255e-09
prevent O 0 1.822701989340203e-09
or O 0 4.2527170673878345e-10
modify O 0 3.806590598287585e-09
the O 0 1.836628904516857e-10
clinical O 0 3.044990704026418e-09
manifestations O 0 4.833278666183105e-08
of O 0 1.806367500023498e-08
BPAD B-Disease 1 1.0
and O 0 2.2933636933952783e-10
perhaps O 0 1.3438652968211784e-10
other O 0 1.2032546833906643e-11
related O 0 1.9285985786154924e-07
affective B-Disease 1 0.9999927282333374
disorders I-Disease 1 1.0
. O 0 4.107128006580751e-06

Segregation O 0 6.1012982769170776e-05
distortion O 0 0.0009647231781855226
in O 0 4.3151794670848176e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0004425205697771162

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.071512199108838e-06
DM B-Disease 1 1.0
) O 0 6.305256317062913e-10
is O 0 5.027599517259951e-11
an O 0 4.6570653583488664e-11
autosomal B-Disease 1 0.999990701675415
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
which O 0 1.1038622238501716e-09
, O 0 1.9470421802614268e-11
in O 0 1.5569193503872647e-11
the O 0 3.867623582509694e-11
typical O 0 2.2878500482992337e-10
pedigree O 0 1.207370980971234e-09
, O 0 5.516619279444246e-12
shows O 0 6.305827388031204e-12
a O 0 6.358221588120827e-11
three O 0 3.7756024001689426e-11
generation O 0 2.8550641850699776e-09
anticipation O 0 1.0280971629583746e-08
cascade O 0 2.4132488761097193e-05
. O 0 1.3976795116832363e-06

This O 0 1.1496272822597575e-09
results O 0 3.1278137857526644e-09
in O 0 1.92815186039752e-09
infertility B-Disease 1 0.9999954700469971
and O 0 2.1985802050039638e-06
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.3268268617139256e-07
CDM B-Disease 0 1.0109048162121326e-05
) O 0 2.282861183075524e-12
with O 0 4.1370775078278244e-13
the O 0 4.0706843451587815e-10
disappearance O 0 3.32101777189564e-08
of O 0 2.8967702903059944e-08
DM B-Disease 1 1.0
in O 0 1.6268511870976e-08
that O 0 4.137235887213819e-09
pedigree O 0 1.0818561690939532e-07
. O 0 2.5650212620575985e-08

The O 0 4.365393380112437e-09
concept O 0 2.7450706152620796e-09
of O 0 1.04797264199874e-08
segregation O 0 2.0709556736164814e-07
distortion O 0 1.1466372598079033e-05
, O 0 5.941466069137036e-11
where O 0 2.0735330119592277e-11
there O 0 2.5299350288332523e-12
is O 0 1.2197200714714196e-12
preferential O 0 5.648266299118632e-10
transmission O 0 1.1231311436432634e-09
of O 0 1.4578897811201585e-10
the O 0 8.781900553977984e-12
larger O 0 1.2309904831586671e-11
allele O 0 4.6427534039494844e-10
at O 0 3.000595605318068e-10
the O 0 6.06640918054957e-11
DM B-Disease 1 1.0
locus O 0 6.495394444527847e-08
, O 0 1.4921544902457562e-11
has O 0 2.0220862744640966e-12
been O 0 7.467345318479257e-12
put O 0 4.0788893096443957e-11
forward O 0 3.5709973866815403e-10
to O 0 1.1776572772514982e-10
explain O 0 6.198628832443376e-10
partially O 0 2.6253217377814053e-09
the O 0 7.796008283378342e-11
maintenance O 0 8.139870111278924e-09
of O 0 1.069798472030925e-08
DM B-Disease 1 1.0
in O 0 1.0928351557026872e-08
the O 0 3.3472675742274305e-09
population O 0 1.9780328763818744e-10
. O 0 2.0364294694985574e-09

In O 0 2.591418457598138e-08
a O 0 2.4232000850332724e-09
survey O 0 8.740483892211159e-10
of O 0 8.326260569901933e-09
DM B-Disease 1 1.0
in O 0 2.6266501862437508e-08
Northern O 0 2.72548248858584e-07
Ireland O 0 1.1561544610572128e-08
, O 0 4.446111256939389e-10
59 O 0 1.679764416451235e-08
pedigrees O 0 2.1866417565519214e-09
were O 0 2.668888221535326e-09
ascertained O 0 1.1214319783903193e-06
. O 0 3.01623472864776e-08

Sibships O 0 3.8350117392838e-05
where O 0 1.3969517764778061e-09
the O 0 1.8731102779945275e-10
status O 0 9.16699216535477e-10
of O 0 5.174783379580106e-10
all O 0 1.9780205251507255e-11
the O 0 3.16697466862248e-11
members O 0 1.7447573334022914e-12
had O 0 4.61044466493199e-11
been O 0 2.2996615028914036e-11
identified O 0 3.733331005451035e-11
were O 0 1.1117424689177646e-11
examined O 0 8.220996799979119e-11
to O 0 1.226738675919048e-11
determine O 0 7.231145543462603e-11
the O 0 2.675797083906417e-11
transmission O 0 8.70378435990915e-10
of O 0 1.357519874289892e-09
the O 0 1.6372566635780572e-09
DM B-Disease 1 1.0
expansion O 0 5.736989123761305e-07
from O 0 2.0976180792331434e-08
affected O 0 3.5539525100602987e-08
parents O 0 1.7639860405704866e-10
to O 0 2.997159409545702e-09
their O 0 9.272785872482814e-10
offspring O 0 5.690028892502141e-09
. O 0 1.1200661731436412e-08

Where O 0 2.941024490610289e-08
the O 0 1.938506688503594e-09
transmitting O 0 9.570593562102658e-08
parent O 0 1.9687417918134997e-08
was O 0 1.501401385439749e-07
male O 0 6.897369342340198e-09
, O 0 3.312120300247301e-10
58 O 0 1.6314943707129714e-07
. O 0 5.436367800371045e-08

3 O 0 1.0673384167603217e-06
% O 0 3.2130195393165195e-08
of O 0 1.5688117471768237e-09
the O 0 1.0995565569160703e-09
offspring O 0 3.6702780814579228e-09
were O 0 5.359598320708869e-10
affected O 0 3.459712072384491e-09
, O 0 4.409809670202769e-11
and O 0 1.008679771652421e-11
in O 0 1.3513494143135851e-11
the O 0 2.7246978978601177e-11
case O 0 2.2121122988938424e-10
of O 0 4.7866932639806237e-11
a O 0 4.5748623639374486e-11
female O 0 1.9055699726489017e-11
transmitting O 0 2.292324108310595e-09
parent O 0 1.0550142093279646e-08
, O 0 4.1375196602189135e-09
68 O 0 1.1397721664252458e-06
. O 0 1.5359276517301623e-07

7 O 0 1.0087534974445589e-05
% O 0 3.932164531761373e-07
were O 0 9.477057361095831e-09
affected O 0 4.800067188170942e-08
. O 0 1.6888502329948096e-07

Studies O 0 3.4415953109601105e-07
on O 0 8.562269471212858e-08
meiotic O 0 3.6784872463613283e-06
drive O 0 3.181559407039458e-07
in O 0 9.251203358928706e-09
DM B-Disease 1 1.0
have O 0 3.648144286660937e-10
shown O 0 8.275820133352152e-12
increased O 0 2.513467906029021e-11
transmission O 0 2.0096767305854968e-10
of O 0 1.0722850558864128e-11
the O 0 2.8823850858200606e-12
larger O 0 4.16310649148377e-12
allele O 0 1.4343073950762175e-10
at O 0 1.7478032909856722e-10
the O 0 5.7438456768643675e-11
DM B-Disease 1 0.9998906850814819
locus O 0 6.594081281008357e-09
in O 0 1.993565867941527e-10
non O 0 2.970781309841186e-08
- O 0 1.4474227327809785e-07
DM O 1 1.0
heterozygotes O 0 2.3466532184102107e-07
for O 0 3.730210362817843e-09
CTGn O 0 7.180459306255216e-06
. O 0 3.3054465831128255e-08

This O 0 8.388844285889263e-09
study O 0 3.7136888009214886e-10
provides O 0 7.166385540546827e-13
further O 0 3.664894776544969e-11
evidence O 0 5.921237805628365e-11
that O 0 6.0067875153058115e-12
the O 0 3.3443431357582654e-10
DM B-Disease 1 1.0
expansion O 0 3.04062837130914e-07
tends O 0 1.924574277722968e-08
to O 0 7.956342806814121e-10
be O 0 6.672086771963848e-10
transmitted O 0 1.7581289757373497e-09
preferentially O 0 2.7013593140168268e-08
. O 0 8.178902000111066e-09

Diagnosis O 1 0.9999902248382568
of O 0 0.003149573225528002
hemochromatosis B-Disease 1 1.0
. O 0 0.057525165379047394

If O 0 0.0007303720922209322
untreated O 1 0.9999991655349731
, O 0 3.1926450372310455e-09
hemochromatosis B-Disease 1 1.0
can O 0 1.1209749573026784e-07
cause O 1 0.9999951124191284
serious O 1 1.0
illness O 1 0.9999978542327881
and O 0 1.2324265219465502e-10
early B-Disease 0 3.794653480326815e-08
death I-Disease 0 2.411067079322038e-08
, O 0 5.0169451926151964e-12
but O 0 1.0476453905783334e-11
the O 0 1.4332791897775365e-10
disease O 0 2.2422236511943083e-08
is O 0 2.674316063738802e-12
still O 0 1.6628976841348564e-12
substantially O 0 3.7095401750342205e-10
under O 0 2.4040357402554946e-06
- O 1 0.76677006483078
diagnosed O 1 0.9922817349433899
. O 0 5.149151434125088e-07

The O 0 1.2594965426160343e-07
cornerstone O 0 1.429542408004636e-06
of O 0 1.6140093705985237e-08
screening O 0 2.4328701275777576e-09
and O 0 1.1546584868793452e-11
case O 0 2.4361843098397173e-10
detection O 0 8.52548431851119e-09
is O 0 1.7151219680600072e-11
the O 0 3.0779621906784627e-11
measurement O 0 5.57567592096575e-09
of O 0 1.6008007142076508e-09
serum O 0 1.3041080437758978e-09
transferrin O 0 2.7149960502015347e-08
saturation O 0 4.7077463705136324e-08
and O 0 7.602918294935535e-11
the O 0 1.3138017063152319e-10
serum O 0 1.844430164155142e-09
ferritin O 0 1.5067071501562168e-07
level O 0 1.412958994251312e-07
. O 0 1.5458814672797416e-08

Once O 0 5.112906364956871e-07
the O 0 5.572634798056697e-09
diagnosis O 0 1.0699273843783885e-05
is O 0 8.314291477518054e-10
suspected O 0 2.693961107524956e-07
, O 0 2.820186029151017e-10
physicians O 0 1.5221259808129162e-09
must O 0 1.577065944502465e-08
use O 0 8.222793113077387e-09
serum O 0 1.4942278880880622e-07
ferritin O 0 9.269800102629233e-06
levels O 0 1.468350092181936e-06
and O 0 7.711880023464346e-09
hepatic O 1 0.909473717212677
iron O 0 0.001251033740118146
stores O 0 1.7091427650939295e-07
on O 0 7.257373795255262e-07
liver O 0 1.2577683037306997e-06
biopsy O 0 8.451836919221023e-08
specimens O 0 8.896140768488436e-11
to O 0 9.961988872708716e-11
assess O 0 6.998761570287115e-09
patients O 0 7.377523592033697e-11
for O 0 1.725852447065357e-11
the O 0 3.1612309991935206e-10
presence O 0 2.2164581281458595e-10
of O 0 2.1440058617372415e-08
iron B-Disease 0 4.04742022510618e-05
overload I-Disease 0 1.4675081729365047e-05
. O 0 1.014853125980153e-07

Liver O 1 0.9999732971191406
biopsy O 1 0.9984012246131897
is O 0 2.05559924637555e-08
also O 0 3.012527727275227e-11
used O 0 8.195974281199891e-12
to O 0 5.5215904765093526e-11
establish O 0 1.500420204747499e-10
the O 0 1.652666371809719e-11
presence O 0 2.5047863089211475e-11
or O 0 1.596696330707914e-09
absence O 0 2.107785519456229e-07
of O 0 1.2652354541842215e-07
cirrhosis B-Disease 1 1.0
, O 0 9.495829123018495e-11
which O 0 8.898139169932762e-12
can O 0 2.46060782860269e-10
affect O 0 2.2710793246005778e-07
prognosis O 0 0.0001780363527359441
and O 0 5.3123567766988344e-09
management O 0 2.395400429122674e-07
. O 0 5.270857528216766e-08

A O 0 7.843296998544247e-07
DNA O 0 2.96641005093079e-08
- O 0 1.7267696161837875e-09
based O 0 8.245038679577377e-11
test O 0 9.756272179028969e-11
for O 0 1.5188850177594304e-11
the O 0 2.382443131665468e-10
HFE O 0 2.662811311893165e-06
gene O 0 1.145726513662737e-09
is O 0 1.2637786650504523e-11
commercially O 0 6.970950205964499e-11
available O 0 2.8208733959811383e-11
, O 0 9.544597751043327e-12
but O 0 4.73467966222163e-12
its O 0 5.318228496475896e-12
place O 0 1.3883025284933126e-10
in O 0 2.8430721318861707e-12
the O 0 1.6335681071733e-11
diagnosis O 0 2.1877947631310235e-07
of O 0 1.6134553249003147e-08
hemochromatosis B-Disease 1 1.0
is O 0 3.07112877351301e-08
still O 0 7.215126274218164e-10
being O 0 1.22452312179e-10
evaluated O 0 3.240355983535892e-09
. O 0 4.534012276735666e-09

Currently O 0 4.5395701420147816e-08
, O 0 5.898121990810523e-10
the O 0 1.4187713504032473e-10
most O 0 2.086568764991803e-12
useful O 0 1.5760172680789886e-11
role O 0 5.213037466977877e-12
for O 0 1.614086034967821e-12
this O 0 1.7294632522965592e-12
test O 0 6.314372635873866e-12
is O 0 1.8144879587560225e-13
in O 0 1.628793942168999e-13
the O 0 1.017940831453401e-12
detection O 0 1.3217802408149737e-09
of O 0 6.248106476647308e-09
hemochromatosis B-Disease 1 1.0
in O 0 1.9910368465048123e-08
the O 0 1.3249006336479852e-08
family O 0 6.923394496594071e-11
members O 0 6.510809144426311e-13
of O 0 5.411706152647078e-11
patients O 0 6.654642982495407e-12
with O 0 6.994113675804631e-14
a O 0 4.19762523351519e-11
proven O 0 2.0906032460743518e-09
case O 0 6.589149226243762e-10
of O 0 7.115579236938174e-10
the O 0 3.419711847030271e-09
disease O 0 7.89465786965593e-07
. O 0 1.8478820251743855e-08

It O 0 8.297059039819032e-09
is O 0 1.2741850907715957e-09
crucial O 0 4.113035600994408e-08
to O 0 3.156450389951715e-08
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 4.695864390669158e-06
because O 0 9.46533340595579e-09
phlebotomy O 0 3.7719954093518027e-07
therapy O 0 1.9978987353397315e-09
can O 0 4.5950895866120334e-11
avert O 0 0.2978261411190033
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 0 6.152572895601338e-10
can O 0 9.514797838505729e-10
even O 0 6.251512640886858e-10
lead O 0 1.0665538591192458e-10
to O 0 1.1397277566160824e-10
normal O 0 1.1129046129099152e-08
life O 0 4.4083989236831655e-10
expectancy O 0 8.680375307434929e-10
. O 0 1.4348848498269007e-10
. O 0 7.695863502021894e-09

Prevalence O 0 0.00010707210458349437
of O 0 1.0466506950024268e-07
the O 0 2.3140350080552707e-08
I1307K O 0 5.6726021284703165e-06
APC B-Disease 0 2.0151599500195516e-08
gene O 0 1.3380995096679005e-11
variant O 0 1.9858456892785092e-11
in O 0 1.6415318540227708e-12
Israeli O 0 4.66238270213637e-10
Jews O 0 6.475074643130796e-11
of O 0 1.4366277265032146e-12
differing O 0 5.970017774407921e-13
ethnic O 0 3.5578859736845603e-12
origin O 0 5.057219400195212e-12
and O 0 6.063722440829977e-12
risk O 0 7.627967590906337e-09
for O 0 2.0929368815814087e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0006161796627566218

BACKGROUND O 0 6.336541105156357e-07
& O 0 8.779769800071335e-09
AIMS O 0 1.7372492777667503e-08
Israeli O 0 5.870014874176377e-08
Jews O 0 3.927259850655673e-09
of O 0 1.4987125429577475e-10
European O 0 6.138685559875512e-09
birth O 0 7.148436225179466e-07
, O 0 9.986459437172357e-10
i O 0 1.5436038225402626e-08
. O 0 1.2214859679282597e-10
e O 0 1.9771463632967112e-10
. O 0 7.035386162534962e-11
, O 0 3.811410909104751e-11
Ashkenazim O 0 3.250538043175766e-07
, O 0 3.080158350599049e-11
have O 0 1.2989556479048314e-11
the O 0 1.8118624656171534e-10
highest O 0 0.0001851319830166176
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.028575927019119263
of O 0 1.06494846274785e-09
any O 0 5.746807474338311e-10
Israeli O 0 8.805449880355809e-08
ethnic O 0 3.85138809733121e-09
group O 0 1.0776082109975604e-10
. O 0 1.0283555118562049e-09

The O 0 5.635712909679569e-07
I1307K O 0 1.0862508133868687e-05
APC B-Disease 0 2.285488420739057e-08
gene O 0 5.201102395990809e-11
variant O 0 6.03430805323768e-10
was O 0 5.191077789845622e-09
found O 0 2.2957796774747408e-10
in O 0 3.6041364337435766e-10
6 O 0 6.615480288019171e-07
. O 0 9.61995212378497e-08

1 O 0 7.018655878709978e-07
% O 0 5.495235821939559e-09
of O 0 2.730583537058351e-10
American O 0 1.2054099385316874e-10
Jews O 0 1.3127854359140656e-09
, O 0 1.0136285040485138e-11
28 O 0 8.622834668514656e-10
% O 0 3.320115293803383e-10
of O 0 1.4232433287464374e-10
their O 0 7.578974114963444e-10
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 3.1510180633631535e-06
, O 0 1.4238398654553563e-11
but O 0 3.833931436214577e-12
not O 0 1.659109481744192e-11
in O 0 3.712737756123019e-11
non O 0 1.662964521642607e-08
- O 0 2.053902292686871e-08
Jews O 0 3.866729514356848e-08
. O 0 3.021872529984648e-08

We O 0 2.0883989293452032e-07
assessed O 0 7.166361228883034e-07
the O 0 6.8730874325240165e-09
I1307K O 0 3.951414782932261e-06
prevalence O 0 1.2130315418801274e-08
in O 0 1.0094298443993899e-12
Israeli O 0 7.879893959561457e-10
Jews O 0 8.173638155195562e-11
of O 0 1.2642408821206264e-12
differing O 0 3.8801362296780884e-13
ethnic O 0 2.1837126291252007e-12
origin O 0 2.3463949967023057e-12
and O 0 2.1408836075459403e-12
risk O 0 7.406434132661843e-09
for O 0 1.8895761400017363e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0006000317516736686

METHODS O 0 5.023231892664626e-07
DNA O 0 9.61760004969392e-09
samples O 0 2.6303112465875245e-11
from O 0 7.510727283166485e-12
500 O 0 1.4327646707945618e-11
unrelated O 0 5.829048355110444e-11
Jews O 0 1.7447256139835332e-10
of O 0 3.725023414724582e-11
European O 0 1.1952221157240928e-10
or O 0 2.0021777291656662e-10
non O 0 2.8188591461031365e-09
- O 0 6.230451571331841e-11
European O 0 1.3463694048532204e-10
origin O 0 4.447830645459838e-11
, O 0 1.6318349937375493e-13
with O 0 5.276572263162877e-15
or O 0 1.7776769639654688e-12
without O 0 9.522540742046282e-12
a O 0 7.963516131248571e-12
personal O 0 2.8479800115444043e-11
and O 0 7.349742342510623e-11
/ O 0 3.1551496704196325e-06
or O 0 1.0858418164616523e-07
family O 0 3.815857352318375e-10
history O 0 2.9720478855743693e-10
of O 0 3.613780386046983e-10
neoplasia B-Disease 0 1.9032793261430925e-06
, O 0 3.73588326940677e-10
were O 0 1.51036350093392e-10
examined O 0 7.745914465395742e-10
for O 0 1.5480065146400435e-11
the O 0 7.280843983270557e-11
I1307K O 0 1.7566810228686336e-09
variant O 0 2.6588049470421815e-11
by O 0 5.916797867627777e-12
the O 0 3.749516322426594e-11
allele O 0 1.1066021710082197e-10
- O 0 6.170927657755954e-11
specific O 0 1.5064305358691854e-10
oligonucleotide O 0 3.177774487994611e-08
( O 0 8.660612782485089e-10
ASO O 0 2.9657721825060435e-05
) O 0 2.4517768371090654e-10
method O 0 3.466404763230457e-08
. O 0 8.183786093240997e-09

RESULTS O 0 6.8627546170318965e-06
In O 0 6.462643753479824e-09
persons O 0 1.4518799495988333e-09
at O 0 3.2333097310655035e-10
average O 0 1.1588864590184045e-10
risk O 0 9.676517365164727e-09
for O 0 1.4442746021359198e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 8.203199541867434e-08
I1307K O 0 5.6303379096789286e-06
was O 0 6.061719570737978e-09
found O 0 3.50164584828061e-11
in O 0 6.267483754207603e-11
5 O 0 1.6858853868484402e-08
. O 0 8.738737733438029e-09

0 O 0 5.918593046772003e-07
% O 0 7.561204107275898e-09
of O 0 6.162555465927255e-10
120 O 0 2.1649251280564386e-09
European O 0 5.075006637156321e-09
and O 0 3.1558828883504475e-09
1 O 0 1.2152997442171909e-05
. O 0 2.699474919154454e-07

6 O 0 1.813373501136084e-06
% O 0 1.3405232479613005e-08
of O 0 1.6873933361694071e-09
188 O 0 2.8436080157234755e-09
non O 0 1.6546907843917324e-08
- O 0 3.394400316381052e-09
European O 0 6.854445011583721e-09
Jews O 0 5.012727299913422e-08
( O 0 1.1846236214196892e-09
P O 0 6.506021691166097e-06
= O 0 9.948175616614208e-09
0 O 0 1.9126362715837786e-09
. O 0 8.671070805821302e-11
08 O 0 1.8584992433900993e-09
) O 0 1.1675459210547245e-10
. O 0 5.901410915498673e-09

It O 0 3.31853584611963e-08
occurred O 0 6.755358299415093e-07
in O 0 3.231301892725469e-09
15 O 0 1.1810601563411183e-07
. O 0 3.325315489632885e-08

4 O 0 2.283184272755534e-07
% O 0 2.6903490546459352e-09
of O 0 2.2827675860703778e-10
52 O 0 1.5709467060531779e-09
Ashkenazi O 0 5.180553763750595e-09
Israelis O 0 2.3155010353548278e-08
with O 0 1.1696144053274793e-10
familial O 1 0.933379054069519
cancer B-Disease 1 1.0
( O 0 1.5671586695020778e-08
P O 0 0.00022589766012970358
= O 0 7.410729807588723e-09
0 O 0 2.094446838185604e-09
. O 0 3.13423662023915e-11
02 O 0 3.3662300724657257e-10
) O 0 7.742686700118462e-12
and O 0 2.0875093320604776e-11
was O 0 2.4765329786902157e-09
not O 0 4.893334626387968e-10
detected O 0 3.2890057344303614e-09
in O 0 6.706097482878093e-11
51 O 0 7.834758619651438e-09
non O 0 2.1528652638380663e-08
- O 0 3.756004840482774e-09
European O 0 8.766416925709564e-09
Jews O 0 1.6603276975502013e-08
at O 0 4.134601105931779e-09
increased O 0 7.767978260631025e-09
cancer B-Disease 0 1.2165450016254908e-06
risk O 0 9.928938737857607e-08
. O 0 2.340294180669389e-08

Colorectal B-Disease 1 0.9956281185150146
neoplasia I-Disease 1 0.9825072884559631
occurred O 0 0.02111109532415867
personally O 0 2.576073256932432e-07
or O 0 8.609752910615498e-10
in O 0 3.042944021758309e-11
the O 0 3.914109661384835e-11
families O 0 1.6336989053233886e-11
of O 0 1.806830657313796e-10
13 O 0 4.157090227607796e-09
of O 0 1.3890130157179215e-09
20 O 0 4.089331984147293e-09
Ashkenazi O 0 6.139657671155874e-09
I1307K O 0 6.406935426639393e-09
carriers O 0 6.948420137875555e-12
, O 0 1.7051106620397105e-12
8 O 0 2.2782264963439047e-10
of O 0 8.958666447567154e-11
whom O 0 6.892312415240909e-11
also O 0 7.753504435714653e-12
had O 0 1.1487083506622753e-10
a O 0 7.395415529964922e-11
personal O 0 4.03946071036998e-10
or O 0 1.1822987033838217e-09
family O 0 1.0025616448139374e-10
history O 0 4.065547620779597e-10
of O 0 3.2566143115531077e-09
noncolonic O 0 6.200808002176927e-06
neoplasia B-Disease 1 0.8314738273620605
. O 0 6.5907411226362456e-06

CONCLUSIONS O 0 4.2988740460714325e-05
The O 0 1.101560158645043e-07
I1307K O 0 5.358363978302805e-06
APC O 0 1.8121232514545227e-08
variant O 0 3.3692379997063426e-09
may O 0 2.4205439874691592e-09
represent O 0 7.527495987647015e-11
a O 0 2.6805593855705467e-10
susceptibility O 0 3.271214410460743e-08
gene O 0 5.492623578184919e-10
for O 0 2.5717410423453657e-09
colorectal B-Disease 1 1.0
, I-Disease 0 2.3768077880959027e-05
or I-Disease 0 0.06644928455352783
other I-Disease 0 7.450316985568861e-08
, I-Disease 0 1.8261724576973393e-08
cancers I-Disease 1 0.9999097585678101
in O 0 5.987708107113576e-08
Ashkenazi O 0 0.0004594309430103749
Jews O 0 3.208271266430529e-07
, O 0 1.2435409646460727e-10
and O 0 2.2284661962967967e-11
partially O 0 1.493506296412761e-08
explains O 0 1.3032146195524064e-10
the O 0 1.1998078745800722e-11
higher O 0 5.114729750843594e-10
incidence O 0 7.715354399806529e-07
of O 0 4.921786285194685e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 3.676957049947305e-08
European O 0 4.6587956603616476e-08
Israelis O 0 8.651843472762266e-07
. O 0 4.645946916070898e-08

Systematic O 0 4.728444125134956e-08
analysis O 0 1.8283181635325718e-09
of O 0 1.0100366765186664e-08
coproporphyrinogen O 0 1.0394907803856768e-05
oxidase O 0 1.1578988505789312e-06
gene O 0 1.220670213797348e-07
defects O 0 6.771508924430236e-05
in O 0 1.2033981588999154e-09
hereditary B-Disease 1 0.9999665021896362
coproporphyria I-Disease 1 0.999525785446167
and O 0 1.525289405890362e-07
mutation O 0 7.223821398838481e-07
update O 0 1.4737045717083674e-07
. O 0 9.214313223537829e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999998807907104
( O 0 8.426001159023144e-07
HC B-Disease 1 1.0
) O 0 1.5757121163417764e-09
is O 0 2.4433877143792415e-10
an O 0 6.089098669725956e-10
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 2.1108817236381583e-05
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 1 0.9999773502349854
caused O 0 5.5655698815826327e-05
by O 0 5.057513852158024e-10
deficient B-Disease 0 1.6438951888630982e-07
activity I-Disease 0 8.436584408855197e-08
of I-Disease 0 2.28164687143817e-08
coproporphyrinogen I-Disease 0 1.1674790130200563e-06
III I-Disease 0 0.002771971048787236
oxidase I-Disease 0 2.69720476353541e-06
( O 0 7.434231008573988e-09
CPO O 0 5.5814093684602994e-06
) O 0 2.9379826349540394e-10
. O 0 4.097717276607682e-09

Clinical O 0 1.1690159226418473e-05
manifestations O 0 9.096385474549606e-05
of O 0 1.0628303925841465e-06
the O 0 1.3410046051376412e-07
disease O 1 0.8306944370269775
are O 0 1.5821726524409274e-12
characterized O 0 2.2269790178608417e-11
by O 0 2.577816866217164e-12
acute O 0 0.0003017652197740972
attacks O 0 6.789202871004818e-06
of O 1 0.9990357160568237
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 8.179962485144188e-09
precipitated O 0 7.370386079230684e-09
by O 0 1.0394271381108933e-11
drugs O 0 5.979622352825231e-10
, O 0 6.929573234670805e-12
fasting O 0 7.3981460957384115e-09
, O 0 4.5816298671619293e-11
cyclical O 0 6.070955578252324e-07
hormonal O 0 2.465313286847959e-07
changes O 0 1.4337946829812154e-08
, O 0 1.8008073920938727e-09
or O 0 1.9511439859343227e-06
infectious B-Disease 0 0.29540205001831055
diseases I-Disease 0 0.37995481491088867
. O 0 3.667180408228887e-07

Skin O 1 0.9999994039535522
photosensitivity O 1 0.999866247177124
may O 0 4.223657742841169e-05
also O 0 3.4185378972040326e-09
be O 0 1.943749161625874e-09
present O 0 8.733872292054912e-09
. O 0 3.4429735507046644e-08

The O 0 3.0895779445927474e-07
seven O 0 1.56381751992285e-08
exons O 0 9.252529764580686e-08
, O 0 6.210320591115703e-10
the O 0 1.444791286608904e-09
exon O 0 1.452473252783193e-08
/ O 0 1.164241894002771e-07
intron O 0 2.0722872307032958e-07
boundaries O 0 8.140708551707121e-09
and O 0 1.4203145604074763e-10
part O 0 1.903399882152712e-09
of O 0 4.2395040367182446e-08
3 O 0 9.607190065707982e-08
noncoding O 0 1.8370937482359295e-07
sequence O 0 1.2376267122249374e-08
of O 0 1.2284825601227567e-08
the O 0 6.172793831638046e-09
CPO O 0 9.985369615606032e-07
gene O 0 2.2657720144536597e-10
were O 0 7.630288068050106e-11
systematically O 0 1.5232577699197947e-10
analyzed O 0 1.0034162736816121e-11
by O 0 1.1816656594193509e-12
an O 0 6.95487721233401e-12
exon O 0 4.684104770724673e-10
- O 0 1.849901676287402e-09
by O 0 1.6595417262621481e-09
- O 0 1.213182372339361e-07
exon O 0 6.466641622182578e-08
denaturing O 0 4.099121724721044e-06
gradient O 0 2.073019913950702e-06
gel O 0 9.93871509535893e-08
electrophoresis O 0 6.500485927318778e-09
( O 0 4.120135482788001e-11
DGGE O 0 4.2101964936591685e-07
) O 0 2.710923282731037e-12
strategy O 0 4.0054782407539236e-11
followed O 0 1.2518498607519413e-12
by O 0 1.4223862430766399e-13
direct O 0 2.9198699014187923e-11
sequencing O 0 1.0537542366462205e-10
in O 0 2.332955009731741e-11
seven O 0 4.105348699878775e-11
unrelated O 0 3.7395833651920896e-10
heterozygous O 0 2.5998976305174892e-09
HC B-Disease 1 0.9999802112579346
patients O 0 1.6745502762205433e-08
from O 0 1.934082005661253e-09
France O 0 3.2911016134562487e-09
, O 0 3.324942404736575e-11
Holland O 0 1.5892553939522713e-09
, O 0 3.723943722833134e-11
and O 0 8.613821461667115e-11
Czech O 0 5.602018404715636e-07
Republic O 0 2.0156528989900835e-05
. O 0 7.0590795075986534e-06

Seven O 0 5.0456293365641613e-08
novel O 0 9.374867993017233e-09
mutations O 0 1.7058068735309462e-08
and O 0 1.0898761060307294e-10
two O 0 2.262825517240774e-11
new O 0 1.8994891770596212e-10
polymorphisms O 0 6.211190850535786e-08
were O 0 1.391238839687503e-07
detected O 0 4.00950011680834e-06
. O 0 1.6181186879293818e-07

Among O 0 1.6200482733097488e-08
these O 0 4.782917950585386e-10
mutations O 0 4.254406604786709e-09
two O 0 5.18517485892378e-11
are O 0 3.123113226366492e-11
missense O 0 2.30113528232323e-07
( O 0 1.9295427478027705e-09
G197W O 0 5.150499418959953e-05
, O 0 7.053044259741625e-10
W427R O 0 1.1860428230647813e-06
) O 0 8.90483242699247e-11
, O 0 3.150046543054508e-11
two O 0 1.3270534844622706e-11
are O 0 1.4368230563666096e-11
nonsense O 0 3.5030268463742686e-08
( O 0 7.188806772084888e-10
Q306X O 0 9.90435728454031e-06
, O 0 9.439853343451432e-10
Q385X O 0 1.5416509313581628e-06
) O 0 3.6482000753679245e-10
, O 0 1.4036120876692593e-10
two O 0 3.111305310610213e-11
are O 0 1.1841751537677858e-11
small O 0 1.48916975972746e-10
deletions O 0 1.767443258415824e-08
( O 0 2.6381166140510004e-09
662de14bp O 0 4.980936864740215e-06
; O 0 5.412792991599247e-10
1168del3bp O 0 4.6698366418240767e-07
removing O 0 8.640837734219531e-08
a O 0 1.7080981074002466e-09
glycine O 0 5.371307842949591e-09
at O 0 8.015293317953365e-09
position O 0 1.0946245021514756e-09
390 O 0 1.3397244424950827e-10
) O 0 1.1228837304422257e-11
, O 0 8.869434700575773e-12
and O 0 6.043493396695743e-12
one O 0 1.2000687769908591e-11
is O 0 5.17432451052624e-12
a O 0 7.070241614393069e-11
splicing O 0 7.217287323335597e-10
mutation O 0 1.0477764211813678e-09
( O 0 1.2101086625804225e-11
IVS1 O 0 9.172139243673882e-07
- O 0 2.1520358828297503e-08
15c O 0 5.619392595690442e-07
- O 0 1.5830934785299178e-08
- O 0 6.9469465735494396e-09
> O 0 1.5563813349217526e-08
g O 0 6.947221131703429e-10
) O 0 5.175072067924169e-13
which O 0 9.563672553544733e-13
creates O 0 3.502700907098699e-11
a O 0 1.3049110403340336e-10
new O 0 9.696646957602084e-11
acceptor O 0 1.9476904533632933e-09
splice O 0 1.1792616305683623e-07
site O 0 1.6606696462417858e-08
. O 0 9.926832689188814e-09

The O 0 1.1495670548811177e-07
pathological O 0 7.925027603050694e-06
significance O 0 1.1244654984920999e-07
of O 0 3.1455723359385956e-08
the O 0 3.2494975599206555e-09
point O 0 7.328321771638002e-08
mutations O 0 6.510747940779993e-09
G197W O 0 1.21915820727736e-06
, O 0 2.031137341651501e-10
W427R O 0 4.053855809615925e-05
, O 0 3.251864055808795e-10
and O 0 4.4449895153508834e-11
the O 0 3.0943569928609804e-10
in O 0 1.2622086709157543e-10
- O 0 9.988325722076752e-10
frame O 0 6.474216274199307e-09
deletion O 0 2.4801078524205877e-08
390delGly O 0 4.441180756487029e-09
were O 0 3.375396490090665e-11
assessed O 0 1.0356739910122315e-09
by O 0 2.8554738868563634e-12
their O 0 7.441766820825979e-12
respective O 0 5.525414847884491e-11
expression O 0 1.0792949173277222e-10
in O 0 3.5572770423764055e-11
a O 0 6.044822281614515e-11
prokaryotic O 0 1.4505774185991083e-11
system O 0 7.989185701884338e-11
using O 0 2.0797356892199304e-11
site O 0 3.3971836455037874e-10
- O 0 2.214839422975956e-10
directed O 0 1.5577933387689313e-10
mutagenesis O 0 1.5681581544413348e-06
. O 0 5.124998381234036e-08

These O 0 1.3939654985861694e-09
mutations O 0 3.1532354505259264e-09
resulted O 0 1.097723023590902e-09
in O 0 4.933122660366607e-11
the O 0 9.4610508316606e-10
absence O 0 1.540045424519576e-08
or O 0 1.551857087278563e-09
a O 0 1.607759037014489e-09
dramatic O 0 1.3879914106951219e-08
decrease O 0 2.387748452292726e-07
of O 0 1.1402968880247499e-07
CPO O 0 6.262915849220008e-05
activity O 0 3.162278119361872e-07
. O 0 5.620062992761632e-08

The O 0 7.388884171177779e-08
two O 0 5.919366108386726e-10
polymorphisms O 0 1.800035498433772e-08
were O 0 2.8225177750584862e-09
localized O 0 1.9635295700481947e-07
in O 0 7.126580436889185e-10
noncoding O 0 1.0732446753536351e-07
part O 0 4.368741812754706e-09
of O 0 4.783585971779303e-09
the O 0 5.954890469617169e-10
gene O 0 7.388168549171681e-11
1 O 0 7.2287531516224135e-09
) O 0 1.1573485225735425e-11
a O 0 7.281485969734547e-10
C O 0 3.841072668819834e-07
/ O 0 2.9089012087979427e-08
G O 0 1.1658335630215788e-08
polymorphism O 0 1.5770892369815215e-09
in O 0 1.3965301137730535e-10
the O 0 5.723027607373865e-10
promotor O 0 1.1974044582530041e-06
region O 0 2.0325933292042464e-07
, O 0 3.105355972365942e-09
142 O 0 1.1343590955448235e-08
bp O 0 2.9799521072959578e-08
upstream O 0 6.808514196876558e-09
from O 0 6.362976812113175e-11
the O 0 5.371773859064177e-11
transcriptional O 0 2.5925231406098703e-10
initiation O 0 1.4370923895334897e-10
site O 0 5.0923966432581125e-11
( O 0 3.2777157724095396e-12
- O 0 1.1319982728963396e-09
142C O 0 2.782579429094767e-07
/ O 0 4.8918096240413433e-08
G O 0 7.671334145697983e-08
) O 0 5.656953031007994e-11
, O 0 7.85038284378814e-11
and O 0 1.4654839841643508e-10
2 O 0 4.647932527745979e-08
) O 0 4.67964889061534e-10
a O 0 2.1199854316478195e-08
6 O 0 8.323739564275456e-08
bp O 0 3.2702537566819956e-08
deletion O 0 2.9539928281252514e-09
polymorphism O 0 2.602433157861128e-09
in O 0 1.678430450180457e-10
the O 0 1.8660854805840899e-10
3 O 0 5.1678221701934035e-09
noncoding O 0 5.101951572328289e-08
part O 0 2.634516382826746e-09
of O 0 1.5541742115487978e-08
the O 0 2.1534278360491044e-08
CPO O 0 1.4081382687436417e-05
gene O 0 2.3807864568681225e-09
, O 0 2.1177000431027437e-10
574 O 0 2.57192382946414e-08
bp O 0 7.281160208094661e-08
downstream O 0 5.194606700342774e-08
of O 0 8.438362786300502e-10
the O 0 1.1611654693322038e-10
last O 0 1.825104928299126e-10
base O 0 1.2929841919362417e-10
of O 0 4.011724633046221e-11
the O 0 4.1148657398126787e-11
normal O 0 1.2461651710538035e-09
termination O 0 2.1872686772894667e-08
codon O 0 2.6477918524392408e-08
( O 0 7.402532475886403e-10
+ O 0 1.9167858411606176e-08
574 O 0 5.204206487974261e-08
delATTCTT O 0 2.933574023700203e-07
) O 0 9.25947707397512e-10
. O 0 1.1378522124516621e-08

Five O 0 9.565373915165765e-08
intragenic O 0 7.696306965954136e-06
dimorphisms O 0 7.984581316122785e-05
are O 0 1.0646560300031638e-09
now O 0 1.4724241270691607e-10
well O 0 1.1493170130882913e-11
characterized O 0 1.809696975607622e-10
and O 0 6.978210544128505e-12
the O 0 2.656270689516127e-11
high O 0 1.9365579972951963e-10
degree O 0 2.7543325398227125e-09
of O 0 1.4282851290570164e-10
allelic O 0 1.1860169735200543e-08
heterogeneity O 0 6.471206859259837e-08
in O 0 9.712458615140918e-10
HC B-Disease 1 0.9999791383743286
is O 0 2.1962889285020992e-09
demonstrated O 0 3.37990135879096e-10
with O 0 1.2847133296425839e-12
seven O 0 1.0596874072676954e-11
new O 0 3.6372169382251074e-13
different O 0 3.841666839244501e-13
mutations O 0 7.724090117511295e-11
making O 0 3.640265606313919e-12
a O 0 2.996178999348231e-11
total O 0 2.5222382515899255e-10
of O 0 6.407457342483269e-10
nineteen O 0 1.8492434605832386e-07
CPO O 0 0.0002973883238155395
gene B-Disease 0 6.625929813708353e-07
defects I-Disease 1 0.7512694597244263
reported O 0 7.90918530668705e-09
so O 0 2.875052418360724e-10
far O 0 1.6490595555751497e-09
. O 0 4.197467373678876e-10
. O 0 9.24485288322785e-09

Coincidence O 0 3.296071326985839e-06
of O 0 2.2604563554295964e-08
two O 0 1.1360815066474572e-10
novel O 0 8.036844523218178e-10
arylsulfatase O 0 4.224836800403864e-07
A O 0 7.566314508267169e-08
alleles O 0 2.687230882258973e-09
and O 0 5.226962196402951e-10
mutation O 0 7.952539071709452e-09
459 O 0 1.52157522137486e-08
+ O 0 7.963969039792573e-09
1G O 0 3.268514490173402e-07
> O 0 3.44539756724771e-08
A O 0 4.4545509503279845e-09
within O 0 8.531417794443996e-10
a O 0 5.330288432858765e-10
family O 0 4.8708443528555634e-11
with O 0 4.330013084197226e-11
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 3.7370806449388283e-10
molecular O 0 2.141046007153591e-09
basis O 0 8.419296371187102e-10
of O 0 2.1616272660729408e-10
phenotypic O 0 2.324564150057995e-07
heterogeneity O 0 3.850637767754961e-06
. O 0 1.5876783265866834e-07

In O 0 8.586404476318421e-09
a O 0 2.008601063252513e-09
family O 0 6.183321910047113e-11
with O 0 7.836954826409559e-13
three O 0 1.0808832301423266e-10
siblings O 0 2.292673828563352e-09
, O 0 2.570423041081682e-12
one O 0 2.240248568249892e-12
developed O 0 5.5121830710991304e-11
classical O 0 1.8026433679096954e-08
late O 0 4.971372982254252e-05
infantile O 1 0.9999803304672241
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 3.4634307866099334e-08
MLD B-Disease 1 1.0
) O 0 5.677028291906083e-10
, O 0 1.1675124755861077e-10
fatal O 0 1.251001862101475e-07
at O 0 8.861991140918235e-09
age O 0 1.1403094468676045e-08
5 O 0 2.228138029636284e-08
years O 0 4.7724770801949035e-09
, O 0 4.305750547772824e-11
with O 0 2.5568405032094788e-11
deficient O 0 9.218335890182061e-07
arylsulfatase O 0 2.128240703314077e-05
A O 0 8.600899491284508e-06
( O 0 2.8135898055836606e-09
ARSA O 0 2.3137540665629786e-06
) O 0 2.3826465106457917e-11
activity O 0 2.4575827484163426e-10
and O 0 5.664659713522369e-12
increased O 0 8.122496564233472e-10
galactosylsulfatide O 0 5.376558078751259e-07
( O 0 3.4285434935554804e-08
GS O 1 0.9955377578735352
) O 0 7.1546955027201875e-09
excretion O 0 4.840059375510464e-08
. O 0 3.4639511259371147e-09

The O 0 5.343425257819945e-08
two O 0 1.844527725003431e-10
other O 0 6.095102894621007e-11
siblings O 0 6.466293722695582e-09
, O 0 1.6156154192259464e-10
apparently O 0 5.529951181415527e-07
healthy O 0 8.136703755212693e-09
at O 0 3.44473392033251e-08
12 O 0 8.269127604876303e-09
( O 0 9.193251715444717e-11
1 O 0 8.567110398871591e-07
/ O 0 5.5788270003631624e-08
2 O 0 6.008266240087323e-08
) O 0 2.043715370547705e-11
and O 0 2.3653946856772023e-11
15 O 0 8.764540204708737e-10
years O 0 2.8194224732658313e-10
, O 0 3.711037119963345e-12
respectively O 0 1.0648586179495823e-10
, O 0 7.370121006544661e-12
and O 0 9.15195870476726e-12
their O 0 7.028033537082035e-12
father O 0 3.85659992829801e-09
, O 0 2.1102526670535582e-10
apparently O 0 9.830348801642685e-08
healthy O 0 8.932087847135506e-10
as O 0 2.2945614158720318e-11
well O 0 1.2877363238239514e-11
, O 0 1.0724364105096917e-11
presented O 0 1.6898219490357747e-09
ARSA O 0 2.0793953808606602e-05
and O 0 2.367847917739141e-09
GS O 1 0.8947954773902893
values O 0 2.7767385613053364e-10
within O 0 1.0497741564918783e-10
the O 0 1.3643532484342025e-11
range O 0 3.2383109527245324e-09
of O 0 1.0286698604033973e-08
MLD B-Disease 1 1.0
patients O 0 3.016051550730481e-07
. O 0 7.731176054903699e-08

Mutation O 0 9.565574998759985e-08
screening O 0 3.9612344515660425e-09
and O 0 1.5225831012655178e-11
sequence O 0 4.213612098125097e-11
analysis O 0 4.368126953896434e-12
disclosed O 0 4.5886108801518333e-10
the O 0 4.2210044487456244e-11
involvement O 0 1.736244814587451e-09
of O 0 5.12564823917927e-10
three O 0 1.0144622121510682e-11
different O 0 1.145561510235149e-11
ARSA O 0 3.3083310881920625e-06
mutations O 0 7.730523776672271e-09
being O 0 7.361751486190116e-11
the O 0 7.750517241889021e-12
molecular O 0 7.429459825125662e-11
basis O 0 1.7590404133294157e-10
of O 0 1.8277175606318252e-10
intrafamilial O 0 3.345214736327762e-07
phenotypic O 0 1.1893162081832998e-06
heterogeneity O 0 2.087298889819067e-05
. O 0 2.0224342733854428e-07

The O 0 6.134846408656358e-09
late O 0 7.007766953393002e-07
infantile O 0 0.37825047969818115
patient O 0 7.080269824655261e-06
inherited O 0 1.8775206626742147e-05
from O 0 4.2049475723615615e-07
his O 0 3.563571624454198e-07
mother O 0 2.5793470470603097e-08
the O 0 5.38351319079311e-09
frequent O 0 1.0240728265387133e-09
0 O 0 6.49028963906062e-09
- O 0 3.983342100610798e-09
type O 0 2.452831893151597e-08
mutation O 0 1.905195112783531e-08
459 O 0 4.901857142414201e-09
+ O 0 1.3036977053459964e-09
1G O 0 3.475899035265684e-08
> O 0 6.129267315913012e-09
A O 0 1.1752284478916408e-08
, O 0 2.0284570897977083e-11
and O 0 4.431983859770616e-12
from O 0 2.356452533103237e-10
his O 0 2.84830742325326e-10
father O 0 9.488225483078594e-11
a O 0 1.761934001476284e-11
novel O 0 7.423142656115544e-11
, O 0 4.972930053859237e-12
single O 0 1.3267958953733228e-10
basepair O 0 2.054163417142263e-07
microdeletion O 0 9.261548825634236e-07
of O 0 4.32691535934282e-08
guanine O 0 1.3560708111981512e-09
at O 0 8.366153991801184e-09
nucleotide O 0 4.029874212108098e-09
7 O 0 6.5264882387339185e-09
in O 0 1.0762175178813393e-10
exon O 0 1.551481165762425e-09
1 O 0 3.4902619461263384e-08
( O 0 2.2348180250819638e-10
7delG O 0 1.428393403557493e-07
) O 0 1.6215869758084978e-09
. O 0 2.186642866774946e-08

The O 0 7.95000971720583e-08
two O 0 1.6249556145098154e-09
clinically O 0 1.642180905037094e-05
unaffected O 0 2.6941151531900687e-07
siblings O 0 2.2523682918773602e-09
carried O 0 1.1994789883562618e-10
the O 0 3.9805603258002975e-10
maternal O 0 1.0039786779714177e-08
mutation O 0 2.6765668792450015e-08
459 O 0 2.003119448090729e-08
+ O 0 1.6136583624870582e-08
1G O 0 5.347473006622749e-07
> O 0 1.0669988625977567e-07
A O 0 1.4857502605991613e-07
and O 0 2.2333562776921667e-10
, O 0 4.801662539799523e-11
on O 0 6.837936328274452e-10
their O 0 4.287064626906645e-12
paternal O 0 6.632397964168035e-10
allele O 0 7.019844705524747e-09
, O 0 6.728505946851371e-11
a O 0 2.479121630205583e-10
novel O 0 3.538142556713808e-10
cytosine O 0 1.4909837808829707e-09
to O 0 1.3120093900198526e-09
thymidine O 0 1.2539797467070457e-07
transition O 0 2.512640833174373e-07
at O 0 2.2818557710024834e-08
nucleotide O 0 1.7115231898401362e-08
2435 O 0 9.444057980090292e-08
in O 0 9.327771888223424e-11
exon O 0 1.4012803140062147e-09
8 O 0 6.001712460346198e-09
, O 0 1.6511099779070726e-11
resulting O 0 1.7003413954608249e-10
in O 0 3.703062856352801e-11
substitution O 0 1.4109944324047774e-09
of O 0 5.172555717081195e-09
alanine O 0 1.2977491081755943e-08
464 O 0 1.0127875427201616e-08
by O 0 3.5746789972535e-09
valine O 0 7.226278285088483e-06
( O 0 4.577310530606837e-09
A464V O 0 1.3390431377047207e-05
) O 0 3.129257963863097e-09
. O 0 2.595905357338779e-08

The O 0 2.089727928478169e-07
fathers O 0 2.5917941570696712e-08
genotype O 0 1.1260425480941194e-08
thus O 0 3.350103527921533e-09
was O 0 1.9785440841246782e-08
7delG O 0 2.056071707556839e-06
/ O 0 7.673024811083451e-05
A464V O 0 0.000672286783810705
. O 0 6.383481263583235e-07

Mutation O 0 1.5268917650246294e-06
A464V O 0 1.4921950423740782e-05
was O 0 1.2893850431794363e-08
not O 0 7.830656956198112e-11
found O 0 7.323570569428561e-12
in O 0 7.392393988614465e-12
18 O 0 2.244319174948828e-09
unrelated O 0 1.7392659401593846e-07
MLD B-Disease 1 1.0
patients O 0 2.2302261015738623e-07
and O 0 1.802996640876131e-09
50 O 0 2.5426922789506534e-08
controls O 0 1.9538815365649498e-07
. O 0 7.96406354197643e-08

A464V O 0 0.09850554913282394
, O 0 1.0806430417176216e-08
although O 0 8.005205942573923e-10
clearly O 0 3.138732385110643e-09
modifying O 0 3.2459311682941916e-08
ARSA O 0 0.0054949806071817875
and O 0 1.9178359877969342e-07
GS O 1 1.0
levels O 0 5.976486136205494e-06
, O 0 3.821006566706586e-10
apparently O 0 1.334316923617962e-08
bears O 0 4.30112362392876e-10
little O 0 8.293549874638373e-12
significance O 0 2.564547706140896e-11
for O 0 4.881621148977722e-12
clinical O 0 2.049103997592283e-09
manifestation O 0 8.947613139298483e-08
of O 0 5.903372652937833e-07
MLD B-Disease 1 1.0
, O 0 3.4462437348281583e-09
mimicking O 0 1.3259017883626711e-08
the O 0 1.2371185187376454e-09
frequent O 0 3.456631647580366e-09
ARSA O 0 6.847711483715102e-05
pseudodeficiency O 0 1.9879853425663896e-05
allele O 0 3.405996039873571e-06
. O 0 1.865251419985725e-07

Our O 0 6.707590927135243e-08
results O 0 7.681106861667786e-10
demonstrate O 0 1.2821051165179398e-10
that O 0 4.672597812144241e-12
in O 0 6.134497423926355e-12
certain O 0 1.2001288851593017e-10
genetic O 0 3.08589633846168e-08
conditions O 0 3.839171313302359e-06
MLD B-Disease 1 1.0
- O 1 0.6880015134811401
like O 0 2.5935644742958175e-08
ARSA O 0 0.002546417759731412
and O 0 8.651800165182522e-09
GS O 1 0.999980092048645
values O 0 1.3322131175996788e-09
need O 0 7.091188053420794e-11
not O 0 2.7570404726590114e-12
be O 0 1.4680451949564133e-12
paralleled O 0 1.850030371952638e-11
by O 0 2.3191648254594632e-12
clinical O 0 1.0253441473651037e-07
disease O 0 6.290612759585201e-07
, O 0 1.4855434590788086e-11
a O 0 7.236140159294635e-11
finding O 0 2.859815440015012e-10
with O 0 1.909942906955231e-12
serious O 0 7.054692474639523e-08
diagnostic O 0 9.006495815810922e-08
and O 0 2.2031949598044775e-09
prognostic O 0 0.08038072288036346
implications O 0 5.318142575561069e-05
. O 0 3.7394053720163356e-07

Moreover O 0 1.2242451248312136e-06
, O 0 2.1038757402891406e-09
further O 0 2.045153557617141e-08
ARSA O 0 7.614842616021633e-05
alleles O 0 2.4716170443639385e-08
functionally O 0 4.143000609246883e-09
similar O 0 4.69156614599231e-12
to O 0 1.8091689257815347e-10
A464V O 0 8.797952091299521e-07
might O 0 1.9165729003844945e-09
exist O 0 5.322272622620972e-10
which O 0 1.9021638431038213e-11
, O 0 6.810751181779429e-12
together O 0 1.541464872412135e-12
with O 0 3.754550381533661e-13
0 O 0 3.2219351631113113e-09
- O 0 4.423570842959634e-09
type O 0 3.8823667836140885e-08
mutations O 0 2.0602355732535216e-07
, O 0 1.666290300184059e-10
may O 0 2.850723568315061e-08
cause O 0 1.0237773494736757e-05
pathological O 1 0.8721320033073425
ARSA O 0 0.00950593501329422
and O 0 9.005345447121726e-08
GS O 1 1.0
levels O 0 2.623504258281173e-07
, O 0 1.4475289022986004e-11
but O 0 1.4345714286628786e-12
not O 0 2.6008908568520006e-12
clinical O 0 1.0745355993879713e-10
outbreak O 0 2.2204907357270542e-10
of O 0 4.774969308840582e-10
the O 0 1.4481682519829064e-09
disease O 0 2.185930298992389e-07
. O 0 2.642871033131655e-09
. O 0 3.908624890414103e-08

Human O 0 0.21111822128295898
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 0 5.350846913643181e-05
to O 0 2.590013252756762e-07
hematological B-Disease 1 0.9999704360961914
malignancy I-Disease 1 0.9999978542327881
and O 0 5.754158927118169e-09
neurofibromatosis B-Disease 1 0.5872631072998047
type I-Disease 0 0.000572058605030179
1 I-Disease 0 0.010529652237892151
. O 0 3.0884788770890736e-07

Heterozygous O 0 6.582145601896627e-07
germ O 0 2.8206140996189788e-05
- O 0 4.6412128540396225e-07
line O 0 1.318964564234193e-07
mutations O 0 1.5085483084931184e-08
in O 0 6.257892121164232e-11
the O 0 2.1250803894368175e-10
DNA O 0 2.5461037722607216e-08
mismatch O 0 4.8470374167663977e-05
repair O 0 4.678161349147558e-05
genes O 0 9.688950797226425e-08
lead O 0 2.603286919367065e-09
to O 0 4.444977275142037e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7949391603469849

The O 0 9.110959098279636e-08
disease O 0 7.124520493562159e-07
susceptibility O 0 3.19672381010605e-07
of O 0 2.058271064697692e-08
individuals O 0 4.8154888965257214e-09
who O 0 1.1145874623252894e-07
constitutionally O 0 1.2011950275336858e-05
lack O 0 1.3595920336229028e-06
both O 0 7.08690550688118e-10
wild O 0 2.7177182726489946e-10
- O 0 5.3427238327907745e-11
type O 0 5.787882395580368e-10
alleles O 0 6.662727036754745e-10
is O 0 7.99378896410019e-11
unknown O 0 8.338911783312142e-09
. O 0 4.775900563913638e-09

We O 0 4.576352807816875e-08
have O 0 6.092523013867535e-11
identified O 0 1.3639193940928607e-10
three O 0 3.2080716121790642e-12
offspring O 0 1.6909872807557846e-11
in O 0 4.0182454260663525e-13
a O 0 1.796716803115217e-10
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9931586384773254
who O 0 1.1358703311259433e-08
developed O 0 2.1604051880785846e-08
hematological B-Disease 1 0.996894121170044
malignancy I-Disease 1 0.9999996423721313
at O 0 7.601000362456034e-08
a O 0 5.623582155500628e-11
very O 0 3.3553676330455584e-12
early O 0 1.0423684138061162e-09
age O 0 7.410051239276072e-09
, O 0 5.1933084568855925e-12
and O 0 6.302857107759463e-12
at O 0 3.323390729281783e-10
least O 0 5.332980237970908e-11
two O 0 2.4548115276634697e-12
of O 0 2.789328316932238e-11
them O 0 5.049987663284516e-13
displayed O 0 2.997493919743022e-11
signs O 0 1.0861889165880712e-09
of O 0 8.23176471431708e-10
neurofibromatosis B-Disease 0 0.0009393386426381767
type I-Disease 0 1.962740861927159e-05
1 I-Disease 0 0.00023661789600737393
( O 0 1.0936525463023372e-08
NF1 B-Disease 0 3.716691935551353e-05
) O 0 3.82958864619809e-09
. O 0 3.178720220375908e-08

DNA O 0 2.992614156482887e-08
sequence O 0 5.861595098188843e-10
analysis O 0 1.038176836165583e-11
and O 0 9.033451070505905e-13
allele O 0 6.314544026553293e-11
- O 0 2.5793525301742726e-11
specific O 0 4.210270326820975e-11
amplification O 0 1.79839432234985e-09
in O 0 9.406723316951471e-11
two O 0 6.989816364599832e-11
siblings O 0 2.655969222331578e-09
revealed O 0 5.57333690309747e-09
a O 0 5.4990834108537e-09
homozygous O 0 2.145609556691852e-08
MLH1 O 0 4.173863271716982e-05
mutation O 0 1.5923698981623602e-07
( O 0 3.875571252809351e-10
C676T O 0 1.338764946012816e-06
- O 0 3.255669298596331e-07
- O 0 2.2111723296802666e-07
> O 0 8.397378223889973e-07
Arg226Stop O 0 5.682965820597019e-06
) O 0 1.0463843125307903e-09
. O 0 9.85211823234522e-09

Thus O 0 5.366476329982106e-07
, O 0 3.655592273332786e-09
a O 0 6.659274465192766e-09
homozygous O 0 1.927083204122937e-08
germ O 0 1.582171353220474e-05
- O 0 2.9442219329212094e-07
line O 0 1.7638878091474908e-07
MLH1 O 0 6.348131864797324e-05
mutation O 0 3.777430634954726e-08
and O 0 1.7630946702595907e-10
consequent O 0 1.2811997294193134e-05
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 1.523039259154757e-06
in O 0 8.662198736075766e-10
a O 0 2.542461796650741e-10
mutator O 0 2.619446490825794e-07
phenotype O 0 1.4853275942527944e-08
characterized O 0 1.5938353414846063e-10
by O 0 2.6982140480247274e-11
leukemia B-Disease 1 0.9999992847442627
and O 0 1.245395378646208e-05
/ O 1 1.0
or O 1 1.0
lymphoma B-Disease 1 1.0
associated O 1 0.9849668145179749
with O 0 2.437812396394179e-09
neurofibromatosis B-Disease 1 0.9999785423278809
type I-Disease 0 0.03763755410909653
1 I-Disease 0 0.0001567041763337329
. O 0 1.2059906850936386e-08
. O 0 2.2891706308314497e-08

Missense O 0 0.0009089550585485995
mutations O 0 1.028949463943718e-05
in O 0 8.657925043564774e-09
the O 0 4.094264038911888e-09
most O 0 9.51862269560344e-11
ancient O 0 1.364690360716736e-09
residues O 0 1.7272029140258383e-07
of O 0 7.188341033526058e-10
the O 0 6.811212704960212e-10
PAX6 O 0 4.586328941513784e-06
paired O 0 6.812901909292179e-10
domain O 0 1.3734649861874004e-08
underlie O 0 2.3952718919417748e-08
a O 0 1.0779904746627267e-10
spectrum O 0 4.289371986487822e-07
of O 0 8.662752293275844e-08
human O 1 0.9526663422584534
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 0.001238602097146213

Mutations O 0 1.45855540267803e-06
of O 0 1.8567675397207495e-08
the O 0 8.560611663988027e-10
human O 0 9.698094549648317e-10
PAX6 O 0 1.1514005564094987e-05
gene O 0 1.6077843056905294e-08
underlie O 0 0.006638520862907171
aniridia B-Disease 1 1.0
( O 1 0.9999868869781494
congenital B-Disease 1 1.0
absence I-Disease 1 0.9999998807907104
of I-Disease 0 0.029869763180613518
the I-Disease 0 5.381385221880919e-07
iris I-Disease 0 2.340822220503469e-06
) O 0 3.474940890590972e-10
, O 0 2.5235940073753405e-11
a O 0 2.945046151392461e-10
rare O 0 1.445255115584132e-08
dominant O 1 0.9990578293800354
malformation B-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 1 0.9999828338623047
eye I-Disease 1 0.9999954700469971
. O 0 6.084430879127467e-06

The O 0 3.379408397563566e-08
spectrum O 0 8.126243642436748e-07
of O 0 7.171010452111659e-08
PAX6 O 0 0.0033527868799865246
mutations O 0 3.500747880025301e-06
in O 0 2.326062542579166e-08
aniridia B-Disease 1 1.0
patients O 0 1.7815182218328118e-06
is O 0 8.609945395532392e-11
highly O 0 3.428433578700485e-11
biased O 0 1.2079560685052115e-09
, O 0 1.0698452757376686e-12
with O 0 8.721365643560297e-14
92 O 0 1.4328972453014899e-09
% O 0 5.239009226443159e-10
of O 0 2.0852460036469012e-10
all O 0 4.924539595552169e-11
reported O 0 1.622406764489881e-09
mutations O 0 8.769911907791084e-09
leading O 0 8.73806693668655e-10
to O 0 5.867389352154362e-10
premature O 0 4.510570406068837e-08
truncation O 0 2.585849756542302e-07
of O 0 3.910414392294115e-08
the O 0 3.0889573121584135e-09
protein O 0 7.1693122549731925e-09
( O 0 5.851393675149197e-11
nonsense O 0 1.5639336936601467e-08
, O 0 5.551179307894394e-11
splicing O 0 2.0739057693397456e-10
, O 0 3.9367489303165915e-12
insertions O 0 9.256240912636216e-11
and O 0 2.5883913068458497e-11
deletions O 0 1.0365396319045317e-09
) O 0 2.6938635350193252e-11
and O 0 8.46728243075745e-11
just O 0 3.96731358875968e-09
2 O 0 2.337394633400436e-08
% O 0 1.0294977093039392e-09
leading O 0 6.310402894671441e-11
to O 0 3.880510149323335e-11
substitution O 0 5.39427225110245e-10
of O 0 1.28455346359857e-09
one O 0 2.209700061817088e-10
amino O 0 2.6902091665448324e-10
acid O 0 5.5999489767533106e-11
by O 0 2.3347966355419247e-12
another O 0 2.918095209913929e-10
( O 0 1.177824171527675e-09
missense O 0 3.446802338658017e-06
) O 0 1.0214670886909971e-08
. O 0 5.427975580118982e-08

The O 0 4.6412083065661136e-08
extraordinary O 0 2.1052095178220043e-08
conservation O 0 7.80474973538503e-09
of O 0 3.882824284318076e-09
the O 0 3.627289579810622e-09
PAX6 O 0 3.6092937989451457e-06
protein O 0 4.41917080706844e-08
at O 0 9.668695177822428e-09
the O 0 1.5488113014328064e-09
amino O 0 4.661586672227713e-08
acid O 0 1.1195796645324663e-07
level O 0 1.1127473271699273e-06
amongst O 0 3.65221919373937e-09
vertebrates O 0 5.0741189028258304e-08
predicts O 0 3.480463206528839e-08
that O 0 1.7641811622670645e-10
pathological O 0 4.777889898832655e-06
missense O 0 3.842827482003486e-06
mutations O 0 3.468588261057448e-07
should O 0 4.662595864957098e-10
in O 0 9.711301207637746e-12
fact O 0 1.2585971327638834e-11
be O 0 2.2620660553029914e-11
common O 0 5.4628024326319746e-11
even O 0 9.40488919382032e-12
though O 0 2.495895634266332e-12
they O 0 2.800649902962027e-12
are O 0 7.586020570396479e-13
hardly O 0 7.65697172333546e-10
ever O 0 7.998979256740313e-10
seen O 0 1.1361145357824398e-09
in O 0 1.4436509765403116e-09
aniridia B-Disease 1 1.0
patients O 0 5.824888944516715e-07
. O 0 2.780844567951135e-07

This O 0 2.641737051334303e-09
indicates O 0 4.675832165901284e-09
that O 0 1.570154249674882e-11
there O 0 1.00795665217146e-11
is O 0 2.2782069199894783e-12
a O 0 1.7630164689252936e-11
heavy O 0 1.2384058223346983e-08
ascertainment O 0 5.743656856793677e-07
bias O 0 5.779548928330769e-08
in O 0 5.589384857729307e-11
the O 0 3.742278709140123e-11
selection O 0 7.532766771456423e-11
of O 0 1.3348577798666383e-10
patients O 0 2.4245848384563118e-11
for O 0 3.610809221066269e-11
PAX6 O 0 5.031924388276821e-07
mutation O 0 4.097326922192224e-09
analysis O 0 7.298112114639821e-11
and O 0 2.080163081716324e-12
that O 0 3.8598542764778365e-12
the O 0 4.802764297373585e-10
missing O 0 1.359847878745768e-08
PAX6 O 0 6.992949056439102e-05
missense O 0 4.0057580918073654e-05
mutations O 0 9.04189903394581e-07
frequently O 0 5.196771346582807e-10
may O 0 2.0876784745382793e-09
underlie O 0 2.566267482961848e-07
phenotypes O 0 3.546064419879258e-08
distinct O 0 1.8316927141714956e-10
from O 0 6.215997161440612e-10
textbook O 0 5.596357937065477e-07
aniridia B-Disease 1 1.0
. O 0 3.4017625694104936e-07

Here O 0 1.4694187200348097e-07
we O 0 2.786140873567433e-09
present O 0 1.1298062485565197e-10
four O 0 9.184308695509014e-12
novel O 0 1.8107154664548375e-10
PAX6 O 0 1.4792343563385657e-06
missense O 0 1.5914878304101876e-06
mutations O 0 5.046967430644145e-07
, O 0 1.5060916402909186e-10
two O 0 1.0961360291661393e-11
in O 0 4.221439170448704e-11
association O 0 7.278969788027112e-11
with O 0 2.4481637203588313e-11
atypical O 0 4.068569978699088e-07
phenotypes O 0 8.309572763209871e-07
ectopia B-Disease 0 1.2897097803943325e-05
pupillae I-Disease 0 5.453292033053003e-06
( O 0 9.488605734464528e-11
displaced B-Disease 0 3.557769412410039e-09
pupils I-Disease 0 7.503403454123259e-10
) O 0 1.0817184648015399e-10
and O 0 4.900924466255674e-08
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9963932633399963
( O 0 3.557423022826356e-09
searching B-Disease 0 3.0881935231263924e-07
gaze I-Disease 0 2.7506862920745334e-07
) O 0 2.2259766946364223e-11
, O 0 1.1367571814413502e-11
and O 0 1.2960625628277711e-11
two O 0 1.2104826689618431e-11
in O 0 7.888462105754002e-11
association O 0 1.4362236400167205e-10
with O 0 2.767156989658126e-11
more O 0 4.298007227898637e-10
recognizable O 0 6.248180284273985e-07
aniridia B-Disease 1 1.0
phenotypes O 0 2.5159399228869006e-05
. O 0 1.833292344599613e-07

Strikingly O 0 1.9991668978036614e-06
, O 0 7.313698979771743e-09
all O 0 6.529522478260219e-10
four O 0 6.616095865608074e-11
mutations O 0 1.3809875465398136e-09
are O 0 3.504383415398049e-12
located O 0 2.1198783006770583e-10
within O 0 1.957402906427319e-09
the O 0 2.412814170682509e-09
PAX6 O 0 3.614016122810426e-06
paired O 0 2.7264266400095494e-09
domain O 0 7.282701375288525e-08
and O 0 1.6827844673272807e-09
affect O 0 4.524572361219725e-08
amino O 0 3.920818159031114e-08
acids O 0 1.0870053746003805e-09
which O 0 2.5868896868369573e-12
are O 0 1.9699923116400786e-12
highly O 0 2.0201366621175332e-11
conserved O 0 4.558845800861633e-10
in O 0 5.409301478964679e-11
all O 0 2.6548726758668373e-11
known O 0 1.5943521503025693e-10
paired O 0 3.7734376734377406e-10
domain O 0 1.475723543364893e-08
proteins O 0 1.0293406127459548e-09
. O 0 1.8258021761141663e-09

Our O 0 7.247808753163554e-08
results O 0 6.220539638945866e-10
support O 0 1.5206162717884553e-10
the O 0 7.408828411881174e-11
hypothesis O 0 1.736124716211762e-10
that O 0 1.2112527777649595e-13
the O 0 5.940971998207034e-13
under O 0 8.234300394316385e-12
- O 0 1.047709401874597e-11
representation O 0 7.243693839198428e-11
of O 0 2.3215480926541687e-10
missense O 0 2.566137709436589e-06
mutations O 0 3.913892214768566e-07
is O 0 3.2076816897097515e-11
caused O 0 1.8839560467220906e-10
by O 0 1.0950932001485558e-11
ascertainment O 0 1.9681012872752035e-06
bias O 0 8.974872685030277e-07
and O 0 5.867509950130412e-11
suggest O 0 1.6667671409731355e-10
that O 0 4.167974288187687e-13
a O 0 3.5486823982827653e-12
substantial O 0 3.086511601857467e-10
burden O 0 3.578576013296697e-08
of O 0 1.615148725875315e-08
PAX6 B-Disease 1 0.9999996423721313
- I-Disease 1 0.9931730628013611
related I-Disease 1 0.9997788071632385
disease I-Disease 1 1.0
remains O 0 3.5858253255582895e-08
to O 0 3.924569835778158e-10
be O 0 7.632257048584279e-10
uncovered O 0 7.28082696355159e-08
. O 0 7.581692496039238e-10
. O 0 7.441522953399726e-09

The O 0 1.6272762692892684e-08
chromosomal O 0 4.838291260966798e-07
order O 0 5.503721478561374e-09
of O 0 1.4007305537688808e-08
genes O 0 1.49173846608619e-08
controlling O 0 3.329042328914511e-06
the O 0 2.0857651605865613e-08
major O 0 3.2603736599412514e-07
histocompatibility O 0 0.005624392069876194
complex O 0 8.053636975091649e-07
, O 0 2.5918892032628094e-11
properdin O 0 3.779648594104401e-09
factor O 0 3.035143525398354e-10
B O 0 2.1374157554987505e-08
, O 0 1.4995831182709751e-12
and O 0 2.0583385690331468e-11
deficiency B-Disease 0 7.914884918136522e-06
of I-Disease 0 4.3088562961202115e-05
the I-Disease 0 3.786989850596001e-07
second I-Disease 0 5.725260265876386e-08
component I-Disease 0 2.2925483733615692e-08
of I-Disease 0 1.5197770153463352e-08
complement I-Disease 0 9.085532326480461e-09
. O 0 7.150264735855671e-08

The O 0 6.030884236452039e-08
relationship O 0 9.251414745392594e-09
of O 0 1.050019537984781e-08
the O 0 1.4018256555559105e-09
genes O 0 9.599135375459866e-11
coding O 0 1.1190364190838409e-09
for O 0 1.3347355165560515e-10
HLA O 0 6.50623164233366e-08
to O 0 4.794170060939962e-10
those O 0 1.0601118941022669e-11
coding O 0 9.249040422432131e-11
for O 0 5.909444374813111e-12
properdin O 0 2.4876676274487863e-09
Factor O 0 2.0700051395206032e-10
B O 0 8.093515302398657e-10
allotypes O 0 1.4995968911080126e-09
and O 0 3.99289802610614e-12
for O 0 3.8465463453318804e-11
deficiency B-Disease 0 3.7129746033315314e-06
of I-Disease 0 1.4157567420625128e-06
the I-Disease 0 1.2145733307988849e-08
second I-Disease 0 1.0724783283677652e-09
component I-Disease 0 5.517992729409116e-10
of I-Disease 0 6.825049414516116e-10
complement I-Disease 0 2.330607928868744e-10
( O 0 9.812519546903431e-11
C2 O 0 2.9627807407450746e-07
) O 0 1.1013962311623438e-11
was O 0 2.6455931889657336e-10
studied O 0 5.681499368193066e-11
in O 0 1.294710432614421e-12
families O 0 1.7695647464704978e-12
of O 0 6.145896291886999e-11
patients O 0 1.4312603879851338e-10
with O 0 1.1336873800837921e-10
connective O 1 0.9999984502792358
tissue O 1 1.0
disorders O 1 1.0
. O 0 1.6097694242489524e-05

Patients O 0 3.542647846188629e-06
were O 0 3.4938036908016556e-09
selected O 0 6.026874138642668e-11
because O 0 3.5508644635751097e-11
they O 0 6.793431268914407e-12
were O 0 6.156933470002901e-12
heterozygous O 0 1.1920409104249075e-11
or O 0 4.28087509884989e-10
homozygous O 0 1.354122591834539e-08
for O 0 1.1408396716205971e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 4.2254385334672406e-05

12 O 0 1.4033506658961414e-06
families O 0 2.8566549126196605e-09
with O 0 1.48716303161045e-10
15 O 0 4.4624531625458985e-08
matings O 0 9.483223948336672e-07
informative O 0 1.0165230435177364e-07
for O 0 8.867589258443331e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 3.1289732760342304e-07
found O 0 6.9944783298581115e-09
. O 0 8.392092354370106e-09

Of O 0 6.385676442732802e-06
57 O 0 1.3001680372326518e-06
informative O 0 3.2679466244189825e-08
meioses O 0 4.1580069591873325e-06
, O 0 3.9857267486453907e-10
two O 0 9.330186796774331e-12
crossovers O 0 1.6094210686379284e-10
were O 0 7.503113408358075e-11
noted O 0 3.844206897252178e-11
between O 0 1.119369374968926e-09
the O 0 1.0399406846772763e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 2.9935716128193235e-09
and O 0 1.0784675930075593e-10
the O 0 4.399973441149285e-10
HLA O 0 3.2373122849094216e-08
- O 0 2.0009046863833646e-08
B O 0 1.5217732141081797e-07
gene O 0 5.826124999108728e-11
, O 0 1.4593571576876352e-12
with O 0 1.9099928886753825e-13
a O 0 5.6508710905012194e-11
recombinant O 0 3.915244864427514e-11
fraction O 0 4.370842354717297e-09
of O 0 5.9069291680202696e-09
0 O 0 1.6545210712592961e-07
. O 0 3.4408202509439434e-08

035 O 0 0.0058320011012256145
. O 0 1.4057742191653233e-05

A O 0 4.11976725445129e-06
lod O 0 4.5825610868632793e-05
score O 0 4.442809142801707e-08
of O 0 1.6507211153538037e-09
13 O 0 4.6558421007425466e-10
was O 0 8.702833592666437e-11
calculated O 0 3.7870287461494456e-10
for O 0 4.0441840848393085e-11
linkage O 0 6.069334972380602e-07
between O 0 0.017304716631770134
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.4870715858705807e-07
HLA O 0 1.0425150094306446e-06
- O 0 2.2273432875863364e-08
B O 0 1.6093860466526166e-08
at O 0 5.866130064341446e-12
a O 0 1.4763221840765478e-13
maximum O 0 1.9399693657051742e-11
likelihood O 0 3.038953463874172e-11
value O 0 1.1994096688061617e-11
of O 0 1.731358632850455e-11
the O 0 1.0782880664750305e-11
recombinant O 0 5.9739505009481775e-12
fraction O 0 4.4796322207218964e-10
of O 0 4.813668352809941e-10
0 O 0 4.029906719438259e-08
. O 0 1.3509288798729813e-08

04 O 0 0.003590752137824893
. O 0 1.216140117321629e-05

18 O 0 3.208686166544794e-06
families O 0 2.9930178335746405e-09
with O 0 4.780270276838472e-11
21 O 0 9.313966486956815e-09
informative O 0 6.284101572440193e-10
matings O 0 6.649478478948367e-08
for O 0 1.1549190076509674e-10
both O 0 2.715997982072338e-10
properdin O 0 3.0395267458516173e-07
Factor O 0 1.3310505586616728e-08
B O 0 3.246265123379999e-08
allotype O 0 1.6023777860141308e-08
and O 0 1.8223916820048203e-10
HLA O 0 4.781408335929882e-08
- O 0 6.772133964716431e-09
B O 0 8.837418619123127e-08
were O 0 2.0423215896236968e-10
found O 0 1.963448292841008e-10
. O 0 1.8001616863827508e-09

Of O 0 2.3925127607071772e-05
72 O 0 4.841175723413471e-06
informative O 0 7.186482520182835e-08
meioses O 0 1.5555078789475374e-05
, O 0 1.8817125635450793e-09
three O 0 2.3158254480737384e-10
recombinants O 0 1.1931628023376106e-06
were O 0 4.258611685514779e-09
found O 0 4.3449066566836336e-10
, O 0 1.2093472057106425e-11
giving O 0 5.9567468145560465e-12
a O 0 5.774273073577696e-11
recombinant O 0 4.0493629283044896e-11
fraction O 0 1.6689764237298732e-08
of O 0 1.523474502107547e-08
0 O 0 2.604597852950974e-07
. O 0 4.538946640764152e-08

042 O 0 0.009501074440777302
. O 0 1.718368730507791e-05

A O 0 2.0267643776605837e-06
lod O 0 2.8183207177789882e-05
score O 0 3.494605138598672e-08
of O 0 3.4051061970075125e-09
16 O 0 3.2941789296359048e-09
between O 0 4.743445636279375e-09
HLA O 0 1.1199975915587856e-06
- O 0 4.227303307402508e-08
B O 0 4.756303795261374e-08
and O 0 8.57035623025304e-12
Factor O 0 8.865464612428653e-11
B O 0 1.3201777449012297e-09
allotypes O 0 2.169757706838027e-09
was O 0 4.523176624915415e-11
calculated O 0 1.4552060945138834e-10
at O 0 1.927815372615438e-11
a O 0 1.3194809828087628e-12
maximum O 0 1.1983859737885183e-10
likelihood O 0 1.4623149913184363e-10
value O 0 6.989576972760148e-11
of O 0 7.025396236981507e-11
the O 0 1.9706396237051393e-11
recombinant O 0 2.6102091408436445e-12
fraction O 0 5.408169467813195e-10
of O 0 2.89969159794623e-10
0 O 0 1.4750819232745016e-08
. O 0 4.910540862823609e-09

04 O 0 0.0036784671247005463
. O 0 1.2330881872912869e-05

A O 0 1.1808393907131176e-07
crossover O 0 1.2872079402370673e-08
was O 0 3.2896330104392746e-09
shown O 0 2.880298430318895e-11
to O 0 1.156267928625887e-10
have O 0 2.041549221343253e-11
occurred O 0 1.1752053774571891e-09
between O 0 2.255646364135444e-11
genes O 0 2.0491869919675443e-12
for O 0 5.397979697778499e-13
Factor O 0 4.0633724683603045e-12
B O 0 4.5598111397815444e-10
and O 0 9.845359770499496e-12
HLA O 0 1.2254385239884868e-07
- O 0 3.681505233998905e-07
D O 0 1.543108538726301e-07
, O 0 5.8034330813194757e-11
in O 0 4.1597905675594404e-11
which O 0 1.4766146638756084e-10
HLA O 0 8.407012330735597e-08
- O 0 2.032290247200308e-08
D O 0 7.629436638012521e-09
segregared O 0 3.967345563182789e-08
with O 0 8.196165274254597e-11
HLA O 0 4.0038045767687436e-07
- O 0 1.2153241968348993e-08
A O 0 7.79790809701808e-08
and O 0 1.0561471697201341e-09
B O 0 9.018973514685058e-07
. O 0 6.558270815304468e-09

These O 0 4.182069801572652e-09
studies O 0 4.936833719604294e-10
suggest O 0 2.045323355126527e-10
that O 0 2.5950634870153255e-12
the O 0 4.671528355121302e-12
genes O 0 5.30121140127765e-13
for O 0 4.913866622630048e-13
Factor O 0 1.7446193101289253e-10
B O 0 8.50023866405536e-07
and O 0 5.3003759603598155e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 6.753181902574568e-10
located O 0 4.0999512118666814e-10
outside O 0 1.7667167728774302e-10
those O 0 4.950991873420296e-12
for O 0 4.876654635666e-11
HLA O 0 2.180005509444527e-07
, O 0 4.66691529171781e-12
that O 0 4.698405293296348e-13
the O 0 1.6091431572634596e-12
order O 0 5.1901694747558125e-12
of O 0 1.6956444928717396e-11
genese O 0 1.2760683176793464e-08
is O 0 1.6363817245679257e-10
HLA O 0 4.6054150715235664e-08
- O 0 4.402267439473917e-09
A O 0 5.386741008805984e-08
, O 0 6.632547289164847e-11
- O 0 1.0261258509558502e-09
B O 0 7.335481910786257e-08
, O 0 6.072232300313729e-11
- O 0 3.2420315321246562e-09
D O 0 8.423604924701067e-09
, O 0 6.348769426844925e-11
Factor O 0 1.2752718880904013e-09
B O 0 1.0087259028068729e-07
allotype O 0 3.4252409477630863e-06
, O 0 1.1360636165136384e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 1.9758043812156956e-10
that O 0 4.680081409219605e-12
the O 0 2.609548341303558e-11
genes O 0 1.7032293977981006e-11
coding O 0 2.929629649983667e-09
for O 0 5.362893240601352e-09
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.5747184889391974e-08
Factor O 0 1.552923833969544e-08
B O 0 2.83412280310813e-08
allotypes O 0 4.059768965447574e-09
are O 0 4.878984586134671e-13
approximately O 0 5.034582993557191e-12
3 O 0 5.4773255375728525e-11
- O 0 7.711533495102785e-11
- O 0 2.588343428477913e-10
5 O 0 6.03136263155335e-10
centimorgans O 0 2.7426003690322887e-09
from O 0 8.441223414701327e-11
the O 0 1.0441389419746372e-10
HLA O 0 5.507459377440682e-09
- O 0 1.6931052393420742e-10
A O 0 1.8160705161918145e-09
and O 0 3.360659667217547e-11
HLA O 0 2.51657894523305e-09
- O 0 4.2765499475017066e-10
B O 0 1.0146804285682265e-08
loci O 0 7.676376201359858e-10
, O 0 9.604089442130648e-13
and O 0 9.669298510744245e-14
that O 0 2.191526582602521e-13
the O 0 7.324800488373029e-12
apparent O 0 4.8950177244933e-09
lack O 0 3.7688070442243315e-09
of O 0 5.980614337097734e-10
recombinants O 0 3.4957118089096184e-08
between O 0 1.3255168074266521e-09
the O 0 4.89441764894849e-10
Factor O 0 7.324779671691317e-10
B O 0 3.70172692498727e-08
gene O 0 1.9496677605701507e-09
and O 0 9.902174191722679e-09
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.7810778629723245e-08
suggests O 0 3.4560035389041843e-10
that O 0 3.997675888239849e-12
these O 0 1.7545485463815735e-12
two O 0 8.182478132556792e-12
genes O 0 3.617449118031857e-10
lie O 0 2.575723456743617e-08
in O 0 1.7424036172219992e-11
close O 0 2.537226206911214e-09
proximity O 0 1.1511726683011148e-08
to O 0 9.260665123633771e-09
one O 0 2.285574396410084e-09
another O 0 9.23744991609965e-09
. O 0 2.9421295622000798e-08

Distribution O 0 1.9623838909410551e-07
of O 0 1.813253902582801e-08
emerin O 0 5.359697388485074e-05
and O 0 9.854411509024885e-09
lamins O 0 0.0002242666232632473
in O 0 9.355612284878134e-09
the O 0 2.3337328514116962e-08
heart O 0 2.1384519754974463e-07
and O 0 5.778922479438009e-11
implications O 0 2.3070104049338624e-08
for O 0 3.637138923373584e-10
Emery B-Disease 0 0.00445654708892107
- I-Disease 1 0.9833374619483948
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0003256155177950859

Emerin O 0 0.0045024133287370205
is O 0 2.696273604385624e-08
a O 0 2.1738502109514e-09
nuclear O 0 2.5780957457754994e-07
membrane O 0 2.0917918508445155e-09
protein O 0 3.63701430083907e-10
which O 0 1.9030157224347866e-12
is O 0 2.1494975938063376e-11
missing O 0 3.453848873569143e-10
or O 0 1.5893060478777699e-10
defective O 0 2.5566151862221886e-08
in O 0 3.5426400701865646e-10
Emery B-Disease 0 0.0013592737959697843
- I-Disease 1 0.936826229095459
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.34898698181496e-06
EDMD B-Disease 1 1.0
) O 0 7.709045490855715e-08
. O 0 2.051737624242378e-07

It O 0 1.8998587425489433e-10
is O 0 1.604522417708587e-11
one O 0 1.4732801784100857e-11
member O 0 1.921065216625717e-11
of O 0 9.02159666416047e-11
a O 0 1.400521365546581e-09
family O 0 9.908781573031433e-10
of O 0 2.0078626761232954e-08
lamina O 1 0.9994768500328064
- O 0 9.152269922196865e-05
associated O 0 1.3840424628597248e-07
proteins O 0 8.430701275985442e-11
which O 0 6.79918621404596e-12
includes O 0 4.227206258644589e-12
LAP1 O 0 3.218122219550423e-05
, O 0 8.336634160777123e-10
LAP2 O 0 0.0001275969116250053
and O 0 1.0266765215760643e-08
lamin O 0 6.119871159171453e-06
B O 0 4.948362857248867e-06
receptor O 0 9.100700708586373e-07
( O 0 6.477786307357292e-09
LBR O 0 4.459689534996869e-06
) O 0 1.6356086485203036e-09
. O 0 1.6947870662420428e-08

A O 0 1.2365183465590235e-05
panel O 0 3.5761647154686216e-07
of O 0 3.885330102093576e-08
16 O 0 6.6883227844982684e-09
monoclonal O 0 4.201552161742228e-10
antibodies O 0 1.3581052948907768e-09
( O 0 3.47483486429212e-10
mAbs O 0 5.0286431019230804e-08
) O 0 4.8929402196584704e-11
has O 0 3.150960048436957e-11
been O 0 2.4779574225863854e-11
mapped O 0 2.4738122661460693e-10
to O 0 1.483516781641825e-10
six O 0 2.2554142581343584e-11
specific O 0 2.2746951891527978e-11
sites O 0 2.0667111078065403e-10
throughout O 0 4.410516396546882e-11
the O 0 3.4121977465773057e-10
emerin O 0 3.014175931070895e-08
molecule O 0 1.1777567809900802e-09
using O 0 7.813797525679789e-11
phage O 0 6.191019363832595e-10
- O 0 1.025839621582314e-10
displayed O 0 1.255925745347053e-11
peptide O 0 3.33952421271988e-10
libraries O 0 1.417648637369595e-10
and O 0 3.8584576506073276e-11
has O 0 1.1865173774050497e-11
been O 0 6.003878384036598e-12
used O 0 1.3177757496318776e-12
to O 0 6.432949312129566e-11
localize O 0 1.0596854593813987e-07
emerin O 0 1.928636720549548e-06
in O 0 7.879654151388138e-10
human O 0 2.4033617318508504e-09
and O 0 2.189269737717936e-10
rabbit O 0 6.813960595764001e-08
heart O 0 1.541549522698915e-06
. O 0 3.1778839115759183e-07

Several O 0 3.6110279211243324e-08
mAbs O 0 6.725192065459851e-07
against O 0 7.218791786556267e-09
different O 0 8.963593201016806e-10
emerin O 0 8.469029353364022e-07
epitopes O 0 6.272443329180533e-07
did O 0 9.486533336655611e-09
not O 0 6.061485202657479e-10
recognize O 0 5.814682069171795e-10
intercalated O 0 1.0064520772345986e-08
discs O 0 1.2986842534701282e-07
in O 0 9.955668511807403e-10
the O 0 5.462766239361372e-09
heart O 0 9.457131682211184e-07
, O 0 6.894994991624159e-11
though O 0 1.1085789404507995e-11
they O 0 1.6247114330986134e-12
recognized O 0 6.653602148409821e-12
cardiomyocyte O 0 1.0618377288551528e-08
nuclei O 0 1.1397554544601007e-07
strongly O 0 1.1233096230967021e-08
, O 0 2.017034594903322e-10
both O 0 7.872108520601273e-11
at O 0 1.3275617050112487e-08
the O 0 3.5922428920365235e-10
rim O 0 2.5257600455574902e-08
and O 0 8.94338630930136e-11
in O 0 2.9858718275654894e-10
intranuclear O 0 9.277283652409096e-07
spots O 0 2.706444490740978e-08
or O 0 3.026173756026651e-09
channels O 0 1.7830518572736764e-07
. O 0 3.1548015755333836e-08

A O 0 2.616710389702348e-06
polyclonal O 0 1.7038547639458557e-06
rabbit O 0 2.000805565671726e-08
antiserum O 0 9.029958647488456e-08
against O 0 3.306114848555808e-08
emerin O 0 9.482107998337597e-06
did O 0 3.252190339253502e-08
recognize O 0 8.935739259641196e-09
both O 0 2.0493071684057895e-09
nuclear O 0 2.139105845344602e-06
membrane O 0 2.2742431937672336e-08
and O 0 1.1920166242962438e-10
intercalated O 0 7.706464355550224e-10
discs O 0 6.938590590976901e-09
but O 0 1.201672789052921e-10
, O 0 6.025790977304268e-12
after O 0 3.643024770738634e-11
affinity O 0 3.17917601966311e-11
purification O 0 3.679252735810934e-11
against O 0 5.46974653070631e-11
a O 0 7.494159459664473e-11
pure O 0 1.7560645160230592e-09
- O 0 1.0366938418826521e-09
emerin O 0 6.578481759333954e-08
band O 0 6.808484886988708e-10
on O 0 6.514408457114484e-10
a O 0 5.5662346259977014e-11
western O 0 9.951851565048742e-10
blot O 0 2.150166892533889e-06
, O 0 1.2743667232584244e-10
it O 0 2.7398267682388067e-11
stained O 0 6.791316398135905e-09
only O 0 1.2460487086585204e-09
the O 0 2.7493096688147034e-09
nuclear O 0 3.823733550234465e-06
membrane O 0 7.838391979930748e-07
. O 0 5.7446982282272074e-08

These O 0 1.5970130773368396e-09
results O 0 8.455973143917106e-10
would O 0 5.75286096538008e-10
not O 0 3.09336556369999e-10
be O 0 2.499104256870055e-10
expected O 0 6.6721539404568375e-09
if O 0 3.4165954510001484e-09
immunostaining O 0 6.112686037340609e-07
at O 0 2.6760666571590264e-08
intercalated O 0 4.180817914090085e-09
discs O 0 2.037440616220465e-08
were O 0 7.310403393745446e-10
due O 0 1.044522424109573e-08
to O 0 1.0118153537241881e-10
a O 0 4.750095455863246e-11
product O 0 1.0205586375988673e-10
of O 0 6.679264780151684e-11
the O 0 8.066325385414075e-11
emerin O 0 9.063916905915903e-08
gene O 0 8.953238150866127e-10
and O 0 3.831710990165327e-11
, O 0 2.958443906520003e-11
therefore O 0 1.3962112577203811e-09
, O 0 6.093731075296205e-11
cast O 0 9.595255145988801e-11
some O 0 1.3682223756750211e-12
doubt O 0 7.376257243896234e-11
upon O 0 2.8456995440628852e-11
the O 0 3.714039492619392e-12
hypothesis O 0 2.2592472337379377e-10
that O 0 3.45765673037679e-11
cardiac B-Disease 0 0.00043486381764523685
defects I-Disease 0 0.04008214920759201
in O 0 1.8345160057720022e-08
EDMD B-Disease 1 1.0
are O 0 1.2892614753567955e-09
caused O 0 4.7542176417891824e-08
by O 0 2.9855928840305523e-10
absence O 0 8.935265327636444e-08
of O 0 3.9136974550046943e-08
emerin O 0 4.893008281214861e-06
from O 0 1.3560719480665284e-07
intercalated O 0 3.71169278423622e-07
discs O 0 4.4591110963665415e-06
. O 0 2.0458917049381853e-07

Although O 0 3.580972673944416e-08
emerin O 0 4.104942490812391e-05
was O 0 4.447422270459356e-07
abundant O 0 1.7461115886518996e-09
in O 0 5.900437083372623e-11
the O 0 2.0252921562047277e-10
membranes O 0 1.496385459986982e-09
of O 0 3.5406151344119507e-09
cardiomyocyte O 0 1.2645300557778683e-06
nuclei O 0 2.470802655807347e-06
, O 0 1.5017286025820198e-10
it O 0 3.943258566896368e-11
was O 0 6.136578356574773e-09
absent O 0 2.354036965357409e-09
from O 0 1.241602237689321e-10
many O 0 1.0550347921689518e-11
non O 0 4.26026947053515e-09
- O 0 4.8407580166554e-09
myocyte O 0 6.172042077423612e-08
cells O 0 3.7321085111230445e-10
in O 0 5.543328296386818e-11
the O 0 7.424166281744249e-10
heart O 0 9.728541527920243e-08
. O 0 1.4309048879113107e-07

This O 0 7.617219077715731e-10
distribution O 0 2.4629944750387267e-09
of O 0 1.0579759290862967e-09
emerin O 0 2.267980789838475e-06
was O 0 3.035399931405891e-09
similar O 0 3.6246975473192e-12
to O 0 1.1885430140079478e-10
that O 0 2.095119910894283e-11
of O 0 1.728018395041886e-09
lamin O 0 3.0744809009775054e-06
A O 0 6.433118215909417e-08
, O 0 2.3892953587845156e-11
a O 0 3.776070428562761e-11
candidate O 0 3.1406890976803936e-10
gene O 0 5.944942454982893e-12
for O 0 1.6881375854496672e-12
an O 0 7.698934371969113e-12
autosomal O 0 1.258503488088536e-07
form O 0 7.702642506046686e-07
of O 1 0.9999690055847168
EDMD B-Disease 1 1.0
. O 0 0.0008075659279711545

In O 0 9.267383660471751e-08
contrast O 0 6.848736688880308e-08
, O 0 6.372654581809911e-08
lamin O 0 0.00029971887124702334
B1 O 0 0.001300412928685546
was O 0 1.767807589203585e-06
absent O 0 1.6120134205266368e-07
from O 0 2.1112130710321253e-08
cardiomyocyte O 0 5.198157396080205e-06
nuclei O 0 9.889464308798779e-06
, O 0 9.435064951546224e-10
showing O 0 4.844062373443592e-10
that O 0 5.175257444811621e-10
lamin O 0 4.39878795077675e-06
B1 O 0 1.5211217032629065e-06
is O 0 5.333468389157048e-11
not O 0 6.143845154849004e-11
essential O 0 1.0973352088106125e-10
for O 0 2.0714142207056696e-11
localization O 0 3.684342786414163e-08
of O 0 1.054414777712509e-08
emerin O 0 1.0875928637688048e-06
to O 0 3.569244100276592e-08
the O 0 2.682403277276535e-08
nuclear O 0 6.638771446887404e-05
lamina O 1 0.9994780421257019
. O 0 1.9321971649333136e-06

Lamin O 1 0.9912118315696716
B1 O 1 0.9295511841773987
is O 0 4.085472848913696e-09
also O 0 6.447838096779179e-11
almost O 0 4.6086970351133516e-10
completely O 0 2.4464494430276318e-08
absent O 0 4.249510610065954e-08
from O 0 5.0153263764229905e-09
skeletal O 0 8.127507271638024e-07
muscle O 0 5.414552788352012e-07
nuclei O 0 0.00024360278621315956
. O 0 2.04993170882517e-06

In O 0 8.774422894930467e-07
EDMD B-Disease 1 1.0
, O 0 6.199909030613071e-09
the O 0 5.658013502163328e-10
additional O 0 5.059211938274188e-10
absence O 0 1.9483826108057656e-08
of O 0 5.507210332211798e-08
lamin O 0 0.00014289953105617315
B1 O 0 0.369645893573761
from O 0 1.476015768275829e-06
heart O 1 0.9995644688606262
and O 0 1.2800519755273854e-07
skeletal O 0 3.488474976620637e-05
muscle O 0 5.124283234181348e-06
nuclei O 1 0.8068919777870178
which O 0 1.4773463874462323e-07
already O 0 5.140005754356025e-08
lack O 0 9.617769336500714e-08
emerin O 0 4.629401075817441e-07
may O 0 6.648204764481136e-10
offer O 0 5.4008887639955816e-11
an O 0 2.167872218544753e-12
alternative O 0 2.408040711276982e-10
explanation O 0 6.323032097910186e-10
of O 0 1.9992166255811128e-10
why O 0 9.513994453369534e-11
these O 0 8.217355615403044e-12
tissues O 0 4.4494027906516465e-10
are O 0 8.412191949969117e-12
particularly O 0 7.782948591161798e-11
affected O 0 4.218095206454109e-09
. O 0 1.9832206987757672e-09
. O 0 4.595903035919946e-08

Genetic O 0 1.4173710951581597e-06
mapping O 0 6.036541435605614e-07
of O 0 7.194244631136826e-07
the O 0 8.599618439575352e-08
copper B-Disease 0 9.561947081238031e-06
toxicosis I-Disease 1 0.7187213897705078
locus O 0 1.316034854426107e-06
in O 0 6.79556633187417e-09
Bedlington O 0 4.263783637270535e-07
terriers O 0 1.8886964880948653e-08
to O 0 1.226885038008163e-09
dog O 0 4.719188595458945e-09
chromosome O 0 6.900227162986994e-07
10 O 0 2.0030546110660907e-08
, O 0 1.302518249507445e-11
in O 0 1.3504218576709803e-11
a O 0 4.3966263962857965e-10
region O 0 5.686885273803455e-08
syntenic O 0 5.096499080536887e-06
to O 0 1.0133421213254223e-08
human O 0 4.270479525558812e-09
chromosome O 0 2.609468538139481e-06
region O 0 9.186163651975221e-07
2p13 O 0 4.125769919482991e-05
- O 0 8.003852940419165e-07
p16 O 0 8.771720558797824e-07
. O 0 3.417991933929443e-08

Abnormal O 1 0.9999980926513672
hepatic B-Disease 1 1.0
copper I-Disease 0 0.009653178974986076
accumulation I-Disease 0 0.0021566683426499367
is O 0 1.5150548871023517e-10
recognized O 0 1.0530665749131085e-11
as O 0 3.5387057867319882e-12
an O 0 1.4179596385943682e-10
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 0.2055143266916275
man O 0 0.03288460895419121
, O 0 5.651024648223313e-10
mouse O 0 5.985298656696614e-08
, O 0 9.617711071996382e-09
rat O 0 1.6470727359774173e-06
and O 0 5.269869429724849e-09
dog O 0 3.0794226404395886e-06
. O 0 4.1224336655432126e-07

The O 0 7.906036358917845e-08
major O 0 1.761154635460116e-07
cause O 0 0.00023188705381471664
of O 0 0.0001394857099512592
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 1.0
in O 0 3.720487075042911e-05
man O 0 9.38998709898442e-06
is O 0 2.110007168987238e-10
a O 0 2.9738453366512374e-10
dysfunctional O 0 4.8234888083698024e-08
ATP7B O 0 0.00018777755030896515
gene O 0 5.987649043248666e-09
, O 0 8.607909524060986e-11
causing O 0 4.321076687574532e-07
Wilson B-Disease 0 5.9145913837710395e-06
disease I-Disease 0 0.3409125506877899
( O 0 6.807683305964929e-09
WD B-Disease 0 0.03710009157657623
) O 0 1.8688940173205992e-08
. O 0 2.473744586950488e-07

Mutations O 0 2.8013266728521558e-06
in O 0 3.8948777536518264e-09
the O 0 8.800056683355706e-09
ATP7B O 1 0.9319208264350891
genes O 0 4.790664931419997e-08
have O 0 7.81259154591929e-11
also O 0 4.59219598111793e-12
been O 0 1.60129080134519e-11
demonstrated O 0 2.5292705430057794e-11
in O 0 8.517820476727778e-11
mouse O 0 2.0831807390209178e-08
and O 0 1.1850943337776698e-08
rat O 0 1.8855865846489905e-06
. O 0 5.1681801949143846e-08

The O 0 2.820700899519579e-07
ATP7B O 0 0.07585587352514267
gene O 0 1.932298410167732e-08
has O 0 2.3785884373239696e-10
been O 0 1.8713462723862762e-10
excluded O 0 3.3365845641952774e-09
in O 0 5.409022882374437e-11
the O 0 2.1275786687979803e-10
much O 0 9.39799460475399e-10
rarer O 0 3.556062040388497e-07
human O 0 3.9642969795750105e-08
copper B-Disease 0 1.946664724528091e-06
overload I-Disease 1 0.5730651021003723
disease O 1 0.9926344752311707
non B-Disease 0 1.599859047018981e-06
- I-Disease 0 5.493006227652586e-08
Indian I-Disease 0 1.5430446254072194e-08
childhood I-Disease 0 3.851052497338969e-06
cirrhosis I-Disease 1 0.9999980926513672
, O 0 7.674780255761959e-10
indicating O 0 4.290247446192552e-08
genetic O 0 7.340576075876015e-07
heterogeneity O 0 9.140763722825795e-06
. O 0 1.3581427538156277e-07

By O 0 1.111287728505772e-09
investigating O 0 4.043912582574194e-08
the O 0 9.419210300620762e-09
common O 0 1.5685694734202116e-06
autosomal O 1 0.9999758005142212
recessive O 1 1.0
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 0 4.379414804134285e-07
CT B-Disease 1 0.9998869895935059
) O 0 4.060109581871529e-09
in O 0 1.327445353638268e-08
Bedlington O 0 5.038881135988049e-05
terriers O 0 6.529095117002726e-06
, O 0 1.9106454196560207e-09
we O 0 4.253690732980431e-10
have O 0 4.382363829463776e-12
identified O 0 5.455135908966069e-12
a O 0 3.3466222956919645e-13
new O 0 5.316336902498088e-14
locus O 0 1.1839899720367253e-11
involved O 0 2.95276043199566e-12
in O 0 3.0323760863426585e-11
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0003468426293693483

We O 0 3.355548017225374e-07
examined O 0 4.643555229222329e-08
whether O 0 2.6643616202193243e-09
the O 0 1.153559026079165e-09
WD B-Disease 0 4.75880415251595e-06
gene O 0 1.77446235483103e-08
ATP7B O 0 0.2123035043478012
was O 0 9.301064096689515e-08
also O 0 1.5836264244395437e-10
causative O 0 1.788603820607193e-09
for O 0 1.5449985735216387e-10
CT B-Disease 0 2.2484772443931433e-07
by O 0 6.320616946497992e-11
investigating O 0 4.314107293623692e-09
the O 0 1.8565222692501493e-09
chromosomal O 0 2.1372950413933722e-06
co O 0 2.954157451995343e-08
- O 0 1.2377682878650376e-08
localization O 0 6.722934813296888e-07
of O 0 3.425296199566219e-06
ATP7B O 1 0.9932264685630798
and O 0 3.062068643089333e-08
C04107 O 0 3.4359914025117178e-06
, O 0 1.4133343106959018e-10
using O 0 4.4476550220551303e-10
fluorescence O 0 3.357340006004961e-08
in O 0 1.2077747690852902e-08
situ O 0 2.721897942592477e-07
hybridization O 0 1.7178876987600233e-08
( O 0 7.474834640142092e-10
FISH O 0 1.3194716075304314e-07
) O 0 6.308239486330081e-10
. O 0 7.65031860083809e-09

C04107 O 0 0.004024404101073742
is O 0 6.157401255535433e-09
an O 0 5.779330486399559e-11
anonymous O 0 1.999277549069589e-10
microsatellite O 0 8.057511280412655e-08
marker O 0 2.1599916522063722e-07
closely O 0 4.722889634933836e-09
linked O 0 2.66852140384799e-07
to O 0 8.45509191549354e-07
CT B-Disease 1 0.9999657869338989
. O 0 8.151794645527843e-06

However O 0 2.313154027433484e-06
, O 0 1.958485711384128e-07
BAC O 0 0.00043125124648213387
clones O 0 5.650512662214169e-07
containing O 0 8.328070677521282e-09
ATP7B O 0 0.00019420834723860025
and O 0 8.198706602513539e-09
C04107 O 0 2.9525574518629583e-06
mapped O 0 2.299686663320699e-08
to O 0 5.711449091450049e-09
the O 0 1.0512614112556662e-09
canine O 0 2.9149441971298984e-08
chromosome O 0 1.8624747326612123e-06
regions O 0 4.282178451830987e-07
CFA22q11 O 0 2.259322536701802e-05
and O 0 7.64442553702338e-09
CFA10q26 O 0 8.07726028142497e-05
, O 0 1.1509020403366321e-09
respectively O 0 4.929872954306802e-09
, O 0 6.734553192888626e-11
demonstrating O 0 4.935211961321073e-11
that O 0 2.5419513716151698e-11
WD B-Disease 0 4.2963151258845755e-07
cannot O 0 3.824728977974701e-08
be O 0 2.6281372633718547e-09
homologous O 0 2.619114924939936e-09
to O 0 2.3735511334166404e-08
CT B-Disease 0 0.00014141312567517161
. O 0 2.6232814320792386e-07

The O 0 2.8546576231747167e-06
copper O 0 1.8344167074246798e-06
transport O 0 1.2206213284571277e-07
genes O 0 8.037031484775525e-09
CTR1 O 0 3.815619493252598e-05
and O 0 6.227318105622714e-10
CTR2 O 0 0.0001854314177762717
were O 0 2.3329973508623425e-09
also O 0 3.013907179383324e-11
excluded O 0 1.1424794443826158e-09
as O 0 2.7613626663036683e-11
candidate O 0 2.060045245499964e-09
genes O 0 1.0914300713205094e-10
for O 0 7.568251580991614e-11
CT B-Disease 0 5.842661266797222e-05
since O 0 9.363577646581689e-08
they O 0 8.610043233936437e-11
both O 0 1.1540640838803018e-11
mapped O 0 1.5608278003398368e-09
to O 0 1.920649417286313e-09
canine O 0 5.6603834508450745e-08
chromosome O 0 2.6181050998275168e-05
region O 0 1.1288937457720749e-05
CFA11q22 O 0 0.0005936308880336583
. O 0 6.624653678954928e-07

2 O 0 5.478703315020539e-05
- O 0 6.859037966933101e-06
22 O 0 2.3668053472647443e-06
. O 0 7.541662228049972e-08

5 O 0 9.10050657694228e-05
. O 0 2.1293808458722197e-06

A O 0 1.8023602024186403e-06
transcribed O 0 3.0997654221209814e-08
sequence O 0 1.0801645133895477e-09
identified O 0 3.0611899126675723e-10
from O 0 5.234801134235134e-11
the O 0 7.714873184738735e-11
C04107 O 0 3.45300925630454e-08
- O 0 1.2423324591281926e-09
containing O 0 9.343441298437227e-11
BAC O 0 5.133008926350158e-06
was O 0 3.9774206150866576e-09
found O 0 1.613191351335086e-11
to O 0 4.105912485008467e-11
be O 0 5.021648374903265e-11
homologous O 0 1.3892083317035286e-10
to O 0 7.969248871919632e-11
a O 0 1.7733507717831998e-10
gene O 0 1.8305156002096368e-10
expressed O 0 4.047301382925639e-11
from O 0 2.6165322686289016e-10
human O 0 4.261803410177123e-10
chromosome O 0 2.860618337763299e-07
2p13 O 0 1.8020884908764856e-06
- O 0 3.7028144106443506e-08
p16 O 0 2.2963686063803834e-08
, O 0 6.921845908947066e-12
a O 0 2.155154527061498e-11
region O 0 1.7946044650329895e-09
devoid O 0 6.310457045799467e-09
of O 0 1.1823296508506331e-10
any O 0 3.1444652437429e-10
positional O 0 3.8533375601446096e-08
candidate O 0 5.439841856968997e-07
genes O 0 3.4469422871552524e-08
. O 0 6.318478185107779e-09

Molecular O 0 5.850732875956055e-08
analysis O 0 3.5121422437001115e-10
of O 0 1.0893632662600794e-09
the O 0 7.361868337163457e-10
APC B-Disease 0 7.87548071201627e-09
gene O 0 6.181365141966211e-11
in O 0 2.6048987619708974e-11
205 O 0 2.808430432654774e-10
families O 0 4.377679468925422e-11
: O 0 1.3434186922622882e-11
extended O 0 4.8665032004180375e-09
genotype O 0 4.929565307065786e-07
- O 0 2.8029060672452033e-07
phenotype O 0 5.972128036546565e-08
correlations O 0 5.186864626693932e-08
in O 0 5.244437661922063e-10
FAP B-Disease 0 1.409025784937512e-09
and O 0 4.9743056895756865e-12
evidence O 0 1.3539707549581337e-11
for O 0 1.4201343009542788e-12
the O 0 1.2259526727120829e-11
role O 0 7.400072221663834e-11
of O 0 5.724337670542923e-10
APC B-Disease 0 4.159770750078451e-09
amino O 0 2.3387580760925175e-09
acid O 0 7.598007778497617e-10
changes O 0 3.842815787802323e-10
in O 0 1.905497271081913e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 0 5.313452857080847e-05

BACKGROUND O 0 2.9406735393422423e-06
/ O 0 2.013455969063216e-06
AIMS O 0 1.3805624803353567e-06
The O 0 3.800743275661489e-09
development O 0 8.825104913512405e-08
of O 0 1.2858399713877589e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 5.018426563196954e-09
a O 0 8.360898084980306e-11
variable O 0 4.562769051474902e-10
range O 0 1.140184946457623e-09
of O 0 3.638651879800392e-10
extracolonic O 0 9.080293239094317e-06
manifestations O 0 1.5105317288544029e-05
in O 0 3.875597940350417e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 4.130352504461143e-09
FAP B-Disease 0 7.880995411824188e-09
) O 0 3.328314457807374e-13
is O 0 1.9364663952220473e-13
the O 0 5.548908229603688e-13
result O 0 1.4480231250169062e-11
of O 0 6.409947572727503e-11
the O 0 5.830293192676805e-11
dominant O 0 1.326438070492486e-08
inheritance O 0 4.888660896540387e-06
of O 0 1.2105062523914967e-05
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.999998927116394
coli I-Disease 1 1.0
( O 0 1.1390856258230997e-08
APC B-Disease 0 6.603850977171533e-08
) O 0 3.74906022893029e-10
gene O 0 3.503760392931099e-09
mutations O 0 3.5312868362780137e-07
. O 0 1.1841729019579361e-07

In O 0 1.6322374563060293e-08
this O 0 6.856389900278259e-10
study O 0 1.5864137781207432e-10
, O 0 6.818481326428816e-13
direct O 0 1.4277342329227505e-11
mutation O 0 3.647307803000821e-11
analysis O 0 2.5951638407684108e-11
of O 0 2.7465357765876774e-10
the O 0 2.822419520320807e-10
APC B-Disease 0 3.445441931759774e-09
gene O 0 1.6733928132062204e-10
was O 0 9.240264664533981e-10
performed O 0 3.875656306301378e-12
to O 0 1.6891175957933768e-11
determine O 0 1.4868369035969664e-10
genotype O 0 5.588004281520398e-09
- O 0 1.1928524834559084e-08
phenotype O 0 9.322800309519153e-09
correlations O 0 1.1284204681771826e-08
for O 0 4.128987984852728e-10
nine O 0 1.1384203579822838e-09
extracolonic O 0 1.1025775137341043e-07
manifestations O 0 4.346303583702138e-08
and O 0 9.350424948206815e-12
to O 0 1.9828251887621384e-11
investigate O 0 4.3749830147543634e-11
the O 0 1.6537384309178726e-11
incidence O 0 7.948641744803808e-09
of O 0 1.9651831550948629e-10
APC B-Disease 0 3.224172706595141e-09
mutations O 0 9.104718756702823e-09
in O 0 4.270471531953035e-09
non O 1 0.9997518658638
- O 1 0.9999998807907104
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.488583312602714e-05

METHODS O 0 4.111767793801846e-06
The O 0 6.365486626691563e-08
APC B-Disease 0 3.7682269748984254e-08
gene O 0 2.780607410990399e-10
was O 0 5.786458534551286e-10
analysed O 0 2.0779959697403427e-10
in O 0 5.2400531830310015e-12
190 O 0 1.795603388199396e-10
unrelated O 0 5.091039811944142e-10
FAP B-Disease 0 2.7275659508774197e-09
and O 0 6.435281474370669e-11
15 O 0 9.889078711466937e-08
non O 1 0.5696904063224792
- O 1 0.9999978542327881
FAP O 1 0.9999996423721313
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 2.228346858146324e-07
using O 0 8.037139842542729e-09
denaturing O 0 1.2870823411503807e-06
gradient O 0 5.632961688206706e-07
gel O 0 1.876423461055765e-08
electrophoresis O 0 2.1539692252048326e-09
, O 0 2.0223031582666806e-11
the O 0 2.5959706606570876e-11
protein O 0 4.8480899850211756e-11
truncation O 0 5.574803729757605e-09
test O 0 5.051093432406617e-10
, O 0 2.3454912057713218e-12
and O 0 2.3172546780719783e-12
direct O 0 3.003826742897786e-09
sequencing O 0 4.8488740134189356e-08
. O 0 4.18012611191898e-08

RESULTS O 0 3.6659566831076518e-06
Chain O 0 4.1562913111192756e-08
terminating O 0 4.0665984357701745e-08
signals O 0 1.2550195327420965e-09
were O 0 2.844646740385315e-11
only O 0 5.153650509820418e-12
identified O 0 2.7837477115100207e-11
in O 0 2.824285076641342e-12
patients O 0 6.932415579086193e-12
belonging O 0 2.592309353288691e-11
to O 0 1.6788595513794746e-10
the O 0 6.478239611418246e-10
FAP B-Disease 0 2.731471759886972e-08
group O 0 1.770559254765658e-10
( O 0 1.6530393720515235e-10
105 O 0 2.3525217329734005e-07
patients O 0 8.800711270851025e-09
) O 0 1.187913545308561e-09
. O 0 7.776935717629385e-08

Amino O 0 3.608154202083824e-07
acid O 0 2.8725215539537885e-09
changes O 0 2.3212459732135926e-11
were O 0 8.994393771444287e-12
identified O 0 6.352060804432069e-12
in O 0 2.518784009489239e-12
four O 0 1.9888997133260533e-12
patients O 0 1.3368469525820714e-11
, O 0 1.6357590195553717e-12
three O 0 5.953316832563171e-12
of O 0 1.2848818675692542e-09
whom O 0 1.2449464792396725e-09
belonged O 0 1.2390933612493882e-08
to O 0 8.234591342137776e-10
the O 0 2.7236979338596257e-09
non O 0 2.908144836055726e-07
- O 0 8.512765248269716e-08
FAP O 0 1.2883185718237655e-07
group O 0 3.6511604850630874e-09
of O 0 0.00109015719499439
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999990463256836
. O 0 2.5736157112987712e-05

Genotype O 0 3.851827932521701e-05
- O 0 9.005978540699289e-07
phenotype O 0 6.372751215621975e-08
correlations O 0 2.357875672487353e-08
identified O 0 7.959894965381409e-10
significant O 0 2.1577797881811023e-10
differences O 0 2.9035560622503453e-09
in O 0 7.073950453184707e-11
the O 0 1.327089410585458e-10
nature O 0 9.426139035983994e-11
of O 0 5.968282118518076e-11
certain O 0 3.039198614995797e-10
extracolonic O 0 1.7471072624175576e-06
manifestations O 0 1.8367188658885425e-07
in O 0 4.209942949806589e-10
FAP B-Disease 0 9.311177606718957e-09
patients O 0 5.13266998347639e-11
belonging O 0 1.3471444446078173e-11
to O 0 2.1774054781431573e-10
three O 0 2.006926430597744e-10
mutation O 0 6.373079486365896e-08
subgroups O 0 3.6222587596057565e-07
. O 0 2.4227578165891828e-08

CONCLUSIONS O 0 7.638410352228675e-06
Extended O 0 5.8858113050064276e-08
genotype O 0 2.405457166787528e-07
- O 0 3.145500215850916e-08
phenotype O 0 1.4974313344850998e-08
correlations O 0 9.56991463851864e-09
made O 0 2.6651122975174246e-10
in O 0 3.3246256442298616e-11
this O 0 1.6069725411460567e-11
study O 0 4.85488177437432e-11
may O 0 1.9294828235150163e-10
have O 0 1.3190890220393658e-11
the O 0 4.2876067279928876e-11
potential O 0 4.22682132350527e-11
to O 0 2.2257050369400844e-11
determine O 0 2.4520810382178126e-10
the O 0 2.9111060784181575e-11
most O 0 1.889099553870066e-12
appropriate O 0 4.8767847399266984e-11
surveillance O 0 3.9559922004883674e-10
and O 0 9.209117496356001e-11
prophylactic O 0 8.413759132963605e-06
treatment O 0 1.0870023459119693e-07
regimens O 0 9.612736162623037e-10
for O 0 3.4382939204102847e-12
those O 0 2.2613488772499357e-12
patients O 0 1.2543355026525815e-12
with O 0 1.1721965629055142e-13
mutations O 0 4.4207595917278297e-10
associated O 0 1.1985831216421161e-09
with O 0 2.8671433283111725e-11
life O 0 6.2720104665459075e-09
threatening O 0 7.59765839575266e-07
conditions O 0 0.00013016183220315725
. O 0 5.820901947117818e-07

This O 0 1.896703416548462e-08
study O 0 4.670072106804923e-10
also O 0 9.552206031368526e-13
provided O 0 7.06664761429554e-13
evidence O 0 1.694700456356113e-11
for O 0 1.113393318513678e-11
the O 0 1.690362572137616e-10
pathological O 0 1.1400178436815622e-06
nature O 0 9.130944000901309e-09
of O 0 9.584418592112343e-09
amino O 0 4.688567312172154e-09
acid O 0 5.271384440064253e-10
changes O 0 3.852508589918813e-11
in O 0 3.598598155574173e-11
APC O 0 3.5803289222258172e-09
associated O 0 2.4042820512271135e-10
with O 0 8.791012622716421e-13
both O 0 1.4608394355297705e-11
FAP B-Disease 0 1.0211554268835243e-08
and O 0 2.4163877565541725e-09
non O 1 0.9999371767044067
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.0023993127106223e-05
. O 0 2.7487500275924504e-08
. O 0 4.2658172105802805e-08

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.0010261803399771452
cancer B-Disease 1 1.0
risk O 1 0.8827337026596069
of O 0 4.26825754402671e-05
the O 0 1.5387294070023927e-06
APC O 0 1.2028157243548776e-06
I1307K O 0 8.768694897298701e-06
polymorphism O 0 5.94914524754131e-07
. O 0 6.638985894369398e-08

Germ O 0 0.0002132489753421396
- O 0 1.4655311133537907e-06
line O 0 1.5968440436608944e-07
and O 0 1.1879067729481108e-09
somatic O 0 3.4692888561949076e-08
truncating O 0 1.4201432918525825e-07
mutations O 0 1.548540318196956e-08
of O 0 3.5266771725162016e-09
the O 0 7.256626965990165e-10
APC B-Disease 0 4.0920937749433506e-09
gene O 0 3.937571380063787e-10
are O 0 4.493216129025646e-12
thought O 0 2.3123683523529337e-11
to O 0 2.1988319498511544e-10
initiate O 0 2.748619749581849e-07
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999949932098389
formation O 0 1.740561674523633e-05
in O 0 3.3176547731272876e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.0567875253618695e-05
sporadic O 1 0.9991942048072815
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 2.3233982915371598e-07
respectively O 0 6.151957450128975e-07
. O 0 1.637886128946775e-07

Recently O 0 1.4346750276672537e-06
, O 0 6.354760717641739e-09
an O 0 3.6002427705739137e-09
isoleucine O 0 9.357716407976113e-06
- O 0 1.62821913818334e-06
- O 0 8.746727644393104e-07
> O 0 6.916117172295344e-07
lysine O 0 4.0126496969605796e-07
polymorphism O 0 7.710115212944402e-09
at O 0 5.172634764960549e-09
codon O 0 2.8196442958261514e-09
1307 O 0 2.8782652705672263e-08
( O 0 1.468032639895256e-10
I1307K O 0 1.1328427973467114e-07
) O 0 1.059905722217147e-11
of O 0 1.6568207916733968e-10
the O 0 1.8984169791735894e-10
APC B-Disease 0 3.6669820513424156e-09
gene O 0 9.267581840832761e-11
has O 0 6.2584017829214744e-12
been O 0 4.3679435068888495e-12
identified O 0 4.412390158109458e-12
in O 0 2.2722613721160023e-12
6 O 0 7.061363160865142e-10
% O 0 2.839617430083763e-10
- O 0 4.137557241268297e-10
7 O 0 8.769460713153876e-09
% O 0 2.0965520985960495e-10
of O 0 5.093980445791679e-11
the O 0 7.213746960887946e-11
Ashkenazi O 0 1.0887115209357034e-08
Jewish O 0 3.310921981025672e-09
population O 0 5.506319705750329e-11
. O 0 1.920884118433719e-09

To O 0 2.31982433263056e-08
assess O 0 9.750592511181821e-08
the O 0 1.235390123532909e-09
risk O 0 1.670546545540219e-08
of O 0 3.6072106412987637e-10
this O 0 2.5889937763090565e-11
common O 0 1.7116585926402195e-10
APC B-Disease 0 5.226724830720286e-09
allelic O 0 6.740342950450895e-09
variant O 0 3.246921664867841e-08
in O 0 9.436459436074074e-08
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 1.3886476608604426e-06
we O 0 5.157289351132022e-08
have O 0 1.0587929838434817e-10
analyzed O 0 1.4536163939204982e-10
a O 0 1.756163096888752e-11
large O 0 3.9511938859648765e-11
cohort O 0 1.2711072194804274e-09
of O 0 9.110598386818936e-11
unselected O 0 4.5278056859388016e-07
Ashkenazi O 0 6.763874438320272e-08
Jewish O 0 4.876919756924281e-09
subjects O 0 2.2066435345635682e-09
with O 0 1.9865994266288212e-11
adenomatous B-Disease 0 3.529765535859042e-06
polyps I-Disease 0 8.082845397439087e-07
and O 0 1.762829049400949e-10
. O 0 1.6202390540343004e-09
or O 1 0.9999912977218628
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 5.7343971349155254e-08
for O 0 1.4435408424162688e-09
the O 0 2.65791157971762e-08
APC O 0 1.1152680201576004e-07
I1307K O 0 2.063410420305445e-06
polymorphism O 0 4.4515977037917764e-07
. O 0 6.844584277132526e-08

The O 0 3.6428224348128424e-07
APC O 0 2.095619180408903e-07
I1307K O 0 5.660220949721406e-07
allele O 0 1.0336774103336666e-08
was O 0 2.175891244959871e-09
identified O 0 1.1082074147239496e-10
in O 0 4.0382950455830624e-11
48 O 0 4.115796148340678e-09
( O 0 3.5039571938400016e-11
10 O 0 9.113992893716727e-10
. O 0 2.5545201370880122e-11
1 O 0 2.340160243363698e-08
% O 0 1.2383060132847845e-09
) O 0 2.529203062262564e-11
of O 0 9.464371508727254e-10
476 O 0 4.574563661208231e-08
patients O 0 6.835527255333318e-09
. O 0 1.7413796626897238e-08

Compared O 0 1.9582778065796447e-08
with O 0 5.0232266263217085e-12
the O 0 4.512422380198444e-11
frequency O 0 7.180365746428663e-10
in O 0 3.086956038012012e-12
two O 0 1.4758070525193456e-13
separate O 0 2.6552092230631985e-13
population O 0 2.727336585739426e-13
control O 0 1.874832233905721e-11
groups O 0 1.9309829343144846e-12
, O 0 2.3418970755695323e-12
the O 0 4.144118728732771e-11
APC O 0 1.9767327774644627e-09
I1307K O 0 1.5325412050515297e-08
allele O 0 8.870221779311294e-10
is O 0 1.7124210036079113e-12
associated O 0 5.415407705600117e-13
with O 0 6.6713064549907015e-15
an O 0 2.184323820994885e-13
estimated O 0 3.199200973580396e-11
relative O 0 3.5728320302297334e-09
risk O 0 2.7789456069626794e-08
of O 0 7.532490542416781e-08
1 O 0 8.786614489508793e-05
. O 0 4.0540109580433636e-07

5 O 0 2.7577476430451497e-05
- O 0 5.685415999323595e-06
1 O 0 1.675032399361953e-05
. O 0 3.2838428865034075e-07

7 O 0 1.1212972822249867e-05
for O 0 1.884515654637653e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9982216954231262
( O 0 1.140920868891726e-08
both O 0 2.9136545620644938e-08
P O 0 0.0016459791222587228
= O 0 2.9252925415335085e-08
. O 0 3.62961993793931e-10
01 O 0 8.511982230174908e-09
) O 0 2.4479407390032293e-10
. O 0 9.632250552726873e-09

Furthermore O 0 1.1337576779624214e-06
, O 0 1.8841905813360427e-09
compared O 0 2.146275601688785e-09
with O 0 5.532279842568322e-11
noncarriers O 0 1.638339199416805e-05
, O 0 7.856306716291783e-09
APC O 0 1.6453633122637257e-07
I1307K O 0 5.392707862483803e-07
carriers O 0 1.3022978528898221e-10
had O 0 1.8564504100648804e-10
increased O 0 8.131390005772232e-11
numbers O 0 6.060530983315049e-12
of O 0 1.991042469784432e-10
adenomas B-Disease 0 0.00011353991430951282
and O 0 2.6191021333943354e-06
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 0.00011902947881026193
patient O 0 1.952424554474419e-06
( O 0 7.806190138737179e-10
P O 0 1.5331077520386316e-05
= O 0 2.659152675832388e-09
. O 0 3.2626977508609656e-11
03 O 0 3.580641338984947e-10
) O 0 6.762842456181639e-12
, O 0 5.334737859796768e-12
as O 0 4.817116757566131e-12
well O 0 2.3182890069445294e-12
as O 0 2.4626240716779657e-12
a O 0 4.107604534286935e-11
younger O 0 2.0333738859346084e-10
age O 0 7.798633738786975e-09
at O 0 2.5984219220731575e-08
diagnosis O 0 2.779502665362088e-06
. O 0 6.721499090645011e-08

We O 0 2.8307960064921645e-07
conclude O 0 6.342654046420648e-07
that O 0 3.528101699679098e-10
the O 0 1.0834307895279949e-09
APC O 0 3.4752094535406286e-08
I1307K O 0 3.1054202054292546e-07
variant O 0 1.3427238876317915e-08
leads O 0 1.788358239274146e-09
to O 0 2.1291009233426195e-10
increased O 0 1.0803359984379313e-08
adenoma B-Disease 1 1.0
formation O 0 1.182216806228098e-06
and O 0 5.290987092898547e-10
directly O 0 1.0275909012591455e-09
contributes O 0 1.3479675708971683e-10
to O 0 9.994533672896821e-11
3 O 0 9.071433049179234e-10
% O 0 1.1044555547901069e-10
- O 0 3.592604339019978e-11
4 O 0 2.7628549448266426e-10
% O 0 2.087063334654804e-11
of O 0 4.3789299443430796e-12
all O 0 4.947414439931963e-12
Ashkenazi O 0 7.109236577207412e-08
Jewish O 0 3.3945703762583435e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.971531547605991e-07

The O 0 2.652275377101887e-08
estimated O 0 8.149253716283056e-09
relative O 0 1.0929334592901796e-07
risk O 0 1.5178359902279226e-08
for O 0 3.0883826745986553e-11
carriers O 0 7.561456322191518e-11
may O 0 1.1864055293742126e-09
justify O 0 2.7434481353338924e-09
specific O 0 8.47300146711305e-11
clinical O 0 7.955899133937905e-11
screening O 0 3.7781309331075263e-11
for O 0 4.477850815837181e-12
the O 0 4.042348747401725e-11
360 O 0 7.802870016782038e-10
, O 0 3.5562733313732053e-11
000 O 0 6.171637090268689e-10
Americans O 0 8.580366452071164e-12
expected O 0 5.408685166408134e-10
to O 0 3.084057453861533e-10
harbor O 0 8.753969105157466e-09
this O 0 2.92987266392597e-11
allele O 0 2.8924665440577257e-10
, O 0 4.434385150742237e-12
and O 0 2.662833278530008e-12
genetic O 0 5.22446738648874e-11
testing O 0 1.099205275412185e-11
in O 0 7.82005211454051e-13
the O 0 5.132902349685997e-12
setting O 0 2.1172112674161525e-10
of O 0 3.529326553231016e-10
long O 0 4.253797758480005e-09
- O 0 3.5817379284708295e-08
term O 0 2.991626615767018e-06
- O 0 9.47971869891262e-08
outcome O 0 5.907399440729932e-07
studies O 0 1.546835576293759e-10
may O 0 1.8336422658027374e-11
impact O 0 2.2367796503885984e-10
significantly O 0 2.1842490038892493e-09
on O 0 1.0252643733110745e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 1.7670979559625266e-06
in O 0 2.285532874068963e-11
this O 0 1.3552781293058036e-11
population O 0 3.672367965279477e-11
. O 0 1.1534534438695232e-09

Localization O 0 1.0004090654547326e-05
of O 0 3.3574107760614424e-07
human O 0 3.192877784385928e-08
BRCA1 O 0 1.4320433194825455e-07
and O 0 6.106879585354719e-11
its O 0 2.720766667518859e-11
loss O 0 2.548593835971502e-10
in O 0 3.20640944351247e-11
high O 0 1.009253267625354e-07
- O 0 8.119499028680366e-08
grade O 0 1.948864337464329e-05
, O 0 4.0690095737261345e-09
non B-Disease 1 0.5079812407493591
- I-Disease 1 0.999884843826294
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.008735580369830132

Although O 0 5.8051665696723376e-09
the O 0 4.803414332954503e-10
link O 0 1.4062576658702142e-09
between O 0 3.704267559356822e-09
the O 0 4.8798227680890705e-09
BRCA1 O 0 1.549492338881464e-07
tumour B-Disease 1 1.0
- O 0 1.1103391095446113e-08
suppressor O 0 2.5692713734315475e-08
gene O 0 4.3340719901863167e-10
and O 0 2.6307389600077613e-10
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 3.271788955316879e-07
established O 0 6.616326930775074e-10
, O 0 1.7458957456834012e-12
the O 0 5.618304866478185e-12
role O 0 3.0315434190741897e-11
, O 0 6.274198825415023e-13
if O 0 1.0211168716134367e-11
any O 0 1.4377120327591086e-10
, O 0 8.197912834684296e-12
of O 0 2.2587128001294587e-10
BRCA1 O 0 3.379111745971386e-08
in O 0 6.8016094978418096e-09
non B-Disease 0 0.038227979093790054
- I-Disease 1 0.9979281425476074
familial I-Disease 1 1.0
cancers I-Disease 1 1.0
is O 0 1.4063608944070438e-07
unclear O 0 6.898160904711403e-07
. O 0 3.7327886559523904e-08

BRCA1 O 0 2.369215144426562e-05
mutations O 0 1.2592062148542027e-06
are O 0 1.905356566966887e-10
rare O 0 5.488915988394183e-10
in O 0 8.949072594077734e-10
sporadic B-Disease 0 0.08988786488771439
cancers I-Disease 1 1.0
, O 0 5.0847756227767604e-08
but O 0 2.337323401491176e-08
loss O 0 2.2844997715765203e-07
of O 0 9.388614330418932e-08
BRCA1 O 0 2.6584844547983266e-08
resulting O 0 5.589742002598541e-09
from O 0 3.156278571836424e-10
reduced O 0 2.470460946923936e-09
expression O 0 1.0727519567099719e-10
or O 0 1.1094678648015943e-10
incorrect O 0 7.643546906521692e-10
subcellular O 0 5.8151982784693246e-08
localization O 0 4.057146796299094e-08
is O 0 3.5278575200026197e-11
postulated O 0 7.057552875444628e-10
to O 0 2.232729105766662e-11
be O 0 1.89343297984923e-11
important O 0 1.9792433317289415e-11
in O 0 4.8422769266531773e-11
non B-Disease 0 7.184193577813858e-07
- I-Disease 0 3.977813321398571e-06
familial I-Disease 1 0.9999951124191284
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9787912368774414

Epigenetic O 1 0.5477750301361084
loss O 1 0.528948187828064
, O 0 1.179510888960067e-08
however O 0 1.0773975489541954e-08
, O 0 3.1964136198991966e-11
has O 0 2.3767084220832624e-12
not O 0 1.4987997822013543e-12
received O 0 4.874039106345096e-12
general O 0 1.6997513119232366e-10
acceptance O 0 1.5635214234421824e-09
due O 0 1.4224361244430384e-08
to O 0 5.704957617425066e-10
controversy O 0 6.374836769573733e-10
regarding O 0 7.457717776659933e-10
the O 0 1.374873687121081e-10
subcellular O 0 4.576536127842701e-08
localization O 0 4.5185270636238783e-08
of O 0 5.520016888027612e-09
BRCA1 O 0 5.066437491763054e-09
proteins O 0 1.5953613430319535e-11
, O 0 1.1280308284677965e-12
reports O 0 1.4292375876551189e-12
of O 0 7.750709796194855e-12
which O 0 1.7319324143241777e-12
have O 0 5.1036930757975e-12
ranged O 0 1.7469643509571142e-09
from O 0 2.04358793776116e-10
exclusively O 0 9.740745710029586e-11
nuclear O 0 5.390378419178887e-07
, O 0 1.3965301137730535e-10
to O 0 9.521951005453388e-10
conditionally O 0 2.3368603763174178e-07
nuclear O 0 4.340498890087474e-06
, O 0 3.5742955817319455e-10
to O 0 4.540225972959888e-09
the O 0 2.5490338728673123e-08
ER O 0 2.916059020208195e-05
/ O 0 6.842058155598352e-07
golgi O 0 1.172567181129125e-06
, O 0 2.910252316912221e-10
to O 0 8.517727634327343e-10
cytoplasmic O 0 5.942585445950499e-08
invaginations O 0 2.1460070342982362e-07
into O 0 2.2606838623318026e-09
the O 0 1.4220229438421939e-09
nucleus O 0 6.365486626691563e-08
. O 0 1.80882562261786e-08

In O 0 1.214341693867027e-08
an O 0 1.6481342679508515e-10
attempt O 0 9.925375188402086e-09
to O 0 2.2269641686278874e-09
resolve O 0 2.5412094828425325e-07
this O 0 8.330021672442456e-10
issue O 0 4.034051670487315e-08
, O 0 2.3662441450689187e-10
we O 0 5.268731007035399e-10
have O 0 3.398024223111307e-11
comprehensively O 0 3.037439810782416e-08
characterized O 0 2.4281552324367794e-09
19 O 0 3.006889315315675e-08
anti O 0 1.266835312208059e-07
- O 0 3.8424903436862223e-07
BRCA1 O 0 5.5805084997473386e-08
antibodies O 0 2.4697980549603926e-08
. O 0 1.876029820380154e-08

These O 0 7.619769348821137e-08
reagents O 0 1.767949839859284e-07
detect O 0 6.241069172574498e-07
a O 0 2.1380110126756335e-08
220 O 0 3.185517627457557e-08
- O 0 3.1152765700426244e-08
kD O 0 1.9039023868572258e-07
protein O 0 6.128040297426196e-09
localized O 0 2.0778513132313492e-08
in O 0 3.523125402526972e-10
discrete O 0 8.12805183159071e-08
nuclear O 0 8.203501238313038e-06
foci O 0 7.910438739600067e-07
in O 0 3.6051470142517417e-10
all O 0 1.613629091457014e-10
epithelial O 0 3.6795107405396266e-08
cell O 0 5.505383171566791e-08
lines O 0 8.616373170511338e-10
, O 0 4.368418821121267e-12
including O 0 5.881105606848902e-13
those O 0 3.462287748168258e-12
derived O 0 1.8565424197980462e-10
from O 0 1.3997797587705918e-08
breast B-Disease 0 5.045166290074121e-06
malignancies I-Disease 0 1.9301847714814357e-05
. O 0 3.7866249158469145e-07

Immunohistochemical O 0 1.0205263606621884e-05
staining O 0 5.2675081860797945e-06
of O 0 1.2223727026139386e-06
human O 0 3.184871104622289e-07
breast O 0 6.641247637162451e-06
specimens O 0 4.285289012528892e-09
also O 0 4.696781852331355e-10
revealed O 0 7.102351418097896e-08
BRCA1 O 0 1.5622039200025029e-06
nuclear O 0 0.0018931716913357377
foci O 0 4.8512967623537406e-05
in O 0 1.2027975948569747e-08
benign O 1 0.9999991655349731
breast O 1 1.0
, O 0 7.749614496788126e-07
invasive B-Disease 1 0.9999864101409912
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.014574945904314518
low B-Disease 1 1.0
- I-Disease 1 1.0
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.0003097626322414726

Conversely O 0 2.494069804015453e-06
, O 0 1.4199766917855072e-09
BRCA1 O 0 5.3907265318287045e-09
expression O 0 2.853070557584658e-10
was O 0 3.197482001393581e-10
reduced O 0 1.2383431780005338e-10
or O 0 4.630952912809683e-11
undetectable O 0 8.707520815498526e-10
in O 0 4.0007654307505636e-12
the O 0 6.7528664951521655e-12
majority O 0 1.0417214833802202e-11
of O 0 4.1495148983550223e-10
high O 0 7.263750489983067e-07
- O 0 1.565475577081088e-05
grade O 0 0.002284982707351446
, O 0 8.408423468608817e-08
ductal B-Disease 1 0.9999994039535522
carcinomas I-Disease 1 1.0
, O 0 1.6455469209475382e-09
suggesting O 0 2.2641315489124736e-09
that O 0 1.221122647443451e-10
absence O 0 1.567439689154071e-08
of O 0 1.1770926455767494e-08
BRCA1 O 0 4.764748240404515e-08
may O 0 1.3287466682498916e-09
contribute O 0 3.818645955000477e-10
to O 0 4.5947329274653725e-10
the O 0 3.5838390588516233e-10
pathogenesis O 0 5.938053249110453e-08
of O 0 1.0415968088040017e-10
a O 0 1.6463363658458796e-11
significant O 0 1.32241509409603e-10
percentage O 0 7.429496129418567e-09
of O 0 2.982418312313939e-09
sporadic B-Disease 0 0.0003141844645142555
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 1.881964863059693e-06
. O 0 8.95577159099048e-07

